{"BGC0000254.1|Oxytetracycline_1 # 173 # 625 # 1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.755": {"gnl|BL_ORD_ID|2738|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 173, "orf_end": 625, "orf_from": "BGC0000254.1|Oxytetracycline_1 ", "model_name": "ERP-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "3582", "ARO_accession": "3004782", "ARO_name": "ERP-1", "ARO_category": {"42897": {"category_aro_accession": "3004781", "category_aro_cvterm_id": "42897", "category_aro_name": "ERP beta-lactamase", "category_aro_description": "ERP is a class A beta-lactamase gene family found in Erwinia persicina.", "category_aro_class_name": "AMR Gene Family"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.76724, "max_identities": 16, "bit_score": 24.6386, "cvterm_id": "42899", "query": "LREGDSLTAHAGLTSARWQVAGLLLSGPSTVARLARERG", "match": "L+  D+L A+  LT         LL GP++V RLAR  G", "sequence_from_db": "LQYSDNLAANVLLT---------LLGGPASVTRLARSLG", "sequence_from_broadstreet": "MTILLQRRQLLVAGAALALTASLTPLNVFAAGDSLQRQLAALETEVNGRIGLSLIDSASQQAWSYRGDERFPLCSTFKLLLVAAVLKRSESQPALMQQTLHWTPADHLSYMPVTAKHPQGMTVSDLCAAALQYSDNLAANVLLTLLGGPASVTRLARSLGDSVTQLDRNEPTLNTAIPGDPRDTTTPLHMSHSVQQLLVKSGLQTAQQQQLIAWLKGNTTGKNAIAAALPAGWEIGDKTGSGGYGTTNDVAILWPPGKAPLILAIYFTQHAPEAKSRQDVLAKAAAIALKSVI", "dna_sequence_from_broadstreet": "ATGACGATTTTACTGCAACGCCGCCAGCTTCTGGTGGCGGGCGCGGCGCTGGCGCTGACCGCCTCGCTGACACCACTGAACGTATTTGCAGCAGGTGACTCGCTGCAGCGGCAGCTTGCCGCACTGGAAACGGAGGTGAATGGCCGTATCGGGCTGTCTCTGATCGACAGCGCCAGCCAGCAGGCGTGGAGCTATCGCGGTGACGAACGCTTTCCGCTGTGCAGCACCTTTAAACTGCTGCTGGTGGCTGCCGTTTTAAAACGCAGCGAGTCACAGCCCGCCCTGATGCAACAAACCCTGCACTGGACACCTGCGGATCACCTGAGCTATATGCCGGTAACGGCGAAGCATCCGCAGGGGATGACCGTCAGCGATCTGTGTGCAGCCGCGCTGCAGTACAGTGATAACCTGGCGGCCAACGTACTGTTGACACTGCTGGGGGGACCCGCGTCGGTGACCCGGCTGGCCCGCTCTTTAGGTGACAGTGTCACGCAGCTCGATCGTAATGAACCGACACTGAATACCGCGATCCCGGGCGATCCGCGTGACACCACCACGCCGCTGCACATGTCGCACAGCGTGCAGCAGTTGCTGGTGAAGTCGGGATTACAGACAGCACAGCAGCAGCAGCTGATCGCCTGGCTGAAGGGGAACACCACAGGGAAAAACGCCATTGCCGCAGCGCTGCCTGCGGGCTGGGAAATCGGGGATAAGACCGGCAGCGGGGGCTATGGCACAACCAACGATGTCGCCATCCTCTGGCCTCCGGGCAAGGCTCCGCTGATCCTGGCCATCTATTTTACCCAGCATGCCCCGGAGGCGAAGAGTCGTCAGGACGTGCTGGCGAAAGCGGCCGCCATTGCACTGAAATCTGTTATCTGA", "partial": "0", "query_start": 209, "query_end": 325, "hit_start": 390, "hit_end": 480, "orf_dna_sequence": "GTGACCGCCGAGGTCTTCGCGGTCAACGGCCGCCTGCTCCGCGAAGGCGACAGCCTCACCGCCCACGCGGGGCTGACCTCGGCGCGCTGGCAGGTGGCCGGACTGCTGCTGAGCGGCCCCTCGACGGTCGCCCGCCTGGCCCGCGAGCGGGGGCTGCGGCGGCAGGCGGTCCAGCAGACCGTCGAGCGGCTGAAGGCCGAGGGCGTCGTCACGACCCGGCCCAACCCGCAGGACCAGCGCAGCCCCCTGGTCGAGCTCACCGCACGCGGCCGGCAGGCGCTGGACGACCTGCGTCCCCTGGAACGGCGGTGGCTGGAGTATCTGGCCGAGGACATTCCGGTCGAGGACATGCGCGTGGCGATCGCGGTGCTGAGCCGCCTGCGGGAGAAGCTGGACGCCCGTCCGGCGACGGAGTTCGGGACCGGGGCCGGGTCCGGGCGGCAGTCCGCCTGA", "orf_prot_sequence": "MTAEVFAVNGRLLREGDSLTAHAGLTSARWQVAGLLLSGPSTVARLARERGLRRQAVQQTVERLKAEGVVTTRPNPQDQRSPLVELTARGRQALDDLRPLERRWLEYLAEDIPVEDMRVAIAVLSRLREKLDARPATEFGTGAGSGRQSA", "perc_identity": 41.03}, "gnl|BL_ORD_ID|1907|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 173, "orf_end": 625, "orf_from": "BGC0000254.1|Oxytetracycline_1 ", "model_name": "patA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "2081", "ARO_accession": "3000024", "ARO_name": "patA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.30863, "max_identities": 12, "bit_score": 24.6386, "cvterm_id": "40078", "query": "LTAHAGLTSARWQVAGLLLSGPSTVARLARERGLRRQAVQQTV", "match": "L  +  +  + W VAG++ S PS V  +A       Q +   V", "sequence_from_db": "LVGYGAVFLSIWLVAGMVQSDPSVVGSIASFVNYLSQIIFTIV", "sequence_from_broadstreet": "MLIQKIKTYKWQALASLLMTGLMVASSLLQPRYLQEVLGALLTGKYEAIYSIGAWLIGVAVVGLVAGGLNVVLAAYIAQGVSSDLREDAFRKIQTFSYADIEQFNAGNLVVRMTNDINQIQNVVMMTFQILFRLPLLFIGSFILAVQTLPSLWWVIVLMVVLIFGLTAVMMGMMGPRFAKFQTLLERINAIAKENLRGVRVVKSFVQEKEQFAKFTEVSDELLGQNLYIGYAFSVVEPFMMLVGYGAVFLSIWLVAGMVQSDPSVVGSIASFVNYLSQIIFTIVMVGFLGNSVSRAMISMRRIREILDAEPAMTFKDIPDEELVGSLSFENVTFTYPMDKEPMLKDVSFTIEPGQMVGVVGATGAGKSTLAQLIPRLFDPQDGAIKIGGKDIREVSEGTLRKTVSIVLQRAILFSGTIADNLRQGKGNATLFEMERAANIAQASEFIHRMEKTFESPVEERGTNFSGGQKQRMSIARGIVSNPRILIFDDSTSALDAKSERLVQEALNKDLKGTTTIIIAQKISSVVHADKILVLNQGRLIGQGTHADLVANNAVYREIYETQK", "dna_sequence_from_broadstreet": "ATGCTGATTCAGAAAATAAAAACCTACAAGTGGCAGGCCCTGGCTTCGCTCCTGATGACAGGCTTGATGGTTGCTAGTTCACTTCTGCAACCGCGTTATCTGCAGGAAGTCTTAGGCGCCCTCCTTACTGGGAAATATGAAGCTATTTATAGTATCGGGGCTTGGTTGATTGGTGTGGCCGTAGTCGGTCTAGTTGCTGGTGGACTCAATGTTGTCCTCGCAGCCTATATTGCCCAAGGAGTTTCATCCGACCTTCGGGAGGATGCCTTCCGTAAAATTCAAACCTTTTCTTATGCTGATATTGAACAATTTAATGCGGGAAATCTAGTCGTTCGAATGACAAATGATATCAACCAGATTCAGAACGTTGTCATGATGACCTTCCAAATTCTTTTCAGACTTCCCCTCTTGTTCATCGGTTCGTTTATCCTAGCGGTTCAAACCTTACCTTCTCTGTGGTGGGTGATTGTTCTCATGGTAGTCTTGATTTTTGGTTTGACTGCTGTCATGATGGGAATGATGGGGCCTCGTTTTGCCAAGTTTCAAACCCTTCTTGAGCGCATCAATGCCATTGCCAAGGAAAATTTACGTGGCGTTCGTGTGGTCAAGTCCTTTGTCCAAGAAAAAGAGCAATTTGCTAAGTTTACAGAGGTCTCAGACGAGCTTCTTGGTCAAAACCTTTACATTGGTTATGCCTTTTCAGTAGTGGAACCCTTTATGATGTTGGTTGGTTACGGGGCGGTCTTCCTCTCTATTTGGCTGGTCGCGGGAATGGTTCAGTCGGATCCGTCTGTTGTTGGTTCCATCGCTTCTTTTGTTAATTACCTAAGCCAGATTATCTTTACCATTGTTATGGTTGGATTTTTGGGAAATTCTGTCAGCCGTGCCATGATTTCCATGCGTCGTATTCGAGAAATTCTTGACGCAGAGCCAGCTATGACCTTCAAGGATATCCCAGATGAAGAGTTGGTTGGAAGTCTTAGCTTTGAAAATGTGACCTTTACCTATCCAATGGACAAGGAACCGATGCTGAAAGATGTGAGCTTTACTATTGAACCTGGTCAAATGGTTGGTGTAGTTGGAGCGACTGGTGCAGGAAAGTCAACCTTGGCTCAATTGATTCCACGTCTCTTTGATCCACAGGACGGGGCCATTAAAATCGGTGGCAAGGATATTCGAGAAGTGAGTGAAGGAACCCTGCGTAAAACAGTTTCCATCGTTCTCCAACGTGCCATTCTTTTTAGTGGAACGATTGCAGATAACTTGAGACAGGGGAAGGGGAATGCTACTCTATTTGAAATGGAGCGCGCAGCCAATATTGCCCAGGCTAGTGAATTCATTCATCGTATGGAGAAAACCTTTGAAAGTCCAGTTGAAGAACGGGGAACCAATTTCTCTGGTGGACAAAAACAAAGGATGTCGATTGCGCGTGGGATTGTCAGCAATCCACGTATTCTGATTTTTGATGATTCGACCTCAGCCTTGGATGCCAAATCAGAGCGCTTGGTGCAAGAAGCTTTGAATAAGGACTTGAAGGGGACGACAACCATTATTATTGCTCAAAAAATTAGCTCGGTTGTCCATGCAGACAAGATCTTGGTTCTAAATCAAGGACGATTGATTGGTCAAGGTACGCATGCAGACTTGGTTGCCAACAATGCCGTTTACCGTGAAATCTATGAAACACAGAAATGA", "partial": "0", "query_start": 227, "query_end": 355, "hit_start": 723, "hit_end": 852, "orf_dna_sequence": "GTGACCGCCGAGGTCTTCGCGGTCAACGGCCGCCTGCTCCGCGAAGGCGACAGCCTCACCGCCCACGCGGGGCTGACCTCGGCGCGCTGGCAGGTGGCCGGACTGCTGCTGAGCGGCCCCTCGACGGTCGCCCGCCTGGCCCGCGAGCGGGGGCTGCGGCGGCAGGCGGTCCAGCAGACCGTCGAGCGGCTGAAGGCCGAGGGCGTCGTCACGACCCGGCCCAACCCGCAGGACCAGCGCAGCCCCCTGGTCGAGCTCACCGCACGCGGCCGGCAGGCGCTGGACGACCTGCGTCCCCTGGAACGGCGGTGGCTGGAGTATCTGGCCGAGGACATTCCGGTCGAGGACATGCGCGTGGCGATCGCGGTGCTGAGCCGCCTGCGGGAGAAGCTGGACGCCCGTCCGGCGACGGAGTTCGGGACCGGGGCCGGGTCCGGGCGGCAGTCCGCCTGA", "orf_prot_sequence": "MTAEVFAVNGRLLREGDSLTAHAGLTSARWQVAGLLLSGPSTVARLARERGLRRQAVQQTVERLKAEGVVTTRPNPQDQRSPLVELTARGRQALDDLRPLERRWLEYLAEDIPVEDMRVAIAVLSRLREKLDARPATEFGTGAGSGRQSA", "perc_identity": 27.91}, "gnl|BL_ORD_ID|455|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 173, "orf_end": 625, "orf_from": "BGC0000254.1|Oxytetracycline_1 ", "model_name": "vanR gene in vanL cluster", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "409", "ARO_accession": "3002927", "ARO_name": "vanR gene in vanL cluster", "ARO_category": {"36373": {"category_aro_accession": "3000234", "category_aro_cvterm_id": "36373", "category_aro_name": "glycopeptide resistance gene cluster", "category_aro_description": "Genes that when expressed confer resistance to vancomycin and teicoplanin type antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36713": {"category_aro_accession": "3000574", "category_aro_cvterm_id": "36713", "category_aro_name": "vanR", "category_aro_description": "VanR is a OmpR-family transcriptional activator in the VanSR regulatory system. When activated by VanS, it promotes cotranscription of VanA, VanH, and VanX.", "category_aro_class_name": "AMR Gene Family"}, "35947": {"category_aro_accession": "0000028", "category_aro_cvterm_id": "35947", "category_aro_name": "vancomycin", "category_aro_description": "Vancomycin is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. Vancomycin inhibits the synthesis of peptidoglycan, the major component of the cell wall of gram-positive bacteria. Its mechanism of action is unusual in that it acts by binding precursors of peptidoglycan, rather than by interacting with an enzyme.", "category_aro_class_name": "Antibiotic"}, "36220": {"category_aro_accession": "3000081", "category_aro_cvterm_id": "36220", "category_aro_name": "glycopeptide antibiotic", "category_aro_description": "Glycopeptide antibiotics are natural products produced non-ribosomally by Actinomycetales bacteria. With the exception of bleomycins, they act by binding the terminal D-Ala-D-Ala in peptidoglycan precursors of the growing bacterial cell wall and are generally active against Gram-positive bacteria.  This inhibits transglycosylation leading to cell death due to osmotic stress.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.0925, "max_identities": 10, "bit_score": 23.8682, "cvterm_id": "35918", "query": "VEDMRVAIAVLSRLREKLDARP", "match": "+E+    +A ++RLREKLD +P", "sequence_from_db": "LENNNTIMAHIARLREKLDEQP", "sequence_from_broadstreet": "MTDRIVVVDDEQEIANLITTFLENEGFQVTTFYKGEDFLTYIARESISLAILDVMLPDIDGFRILQEIRKNFYFPVLMLTAKEENMDKIMGLTLGADDYITKPFNPIEVVARVKTQLRRVQKYNRKVENESVIEFNKDGLTLKKDSHQVFLFDKEITVTPIEFNLLLYLFEHQGVVVSSEELFEAVWKEKYLENNNTIMAHIARLREKLDEQPRKPKFIKTVWGVGYIIEK", "dna_sequence_from_broadstreet": "ATGACGGATAGAATAGTTGTTGTGGATGATGAACAAGAGATAGCCAATTTGATTACAACTTTTTTAGAAAATGAAGGGTTTCAAGTAACAACCTTTTATAAAGGAGAAGATTTTTTGACTTATATAGCTAGAGAGTCAATTTCTTTAGCTATATTAGATGTCATGCTACCTGATATTGATGGGTTTCGAATCTTGCAAGAAATTAGAAAGAATTTTTATTTTCCGGTATTAATGCTTACAGCTAAGGAAGAAAATATGGACAAGATTATGGGACTAACCTTGGGAGCGGATGATTATATTACTAAACCATTTAACCCAATAGAAGTAGTTGCCCGGGTAAAAACACAACTAAGACGAGTCCAAAAGTATAACCGGAAAGTGGAAAATGAATCAGTCATAGAGTTTAACAAAGACGGACTAACGCTAAAAAAAGACAGTCATCAAGTATTTTTATTTGATAAAGAAATAACTGTAACACCTATTGAATTCAATTTGCTTTTATATTTATTTGAACACCAAGGAGTGGTTGTTAGTTCAGAAGAACTATTTGAAGCTGTTTGGAAAGAGAAATATTTAGAAAATAATAACACAATCATGGCACACATTGCTCGCTTAAGGGAAAAATTAGACGAACAGCCACGCAAACCTAAATTCATAAAAACCGTATGGGGGGTAGGATATATTATTGAAAAGTAA", "partial": "0", "query_start": 512, "query_end": 577, "hit_start": 573, "hit_end": 639, "orf_dna_sequence": "GTGACCGCCGAGGTCTTCGCGGTCAACGGCCGCCTGCTCCGCGAAGGCGACAGCCTCACCGCCCACGCGGGGCTGACCTCGGCGCGCTGGCAGGTGGCCGGACTGCTGCTGAGCGGCCCCTCGACGGTCGCCCGCCTGGCCCGCGAGCGGGGGCTGCGGCGGCAGGCGGTCCAGCAGACCGTCGAGCGGCTGAAGGCCGAGGGCGTCGTCACGACCCGGCCCAACCCGCAGGACCAGCGCAGCCCCCTGGTCGAGCTCACCGCACGCGGCCGGCAGGCGCTGGACGACCTGCGTCCCCTGGAACGGCGGTGGCTGGAGTATCTGGCCGAGGACATTCCGGTCGAGGACATGCGCGTGGCGATCGCGGTGCTGAGCCGCCTGCGGGAGAAGCTGGACGCCCGTCCGGCGACGGAGTTCGGGACCGGGGCCGGGTCCGGGCGGCAGTCCGCCTGA", "orf_prot_sequence": "MTAEVFAVNGRLLREGDSLTAHAGLTSARWQVAGLLLSGPSTVARLARERGLRRQAVQQTVERLKAEGVVTTRPNPQDQRSPLVELTARGRQALDDLRPLERRWLEYLAEDIPVEDMRVAIAVLSRLREKLDARPATEFGTGAGSGRQSA", "perc_identity": 45.45}, "gnl|BL_ORD_ID|1012|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 173, "orf_end": 625, "orf_from": "BGC0000254.1|Oxytetracycline_1 ", "model_name": "AAC(3)-VIa", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "300", "model_id": "1105", "ARO_accession": "3002540", "ARO_name": "AAC(3)-VIa", "ARO_category": {"36461": {"category_aro_accession": "3000322", "category_aro_cvterm_id": "36461", "category_aro_name": "AAC(3)", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 3-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 3-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35953": {"category_aro_accession": "0000035", "category_aro_cvterm_id": "35953", "category_aro_name": "sisomicin", "category_aro_description": "Sisomicin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Sisomicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "46127": {"category_aro_accession": "3007377", "category_aro_cvterm_id": "46127", "category_aro_name": "6'-N-ethylnetilmicin", "category_aro_description": "6'-N-ethylnetilmicin is an aminoglycoside antibiotic and a derivative of netilmicin.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.57311, "max_identities": 18, "bit_score": 23.8682, "cvterm_id": "36884", "query": "LLREGDSLTAHAGLTSARWQVAGLL-----LSGPSTVARLARERGLRRQAVQQTV", "match": "LLREG  +     +T++ W   G+L       GP  V R+AR+   R +  Q  V", "sequence_from_db": "LLREGKRVW----VTTSDWDSNGILDEYAAPDGPDAVERIARDYLARTRVAQGPV", "sequence_from_broadstreet": "MTDPRKNGDLHEPATAPATPWSKSELVRQLRDLGVRSGDMVMPHVSLRAVGPLADGPQTLVDALIEAVGPTGNILAFVSWRDSPYEQTLGHDAPPAAIAQSWPAFDPDHAPAYPGFGAINEFIRTYPGCRRTAHPDASMAAIGPDAAWLVAPHEMGAAYGPRSPIARFLAHAGKILSIGAGPDAVTALHYAEAVARIEGKRRVTYSMPLLREGKRVWVTTSDWDSNGILDEYAAPDGPDAVERIARDYLARTRVAQGPVGGAQSRLIDAADIVSFGIEWLEARHAAPAAAALKPKQRRD", "dna_sequence_from_broadstreet": "ATGACTGATCCCCGCAAAAACGGCGATTTGCACGAACCCGCGACGGCACCCGCGACGCCCTGGTCCAAAAGCGAGCTGGTCCGGCAATTGCGCGACCTCGGCGTGCGCTCAGGCGATATGGTGATGCCGCATGTGTCGTTGCGCGCCGTCGGGCCGCTGGCGGACGGACCGCAGACACTTGTCGATGCGCTGATCGAGGCCGTCGGCCCCACCGGGAATATTCTCGCCTTCGTCTCGTGGCGCGATTCGCCCTATGAACAGACGCTGGGTCATGATGCGCCGCCCGCCGCCATCGCCCAAAGCTGGCCTGCGTTCGACCCCGACCATGCGCCCGCCTACCCCGGCTTTGGCGCGATCAACGAATTTATCCGAACCTATCCGGGGTGTCGGCGCACGGCCCATCCCGACGCATCGATGGCGGCGATCGGGCCCGATGCGGCGTGGCTGGTGGCGCCGCACGAGATGGGCGCCGCTTATGGCCCCCGCTCGCCGATCGCGCGTTTTCTCGCCCACGCAGGAAAAATCCTGTCGATCGGCGCCGGGCCCGATGCAGTCACCGCGCTCCATTATGCCGAAGCGGTGGCGCGGATCGAGGGCAAGCGCCGCGTCACTTATTCGATGCCCTTACTGCGCGAAGGCAAGCGCGTCTGGGTCACCACGTCCGACTGGGATTCGAACGGCATCCTCGACGAATATGCCGCGCCCGACGGCCCCGACGCGGTCGAACGGATCGCCCGCGACTATCTCGCCCGCACCAGGGTTGCGCAAGGCCCGGTCGGCGGCGCGCAATCCCGGCTGATCGACGCGGCCGATATCGTTTCCTTCGGCATCGAATGGCTCGAGGCGCGCCACGCCGCGCCAGCGGCGGCAGCGCTGAAGCCGAAACAACGCCGCGACTGA", "partial": "0", "query_start": 206, "query_end": 355, "hit_start": 624, "hit_end": 777, "orf_dna_sequence": "GTGACCGCCGAGGTCTTCGCGGTCAACGGCCGCCTGCTCCGCGAAGGCGACAGCCTCACCGCCCACGCGGGGCTGACCTCGGCGCGCTGGCAGGTGGCCGGACTGCTGCTGAGCGGCCCCTCGACGGTCGCCCGCCTGGCCCGCGAGCGGGGGCTGCGGCGGCAGGCGGTCCAGCAGACCGTCGAGCGGCTGAAGGCCGAGGGCGTCGTCACGACCCGGCCCAACCCGCAGGACCAGCGCAGCCCCCTGGTCGAGCTCACCGCACGCGGCCGGCAGGCGCTGGACGACCTGCGTCCCCTGGAACGGCGGTGGCTGGAGTATCTGGCCGAGGACATTCCGGTCGAGGACATGCGCGTGGCGATCGCGGTGCTGAGCCGCCTGCGGGAGAAGCTGGACGCCCGTCCGGCGACGGAGTTCGGGACCGGGGCCGGGTCCGGGCGGCAGTCCGCCTGA", "orf_prot_sequence": "MTAEVFAVNGRLLREGDSLTAHAGLTSARWQVAGLLLSGPSTVARLARERGLRRQAVQQTVERLKAEGVVTTRPNPQDQRSPLVELTARGRQALDDLRPLERRWLEYLAEDIPVEDMRVAIAVLSRLREKLDARPATEFGTGAGSGRQSA", "perc_identity": 32.73}, "gnl|BL_ORD_ID|1232|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 173, "orf_end": 625, "orf_from": "BGC0000254.1|Oxytetracycline_1 ", "model_name": "mtrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "790", "model_id": "1340", "ARO_accession": "3000810", "ARO_name": "mtrC", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35971": {"category_aro_accession": "0000054", "category_aro_cvterm_id": "35971", "category_aro_name": "penicillin", "category_aro_description": "Penicillin (sometimes abbreviated PCN) is a beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms. It works by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.84782, "max_identities": 22, "bit_score": 23.8682, "cvterm_id": "39597", "query": "GRLLREGDSLTAHAGLTSARWQVAGLLLSGPSTVARLARERGLRRQAVQQTVERLKAEGVVTTR", "match": "G+ L + DS T  AGL SAR Q+A    +     A LAR + L      + V R + +  VT +", "sequence_from_db": "GQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYKPL---VAAEAVSRQEYDAAVTAK", "sequence_from_broadstreet": "MAFYAFKAMRAAALAAAVALVLSSCGKGGDAAQGGQPAGREAPAPVVGVVTVHPQTVALTVELPGRLESLRTADVRAQVGGIIQKRLFQEGSYVRAGQPLYQIDSSTYEAGLESARAQLATAQATLAKADADLARYKPLVAAEAVSRQEYDAAVTAKRSAEAGVKAAQAAIKSAGISLNRSRITAPISGFIGQSKVSEGTLLNAGDATVLATIRQTNPMYVNVTQSASEVMKLRRQIAEGKLLAADGVIAVGIKFDDGTVYPEKGRLLFADPAVNESTGQITLRAAVPNDQNILMPGLYVRVLMDQVAVDNAFVVPQQAVTRGAKDTVMIVNAQGGMEPREVTVAQQQGTNWIVTSGLKDGDKVVVEGISIAGITGAKKVTPKEWASSENQAAAPQSGVQTASEAKPASEAK", "dna_sequence_from_broadstreet": "ATGGCTTTTTATGCTTTTAAGGCGATGCGTGCGGCCGCGTTGGCTGCCGCCGTTGCATTGGTACTGTCGTCTTGCGGTAAAGGCGGAGACGCGGCGCAGGGCGGGCAGCCTGCTGGTCGGGAAGCCCCTGCGCCCGTCGTCGGTGTCGTAACCGTCCATCCGCAAACCGTCGCATTGACCGTCGAGTTGCCGGGGCGTTTGGAATCGCTGCGTACCGCCGATGTCCGCGCCCAAGTCGGCGGCATCATCCAAAAACGCCTGTTCCAAGAAGGCAGTTATGTCCGTGCCGGACAGCCGCTGTATCAGATCGACAGTTCCACTTATGAAGCAGGTCTGGAAAGCGCGCGCGCGCAACTGGCAACGGCTCAGGCAACGCTTGCCAAAGCGGATGCGGATTTGGCGCGATACAAGCCTTTGGTTGCCGCCGAAGCCGTCAGCCGGCAGGAATACGATGCTGCGGTAACGGCGAAACGTTCTGCCGAGGCAGGCGTTAAAGCGGCGCAGGCGGCAATCAAATCCGCCGGCATCAGCCTGAACCGTTCGCGCATTACCGCGCCGATTTCCGGCTTTATCGGTCAGTCCAAAGTTTCCGAAGGTACGTTGCTGAACGCTGGCGATGCGACCGTACTGGCGACCATCCGCCAAACCAATCCGATGTATGTGAACGTTACCCAGTCTGCATCCGAAGTGATGAAATTGCGCCGTCAGATAGCCGAAGGCAAACTGCTGGCGGCGGATGGTGTGATTGCGGTCGGCATCAAATTTGACGACGGCACAGTTTACCCTGAAAAAGGCCGCCTGCTGTTTGCCGATCCGGCCGTCAACGAATCGACCGGTCAGATTACCCTGCGCGCCGCCGTACCGAACGATCAGAATATCTTGATGCCCGGTCTGTATGTGCGCGTGCTGATGGACCAAGTGGCGGTGGATAACGCATTTGTTGTGCCGCAGCAGGCGGTAACGCGCGGTGCGAAAGATACCGTGATGATTGTGAATGCCCAAGGCGGTATGGAACCCCGCGAGGTAACGGTTGCGCAACAGCAGGGTACGAATTGGATTGTTACGTCGGGTCTGAAGGACGGGGACAAGGTGGTTGTGGAAGGCATCAGTATCGCCGGTATAACGGGTGCGAAAAAGGTAACGCCCAAAGAATGGGCGTCGTCTGAAAACCAAGCCGCCGCGCCTCAATCCGGCGTTCAGACGGCATCTGAAGCCAAACCTGCTTCTGAAGCGAAATAA", "partial": "0", "query_start": 200, "query_end": 391, "hit_start": 288, "hit_end": 471, "orf_dna_sequence": "GTGACCGCCGAGGTCTTCGCGGTCAACGGCCGCCTGCTCCGCGAAGGCGACAGCCTCACCGCCCACGCGGGGCTGACCTCGGCGCGCTGGCAGGTGGCCGGACTGCTGCTGAGCGGCCCCTCGACGGTCGCCCGCCTGGCCCGCGAGCGGGGGCTGCGGCGGCAGGCGGTCCAGCAGACCGTCGAGCGGCTGAAGGCCGAGGGCGTCGTCACGACCCGGCCCAACCCGCAGGACCAGCGCAGCCCCCTGGTCGAGCTCACCGCACGCGGCCGGCAGGCGCTGGACGACCTGCGTCCCCTGGAACGGCGGTGGCTGGAGTATCTGGCCGAGGACATTCCGGTCGAGGACATGCGCGTGGCGATCGCGGTGCTGAGCCGCCTGCGGGAGAAGCTGGACGCCCGTCCGGCGACGGAGTTCGGGACCGGGGCCGGGTCCGGGCGGCAGTCCGCCTGA", "orf_prot_sequence": "MTAEVFAVNGRLLREGDSLTAHAGLTSARWQVAGLLLSGPSTVARLARERGLRRQAVQQTVERLKAEGVVTTRPNPQDQRSPLVELTARGRQALDDLRPLERRWLEYLAEDIPVEDMRVAIAVLSRLREKLDARPATEFGTGAGSGRQSA", "perc_identity": 34.38}, "gnl|BL_ORD_ID|2242|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 173, "orf_end": 625, "orf_from": "BGC0000254.1|Oxytetracycline_1 ", "model_name": "MuxA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "2717", "ARO_accession": "3004073", "ARO_name": "MuxA", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "36689": {"category_aro_accession": "3000550", "category_aro_cvterm_id": "36689", "category_aro_name": "aztreonam", "category_aro_description": "Aztreonam was the first monobactam discovered, and is greatly effective against Gram-negative bacteria while inactive against Gram-positive bacteria. Artreonam is a poor substrate for beta-lactamases, and may even act as an inhibitor. In Gram-negative bacteria, Aztreonam interferes with filamentation, inhibiting cell division and leading to cell death.", "category_aro_class_name": "Antibiotic"}, "37626": {"category_aro_accession": "3001227", "category_aro_cvterm_id": "37626", "category_aro_name": "kitasamycin", "category_aro_description": "Kitasamycin is a macrolide antibiotic and is produced by Streptoverticillium kitasatoense. The drug has antimicrobial activity against a wide spectrum of pathogens.", "category_aro_class_name": "Antibiotic"}, "40353": {"category_aro_accession": "3003701", "category_aro_cvterm_id": "40353", "category_aro_name": "rokitamycin", "category_aro_description": "Rokitamycin is a macrolide antibiotic. Synthesized from strains of Streptomyces kitasatoensis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.48421, "max_identities": 16, "bit_score": 23.8682, "cvterm_id": "36804", "query": "ERLKAEGVVTTRPNPQDQRSPLVELTARGRQALDDLRPLERRWLEYLAEDI", "match": "+++ AEG +TT  N  D  +  V+L AR   A   L P +   +  LA+ +", "sequence_from_db": "DKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTL", "sequence_from_broadstreet": "MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE", "dna_sequence_from_broadstreet": "ATGACTCCAACGACCGGTAAATCCAAGTTCCGTACCCTGCGCCCGTGGCTGATCACCGCCCTGGCCTTCGCCGCCGTGATCGGCCTGGTGATGTGGCTGGCGGCGCCCGCCTCGGCACCGTCCTCCGACGGGCGACCCGGTCGCGGCGGCAAGCCGGGCGCCGCGCTGCCCAAGGCCAACGCGCTCACCGTCGGCGTGGCCAGGGTGGAGCAGGGCGACCTGGCGCTGCATTTCAACGCGCTTGGCACCGTCACCGCCTTCAACACGGTGAACGTCAAGCCGCGGGTCAACGGCGAGCTGGTCAAGGTGCTGTTCCAGGAGGGGCAGGAGGTCAAGGCCGGCGACCTGCTGGCGGTGGTCGACCCGCGCACCTACAAGGCGGCGCTGGCCCAGGCCGAGGGCACGCTGATGCAGAACCAGGCGCAACTGAAGAACGCCGAGATCGACCTGCAGCGCTACAAGGGGCTGTATGCCGAGGACTCGATAGCCAAGCAGACCCTGGATACCCAGGAAGCCCAGGTCCGCCAGTTGCAGGGCACCATCCGTACCAACCAGGGCCAGGTCGACGACGCCCGCCTCAACCTGACCTTCACCGAGGTCCGCGCACCGATTTCCGGGCGCCTCGGCCTGCGCCAGGTGGACATCGGCAACCTGGTCACCAGCGGCGATACCACGCCGCTGGTGGTGATCACCCAGGTCAAGCCGATCTCGGTGGTGTTCAGCCTGCCGCAGCAGCAGATCGGCACCGTCGTCGAGCAGATGAACGGCCCCGGCAAGCTGACGGTCACCGCGCTGGACCGCAACCAGGACAAGGTTCTCGCCGAAGGCACCCTGACCACCCTGGACAACCAGATCGACACCACCACCGGCACGGTCAAGCTCAAGGCGCGCTTCGAGAACGCCGACGGCAAGCTGTTCCCCAACCAGTTCGTCAACGTGCGCCTGCTGGCGCAGACCCTCAAAGGCGTGCTGACCATTCCGGCCAACGCCGTGCAGCGCGGCACCAACGGTATCTATGTCTACGTGGTCGGCGCCGACAACAAGGTCAGCCAGCGCAGCGTCGCCATCGGCACCAGCGAGAACGAGCGGGTGGTGGTGGAAAGCGGCCTGAAGGCCGGCGAGCAGGTGGTGGTGGAAGGCACCGACCGCCTGCGCGACGGTATGGAAGTGCGTGTCGCCGAGGCCTCCCCGCAGGTCCTCGAGGGCGAGCCGCAGAAACCGCAGACTGGCCGCCCCAGCGGCCTCCAGGGCGACTCGGTGGGTAGCGGGAGCGCTGAATGA", "partial": "0", "query_start": 356, "query_end": 508, "hit_start": 807, "hit_end": 960, "orf_dna_sequence": "GTGACCGCCGAGGTCTTCGCGGTCAACGGCCGCCTGCTCCGCGAAGGCGACAGCCTCACCGCCCACGCGGGGCTGACCTCGGCGCGCTGGCAGGTGGCCGGACTGCTGCTGAGCGGCCCCTCGACGGTCGCCCGCCTGGCCCGCGAGCGGGGGCTGCGGCGGCAGGCGGTCCAGCAGACCGTCGAGCGGCTGAAGGCCGAGGGCGTCGTCACGACCCGGCCCAACCCGCAGGACCAGCGCAGCCCCCTGGTCGAGCTCACCGCACGCGGCCGGCAGGCGCTGGACGACCTGCGTCCCCTGGAACGGCGGTGGCTGGAGTATCTGGCCGAGGACATTCCGGTCGAGGACATGCGCGTGGCGATCGCGGTGCTGAGCCGCCTGCGGGAGAAGCTGGACGCCCGTCCGGCGACGGAGTTCGGGACCGGGGCCGGGTCCGGGCGGCAGTCCGCCTGA", "orf_prot_sequence": "MTAEVFAVNGRLLREGDSLTAHAGLTSARWQVAGLLLSGPSTVARLARERGLRRQAVQQTVERLKAEGVVTTRPNPQDQRSPLVELTARGRQALDDLRPLERRWLEYLAEDIPVEDMRVAIAVLSRLREKLDARPATEFGTGAGSGRQSA", "perc_identity": 31.37}, "gnl|BL_ORD_ID|1984|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 173, "orf_end": 625, "orf_from": "BGC0000254.1|Oxytetracycline_1 ", "model_name": "Escherichia coli marR mutant conferring antibiotic resistance", "model_type": "protein overexpression model", "model_type_id": 41091, "pass_evalue": "n/a", "pass_bitscore": "210", "model_id": "431", "ARO_accession": "3003378", "ARO_name": "Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36981": {"category_aro_accession": "3000637", "category_aro_cvterm_id": "36981", "category_aro_name": "ampicillin", "category_aro_description": "Ampicillin is a penicillin derivative that is highly acid stable, with its activity similar to benzylpenicillin.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "37250": {"category_aro_accession": "3000870", "category_aro_cvterm_id": "37250", "category_aro_name": "triclosan", "category_aro_description": "Triclosan is a common antibacterial agent added to many consumer products as a biocide.  It is an inhibitor of fatty acid biosynthesis by blocking enoyl-carrier protein reductase (FabI).", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0130732, "max_identities": 20, "bit_score": 31.5722, "cvterm_id": "36849", "query": "LTSARWQV-AGLLLSGPSTVARLARERGLRRQAVQQTVERLKAEGVVTTRPNPQDQRSPLVELTARG", "match": "+T+A+++V   +  +   T   L +   +   A+ + ++RL  +G V   PNP D+R  LV+LT  G", "sequence_from_db": "ITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGG", "sequence_from_broadstreet": "MKSTSDLFNEIIPLGRLIHMVNQKKDRLLNEYLSPLDITAAQFKVLCSIRCAACITPVELKKVLSVDLGALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLHQELTKNLTADEVATLEYLLKKVLP", "dna_sequence_from_broadstreet": "GTGAAAAGTACCAGCGATCTGTTCAATGAAATTATTCCATTGGGTCGCTTAATCCATATGGTTAATCAGAAGAAAGATCGCCTGCTTAACGAGTATCTGTCTCCGCTGGATATTACCGCGGCACAGTTTAAGGTGCTCTGCTCTATCCGCTGCGCGGCGTGTATTACTCCGGTTGAACTGAAAAAGGTATTGTCGGTCGACCTGGGAGCACTGACCCGTATGCTGGATCGCCTGGTCTGTAAAGGCTGGGTGGAAAGGTTGCCGAACCCGAATGACAAGCGCGGCGTACTGGTAAAACTTACCACCGGCGGCGCGGCAATATGTGAACAATGCCATCAATTAGTTGGCCAGGACCTGCACCAAGAATTAACAAAAAACCTGACGGCGGACGAAGTGGCAACACTTGAGTATTTGCTTAAGAAAGTCCTGCCGTAA", "partial": "0", "query_start": 245, "query_end": 442, "hit_start": 111, "hit_end": 312, "orf_dna_sequence": "GTGACCGCCGAGGTCTTCGCGGTCAACGGCCGCCTGCTCCGCGAAGGCGACAGCCTCACCGCCCACGCGGGGCTGACCTCGGCGCGCTGGCAGGTGGCCGGACTGCTGCTGAGCGGCCCCTCGACGGTCGCCCGCCTGGCCCGCGAGCGGGGGCTGCGGCGGCAGGCGGTCCAGCAGACCGTCGAGCGGCTGAAGGCCGAGGGCGTCGTCACGACCCGGCCCAACCCGCAGGACCAGCGCAGCCCCCTGGTCGAGCTCACCGCACGCGGCCGGCAGGCGCTGGACGACCTGCGTCCCCTGGAACGGCGGTGGCTGGAGTATCTGGCCGAGGACATTCCGGTCGAGGACATGCGCGTGGCGATCGCGGTGCTGAGCCGCCTGCGGGAGAAGCTGGACGCCCGTCCGGCGACGGAGTTCGGGACCGGGGCCGGGTCCGGGCGGCAGTCCGCCTGA", "orf_prot_sequence": "VTAEVFAVNGRLLREGDSLTAHAGLTSARWQVAGLLLSGPSTVARLARERGLRRQAVQQTVERLKAEGVVTTRPNPQDQRSPLVELTARGRQALDDLRPLERRWLEYLAEDIPVEDMRVAIAVLSRLREKLDARPATEFGTGAGSGRQSA", "perc_identity": 29.85}}, "BGC0000254.1|Oxytetracycline_4 # 3388 # 3675 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=CCCCG;rbs_spacer=15bp;gc_cont=0.708": {"gnl|BL_ORD_ID|1476|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3388, "orf_end": 3675, "orf_from": "BGC0000254.1|Oxytetracycline_4 ", "model_name": "APH(2'')-IIa", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "1615", "ARO_accession": "3002635", "ARO_name": "APH(2'')-IIa", "ARO_category": {"36267": {"category_aro_accession": "3000128", "category_aro_cvterm_id": "36267", "category_aro_name": "APH(2'')", "category_aro_description": "A category of aminoglycoside O-phosphotransferase enzymes with modification regiospecificity based at the 2''-hydroxyl group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics, specifically kanamycin, tobramycin and amikacin, by the ATP-dependent phosphorylation of the 3'-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "40307": {"category_aro_accession": "3003675", "category_aro_cvterm_id": "40307", "category_aro_name": "plazomicin", "category_aro_description": "Plazomicin is a neoglycoside, or next-generation, aminoglycoside, that has been identified as a potentially useful agent to combat drug-resistant bacteria, such as Acinetobacter baumannii and Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.111395, "max_identities": 17, "bit_score": 28.1054, "cvterm_id": "35914", "query": "SDLLTLLRECAGEEESIDLGGDVEDVAFDALGYDSLALLNTVGRIERDYGVQLGDDAV", "match": "SD   +++   GE  + +    + +   DAL YD    L  +  IE D  V L  DA+", "sequence_from_db": "SDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKELHSIEIDCSVSLFSDAL", "sequence_from_broadstreet": "MVNLDAEIYEHLNKQIKINELRYLSSGDDSDTFLCNEQYVVKVPKRDSVRISQKRELELYRFLENCKLSYQIPAVVYQSDRFNIMKYIKGERITYEQYHKLSEKEKDALAYDEATFLKELHSIEIDCSVSLFSDALVNKKDKFLQDKKLLISILEKEQLLTDEMLEHIETIYENILSNAVLFKYTPCLVHNDFSANNMIFRNNRLFGVIDFGDFNVGDPDNDFLCLLDCSTDDFGKEFGRKVLKYYQHKAPEVAERKAELNDVYWSIDQIIYGYERKDREMLIKDVSELLQTQAEMFIF", "dna_sequence_from_broadstreet": "ATGGTTAACTTGGACGCTGAGATATATGAGCACTTAAATAAACAGATAAAAATAAATGAACTCCGTTATTTATCGTCCGGCGATGATAGTGATACTTTTTTGTGTAATGAACAATATGTTGTGAAAGTTCCTAAACGAGATTCTGTTAGAATTTCTCAGAAACGAGAGCTTGAATTGTATCGTTTTTTAGAAAACTGTAAGCTATCTTATCAAATCCCTGCGGTAGTGTATCAAAGTGACCGATTTAATATTATGAAATATATTAAAGGGGAACGTATTACTTATGAGCAGTATCATAAGTTGAGTGAAAAGGAAAAGGATGCCCTTGCATATGATGAAGCGACGTTTTTGAAAGAGTTACATTCCATAGAGATTGATTGTTCTGTCAGTTTGTTTTCAGATGCTCTGGTGAATAAGAAAGATAAGTTTTTGCAAGATAAAAAATTACTTATAAGTATTCTGGAAAAGGAGCAGCTGTTAACTGATGAGATGTTGGAACATATCGAAACAATATATGAAAACATATTAAGCAATGCTGTTTTATTTAAATATACCCCTTGTTTGGTACATAATGATTTCAGTGCAAATAACATGATTTTTAGAAATAATAGACTGTTTGGAGTTATTGATTTTGGCGATTTTAATGTAGGTGACCCGGATAATGATTTTTTGTGCTTGCTGGATTGTAGTACAGATGATTTCGGGAAAGAATTTGGCAGGAAGGTATTAAAATACTATCAGCATAAGGCGCCGGAAGTAGCAGAAAGAAAAGCAGAGCTTAATGATGTATATTGGTCGATAGACCAAATCATTTATGGTTATGAAAGAAAAGATAGGGAAATGTTGATTAAGGATGTTTCTGAATTGCTACAAACACAAGCAGAGATGTTTATATTTTAG", "partial": "0", "query_start": 3406, "query_end": 3579, "hit_start": 234, "hit_end": 408, "orf_dna_sequence": "ATGACCCTGCTCACCCTCTCCGACCTGCTCACCCTGCTGCGCGAGTGCGCGGGCGAGGAGGAATCCATCGACCTGGGAGGGGACGTCGAGGACGTCGCCTTCGACGCCCTCGGCTACGACTCGCTGGCGCTGCTGAACACCGTGGGACGCATCGAGCGCGACTACGGGGTCCAGCTCGGGGACGACGCGGTGGAGAAGGCGACCACGCCGCGCGCCCTGATCGAGATGACCAACGCGTCGCTCACCGGCGCGTCCCCGTCCGCGGGTGGCGCCGCGCGGGACAAGTGA", "orf_prot_sequence": "MTLLTLSDLLTLLRECAGEEESIDLGGDVEDVAFDALGYDSLALLNTVGRIERDYGVQLGDDAVEKATTPRALIEMTNASLTGASPSAGGAARDK", "perc_identity": 29.31}, "gnl|BL_ORD_ID|1425|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3388, "orf_end": 3675, "orf_from": "BGC0000254.1|Oxytetracycline_4 ", "model_name": "smeR", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "420", "model_id": "1550", "ARO_accession": "3003066", "ARO_name": "smeR", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.90034, "max_identities": 15, "bit_score": 25.409, "cvterm_id": "37076", "query": "VGRIERDYGVQLG-DDAVEKATTPRALIEMTNASLTGASPSAGGAA", "match": "V  I+R  G+++G DD + K  +PR ++    A L    P  G  A", "sequence_from_db": "VEEIDRLLGLEIGADDYICKPFSPREVVARVMAVLRRYRPDPGARA", "sequence_from_broadstreet": "MSTSPATSTKILIVEDEPRLASVLRDYLAAAGMASEWVDDGGQVIDAFARYQPDLVLLDLMLPQRDGVDLCRELRASSDVPVIMVTARVEEIDRLLGLEIGADDYICKPFSPREVVARVMAVLRRYRPDPGARANGGLHIDEPAARATWNGKGLDLTPVEYRLLRTLLATPGRIWARDELLDRLYLDHRVVVDRTVDSHVRNLRRKLADAGMEGEPIRSVYGMGYSYEP", "dna_sequence_from_broadstreet": "ATGAGCACGTCGCCCGCCACGTCCACGAAGATCCTGATCGTCGAGGACGAGCCACGCCTGGCCTCGGTACTGCGCGACTACCTGGCCGCCGCCGGCATGGCCAGCGAGTGGGTGGACGACGGTGGCCAGGTGATCGACGCATTCGCGCGCTACCAGCCCGACCTGGTGCTGCTGGACCTGATGCTGCCGCAGCGCGACGGCGTGGACCTGTGCCGCGAACTGCGTGCCAGCAGCGATGTACCGGTCATCATGGTCACCGCACGGGTGGAAGAGATCGACCGCCTGCTGGGCCTGGAGATCGGCGCCGACGACTACATCTGCAAGCCGTTCAGTCCGCGCGAAGTGGTCGCGCGGGTAATGGCGGTGCTGCGCCGCTACCGCCCGGACCCGGGTGCGCGCGCCAACGGTGGCCTGCACATCGACGAGCCGGCCGCACGCGCCACCTGGAACGGCAAGGGCCTGGACCTGACGCCGGTGGAGTACCGCCTGCTGCGCACGCTGCTGGCCACCCCAGGCCGGATCTGGGCGCGCGATGAACTGCTCGACCGGCTGTACCTGGACCATCGCGTGGTGGTCGACCGCACCGTCGACAGCCATGTGCGCAACCTGCGCCGCAAGCTGGCCGACGCCGGCATGGAAGGCGAGCCGATCCGTTCGGTGTACGGCATGGGCTACAGCTACGAGCCCTGA", "partial": "0", "query_start": 3529, "query_end": 3663, "hit_start": 264, "hit_end": 402, "orf_dna_sequence": "ATGACCCTGCTCACCCTCTCCGACCTGCTCACCCTGCTGCGCGAGTGCGCGGGCGAGGAGGAATCCATCGACCTGGGAGGGGACGTCGAGGACGTCGCCTTCGACGCCCTCGGCTACGACTCGCTGGCGCTGCTGAACACCGTGGGACGCATCGAGCGCGACTACGGGGTCCAGCTCGGGGACGACGCGGTGGAGAAGGCGACCACGCCGCGCGCCCTGATCGAGATGACCAACGCGTCGCTCACCGGCGCGTCCCCGTCCGCGGGTGGCGCCGCGCGGGACAAGTGA", "orf_prot_sequence": "MTLLTLSDLLTLLRECAGEEESIDLGGDVEDVAFDALGYDSLALLNTVGRIERDYGVQLGDDAVEKATTPRALIEMTNASLTGASPSAGGAARDK", "perc_identity": 32.61}, "gnl|BL_ORD_ID|2058|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3388, "orf_end": 3675, "orf_from": "BGC0000254.1|Oxytetracycline_4 ", "model_name": "Clostridium perfringens mprF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "2282", "ARO_accession": "3003773", "ARO_name": "Clostridium perfringens mprF", "ARO_category": {"37243": {"category_aro_accession": "3000863", "category_aro_cvterm_id": "37243", "category_aro_name": "defensin resistant mprF", "category_aro_description": "MprF is a integral membrane protein that modifies the negatively-charged phosphatidylglycerol on the membrane surface of both Gram-positive and Gram-negative bacteria. This confers resistance to cationic peptides that disrupt the cell membrane, including defensins.", "category_aro_class_name": "AMR Gene Family"}, "37037": {"category_aro_accession": "3000693", "category_aro_cvterm_id": "37037", "category_aro_name": "defensin", "category_aro_description": "Defensins are natural cationic peptides that have antibiotic properties. It is part of the innate immune system of plants and animals.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.83911, "max_identities": 14, "bit_score": 24.6386, "cvterm_id": "40448", "query": "GEEESIDLGGDVEDVAFDALGYDSLALLNTVGRIERD", "match": "GEE  IDL        F+ +G    A  NT+ R+ER+", "sequence_from_db": "GEEARIDLE------EFNLIGSKKSAFRNTLRRVERE", "sequence_from_broadstreet": "MWDSLKKSYRHLKNILGFVTDKRNYENIKKLLKNYKILSDISNIIVSVLVFLSGILLIISGIYPSIFYKIKFLDNIYSLSFLRFSHRASILIGLMLIMTSKEVFFKVKRAYYVTLTLLIVGGAFAFIKDLDYKEGIFILGVIILLILSKKSFYRKSIPIKVTKLSGILIVLSIVMIIFASFIHKFNIHFSKNYKYYIDFFHSTKGYLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLKDKKVFWANEGESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGYDVVFYEIEEKNFSTYHDAGYYFFKLGEEARIDLEEFNLIGSKKSAFRNTLRRVEREGYNFSIIEPPFNNEVVSQLKEISDKWLGDRKEKGFSLGWFSEDYIQRSPIAILKNEEENKIMGFVTIMDANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHSHLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKFMSLPEVFINLCLLIANSKERVEKK", "dna_sequence_from_broadstreet": "ATGTGGGATTCACTAAAAAAAAGTTATAGACATTTAAAAAATATTTTAGGATTTGTTACTGATAAAAGAAATTATGAAAATATAAAGAAGCTATTAAAAAATTACAAAATCTTAAGTGATATATCAAATATAATAGTATCAGTTTTGGTATTTCTAAGTGGTATTCTTTTAATAATTTCAGGGATTTATCCTAGTATATTTTATAAGATAAAATTTTTAGATAATATATACAGTTTATCTTTTTTAAGGTTTTCACATAGAGCTTCAATATTAATTGGATTAATGTTAATAATGACCTCTAAGGAAGTTTTCTTTAAGGTAAAAAGAGCTTATTATGTTACATTAACATTGCTTATAGTAGGAGGAGCCTTTGCCTTTATAAAAGATTTAGATTACAAAGAAGGAATTTTTATTTTAGGAGTAATAATACTTCTAATATTATCAAAAAAGAGTTTTTACAGAAAAAGTATTCCTATTAAGGTTACTAAATTAAGTGGGATATTAATAGTTCTTTCAATTGTAATGATTATCTTTGCGAGTTTTATACATAAATTTAACATACATTTTAGCAAGAACTATAAATACTATATAGACTTTTTCCATAGCACAAAGGGGTATTTAAGAATAGCATTATTCACATATATATCCTTTATAATATTTGTGATAATATGGTATTTAACAATGCCTAAAATAGAAGATGACGAAAGGTATATGGATGCTGATTTAGAAAAGGTATCAAAATTCTTTAAAGAAATAGATTATGGAACAATATTCTCCCATTTAGTTTATTTAAAGGATAAAAAGGTCTTTTGGGCTAATGAAGGAGAGTCCTTAATAATGTATAGCAAGTACAAAGATAAGATAATAGTTTTAGGAGATCCTATAGCTACTAAGGAAAACCTATATAGTTGTATAGAAGAGTTTCAAGCTTTTACAAATTTATATGGATATGATGTTGTCTTTTATGAAATAGAAGAAAAAAACTTTTCTACCTATCATGATGCAGGGTATTATTTCTTTAAGTTAGGAGAAGAGGCAAGGATAGATTTAGAAGAATTTAATTTGATTGGTTCTAAAAAGAGTGCCTTTAGAAACACCTTAAGAAGAGTTGAAAGGGAAGGATATAATTTTAGCATTATAGAGCCTCCTTTTAATAATGAGGTAGTAAGTCAATTGAAGGAAATATCTGATAAATGGTTAGGGGACAGAAAAGAAAAGGGATTTTCTTTAGGATGGTTTAGTGAGGATTATATACAAAGATCACCTATAGCTATTTTAAAGAATGAAGAAGAAAATAAGATTATGGGCTTTGTAACAATAATGGATGCTAATGATGGAGGGGAGACAGTAGCAATAGATTTAATGAGAATAGATAAAGATGCTCCAAATGCCTCTATGGATTACCTAATGCTTAATTTATTCTTAACCTTTAAAGAAAAAGGATATAAGTATTTTAGCTTAGGAGAAGCACCATTATCTAATGTAGGATTTAACACTCATTCACATTTACAAGAAAAGCTTGCAAGGTTAGTTTATAATAGTGGTAATATATTCTATAGTTTTGATGGACTAAGAAGATATAAGTCAAAGTTTTCTCCAATTTGGCAACCTAGATATTTAGCATATCCTAAGTTTATGTCCTTACCAGAGGTGTTTATTAACTTATGTTTATTAATAGCTAATTCAAAGGAAAGAGTAGAGAAAAAATAA", "partial": "0", "query_start": 3439, "query_end": 3549, "hit_start": 1026, "hit_end": 1119, "orf_dna_sequence": "ATGACCCTGCTCACCCTCTCCGACCTGCTCACCCTGCTGCGCGAGTGCGCGGGCGAGGAGGAATCCATCGACCTGGGAGGGGACGTCGAGGACGTCGCCTTCGACGCCCTCGGCTACGACTCGCTGGCGCTGCTGAACACCGTGGGACGCATCGAGCGCGACTACGGGGTCCAGCTCGGGGACGACGCGGTGGAGAAGGCGACCACGCCGCGCGCCCTGATCGAGATGACCAACGCGTCGCTCACCGGCGCGTCCCCGTCCGCGGGTGGCGCCGCGCGGGACAAGTGA", "orf_prot_sequence": "MTLLTLSDLLTLLRECAGEEESIDLGGDVEDVAFDALGYDSLALLNTVGRIERDYGVQLGDDAVEKATTPRALIEMTNASLTGASPSAGGAARDK", "perc_identity": 37.84}, "gnl|BL_ORD_ID|297|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3388, "orf_end": 3675, "orf_from": "BGC0000254.1|Oxytetracycline_4 ", "model_name": "JOHN-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "222", "ARO_accession": "3000840", "ARO_name": "JOHN-1", "ARO_category": {"41366": {"category_aro_accession": "3004202", "category_aro_cvterm_id": "41366", "category_aro_name": "JOHN beta-lactamase", "category_aro_description": "JOHN beta-lactamases hydrolyse penicillins, narrow- and expanded-spectrum cephalosporins, and carbapenems.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.91048, "max_identities": 9, "bit_score": 24.2534, "cvterm_id": "39076", "query": "RDYGVQLGDDAVEKATTPRALIEMTN", "match": "+ Y ++L DD ++K   PRA   ++N", "sequence_from_db": "KTYSIKLTDDILKKNKEPRAEFIISN", "sequence_from_broadstreet": "MRKLASIILFLAAVSNSLGQSKNSPLQISHLTGDFYVYRTFNDYKGTKISANAMYVVTDKGVVLFDAPWDKTQFQPLLDSIKAKHNKEVVMLFGTHSHEDRAGGFDFYKKKGIKTYSIKLTDDILKKNKEPRAEFIISNDTTFTVGNHTFEVYYPGKGHAPDNIVAWFKKEKILYGGCFVKSAEALDLGYLGDADVKEWQKSIKKVQAKFKKPDYIISGHDDWTSKESLNHTLKLVDEYLAQKSAGKK", "dna_sequence_from_broadstreet": "ATGCGAAAATTAGCTTCGATAATTTTATTCTTAGCCGCGGTTTCAAATAGTTTGGGACAATCTAAGAATTCGCCATTACAAATAAGTCATCTTACAGGTGACTTTTATGTTTATAGAACTTTTAATGATTACAAAGGAACTAAGATTTCTGCCAATGCTATGTATGTTGTTACAGATAAAGGCGTTGTGCTTTTTGATGCGCCTTGGGATAAAACACAGTTTCAGCCGTTATTAGACAGCATAAAAGCAAAACACAATAAAGAGGTTGTGATGCTTTTTGGCACGCATTCTCATGAAGATCGTGCAGGAGGATTTGATTTTTACAAGAAAAAAGGAATCAAAACGTACTCAATTAAACTGACTGATGATATTCTTAAAAAGAATAAGGAACCAAGAGCAGAATTTATAATTTCAAATGATACAACATTTACTGTTGGAAATCATACTTTTGAAGTTTATTACCCAGGAAAAGGACATGCTCCTGATAATATTGTAGCATGGTTTAAAAAAGAGAAAATTCTTTACGGAGGCTGTTTTGTAAAAAGTGCAGAAGCATTAGATTTAGGTTATCTGGGTGATGCTGATGTTAAAGAATGGCAGAAATCTATAAAAAAAGTGCAGGCAAAATTCAAAAAACCGGATTATATAATTTCGGGACATGATGACTGGACTAGTAAAGAATCTTTAAATCATACTTTGAAATTGGTTGACGAGTATTTGGCTCAAAAATCTGCCGGAAAAAAGTAA", "partial": "0", "query_start": 3544, "query_end": 3621, "hit_start": 339, "hit_end": 417, "orf_dna_sequence": "ATGACCCTGCTCACCCTCTCCGACCTGCTCACCCTGCTGCGCGAGTGCGCGGGCGAGGAGGAATCCATCGACCTGGGAGGGGACGTCGAGGACGTCGCCTTCGACGCCCTCGGCTACGACTCGCTGGCGCTGCTGAACACCGTGGGACGCATCGAGCGCGACTACGGGGTCCAGCTCGGGGACGACGCGGTGGAGAAGGCGACCACGCCGCGCGCCCTGATCGAGATGACCAACGCGTCGCTCACCGGCGCGTCCCCGTCCGCGGGTGGCGCCGCGCGGGACAAGTGA", "orf_prot_sequence": "MTLLTLSDLLTLLRECAGEEESIDLGGDVEDVAFDALGYDSLALLNTVGRIERDYGVQLGDDAVEKATTPRALIEMTNASLTGASPSAGGAARDK", "perc_identity": 34.62}, "gnl|BL_ORD_ID|1112|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3388, "orf_end": 3675, "orf_from": "BGC0000254.1|Oxytetracycline_4 ", "model_name": "novA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1190", "model_id": "1210", "ARO_accession": "3002522", "ARO_name": "novA", "ARO_category": {"36002": {"category_aro_accession": "0010001", "category_aro_cvterm_id": "36002", "category_aro_name": "ATP-binding cassette (ABC) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. ATP-binding cassette (ABC) transporters are present in all cells of all organisms and use the energy of ATP binding/hydrolysis to transport substrates across cell membranes.", "category_aro_class_name": "AMR Gene Family"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.17451, "max_identities": 15, "bit_score": 23.0978, "cvterm_id": "39503", "query": "TLSDLLTLLRECAGEEESIDLGGDVEDVAFDALG", "match": "TLS L+  L +  G    +D G DV D+AFD L ", "sequence_from_db": "TLSYLVPRLYDVTGGRVLLD-GVDVRDLAFDTLA", "sequence_from_broadstreet": "MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA", "dna_sequence_from_broadstreet": "ATGAAGTCCGCACTCTCGACCTGGAAGCCCTCGGACCGGCCGCCGGATCCGACACTGCCCGAGCCGCCGGCCCAGCTGCGCCGCATCTTCCGGCTCTTCCGCCCGTACCGCGGCAGGCTCGCCGTCGTCGGCCTGCTCGTCGGCGCCTCGTCGCTGGTGGCCGTCGCCTCGCCGTTCATGCTGCGCGAGATCCTCGACACCGCGATCCCGCAGGGCCGCACCGGGCTGCTCAGCCTGCTCGCCCTCGGCATGATCCTGACCGCCGTCCTCAGCAGCGTCTTCGGCGTCGTCCAGACCCTCATCTCCACGACGGTCGGCCAGCGCGTCATGCACGACCTGCGCACCGCCGTCTACGCGCAGCTCCAGCGCATGCCCCTCGCGTTCTTCACCCGCACCCGCACCGGTGAGGTCCAGTCCCGGATAGCCAACGACATCGGCGGCATGCAGGCGACCGTCACCTCAACCGCCACGTCGCTGGTCTCCAACCTCACCGCCGTCATCGCCACCGTCGTCGCGATGCTCGCGCTGGACTGGCGGCTGACCGTCGTCTCGCTGCTCCTGCTGCCGGTGTTCGTCTGGATCAGCCGCCGCGTCGGCCGTGAGCGCAAACGGATCACCCTGCAACGGCAGAAGCAGATGGCCACGATGGCCGCCACGGTCACGGAGTCGCTGTCGGTCAGCGGCATCCTCCTCGGCCGCACGATGGGGCGCGCCGACTCGCTCACCAGATCCTTCGCCGAGGAGTCCGAGCGACTCGTCGACCTGGAGGTCCGCTCCAACATGGCCGGGCGGTGGCGGATGTCCGTCATCGGCATCGTCATGGCCGCCATGCCCGCCGTCATCTACTGGGCGGCCGGCTTCGTCCTCCAGTCCGGCGGCACGGTCGTCTCCATCGGCACACTCGTCGCCTTCGTCTCCCTCCAGCAGGGCCTCTTCCGCCCGGCCGTGAGCCTGCTCGCCACCGGCGTGCAGATGCAGACGTCCCTCGCGCTCTTCCAGCGCATCTTCGAATATCTCGACCTGCCCGTCGACATCACCGAACCCGAGCGTCCGGTGGCCCTCGACAAGGTCCGGGGCGAAGTGCGCTTCGACGGCGTCGACTTCAGTTACGAGGAGAAGGACGGCAACACCCTCCACGGCCTGGATCTGACCGTCCCGGCCGGCGGCAGCCTCGCCGTCGTCGGTCCCACCGGATCGGGCAAGTCGACCCTGAGCTATCTCGTGCCGCGTCTGTACGACGTGACGGGCGGCCGGGTCCTGCTCGACGGCGTCGACGTACGCGACCTGGCCTTCGACACCCTCGCCCGCGCGGTGGGCGTCGTGTCGCAGGAGACGTATCTCTTCCACGCCTCCGTCGCCGACAACCTCCGCTTCGCCAAACCGGACGCGACGGACGAGGAGATCGAGAAGGCGGCCAGGGCCGCCCAGATCCACGAGCACATCGTCACCCTGCCCGACGGGTACGACACACTGGTCGGCGAGCGCGGATACCGGTTCTCCGGCGGCGAGAAACAGCGCCTCGCGATCGCCCGCACCATCCTGCGCGACCCGCCCGTCCTCGTGCTGGACGAGGCGACGAGCGCGCTCGACACCCGTACCGAACACGCGGTCCAGCAGGCCATCGACTCCCTCTCCGAGGGCCGTACGACCATCACCATCGCCCACCGGCTCTCCACGGTGCGCGACGCCGACCAGATCGTCGTCCTCGACGCCGGTCGCATAGCCGAGCGCGGCACGCACGAGGAGCTGATCGACCGGGACGGCAGGTACGCGGCGCTCGTCCGCCGGGACGGCGCGCCGGCGCCCGCGCCCGTGCCCGCCCGGGACGAGCGCGTGGGCGCCGCCTGA", "partial": "0", "query_start": 3400, "query_end": 3501, "hit_start": 1206, "hit_end": 1305, "orf_dna_sequence": "ATGACCCTGCTCACCCTCTCCGACCTGCTCACCCTGCTGCGCGAGTGCGCGGGCGAGGAGGAATCCATCGACCTGGGAGGGGACGTCGAGGACGTCGCCTTCGACGCCCTCGGCTACGACTCGCTGGCGCTGCTGAACACCGTGGGACGCATCGAGCGCGACTACGGGGTCCAGCTCGGGGACGACGCGGTGGAGAAGGCGACCACGCCGCGCGCCCTGATCGAGATGACCAACGCGTCGCTCACCGGCGCGTCCCCGTCCGCGGGTGGCGCCGCGCGGGACAAGTGA", "orf_prot_sequence": "MTLLTLSDLLTLLRECAGEEESIDLGGDVEDVAFDALGYDSLALLNTVGRIERDYGVQLGDDAVEKATTPRALIEMTNASLTGASPSAGGAARDK", "perc_identity": 44.12}, "gnl|BL_ORD_ID|2517|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3388, "orf_end": 3675, "orf_from": "BGC0000254.1|Oxytetracycline_4 ", "model_name": "CBP-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "3567", "ARO_accession": "3004764", "ARO_name": "CBP-1", "ARO_category": {"42877": {"category_aro_accession": "3004763", "category_aro_cvterm_id": "42877", "category_aro_name": "CBP beta-lactamase", "category_aro_description": "CBP is a class A beta-lactamase family found in C. botulinum.", "category_aro_class_name": "AMR Gene Family"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.18397, "max_identities": 10, "bit_score": 22.7126, "cvterm_id": "41649", "query": "RIERDYGVQLGDDAVEKAT", "match": "+IE DYGV+LG  A +  T", "sequence_from_db": "KIESDYGVKLGVYAFDTET", "sequence_from_broadstreet": "MKKIVNSKLKVNKFKMCIFISILIFSLTGCGNVENKTSENTKPEIQYNSAFSKIESDYGVKLGVYAFDTETNKEVTYNADKRFAYCSTFKSLISGAILQKYSSDQLKQVIKYSPKDVLSYAPVTKNHVDKGMTIEELCDAAVRFSDNTAANLLINLIGGPNGFKSALNQLGDTVTEPARIEPELNVATPGDNRDTSTPRQLSIDLKEYTTGNILSDDKKKILINWMSGNATGDKLIRAGAPKDWMVSDKSGTGSYGTRNDIAIVIPPNKKPIFIAILSSKNDKDAKYDDKTISEASKIVFDYFINTRK", "dna_sequence_from_broadstreet": "ATGAAAAAAATAGTAAACTCAAAATTAAAGGTAAATAAATTTAAAATGTGTATATTTATATCAATTCTTATATTTTCTCTTACTGGATGTGGAAATGTAGAAAATAAAACTTCTGAAAATACAAAACCTGAGATACAATATAATTCAGCATTTTCAAAAATTGAAAGTGATTATGGTGTTAAACTTGGTGTATATGCTTTTGATACAGAAACAAATAAAGAAGTTACATATAATGCTGATAAGAGATTCGCTTACTGTTCTACCTTTAAATCTTTAATATCCGGTGCGATTTTACAAAAATATTCATCAGACCAACTTAAACAAGTAATTAAATATAGCCCAAAAGATGTACTGTCTTATGCACCAGTTACAAAAAATCATGTTGATAAAGGTATGACTATTGAAGAACTTTGCGATGCGGCAGTACGCTTTAGTGATAATACAGCTGCAAATCTTTTGATTAATCTTATAGGTGGACCTAATGGTTTTAAATCAGCACTTAATCAATTAGGTGACACAGTTACAGAACCTGCACGTATCGAACCAGAACTAAATGTTGCTACACCTGGAGATAATAGGGATACTAGTACTCCAAGACAATTATCAATTGATTTAAAAGAATACACAACTGGAAATATATTATCAGATGATAAGAAAAAAATTCTTATTAATTGGATGTCAGGAAATGCAACAGGTGATAAGCTAATTCGTGCAGGAGCACCAAAAGACTGGATGGTTTCTGATAAAAGTGGAACTGGTTCTTACGGAACAAGAAATGATATTGCAATAGTAATACCACCAAATAAAAAGCCTATATTTATTGCAATATTATCAAGTAAAAACGATAAAGATGCTAAATATGATGACAAAACAATTTCTGAGGCTTCTAAAATTGTATTTGATTATTTTATTAACACCAGGAAATAG", "partial": "0", "query_start": 3535, "query_end": 3591, "hit_start": 156, "hit_end": 213, "orf_dna_sequence": "ATGACCCTGCTCACCCTCTCCGACCTGCTCACCCTGCTGCGCGAGTGCGCGGGCGAGGAGGAATCCATCGACCTGGGAGGGGACGTCGAGGACGTCGCCTTCGACGCCCTCGGCTACGACTCGCTGGCGCTGCTGAACACCGTGGGACGCATCGAGCGCGACTACGGGGTCCAGCTCGGGGACGACGCGGTGGAGAAGGCGACCACGCCGCGCGCCCTGATCGAGATGACCAACGCGTCGCTCACCGGCGCGTCCCCGTCCGCGGGTGGCGCCGCGCGGGACAAGTGA", "orf_prot_sequence": "MTLLTLSDLLTLLRECAGEEESIDLGGDVEDVAFDALGYDSLALLNTVGRIERDYGVQLGDDAVEKATTPRALIEMTNASLTGASPSAGGAARDK", "perc_identity": 52.63}}, "BGC0000254.1|Oxytetracycline_5 # 3653 # 5524 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=CCGGCG;rbs_spacer=15bp;gc_cont=0.717": {"gnl|BL_ORD_ID|1507|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3653, "orf_end": 5524, "orf_from": "BGC0000254.1|Oxytetracycline_5 ", "model_name": "MOX-7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1637", "ARO_accession": "3002189", "ARO_name": "MOX-7", "ARO_category": {"36222": {"category_aro_accession": "3000083", "category_aro_cvterm_id": "36222", "category_aro_name": "MOX beta-lactamase", "category_aro_description": "MOX beta-lactamases are plasmid-mediated AmpC-type beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.91793, "max_identities": 19, "bit_score": 27.335, "cvterm_id": "36936", "query": "GRGLFDRKLLDKLDLPGYQRDRYAEARKEVPVLPGEDAREAELRRVTYLNLTRFVQTLLDRKDRMSMATGLEV", "match": "G GL+   L       G+    Y++  K + V PG  A EA   + +  +L RFV+  +   D  +M   +++", "sequence_from_db": "GLGLYHTYLTVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANIGGVDNAAMQQAIDL", "sequence_from_broadstreet": "MQQRQSILWGALATLMWAGLVHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFAPWLKGSVFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTMLPGLGLYHTYLTVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANIGGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYPVSEQTLLAGNSPAMIYNAIPAVPAPAAAGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVMLANRNSPIEARIKAAHAILTQLAR", "dna_sequence_from_broadstreet": "ATGCAACAACGACAATCCATCCTGTGGGGCGCTCTGGCCACCTTGATGTGGGCCGGCTTGGTTCATGCCGGTGACAAGGCGGCGACCGATCCCCTGCGCCCCGTGGTGGATGCCAGCATCCGGCCGCTGCTCAAGGAGCACAGGATCCCGGGCATGGCGGTGGCCGTGCTCAAGGATGGCAAGGCCCACTATTTCAACTACGGTGTGGCCGATCGGGAGCGCGCAGTCGGTGTCAGCGAGCAGACCCTGTTCGAGATAGGTTCCGTGAGCAAGACCCTGACCGCGACGCTGGGGGCCTACGCCGTGGTGCAGGGGAGCTTCGAGCTCGATGACAAGGCGAGTCTGTTCGCCCCCTGGCTCAAGGGATCCGTCTTTGACAACATCACCATGGGGGAGCTGGCTACCTACAGCGCAGGCGGCTTGCCGCTGCAATTCCCCGAGGAGGTGGATTCGCTCGAGAAGATGCAGGCCTACTACCGCCAGTGGACTCCAGCCTACTCGCCGGGTTCCCATCGCCAGTACGCCAACCCCAGCATCGGGCTCTTTGGCTATCTGGCGGCGAGCAGCATGAAGCAGCCGTTCGATCGCCTGATGGAGCAGACGATGCTGCCGGGGCTAGGCCTGTACCATACTTACCTCACTGTGCCCGAGCAGGCCATGGGGCACTACGCCTACGGCTACTCGAAGGAGGACAAGCCGATCCGCGTCACTCCCGGCATGCTGGCGGACGAGGCCTACGGCATCAAGACCAGTTCGGCGGATCTGCTGCGCTTTGTGAAGGCGAACATCGGCGGGGTGGATAATGCGGCCATGCAGCAGGCCATCGACCTGACTCACCAGGGCCAGTATGCGGTGGGGGAGATGACCCAGGGACTGGGCTGGGAGCGTTACGCCTATCCCGTCAGCGAGCAGACGCTGCTGGCGGGCAACTCCCCGGCGATGATTTACAATGCCATCCCGGCTGTGCCCGCGCCCGCTGCGGCAGGCCACCCTGTGCTTTTCAACAAGACCGGCTCGACCAATGGCTTCGGGGCTTATGTGGCCTTCGTGCCGGCCAAAGGGATCGGCATCGTCATGCTGGCCAATCGCAACTCTCCCATCGAGGCGCGCATCAAGGCGGCTCACGCAATCCTGACGCAACTGGCCAGGTAA", "partial": "0", "query_start": 4925, "query_end": 5143, "hit_start": 612, "hit_end": 831, "orf_dna_sequence": "GTGGCGCCGCGCGGGACAAGTGAGGACCGGCCGATGTGCGGAATCGCCGGCTGGATCGATTTCGAACGCAATCTGGCGCAGGAGCGGGCGACGGCCTGGGCCATGACGGACACCATGGCCTGCCGGGGCCCGGACGACGCGGGCCTGTGGACCGGTGGCCACGCGGCGCTCGGCCACCGCAGGCTGGCCGTCATCGACCCGGCGCACGGGCGGCAGCCGATGCACAGCACGCTGCCGGACGGCACGAGCCACGTCATCACGTTCAGCGGGGAGATCTACAACTTCCGTGAACTGCGGGTCGAGCTGGAGTCCCAGGGGCACCGCTTCCGTACCCACTGCGACACGGAGGTGGTGCTGCACGGCTACACCCGGTGGGGCCGGGAGCTGGTGGACCGGCTCAACGGCATGTACGCGTTCGCCGTGTGGGACGAGGCCCGGCAGGAACTGCTGCTGGTCCGCGACCGGATGGGGGTCAAGCCGCTCTACTACCACCCCACCGCCACCGGTGTGCTGTTCGGCTCCGAGCCGAAGGCCGTGCTCGCGCACCCCTCGCTGCGGCGGCGGGTGACGGCCGAGGGCCTGTGCGAGGTGCTGGACATGGTCAAGACCCCCGGCCGGACCGTCTTCTCCGGTATGCGCGAGGTGCTGCCGGGCGAGATGGTCACCGTCGGGCGCTCCGGTGTGGCCCGCAGGCGGTACTGGACGCTCCAGGCGCGGGAGCACACCGACGATCTGGAGACCACCATCGCCACGGTGCGCGGCCTGCTGACGGACAGGGTGCGCCGGCAGCTGGTCTCCGATGTGCCGCTGTGCACCCTGCTCTCCGGCGGGCTGGACTCGTCGGCGGTGACGGCGCTGGCGGCGCGGGCGGGCGACGGGCCGGTCCGTACGTTCTCGGTGGACTTCTCCGGCGCGGGCACCCGGTTCCAGCCGGACGCCGTACGGGGCAACACGGACGCGCCGTACGTCCAGGAGATGGTGCGGCACGTGGCGGCGGACCATACGGAAGTCGTGCTGGACAGCGCCGATCTCGCGGCACCCGAGGTGCGTGCCGCCGTCCTGGGGGCCACCGACCTGCCCCCGGCGTTCTGGGGCGACATGTGGCCCTCGCTGTACCTGTTCTTCCGGCAGGTGCGGCAGCACTGCACGGTGGCCCTGTCGGGCGAGGCGGCGGACGAACTCTTCGGCGGTTACCGGTGGTTCCACCGGACGGCGGCCATCGACGCCGGTACGTTCCCCTGGCTGACCGCCGGCTCGGCCCGGTACTTCGGCGGCCGGGGCCTGTTCGACCGCAAGCTGCTGGACAAGCTCGACCTGCCGGGCTACCAGCGCGACCGGTACGCCGAGGCCCGTAAGGAAGTCCCCGTCCTGCCCGGCGAGGACGCGCGGGAGGCGGAGCTGCGCCGGGTGACCTACCTCAACCTCACCCGCTTCGTGCAGACCCTGCTGGACCGCAAGGACCGGATGAGCATGGCGACCGGCCTGGAGGTGCGGGTGCCGTTCTGCGACCACCGGCTGGTCGACTACGTCTTCAACGTGCCGTGGGCCATGAAGTCCTTCGACGGCAGGGAGAAGAGCCTGCTGCGGGCCGCGGTGCGCGACCTGCTGCCGGAGTCGGTGGTCACCCGGGTCAAGACGCCCTACCCCGCCACACAGGACCCGGTCTACGAGCGGCTGTTGCGCGACGAACTGGCCGCGCTGCTGGCCGACAGCCAGGCGCCGGTCCGCGAACTGCTCGACCTGGGTCGGGCGCGCGACCTGCTGCGGCGGCCGGTCGGCGCCGTCAGCCAACCGTACGACCGCGGCAGTCTGGAGCTGGTCCTGTGGATGAACACCTGGCTGGCGGAGTACGGCGTCAGCCTGGAGCTATGA", "orf_prot_sequence": "MAPRGTSEDRPMCGIAGWIDFERNLAQERATAWAMTDTMACRGPDDAGLWTGGHAALGHRRLAVIDPAHGRQPMHSTLPDGTSHVITFSGEIYNFRELRVELESQGHRFRTHCDTEVVLHGYTRWGRELVDRLNGMYAFAVWDEARQELLLVRDRMGVKPLYYHPTATGVLFGSEPKAVLAHPSLRRRVTAEGLCEVLDMVKTPGRTVFSGMREVLPGEMVTVGRSGVARRRYWTLQAREHTDDLETTIATVRGLLTDRVRRQLVSDVPLCTLLSGGLDSSAVTALAARAGDGPVRTFSVDFSGAGTRFQPDAVRGNTDAPYVQEMVRHVAADHTEVVLDSADLAAPEVRAAVLGATDLPPAFWGDMWPSLYLFFRQVRQHCTVALSGEAADELFGGYRWFHRTAAIDAGTFPWLTAGSARYFGGRGLFDRKLLDKLDLPGYQRDRYAEARKEVPVLPGEDAREAELRRVTYLNLTRFVQTLLDRKDRMSMATGLEVRVPFCDHRLVDYVFNVPWAMKSFDGREKSLLRAAVRDLLPESVVTRVKTPYPATQDPVYERLLRDELAALLADSQAPVRELLDLGRARDLLRRPVGAVSQPYDRGSLELVLWMNTWLAEYGVSLEL", "perc_identity": 26.03}, "gnl|BL_ORD_ID|1261|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3653, "orf_end": 5524, "orf_from": "BGC0000254.1|Oxytetracycline_5 ", "model_name": "MOX-6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "1376", "ARO_accession": "3002185", "ARO_name": "MOX-6", "ARO_category": {"36222": {"category_aro_accession": "3000083", "category_aro_cvterm_id": "36222", "category_aro_name": "MOX beta-lactamase", "category_aro_description": "MOX beta-lactamases are plasmid-mediated AmpC-type beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.61706, "max_identities": 19, "bit_score": 27.335, "cvterm_id": "36936", "query": "GRGLFDRKLLDKLDLPGYQRDRYAEARKEVPVLPGEDAREAELRRVTYLNLTRFVQTLLDRKDRMSMATGLEV", "match": "G GL+   L       G+    Y++  K + V PG  A EA   + +  +L RFV+  +   D  +M   +++", "sequence_from_db": "GLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDL", "sequence_from_broadstreet": "MQQRQSILWGVLPTLMWAGLAHAGDRAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFAPWLKGSVFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTILPGLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYPVSEQTLLAGNSAAMIYNANPAAPAPAARGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVMLANRNSPIEGTLKAGHAILTQLAR", "dna_sequence_from_broadstreet": "ATGCAACAACGACAATCCATCCTGTGGGGCGTTCTGCCCACCCTGATGTGGGCCGGCCTGGCCCATGCAGGTGACAGGGCGGCGACCGATCCCCTGCGCCCCGTGGTGGATGCCAGCATCCGGCCGCTGCTCAAGGAGCACAGGATCCCGGGCATGGCGGTGGCCGTGCTCAAGGATGGCAAGGCCCACTATTTCAACTACGGTGTGGCCGATCGGGAGCGCGCAGTCGGTGTCAGCGAGCAGACCCTGTTCGAGATAGGTTCCGTGAGCAAGACCCTGACCGCGACGCTGGGGGCCTACGCCGTGGTGCAGGGGAGCTTCGAGCTCGATGACAAGGCGAGTCTGTTCGCCCCCTGGCTCAAGGGATCCGTCTTTGACAACATCACCATGGGGGAGCTGGCTACCTACAGCGCGGGCGGCTTGCCGCTGCAATTCCCCGAGGAGGTGGATTCGCTCGAGAAGATGCAGGCCTACTACCGCCAGTGGACCCCAGCCTACTCGCCGGGTTCCCATCGCCAGTACGCCAACCCCAGCATCGGGCTCTTTGGCTATCTGGCGGCGAGCAGCATGAAGCAGCCGTTCGATCGCCTGATGGAGCAGACGATCCTGCCGGGGCTTGGCCTGTACCATACCTACCTCAATGTGCCCGAGCAGGCCATGGGGCACTACGCCTACGGCTACTCGAAGGAGGACAAGCCCATCCGCGTCACTCCCGGCATGCTGGCGGACGAGGCCTACGGCATCAAGACCAGCTCGGCGGATCTGCTGCGCTTTGTGAAGGCCAACATCAGCGGGGTGGATAATGCGGCCATGCAGCAGGCCATCGACCTGACTCACCAGGGGCAGTATGCGGTGGGGGAGATGACCCAGGGACTGGGCTGGGAGCGTTACGCCTATCCCGTCAGCGAGCAGACGCTGCTGGCGGGCAACTCCGCGGCGATGATTTACAATGCGAACCCGGCTGCGCCCGCGCCCGCTGCAAGGGGGCACCCTGTGCTCTTCAACAAGACCGGCTCGACCAACGGCTTCGGGGCCTATGTGGCCTTCGTGCCGGCCAAAGGGATCGGCATCGTCATGCTGGCCAATCGCAACTCTCCCATCGAGGGCACGCTCAAGGCGGGCCACGCCATCCTGACGCAACTGGCCAGGTAA", "partial": "0", "query_start": 4925, "query_end": 5143, "hit_start": 612, "hit_end": 831, "orf_dna_sequence": "GTGGCGCCGCGCGGGACAAGTGAGGACCGGCCGATGTGCGGAATCGCCGGCTGGATCGATTTCGAACGCAATCTGGCGCAGGAGCGGGCGACGGCCTGGGCCATGACGGACACCATGGCCTGCCGGGGCCCGGACGACGCGGGCCTGTGGACCGGTGGCCACGCGGCGCTCGGCCACCGCAGGCTGGCCGTCATCGACCCGGCGCACGGGCGGCAGCCGATGCACAGCACGCTGCCGGACGGCACGAGCCACGTCATCACGTTCAGCGGGGAGATCTACAACTTCCGTGAACTGCGGGTCGAGCTGGAGTCCCAGGGGCACCGCTTCCGTACCCACTGCGACACGGAGGTGGTGCTGCACGGCTACACCCGGTGGGGCCGGGAGCTGGTGGACCGGCTCAACGGCATGTACGCGTTCGCCGTGTGGGACGAGGCCCGGCAGGAACTGCTGCTGGTCCGCGACCGGATGGGGGTCAAGCCGCTCTACTACCACCCCACCGCCACCGGTGTGCTGTTCGGCTCCGAGCCGAAGGCCGTGCTCGCGCACCCCTCGCTGCGGCGGCGGGTGACGGCCGAGGGCCTGTGCGAGGTGCTGGACATGGTCAAGACCCCCGGCCGGACCGTCTTCTCCGGTATGCGCGAGGTGCTGCCGGGCGAGATGGTCACCGTCGGGCGCTCCGGTGTGGCCCGCAGGCGGTACTGGACGCTCCAGGCGCGGGAGCACACCGACGATCTGGAGACCACCATCGCCACGGTGCGCGGCCTGCTGACGGACAGGGTGCGCCGGCAGCTGGTCTCCGATGTGCCGCTGTGCACCCTGCTCTCCGGCGGGCTGGACTCGTCGGCGGTGACGGCGCTGGCGGCGCGGGCGGGCGACGGGCCGGTCCGTACGTTCTCGGTGGACTTCTCCGGCGCGGGCACCCGGTTCCAGCCGGACGCCGTACGGGGCAACACGGACGCGCCGTACGTCCAGGAGATGGTGCGGCACGTGGCGGCGGACCATACGGAAGTCGTGCTGGACAGCGCCGATCTCGCGGCACCCGAGGTGCGTGCCGCCGTCCTGGGGGCCACCGACCTGCCCCCGGCGTTCTGGGGCGACATGTGGCCCTCGCTGTACCTGTTCTTCCGGCAGGTGCGGCAGCACTGCACGGTGGCCCTGTCGGGCGAGGCGGCGGACGAACTCTTCGGCGGTTACCGGTGGTTCCACCGGACGGCGGCCATCGACGCCGGTACGTTCCCCTGGCTGACCGCCGGCTCGGCCCGGTACTTCGGCGGCCGGGGCCTGTTCGACCGCAAGCTGCTGGACAAGCTCGACCTGCCGGGCTACCAGCGCGACCGGTACGCCGAGGCCCGTAAGGAAGTCCCCGTCCTGCCCGGCGAGGACGCGCGGGAGGCGGAGCTGCGCCGGGTGACCTACCTCAACCTCACCCGCTTCGTGCAGACCCTGCTGGACCGCAAGGACCGGATGAGCATGGCGACCGGCCTGGAGGTGCGGGTGCCGTTCTGCGACCACCGGCTGGTCGACTACGTCTTCAACGTGCCGTGGGCCATGAAGTCCTTCGACGGCAGGGAGAAGAGCCTGCTGCGGGCCGCGGTGCGCGACCTGCTGCCGGAGTCGGTGGTCACCCGGGTCAAGACGCCCTACCCCGCCACACAGGACCCGGTCTACGAGCGGCTGTTGCGCGACGAACTGGCCGCGCTGCTGGCCGACAGCCAGGCGCCGGTCCGCGAACTGCTCGACCTGGGTCGGGCGCGCGACCTGCTGCGGCGGCCGGTCGGCGCCGTCAGCCAACCGTACGACCGCGGCAGTCTGGAGCTGGTCCTGTGGATGAACACCTGGCTGGCGGAGTACGGCGTCAGCCTGGAGCTATGA", "orf_prot_sequence": "MAPRGTSEDRPMCGIAGWIDFERNLAQERATAWAMTDTMACRGPDDAGLWTGGHAALGHRRLAVIDPAHGRQPMHSTLPDGTSHVITFSGEIYNFRELRVELESQGHRFRTHCDTEVVLHGYTRWGRELVDRLNGMYAFAVWDEARQELLLVRDRMGVKPLYYHPTATGVLFGSEPKAVLAHPSLRRRVTAEGLCEVLDMVKTPGRTVFSGMREVLPGEMVTVGRSGVARRRYWTLQAREHTDDLETTIATVRGLLTDRVRRQLVSDVPLCTLLSGGLDSSAVTALAARAGDGPVRTFSVDFSGAGTRFQPDAVRGNTDAPYVQEMVRHVAADHTEVVLDSADLAAPEVRAAVLGATDLPPAFWGDMWPSLYLFFRQVRQHCTVALSGEAADELFGGYRWFHRTAAIDAGTFPWLTAGSARYFGGRGLFDRKLLDKLDLPGYQRDRYAEARKEVPVLPGEDAREAELRRVTYLNLTRFVQTLLDRKDRMSMATGLEVRVPFCDHRLVDYVFNVPWAMKSFDGREKSLLRAAVRDLLPESVVTRVKTPYPATQDPVYERLLRDELAALLADSQAPVRELLDLGRARDLLRRPVGAVSQPYDRGSLELVLWMNTWLAEYGVSLEL", "perc_identity": 26.03}, "gnl|BL_ORD_ID|3703|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3653, "orf_end": 5524, "orf_from": "BGC0000254.1|Oxytetracycline_5 ", "model_name": "MOX-12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4773", "ARO_accession": "3006477", "ARO_name": "MOX-12", "ARO_category": {"36222": {"category_aro_accession": "3000083", "category_aro_cvterm_id": "36222", "category_aro_name": "MOX beta-lactamase", "category_aro_description": "MOX beta-lactamases are plasmid-mediated AmpC-type beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.86276, "max_identities": 19, "bit_score": 26.9498, "cvterm_id": "37047", "query": "GRGLFDRKLLDKLDLPGYQRDRYAEARKEVPVLPGEDAREAELRRVTYLNLTRFVQTLLDRKDRMSMATGLEV", "match": "G GL+   L       G+    Y++  K + V PG  A EA   + +  +L RFV+  +   D  +M   +++", "sequence_from_db": "GLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDL", "sequence_from_broadstreet": "MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGGFELDDKASLFAPWLKGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTILPGLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYPVSEQTLLAGNSPAMIYNTNPAAPAPAAAGHPVLFNKTGSTNGFGAYVAFVPAKGIGVVMLANRNYPNEARIKAAHAILTKLAR", "dna_sequence_from_broadstreet": "ATGCAACAACGACAATCCATCCTGTGGGGCGCTCTGGCCACCCTGATGTGGGCCGGCCTGGCTCATGCCGGTGACAAGGCGGCGACCGATCCCCTGCGCCCCGTGGTGGATGCCAGCATCCGGCCGCTGCTCAAGGAGCACAGGATCCCGGGCATGGCGGTGGCCGTGCTCAAGGATGGCAAGGCCCACTATTTCAACTACGGTGTGGCCGATCGGGAGCGCGCGGTCGGTGTCAGCGAGCAGACCCTGTTCGAGATAGGCTCCGTGAGCAAGACCCTGACCGCGACGCTGGGGGCCTACGCCGTGGTGCAGGGGGGCTTCGAGCTCGATGACAAGGCGAGTCTGTTCGCCCCCTGGCTCAAGGGATCCGCCTTTGACAACATCACCATGGGGGAGCTGGCTACCTACAGCGCAGGCGGCTTGCCGCTGCAATTCCCCGAGGAGGTGGATTCGCTCGAGAAGATGCAGGCCTACTACCGCCAGTGGACCCCAGCCTACTCGCCGGGTTCCCATCGCCAGTACGCCAACCCCAGCATCGGGCTCTTTGGCTATCTGGCGGCGAGCAGCATGAAGCAGCCGTTCGATCGCCTGATGGAGCAGACGATCCTGCCGGGGCTTGGCCTGTACCATACCTACCTCAATGTGCCCGAGCAGGCCATGGGGCACTACGCCTACGGCTACTCGAAGGAGGACAAGCCCATCCGCGTCACTCCCGGCATGCTGGCGGACGAGGCCTACGGCATCAAGACCAGCTCGGCGGATCTGCTGCGCTTTGTGAAGGCGAACATCAGCGGGGTGGATAATGCGGCCATGCAGCAGGCCATCGACCTGACTCACCAGGGCCAGTATGCGGTGGGGGAGATGACCCAGGGACTGGGCTGGGAGCGTTACGCCTATCCCGTCAGCGAGCAGACGCTGCTGGCGGGCAACTCCCCGGCGATGATTTATAATACGAACCCGGCGGCGCCCGCGCCCGCTGCGGCAGGGCACCCTGTGCTCTTCAACAAGACCGGCTCGACCAACGGCTTCGGGGCCTATGTGGCCTTCGTGCCGGCCAAAGGGATCGGCGTCGTCATGCTGGCCAATCGCAACTACCCCAACGAGGCGCGCATCAAGGCGGCTCACGCCATCCTGACGAAACTGGCCAGGTAA", "partial": "0", "query_start": 4925, "query_end": 5143, "hit_start": 612, "hit_end": 831, "orf_dna_sequence": "GTGGCGCCGCGCGGGACAAGTGAGGACCGGCCGATGTGCGGAATCGCCGGCTGGATCGATTTCGAACGCAATCTGGCGCAGGAGCGGGCGACGGCCTGGGCCATGACGGACACCATGGCCTGCCGGGGCCCGGACGACGCGGGCCTGTGGACCGGTGGCCACGCGGCGCTCGGCCACCGCAGGCTGGCCGTCATCGACCCGGCGCACGGGCGGCAGCCGATGCACAGCACGCTGCCGGACGGCACGAGCCACGTCATCACGTTCAGCGGGGAGATCTACAACTTCCGTGAACTGCGGGTCGAGCTGGAGTCCCAGGGGCACCGCTTCCGTACCCACTGCGACACGGAGGTGGTGCTGCACGGCTACACCCGGTGGGGCCGGGAGCTGGTGGACCGGCTCAACGGCATGTACGCGTTCGCCGTGTGGGACGAGGCCCGGCAGGAACTGCTGCTGGTCCGCGACCGGATGGGGGTCAAGCCGCTCTACTACCACCCCACCGCCACCGGTGTGCTGTTCGGCTCCGAGCCGAAGGCCGTGCTCGCGCACCCCTCGCTGCGGCGGCGGGTGACGGCCGAGGGCCTGTGCGAGGTGCTGGACATGGTCAAGACCCCCGGCCGGACCGTCTTCTCCGGTATGCGCGAGGTGCTGCCGGGCGAGATGGTCACCGTCGGGCGCTCCGGTGTGGCCCGCAGGCGGTACTGGACGCTCCAGGCGCGGGAGCACACCGACGATCTGGAGACCACCATCGCCACGGTGCGCGGCCTGCTGACGGACAGGGTGCGCCGGCAGCTGGTCTCCGATGTGCCGCTGTGCACCCTGCTCTCCGGCGGGCTGGACTCGTCGGCGGTGACGGCGCTGGCGGCGCGGGCGGGCGACGGGCCGGTCCGTACGTTCTCGGTGGACTTCTCCGGCGCGGGCACCCGGTTCCAGCCGGACGCCGTACGGGGCAACACGGACGCGCCGTACGTCCAGGAGATGGTGCGGCACGTGGCGGCGGACCATACGGAAGTCGTGCTGGACAGCGCCGATCTCGCGGCACCCGAGGTGCGTGCCGCCGTCCTGGGGGCCACCGACCTGCCCCCGGCGTTCTGGGGCGACATGTGGCCCTCGCTGTACCTGTTCTTCCGGCAGGTGCGGCAGCACTGCACGGTGGCCCTGTCGGGCGAGGCGGCGGACGAACTCTTCGGCGGTTACCGGTGGTTCCACCGGACGGCGGCCATCGACGCCGGTACGTTCCCCTGGCTGACCGCCGGCTCGGCCCGGTACTTCGGCGGCCGGGGCCTGTTCGACCGCAAGCTGCTGGACAAGCTCGACCTGCCGGGCTACCAGCGCGACCGGTACGCCGAGGCCCGTAAGGAAGTCCCCGTCCTGCCCGGCGAGGACGCGCGGGAGGCGGAGCTGCGCCGGGTGACCTACCTCAACCTCACCCGCTTCGTGCAGACCCTGCTGGACCGCAAGGACCGGATGAGCATGGCGACCGGCCTGGAGGTGCGGGTGCCGTTCTGCGACCACCGGCTGGTCGACTACGTCTTCAACGTGCCGTGGGCCATGAAGTCCTTCGACGGCAGGGAGAAGAGCCTGCTGCGGGCCGCGGTGCGCGACCTGCTGCCGGAGTCGGTGGTCACCCGGGTCAAGACGCCCTACCCCGCCACACAGGACCCGGTCTACGAGCGGCTGTTGCGCGACGAACTGGCCGCGCTGCTGGCCGACAGCCAGGCGCCGGTCCGCGAACTGCTCGACCTGGGTCGGGCGCGCGACCTGCTGCGGCGGCCGGTCGGCGCCGTCAGCCAACCGTACGACCGCGGCAGTCTGGAGCTGGTCCTGTGGATGAACACCTGGCTGGCGGAGTACGGCGTCAGCCTGGAGCTATGA", "orf_prot_sequence": "MAPRGTSEDRPMCGIAGWIDFERNLAQERATAWAMTDTMACRGPDDAGLWTGGHAALGHRRLAVIDPAHGRQPMHSTLPDGTSHVITFSGEIYNFRELRVELESQGHRFRTHCDTEVVLHGYTRWGRELVDRLNGMYAFAVWDEARQELLLVRDRMGVKPLYYHPTATGVLFGSEPKAVLAHPSLRRRVTAEGLCEVLDMVKTPGRTVFSGMREVLPGEMVTVGRSGVARRRYWTLQAREHTDDLETTIATVRGLLTDRVRRQLVSDVPLCTLLSGGLDSSAVTALAARAGDGPVRTFSVDFSGAGTRFQPDAVRGNTDAPYVQEMVRHVAADHTEVVLDSADLAAPEVRAAVLGATDLPPAFWGDMWPSLYLFFRQVRQHCTVALSGEAADELFGGYRWFHRTAAIDAGTFPWLTAGSARYFGGRGLFDRKLLDKLDLPGYQRDRYAEARKEVPVLPGEDAREAELRRVTYLNLTRFVQTLLDRKDRMSMATGLEVRVPFCDHRLVDYVFNVPWAMKSFDGREKSLLRAAVRDLLPESVVTRVKTPYPATQDPVYERLLRDELAALLADSQAPVRELLDLGRARDLLRRPVGAVSQPYDRGSLELVLWMNTWLAEYGVSLEL", "perc_identity": 26.03}, "gnl|BL_ORD_ID|3704|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3653, "orf_end": 5524, "orf_from": "BGC0000254.1|Oxytetracycline_5 ", "model_name": "MOX-13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4774", "ARO_accession": "3006478", "ARO_name": "MOX-13", "ARO_category": {"36222": {"category_aro_accession": "3000083", "category_aro_cvterm_id": "36222", "category_aro_name": "MOX beta-lactamase", "category_aro_description": "MOX beta-lactamases are plasmid-mediated AmpC-type beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.25602, "max_identities": 19, "bit_score": 26.9498, "cvterm_id": "43553", "query": "GRGLFDRKLLDKLDLPGYQRDRYAEARKEVPVLPGEDAREAELRRVTYLNLTRFVQTLLDRKDRMSMATGLEV", "match": "G GL+   L       G+    Y++  K + V PG  A EA   + +  +L RFV+  +   D  +M   +++", "sequence_from_db": "GLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDL", "sequence_from_broadstreet": "MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRILGMAVAVLKDGKAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGSFELDDKASLFASWLKGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIGLFGYLAASSMKQPFDRLMEQTILPGLGLYHTYLNVPEQAMGHYAYGYSKEDKPIRVTPGMLADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYPVSEQTLLAGNSPAMIYNANPAAPAPAATGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVMLANRNYPNEARIKAAHAILTQLAR", "dna_sequence_from_broadstreet": "ATGCAACAACGACAATCCATCCTGTGGGGCGCTCTGGCCACCCTGATGTGGGCCGGTCTGGCTCATGCCGGTGACAAGGCGGCGACCGATCCCCTGCGCCCCGTGGTGGATGCCAGCATCCGGCCGCTGCTCAAGGAGCACAGGATCCTGGGCATGGCGGTGGCCGTGCTCAAGGATGGCAAGGCCCACTATTTCAACTACGGTGTGGCCGATCGGGAGCGCGCAGTCGGTGTCAGCGAGCAGACCCTGTTCGAGATAGGTTCCGTGAGCAAGACCCTGACCGCGACGCTGGGGGCCTACGCCGTGGTGCAGGGGAGCTTCGAGCTCGATGACAAGGCGAGTCTGTTCGCCTCCTGGCTCAAGGGATCCGCCTTTGACAACATCACCATGGGGGAGCTGGCTACCTACAGCGCGGGCGGCTTGCCGCTGCAATTCCCCGAGGAGGTGGATTCGCTCGAGAAGATGCAGGCCTACTACCGCCAGTGGACCCCAGCCTACTCGCCGGGTTCCCATCGCCAGTACGCCAACCCCAGCATCGGGCTCTTTGGCTATCTGGCGGCGAGCAGCATGAAGCAGCCGTTCGATCGCCTGATGGAGCAGACGATCCTGCCGGGGCTTGGCCTGTACCATACCTACCTCAATGTGCCCGAGCAGGCCATGGGGCACTACGCCTACGGCTACTCGAAGGAGGACAAGCCCATCCGCGTCACTCCCGGCATGCTGGCGGACGAGGCCTACGGCATCAAGACCAGCTCGGCGGATCTGCTGCGCTTTGTGAAGGCCAACATCAGCGGGGTGGATAATGCGGCCATGCAGCAGGCCATCGATCTGACTCACCAGGGCCAGTATGCGGTGGGGGAGATGACCCAGGGACTGGGCTGGGAGCGTTACGCCTATCCCGTCAGCGAGCAGACGCTGCTGGCGGGCAACTCCCCGGCGATGATTTACAATGCCAACCCGGCGGCGCCCGCGCCCGCTGCAACAGGGCACCCTGTGCTCTTCAACAAGACCGGCTCGACCAACGGCTTCGGGGCCTATGTGGCTTTCGTGCCGGCCAAAGGGATCGGCATCGTCATGCTGGCCAATCGCAACTACCCCAACGAGGCGCGCATCAAGGCGGCCCACGCCATCCTGACGCAACTGGCCAGGTAA", "partial": "0", "query_start": 4925, "query_end": 5143, "hit_start": 612, "hit_end": 831, "orf_dna_sequence": "GTGGCGCCGCGCGGGACAAGTGAGGACCGGCCGATGTGCGGAATCGCCGGCTGGATCGATTTCGAACGCAATCTGGCGCAGGAGCGGGCGACGGCCTGGGCCATGACGGACACCATGGCCTGCCGGGGCCCGGACGACGCGGGCCTGTGGACCGGTGGCCACGCGGCGCTCGGCCACCGCAGGCTGGCCGTCATCGACCCGGCGCACGGGCGGCAGCCGATGCACAGCACGCTGCCGGACGGCACGAGCCACGTCATCACGTTCAGCGGGGAGATCTACAACTTCCGTGAACTGCGGGTCGAGCTGGAGTCCCAGGGGCACCGCTTCCGTACCCACTGCGACACGGAGGTGGTGCTGCACGGCTACACCCGGTGGGGCCGGGAGCTGGTGGACCGGCTCAACGGCATGTACGCGTTCGCCGTGTGGGACGAGGCCCGGCAGGAACTGCTGCTGGTCCGCGACCGGATGGGGGTCAAGCCGCTCTACTACCACCCCACCGCCACCGGTGTGCTGTTCGGCTCCGAGCCGAAGGCCGTGCTCGCGCACCCCTCGCTGCGGCGGCGGGTGACGGCCGAGGGCCTGTGCGAGGTGCTGGACATGGTCAAGACCCCCGGCCGGACCGTCTTCTCCGGTATGCGCGAGGTGCTGCCGGGCGAGATGGTCACCGTCGGGCGCTCCGGTGTGGCCCGCAGGCGGTACTGGACGCTCCAGGCGCGGGAGCACACCGACGATCTGGAGACCACCATCGCCACGGTGCGCGGCCTGCTGACGGACAGGGTGCGCCGGCAGCTGGTCTCCGATGTGCCGCTGTGCACCCTGCTCTCCGGCGGGCTGGACTCGTCGGCGGTGACGGCGCTGGCGGCGCGGGCGGGCGACGGGCCGGTCCGTACGTTCTCGGTGGACTTCTCCGGCGCGGGCACCCGGTTCCAGCCGGACGCCGTACGGGGCAACACGGACGCGCCGTACGTCCAGGAGATGGTGCGGCACGTGGCGGCGGACCATACGGAAGTCGTGCTGGACAGCGCCGATCTCGCGGCACCCGAGGTGCGTGCCGCCGTCCTGGGGGCCACCGACCTGCCCCCGGCGTTCTGGGGCGACATGTGGCCCTCGCTGTACCTGTTCTTCCGGCAGGTGCGGCAGCACTGCACGGTGGCCCTGTCGGGCGAGGCGGCGGACGAACTCTTCGGCGGTTACCGGTGGTTCCACCGGACGGCGGCCATCGACGCCGGTACGTTCCCCTGGCTGACCGCCGGCTCGGCCCGGTACTTCGGCGGCCGGGGCCTGTTCGACCGCAAGCTGCTGGACAAGCTCGACCTGCCGGGCTACCAGCGCGACCGGTACGCCGAGGCCCGTAAGGAAGTCCCCGTCCTGCCCGGCGAGGACGCGCGGGAGGCGGAGCTGCGCCGGGTGACCTACCTCAACCTCACCCGCTTCGTGCAGACCCTGCTGGACCGCAAGGACCGGATGAGCATGGCGACCGGCCTGGAGGTGCGGGTGCCGTTCTGCGACCACCGGCTGGTCGACTACGTCTTCAACGTGCCGTGGGCCATGAAGTCCTTCGACGGCAGGGAGAAGAGCCTGCTGCGGGCCGCGGTGCGCGACCTGCTGCCGGAGTCGGTGGTCACCCGGGTCAAGACGCCCTACCCCGCCACACAGGACCCGGTCTACGAGCGGCTGTTGCGCGACGAACTGGCCGCGCTGCTGGCCGACAGCCAGGCGCCGGTCCGCGAACTGCTCGACCTGGGTCGGGCGCGCGACCTGCTGCGGCGGCCGGTCGGCGCCGTCAGCCAACCGTACGACCGCGGCAGTCTGGAGCTGGTCCTGTGGATGAACACCTGGCTGGCGGAGTACGGCGTCAGCCTGGAGCTATGA", "orf_prot_sequence": "MAPRGTSEDRPMCGIAGWIDFERNLAQERATAWAMTDTMACRGPDDAGLWTGGHAALGHRRLAVIDPAHGRQPMHSTLPDGTSHVITFSGEIYNFRELRVELESQGHRFRTHCDTEVVLHGYTRWGRELVDRLNGMYAFAVWDEARQELLLVRDRMGVKPLYYHPTATGVLFGSEPKAVLAHPSLRRRVTAEGLCEVLDMVKTPGRTVFSGMREVLPGEMVTVGRSGVARRRYWTLQAREHTDDLETTIATVRGLLTDRVRRQLVSDVPLCTLLSGGLDSSAVTALAARAGDGPVRTFSVDFSGAGTRFQPDAVRGNTDAPYVQEMVRHVAADHTEVVLDSADLAAPEVRAAVLGATDLPPAFWGDMWPSLYLFFRQVRQHCTVALSGEAADELFGGYRWFHRTAAIDAGTFPWLTAGSARYFGGRGLFDRKLLDKLDLPGYQRDRYAEARKEVPVLPGEDAREAELRRVTYLNLTRFVQTLLDRKDRMSMATGLEVRVPFCDHRLVDYVFNVPWAMKSFDGREKSLLRAAVRDLLPESVVTRVKTPYPATQDPVYERLLRDELAALLADSQAPVRELLDLGRARDLLRRPVGAVSQPYDRGSLELVLWMNTWLAEYGVSLEL", "perc_identity": 26.03}, "gnl|BL_ORD_ID|3404|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 3653, "orf_end": 5524, "orf_from": "BGC0000254.1|Oxytetracycline_5 ", "model_name": "CMY-159", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "4473", "ARO_accession": "3006458", "ARO_name": "CMY-159", "ARO_category": {"36208": {"category_aro_accession": "3000069", "category_aro_cvterm_id": "36208", "category_aro_name": "CMY beta-lactamase", "category_aro_description": "CMY beta-lactamases are plasmid-mediated class C beta-lactamases that encodes for resistance to cephamycins.", "category_aro_class_name": "AMR Gene Family"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.73873, "max_identities": 28, "bit_score": 26.1794, "cvterm_id": "35914", "query": "LDLPGYQRDRYAEARKE---VPVLPGEDAREAELRRVTYLNLTRFVQTLLD--RKDRMSMATGLEVRVPFCDHRLVDYVFNVPWAMKSFDGREKSLLRAAVRDL-LPESVVTRVKTPYPATQ", "match": "+ +P  ++  YA   +E   V V PG+   EA   + + +++TR+VQ  +D  +    ++  G+E+      H + D    + W M ++     S++  +   + L    V  V  P PA +", "sequence_from_db": "ITVPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSLVDMTRWVQANMDASQVQEKTLRQGIEIAQARYWH-IGDMYQGLGWEMLNWPVNADSIINGSDSKVALAALPVVEVNPPAPAVK", "sequence_from_broadstreet": "MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYYFTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQWQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWVPGAKRLYANSSIGLFGALAVKPSGIGYEEAMTKRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSLVDMTRWVQANMDASQVQEKTLRQGIEIAQARYWHIGDMYQGLGWEMLNWPVNADSIINGSDSKVALAALPVVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCGTTATGCTGCGCGTTGCTGCTGACAGCCTCTTTCTCCACGTTTGCCGCCGCAAAAACAGAACAACAGATTGCCGATATCGTAAACCGTACCATCACACCGCTGATGCAAGAACAGGCTATTCCGGGTATGGCCGTAGCAATTATCTACCAGGGAAAACCCTATTACTTTACCTGGGGGAAAGCCGATATCGCCAATGACCGCCCCGTCACCCGGCAAACGCTGTTTGAGCTTGGATCGGTAAGTAAGACGTTTAACGGTGTGCTGGGCGGCGATGCTATCGCCCGTGGTGAAATTAAGCTCAGCGATCCGGTCACCCAATACTGGCCCGAATTAACTGGCAAACAATGGCAGGGTATCAGCCTGCTGCACCTGGCCACCTATACGGCGGGTGGTCTGCCGCTTCAGGTACCTGACGACGTTACAGATAAAGCGGCATTACTGCGCTTTTATCAAAACTGGCAGCCGCAATGGGTCCCGGGAGCTAAACGCCTGTATGCTAACTCCAGTATTGGTCTGTTTGGCGCACTGGCGGTGAAACCTTCAGGAATAGGCTATGAAGAGGCGATGACCAAACGCGTCCTGCAACCATTAAAACTGGCGCATACCTGGATTACGGTTCCACAGAGCGAACAAAAGGATTATGCCTGGGGTTATCGCGAAGGGAAGCCCGTGCACGTATCTCCGGGTCAGCTTGATGCCGAAGCCTACGGGGTGAAATCCAGCCTTGTCGATATGACTCGTTGGGTTCAGGCCAACATGGACGCCAGCCAGGTGCAGGAGAAAACGCTCCGACAGGGAATTGAAATTGCACAGGCTCGTTACTGGCATATTGGCGACATGTACCAGGGATTAGGTTGGGAGATGCTGAACTGGCCGGTGAATGCCGACTCGATAATCAACGGTAGCGACAGTAAAGTCGCGTTAGCGGCGCTTCCCGTCGTTGAGGTCAATCCGCCCGCCCCTGCAGTGAAAGCCTCATGGGTGCACAAAACCGGCTCCACTGGCGGATTTGGCAGCTACGTTGCGTTCGTTCCGGAAAAAAATCTCGGCATCGTGATGCTGGCAAACAAAAGCTACCCAAACCCTGCTCGCGTCGAGGCCGCCTGGCGTATTCTTGAAAAGCTGCAATAA", "partial": "0", "query_start": 4961, "query_end": 5308, "hit_start": 624, "hit_end": 987, "orf_dna_sequence": "GTGGCGCCGCGCGGGACAAGTGAGGACCGGCCGATGTGCGGAATCGCCGGCTGGATCGATTTCGAACGCAATCTGGCGCAGGAGCGGGCGACGGCCTGGGCCATGACGGACACCATGGCCTGCCGGGGCCCGGACGACGCGGGCCTGTGGACCGGTGGCCACGCGGCGCTCGGCCACCGCAGGCTGGCCGTCATCGACCCGGCGCACGGGCGGCAGCCGATGCACAGCACGCTGCCGGACGGCACGAGCCACGTCATCACGTTCAGCGGGGAGATCTACAACTTCCGTGAACTGCGGGTCGAGCTGGAGTCCCAGGGGCACCGCTTCCGTACCCACTGCGACACGGAGGTGGTGCTGCACGGCTACACCCGGTGGGGCCGGGAGCTGGTGGACCGGCTCAACGGCATGTACGCGTTCGCCGTGTGGGACGAGGCCCGGCAGGAACTGCTGCTGGTCCGCGACCGGATGGGGGTCAAGCCGCTCTACTACCACCCCACCGCCACCGGTGTGCTGTTCGGCTCCGAGCCGAAGGCCGTGCTCGCGCACCCCTCGCTGCGGCGGCGGGTGACGGCCGAGGGCCTGTGCGAGGTGCTGGACATGGTCAAGACCCCCGGCCGGACCGTCTTCTCCGGTATGCGCGAGGTGCTGCCGGGCGAGATGGTCACCGTCGGGCGCTCCGGTGTGGCCCGCAGGCGGTACTGGACGCTCCAGGCGCGGGAGCACACCGACGATCTGGAGACCACCATCGCCACGGTGCGCGGCCTGCTGACGGACAGGGTGCGCCGGCAGCTGGTCTCCGATGTGCCGCTGTGCACCCTGCTCTCCGGCGGGCTGGACTCGTCGGCGGTGACGGCGCTGGCGGCGCGGGCGGGCGACGGGCCGGTCCGTACGTTCTCGGTGGACTTCTCCGGCGCGGGCACCCGGTTCCAGCCGGACGCCGTACGGGGCAACACGGACGCGCCGTACGTCCAGGAGATGGTGCGGCACGTGGCGGCGGACCATACGGAAGTCGTGCTGGACAGCGCCGATCTCGCGGCACCCGAGGTGCGTGCCGCCGTCCTGGGGGCCACCGACCTGCCCCCGGCGTTCTGGGGCGACATGTGGCCCTCGCTGTACCTGTTCTTCCGGCAGGTGCGGCAGCACTGCACGGTGGCCCTGTCGGGCGAGGCGGCGGACGAACTCTTCGGCGGTTACCGGTGGTTCCACCGGACGGCGGCCATCGACGCCGGTACGTTCCCCTGGCTGACCGCCGGCTCGGCCCGGTACTTCGGCGGCCGGGGCCTGTTCGACCGCAAGCTGCTGGACAAGCTCGACCTGCCGGGCTACCAGCGCGACCGGTACGCCGAGGCCCGTAAGGAAGTCCCCGTCCTGCCCGGCGAGGACGCGCGGGAGGCGGAGCTGCGCCGGGTGACCTACCTCAACCTCACCCGCTTCGTGCAGACCCTGCTGGACCGCAAGGACCGGATGAGCATGGCGACCGGCCTGGAGGTGCGGGTGCCGTTCTGCGACCACCGGCTGGTCGACTACGTCTTCAACGTGCCGTGGGCCATGAAGTCCTTCGACGGCAGGGAGAAGAGCCTGCTGCGGGCCGCGGTGCGCGACCTGCTGCCGGAGTCGGTGGTCACCCGGGTCAAGACGCCCTACCCCGCCACACAGGACCCGGTCTACGAGCGGCTGTTGCGCGACGAACTGGCCGCGCTGCTGGCCGACAGCCAGGCGCCGGTCCGCGAACTGCTCGACCTGGGTCGGGCGCGCGACCTGCTGCGGCGGCCGGTCGGCGCCGTCAGCCAACCGTACGACCGCGGCAGTCTGGAGCTGGTCCTGTGGATGAACACCTGGCTGGCGGAGTACGGCGTCAGCCTGGAGCTATGA", "orf_prot_sequence": "MAPRGTSEDRPMCGIAGWIDFERNLAQERATAWAMTDTMACRGPDDAGLWTGGHAALGHRRLAVIDPAHGRQPMHSTLPDGTSHVITFSGEIYNFRELRVELESQGHRFRTHCDTEVVLHGYTRWGRELVDRLNGMYAFAVWDEARQELLLVRDRMGVKPLYYHPTATGVLFGSEPKAVLAHPSLRRRVTAEGLCEVLDMVKTPGRTVFSGMREVLPGEMVTVGRSGVARRRYWTLQAREHTDDLETTIATVRGLLTDRVRRQLVSDVPLCTLLSGGLDSSAVTALAARAGDGPVRTFSVDFSGAGTRFQPDAVRGNTDAPYVQEMVRHVAADHTEVVLDSADLAAPEVRAAVLGATDLPPAFWGDMWPSLYLFFRQVRQHCTVALSGEAADELFGGYRWFHRTAAIDAGTFPWLTAGSARYFGGRGLFDRKLLDKLDLPGYQRDRYAEARKEVPVLPGEDAREAELRRVTYLNLTRFVQTLLDRKDRMSMATGLEVRVPFCDHRLVDYVFNVPWAMKSFDGREKSLLRAAVRDLLPESVVTRVKTPYPATQDPVYERLLRDELAALLADSQAPVRELLDLGRARDLLRRPVGAVSQPYDRGSLELVLWMNTWLAEYGVSLEL", "perc_identity": 22.95}}, "BGC0000254.1|Oxytetracycline_6 # 5521 # 6777 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=ACGGCG;rbs_spacer=13bp;gc_cont=0.731": {"gnl|BL_ORD_ID|4833|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "Streptomyces venezuelae rox", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5820", "ARO_accession": "3007209", "ARO_name": "Streptomyces venezuelae rox", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.45598e-17, "max_identities": 121, "bit_score": 80.4925, "cvterm_id": "36873", "query": "DVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDY---------RRLPGPYNCLLSLPQ---QHLLTDLLERCRAHPRFTCLTGTKVNGL-VEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPY----DRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFP--DCVQLGWTLPHKGYQA--LAERGFAHVKERIRA-AVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRP---ETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFE", "match": "DV VVGGGP GL LA  +   G RV ++E+     R  R + L      ++   G+LE             R  ERG T+  G +          RL   ++ +L++PQ   + LL +      A  R     G  + GL  +E GV   +     ADG  +RA  VVG DG  STVRKL G+ +     R+E    ++   ++TA       +          + + P  D V     +P +G      A       K+++RA A  ++     + L+ F D +        A R+  D + L GD+AH H P G QG+NL IQDA      L   +      E  LD   A R P   E    TR Q+     ++ST     AVR   A LV      R ++ +I      + VR D+ E", "sequence_from_db": "DVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLE-------------RFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIR----RGRALVGLRQDEDGVTVDL-----ADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEM---EMTASQEELTSVMTEVRKTQQRFGAMPLGDGV-FRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATR------QAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGW-APEGLLDTYHAERHPVATEVLDNTRAQI----QLMSTEPGPQAVRRLMAELVEFENVNRYLIEKIT----AISVRYDVGE", "sequence_from_broadstreet": "MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG", "dna_sequence_from_broadstreet": "ATGTTTGACGTGATCGTTGTCGGTGGCGGTCCGACCGGCTTGATGCTGGCCGGCGAACTGCGGCTGCACGGCGTGCGCGTACTCGTGCTGGAGAAGGAGACGGAGCCGACGCGGCAGTCCCGCGCGCAGGGGCTGCACGTCCGCAGCATCGAGGTGATGGCCCAGCGCGGGCTCCTGGAGCGCTTCCTCGAACGCGGGCACACGGTCGCGGTCGGCGGCTTCTTCGCCGGTCTGGCGACCTCGTGGCCCGAGCGGCTGGACACCGCGCACTCGTACGTCCTCGCCGTCCCGCAGGTGATCACCGAGCAGCTGCTGGCCGAGCACGCCACCGCACTCGGAGCCGAGATCCGACGCGGCCGGGCACTGGTCGGTCTCCGCCAGGACGAGGACGGCGTGACGGTCGACCTGGCCGACGGCGAACAGCTGCGCGCACGGTACGTCGTCGGCTGCGACGGCGGCCGCAGCACGGTGCGCAAGCTGCTCGGCGTGGCGTTCCCCGGCGAGCCGTCCAGGGTCGAGACCCTGCTCGGCGAGATGGAGATGACCGCCTCCCAGGAGGAGTTGACCTCCGTCATGACCGAGGTCCGCAAGACCCAGCAGCGATTCGGCGCGATGCCCCTGGGGGACGGGGTCTTCCGCGTCGTCGTCCCCGCCGAGGGCGTCGCCGAGGACCGGACGGCCTCCCCGACCCTCGACGAGTTCAAGCAGCAGCTGCGGGCCCACGCCGGGACGGACTTCGGCGTGCACTCGCCCCGGTGGCTCTCCCGCTTCGGCGACGCCACCCGACAGGCCGAGCGCTACCGGGTCGACCGGGTGTTCCTCGCTGGCGACGCGGCGCACATCCACCCGCCGACCGGCGGGCAGGGCCTCAACCTCGGCATCCAGGACGCGTTCAACCTCGGCTGGAAGCTGGCCGCCGAGGTCGACGGCTGGGCGCCGGAGGGACTCCTCGACACGTACCACGCCGAGCGGCACCCGGTGGCCACCGAGGTCCTGGACAACACCCGCGCGCAGATCCAGCTGATGTCGACGGAGCCGGGGCCGCAGGCGGTCCGCCGGCTCATGGCGGAACTCGTGGAGTTCGAGAACGTCAACCGGTACCTGATCGAGAAGATCACGGCGATCTCGGTCCGTTACGACGTCGGCGAGGGCCACGAGCTGCTCGGCCGCCGGATGCGGGACCTCGCGCTCAAGCACGGCCGGCTCTACGAGCGGATGCACGAGGGCCGTGGACTGCTGCTCGACCAGACCGGCCGGCTCTCGGTCGCCGGGTGGGAGGACCGGGTCGACCACGTCGTCGAGGTCAGCGAGGAACTGGACGTGCCCGCGGTGCTGCTGCGTCCCGACGGCCACGTCGTGTGGGCGGGCGAGGACCAGCAGGAGCTGCTCACCCGGATGCCCGCGTGGTTCGGCGCCGCCACGGCCGGCTGA", "partial": "0", "query_start": 5563, "query_end": 6753, "hit_start": 6, "hit_end": 1149, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 28.67}, "gnl|BL_ORD_ID|4834|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "Nocardia farcinica rox", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "5821", "ARO_accession": "3007210", "ARO_name": "Nocardia farcinica rox", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.86583e-14, "max_identities": 112, "bit_score": 71.2478, "cvterm_id": "41346", "query": "DVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQ---QHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPY----DRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLG-WTLPHKGYQALAERGFAHVKERIR----AAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRP---ETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDL", "match": "DV + GGGP GL LA  +   G R  ++E+  + ++  R   L      ++D  G+LE    R     + FR+      L       L   ++ +L++PQ   + LLT+      A  R  C    +V GL ++   V   +    ADG  +RA  +VG DG  STVR+L G+ +     R+E    DV   ++  P      +        L + + P         +P +G    A+R    + E  R     A  ++     + L+ F D + L      A R+    +LL GD+AH H P G QG+NL IQDA      L   +      +  LD+    R P   E    TR Q+     +LS      AVR   A LV      R ++ +I      + VR DL", "sequence_from_db": "DVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLE----RFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGC----EVAGLDQDADGVTAEL----ADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADV---RIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLS--ADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRL------AERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPD-LLDSYHDERHPVAAEVLDNTRAQM----TLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKIT----AIAVRYDL", "sequence_from_broadstreet": "MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT", "dna_sequence_from_broadstreet": "GTGATCGATGTGATCATCGCGGGTGGCGGACCGACCGGCTTGATGCTGGCCGGCGAACTGCGCCTGCACGGTGTGCGCACGGTGGTACTGGAGAAGGAGCCCACCCCGAACCAGCACTCCCGCAGTCGGGGCCTGCACGCGCGCAGCATCGAGGTGATGGACCAGCGCGGGCTGCTGGAGCGGTTCCTCGCGCACGGCGAGCAGTTCCGGGTCGGCGGGTTCTTCGCCGGGCTGGCCGCCGAATGGCCCGCCGACCTGGACACCGCGCACTCCTACGTGCTCGCGATTCCCCAGGTCGTCACCGAGCGCCTGCTCACCGAGCACGCCACCGAACTCGGCGCCGAGATCCGCCGCGGCTGCGAAGTGGCCGGGTTGGATCAGGACGCGGACGGGGTGACCGCCGAGCTGGCCGACGGCACGCGGTTGCGCGCCCGGTACCTGGTCGGCTGCGACGGCGGACGCTCGACCGTGCGCCGTCTGCTCGGGGTCGACTTCCCCGGCGAACCCACCCGGGTCGAGACGTTGCTGGCCGACGTGCGGATCGACGTGCCGGTCGAGACACTGACCGCGGTGGTCGCCGAGGTGCGCAAGACCCAACTGCGATTCGGGGCCGTCCCGGCCGGCGACGGGTTCTTCCGGCTGATCGTGCCCGCGCAGGGCCTGTCCGCGGACCGCGCCGCACCCACCCTCGACGAGCTGAAGCGATGCCTGCACGCGACGGCGGGCACCGATTTCGGCGTGCACTCCCCGCGCTGGCTGTCCCGCTTCGGCGACGCCACCCGGCTCGCCGAGCGCTACCGCACCGGGCGGGTGCTGCTGGCGGGCGACGCCGCCCACATCCATCCGCCGACCGGCGGCCAGGGCCTCAATCTGGGCATCCAGGACGCCTTCAACCTCGGCTGGAAGCTCGCCGCCGCGATCGGCGGCTGGGCGCCGCCGGACCTGCTGGACAGCTACCACGACGAACGCCATCCGGTCGCCGCCGAGGTGCTGGACAACACCCGCGCCCAGATGACGCTGCTCTCCCTCGACCCCGGCCCGCGCGCGGTGCGCAGACTGATGGCGGAGCTGGTCGAATTCCCCGACGTGAACCGGCACCTGATCGAGAAGATCACCGCGATCGCCGTCCGCTACGACCTCGGCGACGGCCACGACCTGGTCGGTCGACGGCTGCGCGACATCCCGCTCACCGAAGGCCGCCTCTACGAGCGGATGCGCGGCGGCCGCGGGCTGCTGCTCGACCGGACCGGGCGGCTGTCGGTATCGGGCTGGTCCGACCGCGTCGACCACCTCGCCGACCCGGGCGCGGCGCTCGACGTCCCGGCGGCGCTGCTGCGCCCGGACGGGCACGTCGCGTGGGTGGGCGAGGACCAGGACGATCTGCTCGCCCACCTGCCCCGCTGGTTCGGCGCCGCCACCTGA", "partial": "0", "query_start": 5563, "query_end": 6747, "hit_start": 6, "hit_end": 1140, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 27.32}, "gnl|BL_ORD_ID|4799|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(47)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3308", "ARO_accession": "3004613", "ARO_name": "tet(47)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.66231e-07, "max_identities": 83, "bit_score": 49.6766, "cvterm_id": "36791", "query": "TDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGV-LEGARRRGCHEHDGFR---------LEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAP-------------ATRTVRIFRAGGNPVLAYTSFPDCVQLGWT-----LPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAV", "match": " ++ V+G G AG ++   + R G    L+E+S +L         + GG AL D  GV ++  +R G +E  G R         ++ +G  L      R        + + +  L+  L++     P   C     ++ + +  G V         DG +   D ++GADG +ST R++     D  +L +    +   + P             A + +    +  NP +A  +F   VQ            K +     +GF     +I   +   +D+ D   +S   V +        + W +  + L+GD+ +  SPI  QG NLA+   V A+ +  E  +  D   +  +       P  E   ++ V+ +   L    VS  V", "sequence_from_db": "NNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANL---------RKGGHAL-DVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGERFCYREGEDVEITRGDLVEILIDAIEGVP---CYLNQSIDSIKQRDGDV----AVRFKDGKIEYYDLIIGADGLHSTTRRMV-FDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELM---SDSDDFYFDSVSQVKM--------KSWTKGRVALLGDAGYCASPISGQGNNLAL---VGAYVLAGELKQASDNYHQAFNRYNELLHPFIEANQKLGVLVNESFLVQDEVSKEV", "sequence_from_broadstreet": "MRCHFRCNLALPLLVFLNLSRAIKDYQTMSSINNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGERFCYREGEDVEITRGDLVEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLIIGADGLHSTTRRMVFDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVSQVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGELKQASDNYHQAFNRYNELLHPFIEANQKLGVLVNESFLVQDEVSKEVAEERSNKIMEEVKIVSNMISLPDYE", "dna_sequence_from_broadstreet": "ATGCGCTGTCATTTCCGATGTAATCTCGCGCTGCCGCTTCTTGTATTCCTCAATCTTAGTAGAGCAATAAAGGATTATCAAACAATGTCTTCTATAAATAATATTCTTGTAATAGGAGCTGGAATTGCTGGACCCTCAGTCTGCTATTGGTTAAAAAGATTTGGTTTTTCTCCCGTTTTAATTGAAAAGTCTGCCAATTTACGAAAAGGAGGGCATGCACTGGATGTTCGAGGTGTTGCAATCGACCTCGTCAAAAGAATGGGCATCTACGAAAAAATAGGCAATAGGCGCACTCAGGTGGAATTTGGACGATACATGGACACTCAAGGCAATATCTTGCATGAAGAAAAGGGTGAAAGATTTTGCTATAGAGAAGGTGAGGATGTTGAAATTACCCGCGGTGATTTAGTTGAGATATTGATAGATGCCATTGAAGGCGTTCCCTGCTATCTCAATCAATCGATTGACAGCATTAAACAGAGGGATGGCGATGTAGCCGTTCGATTTAAAGATGGCAAGATCGAGTATTACGATCTGATTATTGGCGCTGACGGCTTGCATTCAACAACAAGACGCATGGTTTTTGATAAAGATGAATATCAATTAACTAACCTTGGGGCGTACTTTAGCGTTTTTAGTATTCCAAATTATCTCAATTTGAATCACACCGAAATCCAGTTCGAGGCCAATCAAAAACTGATATCTATGACTAGCGACAAGAATCCTAAAATGGCTGAAGTCGCATTCATGTTCCGTGTACAGAATGTCTTGAATAATAGGCGCGATGAAAATGAGCAAAAGAGATTCCTACGCGACACTTTTCAAGGTTTTGGTTGGGAAACGTCGAAAATACTTGAACTGATGTCAGATAGTGATGATTTTTATTTTGATTCAGTCTCCCAAGTGAAAATGAAGTCATGGACTAAGGGTCGAGTTGCCTTATTGGGCGACGCGGGTTACTGCGCATCCCCAATATCTGGTCAAGGTAATAATCTGGCACTAGTTGGTGCTTATGTTTTGGCGGGAGAACTAAAACAGGCAAGCGACAATTATCACCAAGCATTTAATCGTTATAATGAATTGTTACATCCATTCATTGAAGCCAATCAAAAATTGGGAGTCTTGGTTAACGAGTCGTTTCTCGTTCAGGATGAAGTCTCAAAGGAAGTTGCGGAAGAACGATCAAATAAGATAATGGAAGAAGTAAAAATCGTCTCGAATATGATTTCGTTACCGGATTATGAATGA", "partial": "0", "query_start": 5560, "query_end": 6645, "hit_start": 96, "hit_end": 1170, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 21.28}, "gnl|BL_ORD_ID|729|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "iri", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "796", "ARO_accession": "3002884", "ARO_name": "iri", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36669": {"category_aro_accession": "3000530", "category_aro_cvterm_id": "36669", "category_aro_name": "rifabutin", "category_aro_description": "Rifabutin is a semisynthetic rifamycin used in tuberculosis therapy. It inhibits DNA-dependent RNA synthesis.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.64338e-06, "max_identities": 46, "bit_score": 46.2098, "cvterm_id": "36897", "query": "AVPEYADTVDQQLNSFKDVSL-------LDVFAGSAR---RWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAA-MLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGE", "match": "A P   D + QQL +             L  F  + R    + RD + L GD+AH H P+G QG+NL +QDA      L   +         LD   + RRP           Q+ +      +S A  P+A   L+S    +  V R +      + +R D F EG+", "sequence_from_db": "ATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGW-APVGLLDTYESERRPVAADVLDNTRAQAEL------ISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYD-FGEGD", "sequence_from_broadstreet": "MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA", "dna_sequence_from_broadstreet": "ATGAGTGACGTCATCATTGTCGGTGCTGGACCAACTGGATTGATGCTGGCAGGTGAGCTCCGGCTACAGGGCGTCGATGTCGTCGTCGTGGACAAGGACGAGGAGCCGACTCAGTTCGTCCGTGCCCTCGGCATCCATGTGCGCAGCATCGAAATCATGGAGCAGCGCGGGTTGCTGGACAAGTTCCTCGCGCACGGCCGCAAGTATCCGCTCGGTGGATTCTTCGCGGGGATCAGCAAACCGGCACCCGCGCACCTCGATACTGCGCACGGGTACGTCCTGGGCATACCTCAGCCCGAGATCGACAGGATTCTTGCCGAACATGCCACCGAAGTCGGCGCGGACATTCAGCGAGGGAAGCGCGTCGTCGCGATCCGTCAAGATACCGACAACGTCGCAGCGGAATTGTCCGACGGCACAACACTTCACGCGCGGTACCTTGTAGGCTGCGACGGCGGCCGCAGCACTGTTCGGAAGCTGAGATCGACGTCGGTATTCCCGGCGAGCCGTACGAGCGCCGACACGTTGATCGGCGAAATGGACGTGACCATGCCTGCTGATGAACTGGCCGCCGTTGTCGCCGAAATCCGGGAAACGCACAAACGATTCGGAGTCGGTCCCGCCGGCAACGGTGCTTTTCGTGTCGTGGTCCCTGCGGCCGAAGTTGCCGACGGTCGCGCAACACCGACCACCCTCGACGACATCAAACAACAGCTACTGGCCATTGCCGGTACCGACTTCGGTGTGCACTCGCCGCGGTGGCTCTCGCGCTTCGGCGACGCCACTCGTCTGGCGGACGACTACCGGCGCGACCGGGTGTTTCTCGCCGGCGACGCCGCACACATCCACCCACCGATGGGCGGTCAAGGTCTCAATCTCGGTGTGCAGGACGCCTTCAACCTCGGCTGGAAGCTCGCCGCCGAGATCAACGGCTGGGCACCGGTGGGCCTGCTCGACACGTACGAATCGGAACGGCGTCCGGTGGCTGCCGACGTGCTGGACAACACGCGCGCCCAGGCCGAGTTGATCTCCACCGCTGCCGGACCACAAGCGGTGCGGCGCTTGATCTCCGAGCTGATGGAATTCGAAGACGTCAAGCGCTATTTGACCGAGAAGATCACTGCGATCTCGATTCGCTACGATTTCGGCGAAGGCGACGACCTACTCGGTCGGAGGCTGCGGAACATCGCGTTGACGCGCGGCAACCTGTACGACCTGATGCGATCCGGCCGCGGACTTCTTCTCGACCAGGGTGGCCAACTGTCCGTCGATGGTTGGAGCGATCGCGCCGACCATATCGTTGACACAAGCACTGAATTGGAAGCTCCGGCTGTCCTGCTTCGGCCGGACGGTCATGTGGCATGGATCGGGGATGCGCAGGCGGAGTTGGATACTCAGCTGTCCACATGGTTCGGCCGGTCGGCGAGGGACCGCGCGTGA", "partial": "0", "query_start": 6292, "query_end": 6762, "hit_start": 678, "hit_end": 1158, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 27.38}, "gnl|BL_ORD_ID|4802|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(X6)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3797", "ARO_accession": "3005056", "ARO_name": "tet(X6)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.7608e-06, "max_identities": 83, "bit_score": 45.4394, "cvterm_id": "43258", "query": "HTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLD-RAYRG--EILQPGGQALLDALGVLEG----ARRRGCHEHDGFRLEERGRTLINGDYR---RLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFR-AGGNPVLAYTSFPDCVQLGWTLPHKGYQALA---ERGFAHV----------KERIRAAVPEYADTVDQQLNSFKD--------VSLLDVFAGSARR-------WARD---GLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEG", "match": "H  + ++G GP GLT+A L+ ++G  +T+ ER +  D R + G  ++ +  GQ  +   G+L+     A   G +      ++E+G  L   + R   R   P      + +  L T LL   +     T +   K+  L  E    + ++     D     AD V+ A+G  S VRK   +    +E      +   +  P       F+   GN ++A               H+G    A     G  H           K + R    +    VD  L  F D        + L   F G A R       W       + +IGD+AH   P   QG+N  + DA+     L  G", "sequence_from_db": "HKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVN-----IVDEKGNILTTKNVRPENRFDNP-----EINRNDLRTILLNSLQND---TVIWDRKLVTL--EPDKEKWILT--FEDKSSETADLVIIANGGMSKVRKF--VTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMA--------------AHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNG", "sequence_from_broadstreet": "MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL", "dna_sequence_from_broadstreet": "ATGACTTTACTAAAACATAAAAAAATTACAATAATTGGTGCCGGGCCTGTTGGATTAACAATGGCGAGATTGTTACAGCAAAACGGCGTGGACATTACAGTTTACGAGAGAGACAAAGACCAAGATGCAAGGATTTTTGGTGGGACACTTGATCTGCACAGGGATTCGGGACAGGAAGCAATGAAAAGAGCGGGATTGTTACAAACTTATTATGACTTAGCTTTACCAATGGGTGTAAATATTGTTGATGAAAAGGGCAATATTTTAACCACAAAAAATGTAAGACCCGAAAATCGTTTTGACAATCCTGAAATAAACAGAAATGACTTAAGGACTATCCTATTAAATAGTTTACAAAATGATACCGTCATTTGGGATAGAAAACTTGTTACCCTTGAACCTGATAAGGAGAAGTGGATACTAACTTTTGAGGATAAATCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCGGAGGTGAACTGTCCTGGATTTTTTCAGCTTTGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAGCAAAACGCGGGTAGATTTTCAAGACAGAAATAGTGTCGTTGATTTTCTCCTGAAAAAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTTTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGATAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGTGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTGCTTATGGAAGAGAAGCACAGGCAGAATCAATAATAAACGAAACGGAAATGTTCAGCCTCGACTTTTCTTTCCAAAAACTAATGAATCTATAA", "partial": "0", "query_start": 5557, "query_end": 6507, "hit_start": 15, "hit_end": 993, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 23.12}, "gnl|BL_ORD_ID|2698|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(52)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3289", "ARO_accession": "3004587", "ARO_name": "tet(52)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.8432e-06, "max_identities": 86, "bit_score": 44.669, "cvterm_id": "36791", "query": "TDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQA--LLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIE--LFDQDVLWCKLTAPAT---RTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVS-----LLDVFAGSA------------RRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAV", "match": "  + V+G G AG      + R G    LVERS SL +   G  L   G A  L+  +G+ +           G  ++  G TL      R        + + +  L+  L++     P        + N  +E       VV     DG     D V+GADG +ST R+   I +D+ E  L D    +   + P         +       +L+ TS  +             + +AE  F+   + +   V + ++      ++F+D       +L++ + S             + W +  + L+GD+A++ SPI  QG NLA+   V A+ +  E  +     +R  D      RP  E   ++ V+ +   L    VS  V", "sequence_from_db": "NKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKG--GHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVP-------LQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRR---IVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKN-------------RKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLAL---VGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEV", "sequence_from_broadstreet": "MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH", "dna_sequence_from_broadstreet": "ATGTCTAATGTGAATAAAATTCTCGTCATCGGGGCTGGCATTGCTGGCCCCGCGGCTTGTTATTGGTTAAGAAGATTCGGATTTTCTCCCGTCCTCGTAGAAAGATCTGCCAGTTTACGAAAAGGCGGTCATGCACTGGACGTTCGAGGTGTTGCAATAGACCTCGTCAAAAGAATGGGTATTTATCAGAAAATATATAATATGCGCACTCAGCTGGAGTTTGGGCGGCATGTTGACCCCGAAGGGAATACGCTTCATGAAGAGAAGGGCGAAAGATTTGGCTTTAGGGAAGGTCAAGATGTTGAAATTATCCGCAGTGATTTGGTCGAGATATTGATAGATTCCATTGAAGGCGTCCCCCTTCAGTTCAATCAAACGATTGAGAGCGTTAAACAGACTGATGCTGTTGTCGAAGTTCAATTTAAAGATGGCAGAACCGAACACTTCGATTTGGTTATCGGGGCTGACGGCTTGCACTCAACAACAAGACGTATCGTATTTGATAAACATGAATATAAATTAAATGACCTTGGTGCTTACTTTAGTGTTTTCAGTATTCCAAATTATCTAAATTTGAATAACACCGAAGTTCAGTGCGAAGCTAATCAAAAACTGTTATCTATAACGAGCGACAAGAACCGCAAGATGGCTGAGGTCGCATTCTCATTTCGTGGCCAGAATGTTTTGAATAATGTTCGTGATGAAAGCGAGCAACGGCGAGTCCTACGCGACACTTTTCAAGACTTTGGCTGGGAAGCACCAAGAATACTTGAACTGATGTCAGATAGTGATGATTTTTATTCTGATTCATTCACTCAGGTAATAATGAAATCATGGACTAAAGGTCGAGTTGCATTATTGGGAGATGCTGCGTACAGCGCGTCGCCAATATCGGGGCAAGGTAATAATCTGGCCCTGGTCGGCGCTTATGTTTTGGCAGGAGAACTAAAACAGGCAGGCGGCAATTATAAGCGGGCATTTGATCGTTATAATGAAATATTACGTCCATTTATTGAAGCTAATCAAAAATTGGGAGTCTTGGTTAACGAATCGTTTCTTGTTCGCGATGAAGTCTCTAAAGAGGTTGCGGAAGAACGGTCAAATAATATTATGGAACAGGTAAAAATCGCATCGAACATGATTGTGTTGCAGGATTACGCCAATCCGCACTGA", "partial": "0", "query_start": 5560, "query_end": 6645, "hit_start": 12, "hit_end": 1086, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 22.28}, "gnl|BL_ORD_ID|2695|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(49)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3285", "ARO_accession": "3004582", "ARO_name": "tet(49)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.61691e-05, "max_identities": 71, "bit_score": 43.8986, "cvterm_id": "36791", "query": "AHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGV-LEGARRRGCHEHD---------GFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAP-------------ATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPH----KGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAI", "match": "A   + V+G G AG T+   + R G   TL+ERS           ++ GGQ  LD  GV ++  +R G +E           G  ++ RG  L      R        + + +  L+  L++     P   C     ++G+ +    V         DG       V+GADG +S  R++     D  +L +  + +   + P             A + +    +  NP +A  +F  C +    L +       Q      F          +   +D+ +   +S   V +        + W +  + L+GD+ ++ SPI  QG NLA+", "sequence_from_db": "AINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSK---------IRKGGQG-LDVRGVAIDIVKRMGIYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVP---CHFNQWIDGIKQSDNDVEVQF----KDGRTEHYGLVIGADGLHSKTRRMV-FNEDEYKLTNLGLYFSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAF--CFRTQNVLNNIRDENEQQKFLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEM--------KSWTKGRVALLGDAGYSASPISGQGNNLAL", "sequence_from_broadstreet": "MSAINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMGIYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVPCHFNQWIDGIKQSDNDVEVQFKDGRTEHYGLVIGADGLHSKTRRMVFNEDEYKLTNLGLYFSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQKFLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQGNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNESTLVYGEVSQEVAEERSNKIMQEVEIAANMISLPNYE", "dna_sequence_from_broadstreet": "ATGTCTGCAATAAATAAAATTCTCGTAATAGGAGCCGGCATTGCTGGACCTACTGTTTGTTATTGGTTAAAAAGATTTGGCTTTTCTCCCACTCTAATTGAAAGGTCTTCCAAAATACGAAAAGGAGGGCAAGGATTGGATGTTCGGGGTGTTGCCATCGATATCGTTAAAAGAATGGGTATCTATGAGAAAATATGCAATATGCGCACCCAAGTGGAATTAGGACGGTATGTTGACGCCAGAGGCAATATCTTGCATGAAGAAAAAGGTGAAAGATTTGCCTTTAGGCAAGGTGAAGATGTTGAAATTAACCGCGGTGATTTAGTCGAAATACTGATACAGACTATTGAAGGTGTTCCCTGTCATTTCAATCAATGGATTGACGGTATTAAACAGAGTGATAATGATGTAGAAGTTCAATTTAAAGATGGTAGAACCGAACATTATGGCTTGGTTATTGGGGCTGATGGTTTACACTCAAAAACAAGACGTATGGTTTTCAATGAGGATGAATATAAATTAACTAACCTTGGTTTATATTTTAGCGTTTTTAGCATCCCAAATTATCTTAATTTGAACCACACCGAAGTTCAGTTCGAGGCCAATCAAAAACTTATATCTCTTACTAGTGATAAGAATCCTAAGATGGCTGAAGCCGCATTCTGCTTTCGTACACAAAATGTCTTAAATAATATTCGCGATGAAAATGAGCAACAGAAATTCCTACGCGATACTTTTCAAGATTTTGGCTGGGAAACGTCAAAAATACTTGAACTGATGTCTGATAGCGATAATTTTTATTTTGATTCAGTCACCCAGGTGGAAATGAAATCATGGACTAAAGGACGAGTGGCTTTGCTGGGAGATGCGGGTTACTCCGCATCTCCAATATCTGGTCAAGGTAATAATCTGGCACTAGTGGGAGCGTATGTTTTTGCAGGAGAACTAAAACAAGCAGGTGGCAATTATCATCGAGCATTTAGCCGTTATAATGAATTATTACACTCATTTGTTGAAGCCAATCAAAAATTGGGAATTTTGGTTAACGAATCAACTCTTGTTTATGGTGAAGTCTCTCAGGAGGTTGCAGAAGAAAGATCAAATAAGATTATGCAAGAGGTAGAAATCGCAGCGAATATGATTTCGTTACCTAATTATGAATAA", "partial": "0", "query_start": 5554, "query_end": 6468, "hit_start": 6, "hit_end": 918, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 21.39}, "gnl|BL_ORD_ID|2802|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(X5)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3798", "ARO_accession": "3005057", "ARO_name": "tet(X5)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.90215e-05, "max_identities": 86, "bit_score": 42.3578, "cvterm_id": "36787", "query": "AHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLD-RAYRGEI-LQPG-GQALLDALGVLEG----ARRRGCHEHDGFRLEERGRTLINGDYR---RLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFR-AGGNPVLAYTSFPDCVQLGWTLPHKGYQALA---ERGFAHV----------KERIRAAVPEYADTVDQQLNSFKD--------VSLLDVFAGSARR-------WARD---GLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEG", "match": "+  +V ++GGGP GLT+A L+ ++G  V++ ER    + R + G + L  G GQ  +   G+L+     A   G +  D     E+G  L   + R   R   P      + +  L T LL   +     T +   K+  L  E    + ++     D     AD V+ A+G  S VRK   +    +E      +   +  P       F+   GN ++A               H+G    A     G  H           K + R    +    VD  L  F D        + L   F G A R       W       + +IGD+AH   P   QG+N  + DA+     L  G", "sequence_from_db": "SDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIAD-----EKGNILSTKNVRPENRFDNP-----EINRNDLRTILLNSLQND---TVIWDRKLVTL--EPDKEKWILT--FEDKSSETADLVIIANGGMSKVRKF--VTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMA--------------AHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNG", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAGACCCGAAAATCGTTTTGACAATCCTGAAATAAACAGAAATGACTTAAGGACTATCCTATTAAATAGTTTACAAAATGATACCGTCATTTGGGATAGAAAACTTGTTACCCTTGAACCTGATAAGGAGAAGTGGATACTAACTTTTGAGGATAAATCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCGGAGGTGAACTGTCCTGGATTTTTTCAGCTTTGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAGCAAAACGCGGGTAGATTTTCAAGACAGAAATAGTGTCGTTGATTTTCTCCTGAAAAAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTTTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGATAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGTGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTGCTTATGGAAGAGAAGCACAGGCAGAATCAATAATAAACGAAACGGAAATGTTCAGCCTCGACTTTTCTTTCCAAAAACTAATGAATCTATAA", "partial": "0", "query_start": 5554, "query_end": 6507, "hit_start": 42, "hit_end": 1023, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 23.89}, "gnl|BL_ORD_ID|2726|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(54)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3292", "ARO_accession": "3004590", "ARO_name": "tet(54)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0012144, "max_identities": 62, "bit_score": 37.7354, "cvterm_id": "36791", "query": "VCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSF----------------PDCVQLGWTL-----------PHKGYQALAE--RGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAI", "match": "+ V+G G AG  +   + R G    L+E+S  + +  +G  ++     ++  + + E   +       G  ++  G+TL      +     +  + + +  L+  L++     P   C     ++ + +    V         D  V   D ++GADG +S++R++         +FD+D    +L   A     IF       L++T                  P   Q+ +              H+  Q L +    F    ++I   +P   ++ D   +S   V +        R W +  + L+GD++++ SP+  QG NLA+", "sequence_from_db": "ILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVP---CHFNQSIDSIEQNDDDVIVYF----KDARVEHYDLIIGADGIHSSIRRM---------VFDKDEY--RLVNLAEAYFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIFHDFGWEAQKILELMP---NSHDFYFDSVTQVKM--------RSWTKGQVALVGDASYSASPLSGQGNNLAL", "sequence_from_broadstreet": "MSTIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCHFNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQGNNLALVGAYILAGELKAAEGNYRLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKEVAEERSNRILQKVQIISNAIKLPEYE", "dna_sequence_from_broadstreet": "ATGTCTACTATAAAAAAAATTCTCGTGATAGGAGCCGGTATTGCCGGTACTGCAGTCTGTTATTGGTTACGAAGATTTGGTTTTTATCCTGTATTAATTGAAAAATCTGCGTGTATACGAAAAGGCGGCCAAGGTTTGGATATTCGTGGGGTTGCAATCGATATCGTTAAAAAAATGGTTATTTATGAGCAAATATGCAAGATGCGCACGCAGGTAGAATGTGGTCGCTATGTGGATGTCGTAGGCAAAACACTACATGAAGAAAAAGGTGAAAAATTTGCCTTTAGGCAAGATGAAGATGTTGAAATTCTCCGCGGTGATTTAATCGAGATCCTAATGAAAACCATTGACGATGTTCCCTGTCATTTTAATCAATCCATTGACAGTATTGAACAGAATGACGATGACGTCATAGTTTATTTCAAAGATGCCAGAGTTGAGCACTATGATTTGATTATTGGCGCTGATGGGATACACTCATCGATCAGGCGCATGGTATTTGACAAAGATGAATATAGATTAGTTAATCTTGCAGAGGCGTACTTCAGTATATTTAGCATTCCGAATTATCTCAATTTAAGCCACACGGAAGTGCAGTGTGAGACTAATGAAAAATTGGTATCTATCACTAGCGATAAAGATCCCAAGACGGCTCAAGTTGCATTTATGTTCCGTTCGCAACATGTCTGGAATAATCTTCGCGATGAACACGAACAGATGCAATTTTTGCGGGATATTTTTCATGACTTTGGTTGGGAGGCGCAAAAAATACTTGAACTAATGCCAAATAGCCATGATTTTTATTTTGATTCAGTTACACAGGTGAAAATGCGTTCCTGGACCAAAGGACAAGTTGCTTTAGTAGGTGATGCGAGTTACTCTGCATCTCCACTATCGGGTCAAGGTAATAATCTGGCTCTAGTTGGTGCTTATATTTTGGCAGGAGAACTAAAAGCAGCGGAAGGAAATTATAGGCTCGCATTTAATCGTTATAATGAATTATTACATCCCTTCGTTGAGGCTAATCAACAGCTTGGAGCTTGGGTTAGCGAATCGTTTCTTGTCCCAGATGCAGTATCCAAAGAAGTTGCAGAAGAACGCTCAAACAGAATCCTGCAAAAAGTACAAATCATATCGAATGCGATCAAGCTGCCTGAGTATGAATGA", "partial": "0", "query_start": 5566, "query_end": 6468, "hit_start": 18, "hit_end": 921, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 18.79}, "gnl|BL_ORD_ID|2720|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(48)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "3284", "ARO_accession": "3004581", "ARO_name": "tet(48)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0013316, "max_identities": 43, "bit_score": 37.7354, "cvterm_id": "36791", "query": "VCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGV-LEGARRRGCHE---------HDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLA--GIPYDRIEL", "match": "V VVG G AGL +   +   G   TL+E+S +L +   G          +D  G+ ++ A++   +E           GF +   G TL+     +        + + ++ L+  L +  +  P   C    ++  + ++G  V         D      D V+GADG +ST R        YD I+ ", "sequence_from_db": "VLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYG----------VDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIP---CHFNQRIKRIKQDGKHVEVTF----KDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDF", "sequence_from_broadstreet": "MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSGYCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINETFLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK", "dna_sequence_from_broadstreet": "ATGACATTCCTATTTAAGGAATTTAAAGGTGTGTTTAAAATGAAAAAAGTACTAGTGGTTGGTGCAGGGGTTGCTGGATTGGCAGTTTGTTATTGGCTAAAGGAGTTTGGGTTTTCGCCTACATTAATTGAAAAAAGTAATGCTTTAAGGAAGGGTGGTTATGGAGTAGATATCTTTGGTATTGCTGTTGATATTGCTAAAAAAATGAGCGTTTATGAAAAAATATGTGCTATGCGCACCCAGTTAGAACACGGGTTTTATGTGAATGCTGATGGTCATACATTAGTTGAAGAACAAGGGGAAAAATTTGGTTTCAGGCAGGGTGAGGAAGTCGAAATTCTCCGAGAAGATTTAATTGAAATCTTAAAGCAAGCTATTAAAGATATTCCATGCCATTTTAATCAACGTATAAAGCGGATTAAGCAGGATGGTAAACATGTTGAAGTTACTTTTAAGGATAATAAGACTGAAAATTATGATTTAGTTATTGGCGCTGACGGGGTACATTCAACCACTAGAGCTTTTACTTTTGATAAAGAAGAGTATGATCTAATTGATTTTGGATGTTATTCTGCAATATTTAGCCTCCCAAATTATTTAAAATTGAGGCAAAGCGAAATAGCTTTTGATGCGAACCAAAAATTCATTTCTGTCAGTAGCGATAAAAACCCTACTATAGCTCTTGCATCCCTTATGTTCCATTCTAATCGTGGAGACAACATTCGCAATGAGAAGGACCAGAAAAGTTTTTTTAAAGATGCTTTTATTGATCTTGGATGGGAGACAAATAATCTACTTCAGTACATGGAAGAAAGTAATGATTTCTATTTCGATGTTGCTACTCAGATTAAAATGAAATCATGGACAAAAGGAAGAATTGCGTTGGTGGGTGATTCAGGTTATTGTTCAACCGCATTGTCTGGGCAAGGCACCACTACAGCACTTGTTGGAGCTTATATTTTGGCAGGAGAATTAAAAGCTGCAAATGGAAACCATATAACTGCTTTTGAACGCTATAATATGTTGCTACATCCATTTGTTGAAGCTAATCAAGAACTAGGAGCATGGATTAATGAAACGTTTCTTTTAGAAGACGCAGTATCTAAAGAAGCAGTAGAAGCAAGAACAGACAATATCATAAAGAAAATCAGCGCCATCTCGAATGTAATTAAATTACCTGAGTATTCAGCCTATAAATAA", "partial": "0", "query_start": 5566, "query_end": 6093, "hit_start": 48, "hit_end": 561, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 22.87}, "gnl|BL_ORD_ID|2277|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(X4)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3402", "ARO_accession": "3004720", "ARO_name": "tet(X4)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00165811, "max_identities": 22, "bit_score": 37.3502, "cvterm_id": "35914", "query": "AHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLD-RAYRGEI-LQPG-GQALLDALGVLE", "match": "+  +V ++GGGP GLT+A L+ ++G  V++ ER    + R + G + L  G GQ  +   G+L+", "sequence_from_db": "SDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQ", "sequence_from_broadstreet": "MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGAGCAATAAAGAAAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCATCCAGAGGTGAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTGTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGGTAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGCGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTATCTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 5554, "query_end": 5736, "hit_start": 33, "hit_end": 225, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 34.38}, "gnl|BL_ORD_ID|2277|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(X4)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3402", "ARO_accession": "3004720", "ARO_name": "tet(X4)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.14039, "max_identities": 13, "bit_score": 31.187, "cvterm_id": "35914", "query": "LLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEG", "match": "+ +IGD+AH   P   QG+N  + DA+     L  G", "sequence_from_db": "ITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNG", "sequence_from_broadstreet": "MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGAGCAATAAAGAAAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCATCCAGAGGTGAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTGTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGGTAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGCGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTATCTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 6400, "query_end": 6507, "hit_start": 906, "hit_end": 1014, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 36.11}, "gnl|BL_ORD_ID|763|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(X)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "776", "ARO_accession": "3000205", "ARO_name": "tet(X)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35986": {"category_aro_accession": "0000069", "category_aro_cvterm_id": "35986", "category_aro_name": "doxycycline", "category_aro_description": "Doxycycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36667": {"category_aro_accession": "3000528", "category_aro_cvterm_id": "36667", "category_aro_name": "chlortetracycline", "category_aro_description": "Chlortetracycline was an early, first-generation tetracycline antibiotic developed in the 1940's. It inhibits bacterial protein synthesis by binding to the 30S subunit of bacterial ribosomes, preventing the aminoacyl-tRNA from binding to the ribosome.", "category_aro_class_name": "Antibiotic"}, "37011": {"category_aro_accession": "3000667", "category_aro_cvterm_id": "37011", "category_aro_name": "demeclocycline", "category_aro_description": "Demeclocycline is a tetracycline analog with 7-chloro and 6-methyl groups. Due to its fast absorption and slow excretion, it maintains higher effective blood levels compared to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00178504, "max_identities": 22, "bit_score": 37.3502, "cvterm_id": "35916", "query": "AHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLD-RAYRGEI-LQPG-GQALLDALGVLE", "match": "+  +V ++GGGP GLT+A L+ ++G  V++ ER    + R + G + L  G GQ  +   G+L+", "sequence_from_db": "SDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQ", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATAAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGCGGGATGTCCAAGGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCAGAGATAAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCATCTCACCAAGGTAATTTATTATTTGCTAACCCCAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAATTGATTCATACGACGTTGTCATTTGTAGGATTGGCTACACGGATATTTCCTTTAGAAAAGCCTTGGAAAAGCAAGCGCCCATTACCCATAACAATGATTGGGGATGCCGCACATTTGATGCCGCCTTTTGCAGGGCAGGGAGTAAATAGTGGGTTGGTGGATGCCTTGATATTGTCTGATAATCTAGCCGATGGAAAATTTAATAGCATTGAAGAGGCTGTTAAAAATTATGAACAGCAAATGTTTATGTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 5554, "query_end": 5736, "hit_start": 42, "hit_end": 234, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 34.38}, "gnl|BL_ORD_ID|763|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(X)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "776", "ARO_accession": "3000205", "ARO_name": "tet(X)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35986": {"category_aro_accession": "0000069", "category_aro_cvterm_id": "35986", "category_aro_name": "doxycycline", "category_aro_description": "Doxycycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36667": {"category_aro_accession": "3000528", "category_aro_cvterm_id": "36667", "category_aro_name": "chlortetracycline", "category_aro_description": "Chlortetracycline was an early, first-generation tetracycline antibiotic developed in the 1940's. It inhibits bacterial protein synthesis by binding to the 30S subunit of bacterial ribosomes, preventing the aminoacyl-tRNA from binding to the ribosome.", "category_aro_class_name": "Antibiotic"}, "37011": {"category_aro_accession": "3000667", "category_aro_cvterm_id": "37011", "category_aro_name": "demeclocycline", "category_aro_description": "Demeclocycline is a tetracycline analog with 7-chloro and 6-methyl groups. Due to its fast absorption and slow excretion, it maintains higher effective blood levels compared to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.169045, "max_identities": 13, "bit_score": 31.187, "cvterm_id": "35916", "query": "LLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEG", "match": "+ +IGD+AH   P   QG+N  + DA+     L +G", "sequence_from_db": "ITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADG", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATAAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGCGGGATGTCCAAGGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCAGAGATAAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCATCTCACCAAGGTAATTTATTATTTGCTAACCCCAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAATTGATTCATACGACGTTGTCATTTGTAGGATTGGCTACACGGATATTTCCTTTAGAAAAGCCTTGGAAAAGCAAGCGCCCATTACCCATAACAATGATTGGGGATGCCGCACATTTGATGCCGCCTTTTGCAGGGCAGGGAGTAAATAGTGGGTTGGTGGATGCCTTGATATTGTCTGATAATCTAGCCGATGGAAAATTTAATAGCATTGAAGAGGCTGTTAAAAATTATGAACAGCAAATGTTTATGTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 6400, "query_end": 6507, "hit_start": 915, "hit_end": 1023, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 36.11}, "gnl|BL_ORD_ID|4801|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(X3)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "760", "model_id": "3401", "ARO_accession": "3004719", "ARO_name": "tet(X3)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00220226, "max_identities": 22, "bit_score": 36.965, "cvterm_id": "35507", "query": "AHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLD-RAYRGEI-LQPG-GQALLDALGVLE", "match": "+  +V ++GGGP GLT+A L+ ++G  V++ ER    + R + G + L  G GQ  +   G+L+", "sequence_from_db": "SDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQ", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGTGGAATGTCGAAAATAAGGAGCTTTGTTACCGACACGCAAGTTGAAGAAACCGGTACTTTCAACATCCAAGCTGATATTCTTCAACCGGAAATAAACTGTCCCGGATTTTTTCAGCTATGCAACGGCAACCGATTAATGGCGGGACATCAGGGCATTTTATTGTTTGCCAATCCCAATAATAATGGTGCATTGTATTTAGGAATTAGTTTTAAAACGCCCGATGAATGGAAAAATAAAATTCCCTTAGATTTTCAGGACAGAAACAGCGTTGCCGATTTTTTATTGAAAAGATTTTCCAAATGGAGTGAAGTTTACAAACAATTAATACGTTCGGTATCAACATTTCAATGCTTGCCCACAAGGAAATTTCCTTTGAACAATGATTGGAAAAGTAACCGTCCATTACCCATAACAATGATTGGCGATGCTGCTCATTTGATGTCGCCTTTTGCAGGACAGGGTGTAAATACGGGATTATTGGATGCTTTGATATTGTCTGAAAACCTTACAAACGGAGAATTTACAAGTATTGAAAATGCCATCGAAAACTACGAACAACAAATGTTTGTTTATGCAAAAGATACGCAGGACGAATCGACAGAAAACGAAACCGAAATGTTTAGTCCCAATTTTTCGTTTCAAAAATTATTGAATCTATAA", "partial": "0", "query_start": 5554, "query_end": 5736, "hit_start": 42, "hit_end": 234, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 34.38}, "gnl|BL_ORD_ID|4801|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(X3)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "760", "model_id": "3401", "ARO_accession": "3004719", "ARO_name": "tet(X3)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0287664, "max_identities": 14, "bit_score": 33.4982, "cvterm_id": "35507", "query": "LLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEG", "match": "+ +IGD+AH  SP   QG+N  + DA+     L  G", "sequence_from_db": "ITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNG", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGTGGAATGTCGAAAATAAGGAGCTTTGTTACCGACACGCAAGTTGAAGAAACCGGTACTTTCAACATCCAAGCTGATATTCTTCAACCGGAAATAAACTGTCCCGGATTTTTTCAGCTATGCAACGGCAACCGATTAATGGCGGGACATCAGGGCATTTTATTGTTTGCCAATCCCAATAATAATGGTGCATTGTATTTAGGAATTAGTTTTAAAACGCCCGATGAATGGAAAAATAAAATTCCCTTAGATTTTCAGGACAGAAACAGCGTTGCCGATTTTTTATTGAAAAGATTTTCCAAATGGAGTGAAGTTTACAAACAATTAATACGTTCGGTATCAACATTTCAATGCTTGCCCACAAGGAAATTTCCTTTGAACAATGATTGGAAAAGTAACCGTCCATTACCCATAACAATGATTGGCGATGCTGCTCATTTGATGTCGCCTTTTGCAGGACAGGGTGTAAATACGGGATTATTGGATGCTTTGATATTGTCTGAAAACCTTACAAACGGAGAATTTACAAGTATTGAAAATGCCATCGAAAACTACGAACAACAAATGTTTGTTTATGCAAAAGATACGCAGGACGAATCGACAGAAAACGAAACCGAAATGTTTAGTCCCAATTTTTCGTTTCAAAAATTATTGAATCTATAA", "partial": "0", "query_start": 6400, "query_end": 6507, "hit_start": 915, "hit_end": 1023, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 38.89}, "gnl|BL_ORD_ID|4803|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(X1)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "650", "model_id": "3888", "ARO_accession": "3005166", "ARO_name": "tet(X1)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00645389, "max_identities": 16, "bit_score": 35.4242, "cvterm_id": "39568", "query": "LDVFAGSARRWARD---GLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEG", "match": "+ +F    + W  +    + LIGD+AH   P   QG+N+ + DA+     L  G", "sequence_from_db": "IKIFPLDKKPWKSNRPLPITLIGDTAHLMPPFAGQGVNIGLMDALILSENLTNG", "sequence_from_broadstreet": "MANLLQQNGIDITVYERDENPKARVWGGTLDLHKNSGQEAMKKVGLLQTYYDLALPMGVNFADEKGNIIATRNPTLENKFDNPEINRNALRKMLLGSLKNDTVVWDRKSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFIIQGDIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKGLDFKPTKSVSEFLTNRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLIGDTAHLMPPFAGQGVNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTKNEIEMRNPSFTFQQLMNV", "dna_sequence_from_broadstreet": "ATGGCAAACTTGTTACAACAAAACGGTATTGACATTACCGTTTACGAAAGAGATGAAAACCCAAAAGCACGAGTTTGGGGCGGAACGCTTGACCTTCACAAAAATTCAGGACAAGAAGCAATGAAAAAAGTAGGATTGTTGCAAACCTACTATGATTTGGCGCTACCTATGGGCGTAAACTTTGCTGATGAGAAGGGTAACATTATAGCAACAAGAAACCCGACACTCGAAAATAAGTTTGACAACCCCGAAATAAATAGAAACGCGTTGCGAAAAATGTTGCTTGGCAGCTTGAAAAATGACACAGTTGTTTGGGATAGAAAATCTATTGGGCTTGAACAAGAAAACGGAAAATGGCTGCTACATTTTGAAAATAAGCCAACTGCATTGGCCGACTTTATTATTGTTTCCAATGGTGGAATGTCTAAAATAAGAAATTTTGTTTCAGATAATGAAGTCGAAGAAACAGGTACTTTTATTATTCAGGGCGACATTCCTGAACCAGAAACGAACTGCCCTGAATTTTATAAGTTGTGCAACAACAATAGACTAATGACCGCACATCAAGGGAATTTATTAGTTGCGAATCCATTTAACAACGGAATGTTAACTTACGGTGTCATTTTCAAAAAGCCTGAAGAATGGAATAATGGAAAAGGATTAGATTTTAAGCCCACAAAAAGCGTTTCCGAGTTCTTGACAAACAGGTTTTCAAATTGGAGCAATGAATACAAGGAGTTAATTCGTTCAACAACTTTTTTCGTTGGTTTAACAATAAAAATATTTCCGCTAGACAAAAAGCCTTGGAAGAGTAATCGTCCGTTACCCATAACTTTAATTGGCGACACAGCTCACCTAATGCCACCTTTTGCAGGGCAGGGCGTAAACATTGGACTAATGGACGCTTTGATTTTGTCAGAAAATCTTACAAACGGGAAATTTGGAACGATACAAAGTGCTATTGATGACTATGAACAACGAATGTTTGTTTACGCAACAGAAGCACAAGCGGACTCGACAAAGAATGAAATAGAAATGCGAAATCCGAGCTTTACTTTTCAACAGCTAATGAATGTATAA", "partial": "0", "query_start": 6355, "query_end": 6507, "hit_start": 774, "hit_end": 936, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 29.63}, "gnl|BL_ORD_ID|2723|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(51)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3288", "ARO_accession": "3004586", "ARO_name": "tet(51)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00685774, "max_identities": 50, "bit_score": 35.4242, "cvterm_id": "36791", "query": "DGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAP-------------ATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAER----GFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAV", "match": "DG     D V+GADG +ST R++     D  +L +    +   + P             A + +    +  NP +A T F  C +    L +   +    R     F          +   +D+ D   +SF  V +        + W +  + L+GD+ +  SP   QG N A+   V A+    E  +      R  +      +P  E   +  V+ +   L    VS  V", "sequence_from_db": "DGRTELYDLVIGADGLHSTTRRMV-FDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGF--CFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKM--------KSWTKGRVALVGDAGYCASPFPGQGSNQAL---VGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEV", "sequence_from_broadstreet": "MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMGIYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVPCHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSNKIMQEIKIVSNMISLPNYE", "dna_sequence_from_broadstreet": "ATGCCTATCATAAATAAAATTCTGGTAATAGGAGCCGGCATTGCTGGACCCGCGGTTTGTTATTGGTTAAGAAGATTTGGCTTTTCTCCCATTTTAGTTGAAAGGTGTGCCAATTTACGAAAAGGAGGGCATGCTGTGGATATTCGAGGTGTTGCTATCGATCTTGCTAAAAGCATGGGTATTTATAAAAAAATATGCAATATGCGCACCCAGGTGGAATTAGGAAGGTATGTTGACGCCGAAGGTAATATCTTGCATGAAGAAAAAGGCGAAAGATTTGGCTTTAGGGAGGGTGATGATATTGAAATTCTCCGCGGTGATTTAGTTCAAATACTGATAGATGCCATGGGAGATGTTCCCTGTCATTTCAATCAATGGGTTGAGAGCATTAAGCAGAGGGATAATGATGTAGAGGTTCAATTTAAAGATGGTAGAACGGAACTTTACGATTTGGTTATCGGTGCTGATGGCTTGCATTCAACCACCAGAAGGATGGTTTTTGATAAGGATGAATATAAATTAACTAACCTTGGTGCATACTTTAGTGCTTTTAGTATTCCAAATTATCTTAATTTGAATCACACCGATGTGCAATTCGAGGCTAATCAAAAACTTATATCTATGGCTAGCGATAAGAACCCTAAAATTGCTATAACAGGATTCTGTTTCCGTGCACAGAATGTCTTGAATAATTTGCGCGATGAAAACGAGCAACGGAGATTTCTACGCGATACTTTTCAAGATTTTGGCTGGGAGACATCCAAAATACTTGAACTGATGTCAGATAGTAATGATTTTTATTTTGATTCATTCACTCAAGTGAAAATGAAGTCATGGACAAAAGGACGAGTTGCTTTGGTGGGCGATGCAGGTTACTGCGCATCCCCATTCCCTGGTCAAGGTAGTAATCAGGCACTGGTAGGTGCTTATATTTTTGCAGGAGAACTAAAACAGGCAGAAGGCAATTATCATCGAGCATTTAACCGTTATAATGAATTATTACAACCATTTGTTGAAGCCAATCAAAAATTTGGCGTCTTGGTTAACGAATCGTTTCTCGTTCGTGATGAAGTCTCTAAGGAGGTGGCAGAAGAAAGATCGAATAAGATTATGCAAGAGATAAAAATTGTATCGAATATGATTTCGTTGCCGAATTATGAATGA", "partial": "0", "query_start": 5995, "query_end": 6645, "hit_start": 426, "hit_end": 1086, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 21.37}, "gnl|BL_ORD_ID|2724|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(53)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3290", "ARO_accession": "3004589", "ARO_name": "tet(53)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.02751, "max_identities": 46, "bit_score": 33.4982, "cvterm_id": "36791", "query": "DGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDC---VQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQL--NSFKDV-----SLLDVFAGS------------ARRWARDGLLLIGDSAHTHSPIGAQGINLAI", "match": "DG V   D V+GADG YST R   G+ +D+ E         KL         +F       L++T    C    +L     HK    +AE  F    + +   +    +   QQL  ++F+D       +L++  GS             + W +  + L+GD+ ++ SP+  QG  LA+", "sequence_from_db": "DGRVEHYDLVIGADGIYSTTR---GMVFDKDEY--------KLVNLGV-CFGVFSILNYLNLSHTEVQ-CEANQKLISIWSHKN-PKMAEVAFVFRTQNVLNNIRNKNEQ--QQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLAL", "sequence_from_broadstreet": "MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE", "dna_sequence_from_broadstreet": "ATGTCTACTATAAATAAAATTCTCGTGATCGGAGCTGGTATTGCCGGACCCGCGGTTTGTTATTGGTTAAGAAGATTTGGCTTTTCTCCTGTCCTCATTGAAAAATTTGCCAATATACGAAAAGAAGGGCAGGCACTGGATTTTCGAGGCGTTGCGATCGACATCGTTAAAGGAATGAATATTTATGAGAAAATGTGCAATATGCACAAGCAGTTGGAGGTCGGGCGGTATGTGGACACAGAAGGCAATACCCTGCATGAAGAAAGAGGTGAAAGATTTTGCTTTAGACAAGGTGAAGACGTTGAAATTGCCCGCGGTGATTTCGCCGAAATACTGACGGGTGCCATTGAAGGTATTCCCTGTCATTTTAATCAAGTAATTGACAGCATTAAACAGAGTGACGATGATGTAAAAGTCCAGTTCAACGATGGCAGAGTCGAGCATTATGACTTGGTTATTGGTGCTGATGGCATATACTCGACAACGAGAGGTATGGTTTTTGATAAAGACGAATATAAATTAGTTAACCTTGGTGTGTGCTTTGGCGTATTTAGCATTCTGAATTATCTCAATTTGAGCCACACCGAAGTGCAGTGTGAGGCCAATCAAAAGCTGATATCTATCTGGAGCCACAAAAATCCCAAGATGGCTGAAGTTGCGTTTGTGTTCCGTACGCAGAATGTCTTGAATAACATTCGCAATAAAAACGAGCAGCAGCAACTCCTGCGTGATGCTTTTCAAGATTTTGGCTGGGAAGCATCAAAAATACTTGAGCTGATGACAGGTAGTGATGATTTTTATTTTGATTCAGCCACACAGGTAAAAATGAAATCGTGGACGAAAGGGCGGGTTGCTTTATTGGGTGATGCTGGTTACTCTGCATCTCCACTATCTGGTCAGGGTAATTATCTGGCACTGGTTGGCGCTTATATTTTTGCCGGAGAACTAAAAAAAGCAGATGGCAATTATACTCGTGCATTTAGTCGTTATAATGAATTATTACATCCACTCGTTGAAGCCTGTCACAAGTTGGGGGTCTTAGTTAGCGAATCGTTCCTCGTCCCAGATGAAGTCTCCAAAGAAGTTGCAGAAGAACGATCAAATAAGATTCTGCAAGAGGTGAAAATCGTATCGAATATGATTTCGTTGCCAGAGTATGAATGA", "partial": "0", "query_start": 5995, "query_end": 6468, "hit_start": 426, "hit_end": 918, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 25.56}, "gnl|BL_ORD_ID|792|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(56)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "3302", "ARO_accession": "3004603", "ARO_name": "tet(56)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0367675, "max_identities": 68, "bit_score": 33.113, "cvterm_id": "42547", "query": "HTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGV-LEGARRRGCHEH---------DGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAP-------------ATRTVRIFRAGGNPVLAYTSFPDCVQ-----LGWTLPHKGYQALAERGFAHVKERIRAAVPE----YADTVDQ-QLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAI", "match": "+  + V+G G AG  +   + R G    L+E+  S+         + GGQAL D  G+    AR  G ++           G  ++  G+ L      +     +  + + +  L+  L++     P   C     +  + +    V  +      DG + + D V+ ADG +S +R++     +  +L          T P             A   +    +  NP +A   F    Q     +      K +     R F    + I   +PE    Y D + Q ++NS                W +  + L+GD+ +  SP+  QG NLA ", "sequence_from_db": "NIKILVIGAGVAGPAVCYWLRRFGFSPVLIEKYASI---------RKGGQAL-DVRGIATHIAREMGIYDQICEMRTRIERGRFVDSSGKVLHEEQGEKFGFRQDDEVEILRGDLVEILMKTIADVP---CYFNQSIISIEQNADNVTVIFM----DGRIEQYDLVIAADGIHSAIRRMI-FEKNEYQLIHLGAYLSTFTIPNYLGLSHIDLECEANNKLVSINSDNNPEIARAGFMFRSQHLLNDIRDEQEQKQFLRDTFRDFGWETQNILNRMPESNDFYFDAITQVKMNS----------------WTKGRIALVGDAGYCPSPLSGQGNNLAF", "sequence_from_broadstreet": "MSKNIKILVIGAGVAGPAVCYWLRRFGFSPVLIEKYASIRKGGQALDVRGIATHIAREMGIYDQICEMRTRIERGRFVDSSGKVLHEEQGEKFGFRQDDEVEILRGDLVEILMKTIADVPCYFNQSIISIEQNADNVTVIFMDGRIEQYDLVIAADGIHSAIRRMIFEKNEYQLIHLGAYLSTFTIPNYLGLSHIDLECEANNKLVSINSDNNPEIARAGFMFRSQHLLNDIRDEQEQKQFLRDTFRDFGWETQNILNRMPESNDFYFDAITQVKMNSWTKGRIALVGDAGYCPSPLSGQGNNLAFVGAYILAGELKVANGNYTRAFTRYNALLRSFVDANQKFGVWVSESFLVKDEVSKEIAEERSNKILAMIKSISNGITLPQYESS", "dna_sequence_from_broadstreet": "ATGTCTAAAAATATCAAAATTCTCGTCATTGGCGCTGGTGTAGCTGGCCCTGCTGTTTGTTATTGGCTAAGAAGGTTTGGTTTTTCTCCTGTTTTGATTGAAAAATATGCGTCTATTAGAAAAGGGGGTCAGGCACTGGATGTTCGTGGCATAGCAACTCATATCGCCAGAGAAATGGGTATCTATGATCAAATATGTGAGATGCGCACGCGAATAGAGCGCGGTCGCTTTGTAGACTCATCGGGTAAAGTGCTGCATGAAGAACAGGGTGAGAAATTCGGGTTTAGGCAAGATGACGAAGTCGAAATTCTCCGTGGTGATTTGGTTGAAATCCTGATGAAAACAATTGCTGATGTCCCTTGTTATTTCAATCAATCCATTATTAGCATTGAGCAGAATGCTGATAACGTTACCGTTATTTTCATGGATGGCAGGATTGAACAATATGATCTGGTGATCGCTGCAGATGGGATTCACTCTGCTATAAGGCGCATGATTTTTGAAAAAAATGAATATCAGTTAATTCACCTTGGCGCATATCTCAGTACATTTACCATTCCAAATTACCTTGGCTTGAGTCACATAGATCTGGAATGTGAGGCTAATAATAAATTAGTCTCAATAAATAGCGATAACAATCCTGAAATAGCAAGAGCAGGATTTATGTTCCGTTCCCAGCATCTCCTGAATGACATCCGTGATGAGCAGGAACAAAAGCAATTCCTACGTGATACTTTTCGCGATTTTGGCTGGGAAACACAAAATATTTTAAATCGAATGCCAGAAAGCAATGATTTTTATTTTGATGCGATTACGCAAGTAAAAATGAATAGTTGGACCAAAGGTCGAATAGCGCTTGTCGGTGATGCAGGCTATTGTCCTTCTCCGTTATCTGGCCAAGGGAATAATTTGGCATTCGTTGGAGCATATATACTGGCGGGAGAATTAAAAGTTGCTAATGGAAATTATACCCGAGCGTTTACTCGTTATAATGCACTGCTACGTTCCTTCGTTGATGCCAATCAAAAATTTGGTGTTTGGGTCAGTGAATCATTCCTTGTAAAAGATGAAGTTTCCAAGGAAATTGCAGAAGAACGCTCGAACAAAATCCTAGCCATGATAAAATCAATTTCGAATGGGATTACCTTACCTCAATATGAATCATCATAG", "partial": "0", "query_start": 5557, "query_end": 6468, "hit_start": 9, "hit_end": 918, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 20.18}, "gnl|BL_ORD_ID|2722|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(50)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3287", "ARO_accession": "3004584", "ARO_name": "tet(50)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0926205, "max_identities": 18, "bit_score": 31.9574, "cvterm_id": "36791", "query": "RRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRD", "match": "+ W +  + LIGD+A+  SP+  QG NLA    V A+ +L   L++ D", "sequence_from_db": "KSWTKGRIALIGDAAYCPSPLSGQGNNLAF---VGAY-ILAGELKKAD", "sequence_from_broadstreet": "MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMGIYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIPCEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVSKEIAEARSNKILAMIKSVSNSINLPQYE", "dna_sequence_from_broadstreet": "ATGACTAAACATATAAAAATTCTTGTAATAGGGGTTGGGGTTGCGGGCCCTGCAGTCGCTTATTGGTTAAAAAGATTTGGGTTTTCTCCGGTCTTAATTGAAAAATCAGCTGCCGTTAGAAAAGGGGGCCAGGCACTTGATATTCGCGGCATAGCCACACATATCGCTAAAGAAATGGGCATTTACGACCAGATATGTAACATGCGGACTCAAATAAAGTGTGGACGTTATGTGGATGTAAAGGGTAATGTTTTGCATGAAGAACAAGGTGAAACCTTTGGTTTCCGGCAAGATGACGAAGTTGAGATTCTTCGTGGAGACCTAGTTGAAATTCTAATGAAAGCAATTGCAGATATACCTTGTGAATTCAAACAATCCGTCATAAAAATTGAACAAAACGAAGATAGTGTAACTGTCACCTACAAAGATGGCAGAGTTGAAAATTATGACCTTGTGATCGCTGCCGATGGTATTCATTCTGCTACCAGGGGAATGGTTTTTAGTAAAAATGAATATCAGTTGATTAATCTCGGCTCCTACGTCAGCGCATTTACCATCCCAAATTATCTCGGTTTGGATCACATGGAACTCCTATGTGAATCAAATCATAAACTGGTTACTCTACAAAGCGACAGCCAAGCTGACAAAGCCATGGCGGGATTTATGTTCCGTTCAAAACATGTATTAGAAGATATTCGTGATGAGCAAGAACAAAAACATTTCTTACACGCCAGTTTTCAAAATTTCGGTTGGGAAACACAAAATATTTTAAATCGAATGCCAGAAAGCGATGACTTTTATTTTGACGCGATTACTCAAATCAAAATGAAAAGCTGGACTAAAGGCCGTATAGCCTTAATCGGCGATGCCGCTTATTGCCCCTCACCTTTATCAGGTCAGGGGAATAATTTAGCTTTTGTTGGCGCTTATATTTTGGCGGGTGAATTGAAAAAGGCTGATGGTGATTATATACAAGCATTTACCCGATATAACGAATTGCTACATCCCTTTGTTGAGGCTAACCAACAATTTGGTGTGTGGGTAAGCGAATCCTTTCTCCTAAAAGATGATGAAGTCTCTAAAGAGATTGCGGAAGCCCGTTCTAATAAAATTTTGGCAATGATAAAGTCAGTCTCTAATTCAATAAACTTGCCACAATACGAATAA", "partial": "0", "query_start": 6379, "query_end": 6522, "hit_start": 828, "hit_end": 960, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 37.5}, "gnl|BL_ORD_ID|2722|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(50)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3287", "ARO_accession": "3004584", "ARO_name": "tet(50)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.05814, "max_identities": 17, "bit_score": 27.7202, "cvterm_id": "36791", "query": "HTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQAL", "match": "H  + V+G G AG  +A  + R G    L+E+S ++ +         GGQAL", "sequence_from_db": "HIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRK---------GGQAL", "sequence_from_broadstreet": "MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMGIYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIPCEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVSKEIAEARSNKILAMIKSVSNSINLPQYE", "dna_sequence_from_broadstreet": "ATGACTAAACATATAAAAATTCTTGTAATAGGGGTTGGGGTTGCGGGCCCTGCAGTCGCTTATTGGTTAAAAAGATTTGGGTTTTCTCCGGTCTTAATTGAAAAATCAGCTGCCGTTAGAAAAGGGGGCCAGGCACTTGATATTCGCGGCATAGCCACACATATCGCTAAAGAAATGGGCATTTACGACCAGATATGTAACATGCGGACTCAAATAAAGTGTGGACGTTATGTGGATGTAAAGGGTAATGTTTTGCATGAAGAACAAGGTGAAACCTTTGGTTTCCGGCAAGATGACGAAGTTGAGATTCTTCGTGGAGACCTAGTTGAAATTCTAATGAAAGCAATTGCAGATATACCTTGTGAATTCAAACAATCCGTCATAAAAATTGAACAAAACGAAGATAGTGTAACTGTCACCTACAAAGATGGCAGAGTTGAAAATTATGACCTTGTGATCGCTGCCGATGGTATTCATTCTGCTACCAGGGGAATGGTTTTTAGTAAAAATGAATATCAGTTGATTAATCTCGGCTCCTACGTCAGCGCATTTACCATCCCAAATTATCTCGGTTTGGATCACATGGAACTCCTATGTGAATCAAATCATAAACTGGTTACTCTACAAAGCGACAGCCAAGCTGACAAAGCCATGGCGGGATTTATGTTCCGTTCAAAACATGTATTAGAAGATATTCGTGATGAGCAAGAACAAAAACATTTCTTACACGCCAGTTTTCAAAATTTCGGTTGGGAAACACAAAATATTTTAAATCGAATGCCAGAAAGCGATGACTTTTATTTTGACGCGATTACTCAAATCAAAATGAAAAGCTGGACTAAAGGCCGTATAGCCTTAATCGGCGATGCCGCTTATTGCCCCTCACCTTTATCAGGTCAGGGGAATAATTTAGCTTTTGTTGGCGCTTATATTTTGGCGGGTGAATTGAAAAAGGCTGATGGTGATTATATACAAGCATTTACCCGATATAACGAATTGCTACATCCCTTTGTTGAGGCTAACCAACAATTTGGTGTGTGGGTAAGCGAATCCTTTCTCCTAAAAGATGATGAAGTCTCTAAAGAGATTGCGGAAGCCCGTTCTAATAAAATTTTGGCAATGATAAAGTCAGTCTCTAATTCAATAAACTTGCCACAATACGAATAA", "partial": "0", "query_start": 5557, "query_end": 5712, "hit_start": 9, "hit_end": 138, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 32.69}, "gnl|BL_ORD_ID|2727|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "tet(55)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3293", "ARO_accession": "3004591", "ARO_name": "tet(55)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.10807, "max_identities": 13, "bit_score": 31.5722, "cvterm_id": "36791", "query": "LNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAI", "match": "+N   D     +     + W +  + L+GD+ +T SP+  QG +LA+", "sequence_from_db": "MNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQGTSLAL", "sequence_from_broadstreet": "MPHTKKILVIGASIAGPALCYWLNHYGFQPTLVEKNQSTRKGGYAIDLRGIAVDVAKQMGIYDSVCAMRTSLQCVRYVDAAGNLLFEEHGEKGGFRQGDEVEIVRGDLVDILMKTITDIPCFYDHAIESLTQHDDHVTVQFKNGKTENYDLVIAADGLHSATRRMVFSKDDYHLRNLGCYISVFSIPNYLQLDHCETLLEAKQKLVSITSDKDSTKAFAGFMFRSSNSPNYIRDEASQKDFLRENFTNHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQGTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFGVWVSESFLADEPLSAEQAEERNNIVLGIMKKATHAIELPEY", "dna_sequence_from_broadstreet": "ATGCCCCACACCAAAAAAATCCTAGTCATAGGTGCAAGTATCGCCGGCCCAGCATTATGCTACTGGCTAAACCACTACGGCTTCCAACCCACCCTCGTAGAAAAAAACCAATCAACAAGAAAAGGCGGATATGCAATCGATCTCCGCGGCATAGCAGTGGATGTCGCCAAACAAATGGGAATCTACGACTCAGTCTGCGCCATGCGTACCAGTCTGCAGTGCGTCCGCTATGTTGATGCGGCAGGAAATTTACTATTCGAAGAGCACGGCGAAAAAGGCGGTTTCAGGCAAGGCGATGAAGTAGAAATCGTGCGTGGTGATTTAGTGGATATCTTAATGAAAACCATTACGGATATTCCTTGTTTTTATGATCATGCAATCGAAAGTTTGACCCAGCATGATGATCATGTCACCGTGCAATTTAAAAATGGCAAAACCGAAAATTATGATTTAGTGATAGCGGCTGATGGTTTGCATTCTGCTACACGTCGTATGGTTTTCAGTAAAGATGACTATCATTTGCGAAATCTTGGTTGTTACATCAGTGTGTTTAGCATACCTAATTATTTGCAGCTGGATCACTGCGAGACACTATTAGAAGCCAAGCAAAAATTGGTTTCTATTACCAGTGATAAAGATTCTACTAAGGCCTTCGCTGGTTTTATGTTTCGTTCCAGTAATAGTCCAAACTACATTCGTGATGAAGCATCACAAAAAGATTTTCTAAGAGAAAATTTCACAAATCACGGCTGGGAATCAAATAAGCTATTGTCACTGATGAATGATGCCAATGATTTTTATTTTGATGCGATTATGCAGGTTAAAATGAAAGACTGGACTAAAGGGCGTATCGCGTTAGTGGGTGATGCTGGTTATACACCTTCACCCTTATCAGGGCAGGGAACCAGCCTCGCTTTGGTTGGGGCTTATATATTGGCGGGTGAATTGAAAACAGCTACTGATCATGTTGCGGCTTTTGCTCGATATAATGAGTTATTGAAGCCTTATGTTGAGGCTAATCAGGCGTTTGGGGTTTGGGTTAGTGAATCGTTTTTGGCGGATGAGCCTTTGTCTGCAGAGCAGGCGGAAGAGCGGAATAATATTGTTTTAGGGATAATGAAAAAAGCCACGCATGCGATCGAGTTGCCGGAGTATTAA", "partial": "0", "query_start": 6328, "query_end": 6468, "hit_start": 777, "hit_end": 918, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 27.66}, "gnl|BL_ORD_ID|1154|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "OXA-55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "1258", "ARO_accession": "3001813", "ARO_name": "OXA-55", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.0863, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "36891", "query": "FLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPA", "match": "FL  +   + P +ER+ R+     +MML+       +R K    V RTPA", "sequence_from_db": "FLRQLHDNKLPVSERSQRIV---KQMMLTEASTDYIIRAKTGYGVRRTPA", "sequence_from_broadstreet": "MNKGLHRKRLSKRLLLPMLLCLLAQQTQAVAAEQTKVSDVCSEVTAEGWQEVRRWDKLFESAGVKGSLLLWDQKRSLGLSNNLSRAAEGFIPASTFKLPSSLIALETGAVRDETSRFSWDGKVREIAVWNRDQSFRTAMKYSVVPVYQQLAREIGPKVMAAMVRQLEYGNQDIGGQADSFWLDGQLRITAFQQVDFLRQLHDNKLPVSERSQRIVKQMMLTEASTDYIIRAKTGYGVRRTPAIGWWVGWLELDDNTVYFAVNLDLASASQLPLRQQLVKQVLKQEQLLP", "dna_sequence_from_broadstreet": "ATGAATAAAGGTTTGCACAGAAAGCGCCTGAGTAAGCGTTTGCTGCTGCCCATGTTGCTGTGTTTATTGGCTCAACAAACGCAGGCTGTGGCAGCTGAGCAGACCAAGGTCAGTGACGTCTGCTCTGAGGTCACGGCTGAGGGTTGGCAAGAGGTACGCCGCTGGGACAAGCTGTTCGAATCCGCAGGAGTTAAAGGCAGTTTGCTGCTTTGGGATCAAAAGCGTTCTTTGGGGCTCTCCAACAATCTAAGTCGCGCCGCCGAAGGCTTTATTCCGGCTTCCACCTTCAAGCTCCCCTCCAGCCTTATTGCGTTGGAAACCGGGGCGGTGCGCGATGAAACCAGTCGTTTTAGCTGGGACGGAAAGGTTCGCGAAATTGCCGTCTGGAACAGGGACCAGAGTTTTCGCACCGCAATGAAGTACTCTGTGGTGCCTGTATATCAGCAGTTGGCCAGGGAGATAGGCCCCAAAGTGATGGCAGCTATGGTGCGGCAGCTGGAATATGGCAATCAGGATATCGGTGGCCAAGCGGACAGCTTCTGGCTCGACGGCCAACTGAGAATTACAGCATTTCAACAAGTGGATTTTCTAAGGCAACTGCATGACAACAAGTTGCCTGTGTCCGAGCGCAGCCAGCGAATTGTCAAACAGATGATGCTGACCGAAGCGAGTACTGACTATATTATTCGCGCCAAGACAGGCTATGGTGTGCGGCGTACGCCGGCCATAGGTTGGTGGGTCGGTTGGTTGGAGTTGGACGACAACACTGTCTATTTCGCCGTTAACCTGGATCTGGCCTCGGCCAGCCAGTTACCGTTGCGCCAACAACTGGTGAAACAGGTGCTCAAGCAGGAACAGCTGCTGCCTTGA", "partial": "0", "query_start": 6535, "query_end": 6684, "hit_start": 585, "hit_end": 726, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 32.0}, "gnl|BL_ORD_ID|3969|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "OXA-729", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "5039", "ARO_accession": "3005934", "ARO_name": "OXA-729", "ARO_category": {"36026": {"category_aro_accession": "3000017", "category_aro_cvterm_id": "36026", "category_aro_name": "OXA beta-lactamase", "category_aro_description": "OXA beta-lactamases were long recognized as a less common but also plasmid-mediated beta-lactamase variety that could hydrolyze oxacillin and related anti-staphylococcal penicillins. These beta-lactamases differ from the TEM and SHV enzymes in that they belong to molecular class D and functional group 2d. The OXA-type beta-lactamases confer resistance to ampicillin and cephalothin and are characterized by their high hydrolytic activity against oxacillin and cloxacillin and the fact that they are poorly inhibited by clavulanic acid. Amino acid substitutions in OXA enzymes can also give the ESBL phenotype. The OXA beta-lactamase family was originally created as a phenotypic rather than a genotypic group for a few beta-lactamases that had a specific hydrolysis profile. Therefore, there is as little as 20% sequence homology among some of the members of this family. However, recent additions to this family show some degree of homology to one or more of the existing members of the OXA beta-lactamase family. Some confer resistance predominantly to ceftazidime, but OXA-17 confers greater resistance to cefotaxime and cefepime than it does resistance to ceftazidime.", "category_aro_class_name": "AMR Gene Family"}, "35930": {"category_aro_accession": "0000011", "category_aro_cvterm_id": "35930", "category_aro_name": "cloxacillin", "category_aro_description": "Cloxacillin is a semisynthetic, isoxazolyl penicillin derivative in the beta-lactam class of antibiotics. It interferes with peptidogylcan synthesis and is commonly used for treating penicillin-resistant Staphylococcus aureus infections.", "category_aro_class_name": "Antibiotic"}, "35973": {"category_aro_accession": "0000056", "category_aro_cvterm_id": "35973", "category_aro_name": "oxacillin", "category_aro_description": "Oxacillin is a penicillinase-resistant beta-lactam. It is similar to methicillin, and has replaced methicillin in clinical use. Oxacillin, especially in combination with other antibiotics, is effective against many penicillinase-producing strains of Staphylococcus aureus and Staphylococcus epidermidis.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.268, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "36891", "query": "FLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPA", "match": "FL  +   + P +ER+ R+     +MML+       +R K    V RTPA", "sequence_from_db": "FLRQLHDNKLPVSERSQRIV---KQMMLTEASTDYIIRAKTGYGVRRTPA", "sequence_from_broadstreet": "MNKGLHRKRLSKRLLLPMLLCLLAQQTQAVAAEQTKVSDVGSEVTAEGWQEVRRWDKLFESAGVKGSLLLWDQKRSLGLSNNLSRAAEGFIPASTFKIPSSLIALETGAVRDETSRFSWDGKVREIAAWNRDQSFRTAMKYSVVPVYQQLAREIGPKVMAAMVRQLKYGNQDIGGQADSFWLDGQLRITAFQQVDFLRQLHDNKLPVSERSQRIVKQMMLTEASTDYIIRAKTGYGVRRTPAIGWWVGWLELDDNTVYFAVNLDLASASQLPLRQQLVKQVLKQEQLLP", "dna_sequence_from_broadstreet": "ATGAATAAAGGTTTGCACAGAAAGCGCCTGAGTAAGCGTTTGCTGCTGCCCATGTTGCTGTGTTTATTGGCTCAACAAACGCAGGCTGTGGCAGCTGAGCAGACCAAGGTCAGTGACGTCGGCTCTGAGGTCACGGCCGAGGGTTGGCAAGAGGTACGCCGCTGGGACAAACTGTTCGAATCCGCAGGTGTTAAAGGCAGTTTACTGCTTTGGGATCAAAAGCGTTCTTTGGGGCTCTCCAACAATCTAAGTCGCGCCGCCGAAGGCTTTATTCCGGCTTCCACCTTCAAGATCCCCTCCAGCCTTATTGCGTTGGAAACCGGGGCGGTGCGCGATGAAACCAGTCGTTTTAGCTGGGACGGAAAGGTTCGTGAAATTGCCGCCTGGAACAGGGACCAGAGTTTTCGCACCGCAATGAAGTACTCTGTGGTGCCTGTATATCAGCAGTTGGCCAGGGAGATAGGCCCCAAAGTGATGGCAGCTATGGTGCGGCAGCTGAAATATGGCAATCAGGATATCGGTGGCCAAGCGGACAGCTTCTGGCTCGACGGCCAACTGAGAATTACAGCATTTCAACAAGTGGATTTTCTAAGGCAACTGCATGACAACAAGTTGCCTGTGTCCGAGCGCAGCCAGCGAATTGTCAAACAGATGATGCTGACCGAAGCGAGTACTGACTATATCATTCGTGCCAAGACAGGCTATGGTGTGCGGCGTACGCCGGCCATAGGTTGGTGGGTCGGTTGGTTGGAGTTGGACGACAACACTGTCTATTTCGCCGTTAACCTGGATCTGGCCTCGGCCAGCCAGTTACCGTTGCGCCAACAACTGGTGAAACAGGTGCTCAAGCAGGAACAGCTGCTGCCTTGA", "partial": "0", "query_start": 6535, "query_end": 6684, "hit_start": 585, "hit_end": 726, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 32.0}, "gnl|BL_ORD_ID|2689|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 5521, "orf_end": 6777, "orf_from": "BGC0000254.1|Oxytetracycline_6 ", "model_name": "mphN", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "3218", "ARO_accession": "3004542", "ARO_name": "mphN", "ARO_category": {"36472": {"category_aro_accession": "3000333", "category_aro_cvterm_id": "36472", "category_aro_name": "macrolide phosphotransferase (MPH)", "category_aro_description": "Macrolide phosphotransferases (MPH) are enzymes encoded by macrolide phosphotransferase genes (mph genes). These enzymes phosphorylate macrolides in GTP dependent manner at 2'-OH of desosamine sugar thereby inactivating them. Characterized MPH's are differentiated based on their substrate specificity.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.98726, "max_identities": 16, "bit_score": 25.409, "cvterm_id": "39580", "query": "DGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQAL", "match": "D      ++L G+P   I++  QD +W             F     P   Y S    +    TLPH+ ++ +", "sequence_from_db": "DDELIAYKQLDGVPVATIDVEQQDYIWS------------FDKENTPQSYYQSLGKVLAELHTLPHRHFKEI", "sequence_from_broadstreet": "MNEFKRLAKNKGLDVLENSIVVNESGVDFQVAYAKDTLGSKWILRIPRRLDSMRSALKEKMALEIMEEHVSFQVPNWSIFDDELIAYKQLDGVPVATIDVEQQDYIWSFDKENTPQSYYQSLGKVLAELHTLPHRHFKEIGIKTLYARDLKSSMKIRMEKVRQKYHVNSELWERWQEWLANDSLWPSHVGVSHGDLHPGHILINKNFEVSGLIDWTEISIADTSVDFLSHLLLFGKDGLTKLLDAYDNAGGRTWSRMDEHIIELLTTSAITVAEFAEISDLQDMRETAAHMLAQNV", "dna_sequence_from_broadstreet": "ATGAACGAATTTAAACGGCTTGCAAAAAATAAAGGATTAGATGTGTTAGAGAATAGCATTGTGGTAAATGAATCGGGTGTTGATTTTCAAGTTGCTTATGCAAAAGATACGCTTGGTAGCAAGTGGATACTAAGAATTCCTCGAAGATTAGATTCGATGAGGAGCGCCTTGAAAGAAAAGATGGCACTAGAAATTATGGAAGAACATGTGAGTTTTCAAGTTCCAAATTGGTCGATTTTTGATGATGAACTAATTGCGTATAAGCAATTAGATGGTGTTCCGGTTGCAACAATTGATGTAGAGCAACAAGATTACATCTGGAGTTTTGACAAAGAGAATACACCACAATCTTACTATCAGTCATTAGGTAAAGTGTTGGCAGAACTACACACATTACCACATCGACACTTCAAAGAAATCGGTATCAAAACTCTATATGCTAGAGATTTAAAGAGTTCAATGAAGATACGGATGGAGAAGGTGAGACAGAAGTATCATGTGAATTCAGAGCTATGGGAGCGTTGGCAAGAATGGTTGGCGAATGATTCGCTATGGCCATCGCATGTAGGTGTAAGCCACGGGGATTTACACCCTGGCCACATACTAATAAATAAGAATTTTGAGGTCTCTGGTTTGATAGATTGGACAGAAATTAGTATTGCGGACACATCTGTGGATTTTCTATCACATCTATTACTGTTTGGTAAGGATGGTTTGACAAAGTTACTCGATGCTTACGACAATGCAGGCGGAAGAACATGGTCAAGAATGGATGAGCATATAATTGAGTTGTTAACAACCAGCGCAATAACTGTAGCTGAATTCGCAGAGATATCTGACCTACAAGATATGCGTGAAACAGCTGCTCATATGCTTGCACAAAATGTATGA", "partial": "0", "query_start": 6034, "query_end": 6249, "hit_start": 240, "hit_end": 420, "orf_dna_sequence": "ATGACCGGCCACCCGCGGCCGCCGGCCGACGGCGCGCACACCGATGTGTGCGTCGTCGGCGGCGGCCCGGCCGGGCTGACCCTGGCGCTGCTGATGCTGCGCTCGGGGGCGCGGGTGACGCTGGTCGAGCGCAGCCGCTCACTGGACCGCGCCTACCGGGGCGAGATCCTCCAGCCGGGCGGGCAGGCCCTGCTCGACGCGCTCGGCGTCCTGGAGGGTGCCCGGCGGCGCGGCTGCCACGAGCACGACGGTTTCCGGCTGGAGGAGCGCGGCAGGACCCTGATCAACGGGGATTACCGGCGGCTGCCCGGCCCGTACAACTGTCTGCTCAGCCTGCCGCAGCAGCATCTGCTGACCGATCTGCTGGAGCGCTGCCGGGCCCACCCGCGCTTCACCTGCCTGACCGGCACCAAGGTCAACGGGCTGGTGGAGGAGGGCGGCGTGGTGCGCGGTGTGGTGTGCGGCGGCGGGGCGGACGGGCTCGTGGTGCGCGCGGACTGCGTCGTCGGTGCGGACGGGCGGTATTCGACGGTCCGCAAGCTGGCCGGCATTCCGTACGACCGCATCGAGCTGTTCGACCAGGACGTGCTGTGGTGCAAGCTCACCGCGCCCGCCACCCGTACGGTGCGGATCTTCCGGGCCGGCGGCAACCCGGTGCTGGCCTACACGTCCTTCCCCGACTGCGTACAGCTCGGCTGGACGCTGCCGCACAAGGGCTACCAGGCGCTGGCCGAGCGGGGGTTCGCGCACGTCAAGGAGCGTATCCGGGCAGCCGTGCCCGAGTACGCGGACACGGTGGACCAGCAGCTGAACAGCTTCAAGGACGTGTCTCTGCTGGATGTGTTCGCCGGCTCCGCACGGCGGTGGGCGCGCGACGGGCTGCTGCTCATCGGCGACAGCGCGCACACCCACAGCCCGATCGGGGCCCAGGGCATCAACCTCGCCATCCAGGACGCGGTCGCCGCGCACCCGGTGCTGTGCGAGGGCCTGCGGCGACGGGACCTGAGCGAGCGGTTCCTCGACGCGGTCGCGGCGCGGCGCCGTCCGGAGACCGAGCGGGCGACCCGCGTCCAGGTGATGCAGAGCCGGATGATGCTGTCGACCGGACGCGTTTCGGCGGCCGTCCGCCCGAAGGCGGCGATGCTGGTCTCGCGTACCCCGGCCTACCGCTCCGTCCTGCGGCGCATCGCCTACGGCGACCAGACACTGCGGGTCCGCTCCGACCTGTTCGAGGAGGGCGAGCCCGCCACCGTCTGA", "orf_prot_sequence": "MTGHPRPPADGAHTDVCVVGGGPAGLTLALLMLRSGARVTLVERSRSLDRAYRGEILQPGGQALLDALGVLEGARRRGCHEHDGFRLEERGRTLINGDYRRLPGPYNCLLSLPQQHLLTDLLERCRAHPRFTCLTGTKVNGLVEEGGVVRGVVCGGGADGLVVRADCVVGADGRYSTVRKLAGIPYDRIELFDQDVLWCKLTAPATRTVRIFRAGGNPVLAYTSFPDCVQLGWTLPHKGYQALAERGFAHVKERIRAAVPEYADTVDQQLNSFKDVSLLDVFAGSARRWARDGLLLIGDSAHTHSPIGAQGINLAIQDAVAAHPVLCEGLRRRDLSERFLDAVAARRRPETERATRVQVMQSRMMLSTGRVSAAVRPKAAMLVSRTPAYRSVLRRIAYGDQTLRVRSDLFEEGEPATV", "perc_identity": 22.22}}, "BGC0000254.1|Oxytetracycline_7 # 6809 # 7807 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=ACGGCG;rbs_spacer=15bp;gc_cont=0.733": {"gnl|BL_ORD_ID|274|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 6809, "orf_end": 7807, "orf_from": "BGC0000254.1|Oxytetracycline_7 ", "model_name": "chrB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "305", "ARO_accession": "3001302", "ARO_name": "chrB", "ARO_category": {"37697": {"category_aro_accession": "3001298", "category_aro_cvterm_id": "37697", "category_aro_name": "non-erm 23S ribosomal RNA methyltransferase (G748)", "category_aro_description": "Non-erm 23S ribosomal RNA methyltransferases modify guanosine 748 (E. coli numbering) to confer resistance to some macrolides and lincosamides.", "category_aro_class_name": "AMR Gene Family"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37621": {"category_aro_accession": "3001222", "category_aro_cvterm_id": "37621", "category_aro_name": "chalcomycin", "category_aro_description": "Produced by Streptomyces bikiniensis.", "category_aro_class_name": "Antibiotic"}, "37623": {"category_aro_accession": "3001224", "category_aro_cvterm_id": "37623", "category_aro_name": "mycinamicin", "category_aro_description": "Produced by Micromonospora\u00a0griseorubida.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.013654, "max_identities": 18, "bit_score": 33.8834, "cvterm_id": "39573", "query": "GAMVDIAGGQGMVLATLLEKYPALRGTLFDLPKV----VADADPRL", "match": "G +VDI GG G   A ++E +P  +G L D+ K      A A PR+", "sequence_from_db": "GCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRI", "sequence_from_broadstreet": "MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA", "dna_sequence_from_broadstreet": "ATGCTCAACAGGATCGTGCGCTACCTCGCCTGCCCGCACTGCGGTGCTTCGCTGGCTCAGGGCGACCGCGCACTTTTCTGCCCCGCCGGACACTCCTTCGACATCGCGAAGCAGGGTTATGTGAATCTGCTTCCCAGGGCGACGAAGCTGCGGGCCGACACCAAGGAAATGGTGGAGGCCCGGGACGCATTCCTGTCGGCGGGTCACTACGACCCCGTGATGGATGCGCTGGTCGATCTGGCGCGGCGGACGGCCGATCCGGCCGTGCCCGGCTGTGTGGTCGACATCGGTGGGGGGACGGGCCACTATCACGCCGGGGTCATGGAAGCGTTCCCCGATGCCCAGGGCCTGCTGCTGGACATCTCCAAGTACGCCGTGCGGCGTGCCGCGAAGGCGCATCCGCGGATCGCGGCCGCGGTGACCGACGCCTGGCAGACGCTTCCGCTGCGGGATGCCGCAGCCGGCATGGTGATCAACACGTTCGCTCCCCGCAACGGTCCTGAACTGCATCGCGTTCTCCATCCCCGTGGCGTTCTCCTGGTTGTCACTCCTCTGCCCGATCACCTGCGGGAGGTGATCGGCGCCCTCGGCCTGCTGCAGGTGGACGAAGGCAAGGAGTCGCGTCTCGCGGAGCAGCTCGCTCCGCACTTCTCGGCCGTCGCCACGGAGGAGTTGACCCGGACCATGGCTCTCGACCACCAGGCTCTGGCGCACCTGGTCGGCATGGGGCCCAATGCCTGGCACCGTGACGCGCAGCGGGATCTGGAGACGATCCAGCGGCTGCCGGCGCCGACTCGGGTCACGCTCTCCGTGCGGCTCTCCGCCTACCGGTTGTCGGCGTAG", "partial": "0", "query_start": 7304, "query_end": 7429, "hit_start": 270, "hit_end": 408, "orf_dna_sequence": "ATGCGGCTGCGCGAACTCGCCCTGAGCGCCGCCTGTGCCGCCGCCGTCCGCGCCGCGGCGAGCCTGGGCGTCGCGGACGCCCTCGGGGACGAACCCGCGGACGCCGGCACCCTCGCGAAGGCGGTGCGGGCCGACGCGGACGCGCTGGAGCGCCTGCTGCGCGCCCTCGCCGCGTACGACGTCTTCAGCGAACTCCCCGACGGCCGCTTCGAGCACACCGACGCCTCCCGGCTGCTGCGCGAGGACGCCCCGCGCGGCCTGCGCTACTCGGCGCTGTGGGCGACCGAGCCGTGGACCTGGGCGCTGTGGCCGCACCTGGCGGACGCCGTGCGCACCGGCCGGGAGGAGTTCACCGCGCTGTACGGCACCGAGTTCTTCGACTGGCTGCACACCGCCGAGGCCCGCGAGTCGGCCGAGGTGTTCGACAAGGCCATGACCCAGTCCAGCGTGCTGTCGGCGAAGGCCATCGCCGAGGTGCTCGACCTGGACGGCGTCGGCGCCATGGTGGACATCGCCGGGGGCCAGGGCATGGTGCTCGCCACCCTGCTGGAGAAGTACCCGGCGCTGCGCGGCACCCTCTTCGACCTGCCGAAGGTCGTCGCCGACGCCGACCCGCGGCTGCGCGAGGGCGGCGCGCTCGCCGGGCGCGCGCAGCTGGTGGGCGGTGACTGCCGGCAGTCGGTGCCGGAGGGTGCCGACCTGTATCTGCTGAAGAACATCCTGGAGTGGGACGACGAGAGCACGGTGCGCACCCTGCGCAACGTCGCCAAGTCGGCCCCCGCCGGGGCGCGCGTCGTGGTGGTGGAGAACCTGGTCGACGGCAGTCCCGAGACCCGGTTCACCACCGCCATGGACCTGATGCTGCTGCTCAACGTCGGCGGCAAGAAGCACACCAAGGCGGGGCTGAGCGCGCTGGTGGAGCAGGCGGGGCTCCAGCTGGAGGAGGTACGCGCGGTCAACTCCTACCTGCACATGTTCGTGAGCACGGTGCCCGCGTAG", "orf_prot_sequence": "MRLRELALSAACAAAVRAAASLGVADALGDEPADAGTLAKAVRADADALERLLRALAAYDVFSELPDGRFEHTDASRLLREDAPRGLRYSALWATEPWTWALWPHLADAVRTGREEFTALYGTEFFDWLHTAEARESAEVFDKAMTQSSVLSAKAIAEVLDLDGVGAMVDIAGGQGMVLATLLEKYPALRGTLFDLPKVVADADPRLREGGALAGRAQLVGGDCRQSVPEGADLYLLKNILEWDDESTVRTLRNVAKSAPAGARVVVVENLVDGSPETRFTTAMDLMLLLNVGGKKHTKAGLSALVEQAGLQLEEVRAVNSYLHMFVSTVPA", "perc_identity": 39.13}, "gnl|BL_ORD_ID|2699|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 6809, "orf_end": 7807, "orf_from": "BGC0000254.1|Oxytetracycline_7 ", "model_name": "erm(32)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "556", "model_id": "3294", "ARO_accession": "3004592", "ARO_name": "erm(32)", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "37625": {"category_aro_accession": "3001226", "category_aro_cvterm_id": "37625", "category_aro_name": "narbomycin", "category_aro_description": "Produced by Streptomyces narbonensis.", "category_aro_class_name": "Antibiotic"}, "37631": {"category_aro_accession": "3001232", "category_aro_cvterm_id": "37631", "category_aro_name": "methymycin", "category_aro_description": "Produced by Streptomyces venezuelae ATCC 15439.", "category_aro_class_name": "Antibiotic"}, "37632": {"category_aro_accession": "3001233", "category_aro_cvterm_id": "37632", "category_aro_name": "pikromycin", "category_aro_description": "Produced by Streptomyces venezuelae ATCC 15439.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.399475, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "36838", "query": "AMVDIAGGQGMVLATLLEKYPALRGTLFDLPK", "match": " +VDI GG G  LA +LE++    G L D+ K", "sequence_from_db": "CVVDIGGGTGHHLARVLEEFEDAEGLLLDMSK", "sequence_from_broadstreet": "MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAARAALLDSGHYAPLTERLAGTARRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP", "dna_sequence_from_broadstreet": "ATGCGGAAGAACGTCGTGCGATATCTGCGCTGTCCGCACTGCGCAGCCCCTCTGCGGTCATCCGACCGCACCCTCCGCTGCGAAAACGGGCACACCTTCGACGTCGCCCGGCAGGGCTATGTGAATCTGCTCAGACGCCCGACGAAGCTCGCCGCCGACACCACCGACATGGTCGCCGCCCGGGCCGCGCTGCTGGACAGCGGGCATTACGCGCCGCTGACCGAGCGGCTGGCCGGGACGGCCCGGCGCGCGGCGGGCGCCGGGGCACCGGACTGCGTCGTGGACATCGGCGGGGGCACCGGTCACCATCTCGCCCGTGTCCTGGAGGAGTTCGAGGACGCCGAGGGACTCCTGCTGGACATGTCCAAGCCGGCCGTGCGCAGGGCCGCCCGCGCCCATCCCCGGGCCAGCTCCGCCGTCGCCGACGTATGGGACACACTTCCGCTGCGGGACGGGGCCGCCGCGATGGCCCTCAACGTCTTCGCCCCGCGCAACCCGCCGGAGATCCGCAGGATCCTCCGCCCCGGCGGCACCCTGCTGGTCGTCACGCCCCAGCAGGACCACCTCGCCGAACTCGTGGACGCGCTGGGGCTGTTGCGCGTACGGGACCACAAGGAGGGCCGGCTGGCCGAACAGCTCGCGCCGCACTTCGAGGCCGTCGGGCAGGAGCGGCTGCGGACCACTCTCCGCCTCGATCACGACGCGCTCGGCCGGGTGGTCGCCATGGGGCCCAGTTCCTGGCACCAGGACCCGGATGAACTGGCGCGGCGGATCGCGGAGTTGCCCGGCATCCACGAGGTCACGCTCTCGGTCACCTTCACCGTCTGCCGCCCTCTGCCCTGA", "partial": "0", "query_start": 7307, "query_end": 7402, "hit_start": 273, "hit_end": 369, "orf_dna_sequence": "ATGCGGCTGCGCGAACTCGCCCTGAGCGCCGCCTGTGCCGCCGCCGTCCGCGCCGCGGCGAGCCTGGGCGTCGCGGACGCCCTCGGGGACGAACCCGCGGACGCCGGCACCCTCGCGAAGGCGGTGCGGGCCGACGCGGACGCGCTGGAGCGCCTGCTGCGCGCCCTCGCCGCGTACGACGTCTTCAGCGAACTCCCCGACGGCCGCTTCGAGCACACCGACGCCTCCCGGCTGCTGCGCGAGGACGCCCCGCGCGGCCTGCGCTACTCGGCGCTGTGGGCGACCGAGCCGTGGACCTGGGCGCTGTGGCCGCACCTGGCGGACGCCGTGCGCACCGGCCGGGAGGAGTTCACCGCGCTGTACGGCACCGAGTTCTTCGACTGGCTGCACACCGCCGAGGCCCGCGAGTCGGCCGAGGTGTTCGACAAGGCCATGACCCAGTCCAGCGTGCTGTCGGCGAAGGCCATCGCCGAGGTGCTCGACCTGGACGGCGTCGGCGCCATGGTGGACATCGCCGGGGGCCAGGGCATGGTGCTCGCCACCCTGCTGGAGAAGTACCCGGCGCTGCGCGGCACCCTCTTCGACCTGCCGAAGGTCGTCGCCGACGCCGACCCGCGGCTGCGCGAGGGCGGCGCGCTCGCCGGGCGCGCGCAGCTGGTGGGCGGTGACTGCCGGCAGTCGGTGCCGGAGGGTGCCGACCTGTATCTGCTGAAGAACATCCTGGAGTGGGACGACGAGAGCACGGTGCGCACCCTGCGCAACGTCGCCAAGTCGGCCCCCGCCGGGGCGCGCGTCGTGGTGGTGGAGAACCTGGTCGACGGCAGTCCCGAGACCCGGTTCACCACCGCCATGGACCTGATGCTGCTGCTCAACGTCGGCGGCAAGAAGCACACCAAGGCGGGGCTGAGCGCGCTGGTGGAGCAGGCGGGGCTCCAGCTGGAGGAGGTACGCGCGGTCAACTCCTACCTGCACATGTTCGTGAGCACGGTGCCCGCGTAG", "orf_prot_sequence": "MRLRELALSAACAAAVRAAASLGVADALGDEPADAGTLAKAVRADADALERLLRALAAYDVFSELPDGRFEHTDASRLLREDAPRGLRYSALWATEPWTWALWPHLADAVRTGREEFTALYGTEFFDWLHTAEARESAEVFDKAMTQSSVLSAKAIAEVLDLDGVGAMVDIAGGQGMVLATLLEKYPALRGTLFDLPKVVADADPRLREGGALAGRAQLVGGDCRQSVPEGADLYLLKNILEWDDESTVRTLRNVAKSAPAGARVVVVENLVDGSPETRFTTAMDLMLLLNVGGKKHTKAGLSALVEQAGLQLEEVRAVNSYLHMFVSTVPA", "perc_identity": 43.75}, "gnl|BL_ORD_ID|441|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 6809, "orf_end": 7807, "orf_from": "BGC0000254.1|Oxytetracycline_7 ", "model_name": "tlrB conferring tylosin resistance", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "336", "ARO_accession": "3001299", "ARO_name": "tlrB conferring tylosin resistance", "ARO_category": {"37697": {"category_aro_accession": "3001298", "category_aro_cvterm_id": "37697", "category_aro_name": "non-erm 23S ribosomal RNA methyltransferase (G748)", "category_aro_description": "Non-erm 23S ribosomal RNA methyltransferases modify guanosine 748 (E. coli numbering) to confer resistance to some macrolides and lincosamides.", "category_aro_class_name": "AMR Gene Family"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.399475, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "36838", "query": "AMVDIAGGQGMVLATLLEKYPALRGTLFDLPK", "match": " +VDI GG G  LA +LE++    G L D+ K", "sequence_from_db": "CVVDIGGGTGHHLARVLEEFEDAEGLLLDMSK", "sequence_from_broadstreet": "MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAARAALLDSGHYAPLTERLAGTAGRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAARAHPRASSAVADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLRVRDHKEGRLAEQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLSVTFTVCRPLP", "dna_sequence_from_broadstreet": "ATGCGGAAGAACGTCGTGCGATATCTGCGCTGTCCGCACTGCGCAGCCCCTCTGCGGTCATCCGACCGCACCCTCCGCTGCGAAAACGGGCACACCTTCGACGTCGCCCGGCAGGGCTATGTGAATCTGCTCAGACGCCCGACGAAGCTCGCCGCCGACACCACCGACATGGTCGCCGCCCGGGCCGCGCTGCTGGACAGCGGGCATTACGCGCCGCTGACCGAGCGGCTGGCCGGGACGGCCGGGCGCGCGGCGGGCGCCGGGGCACCGGACTGCGTCGTGGACATCGGCGGGGGCACCGGTCACCATCTCGCCCGTGTCCTGGAGGAGTTCGAGGACGCCGAGGGACTCCTGCTGGACATGTCCAAGCCGGCCGTGCGCAGGGCCGCCCGCGCCCATCCCCGGGCCAGCTCCGCCGTCGCCGACGTATGGGACACACTTCCGCTGCGGGACGGGGCCGCCGCGATGGCCCTCAACGTCTTCGCCCCGCGCAACCCGCCGGAGATCCGCAGGATCCTCCGCCCCGGCGGCACCCTGCTGGTCGTCACGCCCCAGCAGGACCACCTCGCCGAACTCGTGGACGCGCTGGGGCTGTTGCGCGTACGGGACCACAAGGAGGGCCGGCTGGCCGAACAGCTCGCGCCGCACTTCGAGGCCGTCGGGCAGGAGCGGCTGCGGACCACTCTCCGCCTCGATCACGACGCGCTCGGCCGGGTGGTCGCCATGGGGCCCAGTTCCTGGCACCAGGACCCGGATGAACTGGCGCGGCGGATCGCGGAGTTGCCCGGCATCCACGAGGTCACGCTCTCGGTCACCTTCACCGTCTGCCGCCCTCTGCCCTGA", "partial": "0", "query_start": 7307, "query_end": 7402, "hit_start": 273, "hit_end": 369, "orf_dna_sequence": "ATGCGGCTGCGCGAACTCGCCCTGAGCGCCGCCTGTGCCGCCGCCGTCCGCGCCGCGGCGAGCCTGGGCGTCGCGGACGCCCTCGGGGACGAACCCGCGGACGCCGGCACCCTCGCGAAGGCGGTGCGGGCCGACGCGGACGCGCTGGAGCGCCTGCTGCGCGCCCTCGCCGCGTACGACGTCTTCAGCGAACTCCCCGACGGCCGCTTCGAGCACACCGACGCCTCCCGGCTGCTGCGCGAGGACGCCCCGCGCGGCCTGCGCTACTCGGCGCTGTGGGCGACCGAGCCGTGGACCTGGGCGCTGTGGCCGCACCTGGCGGACGCCGTGCGCACCGGCCGGGAGGAGTTCACCGCGCTGTACGGCACCGAGTTCTTCGACTGGCTGCACACCGCCGAGGCCCGCGAGTCGGCCGAGGTGTTCGACAAGGCCATGACCCAGTCCAGCGTGCTGTCGGCGAAGGCCATCGCCGAGGTGCTCGACCTGGACGGCGTCGGCGCCATGGTGGACATCGCCGGGGGCCAGGGCATGGTGCTCGCCACCCTGCTGGAGAAGTACCCGGCGCTGCGCGGCACCCTCTTCGACCTGCCGAAGGTCGTCGCCGACGCCGACCCGCGGCTGCGCGAGGGCGGCGCGCTCGCCGGGCGCGCGCAGCTGGTGGGCGGTGACTGCCGGCAGTCGGTGCCGGAGGGTGCCGACCTGTATCTGCTGAAGAACATCCTGGAGTGGGACGACGAGAGCACGGTGCGCACCCTGCGCAACGTCGCCAAGTCGGCCCCCGCCGGGGCGCGCGTCGTGGTGGTGGAGAACCTGGTCGACGGCAGTCCCGAGACCCGGTTCACCACCGCCATGGACCTGATGCTGCTGCTCAACGTCGGCGGCAAGAAGCACACCAAGGCGGGGCTGAGCGCGCTGGTGGAGCAGGCGGGGCTCCAGCTGGAGGAGGTACGCGCGGTCAACTCCTACCTGCACATGTTCGTGAGCACGGTGCCCGCGTAG", "orf_prot_sequence": "MRLRELALSAACAAAVRAAASLGVADALGDEPADAGTLAKAVRADADALERLLRALAAYDVFSELPDGRFEHTDASRLLREDAPRGLRYSALWATEPWTWALWPHLADAVRTGREEFTALYGTEFFDWLHTAEARESAEVFDKAMTQSSVLSAKAIAEVLDLDGVGAMVDIAGGQGMVLATLLEKYPALRGTLFDLPKVVADADPRLREGGALAGRAQLVGGDCRQSVPEGADLYLLKNILEWDDESTVRTLRNVAKSAPAGARVVVVENLVDGSPETRFTTAMDLMLLLNVGGKKHTKAGLSALVEQAGLQLEEVRAVNSYLHMFVSTVPA", "perc_identity": 43.75}, "gnl|BL_ORD_ID|2247|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 6809, "orf_end": 7807, "orf_from": "BGC0000254.1|Oxytetracycline_7 ", "model_name": "vga(E) Staphylococcus cohnii", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "3400", "ARO_accession": "3004715", "ARO_name": "vga(E) Staphylococcus cohnii", "ARO_category": {"36252": {"category_aro_accession": "3000113", "category_aro_cvterm_id": "36252", "category_aro_name": "vga-type ABC-F protein", "category_aro_description": "Vga-type plasmid-borne ABC-F proteins, expressed in staphylococci that confer resistance to streptogramin A antibiotics through ribosomal protection.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "35983": {"category_aro_accession": "0000066", "category_aro_cvterm_id": "35983", "category_aro_name": "clindamycin", "category_aro_description": "Clindamycin is a lincosamide antibiotic that blocks A-site aminoacyl-tRNA binding. It is usually used to treat infections with anaerobic bacteria but can also be used to treat some protozoal diseases, such as malaria.", "category_aro_class_name": "Antibiotic"}, "37013": {"category_aro_accession": "3000669", "category_aro_cvterm_id": "37013", "category_aro_name": "virginiamycin M1", "category_aro_description": "Virginiamycin M1 is a streptogramin A antibiotic.", "category_aro_class_name": "Antibiotic"}, "37015": {"category_aro_accession": "3000671", "category_aro_cvterm_id": "37015", "category_aro_name": "tiamulin", "category_aro_description": "Tiamulin is a pleuromutilin derivative currently used in veterinary medicine. It binds to the 23 rRNA of the 50S ribosomal subunit to inhibit protein translation.", "category_aro_class_name": "Antibiotic"}, "37713": {"category_aro_accession": "3001314", "category_aro_cvterm_id": "37713", "category_aro_name": "retapamulin", "category_aro_description": "Retapamulin is a semi-synthetic pleuromutilin antibiotic approved for the treatment of skin infections.", "category_aro_class_name": "Antibiotic"}, "37714": {"category_aro_accession": "3001315", "category_aro_cvterm_id": "37714", "category_aro_name": "valnemulin", "category_aro_description": "Two semi-synthetic pleuromutilin derivatives, tiamulin and valnemulin, have been developed as antibiotics for veterinary use.", "category_aro_class_name": "Antibiotic"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35952": {"category_aro_accession": "0000034", "category_aro_cvterm_id": "35952", "category_aro_name": "streptogramin A antibiotic", "category_aro_description": "Streptogramin A antibiotics are cyclic polyketide peptide hybrids that bind to the ribosomal peptidyl transfer centre. Structural variation arises from substituting a proline for its desaturated derivative and by its substitution for Ala or Cys. Used alone, streptogramin A antibiotics are bacteriostatic, but is bactericidal when used with streptogramin B antibiotics.", "category_aro_class_name": "Drug Class"}, "37014": {"category_aro_accession": "3000670", "category_aro_cvterm_id": "37014", "category_aro_name": "pleuromutilin antibiotic", "category_aro_description": "Pleuromutilins are natural fungal products that target bacterial protein translation by binding the the 23S rRNA, blocking the ribosome P site at the 50S subunit. They are mostly used for agriculture and veterinary purposes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.709935, "max_identities": 21, "bit_score": 28.8758, "cvterm_id": "36766", "query": "TLAKAVRADADALERLLRALAAYDVFSELPDGRFEHTDASRL-----LREDAPRG-LRYSALWATEPWTWALW", "match": " + K +R+ A ALE  L  L   D   ELP+ + +  +   L     LR +  +G +    LW  EP++  L+", "sequence_from_db": "NIQKKLRSSAKALETRLEQLDKVDKVKELPEIKMDMLNEENLTNQSVLRAENIKGEIEERKLW--EPFSLYLY", "sequence_from_broadstreet": "MLLFEGTSIKKQLHDRVLFDIDLIQVHDNQRIGLVGRNGTGKTSLLKIITGEELPDEGNISPFTSVKLVPQFKESRLEKSGGEITQQYLQNAFNGNPGLLLLDEPTTHLDTERIAWLEKKIRNYQGAAVVVSHDRTFLNNVCTDIWEIEKNTLKIFKGNYDEYAKQKEILKKQKQTEFEKYEREKQKLERAIRQKEERAQRATKKPKNLSSSEARIVGAKTHYANIQKKLRSSAKALETRLEQLDKVDKVKELPEIKMDMLNEENLTNQSVLRAENIKGEIEERKLWEPFSLYLYGGDKVAIIGKNGSGKTTLLKKIVKQDEGVTIPEKVKIGYFSQHLTILNDEKSIIENVQSTSSQNETLIRTVLARMHFWDEDVYKKVGILSGGEKVKLALAKLFLSEVNMLVLDEPTNFLDIAALEALETLMKSYHGTILFVTHDRMLVKNIATKIIDIKDGKITVFDGSYEAYEEWLENKTKSNNDDQLLLIETKISDVLGRLSLEPSQELEDEFQRLLKEKKELTRGE", "dna_sequence_from_broadstreet": "ATGCTATTATTTGAAGGAACATCAATCAAAAAACAATTACATGACAGAGTGCTATTTGATATTGATTTAATACAAGTGCATGATAATCAACGTATAGGCTTAGTAGGTAGGAATGGAACAGGAAAAACAAGCCTATTAAAAATTATTACAGGTGAAGAATTACCTGATGAAGGTAATATCTCTCCTTTTACCTCTGTGAAATTAGTGCCACAATTTAAAGAATCAAGATTGGAGAAAAGTGGTGGCGAAATAACACAGCAATATTTACAGAACGCATTCAATGGGAATCCAGGCTTACTGCTTTTAGATGAACCGACAACACACTTAGATACGGAAAGAATTGCTTGGCTAGAAAAAAAGATAAGAAACTATCAAGGAGCAGCTGTCGTAGTATCTCATGATCGGACATTTTTAAATAATGTATGTACTGACATATGGGAAATTGAAAAAAATACGTTAAAAATATTTAAAGGAAATTATGATGAATATGCAAAGCAAAAAGAAATACTTAAAAAACAAAAACAAACTGAATTTGAAAAGTATGAACGTGAGAAACAAAAATTAGAAAGAGCAATACGTCAAAAAGAAGAAAGAGCTCAACGAGCAACAAAAAAACCTAAGAATCTAAGTTCATCTGAAGCGAGAATAGTGGGTGCTAAAACCCACTACGCCAACATACAGAAAAAGCTGAGAAGTTCGGCAAAAGCTTTAGAAACAAGACTGGAACAATTGGATAAGGTTGACAAGGTGAAAGAGCTGCCTGAAATTAAGATGGATATGTTAAATGAAGAAAACTTAACAAACCAATCTGTATTACGTGCTGAAAATATTAAGGGAGAGATTGAAGAACGTAAGCTCTGGGAACCCTTTAGCTTATATTTATATGGAGGAGATAAAGTTGCTATCATTGGAAAAAATGGCTCAGGTAAAACAACGTTGCTTAAAAAAATAGTGAAGCAAGATGAAGGAGTGACAATTCCAGAAAAAGTAAAGATAGGTTACTTCTCTCAACACTTAACCATCCTAAATGATGAGAAATCAATCATAGAAAATGTACAATCGACCTCTAGTCAAAATGAGACATTAATAAGAACAGTTTTAGCAAGAATGCATTTTTGGGATGAAGATGTCTATAAAAAGGTAGGCATATTAAGTGGTGGTGAAAAAGTAAAGCTAGCTTTAGCTAAACTATTTTTAAGTGAGGTGAATATGCTCGTTTTAGATGAGCCGACTAACTTTTTAGACATTGCAGCTTTAGAAGCGCTAGAAACATTAATGAAAAGTTATCATGGAACGATTCTATTTGTTACTCACGACCGAATGTTAGTAAAAAATATAGCTACAAAAATAATTGATATAAAAGATGGTAAGATAACAGTATTCGATGGATCGTACGAAGCATATGAAGAGTGGCTGGAGAATAAAACAAAGTCTAACAATGATGACCAACTTTTATTAATTGAAACTAAAATATCTGATGTTCTGGGTAGGTTGAGCTTGGAACCTTCGCAAGAGTTAGAAGATGAATTTCAAAGATTATTGAAAGAAAAGAAAGAACTGACTAGAGGGGAATAA", "partial": "0", "query_start": 6917, "query_end": 7117, "hit_start": 672, "hit_end": 885, "orf_dna_sequence": "ATGCGGCTGCGCGAACTCGCCCTGAGCGCCGCCTGTGCCGCCGCCGTCCGCGCCGCGGCGAGCCTGGGCGTCGCGGACGCCCTCGGGGACGAACCCGCGGACGCCGGCACCCTCGCGAAGGCGGTGCGGGCCGACGCGGACGCGCTGGAGCGCCTGCTGCGCGCCCTCGCCGCGTACGACGTCTTCAGCGAACTCCCCGACGGCCGCTTCGAGCACACCGACGCCTCCCGGCTGCTGCGCGAGGACGCCCCGCGCGGCCTGCGCTACTCGGCGCTGTGGGCGACCGAGCCGTGGACCTGGGCGCTGTGGCCGCACCTGGCGGACGCCGTGCGCACCGGCCGGGAGGAGTTCACCGCGCTGTACGGCACCGAGTTCTTCGACTGGCTGCACACCGCCGAGGCCCGCGAGTCGGCCGAGGTGTTCGACAAGGCCATGACCCAGTCCAGCGTGCTGTCGGCGAAGGCCATCGCCGAGGTGCTCGACCTGGACGGCGTCGGCGCCATGGTGGACATCGCCGGGGGCCAGGGCATGGTGCTCGCCACCCTGCTGGAGAAGTACCCGGCGCTGCGCGGCACCCTCTTCGACCTGCCGAAGGTCGTCGCCGACGCCGACCCGCGGCTGCGCGAGGGCGGCGCGCTCGCCGGGCGCGCGCAGCTGGTGGGCGGTGACTGCCGGCAGTCGGTGCCGGAGGGTGCCGACCTGTATCTGCTGAAGAACATCCTGGAGTGGGACGACGAGAGCACGGTGCGCACCCTGCGCAACGTCGCCAAGTCGGCCCCCGCCGGGGCGCGCGTCGTGGTGGTGGAGAACCTGGTCGACGGCAGTCCCGAGACCCGGTTCACCACCGCCATGGACCTGATGCTGCTGCTCAACGTCGGCGGCAAGAAGCACACCAAGGCGGGGCTGAGCGCGCTGGTGGAGCAGGCGGGGCTCCAGCTGGAGGAGGTACGCGCGGTCAACTCCTACCTGCACATGTTCGTGAGCACGGTGCCCGCGTAG", "orf_prot_sequence": "MRLRELALSAACAAAVRAAASLGVADALGDEPADAGTLAKAVRADADALERLLRALAAYDVFSELPDGRFEHTDASRLLREDAPRGLRYSALWATEPWTWALWPHLADAVRTGREEFTALYGTEFFDWLHTAEARESAEVFDKAMTQSSVLSAKAIAEVLDLDGVGAMVDIAGGQGMVLATLLEKYPALRGTLFDLPKVVADADPRLREGGALAGRAQLVGGDCRQSVPEGADLYLLKNILEWDDESTVRTLRNVAKSAPAGARVVVVENLVDGSPETRFTTAMDLMLLLNVGGKKHTKAGLSALVEQAGLQLEEVRAVNSYLHMFVSTVPA", "perc_identity": 28.77}, "gnl|BL_ORD_ID|2152|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 6809, "orf_end": 7807, "orf_from": "BGC0000254.1|Oxytetracycline_7 ", "model_name": "oqxB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2000", "model_id": "2400", "ARO_accession": "3003923", "ARO_name": "oqxB", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35992": {"category_aro_accession": "0000075", "category_aro_cvterm_id": "35992", "category_aro_name": "nitrofurantoin", "category_aro_description": "Nitrofurantoin is an antibiotic used to treat urinary tract infections. It inhibits enzyme synthesis by inhibiting essential enzymes involved in the citric acid cycle, as well as those involved in DNA, RNA, and protein synthesis. It is marketed under the following brand names: Furadantin, Macrobid, Macrodantin, Nitro Macro and Urantoin.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "41240": {"category_aro_accession": "3004116", "category_aro_cvterm_id": "41240", "category_aro_name": "nitrofuran antibiotic", "category_aro_description": "Nitrofurans are chemotherapeutic agents with antibacterial and antiprotozoal activity.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.69171, "max_identities": 26, "bit_score": 25.7942, "cvterm_id": "35914", "query": "SAKAIAEVLDLDGVGAMVDIAGGQGMVLATLLEKYPALRGTLFDLPKVVADADPR-LREGGALAGRAQLVGGDCRQSVPEGADLYLLKNILEWDDES", "match": "S + IA +   +  G MV I  G  + ++T     P +R   +    ++ DADPR L    A+    +L     +Q +P G +       +EW D S", "sequence_from_db": "SVEDIANLRTRNNQGEMVPI--GSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEEL----SKQILPNGMN-------IEWTDLS", "sequence_from_broadstreet": "MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA", "dna_sequence_from_broadstreet": "ATGGACTTTTCCCGCTTTTTTATCGACAGGCCGATTTTCGCCGCGGTGCTGTCGATTTTAATTTTTATCACCGGGTTAATCGCTATCCCACTGCTGCCGGTGAGCGAATATCCGGATGTCGTCCCGCCGAGCGTCCAGGTGCGCGCGGAGTATCCCGGCGCCAACCCGAAAGTGATTGCCGAGACCGTGGCGACGCCGCTGGAGGAAGCGATCAACGGCGTTGAAAACATGATGTACATGAAATCGGTCGCCGGCTCCGACGGCGTGCTGGTCACCACCGTCACCTTCCGCCCGGGTACCGACCCGGATCAGGCGCAGGTTCAGGTGCAGAACCGCGTCGCGCAGGCCGAAGCGCGTCTGCCGGAGGATGTACGCCGTCTGGGGATCACCACCCAGAAGCAGTCTCCGACGCTGACCCTGGTGGTGCATCTGTTCTCCCCCGGCGGGAAGTACGACTCGCTGTATATGCGCAACTACGCCACGCTGAAAGTGAAGGATGAGCTGGCGCGCCTGCCCGGCGTCGGCCAGATCCAGATTTTTGGCTCCGGTGAATATGCGATGCGCGTCTGGCTGGATCCCAATAAGGTCGCTGCCCGCGGTCTGACGGCCTCGGATGTGGTGACGGCGATGCAGGAGCAAAACGTCCAGGTGTCTGCCGGACAGCTTGGCGCCGAGCCGCTGCCGCAGGAGAGCGATTTCCTGATCTCCATTAACGCCCAGGGCCGTCTGCATACCGAAGAAGAGTTTGGCAATATCATTCTGAAAACGGCGCAGGATGGCTCGCTGGTCCGCCTGCGCGACGTGGCGCGCATCGAGATGGGTTCCGGTAGCTATGCGCTGCGCTCCCAGCTCAACAATAAGGATGCGGTCGGGATCGGTATCTTCCAGTCACCCGGCGCTAACGCCATCGATCTGTCGAACGCGGTACGCGCCAAAATGGCCGAGCTGGCCACCCGCTTCCCGGAAGATATGCAATGGGCGGCGCCGTACGACCCGACGGTTTTCGTCCGCGACTCCATCCGCGCGGTGGTGCAGACGCTGCTGGAGGCGGTAGTGCTGGTGGTGCTGGTAGTGATCCTGTTCCTGCAGACCTGGCGCGCGTCGATTATCCCGTTGATCGCTGTGCCGGTATCGGTGGTGGGTACCTTCAGCATTCTCTATCTGCTGGGCTTCTCGCTGAATACCCTGAGCCTGTTCGGGCTGGTACTGGCTATCGGTATCGTGGTGGACGACGCCATCGTGGTGGTGGAGAACGTCGAGCGTAATATCGAAGAGGGGCTTGCGCCGCTTGCCGCGGCGCATCAGGCGATGCGTGAGGTCTCCGGGCCGATTATCGCCATTGCGCTGGTGCTGTGTGCGGTGTTCGTGCCGATGGCGTTTCTCTCCGGGGTCACCGGCCAGTTCTACAAACAGTTCGCGGTGACCATCGCCATCTCGACGGTGATCTCGGCCATCAACTCGCTGACGCTCTCCCCGGCGCTGGCGGCCCTGCTGTTAAAGCCGCACGGCGCGAAGAAAGACCTCCCTACCCGGCTGATCGATCGCCTGTTTGGCTGGATTTTCCGTCCGTTTAACCGCTTTTTCCTGCGCAGCTCGAACGGCTATCAGGGACTGGTAGGCAAAACGCTTGGACGCCGTGGCGCAGTGTTTGCGGTGTACCTGCTGCTGCTCTGCGCCGCTGGGGTGATGTTTAAAGTCGTCCCCGGCGGGTTTATTCCCACCCAGGATAAGCTGTATCTCATTGGCGGCGTGAAGATGCCGGAAGGGTCGTCGCTGGCGCGCACCGACGCGGTGATCCGCAAAATGAGCGAGATCGGGATGAATACCGAAGGGGTCGACTATGCGGTCGCTTTCCCGGGGCTTAACGCGCTGCAGTTCACCAACACGCCGAATACCGGGACGGTCTTTTTTGGCCTGAAACCGTTCGACCAGCGCAAACACACGGCGGCGGAAATTAACGCGGAGATCAACGCCAAAATCGCGCAAATCCAGCAGGGCTTTGGCTTTTCCATCCTGCCGCCGCCGATTTTAGGTCTGGGTCAGGGTTCCGGCTACTCCCTGTACATCCAGGATCGCGGAGGGCTGGGCTATGGCGCGCTGCAAAGCGCGGTGAATGCGATGTCCGGGGCGATTATGCAGACGCCGGGGATGCACTTCCCGATCTCGACTTACCAGGCTAACGTGCCGCAGCTGGACGTGCAGGTCGATCGCGATAAGGCGAAAGCGCAGGGGGTATCGCTAACCGATCTGTTCGGTACGCTGCAGACCTATCTCGGCTCGTCTTATGTCAATGACTTTAACCAGTTCGGGCGTACCTGGCGCGTGATGGCCCAGGCTGACGGACCATACCGCGAGAGCGTGGAAGATATCGCCAATCTGCGCACCCGCAATAATCAGGGCGAAATGGTACCGATCGGCAGTATGGTGAATATCAGTACCACCTACGGGCCGGATCCGGTGATCCGCTACAACGGTTATCCGGCGGCGGACCTGATTGGCGATGCCGATCCGCGGGTCCTCTCTTCTTCGCAGGCGATGACGCATCTGGAAGAGCTGTCGAAGCAGATCCTGCCGAATGGGATGAATATTGAGTGGACGGATCTCAGCTTCCAGCAGGCCACCCAGGGCAACACGGCGCTGATCGTCTTCCCGGTGGCGGTGCTGCTGGCATTCCTCGTACTGGCCGCGCTGTATGAAAGCTGGACCCTGCCGCTGGCGGTGATCCTTATCGTACCGATGACGATGCTCTCCGCGCTGTTTGGCGTCTGGCTGACCGGGGGCGATAACAACGTCTTCGTGCAGGTGGGTCTGGTGGTCCTGATGGGCCTGGCCTGTAAAAACGCCATTCTGATCGTCGAGTTTGCCCGCGAGCTGGAGATCCAGGGGAAAGGCATCATGGAAGCGGCGCTGGAGGCATGCCGCCTGCGTCTGCGCCCGATCGTGATGACCTCCATCGCCTTTATCGCCGGGACCATTCCGCTGATCCTCGGCCACGGCGCGGGGGCGGAAGTCCGCGGCGTCACCGGGATCACGGTGTTCTCCGGGATGCTGGGCGTGACGCTCTTCGGTCTGTTCCTGACGCCGGTGTTTTACGTGACGCTACGGAAACTGGTGACCCGCAGGAAGCCGGTCCAGGAGGATCTGCCCGCCTAG", "partial": "0", "query_start": 7262, "query_end": 7549, "hit_start": 2355, "hit_end": 2607, "orf_dna_sequence": "ATGCGGCTGCGCGAACTCGCCCTGAGCGCCGCCTGTGCCGCCGCCGTCCGCGCCGCGGCGAGCCTGGGCGTCGCGGACGCCCTCGGGGACGAACCCGCGGACGCCGGCACCCTCGCGAAGGCGGTGCGGGCCGACGCGGACGCGCTGGAGCGCCTGCTGCGCGCCCTCGCCGCGTACGACGTCTTCAGCGAACTCCCCGACGGCCGCTTCGAGCACACCGACGCCTCCCGGCTGCTGCGCGAGGACGCCCCGCGCGGCCTGCGCTACTCGGCGCTGTGGGCGACCGAGCCGTGGACCTGGGCGCTGTGGCCGCACCTGGCGGACGCCGTGCGCACCGGCCGGGAGGAGTTCACCGCGCTGTACGGCACCGAGTTCTTCGACTGGCTGCACACCGCCGAGGCCCGCGAGTCGGCCGAGGTGTTCGACAAGGCCATGACCCAGTCCAGCGTGCTGTCGGCGAAGGCCATCGCCGAGGTGCTCGACCTGGACGGCGTCGGCGCCATGGTGGACATCGCCGGGGGCCAGGGCATGGTGCTCGCCACCCTGCTGGAGAAGTACCCGGCGCTGCGCGGCACCCTCTTCGACCTGCCGAAGGTCGTCGCCGACGCCGACCCGCGGCTGCGCGAGGGCGGCGCGCTCGCCGGGCGCGCGCAGCTGGTGGGCGGTGACTGCCGGCAGTCGGTGCCGGAGGGTGCCGACCTGTATCTGCTGAAGAACATCCTGGAGTGGGACGACGAGAGCACGGTGCGCACCCTGCGCAACGTCGCCAAGTCGGCCCCCGCCGGGGCGCGCGTCGTGGTGGTGGAGAACCTGGTCGACGGCAGTCCCGAGACCCGGTTCACCACCGCCATGGACCTGATGCTGCTGCTCAACGTCGGCGGCAAGAAGCACACCAAGGCGGGGCTGAGCGCGCTGGTGGAGCAGGCGGGGCTCCAGCTGGAGGAGGTACGCGCGGTCAACTCCTACCTGCACATGTTCGTGAGCACGGTGCCCGCGTAG", "orf_prot_sequence": "MRLRELALSAACAAAVRAAASLGVADALGDEPADAGTLAKAVRADADALERLLRALAAYDVFSELPDGRFEHTDASRLLREDAPRGLRYSALWATEPWTWALWPHLADAVRTGREEFTALYGTEFFDWLHTAEARESAEVFDKAMTQSSVLSAKAIAEVLDLDGVGAMVDIAGGQGMVLATLLEKYPALRGTLFDLPKVVADADPRLREGGALAGRAQLVGGDCRQSVPEGADLYLLKNILEWDDESTVRTLRNVAKSAPAGARVVVVENLVDGSPETRFTTAMDLMLLLNVGGKKHTKAGLSALVEQAGLQLEEVRAVNSYLHMFVSTVPA", "perc_identity": 26.8}, "gnl|BL_ORD_ID|2056|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 6809, "orf_end": 7807, "orf_from": "BGC0000254.1|Oxytetracycline_7 ", "model_name": "Listeria monocytogenes mprF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1650", "model_id": "2279", "ARO_accession": "3003770", "ARO_name": "Listeria monocytogenes mprF", "ARO_category": {"37243": {"category_aro_accession": "3000863", "category_aro_cvterm_id": "37243", "category_aro_name": "defensin resistant mprF", "category_aro_description": "MprF is a integral membrane protein that modifies the negatively-charged phosphatidylglycerol on the membrane surface of both Gram-positive and Gram-negative bacteria. This confers resistance to cationic peptides that disrupt the cell membrane, including defensins.", "category_aro_class_name": "AMR Gene Family"}, "37037": {"category_aro_accession": "3000693", "category_aro_cvterm_id": "37037", "category_aro_name": "defensin", "category_aro_description": "Defensins are natural cationic peptides that have antibiotic properties. It is part of the innate immune system of plants and animals.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.03447, "max_identities": 20, "bit_score": 25.409, "cvterm_id": "40443", "query": "WDDESTVRTLRNVAKSAPAGARVVVVENLVDGSPETRFTTAMDLML-LLNVGGKKHTKAG", "match": "+ DE T   L   +K AP+G    +  NL + + E  F T    M  L NVG  K+   G", "sequence_from_db": "YTDEMTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYAFLG", "sequence_from_broadstreet": "MKEKLMQAYAWFQKNSTVVKIVFITFVMAFVIFEIINIATGIDYPSLKENLTSQSPEQIFIMFIVGLIAVTPMLLYDYVIVKLLPGKFSPSHVIASGWITNTFTNIGGFGGVLGASLRASFYGKNASHKEILLAISKIALFLVSGLSIYCLVSLATLLIPGFADHFVNYWPWLLAGGLYFPILFTITKWKSKSLFVDLPIKRELTLIIASLLEWGFAFGCFAIIGTLMGEPVDIFKVFPLFVIASVIGIASMVPGGVGTFDVVMILGLSQLGVSQELALAWMLFYRIFYYIIPFVVGLLFFVQKAGKKVNDFLEGLPLLFLQKVAHRFLVIFVYGSGLLLILSSAVPNAIYHVPFLYKIMPFNFLFTSQITIVAFGFLLLGLARGIECKTKKAYIITVIVLGCAIFNTLARVFSMKQAIFLGIVLLCLFLARNEFYREKLVYTWSKVIIDSIIFIVCLAGYIVIGIYNSPNIKHSKEIPDYLRIASEHLWLVGFVGVFIAVVSLVIIYIYLSTTKEKLGSPFEAVKVREHLAKWGGNEVSHTMFLRDKLLFWAAEGEVLFSYRIIADKMVIMGEPTGNMDKMEAAIEEVMMNADRFGYRPVFYEVRGTMIPYLHDHGFDFIKLGEEGFVDVQNFTMSGKKKKGERALMNKLEREGYTFEIIEPPFNHDTWTTLRAVSDEWLDGREEKGFSLGFFDTYYLEQAPIAIAKNGEGTIVGFASMMPSYTDEMTSIDLMRYSKEAPSGIMDFLFINLFEKAKEDGFQTFNAGMAPLANVGESKYAFLGERLAGLVYRYSQGFYGFKGLRNFKSKYVTEWEQKFVAFRKRSSIAFTMLQLMILVGKKRPLANSQVVLDFPLEEETKKPDSE", "dna_sequence_from_broadstreet": "ATGAAAGAAAAATTAATGCAAGCCTATGCCTGGTTTCAAAAAAATAGTACCGTCGTAAAAATCGTTTTTATTACTTTTGTGATGGCTTTTGTTATTTTTGAAATTATTAATATTGCGACGGGGATTGACTATCCGTCGCTAAAAGAAAATTTAACTTCTCAAAGCCCGGAACAAATATTTATTATGTTTATCGTGGGCTTAATTGCTGTCACTCCAATGCTTTTGTATGATTATGTCATCGTTAAGTTGTTACCTGGAAAGTTTTCGCCAAGTCATGTGATTGCCTCTGGTTGGATTACGAATACCTTTACTAATATTGGCGGTTTTGGTGGCGTATTAGGTGCCAGTTTAAGAGCAAGTTTTTATGGGAAAAATGCATCTCATAAGGAAATTTTACTAGCTATTTCTAAGATTGCTTTATTTTTAGTATCTGGTTTATCGATTTACTGTTTAGTATCATTAGCCACTTTACTCATTCCAGGATTTGCAGATCATTTTGTTAATTACTGGCCATGGCTTCTTGCGGGTGGTCTTTACTTCCCGATTTTATTTACTATTACGAAATGGAAAAGTAAGTCACTCTTTGTTGATTTACCTATCAAAAGAGAATTAACGTTAATTATCGCTTCTCTTTTGGAGTGGGGCTTCGCTTTTGGATGTTTCGCGATTATCGGTACATTGATGGGAGAACCAGTCGATATTTTCAAAGTGTTCCCGTTATTTGTTATTGCTTCGGTAATTGGGATTGCTTCGATGGTACCTGGTGGAGTAGGGACATTTGACGTCGTGATGATTCTTGGACTTAGCCAATTAGGTGTTTCTCAAGAATTAGCGCTCGCTTGGATGCTATTTTACCGAATTTTCTACTATATTATTCCTTTTGTAGTGGGACTACTTTTCTTCGTCCAAAAAGCTGGTAAAAAAGTAAATGACTTTTTAGAAGGATTACCGTTATTATTCTTACAAAAAGTGGCCCATCGCTTCTTAGTTATTTTTGTTTACGGCTCTGGGTTATTGTTAATTTTGTCTTCCGCCGTACCAAACGCTATTTACCATGTGCCATTCTTATACAAAATTATGCCGTTTAATTTCTTATTCACTTCCCAAATTACCATTGTTGCATTTGGCTTTTTACTACTGGGGCTTGCGAGAGGGATTGAATGTAAAACAAAGAAAGCGTATATTATTACAGTAATTGTTCTAGGTTGCGCGATTTTCAACACACTTGCTCGCGTATTTTCGATGAAGCAGGCAATCTTTTTAGGAATTGTGCTGTTATGTTTATTCTTAGCTCGAAACGAATTTTACCGAGAAAAACTGGTTTATACTTGGAGTAAAGTAATTATTGATAGCATTATTTTCATCGTATGTCTGGCAGGTTACATTGTTATCGGTATTTACAACTCACCAAATATCAAACACTCCAAAGAAATCCCTGACTATTTACGCATTGCCTCAGAGCATTTATGGTTAGTCGGCTTCGTTGGCGTATTTATCGCCGTTGTTAGTTTAGTCATTATTTACATTTATTTATCCACAACAAAAGAAAAACTTGGCTCTCCATTTGAAGCAGTCAAAGTACGCGAACATTTAGCGAAATGGGGCGGAAATGAAGTCAGTCATACGATGTTCTTACGTGATAAACTGCTATTTTGGGCAGCAGAGGGGGAAGTACTTTTCTCTTACCGAATCATTGCGGACAAAATGGTCATCATGGGCGAACCAACTGGGAACATGGACAAAATGGAAGCAGCGATTGAAGAGGTAATGATGAACGCTGATAGATTTGGCTATCGACCTGTTTTCTATGAAGTCCGGGGCACGATGATTCCATATTTACATGATCACGGATTTGACTTTATCAAGCTTGGCGAGGAAGGTTTTGTCGACGTCCAAAACTTTACAATGAGTGGTAAAAAGAAAAAAGGTGAGCGAGCTCTCATGAATAAATTAGAACGAGAAGGTTATACTTTTGAAATAATAGAACCACCATTCAATCACGACACTTGGACAACTTTACGAGCAGTTTCTGATGAGTGGCTAGATGGTAGGGAAGAAAAAGGTTTCTCATTAGGATTCTTCGATACGTATTATCTCGAACAAGCTCCGATTGCTATCGCTAAAAACGGAGAAGGTACTATCGTTGGATTTGCTTCGATGATGCCGTCATATACAGACGAAATGACTTCGATTGATTTAATGCGTTACTCCAAAGAAGCGCCATCAGGTATTATGGATTTCCTTTTCATTAACCTATTCGAAAAAGCCAAAGAAGATGGCTTCCAAACATTTAATGCCGGTATGGCACCACTTGCCAATGTTGGGGAAAGTAAATATGCTTTCCTAGGTGAACGATTAGCCGGACTTGTATACCGTTATAGTCAAGGTTTTTACGGTTTCAAAGGATTACGTAATTTTAAATCCAAATATGTTACAGAATGGGAACAAAAATTTGTTGCCTTTAGAAAAAGAAGTTCCATTGCTTTCACCATGTTACAATTAATGATTCTTGTTGGTAAAAAACGACCACTTGCAAATAGCCAAGTAGTCCTTGATTTCCCACTCGAAGAAGAAACAAAAAAACCAGATTCTGAGTAA", "partial": "0", "query_start": 7535, "query_end": 7711, "hit_start": 2169, "hit_end": 2349, "orf_dna_sequence": "ATGCGGCTGCGCGAACTCGCCCTGAGCGCCGCCTGTGCCGCCGCCGTCCGCGCCGCGGCGAGCCTGGGCGTCGCGGACGCCCTCGGGGACGAACCCGCGGACGCCGGCACCCTCGCGAAGGCGGTGCGGGCCGACGCGGACGCGCTGGAGCGCCTGCTGCGCGCCCTCGCCGCGTACGACGTCTTCAGCGAACTCCCCGACGGCCGCTTCGAGCACACCGACGCCTCCCGGCTGCTGCGCGAGGACGCCCCGCGCGGCCTGCGCTACTCGGCGCTGTGGGCGACCGAGCCGTGGACCTGGGCGCTGTGGCCGCACCTGGCGGACGCCGTGCGCACCGGCCGGGAGGAGTTCACCGCGCTGTACGGCACCGAGTTCTTCGACTGGCTGCACACCGCCGAGGCCCGCGAGTCGGCCGAGGTGTTCGACAAGGCCATGACCCAGTCCAGCGTGCTGTCGGCGAAGGCCATCGCCGAGGTGCTCGACCTGGACGGCGTCGGCGCCATGGTGGACATCGCCGGGGGCCAGGGCATGGTGCTCGCCACCCTGCTGGAGAAGTACCCGGCGCTGCGCGGCACCCTCTTCGACCTGCCGAAGGTCGTCGCCGACGCCGACCCGCGGCTGCGCGAGGGCGGCGCGCTCGCCGGGCGCGCGCAGCTGGTGGGCGGTGACTGCCGGCAGTCGGTGCCGGAGGGTGCCGACCTGTATCTGCTGAAGAACATCCTGGAGTGGGACGACGAGAGCACGGTGCGCACCCTGCGCAACGTCGCCAAGTCGGCCCCCGCCGGGGCGCGCGTCGTGGTGGTGGAGAACCTGGTCGACGGCAGTCCCGAGACCCGGTTCACCACCGCCATGGACCTGATGCTGCTGCTCAACGTCGGCGGCAAGAAGCACACCAAGGCGGGGCTGAGCGCGCTGGTGGAGCAGGCGGGGCTCCAGCTGGAGGAGGTACGCGCGGTCAACTCCTACCTGCACATGTTCGTGAGCACGGTGCCCGCGTAG", "orf_prot_sequence": "MRLRELALSAACAAAVRAAASLGVADALGDEPADAGTLAKAVRADADALERLLRALAAYDVFSELPDGRFEHTDASRLLREDAPRGLRYSALWATEPWTWALWPHLADAVRTGREEFTALYGTEFFDWLHTAEARESAEVFDKAMTQSSVLSAKAIAEVLDLDGVGAMVDIAGGQGMVLATLLEKYPALRGTLFDLPKVVADADPRLREGGALAGRAQLVGGDCRQSVPEGADLYLLKNILEWDDESTVRTLRNVAKSAPAGARVVVVENLVDGSPETRFTTAMDLMLLLNVGGKKHTKAGLSALVEQAGLQLEEVRAVNSYLHMFVSTVPA", "perc_identity": 33.33}}, "BGC0000254.1|Oxytetracycline_8 # 7899 # 9833 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733": {"gnl|BL_ORD_ID|4935|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7899, "orf_end": 9833, "orf_from": "BGC0000254.1|Oxytetracycline_8 ", "model_name": "almE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1000", "model_id": "5928", "ARO_accession": "3007433", "ARO_name": "almE", "ARO_category": {"46184": {"category_aro_accession": "3007428", "category_aro_cvterm_id": "46184", "category_aro_name": "polymyxin resistance operon", "category_aro_description": "Operon or gene clusters confering resistance to polymyxin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "46188": {"category_aro_accession": "3007432", "category_aro_cvterm_id": "46188", "category_aro_name": "alm glycyltransferase", "category_aro_description": "Glycyl transferase associated with polymyxin resistance operons not interacting with lipid A.", "category_aro_class_name": "AMR Gene Family"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.7453e-08, "max_identities": 94, "bit_score": 53.9138, "cvterm_id": "36789", "query": "DAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPES-VLLNTLPSFHLMHLNIAVTV--GATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAE-TAPSTHFDDLDHPVAGSS--GRPVPGTACRIVD----LRTRAVLPVGGRGEIQVKGPQLMKGYLGRP---REESVDPDG--WFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADR--DAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRK", "match": "D     A +   +    A +  TSG+TG PK + +++ NL    +Q      L  +  V   +  +F L   +I  ++  GA   + P    ++       H  T   S+P  +        L   S+PSLR     G AL    A+        PV+  YG  E T   T+   + H    S   GR        I++    L      P G RGE+ + G QL+ GYL  P   +      +G  W+ +GDI  T + G L  + R     K     V   EIE V+ R       A+   P   SG  A   V   D       D  +     QL      K    +  +PR+  GK   + L++Q    T +", "sequence_from_db": "DVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIV-TKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESG-YASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYE", "sequence_from_broadstreet": "MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH", "dna_sequence_from_broadstreet": "ATGCCATACAATTCTGCGACAGATTTGTTACAGAGAGAGGGTTATGGTGTCGTGCATAACCAATTTATCAATAAAATGGCGATGTGCTGCGAGACAAGACACTCTATTTTGGCGGCCATTCAGGCTAACCGACATGCCCCTGCATTATGGGTTAAACAGAAAACCTACACCTATCAAGAGATGACCGATATGGCACTCTCATTGAGTGACTATTGGCATTTACAGGGCGTGCAGCGAGTTGCGATCCTTTCGGTACGCGATCTCGCGGCTTATTCTGCGATTTGGGCGAGCTATTTGGGCGGTATGACTTATATTCCGCTCAATGCGCGAGCAACAACAGAACAGATCCAAGAGACGCTGATCGCGACACAATGTGATTCCATCATGGTAGACGCGCAGCAATTGAGTCGTTTGTCCTCCTTACTAGATACTTGCATTGACCGATTACACATTTATGCGCTGCCTGATGTGGATATGGAACCGTTACGTCAGCAATATCCTCAGCACACTTTTCACACAGTGCAAATAACCGAACAAGATGTGGAATTACTGGTAGCGAAATACCATTTAGACAATGAACATGAGTACGCTTATATCATGCAAACCTCAGGTTCGACTGGTAAACCCAAACGTATTGCGGTCAGCTACAGTAATTTGCATTGCTATATCAGTCAAATTGACAAACTATTTCCACTCAATGCGCAAGATCGAGTGGGGCAATATTCTGATTTGACTTTTGATCTTTCGGTACATGATATTTTTTACAGTTTGATCTCTGGTGCTTGTTTATATGTTGTGCCTGAATTAGCGAAATTAAGTCCAGCGGAATTTATTCGTCACCATCAATTAACGGTATGGCTTTCTGTGCCTACTGTTATTGAGTTGGCCCTACAAAGACAAACCTTAACCCCACACAGTTTACCTTCTCTGCGACTGAGTTTTTTCTGCGGACAAGCCTTGCTGCATGATTTAGCCGAACAATGGCAACAGGCCACCCAGCAGCCGGTGATCAATCTGTATGGTCCAACAGAGTGCACGATTGCTATTACCTATCATCGATTTGTCGCCCATTCAGGTATGGCATCGGTGCCGATTGGCCGTGCTTTTGAAGAGGAGTGTTTAGCCATCATCAACGAACAAGGTGAATTGATGCGCTTTGAATCTGCACCCGAGGGGTATCGCGGAGAATTACTTCTGTCGGGCAAACAATTAGTCAATGGTTATCTGAATGATCCGCTGAATACGCAAAGTGCCTTTTTCCAGCACGAAGGGCGTATTTGGTATCGTTCAGGTGACATTGTCACTAAATCAAATGGCGTGCTGATTCATCTTGGGCGTCGCGATCACCAAGTGAAAATTGCCGGACAACGGGTGGAATTAGAAGAGATTGAAACCGTTGTTCGCCGCGTGACTCAAGCGCACAGCGTGGCGATAGTGCCTTGGCCTTTAAGTGAGTCGGGCTATGCCAGCGGCACGGTGGCGTTTGTGGATACCCATACCCAATGGCAACCAGATCTGTGGTTGAGCCAATGCAAACAACAATTAAATCCAACTTTTGTGCCTAAGCGTTGGTATGCCATTGAACAATTACCAAGAAATGCCAATGGCAAAACCGATATTAAAGCTTTACAACAACAATTAGCGAGTCAGACATATGAAACAAGCCATTGA", "partial": "0", "query_start": 8427, "query_end": 9503, "hit_start": 537, "hit_end": 1659, "orf_dna_sequence": "ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA", "orf_prot_sequence": "MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG", "perc_identity": 25.0}, "gnl|BL_ORD_ID|3521|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7899, "orf_end": 9833, "orf_from": "BGC0000254.1|Oxytetracycline_8 ", "model_name": "EC-15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "725", "model_id": "4590", "ARO_accession": "3006876", "ARO_name": "EC-15", "ARO_category": {"43866": {"category_aro_accession": "3005406", "category_aro_cvterm_id": "43866", "category_aro_name": "EC beta-lactamase", "category_aro_description": "EC beta-lactamases are class C beta-lactamases found in Escherichia coli.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.67501, "max_identities": 18, "bit_score": 26.9498, "cvterm_id": "35914", "query": "DCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATG", "match": " C+ F  P +++  V   +  L ++       +  +    PYY    Y D+ +  P      + ++ L E  LG   K  TG", "sequence_from_db": "SCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQP------VTQQTLFE--LGSVSKTFTG", "sequence_from_broadstreet": "MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAPPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ", "dna_sequence_from_broadstreet": "ATGTTCAAAACGACGCTCTGCGCCTTATTAATTACCGCCTCTTGCTCCACATTTGCTGCCCCTCAACAAATCAACGATATTGTGCATCGCACAATTACCCCGCTTATAGAGCAACAAAAGATCCCCGGTATGGCGGTGGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACGGGCGTGCTTGGTGGCGACGCTATTGCTCGAGGGGAAATCAAGTTAAGCGATCCCGCAACAAAATACTGGCCTGAACTTACCGCTAAACAGTGGAATGGGATCACACTATTACATCTTGCGACCTACACCGCTGGCGGCCTGCCATTGCAGGTGCCGGATGAAGTGAAATCCTCAAGCGACTTGCTGCGCTTCTATCAAAACTGGCAGCCTGCATGGGCTCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGCAAACTCGTGTCTTCCAGCCACTCAAACTCAACCATACGTGGATTAATGTACCTCCCCCAGAAGAAAAGAATTACGCCTGGGGATATCGCGAAGGTAAGGCAGTGCATGTTTCGCCAGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTACGAAGCAATATGAATCCCCGTGATATCAACGACAAAACACTTCAGCAAGGGATACAACTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGCCTGGGCTGGGAAATGCTGGACTGGCCGGTAAATCCTGACAGCATCATTAACGGCAGTGGCAATAAAATTGCACTGGCAGCACCCCCTGTAAAAGCGATTACGCCCCCAACTCCTGCAGTACGCGCATCATGGGTACATAAAACAGGGGCAACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATAGTGATGCTGGCTAACAAAAACTATCCCAATCCAGCGAGAGTCGCCGCCGCCTGGCAGATTCTCAACGCTCTACAGTAA", "partial": "0", "query_start": 9270, "query_end": 9515, "hit_start": 39, "hit_end": 261, "orf_dna_sequence": "ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA", "orf_prot_sequence": "MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG", "perc_identity": 21.95}, "gnl|BL_ORD_ID|3523|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7899, "orf_end": 9833, "orf_from": "BGC0000254.1|Oxytetracycline_8 ", "model_name": "EC-18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "725", "model_id": "4592", "ARO_accession": "3006878", "ARO_name": "EC-18", "ARO_category": {"43866": {"category_aro_accession": "3005406", "category_aro_cvterm_id": "43866", "category_aro_name": "EC beta-lactamase", "category_aro_description": "EC beta-lactamases are class C beta-lactamases found in Escherichia coli.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.29501, "max_identities": 18, "bit_score": 26.9498, "cvterm_id": "35914", "query": "DCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATG", "match": " C+ F  P +++  V   +  L ++       +  +    PYY    Y D+ +  P      + ++ L E  LG   K  TG", "sequence_from_db": "SCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQP------VTQQTLFE--LGSVSKTFTG", "sequence_from_broadstreet": "MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARFAAAWQILNALQ", "dna_sequence_from_broadstreet": "ATGTTCAAAACGACGCTCTGCGCCTTATTAATTACCGCCTCTTGCTCCACATTTGCTGCCCCTCAACAAATCAACGATATTGTGCATCGCACAATTACCCCGCTTATAGAGCAACAAAAGATCCCCGGTATGGCGGTGGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACGGGCGTGCTTGGTGGCGACGCTATTGCTCGAGGGGAAATCAAGTTAAGCGATCCCACAACAAAATACTGGCCTGAACTTACCGCTAAACAGTGGAATGGGATCACACTATTACATCTCGCAACCTACACTGCTGGCGGCCTGCCATTGCAGGTGCCGGATGAGGTGAAATCCTCAAGCGACTTGCTGCGCTTCTATCAAAACTGGCAGCCTACATGGGCGCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGCAAACACGTGTCTTCCAGCCACTCAAACTCAACCATACGTGGATTAATGTACCTCCCCCAGAAGAAAAGAATTACGCCTGGGGATATCGCGAAGGTAAGGCAGTGCATGTTTCGCCAGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTACGAAGCAATATGAATCCCCGTGATATCAACGACAAAACACTTCAGCAAGGGATACAACTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGCCTGGGCTGGGAAATGCTGGACTGGCCGGTAAATCCTGACAGCATCATTAACGGCAGTGGCAATAAAATTGCACTGGCAGCACACCCTGTAAAAGCGATTACGCCCCCAACTCCTGCAGTACGCGCATCATGGGTACATAAAACAGGGGCAACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATAGTGATGCTGGCTAACAAAAACTATCCCAATCCAGCGAGATTCGCCGCCGCCTGGCAGATTCTCAACGCTCTACAGTAA", "partial": "0", "query_start": 9270, "query_end": 9515, "hit_start": 39, "hit_end": 261, "orf_dna_sequence": "ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA", "orf_prot_sequence": "MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG", "perc_identity": 21.95}, "gnl|BL_ORD_ID|3520|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7899, "orf_end": 9833, "orf_from": "BGC0000254.1|Oxytetracycline_8 ", "model_name": "EC-14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "725", "model_id": "4589", "ARO_accession": "3006875", "ARO_name": "EC-14", "ARO_category": {"43866": {"category_aro_accession": "3005406", "category_aro_cvterm_id": "43866", "category_aro_name": "EC beta-lactamase", "category_aro_description": "EC beta-lactamases are class C beta-lactamases found in Escherichia coli.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.34963, "max_identities": 18, "bit_score": 26.9498, "cvterm_id": "35914", "query": "DCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATG", "match": " C+ F  P +++  V   +  L ++       +  +    PYY    Y D+ +  P      + ++ L E  LG   K  TG", "sequence_from_db": "SCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQP------VTQQTLFE--LGSVSKTFTG", "sequence_from_broadstreet": "MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPLKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ", "dna_sequence_from_broadstreet": "ATGTTCAAAACGACGCTCTGCGCCTTATTAATTACCGCCTCTTGCTCCACATTTGCTGCCCCTCAACAAATCAACGATATTGTGCATCGCACAATTACCCCGCTTATAGAGCAACAAAAGATCCCCGGTATGGCGGTGGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACGGGCGTGCTTGGTGGCGACGCTATTGCTCGAGGGGAAATCAAGTTAAGCGATCCCGCAACAAAATACTGGCCTGAACTTACCGCTAAACAGTGGAATGGGATCACACTATTACATCTTGCGACCTACACCGCTGGCGGCCTGCCATTGCAGGTGCCGGATGAAGTGAAATCCTCAAGCGACTTGCTGCGCTTCTATCAAAACTGGCAGCCTGCATGGGCTCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGCAAACTCGTGTCTTCCAGCCACTCAAACTCAACCATACGTGGATTAATGTACCTCCCCCAGAAGAAAAGAATTACGCCTGGGGATATCGCGAAGGTAAGGCAGTGCATGTTTCGCCAGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTACGAAGCAATATGAATCCCCGTGATATCAACGACAAAACACTTCAGCAAGGGATACAACTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGCCTGGGCTGGGAAATGCTGGACTGGCCGGTAAATCCTGACAGCATCATTAACGGCAGTGGCAATAAAATTGCACTGGCAGCACACCCTTTAAAAGCGATTACGCCCCCAACTCCTGCAGTACGCGCATCATGGGTACATAAAACAGGGGCAACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATAGTGATGCTGGCTAACAAAAACTATCCCAATCCAGCGAGAGTCGCCGCCGCCTGGCAGATTCTCAACGCTCTACAGTAA", "partial": "0", "query_start": 9270, "query_end": 9515, "hit_start": 39, "hit_end": 261, "orf_dna_sequence": "ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA", "orf_prot_sequence": "MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG", "perc_identity": 21.95}, "gnl|BL_ORD_ID|3525|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7899, "orf_end": 9833, "orf_from": "BGC0000254.1|Oxytetracycline_8 ", "model_name": "EC-5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "725", "model_id": "4594", "ARO_accession": "3006880", "ARO_name": "EC-5", "ARO_category": {"43866": {"category_aro_accession": "3005406", "category_aro_cvterm_id": "43866", "category_aro_name": "EC beta-lactamase", "category_aro_description": "EC beta-lactamases are class C beta-lactamases found in Escherichia coli.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.57291, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "40458", "query": "DCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATG", "match": " C+ F  P +++  V   +  L ++       +  +    PYY    Y D+ +  P      + ++ L E  LG   K  TG", "sequence_from_db": "SCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQP------VTQQTLFE--LGSVSKTFTG", "sequence_from_broadstreet": "MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ", "dna_sequence_from_broadstreet": "ATGTTCAAAACGACGCTCTGCACCTTATTAATTACCGCCTCTTGCTCCACATTTGCCGCCCCTCAACAAATCAACGATATTGTGCATCGCACAATTACCCCGCTTATAGAGCAACAAAAGATCCCCGGTATGGCGGTAGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACGGGCGTGCTTGGTGGCGACGCTATTGCTCGAGGGGAAATCAAGTTAAGCGATCCCACAACAAAATACTGGCCTGAACTTACCGCTAAACAGTGGAATGGGATCACACTATTACATCTCGCAACCTACACCGCTGGCGGCCTGCCATTGCAGGTGCCGGATGAGGTGAAATCCTCAAGCGACTTGCTGCGCTTCTATCAAAACTGGCAGCCTGCATGGGCTCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGAAAACTCGTGTCTTCCAGCCACTCAAACTCAATCATACGTGGATTAATGTACCGTCCGCAGAAGAAAAGAACTACGCCTGGGGATATCGCGAAGGTAAGGCAGTACATGTTTCGCCAGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTGCAAAGCAATTTAAAACCCCTTGATATCAATGAGAAAACACTTCAACAAGGGATACAACTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGTCTGGGCTGGGAAATGCTGGACTGGCCGGTAAATCCTGACATCATCATTAACGGCAGTGACAATAAAATTGCACTGGCAGCACGCCCCGTAAAACCGATTACGCCCCCAACTCCTGCAGTACGCGCATCATGGGTACATAAAACGGGGGCGACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATCGTGATGCTGGCTAACAAAAACTACCCCAATCCAGCGAGAGTCGCCGCCGCCTGGCAGATTCTCAACGCTCTACAGTAA", "partial": "0", "query_start": 9270, "query_end": 9515, "hit_start": 39, "hit_end": 261, "orf_dna_sequence": "ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA", "orf_prot_sequence": "MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG", "perc_identity": 21.95}, "gnl|BL_ORD_ID|3526|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7899, "orf_end": 9833, "orf_from": "BGC0000254.1|Oxytetracycline_8 ", "model_name": "EC-8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "725", "model_id": "4595", "ARO_accession": "3006881", "ARO_name": "EC-8", "ARO_category": {"43866": {"category_aro_accession": "3005406", "category_aro_cvterm_id": "43866", "category_aro_name": "EC beta-lactamase", "category_aro_description": "EC beta-lactamases are class C beta-lactamases found in Escherichia coli.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.68748, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "35914", "query": "DCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATG", "match": " C+ F  P +++  V   +  L ++       +  +    PYY    Y D+ +  P      + ++ L E  LG   K  TG", "sequence_from_db": "SCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQP------VTQQTLFE--LGSVSKTFTG", "sequence_from_broadstreet": "MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILNALQ", "dna_sequence_from_broadstreet": "ATGTTCAAAACGACGCTCTGCGCCTTATTAATTACCGCCTCTTGCTCCACATTTGCCGCCCCTCAACAAATCAACGATATTGTGCATCGCACAATTACCCCGCTTATAGAGCAACAAAAGATCCCCGGTATGGCGGTGGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACGGGCGTGCTTGGTGGCGACGCTATTGCACGAGGGGAAATCAAGTTAAGCGATCCCGCGACAAAATACTGGCCTGAACTTACCGCTAAACAATGGAATGGGATCACACTATTACATCTTGCGACCTACACCGCTGGCGGCCTGCCATTGCAGGTGCCGGATGACGTTAAATCCTCAAGCGACTTGCTGCGCTTCTATCAAAACTGGCAGCCTGCATGGGCTCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGCAAACTCGTGTCTTCCAGCCACTCAAACTCAACCATACGTGGATTAATGTACCGCCCGCAGAAGAAAAGAATTACGCCTGGGGATATCGCGAAGGTAAGGCAGTGCATGTTTCGCCAGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTGCAAAGCAATTTAAAACCCCTTGATATCACTGAGAAAACGCTTCAACAAGGGATACAACTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGCCTGGGCTGGGAAATGCTGGACTGGCCGGTAAATCCTGACAGCATCATTAACGGCAGTGACAATAAAATTGCACTGGCAGCACGCCCCGTAAAAGCGATTACGCCCCCAACTCCTGCAGTGCGCGCATCATGGGTACATAAAACAGGGGCGACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATCGTGATGCTGGCTAACAAAAACTATCCCAATCCAGCGAGAGTCACTGCCGCCTGGCAGATTCTCAACGCTCTACAGTAA", "partial": "0", "query_start": 9270, "query_end": 9515, "hit_start": 39, "hit_end": 261, "orf_dna_sequence": "ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA", "orf_prot_sequence": "MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG", "perc_identity": 21.95}, "gnl|BL_ORD_ID|3519|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7899, "orf_end": 9833, "orf_from": "BGC0000254.1|Oxytetracycline_8 ", "model_name": "EC-13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "725", "model_id": "4588", "ARO_accession": "3006874", "ARO_name": "EC-13", "ARO_category": {"43866": {"category_aro_accession": "3005406", "category_aro_cvterm_id": "43866", "category_aro_name": "EC beta-lactamase", "category_aro_description": "EC beta-lactamases are class C beta-lactamases found in Escherichia coli.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.68748, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "35914", "query": "DCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATG", "match": " C+ F  P +++  V   +  L ++       +  +    PYY    Y D+ +  P      + ++ L E  LG   K  TG", "sequence_from_db": "SCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQP------VTQQTLFE--LGSVSKTFTG", "sequence_from_broadstreet": "MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGNGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ", "dna_sequence_from_broadstreet": "ATGTTCAAAACGACGCTCTGCGCCTTATTAATTACCGCCTCTTGCTCCACATTTGCTGCCCCTCAACAAATCAACGATATTGTGCATCGCACAATTACCCCGCTTATAGAGCAACAAAAGATCCCCGGTATGGCGGTGGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACGGGCGTGCTTGGTGGCGACGCTATTGCTCGAGGGGAAATCAAGTTAAGCGATCCCGCAACAAAATACTGGCCTGAACTTACCGCTAAACAGTGGAATGGGATCACACTATTACATCTTGCGACCTACACCGCTGGCGGCCTGCCATTGCAGGTGCCGGATGAAGTGAAATCCTCAAGCGACTTGCTGCGCTTCTATCAAAACTGGCAGCCTGCATGGGCTCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGCAAACTCGTGTCTTCCAGCCACTCAAACTCAACCATACGTGGATTAATGTACCTCCCCCAGAAGAAAAGAATTACGCCTGGGGATATCGCGAAGGTAAGGCAGTGCATGTTTCGCCAGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTACGAAGCAATATGAATCCCCGTGATATCAACGACAAAACACTTCAGCAAGGGATACAACTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGCCTGGGCTGGGAAATGCTGGACTGGCCGGTAAATCCTGACAGCATCATTAACGGCAATGGCAATAAAATTGCACTGGCAGCACACCCTGTAAAAGCGATTACGCCCCCAACTCCTGCAGTACGCGCATCATGGGTACATAAAACAGGGGCAACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATAGTGATGCTGGCTAACAAAAACTATCCCAATCCAGCGAGAGTCGCCGCCGCCTGGCAGATTCTCAACGCTCTACAGTAA", "partial": "0", "query_start": 9270, "query_end": 9515, "hit_start": 39, "hit_end": 261, "orf_dna_sequence": "ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA", "orf_prot_sequence": "MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG", "perc_identity": 21.95}, "gnl|BL_ORD_ID|3524|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7899, "orf_end": 9833, "orf_from": "BGC0000254.1|Oxytetracycline_8 ", "model_name": "EC-19", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "725", "model_id": "4593", "ARO_accession": "3006879", "ARO_name": "EC-19", "ARO_category": {"43866": {"category_aro_accession": "3005406", "category_aro_cvterm_id": "43866", "category_aro_name": "EC beta-lactamase", "category_aro_description": "EC beta-lactamases are class C beta-lactamases found in Escherichia coli.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.86308, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "35914", "query": "DCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATG", "match": " C+ F  P +++  V   +  L ++       +  +    PYY    Y D+ +  P      + ++ L E  LG   K  TG", "sequence_from_db": "SCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQP------VTQQTLFE--LGSVSKTFTG", "sequence_from_broadstreet": "MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPLNPDIIINGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARFAAAWQILNALQ", "dna_sequence_from_broadstreet": "ATGTTCAAAACGACGCTCTGCACCTTATTAATTACCGCCTCTTGCTCCACATTTGCCGCCCCTCAACAAATCAACGATATTGTGCATCGCACAATTACCCCGCTTATAGAGCAACAAAAGATCCCCGGTATGGCGGTGGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACGGGCGTGCTTGGTGGCGACGCTATTGCTCGAGGGGAAATCAAGTTAAGCGATCCCACAACAAAATACTGGCCTGAACTTACCGCTAAACAGTGGAATGGGATCACACTATTACATCTCGCAACCTACACCGCTGGCGGCCTGCCATTGCAGGTGCCGGATGAGGTGAAATCCTCAAGCGACTTGCTGCGCTTCTATCAAAACTGGCAGCCTGCATGGGCTCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGAAAACTCGTGTCTTCCAGCCACTCAAACTCAATCATACGTGGATTAATGTACCGTCCGCAGAAGAAAAGAACTACGCCTGGGGATATCGCGAAGGTAAGGCAGTACATGTTTCGCCAGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTGCAAAGCAATTTAAAACCATTTGATATCAATGAGAAAACACTTCAACAAGGGATACAACTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGTCTGGGCTGGGAAATGCTGGACTGGCCGCTAAATCCTGACATCATCATTAACGGCAGTGACAATAAAATTGCACTGGCAGCACGCCCCGTAAAACCGATTACGCCCCCAACTCCTGCAGTACGCGCATCATGGGTACATAAAACGGGGGCGACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATCGTGATGCTGGCTAACAAAAACTATCCCAATCCAGCGAGATTCGCCGCCGCCTGGCAGATTCTCAACGCTCTACAGTAA", "partial": "0", "query_start": 9270, "query_end": 9515, "hit_start": 39, "hit_end": 261, "orf_dna_sequence": "ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA", "orf_prot_sequence": "MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG", "perc_identity": 21.95}, "gnl|BL_ORD_ID|3522|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7899, "orf_end": 9833, "orf_from": "BGC0000254.1|Oxytetracycline_8 ", "model_name": "EC-16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "725", "model_id": "4591", "ARO_accession": "3006877", "ARO_name": "EC-16", "ARO_category": {"43866": {"category_aro_accession": "3005406", "category_aro_cvterm_id": "43866", "category_aro_name": "EC beta-lactamase", "category_aro_description": "EC beta-lactamases are class C beta-lactamases found in Escherichia coli.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.86308, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "35914", "query": "DCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATG", "match": " C+ F  P +++  V   +  L ++       +  +    PYY    Y D+ +  P      + ++ L E  LG   K  TG", "sequence_from_db": "SCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQP------VTQQTLFE--LGSVSKTFTG", "sequence_from_broadstreet": "MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGCGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ", "dna_sequence_from_broadstreet": "ATGTTCAAAACGACGCTCTGCGCCTTATTAATTACCGCCTCTTGCTCCACATTTGCTGCCCCTCAACAAATCAACGATATTGTGCATCGCACAATTACCCCGCTTATAGAGCAACAAAAGATCCCCGGTATGGCGGTGGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACGGGCGTGCTTGGTGGCGACGCTATTGCTCGAGGGGAAATCAAGTTAAGCGATCCCGCAACAAAATACTGGCCTGAACTTACCGCTAAACAGTGGAATGGGATCACACTATTACATCTTGCGACCTACACCGCTGGCGGCCTGCCATTGCAGGTGCCGGATGAAGTGAAATCCTCAAGCGACTTGCTGCGCTTCTATCAAAACTGGCAGCCTGCATGGGCTCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGCAAACTCGTGTCTTCCAGCCACTCAAACTCAACCATACGTGGATTAATGTACCTCCCCCAGAAGAAAAGAATTACGCCTGGGGATATCGCGAAGGTAAGGCAGTGCATGTTTCGCCAGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTACGAAGCAATATGAATCCCCGTGATATCAACGACAAAACACTTCAGCAAGGGATACAACTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGCCTGGGCTGGGAAATGCTGGACTGGCCGGTAAATCCTGACAGCATCATTAACGGCTGTGGCAATAAAATTGCACTGGCAGCACACCCTGTAAAAGCGATTACGCCCCCAACTCCTGCAGTACGCGCATCATGGGTACATAAAACAGGGGCAACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATAGTGATGCTGGCTAACAAAAACTATCCCAATCCAGCGAGAGTCGCCGCCGCCTGGCAGATTCTCAACGCTCTACAGTAA", "partial": "0", "query_start": 9270, "query_end": 9515, "hit_start": 39, "hit_end": 261, "orf_dna_sequence": "ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA", "orf_prot_sequence": "MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG", "perc_identity": 21.95}, "gnl|BL_ORD_ID|2432|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 7899, "orf_end": 9833, "orf_from": "BGC0000254.1|Oxytetracycline_8 ", "model_name": "Escherichia coli ampC beta-lactamase", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "2843", "ARO_accession": "3004290", "ARO_name": "Escherichia coli ampC beta-lactamase", "ARO_category": {"41396": {"category_aro_accession": "3004232", "category_aro_cvterm_id": "41396", "category_aro_name": "ampC-type beta-lactamase", "category_aro_description": "AmpC beta-lactamases are clinically important class C beta-lactamase enzymes which confer resistance to cephalosporins and penicillin-like antibiotics. AmpC beta-lactamases are typically found in Enterobacteriaceae, and were described in Escherichia coli in 1940 as the first reported enzymatic deactivation of penicillin. The name AmpC connects these enzymes functionally across many species, however these enzymes are generally unnamed and not phylogenetically related.", "category_aro_class_name": "AMR Gene Family"}, "35971": {"category_aro_accession": "0000054", "category_aro_cvterm_id": "35971", "category_aro_name": "penicillin", "category_aro_description": "Penicillin (sometimes abbreviated PCN) is a beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms. It works by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Antibiotic"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.41801, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36849", "query": "DCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATG", "match": " C+ F  P +++  V   +  L ++       +  +    PYY    Y D+ +  P      + ++ L E  LG   K  TG", "sequence_from_db": "SCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQP------VTQQTLFE--LGSVSKTFTG", "sequence_from_broadstreet": "MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVDAAWQILNALQ", "dna_sequence_from_broadstreet": "ATGTTCAAAACGACGCTCTGCGCCTTATTAATTACCGCCTCTTGCTCCACATTTGCTGCCCCTCAACAAATCAACGATATTGTGCATCGCACAATTACCCCGCTTATAGAGCAACAAAAGATCCCGGGTATGGCGGTGGCGGTAATTTATCAGGGTAAACCTTATTACTTTACCTGGGGCTATGCGGACATCGCCAAAAAGCAGCCCGTCACACAGCAAACGTTGTTTGAGTTAGGTTCGGTCAGCAAAACATTTACTGGCGTGCTTGGTGGCGACGCTATTGCTCGAGGGGAAATCAAGTTAAGCGATCCCACAACAAAATACTGGCCTGAACTTACCGCTAAACAGTGGAATGGGATCACACTATTACATCTCGCAACCTACACTGCTGGCGGCCTGCCATTGCAGGTGCCGGATGAGGTGAAATCCTCAAGCGACTTGCTGCGCTTCTATCAAAACTGGCAGCCTGCATGGGCTCCAGGAACACAACGTCTGTATGCCAACTCCAGTATCGGTTTGTTCGGCGCACTGGCTGTGAAGCCGTCTGGTTTGAGTTTTGAGCAGGCGATGCAAACTCGTGTCTTCCAGCCACTCAAACTCAACCATACGTGGATTAATGTACCGCCCGCAGAAGAAAAGAATTACGCCTGGGGATATCGCGAAGGTAAGGCAGTGCATGTTTCGCCTGGGGCGTTAGATGCTGAAGCTTATGGTGTGAAGTCGACCATTGAAGATATGGCCCGCTGGGTGCAAAGCAATTTAAAACCCCTTGATATCAATGAGAAAACGCTTCAACAAGGGATACAACTGGCACAATCTCGCTACTGGCAAACCGGCGATATGTATCAGGGCCTGGGCTGGGAAATGCTGGACTGGCCGGTAAATCCTGACAGCATCATTAACGGCAGTGACAATAAAATTGCACTGGCAGCACGCCCCGTAAAAGCGATTACGCCCCCAACTCCTGCAGTACGCGCATCATGGGTACATAAAACAGGGGCGACCGGCGGATTTGGTAGCTATGTCGCGTTTATTCCAGAAAAAGAGCTGGGTATCGTGATGCTGGCAAACAAAAACTATCCCAATCCAGCGAGAGTCGACGCCGCCTGGCAGATTCTTAACGCTCTACAGTAA", "partial": "0", "query_start": 9270, "query_end": 9515, "hit_start": 39, "hit_end": 261, "orf_dna_sequence": "ATGGCCGAGCGCCACCCCGAGGGCCCGCAGGACAGCACCGCCGAGGGGCCGCCGCTCGACGTGCTGGCGCAGTTGACGGGCGGCCCGCGCATCGACGACGTGCTGTCGCGGGCGGCCCGCCGCGCCCCCAGACGGCTCGCGCTGAGCGGCCCCTCAGGGGACCTGACCTACGCGGCCCTGGAGGAGCGGGCGACGCGGTGCGCCGCCGCGCTGCGCGAACTGGACGGTGAACCCGGCGCGGTGGTGGGCATCGCCGCCGTACTGGACACCTCGTTCGCCGTGGCGTACTTCGGCGCCTCCCGGGCCCGGCACGTCAGCGCGATGTTCAACCCGCTGCTGCGCGAGGAGCGCCTGACGCACGTGCTGCGCTCGGCGGGCGCGCGGACCGTGATCGTCCCGCCGGAGATGTACGCGCGTATCCAGGCCGTACGAGGGGACCTGCCGGCGTTGCGGACCGTGGTGCTCACCCACCGCGAGGCCGGCTTTCAGGAGGCCACGGCCGACGTGCCCACGCTCGACGAGCTGATCGACGCGGCCCCCGCCACGGCGCCGTTCGCCGGCCGCGACCCCGAGGGCGTGGCCAACCTCCAGTTCACCAGCGGCACCACCGGCGCCCCGAAGACCGTCATGCTCACCCACCGCAACCTGACGGTGAACGCGGCCCAGACCGCGTACACCCACCGGCTCACCCCCGAGTCGGTGCTGCTCAACACCCTGCCGTCGTTCCACCTGATGCACCTGAACATCGCGGTGACCGTCGGCGCCACCCACCTGCTGCGGCCCGGCGACGACACCGTGGCCGCACTGCGCGAGGGCGCCCGCCACGGCGCGACGCACCTCTACAGCCTGCCGGTACGGCTGGCCCGGCTGGCGGCGGACGACCGGCTGCCGGAACTGTCCGTGCCCAGCCTGCGGGCCGTGCTCTCCGGCGGATCGGCCCTGCCCGCGCGGACCGCCGATGTCCTGGGCGGGCACTTCGGCGTCCCGGTCGTCCAGGGGTACGGACTGGCCGAGACCGCGCCGTCCACGCACTTCGACGACCTGGACCACCCGGTGGCCGGCTCGTCGGGCAGGCCCGTACCGGGCACCGCCTGCCGGATCGTGGACCTGCGGACCCGCGCCGTCCTCCCGGTGGGCGGCCGCGGCGAGATCCAGGTCAAGGGGCCCCAGCTGATGAAGGGGTACCTCGGCCGGCCGCGGGAGGAGTCCGTGGACCCGGACGGCTGGTTCTCGACCGGCGACATCGGCGAGACCGACGCGGAGGGGCGGCTGTTCGTCGTCGACCGGGTCAAGGACGTCTTCAAGTGCGACAACTGGCTGGTCTCGCCCCTGGAGATCGAGAACGTGCTGGCCCGCTGCCCCGGGGTGACGGACTGCGCGGTCTTCGACCACCCGGACGAGTTGAGCGGCGCCGTCGCGCACGCGCTGGTGGTCCTGGCGGACGAGGCCGCCGACCGCGACGCCGTCATCCGCTTCGTCAACGACCAGCTGCCCTACTACCAGCACATCAAGTACCTCGACGTCGTACGGCACATCCCGCGCTCGCCCACCGGCAAGATCCAGCGCCGCGACCTGCGGGAGCAGACCCTCGGCGGCACCCGGAAGCACGCCACGGGCGCCACCCATCACACGAAGGGCACCTCCACCATGTTCACCTTCATCAACCGGTTCACGGTCCAGGGCGACGCCGCCGAGTTCGAGAAGCGGGTCGGTGAGATCACCGCCCATATGTCGCGGCAGCCCGGCTTCCGCTCGCACCGCCTGCTGCGCTCCGCCAAGGACCCGCAGGTCTATGTCGAGATCGCCGAGTGGGACGACGCCGAGTCGCACGGCCGCGCGCTGCGCACCGAGACGTTCCAGCAGGCCGTGAGCGAGGTCAAGAAGCTCGCGAGCGCCGACCCGGCCCCGTTCGTCCCGGTCACCGCGGCCGGCTGA", "orf_prot_sequence": "MAERHPEGPQDSTAEGPPLDVLAQLTGGPRIDDVLSRAARRAPRRLALSGPSGDLTYAALEERATRCAAALRELDGEPGAVVGIAAVLDTSFAVAYFGASRARHVSAMFNPLLREERLTHVLRSAGARTVIVPPEMYARIQAVRGDLPALRTVVLTHREAGFQEATADVPTLDELIDAAPATAPFAGRDPEGVANLQFTSGTTGAPKTVMLTHRNLTVNAAQTAYTHRLTPESVLLNTLPSFHLMHLNIAVTVGATHLLRPGDDTVAALREGARHGATHLYSLPVRLARLAADDRLPELSVPSLRAVLSGGSALPARTADVLGGHFGVPVVQGYGLAETAPSTHFDDLDHPVAGSSGRPVPGTACRIVDLRTRAVLPVGGRGEIQVKGPQLMKGYLGRPREESVDPDGWFSTGDIGETDAEGRLFVVDRVKDVFKCDNWLVSPLEIENVLARCPGVTDCAVFDHPDELSGAVAHALVVLADEAADRDAVIRFVNDQLPYYQHIKYLDVVRHIPRSPTGKIQRRDLREQTLGGTRKHATGATHHTKGTSTMFTFINRFTVQGDAAEFEKRVGEITAHMSRQPGFRSHRLLRSAKDPQVYVEIAEWDDAESHGRALRTETFQQAVSEVKKLASADPAPFVPVTAAG", "perc_identity": 21.95}}, "BGC0000254.1|Oxytetracycline_9 # 9872 # 10324 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=CGCCG;rbs_spacer=14bp;gc_cont=0.744": {"gnl|BL_ORD_ID|2251|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 9872, "orf_end": 10324, "orf_from": "BGC0000254.1|Oxytetracycline_9 ", "model_name": "FosD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "260", "model_id": "3373", "ARO_accession": "3004674", "ARO_name": "FosD", "ARO_category": {"36272": {"category_aro_accession": "3000133", "category_aro_cvterm_id": "36272", "category_aro_name": "fosfomycin thiol transferase", "category_aro_description": "Catalyzes the addition of a thiol group from a nucleophilic molecule to fosfomycin.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.33486, "max_identities": 9, "bit_score": 23.483, "cvterm_id": "35508", "query": "QEIQHFYGRQMRCLDEARVEEWAGTFTEDGV", "match": " E+Q+ Y      +DE+   +W   F E+ V", "sequence_from_db": "NEVQYSYTHVAFTIDESEFNDWYQWFKENDV", "sequence_from_broadstreet": "MIQSINHICYSVSDLKNSIRFYKNILCGELLVSGKTTAYFNIGGLWVALNEEKDIPRNEVQYSYTHVAFTIDESEFNDWYQWFKENDVNILEGRTRDVRDKQSIYFTDPDGHKLELHTGTLENRLNYYKETKPHMVFYK", "dna_sequence_from_broadstreet": "ATGATACAATCTATCAATCATATATGTTATTCCGTTAGTGATTTAAAAAATTCGATACGCTTTTATAAAAATATTTTATGTGGCGAATTATTAGTAAGTGGAAAAACAACTGCATATTTCAATATTGGTGGCTTATGGGTTGCGTTAAACGAAGAAAAAGACATTCCTCGAAATGAAGTTCAATATTCGTACACACATGTAGCGTTTACTATAGATGAAAGTGAATTTAATGATTGGTATCAATGGTTCAAGGAAAATGACGTGAATATATTAGAAGGGCGTACTAGAGATGTAAGAGATAAGCAATCAATTTATTTTACTGATCCTGACGGACACAAGTTAGAGTTACATACTGGCACACTAGAAAATAGATTGAATTATTATAAAGAAACAAAACCGCATATGGTATTTTACAAATAA", "partial": "0", "query_start": 9923, "query_end": 10015, "hit_start": 171, "hit_end": 264, "orf_dna_sequence": "ATGACCGCCCCGGAACAGCCCTCGGGCGTCCCCGTGGACACCGCGCTCTACCAGGAGATCCAGCACTTCTACGGACGCCAGATGCGCTGCCTGGACGAGGCGCGGGTCGAGGAGTGGGCCGGCACCTTCACCGAGGACGGCGTCTTCGTCGCCAACGCCCACCCCGAGCCGTCCGTCGGGCGGGCCGCCATCGCGGCCGGGGCCCGCAAGGCCGCCGCCCTGCTGGCCGAGCAGGGCGTCCAGCGCCGCCACTGGCTCGGCATGCTGGACGCCGACGCCTGTGACGACGGCACCGTCCGCGCCCGCACCTACGCCCTGATCATCAGCACGCCGCGCGGCGGCCAGGCCGCGGTGCACCTGAGCACGAGCTGCGACGACGTGCTCGTACGGGAGGACGGCCAACTGCGCGTACGGCACCGCGAGGTGCGCCGGGACGACCTGCGGCCCGAGTAG", "orf_prot_sequence": "MTAPEQPSGVPVDTALYQEIQHFYGRQMRCLDEARVEEWAGTFTEDGVFVANAHPEPSVGRAAIAAGARKAAALLAEQGVQRRHWLGMLDADACDDGTVRARTYALIISTPRGGQAAVHLSTSCDDVLVREDGQLRVRHREVRRDDLRPE", "perc_identity": 29.03}}, "BGC0000254.1|Oxytetracycline_10 # 10593 # 11384 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722": {"gnl|BL_ORD_ID|438|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10593, "orf_end": 11384, "orf_from": "BGC0000254.1|Oxytetracycline_10 ", "model_name": "MexA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "650", "model_id": "440", "ARO_accession": "3000377", "ARO_name": "MexA", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35977": {"category_aro_accession": "0000060", "category_aro_cvterm_id": "35977", "category_aro_name": "ceftazidime", "category_aro_description": "Ceftazidime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa, however it has weaker activity against Gram-positive microorganisms and is not used for such infections.", "category_aro_class_name": "Antibiotic"}, "35979": {"category_aro_accession": "0000062", "category_aro_cvterm_id": "35979", "category_aro_name": "ceftriaxone", "category_aro_description": "Ceftriaxone is a third-generation cephalosporin antibiotic. The presence of an aminothiazolyl sidechain increases ceftriazone's resistance to beta-lactamases. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "35990": {"category_aro_accession": "0000073", "category_aro_cvterm_id": "35990", "category_aro_name": "meropenem", "category_aro_description": "Meropenem is an ultra-broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem.", "category_aro_class_name": "Antibiotic"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36468": {"category_aro_accession": "3000329", "category_aro_cvterm_id": "36468", "category_aro_name": "sulfamethoxazole", "category_aro_description": "Sulfamethoxazole is a sulfonamide antibiotic usually taken with trimethoprim, a diaminopyrimidine antibiotic. Sulfamethoxazole inhibits dihydropteroate synthase, essential to tetrahydrofolic acid biosynthesis. This pathway generates compounds used in the synthesis of many amino acids and nucleotides.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36689": {"category_aro_accession": "3000550", "category_aro_cvterm_id": "36689", "category_aro_name": "aztreonam", "category_aro_description": "Aztreonam was the first monobactam discovered, and is greatly effective against Gram-negative bacteria while inactive against Gram-positive bacteria. Artreonam is a poor substrate for beta-lactamases, and may even act as an inhibitor. In Gram-negative bacteria, Aztreonam interferes with filamentation, inhibiting cell division and leading to cell death.", "category_aro_class_name": "Antibiotic"}, "36966": {"category_aro_accession": "3000622", "category_aro_cvterm_id": "36966", "category_aro_name": "colistin A", "category_aro_description": "Colistin A, or polymyxin E1, has a 6-octanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36968": {"category_aro_accession": "3000624", "category_aro_cvterm_id": "36968", "category_aro_name": "colistin B", "category_aro_description": "Colistin B, or polymyxin E2, has a 6-heptanoic acid lipid tail. Polymyxins disrupt the cell membrane of Gram-negative bacteria.", "category_aro_class_name": "Antibiotic"}, "36981": {"category_aro_accession": "3000637", "category_aro_cvterm_id": "36981", "category_aro_name": "ampicillin", "category_aro_description": "Ampicillin is a penicillin derivative that is highly acid stable, with its activity similar to benzylpenicillin.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "40362": {"category_aro_accession": "3003708", "category_aro_cvterm_id": "40362", "category_aro_name": "panipenem", "category_aro_description": "Panipenem is a carbapenem antibacterial agent with a broad spectrum of in vitro activity covering a wide range of Gram-negative and Gram-positive aerobic and anaerobic bacterial.  It is used in combination with betamipron to inhibit panipenem uptake into the renal tubule and prevent nephrotoxicity.", "category_aro_class_name": "Antibiotic"}, "40523": {"category_aro_accession": "3003832", "category_aro_cvterm_id": "40523", "category_aro_name": "ticarcillin", "category_aro_description": "Ticarcillin is a carboxypenicillin used for the treatment of Gram-negative bacteria, particularly P. aeruginosa. Ticarcillin's antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis, when the bacteria try to divide, causing cell death.", "category_aro_class_name": "Antibiotic"}, "40957": {"category_aro_accession": "3004024", "category_aro_cvterm_id": "40957", "category_aro_name": "trimethoprim-sulfamethoxazole", "category_aro_description": "An antibiotic cocktail containing the diaminopyrimidine antibiotic Trimethoprim and the sulfonamide antibiotic sulfamethoxazole (1 TMP:5 SMX).", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "36421": {"category_aro_accession": "3000282", "category_aro_cvterm_id": "36421", "category_aro_name": "sulfonamide antibiotic", "category_aro_description": "Sulfonamides are broad spectrum, synthetic antibiotics that contain the sulfonamide group. Sulfonamides inhibit dihydropteroate synthase, which catalyzes the conversion of p-aminobenzoic acid to dihydropteroic acid as part of the tetrahydrofolic acid biosynthetic pathway. Tetrahydrofolic acid is essential for folate synthesis, a precursor of many nucleotides and amino acids. Many sulfamides are taken with trimethoprim, an inhibitor of dihydrofolate reductase, also disturbing the trihydrofolic acid synthesis pathway.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0873902, "max_identities": 22, "bit_score": 31.187, "cvterm_id": "36804", "query": "LVNNAGRSGGGVTARIPDELWYDVIDTNLNSAFLVTREALTTGGLERAGVDGRIISIASTGGKQ", "match": "LV N G++    T +  D ++ DV  T  ++A L  R  L +G LERAG +   +S+    G Q", "sequence_from_db": "LVTN-GQANAMATVQQLDPIYVDV--TQPSTALLRLRRELASGQLERAGDNAAKVSLKLEDGSQ", "sequence_from_broadstreet": "MQRTPAMRVLVPALLVAISALSGCGKSEAPPPAQTPEVGIVTLEAQTVTLNTELPGRTNAFRIAEVRPQVNGIILKRLFKEGSDVKAGQQLYQIDPATYEADYQSAQANLASTQEQAQRYKLLVADQAVSKQQYADANAAYLQSKAAVEQARINLRYTKVLSPISGRIGRSAVTEGALVTNGQANAMATVQQLDPIYVDVTQPSTALLRLRRELASGQLERAGDNAAKVSLKLEDGSQYPLEGRLEFSEVSVDEGTGSVTIRAVFPNPNNELLPGMFVHAQLQEGVKQKAILAPQQGVTRDLKGQATALVVNAQNKVELRVIKADRVIGDKWLVTEGLNAGDKIITEGLQFVQPGVEVKTVPAKNVASAQKADAAPAKTDSKG", "dna_sequence_from_broadstreet": "ATGCAACGAACGCCAGCCATGCGTGTACTGGTTCCGGCCCTGCTGGTCGCGATTTCGGCCCTTTCCGGGTGCGGAAAAAGCGAGGCGCCGCCGCCGGCGCAAACGCCGGAGGTCGGGATCGTGACCCTGGAAGCGCAGACGGTGACCCTGAATACCGAGCTGCCGGGCCGGACCAATGCGTTCCGCATCGCCGAGGTGCGTCCCCAGGTGAACGGCATCATCCTCAAGCGCCTGTTCAAGGAAGGCAGCGACGTCAAGGCCGGGCAGCAGCTCTACCAGATCGACCCCGCCACCTACGAGGCCGACTACCAGAGCGCCCAGGCCAACCTGGCTTCGACCCAGGAACAGGCCCAGCGCTACAAGCTGCTGGTCGCCGACCAGGCCGTGAGCAAGCAGCAGTACGCCGACGCCAATGCCGCCTACCTGCAGTCCAAGGCGGCGGTGGAGCAGGCGCGGATCAACCTGCGCTACACCAAGGTGCTGTCGCCGATCTCCGGCCGCATCGGCCGTTCCGCGGTGACCGAAGGCGCCCTGGTGACCAACGGCCAGGCCAACGCGATGGCCACCGTGCAACAGCTCGACCCGATCTACGTCGACGTCACCCAGCCGTCCACCGCCCTGCTGCGCCTGCGCCGCGAACTGGCCAGCGGCCAGTTGGAGCGCGCCGGCGACAACGCGGCGAAGGTCTCCCTGAAGCTGGAGGACGGTAGCCAATACCCGCTGGAAGGTCGCCTCGAATTCTCCGAGGTTTCCGTCGACGAAGGCACCGGCTCGGTCACCATCCGCGCCGTGTTCCCCAACCCGAACAACGAGCTGCTGCCCGGCATGTTCGTTCACGCGCAGTTGCAGGAAGGCGTCAAGCAGAAGGCCATCCTCGCTCCGCAGCAAGGCGTGACCCGCGACCTCAAGGGCCAGGCTACCGCGCTGGTGGTGAACGCGCAGAACAAGGTCGAGCTGCGGGTGATCAAGGCCGACCGGGTGATCGGCGACAAGTGGCTGGTTACCGAAGGCCTGAACGCCGGCGACAAGATCATTACCGAAGGCCTGCAGTTCGTGCAGCCGGGTGTCGAGGTGAAGACCGTGCCGGCGAAGAATGTCGCGTCCGCGCAGAAGGCCGACGCCGCTCCGGCGAAAACCGACAGCAAGGGCTGA", "partial": "0", "query_start": 10854, "query_end": 11045, "hit_start": 531, "hit_end": 714, "orf_dna_sequence": "ATGACTACCAGTGCCACGCCCAGGACCGCCCTGGTGACGGGCGGCACCAGCGGCATCGGGCTCGCCGTGGTGAAGACGCTCGCCGCCCGCGGGCTGCGGGTGTTCCTGTGCGCCCGCAGCCGCGAGAACGTCGACGCCGTGGTCAAGGAACTGCGCGACCAGGGGCTTCAGGTGGCCGGGTGCGAGGGGGACGTGCGGTCCCGGGAGTCGGTGGAGCGGGTGGTGCGCGCCGCGGTCGACCGGTTCGGGCCGCTGAGCGTCCTGGTGAACAACGCGGGGCGCAGCGGCGGCGGAGTGACCGCGCGCATCCCCGACGAGCTCTGGTACGACGTGATCGACACCAACCTCAACAGCGCCTTCCTGGTCACCCGTGAGGCCCTGACCACCGGCGGGCTGGAGCGGGCGGGCGTCGACGGGCGGATCATCAGCATCGCCTCCACCGGCGGCAAGCAGGGCGTTCCGCTGGGCGCCCCCTACTCGGCCTCGAAGGCGGGCCTGATCGGTTTCACCAAGGCGCTGGCCAAGGAGCTGGCCCCCACGGGGGTCACCGTCAACGCCGTGTGCCCGGGGTACGTGGAGACGCCGATGGCCGTCCGCGTACGGCAGGCGTACGCGGCCACCTGGGACACCACCGAGGAGGACGTGCTGTCCCGCTTCAACGACAAGATCCCGCTGGGGCGCTACTCCACACCCGAGGAGGTGGCCGCCCTGGTCGGCCACCTGGCGGGCGACGAGGCCGGGTCCATCACCGCGCAGGCCCTCAACGTCTGCGGCGGGCTGGGCATTTACTGA", "orf_prot_sequence": "MTTSATPRTALVTGGTSGIGLAVVKTLAARGLRVFLCARSRENVDAVVKELRDQGLQVAGCEGDVRSRESVERVVRAAVDRFGPLSVLVNNAGRSGGGVTARIPDELWYDVIDTNLNSAFLVTREALTTGGLERAGVDGRIISIASTGGKQGVPLGAPYSASKAGLIGFTKALAKELAPTGVTVNAVCPGYVETPMAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDEAGSITAQALNVCGGLGIY", "perc_identity": 34.38}, "gnl|BL_ORD_ID|2136|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10593, "orf_end": 11384, "orf_from": "BGC0000254.1|Oxytetracycline_10 ", "model_name": "ADC-8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "2341", "ARO_accession": "3003854", "ARO_name": "ADC-8", "ARO_category": {"40543": {"category_aro_accession": "3003846", "category_aro_cvterm_id": "40543", "category_aro_name": "ADC beta-lactamase without carbapenemase activity", "category_aro_description": "ADC beta-lactamases, also known as AmpC beta-lactamases, are cephalosporinases with extended-spectrum resistance to cephalosporins but not to carbapenems. ADC beta-lactamases are found in Acinetobacter sp. and Oligella urethralis.", "category_aro_class_name": "AMR Gene Family"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.76571, "max_identities": 33, "bit_score": 28.1054, "cvterm_id": "41144", "query": "VRSRESVERVVRAAVDRFGPLSVLVN-----NAGRSGGGVTARIPDELWYDVIDTNLNSAFLVTREALTTGGLERAGVDG-RIISIASTGGKQGVPLGAP-----YSASKAGLIGFTKALAKELAPTGVTVNAVCPG------YVETPMA", "match": "V S+++ + V    +   G +S L N      A   G    +  P + + ++ +T +N A L+     T GG      +  +     +   +   P  AP     YS    GL+G+  ALA + + + +  N + P       Y+  P A", "sequence_from_db": "VASKQTEQNVSEHTLFELGSVSKLFNATLTGYAQAQGQLKLSDHPAQYFPELKNTAVNQATLLNLGTYTAGGFPLQFPEQIKTTQDMTQYFQHWQPKAAPRRIREYSNPSIGLMGYVTALAMKNSYSNLIENTLFPALGMHHSYINVPAA", "sequence_from_broadstreet": "MMKDILGNLDNVPFKIMTGCIAGLLSCGTVAQSTVQQSIQQSVDRHFKPLMAQYQISGMAIAVSINGQHYYQNYGVASKQTEQNVSEHTLFELGSVSKLFNATLTGYAQAQGQLKLSDHPAQYFPELKNTAVNQATLLNLGTYTAGGFPLQFPEQIKTTQDMTQYFQHWQPKAAPRRIREYSNPSIGLMGYVTALAMKNSYSNLIENTLFPALGMHHSYINVPAAQMSNYAWGYQADQAIRVSPGMFDAEAYGIKSNTADMLKFLDAQINPQNLKPTLRKAIQTTQMGYFRVGQMRQGLGWEQYTYPVSLTTLLAGNSAKMALQPQPVTGISKPITAPQQALLNKTGATNGFSAYVVVIPSQKIGLVMLANRNFPNDARVKAAYATLQQILNADIQK", "dna_sequence_from_broadstreet": "ATGATGAAAGACATATTAGGTAACTTAGATAACGTGCCATTTAAGATCATGACAGGCTGTATTGCAGGACTATTGTCCTGTGGTACGGTCGCTCAATCGACAGTCCAACAATCAATTCAACAAAGTGTAGATCGACATTTTAAGCCCCTTATGGCTCAGTATCAAATTTCAGGAATGGCGATTGCGGTCAGCATAAATGGGCAACATTACTATCAGAATTATGGCGTAGCATCTAAACAGACCGAGCAAAATGTCTCTGAACATACTCTATTTGAGTTGGGTTCGGTGAGTAAGCTCTTTAATGCAACGCTGACGGGATATGCTCAAGCACAAGGTCAACTTAAGTTGAGTGATCATCCTGCCCAATATTTTCCAGAATTAAAAAATACAGCAGTGAATCAGGCGACTCTCCTGAATCTGGGGACCTATACCGCAGGTGGTTTTCCGCTACAGTTTCCTGAGCAGATCAAGACAACACAAGACATGACTCAGTATTTTCAGCACTGGCAGCCTAAAGCGGCTCCAAGACGTATTCGAGAATATTCAAATCCAAGCATTGGCTTGATGGGCTATGTCACCGCACTTGCGATGAAAAATAGCTATTCAAATCTAATTGAAAATACGTTATTCCCTGCGTTGGGGATGCATCATAGCTATATCAACGTTCCAGCAGCGCAGATGTCAAATTATGCATGGGGATATCAGGCAGATCAGGCGATACGTGTCTCACCAGGTATGTTTGATGCAGAGGCGTATGGCATCAAAAGTAACACTGCCGATATGCTTAAATTTCTAGATGCTCAAATAAATCCCCAAAATCTAAAACCCACGCTCCGAAAGGCCATACAAACCACTCAGATGGGTTATTTTCGGGTGGGACAGATGCGACAGGGCTTGGGTTGGGAGCAATATACTTATCCAGTATCCTTAACAACCTTGCTGGCGGGAAATTCCGCTAAAATGGCTCTACAGCCTCAACCTGTTACAGGCATTTCAAAACCTATCACTGCTCCGCAGCAGGCCCTTTTGAATAAAACTGGTGCAACCAATGGTTTTTCGGCTTATGTGGTGGTTATTCCGAGCCAAAAGATTGGACTGGTGATGCTTGCCAATCGTAATTTTCCCAATGATGCACGGGTGAAAGCAGCTTATGCCACACTACAGCAAATCCTCAATGCAGATATTCAGAAATGA", "partial": "0", "query_start": 10785, "query_end": 11183, "hit_start": 225, "hit_end": 675, "orf_dna_sequence": "ATGACTACCAGTGCCACGCCCAGGACCGCCCTGGTGACGGGCGGCACCAGCGGCATCGGGCTCGCCGTGGTGAAGACGCTCGCCGCCCGCGGGCTGCGGGTGTTCCTGTGCGCCCGCAGCCGCGAGAACGTCGACGCCGTGGTCAAGGAACTGCGCGACCAGGGGCTTCAGGTGGCCGGGTGCGAGGGGGACGTGCGGTCCCGGGAGTCGGTGGAGCGGGTGGTGCGCGCCGCGGTCGACCGGTTCGGGCCGCTGAGCGTCCTGGTGAACAACGCGGGGCGCAGCGGCGGCGGAGTGACCGCGCGCATCCCCGACGAGCTCTGGTACGACGTGATCGACACCAACCTCAACAGCGCCTTCCTGGTCACCCGTGAGGCCCTGACCACCGGCGGGCTGGAGCGGGCGGGCGTCGACGGGCGGATCATCAGCATCGCCTCCACCGGCGGCAAGCAGGGCGTTCCGCTGGGCGCCCCCTACTCGGCCTCGAAGGCGGGCCTGATCGGTTTCACCAAGGCGCTGGCCAAGGAGCTGGCCCCCACGGGGGTCACCGTCAACGCCGTGTGCCCGGGGTACGTGGAGACGCCGATGGCCGTCCGCGTACGGCAGGCGTACGCGGCCACCTGGGACACCACCGAGGAGGACGTGCTGTCCCGCTTCAACGACAAGATCCCGCTGGGGCGCTACTCCACACCCGAGGAGGTGGCCGCCCTGGTCGGCCACCTGGCGGGCGACGAGGCCGGGTCCATCACCGCGCAGGCCCTCAACGTCTGCGGCGGGCTGGGCATTTACTGA", "orf_prot_sequence": "MTTSATPRTALVTGGTSGIGLAVVKTLAARGLRVFLCARSRENVDAVVKELRDQGLQVAGCEGDVRSRESVERVVRAAVDRFGPLSVLVNNAGRSGGGVTARIPDELWYDVIDTNLNSAFLVTREALTTGGLERAGVDGRIISIASTGGKQGVPLGAPYSASKAGLIGFTKALAKELAPTGVTVNAVCPGYVETPMAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDEAGSITAQALNVCGGLGIY", "perc_identity": 22.0}, "gnl|BL_ORD_ID|1061|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10593, "orf_end": 11384, "orf_from": "BGC0000254.1|Oxytetracycline_10 ", "model_name": "AER-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "1149", "ARO_accession": "3002481", "ARO_name": "AER-1", "ARO_category": {"36228": {"category_aro_accession": "3000089", "category_aro_cvterm_id": "36228", "category_aro_name": "AER beta-lactamase", "category_aro_description": "AER beta-lactamases are capable of hydrolyzing arbenicillin.", "category_aro_class_name": "AMR Gene Family"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.63503, "max_identities": 18, "bit_score": 26.5646, "cvterm_id": "36810", "query": "AGVDGRIISIASTGGKQGVPLGAPYSASKAGLIGFTKALAKELAPTGVTVNAVCPGYV", "match": "A VDG+ +S           LG   S SK  L+ ++    K L+P  VT   +C   V", "sequence_from_db": "AKVDGKSLS-----------LGQSVSISKEMLVTYSPITEKSLSPETVTFGKICQAAV", "sequence_from_broadstreet": "MYVLSVEKPTLRNKFAAGIGVVLVCVVASFIPTPVFALDTTKLIQAVQSEESALHARVGMTVFDSNTGTTWNYRGDERFPLNSTHKTFSCAALLAKVDGKSLSLGQSVSISKEMLVTYSPITEKSLSPETVTFGKICQAAVSYSDNTAANVVFDAIGGATGFNAYMRSIGDEETQLDRKEPELNEGTPGDVRDTTTPNAMVNSLRKILLGDALSASSRSQLTQWMLDDQVAGALLRASLPSDWKIADKTGAGGYGSRSIVAVIWPPSKQPLVVGIYITQTKASMQASNQAIARIGVVLKDTVAP", "dna_sequence_from_broadstreet": "ATGTACGTACTTTCCGTGGAGAAACCTACATTGAGAAACAAATTTGCGGCCGGAATAGGCGTCGTGCTTGTATGTGTCGTTGCCTCGTTTATTCCAACCCCAGTATTCGCCCTAGACACCACGAAGCTGATCCAAGCCGTCCAGTCGGAAGAGAGCGCCTTGCATGCCCGAGTCGGCATGACCGTGTTTGACTCAAACACTGGAACGACTTGGAACTATCGGGGCGATGAGCGGTTTCCATTGAACAGTACGCACAAGACGTTTTCCTGTGCAGCTTTGCTCGCGAAGGTCGATGGGAAGTCCCTCTCTCTGGGCCAATCCGTATCGATCAGCAAGGAAATGCTGGTCACCTATTCGCCGATTACGGAAAAGTCGCTGTCACCCGAAACCGTTACCTTCGGCAAGATTTGTCAGGCAGCGGTGAGCTATAGCGATAACACAGCCGCAAACGTCGTCTTTGATGCCATTGGAGGAGCAACCGGATTCAACGCATACATGCGGTCTATCGGCGATGAAGAAACCCAGCTTGATCGCAAAGAACCCGAGTTGAACGAAGGTACGCCGGGCGATGTGCGTGACACCACCACTCCCAACGCCATGGTCAATAGTCTTAGGAAGATACTTCTTGGCGACGCGTTGTCAGCATCATCCCGATCCCAGCTGACGCAATGGATGCTGGACGATCAGGTTGCTGGTGCGCTCCTGCGTGCCTCACTGCCATCCGATTGGAAGATCGCCGACAAGACCGGCGCGGGGGGTTACGGCTCACGCTCGATCGTCGCAGTAATCTGGCCGCCATCGAAGCAGCCACTGGTGGTTGGCATCTATATCACGCAAACCAAAGCATCCATGCAGGCCAGCAATCAGGCGATTGCAAGGATAGGAGTGGTGCTGAAGGATACGGTCGCTCCTTGA", "partial": "0", "query_start": 10995, "query_end": 11168, "hit_start": 282, "hit_end": 423, "orf_dna_sequence": "ATGACTACCAGTGCCACGCCCAGGACCGCCCTGGTGACGGGCGGCACCAGCGGCATCGGGCTCGCCGTGGTGAAGACGCTCGCCGCCCGCGGGCTGCGGGTGTTCCTGTGCGCCCGCAGCCGCGAGAACGTCGACGCCGTGGTCAAGGAACTGCGCGACCAGGGGCTTCAGGTGGCCGGGTGCGAGGGGGACGTGCGGTCCCGGGAGTCGGTGGAGCGGGTGGTGCGCGCCGCGGTCGACCGGTTCGGGCCGCTGAGCGTCCTGGTGAACAACGCGGGGCGCAGCGGCGGCGGAGTGACCGCGCGCATCCCCGACGAGCTCTGGTACGACGTGATCGACACCAACCTCAACAGCGCCTTCCTGGTCACCCGTGAGGCCCTGACCACCGGCGGGCTGGAGCGGGCGGGCGTCGACGGGCGGATCATCAGCATCGCCTCCACCGGCGGCAAGCAGGGCGTTCCGCTGGGCGCCCCCTACTCGGCCTCGAAGGCGGGCCTGATCGGTTTCACCAAGGCGCTGGCCAAGGAGCTGGCCCCCACGGGGGTCACCGTCAACGCCGTGTGCCCGGGGTACGTGGAGACGCCGATGGCCGTCCGCGTACGGCAGGCGTACGCGGCCACCTGGGACACCACCGAGGAGGACGTGCTGTCCCGCTTCAACGACAAGATCCCGCTGGGGCGCTACTCCACACCCGAGGAGGTGGCCGCCCTGGTCGGCCACCTGGCGGGCGACGAGGCCGGGTCCATCACCGCGCAGGCCCTCAACGTCTGCGGCGGGCTGGGCATTTACTGA", "orf_prot_sequence": "MTTSATPRTALVTGGTSGIGLAVVKTLAARGLRVFLCARSRENVDAVVKELRDQGLQVAGCEGDVRSRESVERVVRAAVDRFGPLSVLVNNAGRSGGGVTARIPDELWYDVIDTNLNSAFLVTREALTTGGLERAGVDGRIISIASTGGKQGVPLGAPYSASKAGLIGFTKALAKELAPTGVTVNAVCPGYVETPMAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDEAGSITAQALNVCGGLGIY", "perc_identity": 31.03}, "gnl|BL_ORD_ID|4956|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10593, "orf_end": 11384, "orf_from": "BGC0000254.1|Oxytetracycline_10 ", "model_name": "EstT", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5948", "ARO_accession": "3007459", "ARO_name": "EstT", "ARO_category": {"36459": {"category_aro_accession": "3000320", "category_aro_cvterm_id": "36459", "category_aro_name": "macrolide esterase", "category_aro_description": "Hydrolytic enzymes that cleave the macrocycle lactone ring of macrolide antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.95798, "max_identities": 17, "bit_score": 25.409, "cvterm_id": "46223", "query": "NVDAVVKELRDQGLQVAGCEGDVRSRESVERVVRAAVDRFGPLSVLVNNAGRSGGG", "match": "N D+VV  L  QG ++   +     + S E+++RA  +R      + N+A   GGG", "sequence_from_db": "NEDSVVNYLI-QGAELMSGKKQFDKQRS-EKLIRAEFNRANNYISMFNHAASQGGG", "sequence_from_broadstreet": "MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND", "dna_sequence_from_broadstreet": "ATGAAAAAAAAACTACTTTGGATATTAATTTTAGGACTGATAATAATCAGTTGCAAACAAAGGAAAACAGAAATGAAAGAGAAAATAATTAAAACAAACGGCATTGAACTCTGTACGGAAAGTTTTGGAAATAAGAAAAATCCAGCAATCCTTTTGGTAGCAGGTGCAACCGTATCAATGCTGTATTGGGACACTGAATTTTGCCAACAATTATCTGAAAAAGGATTTTTTGTTATTCGTTACGACAACAGAGATGTAGGAAAATCCACTAATTATGAACCAGGTTCTACTCCATACGATATTGTTGACTTAACTAATGACGCTATTTCAATATTGGATGGCTACAAGATTGACAAAGCACATTTTGTGGGGATTTCTTTGGGCGGACTAATTTCTCAAATAGCATCAATAAAGTTTGCCGACAGAGTTAACTCCTTAACTCTTATGTCATCAGGCCCTTGGGGAGACTCAGACCCAACTATACCTGAAATGGACACGAGTATTTTAGATTTCCATAGTAAAGCAGGTACAGTCAATTGGACAAATGAAGACAGTGTGGTAAACTATTTAATTCAGGGTGCAGAATTAATGAGTGGCAAGAAACAATTTGACAAACAAAGAAGTGAAAAACTGATAAGAGCTGAGTTCAATAGAGCCAACAATTATATAAGTATGTTCAATCACGCTGCATCGCAAGGTGGTGGTGGTGAAGAATATTGGAACAGATTAAACGAAATCAAACAACCCACCTTAATTATCCACGGAACAGACGACAAAATTTGGCATTATAAGAATGCAGGTTTTTTACTAGAAAAAATAAAAGGTTCAAATCTAATCACCCTTGAAGGTACAGGACACGAATTACACGTTGATGATTGGAAATCAATAATTGATGGAATAGAAAAACACATAAATGACTGA", "partial": "0", "query_start": 10719, "query_end": 10886, "hit_start": 543, "hit_end": 705, "orf_dna_sequence": "ATGACTACCAGTGCCACGCCCAGGACCGCCCTGGTGACGGGCGGCACCAGCGGCATCGGGCTCGCCGTGGTGAAGACGCTCGCCGCCCGCGGGCTGCGGGTGTTCCTGTGCGCCCGCAGCCGCGAGAACGTCGACGCCGTGGTCAAGGAACTGCGCGACCAGGGGCTTCAGGTGGCCGGGTGCGAGGGGGACGTGCGGTCCCGGGAGTCGGTGGAGCGGGTGGTGCGCGCCGCGGTCGACCGGTTCGGGCCGCTGAGCGTCCTGGTGAACAACGCGGGGCGCAGCGGCGGCGGAGTGACCGCGCGCATCCCCGACGAGCTCTGGTACGACGTGATCGACACCAACCTCAACAGCGCCTTCCTGGTCACCCGTGAGGCCCTGACCACCGGCGGGCTGGAGCGGGCGGGCGTCGACGGGCGGATCATCAGCATCGCCTCCACCGGCGGCAAGCAGGGCGTTCCGCTGGGCGCCCCCTACTCGGCCTCGAAGGCGGGCCTGATCGGTTTCACCAAGGCGCTGGCCAAGGAGCTGGCCCCCACGGGGGTCACCGTCAACGCCGTGTGCCCGGGGTACGTGGAGACGCCGATGGCCGTCCGCGTACGGCAGGCGTACGCGGCCACCTGGGACACCACCGAGGAGGACGTGCTGTCCCGCTTCAACGACAAGATCCCGCTGGGGCGCTACTCCACACCCGAGGAGGTGGCCGCCCTGGTCGGCCACCTGGCGGGCGACGAGGCCGGGTCCATCACCGCGCAGGCCCTCAACGTCTGCGGCGGGCTGGGCATTTACTGA", "orf_prot_sequence": "MTTSATPRTALVTGGTSGIGLAVVKTLAARGLRVFLCARSRENVDAVVKELRDQGLQVAGCEGDVRSRESVERVVRAAVDRFGPLSVLVNNAGRSGGGVTARIPDELWYDVIDTNLNSAFLVTREALTTGGLERAGVDGRIISIASTGGKQGVPLGAPYSASKAGLIGFTKALAKELAPTGVTVNAVCPGYVETPMAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDEAGSITAQALNVCGGLGIY", "perc_identity": 30.36}, "gnl|BL_ORD_ID|2716|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10593, "orf_end": 11384, "orf_from": "BGC0000254.1|Oxytetracycline_10 ", "model_name": "Acinetobacter baumannii AbaF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3277", "ARO_accession": "3004573", "ARO_name": "Acinetobacter baumannii AbaF", "ARO_category": {"36003": {"category_aro_accession": "0010002", "category_aro_cvterm_id": "36003", "category_aro_name": "major facilitator superfamily (MFS) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Major facilitator superfamily (MFS) transporters and ABC transporters comprise the two largest and most functionally diverse of the transporter superfamilies. However, MFS transporters are distinct from ABC transporters in both their primary sequence and structure and in the mechanism of energy coupling. As secondary transporters they are, like RND and SMR transporters, energized by the electrochemical proton gradient.", "category_aro_class_name": "AMR Gene Family"}, "35944": {"category_aro_accession": "0000025", "category_aro_cvterm_id": "35944", "category_aro_name": "fosfomycin", "category_aro_description": "Fosfomycin (also known as phosphomycin and phosphonomycin) is a broad-spectrum antibiotic produced by certain Streptomyces species. It is effective on gram positive and negative bacteria as it targets the cell wall, an essential feature shared by both bacteria. Its specific target is MurA (MurZ in E.coli), which attaches phosphoenolpyruvate (PEP) to UDP-N-acetylglucosamine, a step of commitment to cell wall synthesis. In the active site of MurA, the active cysteine molecule is alkylated which stops the catalytic reaction.", "category_aro_class_name": "Antibiotic"}, "45731": {"category_aro_accession": "3007149", "category_aro_cvterm_id": "45731", "category_aro_name": "phosphonic acid antibiotic", "category_aro_description": "A group of antibiotics derived from phosphonic acids.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.96868, "max_identities": 22, "bit_score": 25.409, "cvterm_id": "35522", "query": "ALAKELAPTGVTVNAVCPGYVETP-MAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDE", "match": "AL  EL PT +   A+   Y   P MA  +    A T       +L  FN  IP+  Y     + ++V  L   E", "sequence_from_db": "ALMTELFPTHIRYTALSFCYQVAPIMAGSLAPLIALT-------LLKEFNSSIPISLYLVAASLISIVSILLVKE", "sequence_from_broadstreet": "MTTTLKKVVAASMVGSVAEWYEFFLYGTASALVFGELFFQQTGNAIDGILAAFALYAVGFLARPLGGLVFGHYGDKIGRKKLLQISLIIVGITTFLMGCIPTFHQIGYWAPTLLVILRLIQGFAFGGEWGGAVILVSEHSPDDRRGYWASWPQTGVPLGNLVATLVLLLLSKNLSPEQFLDWGWRCAFWFSAVVVLIGLWIRKNVDDAEVFKEAQAKQQLLEKQQLGIIEVLKYHKKSVIAGIGARFAENILYYMVVTFSISYLKLVVHKDTSQILLLMFGAHLIHFFIIPFMGHLSDIFGRKPIYLIGAVLTAFWGFVGFPLMDTGNDWLIMLAIVLGLFIESMTYSPYSALMTELFPTHIRYTALSFCYQVAPIMAGSLAPLIALTLLKEFNSSIPISLYLVAASLISIVSILLVKETKGRSLAFKD", "dna_sequence_from_broadstreet": "ATGACGACAACACTAAAAAAGGTAGTCGCGGCCTCTATGGTCGGCTCCGTAGCAGAATGGTATGAATTTTTCCTTTATGGCACCGCTTCTGCCCTCGTCTTTGGCGAACTTTTCTTTCAACAAACTGGCAATGCTATAGATGGAATTTTGGCGGCCTTTGCTCTGTATGCCGTTGGCTTTTTAGCAAGACCTCTCGGTGGCCTCGTGTTTGGTCACTACGGCGATAAAATTGGGCGCAAGAAATTATTGCAAATTAGCCTGATCATTGTCGGTATCACTACTTTTTTAATGGGCTGTATTCCGACCTTTCATCAAATTGGCTATTGGGCTCCTACACTCCTAGTGATATTACGTTTAATTCAAGGTTTTGCTTTTGGTGGTGAATGGGGCGGCGCAGTTATTTTAGTTTCAGAGCACAGTCCAGATGATCGCAGAGGTTATTGGGCAAGCTGGCCACAAACTGGTGTACCGCTCGGAAATTTAGTAGCCACACTGGTTTTATTATTACTTTCAAAAAACCTCTCACCCGAACAATTTCTAGATTGGGGGTGGCGCTGTGCATTCTGGTTCTCAGCAGTCGTGGTACTGATTGGTTTATGGATTCGAAAAAATGTAGACGATGCCGAAGTGTTTAAAGAAGCACAGGCCAAACAACAGCTTCTTGAAAAGCAACAACTCGGGATTATTGAGGTTTTAAAATATCATAAGAAATCTGTTATTGCGGGTATCGGTGCCAGATTTGCAGAAAATATTTTGTACTATATGGTGGTTACTTTTTCGATCAGTTATTTAAAGTTAGTCGTCCATAAAGATACTTCGCAGATCTTACTGCTCATGTTCGGCGCTCATCTGATCCATTTCTTTATTATTCCTTTTATGGGGCATTTAAGCGATATATTTGGCCGTAAACCTATTTACCTTATTGGGGCTGTACTTACTGCTTTTTGGGGTTTTGTCGGCTTTCCTTTAATGGATACAGGCAATGACTGGCTCATTATGTTAGCAATTGTGCTTGGTTTATTTATTGAGTCCATGACCTACTCGCCTTACTCTGCGTTAATGACTGAGTTATTTCCAACTCACATCCGCTATACGGCGCTTTCATTTTGTTATCAAGTCGCACCCATTATGGCAGGTTCGCTTGCTCCATTAATTGCCCTAACATTACTCAAAGAATTTAATAGTTCGATTCCGATTTCTTTATATTTGGTTGCCGCAAGTCTGATTTCTATTGTCTCGATTTTGCTGGTGAAAGAAACCAAAGGCCGATCTCTAGCTTTTAAAGATTAA", "partial": "0", "query_start": 11106, "query_end": 11327, "hit_start": 1053, "hit_end": 1257, "orf_dna_sequence": "ATGACTACCAGTGCCACGCCCAGGACCGCCCTGGTGACGGGCGGCACCAGCGGCATCGGGCTCGCCGTGGTGAAGACGCTCGCCGCCCGCGGGCTGCGGGTGTTCCTGTGCGCCCGCAGCCGCGAGAACGTCGACGCCGTGGTCAAGGAACTGCGCGACCAGGGGCTTCAGGTGGCCGGGTGCGAGGGGGACGTGCGGTCCCGGGAGTCGGTGGAGCGGGTGGTGCGCGCCGCGGTCGACCGGTTCGGGCCGCTGAGCGTCCTGGTGAACAACGCGGGGCGCAGCGGCGGCGGAGTGACCGCGCGCATCCCCGACGAGCTCTGGTACGACGTGATCGACACCAACCTCAACAGCGCCTTCCTGGTCACCCGTGAGGCCCTGACCACCGGCGGGCTGGAGCGGGCGGGCGTCGACGGGCGGATCATCAGCATCGCCTCCACCGGCGGCAAGCAGGGCGTTCCGCTGGGCGCCCCCTACTCGGCCTCGAAGGCGGGCCTGATCGGTTTCACCAAGGCGCTGGCCAAGGAGCTGGCCCCCACGGGGGTCACCGTCAACGCCGTGTGCCCGGGGTACGTGGAGACGCCGATGGCCGTCCGCGTACGGCAGGCGTACGCGGCCACCTGGGACACCACCGAGGAGGACGTGCTGTCCCGCTTCAACGACAAGATCCCGCTGGGGCGCTACTCCACACCCGAGGAGGTGGCCGCCCTGGTCGGCCACCTGGCGGGCGACGAGGCCGGGTCCATCACCGCGCAGGCCCTCAACGTCTGCGGCGGGCTGGGCATTTACTGA", "orf_prot_sequence": "MTTSATPRTALVTGGTSGIGLAVVKTLAARGLRVFLCARSRENVDAVVKELRDQGLQVAGCEGDVRSRESVERVVRAAVDRFGPLSVLVNNAGRSGGGVTARIPDELWYDVIDTNLNSAFLVTREALTTGGLERAGVDGRIISIASTGGKQGVPLGAPYSASKAGLIGFTKALAKELAPTGVTVNAVCPGYVETPMAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDEAGSITAQALNVCGGLGIY", "perc_identity": 29.33}, "gnl|BL_ORD_ID|2229|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 10593, "orf_end": 11384, "orf_from": "BGC0000254.1|Oxytetracycline_10 ", "model_name": "BahA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1450", "model_id": "2521", "ARO_accession": "3003984", "ARO_name": "BahA", "ARO_category": {"41424": {"category_aro_accession": "3004260", "category_aro_cvterm_id": "41424", "category_aro_name": "Bah amidohydrolase", "category_aro_description": "Bah amidohydrolases are membrane proteins that inactivate bacitracin.", "category_aro_class_name": "AMR Gene Family"}, "35959": {"category_aro_accession": "0000041", "category_aro_cvterm_id": "35959", "category_aro_name": "bacitracin", "category_aro_description": "Bacitracin is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy. Bacitracin interferes with the dephosphorylation of the C55-isoprenyl pyrophosphate, a molecule which carries the building blocks of the peptidoglycan bacterial cell wall outside of the inner membrane.", "category_aro_class_name": "Antibiotic"}, "36192": {"category_aro_accession": "3000053", "category_aro_cvterm_id": "36192", "category_aro_name": "peptide antibiotic", "category_aro_description": "Peptide antibiotics have a wide range of antibacterial mechanisms, depending on the amino acids that make up the antibiotic, although most act to disrupt the cell membrane in some manner. Subclasses of peptide antibiotics can include additional sidechains of other types, such as lipids in the case of the lipopeptide antibiotics.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.3132, "max_identities": 21, "bit_score": 25.0238, "cvterm_id": "40862", "query": "VCPGYVETPMAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDEAGSITAQALNVCG", "match": "+ P   E P    +   +  TW     D  + F  K+ + R        AL+GH  G EA +I A A N  G", "sequence_from_db": "ISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMER-------IALIGHSRGGEAVAIAA-AYNKLG", "sequence_from_broadstreet": "MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS", "dna_sequence_from_broadstreet": "TTGGAAATACACAAAGAGAAAGAAAAAGAAAAAGGCGTTACGTTTTTTCGAAGAATCATGGCAAACCGGAAGCGTAGGGGGCCGCTATCCCCTGGATGGAAGGGTGCGTCGCTTGGGCTCGGCGCCACCGGCTTTATTCTAATTCTGATACAGGCCAATTATCTATTGACGGGGCATGGTGTCGGTAAATTCATCGTGGGCACATTCCTGTTTCTCTTTGCGGCTGCCCTTATAAGCGGCCTAGCATCAATGTTGCTGCACGGGGTCAAGAAACTACCAAGCCGTTATATTTGGATGCTGCTGTATTCCCTGATCATGTTTTTATTCTGTTTTATTGTGCAGCCGGGCGTATCGGCAGTCTTCATCGTCTCTTTGGCCATTGTTTTATCTTTATTTGGTGCATTGGCTTATAAATTTGCAGCGGGAAGCTACAAGCAAGTGTCTAAAACCAGGAAAATCGGCGCGATGGCTTGTTTGTCCTTGATCACCATCGCGATCGGCGCTGGCAGCTTCTGGCTGATTCGGGCCGGAGATGATGCCGCTCCGGACATCACATTGAAACAGCTGAAAACCTCAACCCGATATGAAGACTCGACGATGAACAATCCGGCCGAACAAGGCACATATCCCGTCCAAAGCCTGTTATACGGAAGTCCTGACAACTATCGGACAGAATTTAATCAAAGCGGTTCCCTAACCACCCAAACGGTGGATGCGTCCAGGTTTGTTGAGAAGTGGTCGTCTTTGCGCACGAAGTCGCTTGGATTCGGACCCGAGGCCATGCCGTTAAACGGAAGAGTGTGGTATCCCGAAGGGGAAGGCACCTTTCCGCTTGTTTTGATTGTACATGGTAATCACTTGATGAATGATTATTCCGATCCGGGTTATGAATATCTCGGCAGGCTGCTCGCGAGCAAAGGGTATATATTTGTCTCCGTGGATGAAAATTTCCTCAATTTCTCCCCATATGAGGATCTATTCCTGATCAGCCCGCTGCTAAGTGAAAATCCGGCAAGGGGTCTGCTGCTGCTGGAGCATTTGCAAACCTGGAAGGACTGGAACAGCGATCCGGACAACCCGTTTTACCAAAAGGTCGATATGGAACGAATCGCCCTCATCGGTCATTCCCGGGGCGGCGAAGCGGTCGCGATCGCGGCAGCGTATAACAAGCTTGGCCGTCATCCGGACCATGGGGATATCAAGTTTGATTATAACTTTTCGATCCGCTCGCTCATTTCCATTGCGGGAACGGACGGGCAATATAAGCCCCAAGGCAAACCTCTGCCGCTGCAAGACGTAAATTATCTGTCTTTGCATGGAGCTCATGATATGGATGTCAACAGCCTGGACGGTGCGAAGCAATATCACCGGATTCGTTATACCAAGGGCACAAATTACATGAAATCGCTGGTCTATATTTATGGAGCCAACCACGGCCAGTTTAACGGAGGCTGGGGCAGAGGGGATGGGGCAGGGTTGGGGAACCAACTGTTTAACCTACGTCAAATTATGCCACGGGATGAGCAGGAAACCATCGCAAAAGTGTTCATATCTTCGTTCCTGGATGCCACGCTGAAGGACCAACGGCAATACAGGGAGGTGTTCAAGGATTTGGGTTACGCCAAGGAATGGATTCCCGACAATCTGTATGTGGGCAATTATTACGATTCGCAGACGACCTTGATCGCCGATTTTCATGAAGACATCGATCTGCAGAGCACCACGCTTCCTGGCGGCAGCCTGCGGGGCGAGAACCTGCAGCAATGGAAGGAAGAAAAGGTTAAGACAAAATGGGGCGAAGCGGATTACAGCGCGGTTCGCTTAGGCTGGAATTCGAACGGTTCGTCCGAGCCTGCCTCCTATACGGTTACTTTGCCGGATAACGGGGTGGAAACAGGAAGGGATAGCTCGATCGTATTTTCGCTGGCAGATGCACGCAAAACAGAAGAAAGCGGCGACCCGAAAGAGCTTATCAATTTTACGATTACGGTTGAAGATAGGAAGGGCCATCAGGCAAGTCTTCCCCTCAGCCACATATCCAAGTTGCCGCCTGTTATTGAAGGTAAACTTCTCAAATGGCCATTTTCGAATGCAGGCAATACTTCAGAACCCGTATTTCAAAGCTACGATTTCCAATTAGACGATTATTACAAAATGAATCCGGACTTCAACCCGCAGCAGTTGAGCAAGATTCGCATCGAGTTCAATCTAACCAAGCGGGGAAGCATTCTGCTTCGTGATGTTGGCATTCGATCTTAA", "partial": "0", "query_start": 11151, "query_end": 11366, "hit_start": 984, "hit_end": 1176, "orf_dna_sequence": "ATGACTACCAGTGCCACGCCCAGGACCGCCCTGGTGACGGGCGGCACCAGCGGCATCGGGCTCGCCGTGGTGAAGACGCTCGCCGCCCGCGGGCTGCGGGTGTTCCTGTGCGCCCGCAGCCGCGAGAACGTCGACGCCGTGGTCAAGGAACTGCGCGACCAGGGGCTTCAGGTGGCCGGGTGCGAGGGGGACGTGCGGTCCCGGGAGTCGGTGGAGCGGGTGGTGCGCGCCGCGGTCGACCGGTTCGGGCCGCTGAGCGTCCTGGTGAACAACGCGGGGCGCAGCGGCGGCGGAGTGACCGCGCGCATCCCCGACGAGCTCTGGTACGACGTGATCGACACCAACCTCAACAGCGCCTTCCTGGTCACCCGTGAGGCCCTGACCACCGGCGGGCTGGAGCGGGCGGGCGTCGACGGGCGGATCATCAGCATCGCCTCCACCGGCGGCAAGCAGGGCGTTCCGCTGGGCGCCCCCTACTCGGCCTCGAAGGCGGGCCTGATCGGTTTCACCAAGGCGCTGGCCAAGGAGCTGGCCCCCACGGGGGTCACCGTCAACGCCGTGTGCCCGGGGTACGTGGAGACGCCGATGGCCGTCCGCGTACGGCAGGCGTACGCGGCCACCTGGGACACCACCGAGGAGGACGTGCTGTCCCGCTTCAACGACAAGATCCCGCTGGGGCGCTACTCCACACCCGAGGAGGTGGCCGCCCTGGTCGGCCACCTGGCGGGCGACGAGGCCGGGTCCATCACCGCGCAGGCCCTCAACGTCTGCGGCGGGCTGGGCATTTACTGA", "orf_prot_sequence": "MTTSATPRTALVTGGTSGIGLAVVKTLAARGLRVFLCARSRENVDAVVKELRDQGLQVAGCEGDVRSRESVERVVRAAVDRFGPLSVLVNNAGRSGGGVTARIPDELWYDVIDTNLNSAFLVTREALTTGGLERAGVDGRIISIASTGGKQGVPLGAPYSASKAGLIGFTKALAKELAPTGVTVNAVCPGYVETPMAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDEAGSITAQALNVCGGLGIY", "perc_identity": 29.17}, "gnl|BL_ORD_ID|4712|hsp_num:0": {"type_match": "Loose", "snp": {"original": "F", "change": "A", "position": 203}, "query_snp": {"original": "F", "change": "A", "position": 63}, "orf_strand": "+", "orf_start": 10593, "orf_end": 11384, "orf_from": "BGC0000254.1|Oxytetracycline_10 ", "model_name": "Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 450, "model_id": "2666", "ARO_accession": "3004045", "ARO_name": "Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan", "ARO_category": {"41434": {"category_aro_accession": "3004270", "category_aro_cvterm_id": "41434", "category_aro_name": "antibiotic resistant fabI", "category_aro_description": "fabI is a enoyl-acyl carrier reductase used in lipid metabolism and fatty acid biosynthesis. The bacterial biocide Triclosan blocks the final reduction step in fatty acid elongation, inhibiting biosynthesis. Point mutations in fabI can confer resistance to Triclosan and Isoniazid.", "category_aro_class_name": "AMR Gene Family"}, "37250": {"category_aro_accession": "3000870", "category_aro_cvterm_id": "37250", "category_aro_name": "triclosan", "category_aro_description": "Triclosan is a common antibacterial agent added to many consumer products as a biocide.  It is an inhibitor of fatty acid biosynthesis by blocking enoyl-carrier protein reductase (FabI).", "category_aro_class_name": "Antibiotic"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00204936, "bit_score": 35.8094, "max_identities": 28, "cvterm_id": "36849", "query": "IISIASTGGKQGVPLGAPYSASKAGLIGFTKALAKELAPTGVTVNAVCPGYVETPMAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDEAGSITAQALNVCGGLGI", "match": "+++++  G ++ +P       +KA L    + +A  + P GV VNA+  G + T  A  ++             +L+      P+ R  T E+V      L  D +  I+ + ++V GG  I", "sequence_from_db": "LLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDF---------RKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSI", "sequence_from_broadstreet": "MGFLSGKRILVTGVASKLSIAYGIAQAMHREGAELAFTYQNDKLKGRVEEFAAQLGSDIVLQCDVAEDASIDTMFAELGKVWPKFDGFVHSIGFAPGDQLDGDYVNAVTREGFKIAHDISSYSFVAMAKACRSMLNPGSALLTLSYLGAERAIPNYNVMGLAKASLEANVRYMANAMGPEGVRVNAISAGPIRTLAASGIKDFRKMLAHCEAVTPIRRTVTIEDVGNSAAFLCSDLSAGISGEVVHVDGGFSIAAMNELELK", "dna_sequence_from_broadstreet": "ATGGGTTTTCTTTCCGGTAAGCGCATTCTGGTAACCGGTGTTGCCAGCAAACTATCCATCGCCTACGGTATCGCTCAGGCGATGCACCGCGAAGGAGCTGAACTGGCATTCACCTACCAGAACGACAAACTGAAAGGCCGCGTAGAAGAATTTGCCGCTCAATTGGGTTCTGACATCGTTCTGCAGTGCGATGTTGCAGAAGATGCCAGCATCGACACCATGTTCGCTGAACTGGGGAAAGTTTGGCCGAAATTTGACGGTTTCGTACACTCTATTGGTTTTGCACCTGGCGATCAGCTGGATGGTGACTATGTTAACGCCGTTACCCGTGAAGGCTTCAAAATTGCCCACGACATCAGCTCCTACAGCTTCGTTGCAATGGCAAAAGCTTGCCGCTCCATGCTGAATCCGGGTTCTGCCCTGCTGACCCTTTCCTACCTTGGCGCTGAGCGCGCTATCCCGAACTACAACGTTATGGGTCTGGCAAAAGCGTCTCTGGAAGCGAACGTGCGCTATATGGCGAACGCGATGGGTCCGGAAGGTGTGCGTGTTAACGCCATCTCTGCTGGTCCGATCCGTACTCTGGCGGCCTCCGGTATCAAAGACTTCCGCAAAATGCTGGCTCATTGCGAAGCCGTTACCCCGATTCGCCGTACCGTTACTATTGAAGATGTGGGTAACTCTGCGGCATTCCTGTGCTCCGATCTCTCTGCCGGTATCTCCGGTGAAGTGGTCCACGTTGACGGCGGTTTCAGCATTGCTGCAATGAACGAACTCGAACTGAAATAA", "partial": "0", "query_start": 11013, "query_end": 11378, "hit_start": 420, "hit_end": 759, "orf_dna_sequence": "ATGACTACCAGTGCCACGCCCAGGACCGCCCTGGTGACGGGCGGCACCAGCGGCATCGGGCTCGCCGTGGTGAAGACGCTCGCCGCCCGCGGGCTGCGGGTGTTCCTGTGCGCCCGCAGCCGCGAGAACGTCGACGCCGTGGTCAAGGAACTGCGCGACCAGGGGCTTCAGGTGGCCGGGTGCGAGGGGGACGTGCGGTCCCGGGAGTCGGTGGAGCGGGTGGTGCGCGCCGCGGTCGACCGGTTCGGGCCGCTGAGCGTCCTGGTGAACAACGCGGGGCGCAGCGGCGGCGGAGTGACCGCGCGCATCCCCGACGAGCTCTGGTACGACGTGATCGACACCAACCTCAACAGCGCCTTCCTGGTCACCCGTGAGGCCCTGACCACCGGCGGGCTGGAGCGGGCGGGCGTCGACGGGCGGATCATCAGCATCGCCTCCACCGGCGGCAAGCAGGGCGTTCCGCTGGGCGCCCCCTACTCGGCCTCGAAGGCGGGCCTGATCGGTTTCACCAAGGCGCTGGCCAAGGAGCTGGCCCCCACGGGGGTCACCGTCAACGCCGTGTGCCCGGGGTACGTGGAGACGCCGATGGCCGTCCGCGTACGGCAGGCGTACGCGGCCACCTGGGACACCACCGAGGAGGACGTGCTGTCCCGCTTCAACGACAAGATCCCGCTGGGGCGCTACTCCACACCCGAGGAGGTGGCCGCCCTGGTCGGCCACCTGGCGGGCGACGAGGCCGGGTCCATCACCGCGCAGGCCCTCAACGTCTGCGGCGGGCTGGGCATTTACTGA", "orf_prot_sequence": "MTTSATPRTALVTGGTSGIGLAVVKTLAARGLRVFLCARSRENVDAVVKELRDQGLQVAGCEGDVRSRESVERVVRAAVDRFGPLSVLVNNAGRSGGGVTARIPDELWYDVIDTNLNSAFLVTREALTTGGLERAGVDGRIISIASTGGKQGVPLGAPYSASKAGLIGFTKALAKELAPTGVTVNAVCPGYVETPMAVRVRQAYAATWDTTEEDVLSRFNDKIPLGRYSTPEEVAALVGHLAGDEAGSITAQALNVCGGLGIY", "perc_identity": 22.95}}, "BGC0000254.1|Oxytetracycline_11 # 11443 # 12396 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.724": {"gnl|BL_ORD_ID|2767|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 11443, "orf_end": 12396, "orf_from": "BGC0000254.1|Oxytetracycline_11 ", "model_name": "Yrc-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3779", "ARO_accession": "3005035", "ARO_name": "Yrc-1", "ARO_category": {"43232": {"category_aro_accession": "3005034", "category_aro_cvterm_id": "43232", "category_aro_name": "YRC Beta-lactamase", "category_aro_description": "YRC is a ambler class C beta-lactamase from Yersinia ruckeri. It confers resistance penams and cephalosporins.", "category_aro_class_name": "AMR Gene Family"}, "35927": {"category_aro_accession": "0000008", "category_aro_cvterm_id": "35927", "category_aro_name": "cefoxitin", "category_aro_description": "Cefoxitin is a cephamycin antibiotic often grouped with the second generation cephalosporins. Cefoxitin is bactericidal and acts by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. Cefoxitin's 7-alpha-methoxy group and 3' leaving group make it a poor substrate for most beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35977": {"category_aro_accession": "0000060", "category_aro_cvterm_id": "35977", "category_aro_name": "ceftazidime", "category_aro_description": "Ceftazidime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, it has broad spectrum activity against Gram-positive and Gram-negative bacteria. Unlike most third-generation agents, it is active against Pseudomonas aeruginosa, however it has weaker activity against Gram-positive microorganisms and is not used for such infections.", "category_aro_class_name": "Antibiotic"}, "35980": {"category_aro_accession": "0000063", "category_aro_cvterm_id": "35980", "category_aro_name": "cefuroxime", "category_aro_description": "Cefuroxime is a second-generation cephalosporin antibiotic with increased stability with beta-lactamases than first-generation cephalosporins. Cefuroxime is active against Gram-positive organisms but less active against methicillin-resistant strains.", "category_aro_class_name": "Antibiotic"}, "35981": {"category_aro_accession": "0000064", "category_aro_cvterm_id": "35981", "category_aro_name": "amoxicillin", "category_aro_description": "Amoxicillin is a moderate-spectrum, bacteriolytic, beta-lactam antibiotic used to treat bacterial infections caused by susceptible microorganisms. A derivative of penicillin, it has a wider range of treatment but remains relatively ineffective against Gram-negative bacteria. It is commonly taken with clavulanic acid, a beta-lactamase inhibitor. Like other beta-lactams, amoxicillin interferes with the synthesis of peptidoglycan.", "category_aro_class_name": "Antibiotic"}, "37084": {"category_aro_accession": "3000704", "category_aro_cvterm_id": "37084", "category_aro_name": "cefalotin", "category_aro_description": "Cefalotin is a semisynthetic cephalosporin antibiotic activate against staphylococci. It is resistant to staphylococci beta-lactamases but hydrolyzed by enterobacterial beta-lactamases.", "category_aro_class_name": "Antibiotic"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.00237, "max_identities": 28, "bit_score": 26.5646, "cvterm_id": "42660", "query": "RAVHRTE--IDAPADRVYALIRDAAEWPR-HFTPT----VHVERAELDARSERLRIWATANG---EVKHWTSHRALDPEGQSVRFRQEVCS-----PPVAAMSGEWV", "match": "+AVH +   +DA A  V + I+D A W R + TP+      +++  L A+S  L++     G   E+ +W     +   G   +      S     PP  A++  WV", "sequence_from_db": "KAVHVSPGMLDAEAYGVKSSIKDMASWVRANMTPSEVKDASLQKGILLAQSRYLQVGDMYQGLGWEMLNWPMKATIAVGGSDNKVALAPLSAVEINPPAPALNSSWV", "sequence_from_broadstreet": "MMHKTLSCALLLVASGSTFATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYYFTWGMADVAGKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSKYWPALSGKQWEGISLLNLATYTAGGLPLQVPDNITDETSLQNYYETWQPQWAPGTKRFYSNASIGMFGKLAVKPSGMSFEQAMNKRVFQPLNLTHTWIHVPEREEKHYAWGYRDGKAVHVSPGMLDAEAYGVKSSIKDMASWVRANMTPSEVKDASLQKGILLAQSRYLQVGDMYQGLGWEMLNWPMKATIAVGGSDNKVALAPLSAVEINPPAPALNSSWVHKTGSTGGFGSYVAFIPEKNLGIVMLANKSYPNPARVEAAYRILEALSVE", "dna_sequence_from_broadstreet": "ATGATGCATAAAACCCTTTCCTGTGCGCTGCTGCTCGTCGCGTCAGGTTCCACGTTTGCCACGCCTCAAACGGAAAAAAAACTCAGTGGAATTGTTGATAACGTTGTTATTCCTTTGATGAAAGAACAGGCCATTCCCGGCATGGCGGTGGCGGTGATCTATCAGGGCCAACCTTACTACTTTACCTGGGGAATGGCTGATGTCGCAGGCAAACAGCCTGTTACGCAGCAGACGTTATTCGAGCTCGGCTCCGTGAGTAAAACCTTCACCGGCGTGCTGGGTGGCGATGCCATTGCTCGTGGGGAAATTAAACTTAGTGATCCAGTGAGTAAATACTGGCCAGCGCTTTCCGGGAAACAATGGGAAGGGATTAGTTTGCTGAATTTGGCAACCTATACCGCTGGTGGCTTGCCGCTCCAGGTACCGGATAACATTACTGATGAGACGTCATTGCAGAATTACTATGAAACCTGGCAGCCACAGTGGGCTCCGGGCACCAAGCGTTTTTATTCAAACGCCAGTATTGGGATGTTTGGCAAACTGGCGGTTAAACCTTCAGGCATGAGCTTTGAGCAGGCGATGAACAAACGCGTGTTCCAGCCATTGAATCTCACGCATACTTGGATACATGTTCCTGAACGTGAAGAAAAACACTATGCGTGGGGCTATCGCGATGGGAAAGCCGTTCATGTTTCTCCGGGGATGCTGGACGCTGAAGCCTACGGCGTGAAATCCTCAATAAAGGATATGGCAAGCTGGGTGCGGGCTAACATGACGCCTTCTGAAGTAAAAGATGCCTCGCTGCAAAAGGGGATTTTGCTTGCCCAGTCGCGGTACTTGCAAGTGGGTGACATGTATCAGGGGTTGGGCTGGGAAATGCTGAACTGGCCGATGAAAGCAACAATCGCGGTCGGCGGTAGCGATAATAAAGTCGCACTCGCGCCGCTAAGTGCGGTAGAAATTAACCCGCCAGCGCCAGCATTAAATAGCTCGTGGGTACATAAAACTGGCTCAACCGGCGGATTTGGAAGCTACGTGGCTTTCATTCCCGAGAAGAATCTCGGCATCGTGATGCTGGCGAACAAAAGTTATCCTAACCCTGCGCGTGTCGAAGCAGCTTACCGCATCCTTGAAGCTTTGTCCGTGGAATAG", "partial": "0", "query_start": 11464, "query_end": 11739, "hit_start": 678, "hit_end": 999, "orf_dna_sequence": "ATGCCCGCACCCACATCCCACCGCGCCGTGCACCGCACGGAGATCGACGCCCCGGCCGACCGGGTGTACGCCCTGATCAGGGACGCCGCCGAGTGGCCCCGGCACTTCACCCCGACCGTCCACGTCGAGCGCGCGGAGCTCGACGCCCGCAGCGAGCGGCTGCGGATCTGGGCCACCGCCAACGGCGAGGTCAAGCACTGGACGTCGCACCGCGCCCTGGACCCCGAAGGGCAGAGCGTCCGGTTCCGGCAGGAGGTGTGTTCGCCTCCGGTGGCCGCGATGAGCGGTGAATGGGTCCTCCGGGACCTTCCGGGCGGGCGGTGCGAGCTGACGCTGCACCACACGTTCGCCGCGGTGGACGACCGCCCGGAGGACGTGGAGTGGATCACCACCGCGACCGACCGCAACAGCCGTACCGAGCTGGCGAACATCAAGGCGCTGGCCGAGGCCGCGGGGTCCGACGCGGAGCTGCTGTTCTCGTTCGAGGACTCCGAGACGGTGCACGCCCCGGCCGAGGCGGTGTACGCGTTCCTCGCGGAGGCCGGGAAGTGGCCCGACCGGCTGCCGCACGTCTCCCGGCTCGACCTCACCGAGCCGTCCGACGGCGTGCAGGTGATGACCATGGTCACCCGGGCCAACGACGGCTCGGAGCACACGACGGAGTCGGTGCGGGTCTGCTTCCCCGACGAACTGCGCATCGTCTACAAGCAGATCGGCACCCCGCCGCTGATGACCCTGCACACCGGTGAGTGGTCGATACGGGACACCGGGGACGGGCTGCTCGTCACCTCCCAGCACACCATCCGGATCAACGAATCCGCCATCCCGGAGATCCTCGGCGCGGACGCCACGGCGGCCGACGCGCGGGCCCGGGTGCGCGCGGCGGTCGGCGGCAACAGCGCGGCCACCCTGGCCCTCGCCAAGCGCTTCGCGGAGGCCCCGCATGCCGCCTGA", "orf_prot_sequence": "MPAPTSHRAVHRTEIDAPADRVYALIRDAAEWPRHFTPTVHVERAELDARSERLRIWATANGEVKHWTSHRALDPEGQSVRFRQEVCSPPVAAMSGEWVLRDLPGGRCELTLHHTFAAVDDRPEDVEWITTATDRNSRTELANIKALAEAAGSDAELLFSFEDSETVHAPAEAVYAFLAEAGKWPDRLPHVSRLDLTEPSDGVQVMTMVTRANDGSEHTTESVRVCFPDELRIVYKQIGTPPLMTLHTGEWSIRDTGDGLLVTSQHTIRINESAIPEILGADATAADARARVRAAVGGNSAATLALAKRFAEAPHAA", "perc_identity": 26.17}}, "BGC0000254.1|Oxytetracycline_12 # 12386 # 14059 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.743": {"gnl|BL_ORD_ID|4834|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "Nocardia farcinica rox", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "5821", "ARO_accession": "3007210", "ARO_name": "Nocardia farcinica rox", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.45647e-43, "max_identities": 128, "bit_score": 157.147, "cvterm_id": "41346", "query": "QVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNY-GRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQT-WLNADVVLDADLSRDSNHLVHTGSGTVLL--VPFPDPGKWRAV--DTGYAGQGADP--ETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVAL", "match": " V+IAG GP GL LA EL    VR  V+++   P   SR+  +H R++E   Q GL +  +A G     F V   G         +   L TA+ + L + QV TE +L E    LG  I  G E+A      D V AEL  DG   ++   +LVG DG RSTVR  LG+   G+ T+   L ADV +D  +   +  +       +    VP  D G +R +    G +   A P  + ++R L  +     G    V  P W+S F    R+    R+GR  +AGDAAH+H P  GQG+N G+QDA+NL WKLA  + G A  +LLD+Y  ER PV   +L +TR    L++L", "sequence_from_db": "DVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGE---QFRV---GGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELA-DG--TRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGD-GFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFG----VHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSL", "sequence_from_broadstreet": "MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT", "dna_sequence_from_broadstreet": "GTGATCGATGTGATCATCGCGGGTGGCGGACCGACCGGCTTGATGCTGGCCGGCGAACTGCGCCTGCACGGTGTGCGCACGGTGGTACTGGAGAAGGAGCCCACCCCGAACCAGCACTCCCGCAGTCGGGGCCTGCACGCGCGCAGCATCGAGGTGATGGACCAGCGCGGGCTGCTGGAGCGGTTCCTCGCGCACGGCGAGCAGTTCCGGGTCGGCGGGTTCTTCGCCGGGCTGGCCGCCGAATGGCCCGCCGACCTGGACACCGCGCACTCCTACGTGCTCGCGATTCCCCAGGTCGTCACCGAGCGCCTGCTCACCGAGCACGCCACCGAACTCGGCGCCGAGATCCGCCGCGGCTGCGAAGTGGCCGGGTTGGATCAGGACGCGGACGGGGTGACCGCCGAGCTGGCCGACGGCACGCGGTTGCGCGCCCGGTACCTGGTCGGCTGCGACGGCGGACGCTCGACCGTGCGCCGTCTGCTCGGGGTCGACTTCCCCGGCGAACCCACCCGGGTCGAGACGTTGCTGGCCGACGTGCGGATCGACGTGCCGGTCGAGACACTGACCGCGGTGGTCGCCGAGGTGCGCAAGACCCAACTGCGATTCGGGGCCGTCCCGGCCGGCGACGGGTTCTTCCGGCTGATCGTGCCCGCGCAGGGCCTGTCCGCGGACCGCGCCGCACCCACCCTCGACGAGCTGAAGCGATGCCTGCACGCGACGGCGGGCACCGATTTCGGCGTGCACTCCCCGCGCTGGCTGTCCCGCTTCGGCGACGCCACCCGGCTCGCCGAGCGCTACCGCACCGGGCGGGTGCTGCTGGCGGGCGACGCCGCCCACATCCATCCGCCGACCGGCGGCCAGGGCCTCAATCTGGGCATCCAGGACGCCTTCAACCTCGGCTGGAAGCTCGCCGCCGCGATCGGCGGCTGGGCGCCGCCGGACCTGCTGGACAGCTACCACGACGAACGCCATCCGGTCGCCGCCGAGGTGCTGGACAACACCCGCGCCCAGATGACGCTGCTCTCCCTCGACCCCGGCCCGCGCGCGGTGCGCAGACTGATGGCGGAGCTGGTCGAATTCCCCGACGTGAACCGGCACCTGATCGAGAAGATCACCGCGATCGCCGTCCGCTACGACCTCGGCGACGGCCACGACCTGGTCGGTCGACGGCTGCGCGACATCCCGCTCACCGAAGGCCGCCTCTACGAGCGGATGCGCGGCGGCCGCGGGCTGCTGCTCGACCGGACCGGGCGGCTGTCGGTATCGGGCTGGTCCGACCGCGTCGACCACCTCGCCGACCCGGGCGCGGCGCTCGACGTCCCGGCGGCGCTGCTGCGCCCGGACGGGCACGTCGCGTGGGTGGGCGAGGACCAGGACGATCTGCTCGCCCACCTGCCCCGCTGGTTCGGCGCCGCCACCTGA", "partial": "0", "query_start": 12410, "query_end": 13450, "hit_start": 6, "hit_end": 1029, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 36.06}, "gnl|BL_ORD_ID|4833|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "Streptomyces venezuelae rox", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5820", "ARO_accession": "3007209", "ARO_name": "Streptomyces venezuelae rox", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.26164e-41, "max_identities": 124, "bit_score": 152.525, "cvterm_id": "36873", "query": "VLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNY-GRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTW-LNADVVLDADLSRDSNHLVHTGSGTVLLVPFP-DPGKWRAV--DTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVA", "match": "V++ G GP GL LA EL    VRV V+++   P   SRA  +H R++E   Q GL +  + RG  V        G       T++  RL TA+ + L + QV TE++L E    LG  I  G  L       D V  +L  DG  EQ+   ++VG DG RSTVR+ LG+   G+ ++   L  ++ + A     ++ +             P   G +R V    G A       T+       L    G    V  P W+S F    R     R  R F+AGDAAH+H P  GQG+N G+QDA+NL WKLA  V G A E LLDTY AER PV   +L +TR    L++", "sequence_from_db": "VIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVA------VGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLA-DG--EQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDE-FKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMS", "sequence_from_broadstreet": "MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG", "dna_sequence_from_broadstreet": "ATGTTTGACGTGATCGTTGTCGGTGGCGGTCCGACCGGCTTGATGCTGGCCGGCGAACTGCGGCTGCACGGCGTGCGCGTACTCGTGCTGGAGAAGGAGACGGAGCCGACGCGGCAGTCCCGCGCGCAGGGGCTGCACGTCCGCAGCATCGAGGTGATGGCCCAGCGCGGGCTCCTGGAGCGCTTCCTCGAACGCGGGCACACGGTCGCGGTCGGCGGCTTCTTCGCCGGTCTGGCGACCTCGTGGCCCGAGCGGCTGGACACCGCGCACTCGTACGTCCTCGCCGTCCCGCAGGTGATCACCGAGCAGCTGCTGGCCGAGCACGCCACCGCACTCGGAGCCGAGATCCGACGCGGCCGGGCACTGGTCGGTCTCCGCCAGGACGAGGACGGCGTGACGGTCGACCTGGCCGACGGCGAACAGCTGCGCGCACGGTACGTCGTCGGCTGCGACGGCGGCCGCAGCACGGTGCGCAAGCTGCTCGGCGTGGCGTTCCCCGGCGAGCCGTCCAGGGTCGAGACCCTGCTCGGCGAGATGGAGATGACCGCCTCCCAGGAGGAGTTGACCTCCGTCATGACCGAGGTCCGCAAGACCCAGCAGCGATTCGGCGCGATGCCCCTGGGGGACGGGGTCTTCCGCGTCGTCGTCCCCGCCGAGGGCGTCGCCGAGGACCGGACGGCCTCCCCGACCCTCGACGAGTTCAAGCAGCAGCTGCGGGCCCACGCCGGGACGGACTTCGGCGTGCACTCGCCCCGGTGGCTCTCCCGCTTCGGCGACGCCACCCGACAGGCCGAGCGCTACCGGGTCGACCGGGTGTTCCTCGCTGGCGACGCGGCGCACATCCACCCGCCGACCGGCGGGCAGGGCCTCAACCTCGGCATCCAGGACGCGTTCAACCTCGGCTGGAAGCTGGCCGCCGAGGTCGACGGCTGGGCGCCGGAGGGACTCCTCGACACGTACCACGCCGAGCGGCACCCGGTGGCCACCGAGGTCCTGGACAACACCCGCGCGCAGATCCAGCTGATGTCGACGGAGCCGGGGCCGCAGGCGGTCCGCCGGCTCATGGCGGAACTCGTGGAGTTCGAGAACGTCAACCGGTACCTGATCGAGAAGATCACGGCGATCTCGGTCCGTTACGACGTCGGCGAGGGCCACGAGCTGCTCGGCCGCCGGATGCGGGACCTCGCGCTCAAGCACGGCCGGCTCTACGAGCGGATGCACGAGGGCCGTGGACTGCTGCTCGACCAGACCGGCCGGCTCTCGGTCGCCGGGTGGGAGGACCGGGTCGACCACGTCGTCGAGGTCAGCGAGGAACTGGACGTGCCCGCGGTGCTGCTGCGTCCCGACGGCCACGTCGTGTGGGCGGGCGAGGACCAGCAGGAGCTGCTCACCCGGATGCCCGCGTGGTTCGGCGCCGCCACGGCCGGCTGA", "partial": "0", "query_start": 12413, "query_end": 13447, "hit_start": 9, "hit_end": 1029, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 35.43}, "gnl|BL_ORD_ID|729|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "iri", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "796", "ARO_accession": "3002884", "ARO_name": "iri", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36669": {"category_aro_accession": "3000530", "category_aro_cvterm_id": "36669", "category_aro_name": "rifabutin", "category_aro_description": "Rifabutin is a semisynthetic rifamycin used in tuberculosis therapy. It inhibits DNA-dependent RNA synthesis.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.83557e-38, "max_identities": 135, "bit_score": 144.436, "cvterm_id": "36897", "query": "VLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGR--PVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVL-DADLSRDSNHLVHT----------------GSGTV-LLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAG", "match": "V+I GAGP GL LA EL  + V V V+D+ + P    RAL +H R++E   Q GL D  +A GR  P+  F   +        DT +G       + L + Q   + IL E    +G  I+ G  +       D V AEL  DG +  +   +LVG DG RSTVR+   LR       +  +AD ++ + D++  ++ L                   G+G   ++VP  +    RA  T         + ++++L        G    V  P W+S F    R+    R  R F+AGDAAH+H P  GQG+N G+QDA+NL WKLA  + G A   LLDTY +ER PV   +L +TR    L++   A  P A+   +S L     +KR +  +I A    +++ Y      +G GD   G", "sequence_from_db": "VIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHG-------YVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELS-DGTT--LHARYLVGCDGGRSTVRK---LRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTL-------DDIKQQLLAIAGTDFG----VHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELIS--TAAGPQAVRRLISELMEFEDVKRYLTEKITA----ISIRY-----DFGEGDDLLG", "sequence_from_broadstreet": "MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA", "dna_sequence_from_broadstreet": "ATGAGTGACGTCATCATTGTCGGTGCTGGACCAACTGGATTGATGCTGGCAGGTGAGCTCCGGCTACAGGGCGTCGATGTCGTCGTCGTGGACAAGGACGAGGAGCCGACTCAGTTCGTCCGTGCCCTCGGCATCCATGTGCGCAGCATCGAAATCATGGAGCAGCGCGGGTTGCTGGACAAGTTCCTCGCGCACGGCCGCAAGTATCCGCTCGGTGGATTCTTCGCGGGGATCAGCAAACCGGCACCCGCGCACCTCGATACTGCGCACGGGTACGTCCTGGGCATACCTCAGCCCGAGATCGACAGGATTCTTGCCGAACATGCCACCGAAGTCGGCGCGGACATTCAGCGAGGGAAGCGCGTCGTCGCGATCCGTCAAGATACCGACAACGTCGCAGCGGAATTGTCCGACGGCACAACACTTCACGCGCGGTACCTTGTAGGCTGCGACGGCGGCCGCAGCACTGTTCGGAAGCTGAGATCGACGTCGGTATTCCCGGCGAGCCGTACGAGCGCCGACACGTTGATCGGCGAAATGGACGTGACCATGCCTGCTGATGAACTGGCCGCCGTTGTCGCCGAAATCCGGGAAACGCACAAACGATTCGGAGTCGGTCCCGCCGGCAACGGTGCTTTTCGTGTCGTGGTCCCTGCGGCCGAAGTTGCCGACGGTCGCGCAACACCGACCACCCTCGACGACATCAAACAACAGCTACTGGCCATTGCCGGTACCGACTTCGGTGTGCACTCGCCGCGGTGGCTCTCGCGCTTCGGCGACGCCACTCGTCTGGCGGACGACTACCGGCGCGACCGGGTGTTTCTCGCCGGCGACGCCGCACACATCCACCCACCGATGGGCGGTCAAGGTCTCAATCTCGGTGTGCAGGACGCCTTCAACCTCGGCTGGAAGCTCGCCGCCGAGATCAACGGCTGGGCACCGGTGGGCCTGCTCGACACGTACGAATCGGAACGGCGTCCGGTGGCTGCCGACGTGCTGGACAACACGCGCGCCCAGGCCGAGTTGATCTCCACCGCTGCCGGACCACAAGCGGTGCGGCGCTTGATCTCCGAGCTGATGGAATTCGAAGACGTCAAGCGCTATTTGACCGAGAAGATCACTGCGATCTCGATTCGCTACGATTTCGGCGAAGGCGACGACCTACTCGGTCGGAGGCTGCGGAACATCGCGTTGACGCGCGGCAACCTGTACGACCTGATGCGATCCGGCCGCGGACTTCTTCTCGACCAGGGTGGCCAACTGTCCGTCGATGGTTGGAGCGATCGCGCCGACCATATCGTTGACACAAGCACTGAATTGGAAGCTCCGGCTGTCCTGCTTCGGCCGGACGGTCATGTGGCATGGATCGGGGATGCGCAGGCGGAGTTGGATACTCAGCTGTCCACATGGTTCGGCCGGTCGGCGAGGGACCGCGCGTGA", "partial": "0", "query_start": 12413, "query_end": 13618, "hit_start": 9, "hit_end": 1170, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 31.99}, "gnl|BL_ORD_ID|4802|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(X6)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3797", "ARO_accession": "3005056", "ARO_name": "tet(X6)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000152521, "max_identities": 84, "bit_score": 41.2022, "cvterm_id": "43258", "query": "QVLIAGAGPVGLTLAHELTRRRVRVRVIDR-ADGPA-TTSRALAVHPRT-LEACHQMGLADALVARGRPVVHFTVHLRGRQLI--------RFDT---NYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSR------------DSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLA----GSLARGLGRPVAVSEPTWVSVFRVQQRMI----------TAMRSGR---CFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVG", "match": "++ I GAGPVGLT+A  L +  V + V +R  D  A      L +H  +  EA  + GL         P+    V  +G  L         RFD    N   L T     ++L+ ++ + ++            W  +L    P  D+    L  + +S + T   ++ A+G  S VR     + V D T+        + AD+ +            + N L+    G +L   F +P    A+  G + +  D    + R+      S+   L +  +  +  +  + R+    +           + +S R     + GDAAH+  P +GQG+N+G+ DA  L+  L +  + ++ EE ++ Y  +    G", "sequence_from_db": "KITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRT-----ILLNSLQNDTVI------------WDRKLVTLEP--DKEKWILTFEDKSSE-TADLVIIANGGMSKVR-----KFVTD-TEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLL---FANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTN-GKFNSIEEAIENYEQQMFAYG", "sequence_from_broadstreet": "MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL", "dna_sequence_from_broadstreet": "ATGACTTTACTAAAACATAAAAAAATTACAATAATTGGTGCCGGGCCTGTTGGATTAACAATGGCGAGATTGTTACAGCAAAACGGCGTGGACATTACAGTTTACGAGAGAGACAAAGACCAAGATGCAAGGATTTTTGGTGGGACACTTGATCTGCACAGGGATTCGGGACAGGAAGCAATGAAAAGAGCGGGATTGTTACAAACTTATTATGACTTAGCTTTACCAATGGGTGTAAATATTGTTGATGAAAAGGGCAATATTTTAACCACAAAAAATGTAAGACCCGAAAATCGTTTTGACAATCCTGAAATAAACAGAAATGACTTAAGGACTATCCTATTAAATAGTTTACAAAATGATACCGTCATTTGGGATAGAAAACTTGTTACCCTTGAACCTGATAAGGAGAAGTGGATACTAACTTTTGAGGATAAATCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCGGAGGTGAACTGTCCTGGATTTTTTCAGCTTTGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAGCAAAACGCGGGTAGATTTTCAAGACAGAAATAGTGTCGTTGATTTTCTCCTGAAAAAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTTTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGATAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGTGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTGCTTATGGAAGAGAAGCACAGGCAGAATCAATAATAAACGAAACGGAAATGTTCAGCCTCGACTTTTCTTTCCAAAAACTAATGAATCTATAA", "partial": "0", "query_start": 12410, "query_end": 13402, "hit_start": 21, "hit_end": 1053, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 22.46}, "gnl|BL_ORD_ID|763|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(X)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "776", "ARO_accession": "3000205", "ARO_name": "tet(X)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35986": {"category_aro_accession": "0000069", "category_aro_cvterm_id": "35986", "category_aro_name": "doxycycline", "category_aro_description": "Doxycycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36667": {"category_aro_accession": "3000528", "category_aro_cvterm_id": "36667", "category_aro_name": "chlortetracycline", "category_aro_description": "Chlortetracycline was an early, first-generation tetracycline antibiotic developed in the 1940's. It inhibits bacterial protein synthesis by binding to the 30S subunit of bacterial ribosomes, preventing the aminoacyl-tRNA from binding to the ribosome.", "category_aro_class_name": "Antibiotic"}, "37011": {"category_aro_accession": "3000667", "category_aro_cvterm_id": "37011", "category_aro_name": "demeclocycline", "category_aro_description": "Demeclocycline is a tetracycline analog with 7-chloro and 6-methyl groups. Due to its fast absorption and slow excretion, it maintains higher effective blood levels compared to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00134398, "max_identities": 21, "bit_score": 38.1206, "cvterm_id": "35916", "query": "VAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVG", "match": "+ GDAAH+  P +GQG+N+G+ DA  L+  LAD  + ++ EE +  Y  +    G", "sequence_from_db": "MIGDAAHLMPPFAGQGVNSGLVDALILSDNLAD-GKFNSIEEAVKNYEQQMFMYG", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATAAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGCGGGATGTCCAAGGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCAGAGATAAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCATCTCACCAAGGTAATTTATTATTTGCTAACCCCAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAATTGATTCATACGACGTTGTCATTTGTAGGATTGGCTACACGGATATTTCCTTTAGAAAAGCCTTGGAAAAGCAAGCGCCCATTACCCATAACAATGATTGGGGATGCCGCACATTTGATGCCGCCTTTTGCAGGGCAGGGAGTAAATAGTGGGTTGGTGGATGCCTTGATATTGTCTGATAATCTAGCCGATGGAAAATTTAATAGCATTGAAGAGGCTGTTAAAAATTATGAACAGCAAATGTTTATGTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 13238, "query_end": 13402, "hit_start": 921, "hit_end": 1083, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 38.18}, "gnl|BL_ORD_ID|763|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(X)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "776", "ARO_accession": "3000205", "ARO_name": "tet(X)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35986": {"category_aro_accession": "0000069", "category_aro_cvterm_id": "35986", "category_aro_name": "doxycycline", "category_aro_description": "Doxycycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36667": {"category_aro_accession": "3000528", "category_aro_cvterm_id": "36667", "category_aro_name": "chlortetracycline", "category_aro_description": "Chlortetracycline was an early, first-generation tetracycline antibiotic developed in the 1940's. It inhibits bacterial protein synthesis by binding to the 30S subunit of bacterial ribosomes, preventing the aminoacyl-tRNA from binding to the ribosome.", "category_aro_class_name": "Antibiotic"}, "37011": {"category_aro_accession": "3000667", "category_aro_cvterm_id": "37011", "category_aro_name": "demeclocycline", "category_aro_description": "Demeclocycline is a tetracycline analog with 7-chloro and 6-methyl groups. Due to its fast absorption and slow excretion, it maintains higher effective blood levels compared to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.00185, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "35916", "query": "QVLIAGAGPVGLTLAHELTRRRVRVRVIDRAD", "match": " V I G GPVGLT+A  L +  + V V +R +", "sequence_from_db": "NVAIIGGGPVGLTMAKLLQQNGIDVSVYERDN", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATAAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGCGGGATGTCCAAGGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCAGAGATAAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCATCTCACCAAGGTAATTTATTATTTGCTAACCCCAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAATTGATTCATACGACGTTGTCATTTGTAGGATTGGCTACACGGATATTTCCTTTAGAAAAGCCTTGGAAAAGCAAGCGCCCATTACCCATAACAATGATTGGGGATGCCGCACATTTGATGCCGCCTTTTGCAGGGCAGGGAGTAAATAGTGGGTTGGTGGATGCCTTGATATTGTCTGATAATCTAGCCGATGGAAAATTTAATAGCATTGAAGAGGCTGTTAAAAATTATGAACAGCAAATGTTTATGTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 12410, "query_end": 12505, "hit_start": 51, "hit_end": 147, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 43.75}, "gnl|BL_ORD_ID|2802|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(X5)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3798", "ARO_accession": "3005057", "ARO_name": "tet(X5)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00209453, "max_identities": 81, "bit_score": 37.7354, "cvterm_id": "36787", "query": "QVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPA--TTSRALAVHPRT-LEACHQMGLADALVARGRPVVHFTVHLRGRQLI--------RFDT---NYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSR------------DSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLA----GSLARGLGRPVAVSEPTWVSVFRVQQRMI----------TAMRSGR---CFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVG", "match": " V I G GPVGLT+A  L +  + V V +R +          L +H  +  EA  + GL         P+       +G  L         RFD    N   L T     ++L+ ++ + ++            W  +L    P  D+    L  + +S + T   ++ A+G  S VR     + V D T+        + AD+ +            + N L+    G +L   F +P    A+  G + +  D    + R+      S+   L +  +  +  +  + R+    +           + +S R     + GDAAH+  P +GQG+N+G+ DA  L+  L +  + ++ EE ++ Y  +    G", "sequence_from_db": "NVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVRPENRFDNPEINRNDLRT-----ILLNSLQNDTVI------------WDRKLVTLEP--DKEKWILTFEDKSSE-TADLVIIANGGMSKVR-----KFVTD-TEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLL---FANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTN-GKFNSIEEAIENYEQQMFAYG", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAGACCCGAAAATCGTTTTGACAATCCTGAAATAAACAGAAATGACTTAAGGACTATCCTATTAAATAGTTTACAAAATGATACCGTCATTTGGGATAGAAAACTTGTTACCCTTGAACCTGATAAGGAGAAGTGGATACTAACTTTTGAGGATAAATCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCGGAGGTGAACTGTCCTGGATTTTTTCAGCTTTGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAGCAAAACGCGGGTAGATTTTCAAGACAGAAATAGTGTCGTTGATTTTCTCCTGAAAAAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTTTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGATAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGTGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTGCTTATGGAAGAGAAGCACAGGCAGAATCAATAATAAACGAAACGGAAATGTTCAGCCTCGACTTTTCTTTCCAAAAACTAATGAATCTATAA", "partial": "0", "query_start": 12410, "query_end": 13402, "hit_start": 51, "hit_end": 1083, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 21.66}, "gnl|BL_ORD_ID|4801|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(X3)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "760", "model_id": "3401", "ARO_accession": "3004719", "ARO_name": "tet(X3)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00214991, "max_identities": 17, "bit_score": 37.7354, "cvterm_id": "35507", "query": "VAGDAAHVHSPASGQGMNTGMQDAYNLAWKLAD", "match": "+ GDAAH+ SP +GQG+NTG+ DA  L+  L +", "sequence_from_db": "MIGDAAHLMSPFAGQGVNTGLLDALILSENLTN", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGTGGAATGTCGAAAATAAGGAGCTTTGTTACCGACACGCAAGTTGAAGAAACCGGTACTTTCAACATCCAAGCTGATATTCTTCAACCGGAAATAAACTGTCCCGGATTTTTTCAGCTATGCAACGGCAACCGATTAATGGCGGGACATCAGGGCATTTTATTGTTTGCCAATCCCAATAATAATGGTGCATTGTATTTAGGAATTAGTTTTAAAACGCCCGATGAATGGAAAAATAAAATTCCCTTAGATTTTCAGGACAGAAACAGCGTTGCCGATTTTTTATTGAAAAGATTTTCCAAATGGAGTGAAGTTTACAAACAATTAATACGTTCGGTATCAACATTTCAATGCTTGCCCACAAGGAAATTTCCTTTGAACAATGATTGGAAAAGTAACCGTCCATTACCCATAACAATGATTGGCGATGCTGCTCATTTGATGTCGCCTTTTGCAGGACAGGGTGTAAATACGGGATTATTGGATGCTTTGATATTGTCTGAAAACCTTACAAACGGAGAATTTACAAGTATTGAAAATGCCATCGAAAACTACGAACAACAAATGTTTGTTTATGCAAAAGATACGCAGGACGAATCGACAGAAAACGAAACCGAAATGTTTAGTCCCAATTTTTCGTTTCAAAAATTATTGAATCTATAA", "partial": "0", "query_start": 13238, "query_end": 13336, "hit_start": 921, "hit_end": 1020, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 51.52}, "gnl|BL_ORD_ID|4801|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(X3)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "760", "model_id": "3401", "ARO_accession": "3004719", "ARO_name": "tet(X3)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.902965, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "35507", "query": "QVLIAGAGPVGLTLAHELTRRRVRVRVIDRAD", "match": " V I G GPVGLT+A  L +  + V V +R +", "sequence_from_db": "NVAIIGGGPVGLTMAKLLQQNGIDVSVYERDN", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGTGGAATGTCGAAAATAAGGAGCTTTGTTACCGACACGCAAGTTGAAGAAACCGGTACTTTCAACATCCAAGCTGATATTCTTCAACCGGAAATAAACTGTCCCGGATTTTTTCAGCTATGCAACGGCAACCGATTAATGGCGGGACATCAGGGCATTTTATTGTTTGCCAATCCCAATAATAATGGTGCATTGTATTTAGGAATTAGTTTTAAAACGCCCGATGAATGGAAAAATAAAATTCCCTTAGATTTTCAGGACAGAAACAGCGTTGCCGATTTTTTATTGAAAAGATTTTCCAAATGGAGTGAAGTTTACAAACAATTAATACGTTCGGTATCAACATTTCAATGCTTGCCCACAAGGAAATTTCCTTTGAACAATGATTGGAAAAGTAACCGTCCATTACCCATAACAATGATTGGCGATGCTGCTCATTTGATGTCGCCTTTTGCAGGACAGGGTGTAAATACGGGATTATTGGATGCTTTGATATTGTCTGAAAACCTTACAAACGGAGAATTTACAAGTATTGAAAATGCCATCGAAAACTACGAACAACAAATGTTTGTTTATGCAAAAGATACGCAGGACGAATCGACAGAAAACGAAACCGAAATGTTTAGTCCCAATTTTTCGTTTCAAAAATTATTGAATCTATAA", "partial": "0", "query_start": 12410, "query_end": 12505, "hit_start": 51, "hit_end": 147, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 43.75}, "gnl|BL_ORD_ID|2698|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(52)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3289", "ARO_accession": "3004587", "ARO_name": "tet(52)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00284697, "max_identities": 50, "bit_score": 37.3502, "cvterm_id": "36791", "query": "RDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLN-----ADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRA-VDTGYAGQGA----DPETVRRRLAGSLARGLGRPV-----AVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKL", "match": "+DGR+E   +  ++GADG  ST R     R+V D  +  LN       V    +    +N  V   +   LL    D  +  A V   + GQ        E+ +RR+     +  G         +S+          Q ++ +   GR  + GDAA+  SP SGQG N  +  AY LA +L", "sequence_from_db": "KDGRTEHFDL--VIGADGLHSTTR-----RIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGEL", "sequence_from_broadstreet": "MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH", "dna_sequence_from_broadstreet": "ATGTCTAATGTGAATAAAATTCTCGTCATCGGGGCTGGCATTGCTGGCCCCGCGGCTTGTTATTGGTTAAGAAGATTCGGATTTTCTCCCGTCCTCGTAGAAAGATCTGCCAGTTTACGAAAAGGCGGTCATGCACTGGACGTTCGAGGTGTTGCAATAGACCTCGTCAAAAGAATGGGTATTTATCAGAAAATATATAATATGCGCACTCAGCTGGAGTTTGGGCGGCATGTTGACCCCGAAGGGAATACGCTTCATGAAGAGAAGGGCGAAAGATTTGGCTTTAGGGAAGGTCAAGATGTTGAAATTATCCGCAGTGATTTGGTCGAGATATTGATAGATTCCATTGAAGGCGTCCCCCTTCAGTTCAATCAAACGATTGAGAGCGTTAAACAGACTGATGCTGTTGTCGAAGTTCAATTTAAAGATGGCAGAACCGAACACTTCGATTTGGTTATCGGGGCTGACGGCTTGCACTCAACAACAAGACGTATCGTATTTGATAAACATGAATATAAATTAAATGACCTTGGTGCTTACTTTAGTGTTTTCAGTATTCCAAATTATCTAAATTTGAATAACACCGAAGTTCAGTGCGAAGCTAATCAAAAACTGTTATCTATAACGAGCGACAAGAACCGCAAGATGGCTGAGGTCGCATTCTCATTTCGTGGCCAGAATGTTTTGAATAATGTTCGTGATGAAAGCGAGCAACGGCGAGTCCTACGCGACACTTTTCAAGACTTTGGCTGGGAAGCACCAAGAATACTTGAACTGATGTCAGATAGTGATGATTTTTATTCTGATTCATTCACTCAGGTAATAATGAAATCATGGACTAAAGGTCGAGTTGCATTATTGGGAGATGCTGCGTACAGCGCGTCGCCAATATCGGGGCAAGGTAATAATCTGGCCCTGGTCGGCGCTTATGTTTTGGCAGGAGAACTAAAACAGGCAGGCGGCAATTATAAGCGGGCATTTGATCGTTATAATGAAATATTACGTCCATTTATTGAAGCTAATCAAAAATTGGGAGTCTTGGTTAACGAATCGTTTCTTGTTCGCGATGAAGTCTCTAAAGAGGTTGCGGAAGAACGGTCAAATAATATTATGGAACAGGTAAAAATCGCATCGAACATGATTGTGTTGCAGGATTACGCCAATCCGCACTGA", "partial": "0", "query_start": 12830, "query_end": 13330, "hit_start": 423, "hit_end": 948, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 27.47}, "gnl|BL_ORD_ID|2277|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(X4)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3402", "ARO_accession": "3004720", "ARO_name": "tet(X4)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0030328, "max_identities": 19, "bit_score": 37.3502, "cvterm_id": "35914", "query": "VAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVG", "match": "+ GDAAH+  P +GQG+N+G+ DA  L+  L +  + ++ EE ++ Y  +    G", "sequence_from_db": "MIGDAAHLMPPFAGQGVNSGLMDALILSDNLTN-GKFNSIEEAIENYEQQMFIYG", "sequence_from_broadstreet": "MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGAGCAATAAAGAAAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCATCCAGAGGTGAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTGTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGGTAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGCGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTATCTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 13238, "query_end": 13402, "hit_start": 912, "hit_end": 1074, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 34.55}, "gnl|BL_ORD_ID|2277|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(X4)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3402", "ARO_accession": "3004720", "ARO_name": "tet(X4)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.893041, "max_identities": 14, "bit_score": 29.261, "cvterm_id": "35914", "query": "QVLIAGAGPVGLTLAHELTRRRVRVRVIDRAD", "match": " V I G GPVGLT+A  L +  + V V +R +", "sequence_from_db": "NVAIIGGGPVGLTMAKLLQQNGIDVSVYERDN", "sequence_from_broadstreet": "MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGAGCAATAAAGAAAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCATCCAGAGGTGAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTGTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGGTAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGCGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTATCTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 12410, "query_end": 12505, "hit_start": 42, "hit_end": 138, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 43.75}, "gnl|BL_ORD_ID|4799|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(47)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3308", "ARO_accession": "3004613", "ARO_name": "tet(47)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0368379, "max_identities": 75, "bit_score": 33.8834, "cvterm_id": "36791", "query": "QVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPC--GDRVNAELRRDG----RSEQVTVPW---LVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDS-------NHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGAD------PETVRRRLAGSLARGLGRPVA-----VSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKL", "match": " +L+ GAG  G ++ + L R      +I+++        AL V    ++   +MG+ + +  R R  V F     GR +   DT    L           +    EI R  L      +E  ++  +  PC     +++  +RDG    R +   + +   ++GADG  ST R     R+V D  +  L     L A  S  S       NH          L+        +  +  +  +  +       E  ++R      +G G   +     +S+        V Q  + +   GR  + GDA +  SP SGQG N  +  AY LA +L", "sequence_from_db": "NILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNR-RTQVEF-----GRYM---DTQGNILHEEKGERFCYREGEDVEITRGDL------VEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLIIGADGLHSTTR-----RMVFDKDEYQLTN---LGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVSQVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGEL", "sequence_from_broadstreet": "MRCHFRCNLALPLLVFLNLSRAIKDYQTMSSINNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGERFCYREGEDVEITRGDLVEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLIIGADGLHSTTRRMVFDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVSQVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGELKQASDNYHQAFNRYNELLHPFIEANQKLGVLVNESFLVQDEVSKEVAEERSNKIMEEVKIVSNMISLPDYE", "dna_sequence_from_broadstreet": "ATGCGCTGTCATTTCCGATGTAATCTCGCGCTGCCGCTTCTTGTATTCCTCAATCTTAGTAGAGCAATAAAGGATTATCAAACAATGTCTTCTATAAATAATATTCTTGTAATAGGAGCTGGAATTGCTGGACCCTCAGTCTGCTATTGGTTAAAAAGATTTGGTTTTTCTCCCGTTTTAATTGAAAAGTCTGCCAATTTACGAAAAGGAGGGCATGCACTGGATGTTCGAGGTGTTGCAATCGACCTCGTCAAAAGAATGGGCATCTACGAAAAAATAGGCAATAGGCGCACTCAGGTGGAATTTGGACGATACATGGACACTCAAGGCAATATCTTGCATGAAGAAAAGGGTGAAAGATTTTGCTATAGAGAAGGTGAGGATGTTGAAATTACCCGCGGTGATTTAGTTGAGATATTGATAGATGCCATTGAAGGCGTTCCCTGCTATCTCAATCAATCGATTGACAGCATTAAACAGAGGGATGGCGATGTAGCCGTTCGATTTAAAGATGGCAAGATCGAGTATTACGATCTGATTATTGGCGCTGACGGCTTGCATTCAACAACAAGACGCATGGTTTTTGATAAAGATGAATATCAATTAACTAACCTTGGGGCGTACTTTAGCGTTTTTAGTATTCCAAATTATCTCAATTTGAATCACACCGAAATCCAGTTCGAGGCCAATCAAAAACTGATATCTATGACTAGCGACAAGAATCCTAAAATGGCTGAAGTCGCATTCATGTTCCGTGTACAGAATGTCTTGAATAATAGGCGCGATGAAAATGAGCAAAAGAGATTCCTACGCGACACTTTTCAAGGTTTTGGTTGGGAAACGTCGAAAATACTTGAACTGATGTCAGATAGTGATGATTTTTATTTTGATTCAGTCTCCCAAGTGAAAATGAAGTCATGGACTAAGGGTCGAGTTGCCTTATTGGGCGACGCGGGTTACTGCGCATCCCCAATATCTGGTCAAGGTAATAATCTGGCACTAGTTGGTGCTTATGTTTTGGCGGGAGAACTAAAACAGGCAAGCGACAATTATCACCAAGCATTTAATCGTTATAATGAATTGTTACATCCATTCATTGAAGCCAATCAAAAATTGGGAGTCTTGGTTAACGAGTCGTTTCTCGTTCAGGATGAAGTCTCAAAGGAAGTTGCGGAAGAACGATCAAATAAGATAATGGAAGAAGTAAAAATCGTCTCGAATATGATTTCGTTACCGGATTATGAATGA", "partial": "0", "query_start": 12410, "query_end": 13330, "hit_start": 99, "hit_end": 1032, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 22.46}, "gnl|BL_ORD_ID|2722|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(50)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3287", "ARO_accession": "3004584", "ARO_name": "tet(50)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0391482, "max_identities": 24, "bit_score": 33.4982, "cvterm_id": "36791", "query": "VQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLA----DVVRGHAR-EELL", "match": "+ Q  + +   GR  + GDAA+  SP SGQG N     AY LA +L     D ++   R  ELL", "sequence_from_db": "ITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELL", "sequence_from_broadstreet": "MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMGIYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIPCEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVSKEIAEARSNKILAMIKSVSNSINLPQYE", "dna_sequence_from_broadstreet": "ATGACTAAACATATAAAAATTCTTGTAATAGGGGTTGGGGTTGCGGGCCCTGCAGTCGCTTATTGGTTAAAAAGATTTGGGTTTTCTCCGGTCTTAATTGAAAAATCAGCTGCCGTTAGAAAAGGGGGCCAGGCACTTGATATTCGCGGCATAGCCACACATATCGCTAAAGAAATGGGCATTTACGACCAGATATGTAACATGCGGACTCAAATAAAGTGTGGACGTTATGTGGATGTAAAGGGTAATGTTTTGCATGAAGAACAAGGTGAAACCTTTGGTTTCCGGCAAGATGACGAAGTTGAGATTCTTCGTGGAGACCTAGTTGAAATTCTAATGAAAGCAATTGCAGATATACCTTGTGAATTCAAACAATCCGTCATAAAAATTGAACAAAACGAAGATAGTGTAACTGTCACCTACAAAGATGGCAGAGTTGAAAATTATGACCTTGTGATCGCTGCCGATGGTATTCATTCTGCTACCAGGGGAATGGTTTTTAGTAAAAATGAATATCAGTTGATTAATCTCGGCTCCTACGTCAGCGCATTTACCATCCCAAATTATCTCGGTTTGGATCACATGGAACTCCTATGTGAATCAAATCATAAACTGGTTACTCTACAAAGCGACAGCCAAGCTGACAAAGCCATGGCGGGATTTATGTTCCGTTCAAAACATGTATTAGAAGATATTCGTGATGAGCAAGAACAAAAACATTTCTTACACGCCAGTTTTCAAAATTTCGGTTGGGAAACACAAAATATTTTAAATCGAATGCCAGAAAGCGATGACTTTTATTTTGACGCGATTACTCAAATCAAAATGAAAAGCTGGACTAAAGGCCGTATAGCCTTAATCGGCGATGCCGCTTATTGCCCCTCACCTTTATCAGGTCAGGGGAATAATTTAGCTTTTGTTGGCGCTTATATTTTGGCGGGTGAATTGAAAAAGGCTGATGGTGATTATATACAAGCATTTACCCGATATAACGAATTGCTACATCCCTTTGTTGAGGCTAACCAACAATTTGGTGTGTGGGTAAGCGAATCCTTTCTCCTAAAAGATGATGAAGTCTCTAAAGAGATTGCGGAAGCCCGTTCTAATAAAATTTTGGCAATGATAAAGTCAGTCTCTAATTCAATAAACTTGCCACAATACGAATAA", "partial": "0", "query_start": 13193, "query_end": 13369, "hit_start": 810, "hit_end": 1002, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 37.5}, "gnl|BL_ORD_ID|4803|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(X1)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "650", "model_id": "3888", "ARO_accession": "3005166", "ARO_name": "tet(X1)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0504777, "max_identities": 16, "bit_score": 33.113, "cvterm_id": "39568", "query": "VSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLAD", "match": "+ +F + ++   + R     + GD AH+  P +GQG+N G+ DA  L+  L +", "sequence_from_db": "IKIFPLDKKPWKSNRPLPITLIGDTAHLMPPFAGQGVNIGLMDALILSENLTN", "sequence_from_broadstreet": "MANLLQQNGIDITVYERDENPKARVWGGTLDLHKNSGQEAMKKVGLLQTYYDLALPMGVNFADEKGNIIATRNPTLENKFDNPEINRNALRKMLLGSLKNDTVVWDRKSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFIIQGDIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKGLDFKPTKSVSEFLTNRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLIGDTAHLMPPFAGQGVNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTKNEIEMRNPSFTFQQLMNV", "dna_sequence_from_broadstreet": "ATGGCAAACTTGTTACAACAAAACGGTATTGACATTACCGTTTACGAAAGAGATGAAAACCCAAAAGCACGAGTTTGGGGCGGAACGCTTGACCTTCACAAAAATTCAGGACAAGAAGCAATGAAAAAAGTAGGATTGTTGCAAACCTACTATGATTTGGCGCTACCTATGGGCGTAAACTTTGCTGATGAGAAGGGTAACATTATAGCAACAAGAAACCCGACACTCGAAAATAAGTTTGACAACCCCGAAATAAATAGAAACGCGTTGCGAAAAATGTTGCTTGGCAGCTTGAAAAATGACACAGTTGTTTGGGATAGAAAATCTATTGGGCTTGAACAAGAAAACGGAAAATGGCTGCTACATTTTGAAAATAAGCCAACTGCATTGGCCGACTTTATTATTGTTTCCAATGGTGGAATGTCTAAAATAAGAAATTTTGTTTCAGATAATGAAGTCGAAGAAACAGGTACTTTTATTATTCAGGGCGACATTCCTGAACCAGAAACGAACTGCCCTGAATTTTATAAGTTGTGCAACAACAATAGACTAATGACCGCACATCAAGGGAATTTATTAGTTGCGAATCCATTTAACAACGGAATGTTAACTTACGGTGTCATTTTCAAAAAGCCTGAAGAATGGAATAATGGAAAAGGATTAGATTTTAAGCCCACAAAAAGCGTTTCCGAGTTCTTGACAAACAGGTTTTCAAATTGGAGCAATGAATACAAGGAGTTAATTCGTTCAACAACTTTTTTCGTTGGTTTAACAATAAAAATATTTCCGCTAGACAAAAAGCCTTGGAAGAGTAATCGTCCGTTACCCATAACTTTAATTGGCGACACAGCTCACCTAATGCCACCTTTTGCAGGGCAGGGCGTAAACATTGGACTAATGGACGCTTTGATTTTGTCAGAAAATCTTACAAACGGGAAATTTGGAACGATACAAAGTGCTATTGATGACTATGAACAACGAATGTTTGTTTACGCAACAGAAGCACAAGCGGACTCGACAAAGAATGAAATAGAAATGCGAAATCCGAGCTTTACTTTTCAACAGCTAATGAATGTATAA", "partial": "0", "query_start": 13178, "query_end": 13336, "hit_start": 774, "hit_end": 933, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 30.19}, "gnl|BL_ORD_ID|2723|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(51)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3288", "ARO_accession": "3004586", "ARO_name": "tet(51)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0749739, "max_identities": 44, "bit_score": 32.7278, "cvterm_id": "36791", "query": "RDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWL-NADVVLDADLSRDSNHLVHTG---SGTVLLVPFPDPGKWRAVDTGYAGQGAD------PETVRRRLAGSLARGLGRPVA-----VSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKL", "match": "+DGR+E   +  ++GADG  ST R     R+V D  +  L N      A    +  +L HT         L+        +   TG+  +  +       E  +RR      +  G   +     +S+          Q  + +   GR  + GDA +  SP  GQG N  +  AY  A +L", "sequence_from_db": "KDGRTELYDL--VIGADGLHSTTR-----RMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGEL", "sequence_from_broadstreet": "MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMGIYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVPCHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSNKIMQEIKIVSNMISLPNYE", "dna_sequence_from_broadstreet": "ATGCCTATCATAAATAAAATTCTGGTAATAGGAGCCGGCATTGCTGGACCCGCGGTTTGTTATTGGTTAAGAAGATTTGGCTTTTCTCCCATTTTAGTTGAAAGGTGTGCCAATTTACGAAAAGGAGGGCATGCTGTGGATATTCGAGGTGTTGCTATCGATCTTGCTAAAAGCATGGGTATTTATAAAAAAATATGCAATATGCGCACCCAGGTGGAATTAGGAAGGTATGTTGACGCCGAAGGTAATATCTTGCATGAAGAAAAAGGCGAAAGATTTGGCTTTAGGGAGGGTGATGATATTGAAATTCTCCGCGGTGATTTAGTTCAAATACTGATAGATGCCATGGGAGATGTTCCCTGTCATTTCAATCAATGGGTTGAGAGCATTAAGCAGAGGGATAATGATGTAGAGGTTCAATTTAAAGATGGTAGAACGGAACTTTACGATTTGGTTATCGGTGCTGATGGCTTGCATTCAACCACCAGAAGGATGGTTTTTGATAAGGATGAATATAAATTAACTAACCTTGGTGCATACTTTAGTGCTTTTAGTATTCCAAATTATCTTAATTTGAATCACACCGATGTGCAATTCGAGGCTAATCAAAAACTTATATCTATGGCTAGCGATAAGAACCCTAAAATTGCTATAACAGGATTCTGTTTCCGTGCACAGAATGTCTTGAATAATTTGCGCGATGAAAACGAGCAACGGAGATTTCTACGCGATACTTTTCAAGATTTTGGCTGGGAGACATCCAAAATACTTGAACTGATGTCAGATAGTAATGATTTTTATTTTGATTCATTCACTCAAGTGAAAATGAAGTCATGGACAAAAGGACGAGTTGCTTTGGTGGGCGATGCAGGTTACTGCGCATCCCCATTCCCTGGTCAAGGTAGTAATCAGGCACTGGTAGGTGCTTATATTTTTGCAGGAGAACTAAAACAGGCAGAAGGCAATTATCATCGAGCATTTAACCGTTATAATGAATTATTACAACCATTTGTTGAAGCCAATCAAAAATTTGGCGTCTTGGTTAACGAATCGTTTCTCGTTCGTGATGAAGTCTCTAAGGAGGTGGCAGAAGAAAGATCGAATAAGATTATGCAAGAGATAAAAATTGTATCGAATATGATTTCGTTGCCGAATTATGAATGA", "partial": "0", "query_start": 12830, "query_end": 13330, "hit_start": 423, "hit_end": 948, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 24.18}, "gnl|BL_ORD_ID|792|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(56)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "3302", "ARO_accession": "3004603", "ARO_name": "tet(56)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0848204, "max_identities": 18, "bit_score": 32.7278, "cvterm_id": "42547", "query": "VQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKL", "match": "+ Q  + +   GR  + GDA +  SP SGQG N     AY LA +L", "sequence_from_db": "ITQVKMNSWTKGRIALVGDAGYCPSPLSGQGNNLAFVGAYILAGEL", "sequence_from_broadstreet": "MSKNIKILVIGAGVAGPAVCYWLRRFGFSPVLIEKYASIRKGGQALDVRGIATHIAREMGIYDQICEMRTRIERGRFVDSSGKVLHEEQGEKFGFRQDDEVEILRGDLVEILMKTIADVPCYFNQSIISIEQNADNVTVIFMDGRIEQYDLVIAADGIHSAIRRMIFEKNEYQLIHLGAYLSTFTIPNYLGLSHIDLECEANNKLVSINSDNNPEIARAGFMFRSQHLLNDIRDEQEQKQFLRDTFRDFGWETQNILNRMPESNDFYFDAITQVKMNSWTKGRIALVGDAGYCPSPLSGQGNNLAFVGAYILAGELKVANGNYTRAFTRYNALLRSFVDANQKFGVWVSESFLVKDEVSKEIAEERSNKILAMIKSISNGITLPQYESS", "dna_sequence_from_broadstreet": "ATGTCTAAAAATATCAAAATTCTCGTCATTGGCGCTGGTGTAGCTGGCCCTGCTGTTTGTTATTGGCTAAGAAGGTTTGGTTTTTCTCCTGTTTTGATTGAAAAATATGCGTCTATTAGAAAAGGGGGTCAGGCACTGGATGTTCGTGGCATAGCAACTCATATCGCCAGAGAAATGGGTATCTATGATCAAATATGTGAGATGCGCACGCGAATAGAGCGCGGTCGCTTTGTAGACTCATCGGGTAAAGTGCTGCATGAAGAACAGGGTGAGAAATTCGGGTTTAGGCAAGATGACGAAGTCGAAATTCTCCGTGGTGATTTGGTTGAAATCCTGATGAAAACAATTGCTGATGTCCCTTGTTATTTCAATCAATCCATTATTAGCATTGAGCAGAATGCTGATAACGTTACCGTTATTTTCATGGATGGCAGGATTGAACAATATGATCTGGTGATCGCTGCAGATGGGATTCACTCTGCTATAAGGCGCATGATTTTTGAAAAAAATGAATATCAGTTAATTCACCTTGGCGCATATCTCAGTACATTTACCATTCCAAATTACCTTGGCTTGAGTCACATAGATCTGGAATGTGAGGCTAATAATAAATTAGTCTCAATAAATAGCGATAACAATCCTGAAATAGCAAGAGCAGGATTTATGTTCCGTTCCCAGCATCTCCTGAATGACATCCGTGATGAGCAGGAACAAAAGCAATTCCTACGTGATACTTTTCGCGATTTTGGCTGGGAAACACAAAATATTTTAAATCGAATGCCAGAAAGCAATGATTTTTATTTTGATGCGATTACGCAAGTAAAAATGAATAGTTGGACCAAAGGTCGAATAGCGCTTGTCGGTGATGCAGGCTATTGTCCTTCTCCGTTATCTGGCCAAGGGAATAATTTGGCATTCGTTGGAGCATATATACTGGCGGGAGAATTAAAAGTTGCTAATGGAAATTATACCCGAGCGTTTACTCGTTATAATGCACTGCTACGTTCCTTCGTTGATGCCAATCAAAAATTTGGTGTTTGGGTCAGTGAATCATTCCTTGTAAAAGATGAAGTTTCCAAGGAAATTGCAGAAGAACGCTCGAACAAAATCCTAGCCATGATAAAATCAATTTCGAATGGGATTACCTTACCTCAATATGAATCATCATAG", "partial": "0", "query_start": 13193, "query_end": 13330, "hit_start": 810, "hit_end": 948, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 39.13}, "gnl|BL_ORD_ID|2695|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(49)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3285", "ARO_accession": "3004582", "ARO_name": "tet(49)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.148762, "max_identities": 79, "bit_score": 31.9574, "cvterm_id": "36791", "query": "QVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGI-EW--GVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRE-----------RLGLRLVGDATQTWLN---ADVVLDAD-----LSRDSNHLVHTGSGTV----LLVPFPDPGKWRAV--DTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLA----DVVRGHAR-EELLDTYAAERIPVGGRLLSST", "match": "++L+ GAG  G T+ + L R      +I+R+       + L V    ++   +MG+ +  +   R  V    ++  R  I  +    R        + +++    EIL + + G+     +W  G++ +D     + V  + + DGR+E   +  ++GADG  S  R             LGL     +   +LN    +V  +A+     L+ D N  +   +       +L    D  + +    DT +   G +   +   ++ S          V   +W                GR  + GDA +  SP SGQG N  +  AY  A +L     +  R  +R  ELL ++      +G  +  ST", "sequence_from_db": "KILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMGIYEK-ICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVPCHFNQWIDGIKQSD-----NDVEVQFK-DGRTEHYGL--VIGADGLHSKTRRMVFNEDEYKLTNLGLYFSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQKFLRDT-FQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTK--------------GRVALLGDAGYSASPISGQGNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNEST", "sequence_from_broadstreet": "MSAINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMGIYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVPCHFNQWIDGIKQSDNDVEVQFKDGRTEHYGLVIGADGLHSKTRRMVFNEDEYKLTNLGLYFSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQKFLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQGNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNESTLVYGEVSQEVAEERSNKIMQEVEIAANMISLPNYE", "dna_sequence_from_broadstreet": "ATGTCTGCAATAAATAAAATTCTCGTAATAGGAGCCGGCATTGCTGGACCTACTGTTTGTTATTGGTTAAAAAGATTTGGCTTTTCTCCCACTCTAATTGAAAGGTCTTCCAAAATACGAAAAGGAGGGCAAGGATTGGATGTTCGGGGTGTTGCCATCGATATCGTTAAAAGAATGGGTATCTATGAGAAAATATGCAATATGCGCACCCAAGTGGAATTAGGACGGTATGTTGACGCCAGAGGCAATATCTTGCATGAAGAAAAAGGTGAAAGATTTGCCTTTAGGCAAGGTGAAGATGTTGAAATTAACCGCGGTGATTTAGTCGAAATACTGATACAGACTATTGAAGGTGTTCCCTGTCATTTCAATCAATGGATTGACGGTATTAAACAGAGTGATAATGATGTAGAAGTTCAATTTAAAGATGGTAGAACCGAACATTATGGCTTGGTTATTGGGGCTGATGGTTTACACTCAAAAACAAGACGTATGGTTTTCAATGAGGATGAATATAAATTAACTAACCTTGGTTTATATTTTAGCGTTTTTAGCATCCCAAATTATCTTAATTTGAACCACACCGAAGTTCAGTTCGAGGCCAATCAAAAACTTATATCTCTTACTAGTGATAAGAATCCTAAGATGGCTGAAGCCGCATTCTGCTTTCGTACACAAAATGTCTTAAATAATATTCGCGATGAAAATGAGCAACAGAAATTCCTACGCGATACTTTTCAAGATTTTGGCTGGGAAACGTCAAAAATACTTGAACTGATGTCTGATAGCGATAATTTTTATTTTGATTCAGTCACCCAGGTGGAAATGAAATCATGGACTAAAGGACGAGTGGCTTTGCTGGGAGATGCGGGTTACTCCGCATCTCCAATATCTGGTCAAGGTAATAATCTGGCACTAGTGGGAGCGTATGTTTTTGCAGGAGAACTAAAACAAGCAGGTGGCAATTATCATCGAGCATTTAGCCGTTATAATGAATTATTACACTCATTTGTTGAAGCCAATCAAAAATTGGGAATTTTGGTTAACGAATCAACTCTTGTTTATGGTGAAGTCTCTCAGGAGGTTGCAGAAGAAAGATCAAATAAGATTATGCAAGAGGTAGAAATCGCAGCGAATATGATTTCGTTACCTAATTATGAATAA", "partial": "0", "query_start": 12410, "query_end": 13423, "hit_start": 15, "hit_end": 1056, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 21.29}, "gnl|BL_ORD_ID|2727|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(55)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3293", "ARO_accession": "3004591", "ARO_name": "tet(55)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.187657, "max_identities": 26, "bit_score": 31.5722, "cvterm_id": "36791", "query": "VQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKL---ADVVRGHAR-EELLDTYAAERIPVG", "match": "+ Q  +     GR  + GDA +  SP SGQG +  +  AY LA +L    D V   AR  ELL  Y       G", "sequence_from_db": "IMQVKMKDWTKGRIALVGDAGYTPSPLSGQGTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFG", "sequence_from_broadstreet": "MPHTKKILVIGASIAGPALCYWLNHYGFQPTLVEKNQSTRKGGYAIDLRGIAVDVAKQMGIYDSVCAMRTSLQCVRYVDAAGNLLFEEHGEKGGFRQGDEVEIVRGDLVDILMKTITDIPCFYDHAIESLTQHDDHVTVQFKNGKTENYDLVIAADGLHSATRRMVFSKDDYHLRNLGCYISVFSIPNYLQLDHCETLLEAKQKLVSITSDKDSTKAFAGFMFRSSNSPNYIRDEASQKDFLRENFTNHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQGTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFGVWVSESFLADEPLSAEQAEERNNIVLGIMKKATHAIELPEY", "dna_sequence_from_broadstreet": "ATGCCCCACACCAAAAAAATCCTAGTCATAGGTGCAAGTATCGCCGGCCCAGCATTATGCTACTGGCTAAACCACTACGGCTTCCAACCCACCCTCGTAGAAAAAAACCAATCAACAAGAAAAGGCGGATATGCAATCGATCTCCGCGGCATAGCAGTGGATGTCGCCAAACAAATGGGAATCTACGACTCAGTCTGCGCCATGCGTACCAGTCTGCAGTGCGTCCGCTATGTTGATGCGGCAGGAAATTTACTATTCGAAGAGCACGGCGAAAAAGGCGGTTTCAGGCAAGGCGATGAAGTAGAAATCGTGCGTGGTGATTTAGTGGATATCTTAATGAAAACCATTACGGATATTCCTTGTTTTTATGATCATGCAATCGAAAGTTTGACCCAGCATGATGATCATGTCACCGTGCAATTTAAAAATGGCAAAACCGAAAATTATGATTTAGTGATAGCGGCTGATGGTTTGCATTCTGCTACACGTCGTATGGTTTTCAGTAAAGATGACTATCATTTGCGAAATCTTGGTTGTTACATCAGTGTGTTTAGCATACCTAATTATTTGCAGCTGGATCACTGCGAGACACTATTAGAAGCCAAGCAAAAATTGGTTTCTATTACCAGTGATAAAGATTCTACTAAGGCCTTCGCTGGTTTTATGTTTCGTTCCAGTAATAGTCCAAACTACATTCGTGATGAAGCATCACAAAAAGATTTTCTAAGAGAAAATTTCACAAATCACGGCTGGGAATCAAATAAGCTATTGTCACTGATGAATGATGCCAATGATTTTTATTTTGATGCGATTATGCAGGTTAAAATGAAAGACTGGACTAAAGGGCGTATCGCGTTAGTGGGTGATGCTGGTTATACACCTTCACCCTTATCAGGGCAGGGAACCAGCCTCGCTTTGGTTGGGGCTTATATATTGGCGGGTGAATTGAAAACAGCTACTGATCATGTTGCGGCTTTTGCTCGATATAATGAGTTATTGAAGCCTTATGTTGAGGCTAATCAGGCGTTTGGGGTTTGGGTTAGTGAATCGTTTTTGGCGGATGAGCCTTTGTCTGCAGAGCAGGCGGAAGAGCGGAATAATATTGTTTTAGGGATAATGAAAAAAGCCACGCATGCGATCGAGTTGCCGGAGTATTAA", "partial": "0", "query_start": 13193, "query_end": 13402, "hit_start": 810, "hit_end": 1032, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 35.14}, "gnl|BL_ORD_ID|2726|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(54)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3292", "ARO_accession": "3004590", "ARO_name": "tet(54)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.205215, "max_identities": 21, "bit_score": 31.187, "cvterm_id": "36791", "query": "SVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKL", "match": "SV +V+ R  T    G+  + GDA++  SP SGQG N  +  AY LA +L", "sequence_from_db": "SVTQVKMRSWT---KGQVALVGDASYSASPLSGQGNNLALVGAYILAGEL", "sequence_from_broadstreet": "MSTIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCHFNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQGNNLALVGAYILAGELKAAEGNYRLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKEVAEERSNRILQKVQIISNAIKLPEYE", "dna_sequence_from_broadstreet": "ATGTCTACTATAAAAAAAATTCTCGTGATAGGAGCCGGTATTGCCGGTACTGCAGTCTGTTATTGGTTACGAAGATTTGGTTTTTATCCTGTATTAATTGAAAAATCTGCGTGTATACGAAAAGGCGGCCAAGGTTTGGATATTCGTGGGGTTGCAATCGATATCGTTAAAAAAATGGTTATTTATGAGCAAATATGCAAGATGCGCACGCAGGTAGAATGTGGTCGCTATGTGGATGTCGTAGGCAAAACACTACATGAAGAAAAAGGTGAAAAATTTGCCTTTAGGCAAGATGAAGATGTTGAAATTCTCCGCGGTGATTTAATCGAGATCCTAATGAAAACCATTGACGATGTTCCCTGTCATTTTAATCAATCCATTGACAGTATTGAACAGAATGACGATGACGTCATAGTTTATTTCAAAGATGCCAGAGTTGAGCACTATGATTTGATTATTGGCGCTGATGGGATACACTCATCGATCAGGCGCATGGTATTTGACAAAGATGAATATAGATTAGTTAATCTTGCAGAGGCGTACTTCAGTATATTTAGCATTCCGAATTATCTCAATTTAAGCCACACGGAAGTGCAGTGTGAGACTAATGAAAAATTGGTATCTATCACTAGCGATAAAGATCCCAAGACGGCTCAAGTTGCATTTATGTTCCGTTCGCAACATGTCTGGAATAATCTTCGCGATGAACACGAACAGATGCAATTTTTGCGGGATATTTTTCATGACTTTGGTTGGGAGGCGCAAAAAATACTTGAACTAATGCCAAATAGCCATGATTTTTATTTTGATTCAGTTACACAGGTGAAAATGCGTTCCTGGACCAAAGGACAAGTTGCTTTAGTAGGTGATGCGAGTTACTCTGCATCTCCACTATCGGGTCAAGGTAATAATCTGGCTCTAGTTGGTGCTTATATTTTGGCAGGAGAACTAAAAGCAGCGGAAGGAAATTATAGGCTCGCATTTAATCGTTATAATGAATTATTACATCCCTTCGTTGAGGCTAATCAACAGCTTGGAGCTTGGGTTAGCGAATCGTTTCTTGTCCCAGATGCAGTATCCAAAGAAGTTGCAGAAGAACGCTCAAACAGAATCCTGCAAAAAGTACAAATCATATCGAATGCGATCAAGCTGCCTGAGTATGAATGA", "partial": "0", "query_start": 13181, "query_end": 13330, "hit_start": 810, "hit_end": 951, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 42.0}, "gnl|BL_ORD_ID|2720|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(48)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "800", "model_id": "3284", "ARO_accession": "3004581", "ARO_name": "tet(48)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.616857, "max_identities": 67, "bit_score": 29.6462, "cvterm_id": "36791", "query": "PQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVH-FTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPC--GDRVNAELRRDGRSEQVTVP--------WLVGADGSRSTVR------ERLGLRLVGDATQTWL--------NADVVLDAD-----LSRDSN-------HLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKL", "match": " +VL+ GAG  GL + + L        +I++++        + +    ++   +M + + + A    + H F V+  G  L+            + F     Q    EILRE L      IE   +     PC    R+   +++DG+  +VT           ++GADG  ST R      E   L   G  +  +          +++  DA+     +S D N        + H+  G  +     +  +       +   G +   + + +  S          +   +W                GR  + GD+ +  +  SGQG  T +  AY LA +L", "sequence_from_db": "KKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVE------EQGEKFGFR----QGEEVEILREDL------IEILKQAIKDIPCHFNQRIK-RIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIR---NEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTK--------------GRIALVGDSGYCSTALSGQGTTTALVGAYILAGEL", "sequence_from_broadstreet": "MTFLFKEFKGVFKMKKVLVVGAGVAGLAVCYWLKEFGFSPTLIEKSNALRKGGYGVDIFGIAVDIAKKMSVYEKICAMRTQLEHGFYVNADGHTLVEEQGEKFGFRQGEEVEILREDLIEILKQAIKDIPCHFNQRIKRIKQDGKHVEVTFKDNKTENYDLVIGADGVHSTTRAFTFDKEEYDLIDFGCYSAIFSLPNYLKLRQSEIAFDANQKFISVSSDKNPTIALASLMFHSNRGDNIRNEKDQKSFFKDAFIDLGWETNNLLQYMEESNDFYFDVATQIKMKSWTKGRIALVGDSGYCSTALSGQGTTTALVGAYILAGELKAANGNHITAFERYNMLLHPFVEANQELGAWINETFLLEDAVSKEAVEARTDNIIKKISAISNVIKLPEYSAYK", "dna_sequence_from_broadstreet": "ATGACATTCCTATTTAAGGAATTTAAAGGTGTGTTTAAAATGAAAAAAGTACTAGTGGTTGGTGCAGGGGTTGCTGGATTGGCAGTTTGTTATTGGCTAAAGGAGTTTGGGTTTTCGCCTACATTAATTGAAAAAAGTAATGCTTTAAGGAAGGGTGGTTATGGAGTAGATATCTTTGGTATTGCTGTTGATATTGCTAAAAAAATGAGCGTTTATGAAAAAATATGTGCTATGCGCACCCAGTTAGAACACGGGTTTTATGTGAATGCTGATGGTCATACATTAGTTGAAGAACAAGGGGAAAAATTTGGTTTCAGGCAGGGTGAGGAAGTCGAAATTCTCCGAGAAGATTTAATTGAAATCTTAAAGCAAGCTATTAAAGATATTCCATGCCATTTTAATCAACGTATAAAGCGGATTAAGCAGGATGGTAAACATGTTGAAGTTACTTTTAAGGATAATAAGACTGAAAATTATGATTTAGTTATTGGCGCTGACGGGGTACATTCAACCACTAGAGCTTTTACTTTTGATAAAGAAGAGTATGATCTAATTGATTTTGGATGTTATTCTGCAATATTTAGCCTCCCAAATTATTTAAAATTGAGGCAAAGCGAAATAGCTTTTGATGCGAACCAAAAATTCATTTCTGTCAGTAGCGATAAAAACCCTACTATAGCTCTTGCATCCCTTATGTTCCATTCTAATCGTGGAGACAACATTCGCAATGAGAAGGACCAGAAAAGTTTTTTTAAAGATGCTTTTATTGATCTTGGATGGGAGACAAATAATCTACTTCAGTACATGGAAGAAAGTAATGATTTCTATTTCGATGTTGCTACTCAGATTAAAATGAAATCATGGACAAAAGGAAGAATTGCGTTGGTGGGTGATTCAGGTTATTGTTCAACCGCATTGTCTGGGCAAGGCACCACTACAGCACTTGTTGGAGCTTATATTTTGGCAGGAGAATTAAAAGCTGCAAATGGAAACCATATAACTGCTTTTGAACGCTATAATATGTTGCTACATCCATTTGTTGAAGCTAATCAAGAACTAGGAGCATGGATTAATGAAACGTTTCTTTTAGAAGACGCAGTATCTAAAGAAGCAGTAGAAGCAAGAACAGACAATATCATAAAGAAAATCAGCGCCATCTCGAATGTAATTAAATTACCTGAGTATTCAGCCTATAAATAA", "partial": "0", "query_start": 12407, "query_end": 13330, "hit_start": 42, "hit_end": 975, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 19.42}, "gnl|BL_ORD_ID|1212|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "mdtC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1800", "model_id": "1315", "ARO_accession": "3000794", "ARO_name": "mdtC", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.29659, "max_identities": 15, "bit_score": 28.1054, "cvterm_id": "36849", "query": "GADPETVRRRLAGSLARGLGRPVAVSEPT", "match": "GA PET+   +A  L R LGR   VSE T", "sequence_from_db": "GASPETMASSVATPLERSLGRIAGVSEMT", "sequence_from_broadstreet": "MKFFALFIYRPVATILLSVAITLCGILGFRMLPVAPLPQVDFPVIIVSASLPGASPETMASSVATPLERSLGRIAGVSEMTSSSSLGSTRIILQFDFDRDINGAARDVQAAINAAQSLLPSGMPSRPTYRKANPSDAPIMILTLTSDTYSQGELYDFASTQLAPTISQIDGVGDVDVGGSSLPAVRVGLNPQALFNQGVSLDDVRTAVSNANVRKPQGALEDGTHRWQIQTNDELKTAAEYQPLIIHYNNGGAVRLGDVATVTDSVQDVRNAGMTNAKPAILLMIRKLPEANIIQTVDSIRAKLPELQETIPAAIDLQIAQDRSPTIRASLEEVEQTLIISVALVILVVFLFLRSGRATIIPAVSVPVSLIGTFAAMYLCGFSLNNLSLMALTIATGFVVDDAIVVLENIARHLEAGMKPLQAALQGTREVGFTVLSMSLSLVAVFLPLLLMGGLPGRLLREFAVTLSVAIGISLLVSLTLTPMMCGWMLKASKPREQKRLRGFGRMLVALQQGYGKSLKWVLNHTRLVGVVLLGTIALNIWLYISIPKTFFPEQDTGVLMGGIQADQSISFQAMRGKLQDFMKIIRDDPAVDNVTGFTGGSRVNSGMMFITLKPRDERSETAQQIIDRLRVKLAKEPGANLFLMAVQDIRVGGRQSNASYQYTLLSDDLAALREWEPKIRKKLATLPELADVNSDQQDNGAEMNLVYDRDTMARLGIDVQAANSLLNNAFGQRQISTIYQPMNQYKVVMEVDPRYTQDISALEKMFVINNEGKAIPLSYFAKWQPANAPLSVNHQGLSAASTISFNLPTGKSLSDASAAIDRAMTQLGVPSTVRGSFAGTAQVFQETMNSQVILIIAAIATVYIVLGILYESYVHPLTILSTLPSAGVGALLALELFNAPFSLIALIGIMLLIGIVKKNAIMMVDFALEAQRHGNLTPQEAIFQACLLRFRPIMMTTLAALFGALPLVLSGGDGSELRQPLGITIVGGLVMSQLLTLYTTPVVYLFFDRLRLRFSRKPKQTVTE", "dna_sequence_from_broadstreet": "GTGAAGTTTTTTGCCCTCTTCATTTACCGCCCGGTGGCGACGATTTTACTGTCGGTTGCCATTACCCTGTGCGGCATACTGGGCTTCCGTATGCTGCCGGTCGCCCCGCTGCCGCAGGTCGATTTTCCGGTGATTATCGTCAGCGCCTCGCTGCCCGGTGCGTCACCAGAAACAATGGCGTCTTCCGTTGCCACGCCGCTGGAGCGCTCACTTGGGCGCATTGCCGGAGTCAGTGAAATGACCTCCAGCAGTTCGCTCGGCAGCACGCGTATTATTTTGCAGTTTGATTTTGACCGGGATATCAACGGCGCAGCGCGTGATGTGCAGGCGGCGATCAACGCTGCACAAAGTTTGCTGCCCAGTGGGATGCCCAGCCGCCCGACCTATCGCAAAGCGAACCCGTCGGATGCGCCAATTATGATCCTCACGCTGACGTCCGATACTTATTCGCAGGGTGAACTGTACGATTTCGCCTCGACGCAGCTGGCTCCGACGATTTCGCAAATCGACGGTGTTGGTGATGTCGATGTCGGAGGCAGCTCACTGCCCGCCGTACGCGTCGGGCTGAATCCGCAGGCGCTGTTTAATCAGGGCGTGTCGCTGGACGACGTACGCACCGCCGTCAGCAATGCCAACGTGCGTAAACCGCAGGGCGCGCTGGAAGATGGCACTCACCGCTGGCAGATCCAGACCAATGATGAGCTAAAAACCGCCGCTGAATATCAGCCGTTGATTATTCACTACAACAACGGCGGCGCGGTTCGTCTGGGCGATGTGGCGACGGTGACCGACTCAGTGCAGGATGTGCGCAACGCCGGGATGACCAACGCCAAACCGGCTATTTTACTGATGATCCGCAAACTGCCGGAAGCCAATATTATCCAGACGGTTGACAGCATCCGGGCAAAATTACCGGAGTTGCAGGAAACCATTCCGGCGGCGATTGATCTGCAAATTGCCCAGGATCGCTCCCCCACCATTCGCGCCTCGCTGGAAGAAGTCGAGCAAACGCTGATTATCTCGGTGGCGCTGGTGATTCTGGTGGTGTTTTTATTCCTGCGCTCGGGTCGCGCCACTATTATTCCCGCCGTTTCGGTGCCGGTTTCGCTGATTGGTACGTTTGCGGCGATGTACCTGTGCGGATTCAGTCTCAATAACCTTTCGTTAATGGCGCTCACCATCGCTACTGGTTTCGTGGTGGATGACGCCATCGTGGTGCTGGAAAACATTGCACGTCATCTGGAAGCGGGAATGAAACCGTTGCAAGCCGCACTGCAAGGTACTCGCGAAGTCGGTTTTACGGTGCTGTCGATGAGTCTGTCACTGGTGGCGGTGTTCCTGCCGCTGCTGTTGATGGGCGGATTGCCGGGCCGACTGTTACGCGAATTTGCCGTGACGCTTTCTGTCGCCATTGGTATATCGTTGCTGGTTTCTCTGACATTAACGCCAATGATGTGTGGCTGGATGCTGAAAGCCAGCAAGCCGCGCGAGCAAAAGCGACTGCGTGGTTTTGGTCGCATGTTGGTAGCCCTGCAACAAGGCTACGGCAAGTCACTAAAATGGGTGCTCAATCATACCCGTCTGGTGGGCGTGGTGCTGCTTGGCACCATTGCGCTGAATATCTGGCTGTATATCTCGATCCCGAAAACCTTCTTCCCGGAGCAGGACACTGGCGTGTTGATGGGCGGGATTCAGGCGGATCAGAGTATTTCGTTTCAGGCGATGCGCGGTAAGTTGCAGGATTTCATGAAAATTATCCGTGACGATCCGGCAGTGGATAATGTCACCGGCTTTACAGGCGGTTCGCGAGTGAACAGCGGGATGATGTTTATCACCCTCAAGCCACGCGACGAACGCAGCGAAACGGCGCAGCAAATTATCGACCGTCTGCGCGTAAAACTGGCGAAAGAACCGGGGGCGAATCTGTTCCTGATGGCGGTACAGGATATTCGCGTTGGTGGGCGTCAGTCGAACGCCAGCTACCAGTACACGTTGTTATCCGACGACCTGGCGGCACTGCGAGAATGGGAGCCGAAAATCCGCAAAAAACTGGCGACGTTGCCGGAACTGGCGGACGTGAACTCCGATCAGCAGGATAACGGCGCGGAGATGAATCTGGTTTACGACCGCGACACCATGGCACGGCTGGGAATCGACGTACAAGCCGCCAACAGTCTGTTAAATAACGCCTTCGGTCAGCGGCAAATCTCGACCATTTACCAGCCGATGAACCAGTATAAAGTGGTGATGGAAGTGGATCCGCGCTATACCCAGGACATCAGTGCGCTGGAAAAAATGTTCGTTATCAATAACGAAGGCAAAGCGATCCCGCTGTCGTATTTCGCTAAATGGCAACCGGCGAATGCCCCACTATCGGTGAATCATCAGGGATTATCGGCGGCCTCGACCATTTCGTTTAACCTGCCGACCGGAAAATCGCTCTCGGACGCCAGTGCGGCGATCGATCGCGCAATGACCCAGCTTGGTGTGCCTTCGACGGTGCGCGGCAGTTTTGCCGGCACGGCGCAGGTGTTCCAGGAGACGATGAACTCGCAGGTGATCCTGATTATCGCCGCCATCGCCACGGTGTATATCGTGCTGGGTATCCTTTACGAGAGTTACGTACATCCGCTGACGATTCTCTCCACCCTGCCCTCGGCGGGCGTTGGAGCGCTGTTGGCGCTGGAGCTGTTCAATGCCCCGTTCAGCCTAATCGCCCTGATAGGGATCATGCTATTAATCGGCATCGTGAAGAAAAACGCCATTATGATGGTCGATTTTGCGCTTGAAGCCCAACGGCACGGTAACCTGACGCCGCAGGAAGCTATTTTCCAGGCCTGTCTGCTGCGTTTTCGCCCGATTATGATGACTACCCTGGCGGCGCTGTTTGGTGCGCTGCCGCTGGTATTGTCGGGCGGCGACGGCTCGGAGCTGCGGCAACCCCTGGGGATCACCATTGTCGGCGGACTGGTAATGAGCCAGCTCCTTACGCTGTATACCACGCCGGTGGTGTATCTCTTTTTCGACCGTCTGCGGCTGCGTTTTTCGCGTAAACCTAAACAAACGGTAACCGAGTAA", "partial": "0", "query_start": 13088, "query_end": 13174, "hit_start": 156, "hit_end": 243, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 51.72}, "gnl|BL_ORD_ID|2724|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "tet(53)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3290", "ARO_accession": "3004589", "ARO_name": "tet(53)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.55341, "max_identities": 16, "bit_score": 26.9498, "cvterm_id": "36791", "query": "QRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKL", "match": "Q  + +   GR  + GDA +  SP SGQG    +  AY  A +L", "sequence_from_db": "QVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGEL", "sequence_from_broadstreet": "MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE", "dna_sequence_from_broadstreet": "ATGTCTACTATAAATAAAATTCTCGTGATCGGAGCTGGTATTGCCGGACCCGCGGTTTGTTATTGGTTAAGAAGATTTGGCTTTTCTCCTGTCCTCATTGAAAAATTTGCCAATATACGAAAAGAAGGGCAGGCACTGGATTTTCGAGGCGTTGCGATCGACATCGTTAAAGGAATGAATATTTATGAGAAAATGTGCAATATGCACAAGCAGTTGGAGGTCGGGCGGTATGTGGACACAGAAGGCAATACCCTGCATGAAGAAAGAGGTGAAAGATTTTGCTTTAGACAAGGTGAAGACGTTGAAATTGCCCGCGGTGATTTCGCCGAAATACTGACGGGTGCCATTGAAGGTATTCCCTGTCATTTTAATCAAGTAATTGACAGCATTAAACAGAGTGACGATGATGTAAAAGTCCAGTTCAACGATGGCAGAGTCGAGCATTATGACTTGGTTATTGGTGCTGATGGCATATACTCGACAACGAGAGGTATGGTTTTTGATAAAGACGAATATAAATTAGTTAACCTTGGTGTGTGCTTTGGCGTATTTAGCATTCTGAATTATCTCAATTTGAGCCACACCGAAGTGCAGTGTGAGGCCAATCAAAAGCTGATATCTATCTGGAGCCACAAAAATCCCAAGATGGCTGAAGTTGCGTTTGTGTTCCGTACGCAGAATGTCTTGAATAACATTCGCAATAAAAACGAGCAGCAGCAACTCCTGCGTGATGCTTTTCAAGATTTTGGCTGGGAAGCATCAAAAATACTTGAGCTGATGACAGGTAGTGATGATTTTTATTTTGATTCAGCCACACAGGTAAAAATGAAATCGTGGACGAAAGGGCGGGTTGCTTTATTGGGTGATGCTGGTTACTCTGCATCTCCACTATCTGGTCAGGGTAATTATCTGGCACTGGTTGGCGCTTATATTTTTGCCGGAGAACTAAAAAAAGCAGATGGCAATTATACTCGTGCATTTAGTCGTTATAATGAATTATTACATCCACTCGTTGAAGCCTGTCACAAGTTGGGGGTCTTAGTTAGCGAATCGTTCCTCGTCCCAGATGAAGTCTCCAAAGAAGTTGCAGAAGAACGATCAAATAAGATTCTGCAAGAGGTGAAAATCGTATCGAATATGATTTCGTTGCCAGAGTATGAATGA", "partial": "0", "query_start": 13199, "query_end": 13330, "hit_start": 816, "hit_end": 948, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 36.36}, "gnl|BL_ORD_ID|2367|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 12386, "orf_end": 14059, "orf_from": "BGC0000254.1|Oxytetracycline_12 ", "model_name": "MuxC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1900", "model_id": "2720", "ARO_accession": "3004075", "ARO_name": "MuxC", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "36689": {"category_aro_accession": "3000550", "category_aro_cvterm_id": "36689", "category_aro_name": "aztreonam", "category_aro_description": "Aztreonam was the first monobactam discovered, and is greatly effective against Gram-negative bacteria while inactive against Gram-positive bacteria. Artreonam is a poor substrate for beta-lactamases, and may even act as an inhibitor. In Gram-negative bacteria, Aztreonam interferes with filamentation, inhibiting cell division and leading to cell death.", "category_aro_class_name": "Antibiotic"}, "37626": {"category_aro_accession": "3001227", "category_aro_cvterm_id": "37626", "category_aro_name": "kitasamycin", "category_aro_description": "Kitasamycin is a macrolide antibiotic and is produced by Streptoverticillium kitasatoense. The drug has antimicrobial activity against a wide spectrum of pathogens.", "category_aro_class_name": "Antibiotic"}, "40353": {"category_aro_accession": "3003701", "category_aro_cvterm_id": "40353", "category_aro_name": "rokitamycin", "category_aro_description": "Rokitamycin is a macrolide antibiotic. Synthesized from strains of Streptomyces kitasatoensis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.84842, "max_identities": 17, "bit_score": 26.5646, "cvterm_id": "36804", "query": "GTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSE", "match": "G + + P P+   + A+    +  GA PET+   +A  L R LGR   +SE", "sequence_from_db": "GLLPVAPLPNV-DFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISE", "sequence_from_broadstreet": "MSLSTPFIRRPVATTLLTLALLLAGTLSFGLLPVAPLPNVDFPAIVVSASLPGASPETMASSVATPLERSLGRIAGISEMTSSSSLGSTTVVLVFDLEKDIDGAAREVQAAINGAMSLLPSGMPNNPSYRKANPSDMPIMVLTLTSETQSRGEMYDLASTVLAPKLSQVQGVGQVSIGGSSLPAVRVDLNPDAMSQYGLSLDSVRTAIAAANSNGPKGAVEKDDKHWQVDANDQLRKAREYEPLVIHYNADNGAAVRLGDVAKVSDSVEDVRNAGFSDDLPAVLLIVTRQPGANIIEATDAIHAQLPVLQELLGPQVKLNVMDDRSPSIRASLEEAELTLLISVALVILVVFLFLRNGRATLIPSLAVPVSLIGTFAVMYLCDFSLNNLSLMALIIATGFVVDDAIVVVENIARRIEEGDPPIQAAITGARQVGFTVLSMTLSLVAVFIPLLLMGGLTGRLFREFAVTLSAAILVSLVVSLTLTPMLCARLLRPLKRPEGASLARRSDRFFAAFMLRYRASLGWALEHSRLMVVIMLACIAMNLWLFVVVPKGFLPQQDSGRLRGYAVADQSISFQSLSAKMGEYRKILSSDPAVENVVGFIGGGRWQSSNTGSFFVTLKPIGERDPVEKVLTRLRERIAKVPGAALYLNAGQDVRLGGRDSNAQYEFTLRSDDLTLLREWAPKVEAAMRKLPQLVDVNSDSQDKGVQTRLVIDRDRAATLGINVEMVDAVLNDSFGQRQVSTIFNPLNQYRVVMEVDQQYQQSPEILRQVQVIGNDGQRVPLSAFSHYEPSRAPLEVNHQGQFAATTLSFNLAPGAQIGPTREAIMQALEPLHIPVDVQTSFEGNAGAVQDTQNQMPWLILLALLAVYIVLGILYESYVHPLTILSTLPSAGVGALLALILCRSELSLIALIGIILLIGIVKKNAIMMIDFALEAERNHGLSPREAILEACMMRFRPIMMTTLAALLGALPLIFGIGGDAALRRPLGITIVGGLIGSQLLTLYTTPVVYLYLDRLRHWVNQKRGVRTDGALETPL", "dna_sequence_from_broadstreet": "ATGAGTCTGTCCACGCCCTTCATCCGCCGCCCGGTCGCCACCACGCTGCTGACCCTGGCGTTGCTGCTGGCCGGCACCCTGTCGTTCGGCCTGCTGCCGGTGGCGCCGCTGCCCAACGTCGATTTTCCGGCCATCGTGGTCAGCGCCAGCCTGCCGGGCGCCAGCCCGGAAACCATGGCCTCGTCGGTGGCCACGCCGCTGGAGCGCTCGCTGGGACGGATCGCCGGGATCAGCGAGATGACCTCCAGCAGTTCGCTGGGCTCGACCACCGTGGTGCTCGTGTTCGACCTGGAGAAGGACATCGACGGCGCCGCCCGCGAGGTGCAGGCGGCGATCAACGGCGCGATGAGCCTGCTGCCCAGCGGTATGCCGAACAATCCCAGCTACCGCAAGGCCAACCCCTCGGACATGCCGATCATGGTCCTCACCCTGACCTCGGAGACCCAGAGTCGCGGCGAGATGTACGACCTCGCCTCGACCGTGCTGGCGCCCAAGCTGTCGCAGGTGCAGGGGGTAGGGCAGGTGAGCATCGGCGGCAGCTCGCTGCCGGCGGTGCGGGTCGACCTCAACCCGGATGCCATGAGCCAGTACGGGCTGTCCCTGGACAGCGTGCGCACGGCCATCGCCGCGGCCAACAGCAACGGCCCCAAGGGCGCCGTCGAGAAGGACGACAAGCACTGGCAGGTGGACGCCAACGACCAGTTGCGCAAGGCCCGCGAGTACGAGCCGCTGGTGATCCACTACAACGCCGACAACGGCGCCGCGGTGCGCCTCGGCGACGTGGCCAAGGTCAGCGACTCGGTGGAGGACGTGCGCAACGCCGGCTTTTCCGACGACCTGCCGGCTGTGCTGCTAATCGTCACCCGCCAGCCCGGCGCCAACATCATCGAGGCCACCGACGCCATCCACGCGCAACTGCCGGTGTTGCAGGAACTGCTCGGGCCGCAGGTCAAGCTGAACGTGATGGACGATCGCAGCCCGTCGATCCGTGCGTCGCTGGAAGAGGCCGAGCTGACCCTGCTGATCTCGGTGGCGCTGGTGATCCTGGTGGTCTTCCTGTTCCTGCGCAACGGCCGCGCCACGCTGATCCCCAGCCTGGCGGTGCCGGTCTCGCTGATCGGCACCTTCGCGGTCATGTACCTGTGCGACTTCAGCCTGAACAACCTGTCGCTGATGGCGCTGATCATCGCCACCGGCTTCGTGGTGGATGACGCCATAGTGGTGGTGGAGAACATCGCCCGACGCATCGAGGAGGGCGATCCGCCGATCCAGGCGGCGATCACCGGCGCCCGCCAGGTCGGTTTCACCGTGCTGTCGATGACGCTCTCGCTGGTCGCGGTGTTCATCCCGCTGCTGCTCATGGGTGGCCTCACCGGACGGCTGTTCCGCGAGTTCGCGGTGACTCTCTCGGCGGCGATCCTGGTGTCCCTGGTGGTATCCCTGACCCTCACGCCGATGCTCTGCGCGCGTCTGCTGCGTCCGCTGAAACGGCCCGAAGGCGCTTCCCTGGCGCGGCGCAGCGATCGCTTCTTCGCCGCCTTCATGCTGCGCTACCGCGCCAGCCTGGGCTGGGCGCTGGAGCACTCGCGGCTGATGGTGGTGATCATGCTGGCCTGCATCGCCATGAACCTCTGGTTGTTCGTGGTGGTGCCCAAGGGCTTCCTCCCGCAGCAGGACTCCGGGCGCCTGCGCGGCTACGCGGTGGCCGACCAGAGCATCTCGTTCCAGTCCCTGAGCGCGAAGATGGGCGAGTACCGCAAGATCCTCTCTTCCGATCCGGCGGTGGAAAACGTGGTCGGCTTCATCGGTGGCGGCCGTTGGCAGTCGAGCAACACCGGTTCGTTCTTCGTCACTCTCAAGCCGATCGGCGAGCGCGACCCGGTGGAGAAGGTCCTCACCCGGCTGCGCGAGCGGATCGCCAAGGTGCCCGGCGCGGCGCTCTATCTCAACGCCGGCCAGGACGTGCGCCTGGGCGGCCGCGACAGCAACGCGCAGTACGAATTCACCCTGCGCAGCGACGACCTGACCCTGCTCCGCGAATGGGCGCCGAAGGTCGAGGCGGCGATGCGCAAGCTGCCGCAGCTGGTGGACGTCAACAGCGACTCCCAGGACAAGGGCGTGCAGACCCGCCTGGTGATCGACCGCGACCGCGCGGCGACCCTGGGGATCAACGTGGAAATGGTCGACGCGGTGCTCAACGACTCTTTCGGCCAGCGCCAGGTGTCGACCATCTTCAACCCGCTGAACCAGTACCGGGTGGTGATGGAGGTCGACCAGCAGTACCAGCAGAGCCCGGAGATCCTCCGCCAGGTCCAGGTGATCGGCAACGACGGCCAGCGCGTGCCGCTGTCCGCGTTCAGCCACTACGAACCGAGCCGGGCACCGCTGGAGGTCAACCACCAGGGCCAGTTCGCCGCCACCACGCTGTCCTTCAACCTGGCACCGGGCGCGCAGATCGGCCCGACCCGCGAGGCCATCATGCAGGCCCTGGAGCCGCTGCACATCCCGGTGGACGTGCAGACCAGCTTCGAGGGCAACGCCGGCGCGGTGCAGGACACGCAGAACCAGATGCCCTGGCTGATCCTCCTGGCGCTGCTGGCGGTGTACATCGTCCTCGGCATCCTCTACGAGAGCTACGTGCACCCGCTGACCATCCTCTCGACCCTGCCTTCGGCCGGGGTCGGCGCGCTGCTCGCGCTGATCCTCTGCCGCAGCGAGCTGAGCCTGATCGCGCTGATCGGCATCATCCTGCTGATCGGCATCGTCAAGAAGAACGCGATCATGATGATCGACTTCGCCCTGGAGGCCGAGCGCAACCACGGCCTGAGCCCGCGCGAGGCGATCCTCGAGGCCTGCATGATGCGCTTCCGGCCGATCATGATGACCACCCTGGCCGCCTTGCTCGGCGCCTTGCCGCTGATCTTCGGCATCGGCGGCGACGCCGCGCTGCGCCGGCCGCTGGGCATCACCATCGTCGGCGGGCTGATCGGCAGCCAGTTGCTGACCCTGTACACCACCCCGGTGGTCTACCTCTATCTCGACCGCCTGCGCCACTGGGTCAACCAGAAACGCGGCGTACGCACGGACGGTGCGCTGGAGACACCCCTATGA", "partial": "0", "query_start": 13016, "query_end": 13168, "hit_start": 87, "hit_end": 237, "orf_dna_sequence": "ATGCCGCCTGAGGCGGACGGCCCGCAGGTGCTGATCGCCGGCGCCGGGCCCGTCGGCCTGACCCTGGCGCACGAGCTGACCCGCCGGCGCGTCCGCGTCCGGGTCATCGACCGGGCGGACGGCCCGGCGACCACCAGCCGGGCGCTGGCCGTGCATCCGCGCACCCTGGAGGCGTGCCACCAGATGGGCCTGGCGGACGCCCTGGTGGCGCGGGGCCGGCCGGTCGTCCACTTCACCGTGCACCTGCGCGGCCGGCAGCTGATCCGCTTCGACACCAACTACGGCAGGCTGCCCACGGCGTACCCGTTCAGCCTGATGCTCGACCAGGTCCGTACGGAGGAGATCCTGCGCGAGCGCCTGGCCGGGCTGGGCGTCGGGATCGAGTGGGGCGTGGAACTGGCGGACTGCGCGCCCTGCGGGGACCGGGTCAACGCCGAACTGCGCCGTGACGGCCGCTCCGAACAGGTCACCGTGCCCTGGCTGGTGGGCGCGGACGGCTCGCGCAGCACCGTACGCGAGCGGCTGGGGCTGCGGCTGGTCGGCGACGCGACGCAGACCTGGCTCAACGCGGACGTGGTCCTGGACGCCGACCTGTCCCGCGACAGCAACCACCTGGTGCACACCGGTTCCGGGACGGTGCTGCTGGTGCCGTTCCCCGACCCCGGCAAGTGGCGTGCGGTGGACACCGGGTACGCAGGTCAGGGAGCCGATCCGGAGACGGTACGGCGCCGCCTCGCCGGGTCCCTGGCGCGCGGTCTCGGGCGTCCGGTGGCGGTCTCGGAGCCGACCTGGGTCTCCGTCTTCCGCGTACAGCAGCGCATGATCACCGCCATGCGCTCCGGCCGCTGCTTCGTGGCCGGGGACGCCGCGCACGTCCACAGCCCGGCCTCCGGCCAGGGCATGAACACCGGCATGCAGGACGCCTACAACCTGGCGTGGAAGCTGGCGGACGTGGTGCGCGGACACGCGCGGGAAGAGCTGCTGGACACCTACGCCGCCGAGCGCATCCCGGTGGGCGGCAGGCTGCTGTCCTCGACGCGCACGGCCACGGCCCTGGTGGCGCTGCGCAACGCCGTGGCGCCGGTGGCCATGCCCGTGGGCCTGTCCTTCCTCAAGGCGGTGCGCCCGCTCAAACGACGCGTCGAGCACCGGATCATGGCGGGAATGTCCGGCCTCGCCCTGCACTACGCGGACAGTCCGCTGACGTACGGCACGGGCGACGGGGCGGCAGGGGTACACCCCGGGCACCTGGTCGCGTGCACGGAACAGGACGTGGCGCGCCACCCCGGCCTCCGGGCGCTGCGGCAGGCGCTCACCGATCCCCGGTGGCTGCTTCTGCTGTTCGCTGATGATGGCGGCGCCGCGGAGCTGGCACTGCGGTACGGCCGGGCCGTACAGATACGCACCGTCATCCCTCACGAGGACGAAGACGGCCCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGCTGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACCACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCCGGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA", "orf_prot_sequence": "MPPEADGPQVLIAGAGPVGLTLAHELTRRRVRVRVIDRADGPATTSRALAVHPRTLEACHQMGLADALVARGRPVVHFTVHLRGRQLIRFDTNYGRLPTAYPFSLMLDQVRTEEILRERLAGLGVGIEWGVELADCAPCGDRVNAELRRDGRSEQVTVPWLVGADGSRSTVRERLGLRLVGDATQTWLNADVVLDADLSRDSNHLVHTGSGTVLLVPFPDPGKWRAVDTGYAGQGADPETVRRRLAGSLARGLGRPVAVSEPTWVSVFRVQQRMITAMRSGRCFVAGDAAHVHSPASGQGMNTGMQDAYNLAWKLADVVRGHAREELLDTYAAERIPVGGRLLSSTRTATALVALRNAVAPVAMPVGLSFLKAVRPLKRRVEHRIMAGMSGLALHYADSPLTYGTGDGAAGVHPGHLVACTEQDVARHPGLRALRQALTDPRWLLLLFADDGGAAELALRYGRAVQIRTVIPHEDEDGPALADPDDALRQTLGVPPGGWALIRPDGYLAAKGQRSGTTTLTARLQALHLLPEDTAPGAGDSAGRPAPDGTRRGVTTE", "perc_identity": 33.33}}, "BGC0000254.1|Oxytetracycline_13 # 14056 # 14835 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=CGCCG;rbs_spacer=15bp;gc_cont=0.742": {"gnl|BL_ORD_ID|2024|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14056, "orf_end": 14835, "orf_from": "BGC0000254.1|Oxytetracycline_13 ", "model_name": "VCC-1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "2227", "ARO_accession": "3003713", "ARO_name": "VCC-1", "ARO_category": {"41360": {"category_aro_accession": "3004196", "category_aro_cvterm_id": "41360", "category_aro_name": "VCC beta-lactamase", "category_aro_description": "VCC beta-lactamases are Class A beta-lactamases.", "category_aro_class_name": "AMR Gene Family"}, "35987": {"category_aro_accession": "0000070", "category_aro_cvterm_id": "35987", "category_aro_name": "ertapenem", "category_aro_description": "Ertapenem is a carbapenem antibiotic and is highly resistant to beta-lactamases like other carbapenems. It inhibits bacterial cell wall synthesis.", "category_aro_class_name": "Antibiotic"}, "35990": {"category_aro_accession": "0000073", "category_aro_cvterm_id": "35990", "category_aro_name": "meropenem", "category_aro_description": "Meropenem is an ultra-broad spectrum injectable antibiotic used to treat a wide variety of infections, including meningitis and pneumonia. It is a beta-lactam and belongs to the subgroup of carbapenem, similar to imipenem and ertapenem.", "category_aro_class_name": "Antibiotic"}, "36309": {"category_aro_accession": "3000170", "category_aro_cvterm_id": "36309", "category_aro_name": "imipenem", "category_aro_description": "Imipenem is a broad-spectrum antibiotic and is usually taken with cilastatin, which prevents hydrolysis of imipenem by renal dehydropeptidase-I. It is resistant to hydrolysis by most other beta-lactamases. Notable exceptions are the KPC beta-lactamases and Ambler Class B enzymes.", "category_aro_class_name": "Antibiotic"}, "36689": {"category_aro_accession": "3000550", "category_aro_cvterm_id": "36689", "category_aro_name": "aztreonam", "category_aro_description": "Aztreonam was the first monobactam discovered, and is greatly effective against Gram-negative bacteria while inactive against Gram-positive bacteria. Artreonam is a poor substrate for beta-lactamases, and may even act as an inhibitor. In Gram-negative bacteria, Aztreonam interferes with filamentation, inhibiting cell division and leading to cell death.", "category_aro_class_name": "Antibiotic"}, "36984": {"category_aro_accession": "3000640", "category_aro_cvterm_id": "36984", "category_aro_name": "doripenem", "category_aro_description": "Doripenem is a carbapenem with a broad range of activity against Gram-positive and Gram-negative bacteria, and along with meropenem, it is the most active beta-lactam antibiotic against Pseudomonas aeruginosa. It inhibits bacterial cell wall synthesis.", "category_aro_class_name": "Antibiotic"}, "35923": {"category_aro_accession": "0000004", "category_aro_cvterm_id": "35923", "category_aro_name": "monobactam", "category_aro_description": "Monobactams are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Unlike penams and cephems, monobactams do not have any ring fused to its four-member lactam structure. Monobactam antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.30804, "max_identities": 15, "bit_score": 26.5646, "cvterm_id": "36789", "query": "AAERQLSEEGGKVRLMRADIGRPAGVVRLLEDIRRTHGRLD", "match": "AA  Q S+ G    LM   I  P G+ + +  I  T  RLD", "sequence_from_db": "AATLQYSDNGAANLLMEKYIKGPEGMTQFMNSIGDTKFRLD", "sequence_from_broadstreet": "MKRIAMYVALSISTSTAFADEHNKNMADIEAAFEGRVGVYAINTGSGKAYSYRANERFPLCSSFKAFLAAAVLKMDQDSPGVLLEKVNYHNRTMEPHSPITEKFQSQGMAVGELAAATLQYSDNGAANLLMEKYIKGPEGMTQFMNSIGDTKFRLDRWELDLNSAIPGDERDTSTPKAVAESLNKLISNTVLDNYHQEIFKKWMIGNTTGDNRIRAAVPDGWVVGDKTGTCGKYGTANDHAFILQGNNAAPLILSIYTTRKGEHMKHDDEVIAKAARIAIENVK", "dna_sequence_from_broadstreet": "ATGAAACGTATTGCTATGTATGTTGCATTATCAATCTCTACTTCAACAGCTTTCGCTGATGAGCACAACAAAAATATGGCTGATATTGAAGCTGCTTTTGAGGGGCGTGTCGGTGTTTACGCAATAAACACTGGCAGCGGCAAGGCATATTCATATCGAGCTAACGAACGCTTCCCCTTATGTAGTTCATTTAAAGCATTTTTGGCGGCAGCAGTTTTAAAAATGGATCAAGATAGTCCTGGAGTCCTGCTTGAAAAAGTAAATTATCATAACAGAACTATGGAACCCCATTCACCCATAACAGAGAAATTTCAGTCACAAGGAATGGCCGTAGGGGAACTGGCTGCTGCAACACTTCAGTATAGTGATAATGGTGCTGCTAACCTTCTCATGGAGAAATATATAAAAGGACCAGAGGGCATGACTCAGTTCATGAACAGTATTGGTGATACTAAGTTTAGGTTGGACCGATGGGAGTTGGACCTTAATAGTGCTATACCTGGAGATGAACGTGACACATCAACACCGAAGGCCGTGGCAGAAAGTCTGAATAAGTTAATATCAAATACCGTCTTAGACAACTACCATCAAGAGATATTCAAAAAGTGGATGATCGGTAATACTACAGGAGATAATAGAATAAGAGCTGCTGTGCCTGATGGTTGGGTTGTCGGTGATAAAACGGGAACTTGCGGAAAGTATGGCACAGCAAACGATCATGCGTTTATTTTACAAGGTAATAATGCTGCCCCTCTGATTTTATCTATATATACAACCAGAAAGGGAGAACATATGAAGCATGATGATGAGGTGATTGCTAAAGCAGCTAGGATTGCAATAGAAAATGTAAAGTGA", "partial": "0", "query_start": 14230, "query_end": 14352, "hit_start": 345, "hit_end": 468, "orf_dna_sequence": "ATGACCAAGGAGGACACGCGTATGACAGCGATCAACGGCGCACCGGCGGCAGGCGGTTCGGTGGCACTGGTCATCGGCGGCACCCGCGGCATCGGGCTGGCCGCCGCCCGCAAACTGAGCGCGGCGGGCAGCGAGGTGCTGCTCAACTACGCGCACGACGAGGACGGCGCGCTGGCGGCCGAACGGCAGCTGTCCGAGGAGGGCGGCAAGGTACGGCTGATGCGCGCGGACATCGGCCGCCCCGCCGGTGTGGTGCGGCTGCTGGAGGACATCCGGCGCACCCACGGCCGGCTGGACGTCCTGGTGCACGCAGCCGGTTCCTTCCATCCGGCGCCGACCGCGTCCCCGCACATCGGCAAGTACCTGGGCGACGGCGCCGTGGCGGTCGGACCGCTGCTGTACGGGGCGGCGCGCCTGGGCACCCTGATGACCCCGGACACGGGCCGTATCGTCGCCGTCTCCAGCATCGGCGCCCGGACGGTCGTCCCCGGCTACGCGGGTCTGGGCATGGCCAAGGCGGCCTTGGAGACGCTGGTGCGGTACCTGGCGGTGGAACTCGCCGGGAAGGGCGTCGCGGTGAACGCGGTGGCCGCGGGCAAGATCGCCGACGGCGGTCCCGTACCGGCCCAGGTACTGGAGGGCCTGCTGCGGCGGACCCCGACGGGGCGGCTGGCGACTGCCGAAGAGGTGGCCGACGTGGTGGCGCTGCTGTGCCGCCCCGAGGCCGGCGGCCTGCACGGACAGGTGCTCACCGTGGACGGCGGGGCCTGCCTGCGGTAG", "orf_prot_sequence": "MTKEDTRMTAINGAPAAGGSVALVIGGTRGIGLAAARKLSAAGSEVLLNYAHDEDGALAAERQLSEEGGKVRLMRADIGRPAGVVRLLEDIRRTHGRLDVLVHAAGSFHPAPTASPHIGKYLGDGAVAVGPLLYGAARLGTLMTPDTGRIVAVSSIGARTVVPGYAGLGMAKAALETLVRYLAVELAGKGVAVNAVAAGKIADGGPVPAQVLEGLLRRTPTGRLATAEEVADVVALLCRPEAGGLHGQVLTVDGGACLR", "perc_identity": 36.59}, "gnl|BL_ORD_ID|1964|hsp_num:0": {"type_match": "Loose", "snp": {"original": "S", "change": "A", "position": 94}, "query_snp": {"original": "S", "change": "A", "position": 9}, "orf_strand": "+", "orf_start": 14056, "orf_end": 14835, "orf_from": "BGC0000254.1|Oxytetracycline_13 ", "model_name": "Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 500, "model_id": "1574", "ARO_accession": "3003393", "ARO_name": "Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid", "ARO_category": {"43060": {"category_aro_accession": "3004874", "category_aro_cvterm_id": "43060", "category_aro_name": "isoniazid resistant inhA", "category_aro_description": "Genes with mutations in inhA which confer resistance to isoniazid class antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.25031e-05, "bit_score": 42.743, "max_identities": 53, "cvterm_id": "39507", "query": "GRLDVLVHAAGSFHPAPTA--SPHIGKYLGDGAVAVGPLLYGAARLGTLMTPDT---GRIVAVSSIGARTVVPGYAGLGMAKAALETLVRYLAVELAGKGVAVNAVAAGKI-----------ADGGPVPAQVL---EGLLRRTPTG-RLATAEEVADVVALLCRPEAGGLHGQVLTVDGGA", "match": " +LD +VH+ G F P      +P       D +  +    Y  A +   + P     G IV +    +R + P Y  + +AK+ALE++ R++A E    GV  N VAAG I           A G    AQ+    EG  +R P G  +  A  VA  V  L         G ++  DGGA", "sequence_from_db": "NKLDGVVHSIG-FMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAM-PAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGA", "sequence_from_broadstreet": "MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL", "dna_sequence_from_broadstreet": "ATGACAGGACTGCTGGACGGCAAACGGATTCTGGTTAGCGGAATCATCACCGACTCGTCGATCGCGTTTCACATCGCACGGGTAGCCCAGGAGCAGGGCGCCCAGCTGGTGCTCACCGGGTTCGACCGGCTGCGGCTGATTCAGCGCATCACCGACCGGCTGCCGGCAAAGGCCCCGCTGCTCGAACTCGACGTGCAAAACGAGGAGCACCTGGCCAGCTTGGCCGGCCGGGTGACCGAGGCGATCGGGGCGGGCAACAAGCTCGACGGGGTGGTGCATTCGATTGGGTTCATGCCGCAGACCGGGATGGGCATCAACCCGTTCTTCGACGCGCCCTACGCGGATGTGTCCAAGGGCATCCACATCTCGGCGTATTCGTATGCTTCGATGGCCAAGGCGCTGCTGCCGATCATGAACCCCGGAGGTTCCATCGTCGGCATGGACTTCGACCCGAGCCGGGCGATGCCGGCCTACAACTGGATGACGGTCGCCAAGAGCGCGTTGGAGTCGGTCAACAGGTTCGTGGCGCGCGAGGCCGGCAAGTACGGTGTGCGTTCGAATCTCGTTGCCGCAGGCCCTATCCGGACGCTGGCGATGAGTGCGATCGTCGGCGGTGCGCTCGGCGAGGAGGCCGGCGCCCAGATCCAGCTGCTCGAGGAGGGCTGGGATCAGCGCGCTCCGATCGGCTGGAACATGAAGGATGCGACGCCGGTCGCCAAGACGGTGTGCGCGCTGCTGTCTGACTGGCTGCCGGCGACCACGGGTGACATCATCTACGCCGACGGCGGCGCGCACACCCAATTGCTCTAG", "partial": "0", "query_start": 14341, "query_end": 14823, "hit_start": 255, "hit_end": 792, "orf_dna_sequence": "ATGACCAAGGAGGACACGCGTATGACAGCGATCAACGGCGCACCGGCGGCAGGCGGTTCGGTGGCACTGGTCATCGGCGGCACCCGCGGCATCGGGCTGGCCGCCGCCCGCAAACTGAGCGCGGCGGGCAGCGAGGTGCTGCTCAACTACGCGCACGACGAGGACGGCGCGCTGGCGGCCGAACGGCAGCTGTCCGAGGAGGGCGGCAAGGTACGGCTGATGCGCGCGGACATCGGCCGCCCCGCCGGTGTGGTGCGGCTGCTGGAGGACATCCGGCGCACCCACGGCCGGCTGGACGTCCTGGTGCACGCAGCCGGTTCCTTCCATCCGGCGCCGACCGCGTCCCCGCACATCGGCAAGTACCTGGGCGACGGCGCCGTGGCGGTCGGACCGCTGCTGTACGGGGCGGCGCGCCTGGGCACCCTGATGACCCCGGACACGGGCCGTATCGTCGCCGTCTCCAGCATCGGCGCCCGGACGGTCGTCCCCGGCTACGCGGGTCTGGGCATGGCCAAGGCGGCCTTGGAGACGCTGGTGCGGTACCTGGCGGTGGAACTCGCCGGGAAGGGCGTCGCGGTGAACGCGGTGGCCGCGGGCAAGATCGCCGACGGCGGTCCCGTACCGGCCCAGGTACTGGAGGGCCTGCTGCGGCGGACCCCGACGGGGCGGCTGGCGACTGCCGAAGAGGTGGCCGACGTGGTGGCGCTGCTGTGCCGCCCCGAGGCCGGCGGCCTGCACGGACAGGTGCTCACCGTGGACGGCGGGGCCTGCCTGCGGTAG", "orf_prot_sequence": "MTKEDTRMTAINGAPAAGGSVALVIGGTRGIGLAAARKLSAAGSEVLLNYAHDEDGALAAERQLSEEGGKVRLMRADIGRPAGVVRLLEDIRRTHGRLDVLVHAAGSFHPAPTASPHIGKYLGDGAVAVGPLLYGAARLGTLMTPDTGRIVAVSSIGARTVVPGYAGLGMAKAALETLVRYLAVELAGKGVAVNAVAAGKIADGGPVPAQVLEGLLRRTPTGRLATAEEVADVVALLCRPEAGGLHGQVLTVDGGACLR", "perc_identity": 29.28}}, "BGC0000254.1|Oxytetracycline_14 # 14855 # 15628 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGCGC;rbs_spacer=15bp;gc_cont=0.711": {"gnl|BL_ORD_ID|3577|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14855, "orf_end": 15628, "orf_from": "BGC0000254.1|Oxytetracycline_14 ", "model_name": "GOB-33", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "4646", "ARO_accession": "3005682", "ARO_name": "GOB-33", "ARO_category": {"41376": {"category_aro_accession": "3004212", "category_aro_cvterm_id": "41376", "category_aro_name": "GOB beta-lactamase", "category_aro_description": "The GOB family of beta-lactamases have been discovered in the Elizabethkingia meningoseptica and are classified as subclass B3 beta-lactamase. They confer resistance to cephalosporins, penicillins, and carbapenems.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.06439, "max_identities": 22, "bit_score": 25.7942, "cvterm_id": "35506", "query": "IIDLSTTVDAGRWEVDPVEHEILTPAEGGRHMAEGMRRHHGIDFDPADLPDGELLSLDTLRLTTHTGTHVDAPSH", "match": "++D  T  DA ++  D  + ++L    GG+   E  +  +G  F P  +PD  L +LD ++L   T T +  P H", "sequence_from_db": "LMDFKTETDA-KFYADAADADVLRT--GGQSDYEMGK--YGATFKPI-IPDRTLKNLDKIKLGNTTLTMLHHPGH", "sequence_from_broadstreet": "MKRITTLLFLLVCFGWNAQVVKEPENTPKEWSQNYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGLAGSLSTIKENIAKLGFNYKDIKILLLTQAHYDHTGALMDFKTETDAKFYADAADADVLRTGGQSDYEMGKYGATFKPIIPDRTLKNLDKIKLGNTTLTMLHHPGHTKGSCSFVFDTNDGKRKYRVLIANMPSIIVDNKFSEVTEYPNIQSDYAYTFNAMKKLDFDIWVASHASQFDLHEKRKEGEPYNPKLFMDKQNYFQSLNNLEKSYLDKIKKDLQDK", "dna_sequence_from_broadstreet": "ATGAAAAGAATAACGACTTTACTTTTTCTGTTAGTATGTTTTGGATGGAATGCTCAGGTTGTAAAAGAGCCTGAAAATACACCAAAAGAATGGTCTCAGAATTATGAACCATTCAGGATAGCAGGTAACCTGTATTACGTAGGAACTTATGATCTGGCTTCTTACCTAATCGTTACAGATAAAGGAAATATTCTGATCAATACAGGACTAGCTGGCTCTCTTTCTACAATAAAAGAGAACATTGCTAAATTAGGATTCAATTATAAAGACATCAAGATTCTGCTTCTCACACAGGCTCATTATGACCATACAGGTGCGTTAATGGACTTTAAAACAGAAACAGATGCGAAATTTTATGCAGATGCTGCAGATGCAGATGTTCTGAGAACAGGCGGGCAGTCTGATTATGAAATGGGAAAATATGGTGCAACTTTTAAACCTATTATTCCGGATCGTACGTTAAAAAATCTGGATAAAATAAAATTAGGGAATACAACACTTACGATGCTCCATCATCCAGGACATACAAAAGGTTCCTGTAGTTTTGTATTTGATACAAACGATGGGAAAAGAAAATACAGAGTGCTTATAGCCAATATGCCTTCCATTATTGTTGATAATAAATTCTCTGAAGTTACAGAATATCCGAATATTCAGTCCGATTATGCTTATACCTTTAATGCGATGAAAAAGCTGGATTTTGATATTTGGGTAGCATCGCATGCAAGCCAGTTCGATCTGCATGAAAAACGCAAAGAAGGAGAGCCGTACAACCCAAAATTGTTTATGGATAAGCAAAACTATTTCCAAAGCCTTAATAATCTGGAGAAAAGCTATCTTGATAAAATTAAAAAAGATTTACAAGATAAATAA", "partial": "0", "query_start": 14861, "query_end": 15085, "hit_start": 318, "hit_end": 525, "orf_dna_sequence": "ATGCGCATCATCGATCTGTCGACAACCGTGGACGCCGGCCGGTGGGAGGTCGATCCGGTCGAACACGAAATCCTCACCCCGGCCGAGGGCGGCCGGCACATGGCCGAGGGGATGCGGCGCCACCACGGCATCGACTTCGACCCCGCCGACCTCCCGGACGGCGAACTGCTGTCCCTCGACACCCTGCGGCTGACCACCCACACCGGCACCCACGTCGACGCCCCGTCGCACTACGGGTCCCGCGCGCGCTACGGCACGCCGCGCCACATCGACCAGATGCCACTGGACTGGTTTCTGCGGCCGGGCCTCAAGCTCGACCTTACCGACGAGCCGGTGGGCGCCATCGGAGCCGACCGGATACGGCGGGCCCTCGACGAAGCGGGCCGCGACCCGCGTCCGTACGACATCGTGCTGCTGCACACCGGCGCGGACCGGCGGGCCGGAAAGCCGGAGTACTTCACCGAGTTCGCCGGCCTGGACGCCGCGGCGACCCACCTGCTGCTCGACTTCGGCGTCCGGGTCATCGGCACCGACGCCTTCAGCCTCGACGCCCCGTTCGGGCACATGATCAAGGAGTACCAGCGCACCGGCGACCGCGGTGTGCTGTGGCCCGCCCACTTCGTGGGACGGGAGCGCGAGTACTGCCAGATCGAGCGGCTGGACAACCTCGGCGCGCTGCCCGGACCGGACGGCTTCTTGGTCTCCTGCTTTCCGTTCAAGATCGCGGGAGCGGGGGCGGGGTGGACGCGGGCGGTGGCGGTGGTGGAGGAGTAG", "orf_prot_sequence": "MRIIDLSTTVDAGRWEVDPVEHEILTPAEGGRHMAEGMRRHHGIDFDPADLPDGELLSLDTLRLTTHTGTHVDAPSHYGSRARYGTPRHIDQMPLDWFLRPGLKLDLTDEPVGAIGADRIRRALDEAGRDPRPYDIVLLHTGADRRAGKPEYFTEFAGLDAAATHLLLDFGVRVIGTDAFSLDAPFGHMIKEYQRTGDRGVLWPAHFVGREREYCQIERLDNLGALPGPDGFLVSCFPFKIAGAGAGWTRAVAVVEE", "perc_identity": 29.33}, "gnl|BL_ORD_ID|757|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14855, "orf_end": 15628, "orf_from": "BGC0000254.1|Oxytetracycline_14 ", "model_name": "mdtB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1800", "model_id": "820", "ARO_accession": "3000793", "ARO_name": "mdtB", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "36250": {"category_aro_accession": "3000111", "category_aro_cvterm_id": "36250", "category_aro_name": "novobiocin", "category_aro_description": "Novobiocin is an aminocoumarin antibiotic produced by Streptomyces spheroides and Streptomyces niveus, and binds DNA gyrase subunit B inhibiting ATP-dependent DNA supercoiling.", "category_aro_class_name": "Antibiotic"}, "36242": {"category_aro_accession": "3000103", "category_aro_cvterm_id": "36242", "category_aro_name": "aminocoumarin antibiotic", "category_aro_description": "Aminocoumarin antibiotics bind DNA gyrase subunit B to inhibit ATP-dependent DNA supercoiling.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.77418, "max_identities": 15, "bit_score": 25.7942, "cvterm_id": "36849", "query": "LLSLDTLRLTTHTGTHVDAPSHYGSRARYG--TPRHIDQMPL", "match": "L +LDT+RLT+  G  V   S      R+   +  H+DQ P+", "sequence_from_db": "LAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPV", "sequence_from_broadstreet": "MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVKVTVLSDRTTNIRASVDDTQFELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALDTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGSTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALLIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPREAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLIVSQVLTLFTTPVIYLLFDRLALWTKSRFARHEEEA", "dna_sequence_from_broadstreet": "ATGCAGGTGTTACCCCCGAGCAGCACAGGCGGCCCGTCGCGCCTGTTTATTATGCGTCCTGTGGCCACCACGCTGCTGATGGTGGCGATCTTACTCGCCGGGATTATCGGTTATCGCGCCCTGCCCGTTTCGGCGCTGCCGGAAGTGGACTATCCGACCATTCAGGTGGTCACGCTCTACCCAGGTGCCAGCCCGGATGTCATGACCTCTGCCGTTACCGCGCCGCTAGAACGCCAGTTCGGGCAGATGTCTGGCCTGAAACAGATGTCGTCGCAAAGTTCCGGCGGTGCGTCAGTTATCACTTTGCAGTTCCAGCTAACATTACCGCTCGATGTCGCCGAGCAGGAAGTGCAGGCCGCGATTAACGCTGCGACCAACTTGTTGCCGAGCGATCTGCCTAACCCGCCGGTTTACAGCAAAGTGAACCCGGCAGATCCGCCGATCATGACGCTCGCCGTCACCTCAACCGCCATGCCGATGACGCAAGTGGAAGATATGGTGGAAACCCGCGTCGCGCAGAAAATCTCGCAGATTTCCGGCGTCGGCCTGGTGACGCTTTCCGGCGGTCAGCGTCCGGCTGTTCGCGTCAAACTTAACGCTCAGGCGATTGCCGCCCTCGGCCTGACCAGCGAAACCGTGCGCACCGCCATTACCGGCGCTAACGTTAACTCGGCAAAAGGTAGCCTCGACGGCCCTTCCCGTGCGGTCACGCTTTCCGCGAACGACCAGATGCAATCCGCCGAAGAGTATCGCCAGCTAATCATCGCCTACCAGAACGGCGCGCCAATTCGTCTGGGCGATGTCGCAACTGTAGAGCAAGGTGCAGAAAACAGCTGGCTCGGCGCGTGGGCGAACAAAGAACAGGCCATTGTGATGAATGTTCAGCGCCAGCCCGGTGCTAACATTATCTCCACCGCCGACAGCATTCGGCAGATGCTGCCACAGCTCACTGAGAGTCTGCCGAAATCGGTGAAGGTGACAGTGCTTTCCGATCGCACCACCAATATCCGCGCATCCGTCGATGATACTCAGTTTGAATTGATGATGGCTATCGCGCTGGTAGTCATGATTATCTACCTGTTTTTGCGCAATATTCCGGCGACCATCATTCCCGGTGTTGCTGTACCGCTGTCGTTAATCGGCACTTTCGCGGTTATGGTGTTTCTCGATTTTTCAATCAATAACCTGACACTGATGGCGTTAACTATCGCCACCGGATTCGTGGTCGATGACGCCATCGTGGTGATCGAAAACATTTCCCGCTATATCGAAAAAGGCGAAAAACCGTTGGCGGCGGCGCTCAAGGGCGCAGGTGAAATCGGCTTTACCATTATCTCGCTGACCTTCTCACTGATTGCGGTGTTGATCCCACTGCTGTTTATGGGCGATATCGTCGGGCGACTGTTCCGCGAATTTGCTATTACCCTGGCGGTAGCGATTTTGATCTCAGCGGTGGTGTCGCTGACCCTGACACCGATGATGTGCGCGCGGATGCTCAGCCAGGAGTCGTTGCGTAAACAGAACCGCTTCTCCCGTGCCTCGGAAAAAATGTTCGACAGGATAATCGCCGCCTATGGTCGTGGACTGGCGAAAGTGCTGAATCATCCGTGGCTGACCTTAAGCGTGGCACTCAGCACGCTGCTGCTTAGCGTGCTGCTGTGGGTGTTCATTCCGAAAGGTTTCTTCCCGGTACAGGACAATGGCATTATTCAGGGCACTTTGCAGGCACCGCAATCCAGCTCCTTTGCCAATATGGCCCAGCGACAACGCCAGGTCGCGGACGTGATTTTGCAGGATCCGGCAGTGCAAAGCCTGACCTCATTTGTTGGCGTTGATGGCACTAACCCGTCGCTGAACAGTGCACGTTTACAAATCAACCTCAAACCGTTGGATGAACGTGATGATCGGGTGCAAAAAGTCATCGCCCGTCTGCAAACGGCGGTAGATAAAGTGCCGGGCGTCGATCTCTTCCTGCAACCAACGCAGGATCTGACTATTGATACTCAGGTCAGCCGCACCCAGTACCAGTTTACCTTGCAGGCCACGTCACTGGATGCGCTCAGTACCTGGGTGCCACAGTTGATGGAAAAACTCCAGCAACTGCCACAGCTTTCTGATGTCTCCAGCGACTGGCAGGACAAAGGGCTGGTGGCGTATGTCAATGTTGATCGCGACAGCGCCAGCCGTCTGGGGATCAGCATGGCGGATGTCGATAACGCCCTGTACAACGCGTTTGGTCAGCGGCTGATTTCCACTATTTATACTCAGGCCAACCAGTATCGCGTGGTGCTGGAGCACAACACCGAAAATACCCCAGGCCTCGCGGCGCTGGATACCATTCGCCTGACCAGCAGCGACGGCGGCGTGGTGCCGCTAAGCTCAATTGCCAAAATTGAGCAGCGTTTTGCGCCGCTCTCCATCAACCATCTGGATCAGTTCCCGGTAACGACCATCTCCTTTAACGTGCCGGATAACTATTCGCTGGGCGATGCGGTGCAGGCGATTATGGACACCGAAAAGACGCTGAATCTGCCGGTGGATATCACCACGCAGTTCCAGGGCAGCACCCTCGCCTTCCAGTCGGCGCTGGGCAGCACTGTCTGGCTGATTGTCGCGGCGGTGGTGGCGATGTATATCGTGCTCGGCATTCTGTACGAGAGCTTTATTCACCCGATCACCATTCTCTCGACGCTACCCACCGCAGGGGTTGGCGCACTGCTGGCGTTGCTGATTGCTGGTAGCGAACTGGATGTGATTGCGATTATCGGCATTATTTTGCTGATCGGTATCGTGAAGAAGAACGCCATCATGATGATCGACTTCGCGCTGGCTGCTGAGCGCGAGCAAGGCATGTCGCCGCGCGAGGCAATCTACCAGGCTTGTCTGTTGCGTTTTCGTCCGATCCTGATGACCACTCTGGCGGCTCTGCTTGGCGCGCTGCCGCTGATGTTGAGTACCGGGGTCGGCGCGGAACTGCGTCGTCCGTTAGGTATCGGCATGGTCGGCGGTCTGATTGTCAGCCAGGTGCTGACGCTGTTTACCACGCCGGTGATTTATTTGCTGTTCGACCGCCTGGCATTGTGGACCAAAAGCCGCTTTGCCCGTCATGAAGAGGAGGCGTAA", "partial": "0", "query_start": 15020, "query_end": 15139, "hit_start": 2319, "hit_end": 2445, "orf_dna_sequence": "ATGCGCATCATCGATCTGTCGACAACCGTGGACGCCGGCCGGTGGGAGGTCGATCCGGTCGAACACGAAATCCTCACCCCGGCCGAGGGCGGCCGGCACATGGCCGAGGGGATGCGGCGCCACCACGGCATCGACTTCGACCCCGCCGACCTCCCGGACGGCGAACTGCTGTCCCTCGACACCCTGCGGCTGACCACCCACACCGGCACCCACGTCGACGCCCCGTCGCACTACGGGTCCCGCGCGCGCTACGGCACGCCGCGCCACATCGACCAGATGCCACTGGACTGGTTTCTGCGGCCGGGCCTCAAGCTCGACCTTACCGACGAGCCGGTGGGCGCCATCGGAGCCGACCGGATACGGCGGGCCCTCGACGAAGCGGGCCGCGACCCGCGTCCGTACGACATCGTGCTGCTGCACACCGGCGCGGACCGGCGGGCCGGAAAGCCGGAGTACTTCACCGAGTTCGCCGGCCTGGACGCCGCGGCGACCCACCTGCTGCTCGACTTCGGCGTCCGGGTCATCGGCACCGACGCCTTCAGCCTCGACGCCCCGTTCGGGCACATGATCAAGGAGTACCAGCGCACCGGCGACCGCGGTGTGCTGTGGCCCGCCCACTTCGTGGGACGGGAGCGCGAGTACTGCCAGATCGAGCGGCTGGACAACCTCGGCGCGCTGCCCGGACCGGACGGCTTCTTGGTCTCCTGCTTTCCGTTCAAGATCGCGGGAGCGGGGGCGGGGTGGACGCGGGCGGTGGCGGTGGTGGAGGAGTAG", "orf_prot_sequence": "MRIIDLSTTVDAGRWEVDPVEHEILTPAEGGRHMAEGMRRHHGIDFDPADLPDGELLSLDTLRLTTHTGTHVDAPSHYGSRARYGTPRHIDQMPLDWFLRPGLKLDLTDEPVGAIGADRIRRALDEAGRDPRPYDIVLLHTGADRRAGKPEYFTEFAGLDAAATHLLLDFGVRVIGTDAFSLDAPFGHMIKEYQRTGDRGVLWPAHFVGREREYCQIERLDNLGALPGPDGFLVSCFPFKIAGAGAGWTRAVAVVEE", "perc_identity": 35.71}, "gnl|BL_ORD_ID|1912|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14855, "orf_end": 15628, "orf_from": "BGC0000254.1|Oxytetracycline_14 ", "model_name": "APH(3')-IIa", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "2114", "ARO_accession": "3002644", "ARO_name": "APH(3')-IIa", "ARO_category": {"36265": {"category_aro_accession": "3000126", "category_aro_cvterm_id": "36265", "category_aro_name": "APH(3')", "category_aro_description": "A category of aminoglycoside O-phosphotransferase enzymes with modification regiospecificity based at the 3'-hydroxyl group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics, specifically kanamycin and neomycin, by the ATP-dependent phosphorylation of the 3'-hydroxyl group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35924": {"category_aro_accession": "0000005", "category_aro_cvterm_id": "35924", "category_aro_name": "neomycin", "category_aro_description": "Neomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Neomycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35940": {"category_aro_accession": "0000021", "category_aro_cvterm_id": "35940", "category_aro_name": "ribostamycin", "category_aro_description": "Ribostamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Ribostamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35943": {"category_aro_accession": "0000024", "category_aro_cvterm_id": "35943", "category_aro_name": "butirosin", "category_aro_description": "Butirosin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Butirosin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "36999": {"category_aro_accession": "3000655", "category_aro_cvterm_id": "36999", "category_aro_name": "gentamicin B", "category_aro_description": "Gentamicin B is a semisynthetic aminoglycoside antibacterial.", "category_aro_class_name": "Antibiotic"}, "37001": {"category_aro_accession": "3000657", "category_aro_cvterm_id": "37001", "category_aro_name": "paromomycin", "category_aro_description": "An aminoglycoside antibiotic used for the treatment of parasitic infections. It is similar to neomycin sharing a similar spectrum of activity, but its hydroxyl group at the 6'-position instead of an amino group makes it resistant to AAC(6') modifying enzymes.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.92273, "max_identities": 14, "bit_score": 25.409, "cvterm_id": "35914", "query": "LTPAEGGRHMAEGMRRHHGIDFDPADLP", "match": "L PAE    MA+ MRR H +  DPA  P", "sequence_from_db": "LAPAEKVSIMADAMRRLHTL--DPATCP", "sequence_from_broadstreet": "MIEQDGLHAGSPAAWVERLFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVADRYQDIALATRDIAEELGGEWADRFLVLYGIAAPDSQRIAFYRLLDEFF", "dna_sequence_from_broadstreet": "ATGATTGAACAAGATGGATTGCACGCAGGTTCTCCGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCGGCTGCTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTTGTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAGGACGAGGCAGCGCGGCTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCACTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCCTGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCGGCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACATCGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATCTGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGGCGCGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCCGAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTGGGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAGAGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCCGATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGA", "partial": "0", "query_start": 14927, "query_end": 15010, "hit_start": 318, "hit_end": 396, "orf_dna_sequence": "ATGCGCATCATCGATCTGTCGACAACCGTGGACGCCGGCCGGTGGGAGGTCGATCCGGTCGAACACGAAATCCTCACCCCGGCCGAGGGCGGCCGGCACATGGCCGAGGGGATGCGGCGCCACCACGGCATCGACTTCGACCCCGCCGACCTCCCGGACGGCGAACTGCTGTCCCTCGACACCCTGCGGCTGACCACCCACACCGGCACCCACGTCGACGCCCCGTCGCACTACGGGTCCCGCGCGCGCTACGGCACGCCGCGCCACATCGACCAGATGCCACTGGACTGGTTTCTGCGGCCGGGCCTCAAGCTCGACCTTACCGACGAGCCGGTGGGCGCCATCGGAGCCGACCGGATACGGCGGGCCCTCGACGAAGCGGGCCGCGACCCGCGTCCGTACGACATCGTGCTGCTGCACACCGGCGCGGACCGGCGGGCCGGAAAGCCGGAGTACTTCACCGAGTTCGCCGGCCTGGACGCCGCGGCGACCCACCTGCTGCTCGACTTCGGCGTCCGGGTCATCGGCACCGACGCCTTCAGCCTCGACGCCCCGTTCGGGCACATGATCAAGGAGTACCAGCGCACCGGCGACCGCGGTGTGCTGTGGCCCGCCCACTTCGTGGGACGGGAGCGCGAGTACTGCCAGATCGAGCGGCTGGACAACCTCGGCGCGCTGCCCGGACCGGACGGCTTCTTGGTCTCCTGCTTTCCGTTCAAGATCGCGGGAGCGGGGGCGGGGTGGACGCGGGCGGTGGCGGTGGTGGAGGAGTAG", "orf_prot_sequence": "MRIIDLSTTVDAGRWEVDPVEHEILTPAEGGRHMAEGMRRHHGIDFDPADLPDGELLSLDTLRLTTHTGTHVDAPSHYGSRARYGTPRHIDQMPLDWFLRPGLKLDLTDEPVGAIGADRIRRALDEAGRDPRPYDIVLLHTGADRRAGKPEYFTEFAGLDAAATHLLLDFGVRVIGTDAFSLDAPFGHMIKEYQRTGDRGVLWPAHFVGREREYCQIERLDNLGALPGPDGFLVSCFPFKIAGAGAGWTRAVAVVEE", "perc_identity": 50.0}, "gnl|BL_ORD_ID|940|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 14855, "orf_end": 15628, "orf_from": "BGC0000254.1|Oxytetracycline_14 ", "model_name": "IMP-21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1019", "ARO_accession": "3002212", "ARO_name": "IMP-21", "ARO_category": {"36029": {"category_aro_accession": "3000020", "category_aro_cvterm_id": "36029", "category_aro_name": "IMP beta-lactamase", "category_aro_description": "Plasmid mediated IMP-type carbapenemases, of which at least 26 varieties are currently known, became established in Japan in the 1990s in enteric gram-negative organisms, Pseudomonas and Acinetobacter species. Integron-associated, sometimes within plasmids. Hydrolyses all beta-lactams except monobactams, and evades all beta-lactam inhibitors.", "category_aro_class_name": "AMR Gene Family"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35951": {"category_aro_accession": "0000032", "category_aro_cvterm_id": "35951", "category_aro_name": "cephalosporin", "category_aro_description": "Cephalosporins are a class of beta-lactam antibiotics, containing the beta-lactam ring fused with a dihydrothiazolidine ring. Together with cephamycins they belong to a sub-group called cephems. Cephalosporin are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36017": {"category_aro_accession": "3000008", "category_aro_cvterm_id": "36017", "category_aro_name": "penam", "category_aro_description": "Penams are a group of antibiotics derived from Penicillium fungi that share a skeleton beta-lactam moiety fused with a thiazolidine ring. This is the most defining feature of penicillins. Penicillin antibiotics are historically significant because they are the first drugs that were effective against many previously serious diseases such as syphilis and Staphylococcus infections. Penicillins are still widely used today, though many types of bacteria are now resistant. All penicillins are beta-lactam antibiotics in the penam sub-group, and are used in the treatment of bacterial infections caused by susceptible, usually Gram-positive, organisms.", "category_aro_class_name": "Drug Class"}, "40360": {"category_aro_accession": "3003706", "category_aro_cvterm_id": "40360", "category_aro_name": "penem", "category_aro_description": "Penems are a class of unsaturated beta-lactam antibiotics with a broad spectrum of antibacterial activity and have a structure which renders them highly resistant to beta-lactamases. All penems are all synthetically made and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. They are structurally similar to carbapenems, however, where carbapenems have a carbon, penems have a sulfur.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.6434, "max_identities": 13, "bit_score": 24.6386, "cvterm_id": "36752", "query": "FTEFAGLDAAATHLLLDFGVRVIGTDAFSLDAPF", "match": "F E  G   A+ H L    V ++ TDA+ +D PF", "sequence_from_db": "FEEVNGWGVASKHGL----VVLVNTDAYLIDTPF", "sequence_from_broadstreet": "MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVASKHGLVVLVNTDAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLTNELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKPYGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKKSNTVH", "dna_sequence_from_broadstreet": "ATGAAAAAACTATTTGTTTTATGTATATTTTTGTTTTGTAGCATTACTGCCGCAGGAGCGTCTTTGCCTGATTTAAAAATTGAGAAGCTTGAAGAGGGTGTTTATGTTCATACATCGTTTGAAGAAGTTAACGGCTGGGGTGTTGCTTCTAAACACGGTTTGGTGGTTCTTGTAAATACTGACGCCTATCTGATTGACACTCCATTTACTGCTAAAGATACTGAAAAGTTAGTCAATTGGTTTGTGGAGCGCGGCTATAAAATCAAAGGCAGTATTTCCTCACATTTCCATAGCGACAGCACGGGTGGAATAGAGTGGCTTAATTCTCAATCTATTCCCACGTATGCATCTGTATTAACAAATGAACTTCTCAAAAAAGACGGTAAGGTGCAAGCTAAAAACTCATTTAGCGGAGTTAGCTATTGGCTAGTTAAAAATAAAATTGAAGTTTTTTATCCAGGCCCAGGGCACACTCAAGATAACGTAGTGGTTTGGCTACCTAAAAATAAAATCTTATTTGGTGGTTGTTTTGTTAAACCATATGGTCTTGGTAATCTAGATGACGCAAATGTTGAAGCATGGCCACATTCGGCTGAAAAATTAATATCTAAGTATGGTAATGCAAAACTGGTTGTTCCAAGCCATAGTGACATAGGAGATGCGTCGCTCTTGAAGCTTACGTGGGAACAGGCGGTAAAAGGGCTTAATGAAAGCAAAAAAAGTAACACTGTTCATTAA", "partial": "0", "query_start": 15311, "query_end": 15412, "hit_start": 117, "hit_end": 207, "orf_dna_sequence": "ATGCGCATCATCGATCTGTCGACAACCGTGGACGCCGGCCGGTGGGAGGTCGATCCGGTCGAACACGAAATCCTCACCCCGGCCGAGGGCGGCCGGCACATGGCCGAGGGGATGCGGCGCCACCACGGCATCGACTTCGACCCCGCCGACCTCCCGGACGGCGAACTGCTGTCCCTCGACACCCTGCGGCTGACCACCCACACCGGCACCCACGTCGACGCCCCGTCGCACTACGGGTCCCGCGCGCGCTACGGCACGCCGCGCCACATCGACCAGATGCCACTGGACTGGTTTCTGCGGCCGGGCCTCAAGCTCGACCTTACCGACGAGCCGGTGGGCGCCATCGGAGCCGACCGGATACGGCGGGCCCTCGACGAAGCGGGCCGCGACCCGCGTCCGTACGACATCGTGCTGCTGCACACCGGCGCGGACCGGCGGGCCGGAAAGCCGGAGTACTTCACCGAGTTCGCCGGCCTGGACGCCGCGGCGACCCACCTGCTGCTCGACTTCGGCGTCCGGGTCATCGGCACCGACGCCTTCAGCCTCGACGCCCCGTTCGGGCACATGATCAAGGAGTACCAGCGCACCGGCGACCGCGGTGTGCTGTGGCCCGCCCACTTCGTGGGACGGGAGCGCGAGTACTGCCAGATCGAGCGGCTGGACAACCTCGGCGCGCTGCCCGGACCGGACGGCTTCTTGGTCTCCTGCTTTCCGTTCAAGATCGCGGGAGCGGGGGCGGGGTGGACGCGGGCGGTGGCGGTGGTGGAGGAGTAG", "orf_prot_sequence": "MRIIDLSTTVDAGRWEVDPVEHEILTPAEGGRHMAEGMRRHHGIDFDPADLPDGELLSLDTLRLTTHTGTHVDAPSHYGSRARYGTPRHIDQMPLDWFLRPGLKLDLTDEPVGAIGADRIRRALDEAGRDPRPYDIVLLHTGADRRAGKPEYFTEFAGLDAAATHLLLDFGVRVIGTDAFSLDAPFGHMIKEYQRTGDRGVLWPAHFVGREREYCQIERLDNLGALPGPDGFLVSCFPFKIAGAGAGWTRAVAVVEE", "perc_identity": 38.24}}, "BGC0000254.1|Oxytetracycline_15 # 15893 # 16795 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.715": {"gnl|BL_ORD_ID|2119|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "qnrE2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3336", "ARO_accession": "3004637", "ARO_name": "qnrE2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.56414e-13, "max_identities": 43, "bit_score": 65.855, "cvterm_id": "35914", "query": "RNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": "RN    G+   DL S+   G +  +DR+S    +  RAQL+ AI + CDL  A    ++  G  +       AD R A        R     A ++ +N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "RNCDFSGT---DLTSSEFIGCQF-YDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGCGAGAAAATTGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACGAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGCAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCACAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCTACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGAGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGTTGTTTTAGGCTAA", "partial": "0", "query_start": 16208, "query_end": 16687, "hit_start": 75, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.88}, "gnl|BL_ORD_ID|2119|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "qnrE2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3336", "ARO_accession": "3004637", "ARO_name": "qnrE2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.39561e-06, "max_identities": 21, "bit_score": 44.2838, "cvterm_id": "35914", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "A     +L  C+L + R +GA + GA  + +DL+  +    D R A     +L +++L D +VR  DL+", "sequence_from_db": "ANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQ", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRASQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIVVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGCGAGAAAATTGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACGAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGCAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCACAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCTACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGAGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGTTGTTTTAGGCTAA", "partial": "0", "query_start": 16319, "query_end": 16525, "hit_start": 369, "hit_end": 576, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 30.43}, "gnl|BL_ORD_ID|2118|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "qnrE1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3335", "ARO_accession": "3004636", "ARO_name": "qnrE1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.97681e-13, "max_identities": 43, "bit_score": 65.4698, "cvterm_id": "35915", "query": "RNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": "RN    G+   DL S+   G +  +DR S    +  RAQL+ AI + CDL  A    ++  G  +       AD R A        R     A ++ +N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "RNCDFSGT---DLTSSEFIGCQF-YDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGAGAGAAAATAGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACCAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGAAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCGCAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCCACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGCGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGCTGTTTTAGGCTAA", "partial": "0", "query_start": 16208, "query_end": 16687, "hit_start": 75, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.88}, "gnl|BL_ORD_ID|2118|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "qnrE1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3335", "ARO_accession": "3004636", "ARO_name": "qnrE1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.55678e-06, "max_identities": 21, "bit_score": 44.2838, "cvterm_id": "35915", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "A     +L  C+L + R +GA + GA  + +DL+  +    D R A     +L +++L D +VR  DL+", "sequence_from_db": "ANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQ", "sequence_from_broadstreet": "MALIFEGEKIGRNRFTGEKIENAIFRNCDFSGTDLTSSEFIGCQFYDRESQQGGNFNRAQLKDAIFKSCDLSMADFRHSNALGIEIRECRAQGADFRGASFMNMITTRTWFCCAYITKSNLSYANFSKVVLEKCELWENRWNGAQILGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGIDLQGVKLDSYQVSQLMERLGIAVLG", "dna_sequence_from_broadstreet": "ATGGCATTGATTTTTGAAGGCGAAAAAATAGGTCGTAACCGTTTTACCGGAGAGAAAATAGAGAATGCAATCTTTCGTAACTGCGACTTTTCCGGTACGGATTTAACCAGCTCGGAGTTTATCGGCTGTCAGTTCTATGACCGGGAAAGCCAGCAGGGCGGTAACTTTAATCGGGCGCAACTTAAAGATGCTATTTTCAAAAGCTGCGATTTATCGATGGCGGATTTCAGGCATTCAAATGCATTAGGCATCGAAATCCGTGAATGCAGGGCGCAAGGGGCCGATTTCCGCGGGGCCAGTTTTATGAACATGATCACCACCCGTACCTGGTTTTGCTGTGCTTACATCACAAAAAGCAACCTGAGCTATGCCAATTTTTCGAAGGTGGTTCTGGAAAAATGCGAGCTGTGGGAAAACCGCTGGAACGGCGCGCAGATACTTGGCGCCACCTTTAGCGGCTCGGATCTGTCTGGGGGCGAGTTCTCATCCTTTGACTGGCGAGCGGCCAATTTTACCCACTGCGATCTGACCAATTCAGAACTGGGTGATCTGGACGTGCGGGGTATTGATTTGCAGGGCGTCAAACTGGACAGCTATCAGGTTTCCCAGTTGATGGAGCGACTTGGCATCGCTGTTTTAGGCTAA", "partial": "0", "query_start": 16319, "query_end": 16525, "hit_start": 369, "hit_end": 576, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 30.43}, "gnl|BL_ORD_ID|1882|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.49003e-13, "max_identities": 42, "bit_score": 65.0846, "cvterm_id": "35915", "query": "ISGRNSAHDGSFVPDLRSTHLPGVEL----GWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " +G    +   F+ D     L G E      +DR S    +  RA L+ AI + CDL  A    A   G  ++      AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "FTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 16199, "query_end": 16687, "hit_start": 78, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.15}, "gnl|BL_ORD_ID|1882|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.25646e-06, "max_identities": 22, "bit_score": 44.669, "cvterm_id": "35915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D ++R+ DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQ", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 363, "hit_end": 612, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|1882|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB31", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2044", "ARO_accession": "3002746", "ARO_name": "QnrB31", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00754034, "max_identities": 31, "bit_score": 34.2686, "cvterm_id": "35915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +        SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFLCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGTACAAATATGGCTCTGGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTTATGTGATTTTTCAGGAGCCGACCTGAGCGGCACTGAGTTTATCGGCTGTCAATTCTATGATCGTGAAAGCCAGAAAGGCTGCAATTTTAGTCGTGCGATGTTAAAGGATGCCATTTTTAAAAGCTGCGATTTATCCATGGCGGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTTCTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGCACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGTCGTGTTGGAGAAGTGTGAGTTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGTTGA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 23.31}, "gnl|BL_ORD_ID|322|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.54691e-13, "max_identities": 40, "bit_score": 64.6994, "cvterm_id": "36771", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  ++      AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|322|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.90237e-06, "max_identities": 22, "bit_score": 44.2838, "cvterm_id": "36771", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D ++R+ DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQ", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 327, "hit_end": 576, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|322|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "353", "ARO_accession": "3002715", "ARO_name": "QnrB2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00157718, "max_identities": 31, "bit_score": 36.1946, "cvterm_id": "36771", "query": "KRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": " R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "NRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEISHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTAGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16313, "query_end": 16699, "hit_start": 30, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 23.13}, "gnl|BL_ORD_ID|571|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.3194e-13, "max_identities": 41, "bit_score": 64.6994, "cvterm_id": "35915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+   A L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.33}, "gnl|BL_ORD_ID|571|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.56952e-06, "max_identities": 23, "bit_score": 45.4394, "cvterm_id": "35915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A    A+L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D ++R+ DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQ", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 363, "hit_end": 612, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.71}, "gnl|BL_ORD_ID|571|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB46", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "625", "ARO_accession": "3002761", "ARO_name": "QnrB46", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.2501e-05, "max_identities": 33, "bit_score": 40.0466, "cvterm_id": "35915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ + A + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAGAAAACAGGAACAAATATGGCTCTAGCGCTCGTGGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAAAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGAGCGGACCTGAGCGGCACTGAGTTTATCGGCTGCCAATTTTATGATCGTGAAAGCCAGAAAGGCTGTAATTTTAGCCGTGCGATGTTAAAGGATGCTATTTTTAAAAGCTGCGATTTATCCATGGCCGATTTTCGCAATGCAAGCGCCCTGGGTATTGAGATTCGTCATTGTAGGGCTCAGGGTGCAGATTTTCGCGGCGCAAGCTTTATGAACATGATTACCACGCGAACTTGGTTCTGCAGCGCGTATATCACGAATACGAATCTGTCTTATGCCAATTTTTCGAAAGCAGTGTTGGAGAAGTGTGAATTATGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCAACTTTCGACTGGCGAGCAGCAAACTTTACACATTGCGATCTCACAAATTCGGAGTTGGGTGACTTAGATATTCGTCGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCTTCGTTGCTCATGGAGCGACTTGGCATCGCGATAATTGGATGA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.81}, "gnl|BL_ORD_ID|1296|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.66469e-13, "max_identities": 40, "bit_score": 64.3142, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A+  G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|1296|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1414", "ARO_accession": "3002730", "ARO_name": "QnrB15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000143535, "max_identities": 27, "bit_score": 39.6614, "cvterm_id": "36915", "query": "QLRGAILRDCDLRDARLSGADLRGARLA-RADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "++  +   +CD   A LSG +  G +   R      +   A L++A       +  DLS A+ R A+    ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "KIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAI-----FKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAGTAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAATGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16322, "query_end": 16699, "hit_start": 90, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.26}, "gnl|BL_ORD_ID|661|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "716", "ARO_accession": "3002747", "ARO_name": "QnrB32", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.9362e-13, "max_identities": 40, "bit_score": 63.5438, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A ++++N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTAAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACTCAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|661|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB32", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "716", "ARO_accession": "3002747", "ARO_name": "QnrB32", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000228263, "max_identities": 32, "bit_score": 38.891, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++  ++L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTAAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACTCAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|1506|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.04168e-12, "max_identities": 40, "bit_score": 63.5438, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|1506|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.07067e-06, "max_identities": 26, "bit_score": 43.8986, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R      AN    DL+++ +   D+R  DL+GV L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA-----ANFTHCDLTNSELGNLDIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16552, "hit_start": 363, "hit_end": 624, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 28.26}, "gnl|BL_ORD_ID|1506|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB57", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1636", "ARO_accession": "3002770", "ARO_name": "QnrB57", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000218592, "max_identities": 32, "bit_score": 38.891, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGNLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTAACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|316|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.07231e-12, "max_identities": 40, "bit_score": 63.5438, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|316|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000696727, "max_identities": 32, "bit_score": 37.3502, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +        SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|316|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB23", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "346", "ARO_accession": "3002738", "ARO_name": "QnrB23", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0546586, "max_identities": 19, "bit_score": 31.5722, "cvterm_id": "36915", "query": "VRKADLRFADLRGVDLWGTDLRGAVLY-RAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRI", "match": "+  +   + D  G DL GT+  G   Y R    G   S A L  A  +  DL+ A    +  L   I", "sequence_from_db": "IENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEI", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFYCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTTACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16505, "query_end": 16702, "hit_start": 93, "hit_end": 294, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 28.36}, "gnl|BL_ORD_ID|4925|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.10383e-12, "max_identities": 40, "bit_score": 63.5438, "cvterm_id": "43754", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|4925|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB76", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5919", "ARO_accession": "3003188", "ARO_name": "QnrB76", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000218592, "max_identities": 32, "bit_score": 38.891, "cvterm_id": "43754", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGTGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|869|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "946", "ARO_accession": "3002763", "ARO_name": "QnrB48", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.11628e-12, "max_identities": 40, "bit_score": 63.1586, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGGAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATAACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGGCTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|869|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "946", "ARO_accession": "3002763", "ARO_name": "QnrB48", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.153e-05, "max_identities": 26, "bit_score": 42.743, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R      AN    DL+++ +   D+R  DL+GV L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRA-----ANFTHCDLTNSELGGLDIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGGAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATAACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGGCTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16552, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 28.26}, "gnl|BL_ORD_ID|869|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB48", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "946", "ARO_accession": "3002763", "ARO_name": "QnrB48", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000287144, "max_identities": 32, "bit_score": 38.5058, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGGLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGGAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATAACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGGCTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|1714|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.15844e-12, "max_identities": 40, "bit_score": 63.5438, "cvterm_id": "35914", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|1714|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.70561e-06, "max_identities": 22, "bit_score": 44.2838, "cvterm_id": "35914", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D ++R+ DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQ", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 363, "hit_end": 612, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|1714|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB20", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1856", "ARO_accession": "3002735", "ARO_name": "QnrB20", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000201329, "max_identities": 33, "bit_score": 38.891, "cvterm_id": "35914", "query": "VAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "V     R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "VGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGCACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16298, "query_end": 16699, "hit_start": 51, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 23.74}, "gnl|BL_ORD_ID|377|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "417", "ARO_accession": "3002720", "ARO_name": "QnrB6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.20405e-12, "max_identities": 40, "bit_score": 63.5438, "cvterm_id": "36950", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|377|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "417", "ARO_accession": "3002720", "ARO_name": "QnrB6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000233033, "max_identities": 32, "bit_score": 38.891, "cvterm_id": "36950", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|779|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "843", "ARO_accession": "3002728", "ARO_name": "QnrB14", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.22753e-12, "max_identities": 40, "bit_score": 63.5438, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLTERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTCGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATCTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAGGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCACGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|779|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB14", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "843", "ARO_accession": "3002728", "ARO_name": "QnrB14", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000529986, "max_identities": 32, "bit_score": 37.7354, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLTERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTCGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATCTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAGGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCACGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|1346|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1470", "ARO_accession": "3002741", "ARO_name": "QnrB26", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.23943e-12, "max_identities": 40, "bit_score": 63.5438, "cvterm_id": "36943", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGTAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATGGTACATTTTTTAATTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|1346|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB26", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1470", "ARO_accession": "3002741", "ARO_name": "QnrB26", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000395788, "max_identities": 27, "bit_score": 38.1206, "cvterm_id": "36943", "query": "QLRGAILRDCDLRDARLSGADLRGARLA-RADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "++      +CD   A LSG +  G +   R      +   A L++A       +  DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "KIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAI-----FKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGTAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATGGTACATTTTTTAATTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16322, "query_end": 16699, "hit_start": 90, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.26}, "gnl|BL_ORD_ID|238|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.27585e-12, "max_identities": 40, "bit_score": 63.1586, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|238|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.02647e-06, "max_identities": 22, "bit_score": 44.2838, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D ++R+ DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQ", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 363, "hit_end": 612, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|238|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB13", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "266", "ARO_accession": "3002727", "ARO_name": "QnrB13", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000237331, "max_identities": 32, "bit_score": 38.891, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|1445|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1579", "ARO_accession": "3002723", "ARO_name": "QnrB9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.29103e-12, "max_identities": 40, "bit_score": 63.1586, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|1445|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1579", "ARO_accession": "3002723", "ARO_name": "QnrB9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000295159, "max_identities": 32, "bit_score": 38.5058, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|4920|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.35514e-12, "max_identities": 40, "bit_score": 63.1586, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|4920|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.14238e-05, "max_identities": 25, "bit_score": 42.743, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D ++R       DL+GV L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSV-----DLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16552, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.17}, "gnl|BL_ORD_ID|4920|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB78", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5911", "ARO_accession": "3003190", "ARO_name": "QnrB78", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000309016, "max_identities": 32, "bit_score": 38.5058, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRSVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGAGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|703|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.42242e-12, "max_identities": 40, "bit_score": 63.1586, "cvterm_id": "36884", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|703|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.16371e-05, "max_identities": 27, "bit_score": 42.743, "cvterm_id": "36884", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.84}, "gnl|BL_ORD_ID|703|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "765", "ARO_accession": "3002721", "ARO_name": "QnrB7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000284521, "max_identities": 32, "bit_score": 38.5058, "cvterm_id": "36884", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|1643|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.45025e-12, "max_identities": 40, "bit_score": 62.7734, "cvterm_id": "35914", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|1643|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.17452e-05, "max_identities": 27, "bit_score": 42.743, "cvterm_id": "35914", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.84}, "gnl|BL_ORD_ID|1643|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB44", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1789", "ARO_accession": "3002759", "ARO_name": "QnrB44", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000289792, "max_identities": 32, "bit_score": 38.5058, "cvterm_id": "35914", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFTTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTAAGTGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCAATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGTGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACACGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTACGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTCATTGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|99|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "116", "ARO_accession": "3002733", "ARO_name": "QnrB18", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.48888e-12, "max_identities": 40, "bit_score": 63.1586, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|99|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB18", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "116", "ARO_accession": "3002733", "ARO_name": "QnrB18", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000580593, "max_identities": 32, "bit_score": 37.7354, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|32|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB58", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "40", "ARO_accession": "3002771", "ARO_name": "QnrB58", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.54746e-12, "max_identities": 40, "bit_score": 63.1586, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|32|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB58", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "40", "ARO_accession": "3002771", "ARO_name": "QnrB58", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000591279, "max_identities": 32, "bit_score": 37.7354, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIDNSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGATAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|1392|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.8298e-12, "max_identities": 40, "bit_score": 62.7734, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|1392|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.70617e-06, "max_identities": 22, "bit_score": 43.5134, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D ++R+ DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQ", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 327, "hit_end": 576, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|1392|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB64", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1513", "ARO_accession": "3002776", "ARO_name": "QnrB64", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000392244, "max_identities": 32, "bit_score": 38.1206, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGTCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTATGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|961|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB33", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1048", "ARO_accession": "3002748", "ARO_name": "QnrB33", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.37625e-12, "max_identities": 39, "bit_score": 62.3882, "cvterm_id": "39584", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL ST   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSSTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCAGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|961|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB33", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1048", "ARO_accession": "3002748", "ARO_name": "QnrB33", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000168576, "max_identities": 29, "bit_score": 39.2762, "cvterm_id": "39584", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL           D   RE+  +    +RA L+DA     ++  AD R A   G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSSTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCAGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|61|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB66", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "71", "ARO_accession": "3002778", "ARO_name": "QnrB66", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.59239e-12, "max_identities": 39, "bit_score": 62.3882, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    +   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|61|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB66", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "71", "ARO_accession": "3002778", "ARO_name": "QnrB66", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.90714e-05, "max_identities": 29, "bit_score": 40.4318, "cvterm_id": "36915", "query": "KRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": " R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R +   G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "NRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKINRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTAACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16313, "query_end": 16699, "hit_start": 30, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.64}, "gnl|BL_ORD_ID|459|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.73254e-12, "max_identities": 39, "bit_score": 62.3882, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    +   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|459|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB17", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "498", "ARO_accession": "3002732", "ARO_name": "QnrB17", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.6916e-05, "max_identities": 29, "bit_score": 40.817, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R +   G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|542|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB41", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "594", "ARO_accession": "3002756", "ARO_name": "QnrB41", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.90362e-12, "max_identities": 39, "bit_score": 62.3882, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    +   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTAGC", "partial": "1", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|542|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB41", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "594", "ARO_accession": "3002756", "ARO_name": "QnrB41", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.50743e-05, "max_identities": 29, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R +   G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGDKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIGS", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGATAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTAGC", "partial": "1", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|1613|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.93963e-12, "max_identities": 40, "bit_score": 62.003, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+   A L   +LW     G  +  A L+G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|1613|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.4089e-06, "max_identities": 28, "bit_score": 44.669, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ +   +   A    A+L  C+L + R  G  + GA L+ +DL+  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 28.87}, "gnl|BL_ORD_ID|1613|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB35", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1760", "ARO_accession": "3002750", "ARO_name": "QnrB35", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.84729e-05, "max_identities": 31, "bit_score": 41.9726, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  GA + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ + A + + ++  +R", "sequence_from_db": "RNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENR", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGCAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGCGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGAGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTATGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGATGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCGTTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 23.31}, "gnl|BL_ORD_ID|1435|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.50947e-12, "max_identities": 39, "bit_score": 62.003, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|1435|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB16", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1564", "ARO_accession": "3002731", "ARO_name": "QnrB16", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000205044, "max_identities": 32, "bit_score": 38.891, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYIKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATATAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|682|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "740", "ARO_accession": "3002736", "ARO_name": "QnrB21", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.60108e-12, "max_identities": 40, "bit_score": 62.003, "cvterm_id": "35914", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+   A L   +LW     G  +  A L+G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|682|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB21", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "740", "ARO_accession": "3002736", "ARO_name": "QnrB21", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.47593e-05, "max_identities": 30, "bit_score": 40.4318, "cvterm_id": "35914", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ + A + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|1111|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.74296e-12, "max_identities": 39, "bit_score": 61.6178, "cvterm_id": "35914", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  R  L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|1111|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.08072e-05, "max_identities": 27, "bit_score": 42.743, "cvterm_id": "35914", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.84}, "gnl|BL_ORD_ID|1111|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB45", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1209", "ARO_accession": "3002760", "ARO_name": "QnrB45", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000823856, "max_identities": 31, "bit_score": 36.965, "cvterm_id": "35914", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +R  L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRTMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTACGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 23.31}, "gnl|BL_ORD_ID|1009|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1102", "ARO_accession": "3002744", "ARO_name": "QnrB29", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.75391e-12, "max_identities": 39, "bit_score": 62.003, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL       A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|1009|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB29", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1102", "ARO_accession": "3002744", "ARO_name": "QnrB29", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.77255e-05, "max_identities": 29, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++   D R A   G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|291|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB54", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "324", "ARO_accession": "3002767", "ARO_name": "QnrB54", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.81597e-12, "max_identities": 39, "bit_score": 61.6178, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCACTGGCACTCGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|291|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB54", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "324", "ARO_accession": "3002767", "ARO_name": "QnrB54", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000279347, "max_identities": 32, "bit_score": 38.5058, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVSEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCACTGGCACTCGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|1229|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1335", "ARO_accession": "3002722", "ARO_name": "QnrB8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.8904e-12, "max_identities": 40, "bit_score": 61.6178, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+   A L   +LW     G  +  A L+G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAACTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|1229|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1335", "ARO_accession": "3002722", "ARO_name": "QnrB8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.53585e-05, "max_identities": 30, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ + A + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAACTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTGATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|85|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB38", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "99", "ARO_accession": "3002753", "ARO_name": "QnrB38", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.8904e-12, "max_identities": 40, "bit_score": 61.6178, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+   A L   +LW     G  +  A L+G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|85|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB38", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "99", "ARO_accession": "3002753", "ARO_name": "QnrB38", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.78109e-05, "max_identities": 30, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ + A + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENR", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTACTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|1853|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.00477e-12, "max_identities": 40, "bit_score": 61.6178, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+   A L   +LW     G  +  A L+G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|1853|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.79531e-06, "max_identities": 27, "bit_score": 44.2838, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL", "match": "W  S+ +   +   A    A+L  C+L + R  G  + GA L+ +DL+  +    D R A     +L +++L D      D+R  DL+GV L", "sequence_from_db": "WFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDL-----DIRGVDLQGVKL", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 16280, "query_end": 16552, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.35}, "gnl|BL_ORD_ID|1853|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB60", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2011", "ARO_accession": "3002773", "ARO_name": "QnrB60", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.65734e-05, "max_identities": 30, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ + A + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENR", "sequence_from_broadstreet": "MALALIGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAVLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCATTAATTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGTATTGCTCATGGAACGTCTTGGCATCGCTGTCATTGGCTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|327|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB42", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "358", "ARO_accession": "3002757", "ARO_name": "QnrB42", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.1225e-12, "max_identities": 39, "bit_score": 61.6178, "cvterm_id": "35915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    +   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGTATTAGTTGGCGAAAAAATTGACAGAAACTGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTATTATTGGCTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|327|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB42", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "358", "ARO_accession": "3002757", "ARO_name": "QnrB42", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.62071e-05, "max_identities": 29, "bit_score": 40.0466, "cvterm_id": "35915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R    G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R +   G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGTATTAGTTGGCGAAAAAATTGACAGAAACTGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTATTATTGGCTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|436|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.21308e-12, "max_identities": 39, "bit_score": 62.003, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|436|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.09934e-05, "max_identities": 21, "bit_score": 42.743, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  G  + GA  + +DL+  +    D R A     +L +++L D ++R+ DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQ", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 363, "hit_end": 612, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.3}, "gnl|BL_ORD_ID|436|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB49", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "484", "ARO_accession": "3002764", "ARO_name": "QnrB49", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000237331, "max_identities": 32, "bit_score": 38.891, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRRVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTAGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGGACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGCGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|1868|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.58443e-12, "max_identities": 39, "bit_score": 61.6178, "cvterm_id": "35914", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +L+       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|1868|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.70617e-06, "max_identities": 28, "bit_score": 43.5134, "cvterm_id": "35914", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DLA  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 28.87}, "gnl|BL_ORD_ID|1868|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB43", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2028", "ARO_accession": "3002758", "ARO_name": "QnrB43", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000348158, "max_identities": 32, "bit_score": 38.1206, "cvterm_id": "35914", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLAGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTGCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGCTGCTCATGGAACGTCTTGGCATCGCGGTAATTGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|48|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.81112e-12, "max_identities": 39, "bit_score": 61.6178, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA LR AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|48|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.85195e-05, "max_identities": 30, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA LRDA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|48|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB47", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "58", "ARO_accession": "3002762", "ARO_name": "QnrB47", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00642811, "max_identities": 30, "bit_score": 34.2686, "cvterm_id": "36915", "query": "QLRGAILRDCDLRDARLSGADL-----------RGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRI", "match": "++  +   +CD   A LSG +            +G   +RA L DA  +  DL     + A+ R+       +R    + AD RG               A +    LS A+     L   +L +     +QVL +  ", "sequence_from_db": "KVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDL-----SMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATF", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGTGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16322, "query_end": 16702, "hit_start": 54, "hit_end": 453, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.74}, "gnl|BL_ORD_ID|901|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "975", "ARO_accession": "3002714", "ARO_name": "QnrB1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.95245e-12, "max_identities": 39, "bit_score": 61.6178, "cvterm_id": "35915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    +   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|901|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "975", "ARO_accession": "3002714", "ARO_name": "QnrB1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.36697e-05, "max_identities": 29, "bit_score": 40.4318, "cvterm_id": "35915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R +   G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|499|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.56714e-12, "max_identities": 39, "bit_score": 61.6178, "cvterm_id": "35914", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S       RA L+ AI + CDL  A    +   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|499|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.48785e-06, "max_identities": 27, "bit_score": 43.1282, "cvterm_id": "35914", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 363, "hit_end": 624, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.84}, "gnl|BL_ORD_ID|499|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "548", "ARO_accession": "3002716", "ARO_name": "QnrB3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.91628e-05, "max_identities": 29, "bit_score": 40.4318, "cvterm_id": "35914", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R +   G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|323|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.18745e-12, "max_identities": 38, "bit_score": 61.2326, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " D+  T   G +  +DR S    +  RA L+ AI + CDL       A   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADMSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|323|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.89561e-06, "max_identities": 27, "bit_score": 43.1282, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 363, "hit_end": 624, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.84}, "gnl|BL_ORD_ID|323|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB24", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "354", "ARO_accession": "3002739", "ARO_name": "QnrB24", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000133404, "max_identities": 28, "bit_score": 39.6614, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGAD+ G         D   RE+  +    +RA L+DA     ++   D R A   G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADMSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMVDFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACATGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGTGGATTTTCGCAATGCCAGTGCGCTTGGCATTGAAATTCGCCACTGTCGTGCGCAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACTACTCGCACCTGGTTTTGCAGCGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAATGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.05}, "gnl|BL_ORD_ID|525|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.30323e-12, "max_identities": 38, "bit_score": 61.2326, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A     +  G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A++T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|525|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB65", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "577", "ARO_accession": "3002777", "ARO_name": "QnrB65", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.86729e-06, "max_identities": 30, "bit_score": 43.5134, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RANL+DA     ++  AD R  +  G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGGCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGTGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGCATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|764|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "827", "ARO_accession": "3002768", "ARO_name": "QnrB55", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.8678e-12, "max_identities": 38, "bit_score": 60.8474, "cvterm_id": "39585", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +L +DR S    +  RA L+ AI + CDL  A     +  G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A++T   +  S++", "sequence_from_db": "ADLSGTEFIGCQL-YDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTGAGCGGCACTGAATTTATTGGCTGCCAGTTATATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|764|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB55", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "827", "ARO_accession": "3002768", "ARO_name": "QnrB55", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.9277e-06, "max_identities": 31, "bit_score": 45.0542, "cvterm_id": "39585", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G       L D   RE+  +    +RANL+DA     ++  AD R  +  G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYD---RESQ-KGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTGAGCGGCACTGAATTTATTGGCTGCCAGTTATATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 23.31}, "gnl|BL_ORD_ID|717|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "781", "ARO_accession": "3002740", "ARO_name": "QnrB25", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.09856e-12, "max_identities": 40, "bit_score": 60.8474, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A ++  N+  A+   A L   +LW     G  +  A L+G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAGTACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTATCATTGGCTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.67}, "gnl|BL_ORD_ID|717|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "781", "ARO_accession": "3002740", "ARO_name": "QnrB25", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.7731e-06, "max_identities": 28, "bit_score": 45.0542, "cvterm_id": "36915", "query": "WDRSSPVAADH-KRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ + + +   A    A+L  C+L + R  G  + GA L+ +DL+  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAGTACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTATCATTGGCTAA", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 28.87}, "gnl|BL_ORD_ID|717|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB25", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "781", "ARO_accession": "3002740", "ARO_name": "QnrB25", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.85735e-05, "max_identities": 30, "bit_score": 40.0466, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ + A + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITSTNLSYANFSKAVLEKCELWENRWMGTQVLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAAAAAGTTGAAAATAGCACTTTTTTTAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAATTTATCGGCTGTCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGCAATTTCAGTCGCGCAATACTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGTCAGTGCGTTGGGCATAGAAATTCGCCACTGCCGCGCACAGGGTGCAGATTTTCGCGGCGCAAGTTTCATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAGTACCAATCTAAGCTACGCCAACTTTTCGAAGGCCGTGCTTGAAAAGTGCGAATTGTGGGAAAATCGCTGGATGGGAACTCAGGTGCTGGGTGCGACGTTGAGTGGTTCCGATCTCTCCGGTGGCGAGTTTTCGTCGTTCGACTGGCGGACGGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGCGTCGATTTACAAGGTGTCAAATTGGACAGCTATCAGGCCGCATTGCTCATGGAACGTCTTGGCATCGCTATCATTGGCTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|1153|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB68", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1257", "ARO_accession": "3002780", "ARO_name": "QnrB68", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.25614e-12, "max_identities": 38, "bit_score": 60.8474, "cvterm_id": "39584", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTAATGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|1153|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB68", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1257", "ARO_accession": "3002780", "ARO_name": "QnrB68", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000110442, "max_identities": 29, "bit_score": 39.6614, "cvterm_id": "39584", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVMGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTAATGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|4919|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.41677e-12, "max_identities": 38, "bit_score": 60.8474, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    +   G  +        D R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|4919|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.11113e-05, "max_identities": 27, "bit_score": 42.743, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.84}, "gnl|BL_ORD_ID|4919|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB77", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5910", "ARO_accession": "3003189", "ARO_name": "QnrB77", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.2301e-05, "max_identities": 30, "bit_score": 42.743, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R +   G+++      GTD RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGTDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCACAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCGAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|4917|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB39", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5908", "ARO_accession": "3002754", "ARO_name": "QnrB39", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.09104e-12, "max_identities": 40, "bit_score": 60.8474, "cvterm_id": "39643", "query": "FVPDLRSTHLPGVEL----GWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": "F  D   T L G E      +DR S    +  RA L+ AI + CDL  A    A   G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "FNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTGGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGTGAAAGTTGAAAATAGCACGTTTTTCAACTGTGATTTTTCGGGTACCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCCATGGCGGATTTCAGAAATGCCAGCGCGCTGGGAATCGAGATTCGCCACTGCCGCGCGCAAGGTTCGGATTTTCGCGGTGCCAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGCAGCGCTTATATCACCAATACAAACTTAAGCTACGCCAACTTTTCGAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGGCCGCGAACTTTACGCACTGTGACCTGACCAACTCGGAGCTGGGTGATTTAGACGTCCGTGGGGTGGATTTACAAGGCGTTAAACTGGACAGCTACCAGGCGTCTTTGATCCTGGAGCGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16232, "query_end": 16687, "hit_start": 75, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.64}, "gnl|BL_ORD_ID|4917|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB39", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5908", "ARO_accession": "3002754", "ARO_name": "QnrB39", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.16371e-05, "max_identities": 22, "bit_score": 42.743, "cvterm_id": "39643", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  G  + GA  + +DL+  +    D R A     +L +++L D +VR  DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQ", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTGGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGTGAAAGTTGAAAATAGCACGTTTTTCAACTGTGATTTTTCGGGTACCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCCATGGCGGATTTCAGAAATGCCAGCGCGCTGGGAATCGAGATTCGCCACTGCCGCGCGCAAGGTTCGGATTTTCGCGGTGCCAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGCAGCGCTTATATCACCAATACAAACTTAAGCTACGCCAACTTTTCGAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGGCCGCGAACTTTACGCACTGTGACCTGACCAACTCGGAGCTGGGTGATTTAGACGTCCGTGGGGTGGATTTACAAGGCGTTAAACTGGACAGCTACCAGGCGTCTTTGATCCTGGAGCGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 327, "hit_end": 576, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|4917|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB39", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5908", "ARO_accession": "3002754", "ARO_name": "QnrB39", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.23946e-05, "max_identities": 29, "bit_score": 40.817, "cvterm_id": "39643", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SG DL G         D   RE+  +    +RA L+DA     ++  AD R A   G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGVKVENSTFFNCDFSGTDLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTGGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGTGAAAGTTGAAAATAGCACGTTTTTCAACTGTGATTTTTCGGGTACCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCCATGGCGGATTTCAGAAATGCCAGCGCGCTGGGAATCGAGATTCGCCACTGCCGCGCGCAAGGTTCGGATTTTCGCGGTGCCAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGCAGCGCTTATATCACCAATACAAACTTAAGCTACGCCAACTTTTCGAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGCGAGTTTTCGTCGTTCGACTGGCGGGCCGCGAACTTTACGCACTGTGACCTGACCAACTCGGAGCTGGGTGATTTAGACGTCCGTGGGGTGGATTTACAAGGCGTTAAACTGGACAGCTACCAGGCGTCTTTGATCCTGGAGCGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|354|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "388", "ARO_accession": "3002783", "ARO_name": "QnrB71", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.09104e-12, "max_identities": 38, "bit_score": 60.8474, "cvterm_id": "39584", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGGCAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|354|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB71", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "388", "ARO_accession": "3002783", "ARO_name": "QnrB71", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000112493, "max_identities": 29, "bit_score": 39.6614, "cvterm_id": "39584", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIGRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGGCAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|863|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB70", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "938", "ARO_accession": "3002782", "ARO_name": "QnrB70", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.17903e-12, "max_identities": 38, "bit_score": 60.8474, "cvterm_id": "39584", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGTATTAGTAGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|863|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB70", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "938", "ARO_accession": "3002782", "ARO_name": "QnrB70", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000105478, "max_identities": 29, "bit_score": 39.6614, "cvterm_id": "39584", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLVLVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGTATTAGTAGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|4918|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.35755e-12, "max_identities": 39, "bit_score": 60.4622, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S       RA L+ AI + CDL  A    +   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.0}, "gnl|BL_ORD_ID|4918|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.09076e-05, "max_identities": 27, "bit_score": 42.743, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.84}, "gnl|BL_ORD_ID|4918|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB75", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5909", "ARO_accession": "3003187", "ARO_name": "QnrB75", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000161005, "max_identities": 29, "bit_score": 39.2762, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R +   G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGGKFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGGGCAAATTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCGGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGCTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|1455|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1590", "ARO_accession": "3002742", "ARO_name": "QnrB27", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.35755e-12, "max_identities": 38, "bit_score": 60.4622, "cvterm_id": "39584", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    A   G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|1455|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB27", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1590", "ARO_accession": "3002742", "ARO_name": "QnrB27", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.45954e-05, "max_identities": 30, "bit_score": 41.5874, "cvterm_id": "39584", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R A   G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGCCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|1668|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1809", "ARO_accession": "3002719", "ARO_name": "QnrB5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.99651e-12, "max_identities": 38, "bit_score": 60.8474, "cvterm_id": "35665", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|1668|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1809", "ARO_accession": "3002719", "ARO_name": "QnrB5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.83607e-05, "max_identities": 29, "bit_score": 40.0466, "cvterm_id": "35665", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|787|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.05883e-11, "max_identities": 38, "bit_score": 60.8474, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|787|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB62", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "852", "ARO_accession": "3002775", "ARO_name": "QnrB62", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.68349e-05, "max_identities": 29, "bit_score": 40.0466, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAAAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|1549|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB67", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1683", "ARO_accession": "3002779", "ARO_name": "QnrB67", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.09161e-11, "max_identities": 38, "bit_score": 60.4622, "cvterm_id": "39584", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAACTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|1549|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB67", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1683", "ARO_accession": "3002779", "ARO_name": "QnrB67", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000112493, "max_identities": 29, "bit_score": 39.6614, "cvterm_id": "39584", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAACTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|529|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB19", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "581", "ARO_accession": "3002734", "ARO_name": "QnrB19", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.11283e-11, "max_identities": 38, "bit_score": 60.4622, "cvterm_id": "35914", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|529|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB19", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "581", "ARO_accession": "3002734", "ARO_name": "QnrB19", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000119973, "max_identities": 29, "bit_score": 39.6614, "cvterm_id": "35914", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGTGCCTTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACTAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|349|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB61", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "382", "ARO_accession": "3002774", "ARO_name": "QnrB61", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.12359e-11, "max_identities": 38, "bit_score": 60.4622, "cvterm_id": "39584", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|349|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB61", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "382", "ARO_accession": "3002774", "ARO_name": "QnrB61", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000189961, "max_identities": 29, "bit_score": 38.891, "cvterm_id": "39584", "query": "QLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "++  +   +CD      SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "KVENSTFFNCDF-----SGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16322, "query_end": 16699, "hit_start": 54, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.14}, "gnl|BL_ORD_ID|1453|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1588", "ARO_accession": "3002765", "ARO_name": "QnrB50", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.15651e-11, "max_identities": 38, "bit_score": 60.4622, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAAGCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|1453|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB50", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1588", "ARO_accession": "3002765", "ARO_name": "QnrB50", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000100736, "max_identities": 29, "bit_score": 40.0466, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRKRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAAGCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|120|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "139", "ARO_accession": "3002724", "ARO_name": "QnrB10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.28248e-11, "max_identities": 38, "bit_score": 60.4622, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGTCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCCGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|120|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "139", "ARO_accession": "3002724", "ARO_name": "QnrB10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000135868, "max_identities": 29, "bit_score": 39.6614, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGTCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCCGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGACTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|1163|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.38848e-11, "max_identities": 38, "bit_score": 60.077, "cvterm_id": "39584", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA LR AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +     +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|1163|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.33691e-05, "max_identities": 30, "bit_score": 40.817, "cvterm_id": "39584", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA LRDA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|1163|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB40", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1267", "ARO_accession": "3002755", "ARO_name": "QnrB40", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00415064, "max_identities": 30, "bit_score": 35.039, "cvterm_id": "39584", "query": "QLRGAILRDCDLRDARLSGADL-----------RGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRI", "match": "++  +   +CD   A LSG +            +G   +RA L DA  +  DL     + A+ R+       +R    + AD RG               A +    LS A+     L   +L +     +QVL +  ", "sequence_from_db": "KVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDL-----SMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTF", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGTTFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACTGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAGAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTACGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16322, "query_end": 16702, "hit_start": 54, "hit_end": 453, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.74}, "gnl|BL_ORD_ID|490|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB59", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "539", "ARO_accession": "3002772", "ARO_name": "QnrB59", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.39793e-11, "max_identities": 38, "bit_score": 60.4622, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|490|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB59", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "539", "ARO_accession": "3002772", "ARO_name": "QnrB59", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00021268, "max_identities": 29, "bit_score": 38.891, "cvterm_id": "36915", "query": "QLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "++  +   +CD      SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "KVENSTFFNCDF-----SGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MLSLLYKNTGIDMTLALVGEKIDRNRFTSEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGTTGTCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCAGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACACGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16322, "query_end": 16699, "hit_start": 90, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.14}, "gnl|BL_ORD_ID|1886|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB72", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2049", "ARO_accession": "3002784", "ARO_name": "QnrB72", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.42912e-11, "max_identities": 38, "bit_score": 60.077, "cvterm_id": "39586", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVCEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITMRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTTGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCATGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTTAGTGGTTCAGATCTCTCCGGTGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.33}, "gnl|BL_ORD_ID|1568|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1707", "ARO_accession": "3002718", "ARO_name": "QnrB4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.47095e-11, "max_identities": 37, "bit_score": 60.077, "cvterm_id": "35914", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A     +  G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A++T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|1568|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1707", "ARO_accession": "3002718", "ARO_name": "QnrB4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.36427e-06, "max_identities": 30, "bit_score": 44.2838, "cvterm_id": "35914", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RANL+DA     ++  AD R  +  G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGCACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGTCAGAAAGGATGTAATTTTAGTCGCGCTAACCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCTGATTTCAGGAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGTTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTTACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGCGGGGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|1084|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1174", "ARO_accession": "3002737", "ARO_name": "QnrB22", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.25248e-11, "max_identities": 37, "bit_score": 59.6918, "cvterm_id": "39583", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A     +  G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A++T   +  S++", "sequence_from_db": "ADLCGTEFIGCQF-YDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSEL", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTTGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCTTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAGAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTAACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGGGTAGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 99, "hit_end": 546, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|1084|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1174", "ARO_accession": "3002737", "ARO_name": "QnrB22", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.82158e-06, "max_identities": 30, "bit_score": 43.8986, "cvterm_id": "39583", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RANL+DA     ++  AD R  +  G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYD---RESQ-KGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTTGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCTTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAGAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTAACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGGGTAGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 36, "hit_end": 423, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|1084|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB22", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1174", "ARO_accession": "3002737", "ARO_name": "QnrB22", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.11918e-05, "max_identities": 25, "bit_score": 42.743, "cvterm_id": "39583", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL", "match": "W  S+ +   +   A     +L  C+L + R  G  + GA  + +DL+  +    D R A     +L +++L D      D+R  DL+GV L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDL-----DIRVVDLQGVKL", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLCGTEFIGCQFYDRESQKGCNFSRANLKDAIFKSCDLSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRVVDLQGVKLDSYQASLLLERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAAAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTTGCGGTACTGAATTTATTGGCTGCCAGTTTTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTAACCTGAAGGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGAAATATCAATGCGCTGGGAATCGAAATTCGCCACTGCCGGGCACAAGGGTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATCACCACCCGCACCTGGTTTTGTAGCGCTTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCTAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAGAACCGCTGGATGGGTACTCAGGTGCTGGGCGCAACGTTCAGTGGATCAGACCTCTCTGGCGGCGAGTTTTCATCCTTCGACTGGCGAGCAGCAAACGTAACGCACTGTGATTTGACCAATTCGGAACTGGGCGATTTAGATATCCGGGTAGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGCTCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16280, "query_end": 16552, "hit_start": 330, "hit_end": 591, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.17}, "gnl|BL_ORD_ID|973|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB73", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1063", "ARO_accession": "3002785", "ARO_name": "QnrB73", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.88154e-11, "max_identities": 37, "bit_score": 59.3066, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MSLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGAGTCTGGCACTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCTCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAATCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|973|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB73", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1063", "ARO_accession": "3002785", "ARO_name": "QnrB73", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.71893e-05, "max_identities": 29, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MSLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGAGTCTGGCACTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCTCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAATCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGCGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAACTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|1159|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB56", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1263", "ARO_accession": "3002769", "ARO_name": "QnrB56", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.89173e-11, "max_identities": 37, "bit_score": 59.3066, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R  + T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGTACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGGAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|1159|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB56", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1263", "ARO_accession": "3002769", "ARO_name": "QnrB56", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.75551e-05, "max_identities": 29, "bit_score": 40.0466, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAGNFTHCDLTNSELGDLDIRGVDLQGVKLDSYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAACACAGGCATAGATATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGGTGCAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTTCGCGGTGCAAGCTTTATGAATATGATCACCACGCGTACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGGAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAGCTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|503|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB28", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "552", "ARO_accession": "3002743", "ARO_name": "QnrB28", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.96569e-11, "max_identities": 37, "bit_score": 59.3066, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGAGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|503|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB28", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "552", "ARO_accession": "3002743", "ARO_name": "QnrB28", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.90714e-05, "max_identities": 29, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVSEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVAGATFSGSDLSGGEFSAFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQAALLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTAGCGAAAAAATTGACAGAAACCGCTTCACCGGGGAAAAAGTTGAAAACAGTACTTTTTTTAACTGTGATTTTTCAGGGGCCGATCTTAGCGGCACTGAATTTATCGGCTGTCAGTTTTATGATCGCGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCAATGCTGAAAGATGCCATTTTTAAAAGTTGCGATTTATCCATGGCGGATTTTCGCAACGTCAGTGCCCTGGGAATTGAAATTCGCCACTGCCGCGCGCAGGGTTCAGATTTTCGCGGCGCGAGTTTTATGAACATGATCACCACGCGGACCTGGTTTTGCAGCGCATACATCACGAATACCAATCTAAGCTACGCCAACTTTTCGAAGGTTGTCCTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTAGCGGGTGCAACGTTCAGTGGATCAGATCTCTCGGGAGGTGAATTTTCAGCGTTCGACTGGCGGGCCGCAAATTTCACGCACTGTGATTTGACCAATTCAGAACTGGGTGATTTAGATATTCGGGGTGTAGATTTACAAGGCGTCAAATTGGATAGCTATCAGGCAGCGTTGCTGATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|244|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB36", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "272", "ARO_accession": "3002751", "ARO_name": "QnrB36", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.96569e-11, "max_identities": 37, "bit_score": 59.3066, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+  I + CDL  A        G  +       AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATACCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|244|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB36", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "272", "ARO_accession": "3002751", "ARO_name": "QnrB36", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000314739, "max_identities": 28, "bit_score": 38.5058, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+D      ++  AD R     G+++      G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDTIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAATCGCTTCACCGGTGAGAAAGTTGAAAATAGTACATTTTTTAACTGCGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGCCAGTTCTATGATCGCGAAAGTCAGAAAGGATGCAATTTTAGTCGCGCAATGCTGAAAGATACCATTTTCAAAAGCTGTGATTTATCAATGGCAGATTTCCGCAACGTCAGCGCATTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGTGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGCAGCGCATATATCACTAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTATGGGAAAACCGCTGGATGGGGACTCAGGTACTGGGTGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTAGGTGACTTAGATATTCGGGGTGTTGATTTACAAGGCGTTAAGTTAGACAACTACCAGGCATCGTTGCTCATGGAGCGGCTTGGCATCGCTGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.05}, "gnl|BL_ORD_ID|1072|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB34", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1160", "ARO_accession": "3002749", "ARO_name": "QnrB34", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.15135e-11, "max_identities": 37, "bit_score": 59.3066, "cvterm_id": "39583", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGTACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGGTTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 99, "hit_end": 546, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|1072|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB34", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1160", "ARO_accession": "3002749", "ARO_name": "QnrB34", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.01096e-05, "max_identities": 22, "bit_score": 42.743, "cvterm_id": "39583", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  G  + GA  + +DL+  +    D R A     +L +++L D +VR  DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQ", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGTACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGGTTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 330, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|1072|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB34", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1160", "ARO_accession": "3002749", "ARO_name": "QnrB34", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00015614, "max_identities": 29, "bit_score": 39.2762, "cvterm_id": "39583", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  GA + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  A  R     G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGTACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGGTTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 36, "hit_end": 423, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|1255|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB69", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1369", "ARO_accession": "3002781", "ARO_name": "QnrB69", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.42462e-11, "max_identities": 37, "bit_score": 58.9214, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGAAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTACTTGGCGCAACGTTCAGTGGATCGGACCTCTCTGGCGGCGAGTTTTCATCGTTCGACTGGCGGGCAGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTTAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|1255|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB69", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1369", "ARO_accession": "3002781", "ARO_name": "QnrB69", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.18543e-05, "max_identities": 22, "bit_score": 42.743, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  G  + GA  + +DL+  +    D R A     +L +++L D +VR  DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQ", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGAAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTACTTGGCGCAACGTTCAGTGGATCGGACCTCTCTGGCGGCGAGTTTTCATCGTTCGACTGGCGGGCAGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTTAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 327, "hit_end": 576, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|1255|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB69", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1369", "ARO_accession": "3002781", "ARO_name": "QnrB69", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.29946e-05, "max_identities": 29, "bit_score": 40.4318, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGAAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGTACTCAGGTACTTGGCGCAACGTTCAGTGGATCGGACCTCTCTGGCGGCGAGTTTTCATCGTTCGACTGGCGGGCAGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTTAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|475|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrD2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "517", "ARO_accession": "3002789", "ARO_name": "QnrD2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.52457e-11, "max_identities": 41, "bit_score": 58.9214, "cvterm_id": "35743", "query": "DLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAV", "match": "DL  T        +DR+S    D  RA+L+ A  + CDL  +        G  ++      AD R A+       R+    A ++  N+  A+     L   +LW     GT + GAV   + L+  E S      AD  G DLT  A+", "sequence_from_db": "DLTDTEFVDCSF-YDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGAL", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAGATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGACGAACTAATTTAGATGGCGTGAAGTTGGATGGAGAACAGGCGTTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 16241, "query_end": 16672, "hit_start": 99, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.52}, "gnl|BL_ORD_ID|475|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrD2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "517", "ARO_accession": "3002789", "ARO_name": "QnrD2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.706878, "max_identities": 23, "bit_score": 28.1054, "cvterm_id": "35743", "query": "WDRSSPVAADH-KRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL", "match": "W  S+ +   +   A     IL  C+L + R +G  + GA    +DL+  +    D      + A+    DL+   + + D R  +L GV L", "sequence_from_db": "WFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDW-----SLADFTGCDLTGGALGELDARRTNLDGVKL", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRTNLDGVKLDGEQAFQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAGATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGACGAACTAATTTAGATGGCGTGAAGTTGGATGGAGAACAGGCGTTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 16280, "query_end": 16552, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.0}, "gnl|BL_ORD_ID|758|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrD1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "822", "ARO_accession": "3002788", "ARO_name": "QnrD1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.87922e-11, "max_identities": 41, "bit_score": 58.9214, "cvterm_id": "35711", "query": "DLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAV", "match": "DL  T        +DR+S    D  RA+L+ A  + CDL  +        G  ++      AD R A+       R+    A ++  N+  A+     L   +LW     GT + GAV   + L+  E S      AD  G DLT  A+", "sequence_from_db": "DLTDTEFVDCSF-YDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGAL", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAAATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGGCGAATTAATTTAGATGGAGTGAAGTTGGATGGAGAGCAGGCGCTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 16241, "query_end": 16672, "hit_start": 99, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.52}, "gnl|BL_ORD_ID|758|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrD1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "822", "ARO_accession": "3002788", "ARO_name": "QnrD1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.02244, "max_identities": 23, "bit_score": 27.7202, "cvterm_id": "35711", "query": "WDRSSPVAADH-KRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL", "match": "W  S+ +   +   A     IL  C+L + R +G  + GA    +DL+  +    D      + A+    DL+   + + D R  +L GV L", "sequence_from_db": "WFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDW-----SLADFTGCDLTGGALGELDARRINLDGVKL", "sequence_from_broadstreet": "MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLEGCDFNRAKLKNASFKSCDLSMSNFKNISALGLEISECLAQGADFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVILEKCELWENRWNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGALGELDARRINLDGVKLDGEQALQLVESLGVIVHR", "dna_sequence_from_broadstreet": "ATGGAAAAGCACTTTATCAATGAAAAGTTTTCACGAGATCAATTTACGGGGAATAGAGTTAAAAATATTGCCTTTTCAAATTGTGATTTTTCAGGGGTTGATTTAACTGATACTGAATTTGTTGATTGTAGTTTTTACGACAGGAATAGCTTGGAAGGGTGTGATTTTAATAGAGCCAAACTAAAAAACGCTAGCTTTAAAAGCTGCGATTTATCAATGAGTAATTTTAAAAACATTAGCGCCTTAGGTCTTGAAATTAGTGAGTGTTTAGCTCAAGGAGCTGATTTTCGAGGGGCTAATTTTATGAATATGATAACTACAAGGTCATGGTTTTGTAGTGCTTATATAACCAAGACAAATCTTAGTTACGCTAATTTTTCTAGAGTCATATTAGAAAAGTGCGAACTGTGGGAAAATCGCTGGAATGGCACTGTGATAACTGGCGCCGTGTTTCGTGGCTCCGATCTTTCTTGTGGGGAGTTTTCATCGTTTGATTGGTCTTTGGCTGATTTTACTGGTTGTGATTTAACGGGTGGGGCGCTTGGCGAGCTTGATGCAAGGCGAATTAATTTAGATGGAGTGAAGTTGGATGGAGAGCAGGCGCTTCAGCTTGTTGAGAGTTTAGGTGTTATTGTTCACCGATAA", "partial": "0", "query_start": 16280, "query_end": 16552, "hit_start": 327, "hit_end": 588, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.0}, "gnl|BL_ORD_ID|371|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "411", "ARO_accession": "3002725", "ARO_name": "QnrB11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.00466e-11, "max_identities": 37, "bit_score": 58.9214, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGCGCCGACCTCAGCGGCACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCGGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 99, "hit_end": 546, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|371|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "411", "ARO_accession": "3002725", "ARO_name": "QnrB11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.28562e-05, "max_identities": 22, "bit_score": 42.743, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  G  + GA  + +DL+  +    D R A     +L +++L D +VR  DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQ", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGCGCCGACCTCAGCGGCACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCGGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 330, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|371|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "411", "ARO_accession": "3002725", "ARO_name": "QnrB11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.11693e-05, "max_identities": 30, "bit_score": 41.9726, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  GA + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVMG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCGTTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGCGCCGACCTCAGCGGCACTGAGTTTATTGGCTGCCAGTTCTATGATCGAGAAAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCGGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGTATCGCTGTCATGGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 36, "hit_end": 423, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|1175|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1280", "ARO_accession": "3002726", "ARO_name": "QnrB12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.28243e-11, "max_identities": 37, "bit_score": 58.9214, "cvterm_id": "39583", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGCACTGAGTTTATTGGCTGTCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 99, "hit_end": 546, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|1175|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1280", "ARO_accession": "3002726", "ARO_name": "QnrB12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.34641e-05, "max_identities": 22, "bit_score": 42.3578, "cvterm_id": "39583", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  G  + GA  + +DL+  +    D R A     +L +++L D +VR  DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQ", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGCACTGAGTTTATTGGCTGTCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 330, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|1175|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1280", "ARO_accession": "3002726", "ARO_name": "QnrB12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.19654e-05, "max_identities": 30, "bit_score": 41.9726, "cvterm_id": "39583", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  GA + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGATGACTCTGGCATTAGTTGGCGAAAAAATTGACAGAAACAGATTCACTGGTGCGAAAGTTGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTCAGCGGCACTGAGTTTATTGGCTGTCAGTTCTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGTCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGTGATCTCTCCATGGCGGATTTCAGGAATGTGAGCGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGTTGGATGGGTACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGGGCCGCAAACTTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGCGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 36, "hit_end": 423, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.56}, "gnl|BL_ORD_ID|821|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB37", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "891", "ARO_accession": "3002752", "ARO_name": "QnrB37", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.35203e-11, "max_identities": 37, "bit_score": 58.5362, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A        G  +       +D R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A++T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSEL", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTTGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGGAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGAGCCGCAAACGTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGAGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|821|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB37", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "891", "ARO_accession": "3002752", "ARO_name": "QnrB37", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.12145e-05, "max_identities": 22, "bit_score": 42.743, "cvterm_id": "36915", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLR", "match": "W  S+ +   +   A     +L  C+L + R  G  + GA  + +DL+  +    D R A     +L +++L D +VR  DL+", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQ", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTTGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGGAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGAGCCGCAAACGTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGAGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16280, "query_end": 16525, "hit_start": 327, "hit_end": 576, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.51}, "gnl|BL_ORD_ID|821|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB37", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "891", "ARO_accession": "3002752", "ARO_name": "QnrB37", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.07736e-05, "max_identities": 29, "bit_score": 40.0466, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R     G+++      G+D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAILKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDVRGVDLQGVKLDSYQASLILERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACTCTTGCGTTAGTTGGCGAAAAAATTGACAGAAACAGGTTCACCGGTGAGAAAGTCGAAAATAGCACATTTTTCAACTGTGATTTTTCGGGTGCCGACCTTAGCGGTACTGAGTTTATTGGCTGCCAATTTTATGATCGAGAGAGCCAGAAAGGGTGTAATTTTAGCCGCGCTATCCTGAAAGATGCCATTTTCAAAAGTTGCGATCTCTCCATGGCGGATTTCAGGAATGTGAGTGCGCTGGGAATCGAAATTCGCCACTGCCGCGCACAAGGTTCAGATTTTCGCGGCGCAAGCTTTATGAATATGATTACCACACGCACCTGGTTTTGTAGCGCCTATATCACCAATACCAACTTAAGCTACGCCAACTTTTCAAAAGTCGTACTGGAAAAGTGCGAGCTGTGGGAAAACCGCTGGATGGGAACTCAGGTACTGGGGGCGACGTTCAGTGGTTCAGATCTTTCCGGCGGTGAGTTTTCGTCGTTCGACTGGCGAGCCGCAAACGTTACGCACTGTGATTTGACCAATTCAGAACTGGGCGATCTCGATGTCCGGGGTGTTGATTTGCAAGGAGTCAAACTGGACAGCTACCAGGCATCGTTGATCCTGGAACGTCTTGGCATCGCTGTCATTGGTTAA", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|4921|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB80", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5912", "ARO_accession": "3003192", "ARO_name": "QnrB80", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.78962e-11, "max_identities": 44, "bit_score": 58.5362, "cvterm_id": "36915", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGA-------RLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CD     LS AD R A       R  RA    AD R A        R     A +++ N+  A+     L   +LW     G  +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCD-----LSMADFRNASALDIEIRHCRAQ--GADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGACATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 28.03}, "gnl|BL_ORD_ID|4921|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB80", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5912", "ARO_accession": "3003192", "ARO_name": "QnrB80", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000441897, "max_identities": 32, "bit_score": 38.1206, "cvterm_id": "36915", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNASALDIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAIIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGCTGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTTGACATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATCACCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTACCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGTGACTTAGATATTCGGGGGGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGATTATTGGCTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|1839|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.18598e-11, "max_identities": 37, "bit_score": 57.7658, "cvterm_id": "35914", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI + CDL  A    +   G  +       AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +         D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 96, "hit_end": 543, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.67}, "gnl|BL_ORD_ID|1839|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB74", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1993", "ARO_accession": "3002786", "ARO_name": "QnrB74", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.45954e-05, "max_identities": 29, "bit_score": 41.5874, "cvterm_id": "35914", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDL-----WGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     ++  AD R +   G+++      G D RGA      +       A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSCDLSMADFRNSSALGIEIRHCRAQGADFRGASFMNMIITRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWIGAQVLGATFSGSDFFGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGGCTCTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGTTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACTTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTGAAAGATGCCATTTTTAAAAGTTGTGATTTATCCATGGCGGATTTTCGCAATTCCAGTGCGCTGGGTATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGCTTTATGAATATGATTATCACGCGCACCTGGTTTTGTAGCGCATATATCACGAATACCAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGTTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATAGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATTTCTTCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACTAATTCGGAGTTGGGTGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCGTCGTTGCTCATGGAGCGGCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 33, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.8}, "gnl|BL_ORD_ID|1788|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.42991e-10, "max_identities": 41, "bit_score": 55.8398, "cvterm_id": "39584", "query": "PDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDL-----RDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQV", "match": " DL  T   G +  +DR S    +  RA L+ AI +  DL     R+A   G ++R  R        AD R A        R     A +++ N+  A+     L   +LW     GA +  A  +G +LS       D R A+ T   +  S++", "sequence_from_db": "ADLSGTEFIGCQF-YDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCR-----AQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSEL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16238, "query_end": 16687, "hit_start": 132, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.45}, "gnl|BL_ORD_ID|1788|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.14477e-06, "max_identities": 27, "bit_score": 43.1282, "cvterm_id": "39584", "query": "WDRSSPVA-ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "W  S+ +   +   A     +L  C+L + R  GA + GA  + +DL+  +    D R A     +L +++L D           D+RGVDL G  L", "sequence_from_db": "WFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDL----------DIRGVDLQGVKL", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16280, "query_end": 16567, "hit_start": 363, "hit_end": 624, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.84}, "gnl|BL_ORD_ID|1788|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrB30", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1940", "ARO_accession": "3002745", "ARO_name": "QnrB30", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00021268, "max_identities": 32, "bit_score": 38.891, "cvterm_id": "39584", "query": "RAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R +  G  + +    +   SGADL G         D   RE+  +    +RA L+DA     DLS A+ R A     ++R     G D RGA              A++   +L  A+ +   + + ++  +R", "sequence_from_db": "RNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYD---RESQ-KGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENR", "sequence_from_broadstreet": "MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAMLKDAIFKSSDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQASLLMERLGIAVIG", "dna_sequence_from_broadstreet": "ATGACGCCATTACTGTATAAAAAAACAGGTACAAATATGGCACTGGCACTCGTTGGCGAAAAAATTGACAGAAACCGCTTCACCGGTGAGAAAATTGAAAATAGTACATTTTTTAACTGTGATTTTTCAGGTGCCGACCTGAGCGGCACTGAATTTATCGGCTGTCAGTTCTATGATCGTGAAAGCCAGAAAGGGTGCAATTTTAGTCGTGCGATGCTAAAAGATGCCATTTTTAAAAGCAGTGATTTATCCATGGCGGATTTTCGCAATGCCAGTGCGCTGGGCATTGAAATTCGCCACTGCCGCGCACAAGGCGCAGATTTCCGCGGCGCAAGTTTTATGAATATGATCACTACTCGCACCTGGTTTTGTAGTGCATATATCACTAACACAAATCTAAGCTACGCCAATTTTTCGAAAGTCGTGCTGGAAAAGTGTGAGCTGTGGGAAAACCGTTGGATGGGTGCCCAGGTACTGGGCGCGACGTTCAGTGGTTCAGATCTCTCCGGCGGCGAGTTTTCGACTTTCGACTGGCGAGCAGCAAACTTCACACATTGCGATCTGACCAATTCGGAGTTGGGGGACTTAGATATTCGGGGCGTTGATTTACAAGGCGTTAAGTTGGACAACTACCAGGCATCGTTGCTCATGGAACGTCTTGGCATCGCGGTGATTGGTTAG", "partial": "0", "query_start": 16316, "query_end": 16699, "hit_start": 69, "hit_end": 456, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.06}, "gnl|BL_ORD_ID|1541|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.30047e-08, "max_identities": 42, "bit_score": 51.6026, "cvterm_id": "36771", "query": "RSSPVAADHKRAQLRGAILRDC----------------DLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVAR", "match": "R      D    QLR A   DC                DLRDA      L  A  + A+    + RE DL+ A  +RA   +  +S     K     A + G +L   +L G  L + +L     S A+L GA L G+DL+    +R", "sequence_from_db": "RCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYN-QIS----HKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSR", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16286, "query_end": 16678, "hit_start": 72, "hit_end": 498, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 28.57}, "gnl|BL_ORD_ID|1541|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.08365e-06, "max_identities": 36, "bit_score": 45.0542, "cvterm_id": "36771", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHL-----DGADLRGADLTDA", "match": "A LR A  + C L  A  SGA+  G      DL  A+   A        +     A +S  N+  A+L    L   +L+  +   A L  A L G +LS            +LRG DLT A", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16319, "query_end": 16666, "hit_start": 183, "hit_end": 546, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.75}, "gnl|BL_ORD_ID|1541|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.70357e-05, "max_identities": 36, "bit_score": 40.4318, "cvterm_id": "36771", "query": "ADHKRAQLRGAILRDCDLRDARLS---------------GADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELS", "match": "A+   A   G   R+CDL+ A  S                A + G  LA A+L+   L + +L E   + ANL  A     DLS     +   +  +LRG DL   DL G    R  L G+++ ", "sequence_from_db": "ANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16304, "query_end": 16615, "hit_start": 228, "hit_end": 600, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.03}, "gnl|BL_ORD_ID|1541|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1673", "ARO_accession": "3002712", "ARO_name": "QnrA6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000114219, "max_identities": 28, "bit_score": 39.6614, "cvterm_id": "36771", "query": "LARADLADADLREADLREATPARANLRD---------------------ADLSDANVRKADLRFADLRGVDLWG-----TDLRGAVLYRAKLAG-----LELSEAHLDGADLRGADLTDAAVARSQVL", "match": " +R DL+D+  R     +   +   LRD                     ADL DA+ +   L  A+  G + +G      DL+GA   RA+        +    A++ G +L  A+L+   + + ++ ", "sequence_from_db": "FSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELF", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAIEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCATCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16400, "query_end": 16690, "hit_start": 36, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.88}, "gnl|BL_ORD_ID|50|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "60", "ARO_accession": "3002795", "ARO_name": "QnrS6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.24198e-08, "max_identities": 48, "bit_score": 50.8322, "cvterm_id": "36810", "query": "SSPVAADHKRAQLRGAILRDC----------------DLRDARLSGADLRGARLARADLADADLREADLREATPARANLRD---------------ADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": " + +  D +RA LR A   +C                DLRDA      L  A  + A+    +LRE DL+ A  +RAN  +                +LS AN+ +  L   +L      GT L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "CTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQ", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTATGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 16289, "query_end": 16684, "hit_start": 75, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.97}, "gnl|BL_ORD_ID|50|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "60", "ARO_accession": "3002795", "ARO_name": "QnrS6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.46196e-06, "max_identities": 31, "bit_score": 44.669, "cvterm_id": "36810", "query": "CDLRDARLSGADLRGAR-LARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAG-----LELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "CD R A L  A     + + + D+       ADLR+A+  +  L  A+ S+AN            G++L   DL+GA   RA  A      +    A + G +L  A++    + + ++  +R", "sequence_from_db": "CDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY----------GIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENR", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELYENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTATGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 16349, "query_end": 16699, "hit_start": 90, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.2}, "gnl|BL_ORD_ID|1449|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1583", "ARO_accession": "3002803", "ARO_name": "QnrVC6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.9705e-08, "max_identities": 37, "bit_score": 50.447, "cvterm_id": "39615", "query": "ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": " D   A LR A  +DC L  +   GA+  G  L   DL  A+  +         +     A ++  N+  A+     +   DL+     G +LRGA    + L+               G +LS + L G D R  DLT   +   Q", "sequence_from_db": "CDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQ", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTTCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCAGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 16304, "query_end": 16684, "hit_start": 168, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.17}, "gnl|BL_ORD_ID|1449|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC6", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1583", "ARO_accession": "3002803", "ARO_name": "QnrVC6", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.20283e-06, "max_identities": 34, "bit_score": 45.0542, "cvterm_id": "39615", "query": "WDRSSPVAADHKRAQLRGAILRDCD-LRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-------GTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVAR", "match": "+   + +  + KR+ LR     +C  +    L G D   A L  A   D  L  +  + A      LRD DL  AN   + + F +     ++       G +L  A   +  +   +L E    GA+LRGA   ++ ++R", "sequence_from_db": "FSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANF--SQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSR", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKDCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTTCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCACTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAGATTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGGGCAAATTTTAGCCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGCTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGTCGTGGCGTTTTTTCAGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGTCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACAGGTGTAAAAATATGCTCGTGGCAACAGGAGCAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 16280, "query_end": 16678, "hit_start": 66, "hit_end": 483, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.11}, "gnl|BL_ORD_ID|1692|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1832", "ARO_accession": "3002791", "ARO_name": "QnrS2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.05523e-08, "max_identities": 48, "bit_score": 50.447, "cvterm_id": "35715", "query": "SSPVAADHKRAQLRGAILRDC----------------DLRDARLSGADLRGARLARADLADADLREADLREATPARANLRD---------------ADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": " + +  D +RA LR A   +C                DLRDA      L  A  + A+    +LRE DL+ A  +RAN  +                +LS AN+ +  L   +L      GT L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "CTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQ", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTTTGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 16289, "query_end": 16684, "hit_start": 75, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.97}, "gnl|BL_ORD_ID|1692|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1832", "ARO_accession": "3002791", "ARO_name": "QnrS2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.35996e-06, "max_identities": 31, "bit_score": 45.4394, "cvterm_id": "35715", "query": "CDLRDARLSGADLRGAR-LARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAG-----LELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "CD R A L  A     + + + D+       ADLR+A+  +  L  A+ S+AN            G++L   DL+GA   RA  A      +    A + G +L  A++    + + ++  +R", "sequence_from_db": "CDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCY----------GIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENR", "sequence_from_broadstreet": "METYRHTYRHHSFSHQDLSDITFTACTFIRCDFRRANLRDATFINCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIELRECDLKGANFSRANFANQVSNRMYFCSAFITGCNLSYANMERVCLEKCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIASWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGACACCACAGTTTTTCACATCAAGATCTAAGTGATATTACTTTCACTGCTTGCACCTTTATCCGATGCGATTTTCGACGTGCTAACTTGCGTGATGCGACATTTATTAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGTTGCCATTTTGATGTCGCAGACCTTCGCGATGCAAGTTTCCAACAATGCCAGCTTGCGATGGCAAACTTTAGTAACGCCAATTGCTACGGTATTGAGTTACGTGAGTGTGATTTAAAAGGGGCCAACTTTTCCCGAGCAAACTTTGCCAATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACTGGATGTAACCTGTCTTATGCCAATATGGAGCGGGTCTGTTTAGAAAAATGTGAGCTGTTTGAAAATCGCTGGATAGGGACTCACCTCGCGGGCGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCTGAAGATGTCTGGGGACAGTTTAGCCTACAGGGTGCTAATTTATGTCACGCCGAACTCGACGGTTTAGATCCTCGAAAAGTCGATACATCAGGTATCAAAATTGCCAGCTGGCAACAAGAACAGCTTCTCGAAGCGTTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 16349, "query_end": 16699, "hit_start": 90, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.2}, "gnl|BL_ORD_ID|1062|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1150", "ARO_accession": "3002802", "ARO_name": "QnrVC5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.3619e-08, "max_identities": 39, "bit_score": 50.0618, "cvterm_id": "39525", "query": "DLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGA---------------VLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQ", "match": "+LR T         +R      D   + LR A  ++C L  +   GA+  G      DL  A+  +A        R     A ++  N+  A+     +   DL+     G +L GA                  + +L G +LS + L G D R  DLT   +   Q", "sequence_from_db": "NLRDTQFVDCSFI-ERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQ", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTTCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 16241, "query_end": 16684, "hit_start": 108, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 23.21}, "gnl|BL_ORD_ID|1062|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1150", "ARO_accession": "3002802", "ARO_name": "QnrVC5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.53283e-07, "max_identities": 29, "bit_score": 47.3654, "cvterm_id": "39525", "query": "VAADHKRAQLRGAILRDCDLRDARLSGADLRGARLA------RADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "V AD     + G   ++C         A+LR  +        R +L   D   +DLR+A+    +L  +    AN    + R  DL+G +         V  R     +    A++ G +L  A+     + +  +  +R", "sequence_from_db": "VQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNR-----MYFCSAYITGCNLSYANFERQCIEKCDLFENR", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFSQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTTCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 16298, "query_end": 16699, "hit_start": 24, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 20.71}, "gnl|BL_ORD_ID|1717|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.66912e-08, "max_identities": 43, "bit_score": 49.6766, "cvterm_id": "36789", "query": "DLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPAR-----ANLRDADLSDANVRKADLRFADLR-----GVDLWGTDLRGAVLYR----------AKLAGLELSEAHLDGADLRGADLTDAAVARSQ", "match": "+LR T         +R      D   + LR A  ++C L  +   GA+  G      DL  A+  +A        R     A +   +LS AN  +  +   DL      G +L GT  + + L R           +L G +LS + L G D R  DLT   +   Q", "sequence_from_db": "NLRDTQFVDCSFI-ERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQ", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 16241, "query_end": 16684, "hit_start": 108, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.6}, "gnl|BL_ORD_ID|1717|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1859", "ARO_accession": "3003193", "ARO_name": "QnrVC7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.69648e-07, "max_identities": 30, "bit_score": 47.7506, "cvterm_id": "36789", "query": "VAADHKRAQLRGAILRDCDLRDARLSGADLRGARLA------RADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "V AD     L G   ++C         A+LR  +        R +L   D   +DLR+A+    +L  +    AN    + R  DL+G +         V  R     +    A++ G +L  A+     + +  +  +R", "sequence_from_db": "VQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNR-----MYFCSAYITGCNLSYANFERQCIEKCDLFENR", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDLSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGTSFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCTGACTTTTCACATCAAGACTTGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGGGCAAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGAGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGACGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAGTGCGATTTAAAGGGGGCAAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCCTATATAACAGGTTGTAATCTGTCATACGCAAATTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGTGCAAATTTGAGTGGGACATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGCTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGCTGTATGGTTTAGACCCCCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAACAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 16298, "query_end": 16699, "hit_start": 24, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.43}, "gnl|BL_ORD_ID|1663|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1803", "ARO_accession": "3002800", "ARO_name": "QnrVC3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.66912e-08, "max_identities": 36, "bit_score": 49.6766, "cvterm_id": "36920", "query": "ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": " D   A LR A  ++C L  +   GA+  G  L   DL  A+  +         +     A ++  N+  A+     +   DL+     G +LRGA    + L+               G +LS + L G D R  DLT   +   Q", "sequence_from_db": "CDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQ", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTACTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTACAGAATCATATTTAAGCCGTGGTGATTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 16304, "query_end": 16684, "hit_start": 168, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.49}, "gnl|BL_ORD_ID|1663|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1803", "ARO_accession": "3002800", "ARO_name": "QnrVC3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.03854e-07, "max_identities": 33, "bit_score": 46.2098, "cvterm_id": "36920", "query": "LRGAILRDCDLRDARLSGADLRGARLARADLAD------ADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAV-----LYRAKLAGLELSEAHLD---------------GADLRGADLTDAAVAR", "match": "L+  I  +C         ++LR  +       +       D   ADLR+A+     L  +    AN    +LR  DL+G +         V        A + G  LS A+ +               GA+LRGA  T++ ++R", "sequence_from_db": "LQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSR", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFTQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFTESYLSRGDFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTACTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTACAGAATCATATTTAAGCCGTGGTGATTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 16325, "query_end": 16678, "hit_start": 51, "hit_end": 483, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.92}, "gnl|BL_ORD_ID|408|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.09621e-08, "max_identities": 39, "bit_score": 49.2914, "cvterm_id": "36936", "query": "DLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGA---------------VLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQ", "match": "+LR T         +R      D   + LR A  ++C L  +   GA+  G      DL  A+  +A        R     A ++  N+  A+     +   DL+     G +L GA                  + +L G +LS + L G D R  DLT   +   Q", "sequence_from_db": "NLRDTQFVDCSFI-ERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQ", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 16241, "query_end": 16684, "hit_start": 108, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 23.21}, "gnl|BL_ORD_ID|408|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "452", "ARO_accession": "3002801", "ARO_name": "QnrVC4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.33583e-07, "max_identities": 29, "bit_score": 46.9802, "cvterm_id": "36936", "query": "VAADHKRAQLRGAILRDCDLRDARLSGADLRGARLA------RADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "V AD     + G   ++C         A+LR  +        R +L   D   +DLR+A+    +L  +    AN    + R  DL+G +         V  R     +    A++ G +L  A+     + +  +  +R", "sequence_from_db": "VQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNR-----MYFCSAYITGCNLSYANFERQCIEKCDLFENR", "sequence_from_broadstreet": "MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFSYSDLRDASFKNCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFERQCIEKCDLFENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKICSWQQEQLLEQLGLIVVPD", "dna_sequence_from_broadstreet": "ATGGATAAAACAGACCAGTTATATGTACAAGCAGACTTTTCACATCAAGACATGAGTGGTCAGTATTTTAAAAATTGCAAATTTTTCTGCTGTTCCTTTAAACGAGCGAACCTCCGCGATACACAATTTGTAGATTGTTCTTTCATTGAACGAGGTGAATTAGAGGGGTGTGATTTTTCTTACTCGGATCTTAGAGATGCATCTTTTAAAAACTGCAGTCTTTCAATGTCGTATTTCAAAGGTGCAAATTGTTTTGGTATCGAGTTCAGAGAATGCGATTTAAAGGGTGCCAATTTTGCTCAAGCTAGCTTCATGAATCAGGTATCGAACAGAATGTATTTTTGTTCAGCTTATATAACAGGTTGTAATCTTTCATACGCCAACTTTGAAAGGCAGTGTATCGAAAAGTGTGATTTGTTTGAGAATAGATGGATTGGCGCAAATCTGAGTGGTGCATCATTTAAAGAGTCTGATTTAAGTCGGGGAGTATTTTCTGAAGGGTGTTGGAGCCAGTGTAGGTTGCAAGGTTGTGATTTGAGCCACTCGGAGTTGTATGGTTTAGACCCTCGGAAAGTTGACCTTACAGGTGTAAAAATCTGTTCGTGGCAGCAAGAACAACTTTTAGAGCAATTAGGTTTAATAGTAGTTCCTGACTAA", "partial": "0", "query_start": 16298, "query_end": 16699, "hit_start": 24, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 20.71}, "gnl|BL_ORD_ID|1239|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.21962e-08, "max_identities": 36, "bit_score": 48.9062, "cvterm_id": "36789", "query": "ADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": " D   A LR A  ++C L  +   GA+  G  L   DL  A+  +         +     A ++  N+  A+     +   DL+     G +LRGA    + L+               G +LS + L G D R  DLT   +   Q", "sequence_from_db": "CDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQ", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 16304, "query_end": 16684, "hit_start": 168, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.49}, "gnl|BL_ORD_ID|1239|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000657374, "max_identities": 35, "bit_score": 37.3502, "cvterm_id": "36789", "query": "WDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARAN-----LRDADLSDANVRKAD--------LRF--ADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLT", "match": "+   + +  + KR+ LR     +C   +    GA L G   + ADL DA  +   L  +    AN     LRD DL  AN  +          + F  A + G +L   +    ++ +  L       A+L GA  + +DL+", "sequence_from_db": "FSNCTFIHCNFKRSNLRDTQFINCTFIE---QGA-LEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLS", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 16280, "query_end": 16660, "hit_start": 66, "hit_end": 480, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.65}, "gnl|BL_ORD_ID|1239|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrVC1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1351", "ARO_accession": "3002799", "ARO_name": "QnrVC1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.002832, "max_identities": 23, "bit_score": 35.4242, "cvterm_id": "36789", "query": "RADLADADLREADLREATPARANLRDADLSDANVRKADLRFAD---LRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVAR", "match": "+ + +  DL+E      T    N + ++L D      +  F +   L G D    DLR A     +L+      A+  G +LR  DL  A  ++", "sequence_from_db": "QVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQF--INCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQ", "sequence_from_broadstreet": "MEKSKQLYNQVNFSHQDLQEHIFSNCTFIHCNFKRSNLRDTQFINCTFIEQGALEGCDFSYADLRDASFKNCQLSMSHFKGANCFGIELRDCDLKGANFSQVSFVNQVSNKMYFCSAYITGCNLSYANFEQQLIEKCDLFENRWIGANLRGASFKESDLSRGVFSEDCWEQFRVQGCDLSHSELYGLDPRKIDLTGVKICSWQQEQLLEQLGVIIVPD", "dna_sequence_from_broadstreet": "ATGGAAAAATCAAAGCAATTATATAATCAAGTGAACTTCTCACATCAGGACTTGCAAGAACATATCTTTAGCAATTGTACTTTTATACATTGTAATTTTAAGCGCTCAAACCTCCGAGATACACAGTTCATTAACTGTACTTTCATAGAGCAGGGGGCATTGGAAGGGTGCGATTTTTCTTATGCTGATCTTCGAGATGCTTCATTTAAAAACTGTCAGCTTTCAATGTCCCATTTTAAGGGGGCAAATTGCTTTGGTATTGAACTGAGAGATTGTGATCTTAAAGGAGCAAATTTTAGTCAAGTTAGTTTTGTAAATCAGGTTTCGAATAAAATGTACTTTTGTTCTGCATACATAACAGGTTGTAACTTATCCTATGCCAATTTTGAGCAGCAGCTTATTGAAAAATGTGACCTGTTCGAAAATAGATGGATTGGTGCAAATCTTCGAGGCGCTTCATTTAAAGAATCAGATTTAAGCCGTGGTGTTTTTTCGGAAGACTGCTGGGAACAGTTTAGAGTACAAGGCTGTGATTTAAGCCATTCAGAGCTTTATGGTTTAGATCCTCGAAAGATTGATCTTACGGGTGTAAAAATATGCTCGTGGCAACAGGAACAGTTACTGGAGCAATTAGGGGTAATCATTGTTCCTGACTAA", "partial": "0", "query_start": 16406, "query_end": 16678, "hit_start": 27, "hit_end": 303, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.47}, "gnl|BL_ORD_ID|645|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "699", "ARO_accession": "3002798", "ARO_name": "QnrS9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.2171e-07, "max_identities": 30, "bit_score": 47.7506, "cvterm_id": "35915", "query": "ELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "+L +   + + +D +RA LR     +C                + + D+       ADLR+A+  +  L  A+ S+AN    + R  DL+G + + T+    V  R     +    A + G +L  A++    + + ++  +R", "sequence_from_db": "DLTFTACTFIRSDFRRANLRDTTFVNCKF--------------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNR-----MYFCSAFISGCNLSYANMERVCLEKCELFENR", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTTCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16271, "query_end": 16699, "hit_start": 57, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 20.98}, "gnl|BL_ORD_ID|645|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS9", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "699", "ARO_accession": "3002798", "ARO_name": "QnrS9", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.50062e-06, "max_identities": 38, "bit_score": 44.2838, "cvterm_id": "35915", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": "A LR A  + C L  A  S A+  G      DL  A+    +       R     A +S  N+  A++    L   +L+     GT+L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "ADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQ", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTTCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16319, "query_end": 16684, "hit_start": 183, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.76}, "gnl|BL_ORD_ID|734|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "mfpA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "801", "ARO_accession": "3003035", "ARO_name": "mfpA", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.36973e-07, "max_identities": 42, "bit_score": 46.2098, "cvterm_id": "39507", "query": "DHKRAQLRGAILRDCDLRDARLS-----GADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWG----------TDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAE", "match": "D  R     A+  +CD     L+     G+  R     R  L  +   +  +  +      LR   L D +   A L   DLRG++L G          TDLR  VL  A L+G   + A LD ADLRGA +       + ++ +R+D +", "sequence_from_db": "DLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVD", "sequence_from_broadstreet": "MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG", "dna_sequence_from_broadstreet": "TTGCAGCAGTGGGTTGATTGCGAATTCACCGGTCGAGACTTCCGCGACGAGGACCTTAGCCGCCTGCACACCGAACGGGCGATGTTCAGCGAATGCGATTTCAGCGGCGTGAATCTGGCCGAGTCACAACACCGAGGGTCGGCGTTTCGTAATTGCACCTTCGAACGGACGACACTGTGGCACAGCACATTTGCCCAGTGCAGCATGTTGGGCTCGGTCTTCGTGGCTTGCCGGCTGCGGCCGCTGACGTTGGACGACGTGGATTTCACGCTCGCCGTGCTCGGCGGAAATGATCTGCGTGGTCTCAACTTGACCGGCTGCCGGTTGCGAGAGACCAGCCTGGTGGATACCGACTTGCGCAAGTGCGTGCTGCGCGGCGCCGACCTCAGTGGTGCCCGTACCACGGGCGCCCGGCTGGATGACGCCGACTTGCGGGGCGCGACCGTGGACCCGGTATTGTGGCGGACCGCGTCGTTGGTGGGTGCGCGTGTCGACGTCGACCAAGCCGTGGCCTTTGCGGCGGCGCACGGGCTGTGCTTGGCAGGGGGCTAG", "partial": "0", "query_start": 16307, "query_end": 16711, "hit_start": 51, "hit_end": 501, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 28.0}, "gnl|BL_ORD_ID|734|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "mfpA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "801", "ARO_accession": "3003035", "ARO_name": "mfpA", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.206103, "max_identities": 24, "bit_score": 29.6462, "cvterm_id": "39507", "query": "DARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLT", "match": "D   +G D R   L+R     A   E D      A +  R +   +    +  L  +      + G+      L    L  ++ + A L G DLRG +LT", "sequence_from_db": "DCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLT", "sequence_from_broadstreet": "MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG", "dna_sequence_from_broadstreet": "TTGCAGCAGTGGGTTGATTGCGAATTCACCGGTCGAGACTTCCGCGACGAGGACCTTAGCCGCCTGCACACCGAACGGGCGATGTTCAGCGAATGCGATTTCAGCGGCGTGAATCTGGCCGAGTCACAACACCGAGGGTCGGCGTTTCGTAATTGCACCTTCGAACGGACGACACTGTGGCACAGCACATTTGCCCAGTGCAGCATGTTGGGCTCGGTCTTCGTGGCTTGCCGGCTGCGGCCGCTGACGTTGGACGACGTGGATTTCACGCTCGCCGTGCTCGGCGGAAATGATCTGCGTGGTCTCAACTTGACCGGCTGCCGGTTGCGAGAGACCAGCCTGGTGGATACCGACTTGCGCAAGTGCGTGCTGCGCGGCGCCGACCTCAGTGGTGCCCGTACCACGGGCGCCCGGCTGGATGACGCCGACTTGCGGGGCGCGACCGTGGACCCGGTATTGTGGCGGACCGCGTCGTTGGTGGGTGCGCGTGTCGACGTCGACCAAGCCGTGGCCTTTGCGGCGGCGCACGGGCTGTGCTTGGCAGGGGGCTAG", "partial": "0", "query_start": 16361, "query_end": 16660, "hit_start": 15, "hit_end": 315, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.0}, "gnl|BL_ORD_ID|734|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "mfpA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "350", "model_id": "801", "ARO_accession": "3003035", "ARO_name": "mfpA", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.252035, "max_identities": 23, "bit_score": 29.261, "cvterm_id": "39507", "query": "DLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGA", "match": "DLR  +L G  L    +S V  D ++  LRGA L       ARL  ADLRGA", "sequence_from_db": "DLRGLNLTGCRL--RETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGA", "sequence_from_broadstreet": "MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLWHSTFAQCSMLGSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLSGARTTGARLDDADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG", "dna_sequence_from_broadstreet": "TTGCAGCAGTGGGTTGATTGCGAATTCACCGGTCGAGACTTCCGCGACGAGGACCTTAGCCGCCTGCACACCGAACGGGCGATGTTCAGCGAATGCGATTTCAGCGGCGTGAATCTGGCCGAGTCACAACACCGAGGGTCGGCGTTTCGTAATTGCACCTTCGAACGGACGACACTGTGGCACAGCACATTTGCCCAGTGCAGCATGTTGGGCTCGGTCTTCGTGGCTTGCCGGCTGCGGCCGCTGACGTTGGACGACGTGGATTTCACGCTCGCCGTGCTCGGCGGAAATGATCTGCGTGGTCTCAACTTGACCGGCTGCCGGTTGCGAGAGACCAGCCTGGTGGATACCGACTTGCGCAAGTGCGTGCTGCGCGGCGCCGACCTCAGTGGTGCCCGTACCACGGGCGCCCGGCTGGATGACGCCGACTTGCGGGGCGCGACCGTGGACCCGGTATTGTGGCGGACCGCGTCGTTGGTGGGTGCGCGTGTCGACGTCGACCAAGCCGTGGCCTTTGCGGCGGCGCACGGGCTGTGCTTGGCAGGGGGCTAG", "partial": "0", "query_start": 16241, "query_end": 16396, "hit_start": 291, "hit_end": 441, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 44.23}, "gnl|BL_ORD_ID|1835|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.3135e-07, "max_identities": 37, "bit_score": 46.2098, "cvterm_id": "35915", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVAR", "match": "A LR A  + C L  A  SGA+  G           + RE DL+ A  +RA        +    K     A + G +L  T+L G  L + +L     S A+L GA L G+DL+    +R", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFG----------IEFRECDLKGANFSRARFY-----NQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSR", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16319, "query_end": 16678, "hit_start": 183, "hit_end": 498, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 30.83}, "gnl|BL_ORD_ID|1835|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1987", "ARO_accession": "3002707", "ARO_name": "QnrA1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000150429, "max_identities": 32, "bit_score": 39.2762, "cvterm_id": "35915", "query": "ADHKRAQLRGAILRDCDLRDARLS---------------GADLRGARLARADLADADLREADLREATPARANLRDADL---------------SDANVRKADLRFADLRGVD", "match": "A+   A   G   R+CDL+ A  S                A + G  LA  +L+   L + +L E   + ANL  A L                  N+R  DL FADL G+D", "sequence_from_db": "ANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLD", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCACTGTCAGCTGCAGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGTCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGTCTGTCTTTGGCCAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTCTACAATCAAGTCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGTTGCAACCTGGCCTATACCAACTTGAGTGGCCAATGCCTGGAAAAATGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAATCTCAGCGGCGCTTCCTTGATGGGCTCAGATCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTAACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGAGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGCTGGAACCCTTGGGAGTAATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16304, "query_end": 16549, "hit_start": 228, "hit_end": 564, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 28.57}, "gnl|BL_ORD_ID|1627|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1775", "ARO_accession": "3002796", "ARO_name": "QnrS7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.01043e-06, "max_identities": 33, "bit_score": 45.8246, "cvterm_id": "35914", "query": "ELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "+L +   + + +D +RA LR     +C      +   D+ G     ADL DA  ++  L     A AN      S+AN    + R  DL+G +   T+    V  R     +    A + G +L  A++    + + ++  +R", "sequence_from_db": "DLTFTACTFIRSDFRRANLRDTTFVNCKF----IEQGDIEGCHFDVADLHDASFQQCQL-----AMANF-----SNANCYGIEFRACDLKGANFSRTNFAHQVSNR-----MYFCSAFISGCNLSYANMERVCLEKCELFENR", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCATGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16271, "query_end": 16699, "hit_start": 57, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 23.08}, "gnl|BL_ORD_ID|1627|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1775", "ARO_accession": "3002796", "ARO_name": "QnrS7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.08152e-05, "max_identities": 37, "bit_score": 42.743, "cvterm_id": "35914", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": "A L  A  + C L  A  S A+  G      DL  A+    +       R     A +S  N+  A++    L   +L+     GT+L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "ADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQ", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLHDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCATGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16319, "query_end": 16684, "hit_start": 183, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.06}, "gnl|BL_ORD_ID|2107|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "455", "model_id": "3323", "ARO_accession": "3004624", "ARO_name": "QnrS11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.08835e-06, "max_identities": 30, "bit_score": 45.8246, "cvterm_id": "35914", "query": "RDARLSGADLRGARLARADLADADLREADLREATPAR----------------ANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAG-----LELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R    S  DL G          +D R A+LR+ T                   A+LRDA      +  A+   A+  G++    DL+GA   R   A      +    A + G +L  A++    + + ++  +R", "sequence_from_db": "RHHNFSHKDLSGLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENR", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSGLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGGTCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16358, "query_end": 16699, "hit_start": 24, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.22}, "gnl|BL_ORD_ID|2107|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS11", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "455", "model_id": "3323", "ARO_accession": "3004624", "ARO_name": "QnrS11", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.53136e-06, "max_identities": 38, "bit_score": 44.669, "cvterm_id": "35914", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": "A LR A  + C L  A  S A+  G      DL  A+    +       R     A +S  N+  A++    L   +L+     GT+L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "ADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQ", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSGLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGGTCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16319, "query_end": 16684, "hit_start": 183, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.76}, "gnl|BL_ORD_ID|629|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "682", "ARO_accession": "3002793", "ARO_name": "QnrS4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.16144e-06, "max_identities": 30, "bit_score": 45.8246, "cvterm_id": "35767", "query": "ELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "+L +   + + +D +RA LR     +C                + + D+       ADLR+A+  +  L  A+ S+AN    + R  DL+G +   T+    V  R     +    A + G +L  A++    + + ++  +R", "sequence_from_db": "DLTFTACTFIRSDFRRANLRDTTFVNCKF--------------IEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNR-----MYFCSAFISGCNLSYANMERVCLEKCELFENR", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGCCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16271, "query_end": 16699, "hit_start": 57, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 20.98}, "gnl|BL_ORD_ID|629|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "682", "ARO_accession": "3002793", "ARO_name": "QnrS4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.31144e-06, "max_identities": 38, "bit_score": 44.2838, "cvterm_id": "35767", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": "A LR A  + C L  A  S A+  G      DL  A+    +       R     A +S  N+  A++    L   +L+     GT+L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "ADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQ", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDAADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGCCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16319, "query_end": 16684, "hit_start": 183, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.76}, "gnl|BL_ORD_ID|1470|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1609", "ARO_accession": "3002787", "ARO_name": "QnrC", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.59938e-06, "max_identities": 28, "bit_score": 45.4394, "cvterm_id": "36771", "query": "DLRDARLSGADLRGARLARADLADADLREADLREATPAR-ANLRDADLSDANVRKADLRFADLRGVDLWG-----TDLRGAVLYRAKLAG-----LELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "DL     S     G    R +L DA        E+      N   ADL DA+     L  A+ +G + +G      DL+GA   +A         +    A++ G +L  A+     + +  +  ++", "sequence_from_db": "DLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENK", "sequence_from_broadstreet": "MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF", "dna_sequence_from_broadstreet": "TTGAATTATTCCCATAAAACGTACGATCAAATTGATTTTTCCGGCCAAGATTTGAGCTCTCATCACTTTTCTCACTGTAAATTTTTTGGTTGTAATTTTAATCGAGTGAATTTACGTGATGCTAAATTCATGGGTTGTACATTTATTGAATCGAATGATTTTGAAGGATGTAATTTTATCTATGCAGACCTACGAGATGCTTCATTTATGAATTGCATGCTTTCAATGGCGAATTTCCAAGGGGCAAACTGTTTTGGCCTTGAATTGAGAGAATGCGATTTAAAAGGTGCTAATTTCTCACAGGCAAACTTTGTTAATCATGTTTCTAACAAAATGTATTTTTGCTCTGCTTACATTACGGGTTGTAATTTGTCTTATGCTAATTTCGATAAGCAATGCCTTGAAAAGTGTGATTTATTTGAAAATAAATGGGTAGGTGCAAGCCTGCAAGGGGCCTCTTTTAAAGAGTCAGACTTAAGTAGGGGATCATTTTCTGATGACTTTTGGGAGCAATGCAGAATTCAGGGGTGTGATCTCACTCATTCAGAATTAAATGGCTTAGAACCTCGTAAAGTGGATTTAACTGGCGTGAAAATTTGTTCATGGCAACAAGAGCAGCTTTTGGAGCAGTTGGGGGTGATTGTTATTCCAGACAAAGTGTTTTGA", "partial": "0", "query_start": 16352, "query_end": 16699, "hit_start": 48, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.05}, "gnl|BL_ORD_ID|1470|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrC", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1609", "ARO_accession": "3002787", "ARO_name": "QnrC", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.01601e-05, "max_identities": 37, "bit_score": 43.1282, "cvterm_id": "36771", "query": "AADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREAT----------PARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLY---------------RAKLAGLELSEAHLDGADLRGADLTDAAVARSQ", "match": "+ D +      A LRD    +  LS A+ +GA     +L + DL+ A+  +A              A +   +LS AN  K  L   DL      G  L+GA                  + ++ G +L+ + L+G + R  DLT   +   Q", "sequence_from_db": "SNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQ", "sequence_from_broadstreet": "MNYSHKTYDQIDFSGQDLSSHHFSHCKFFGCNFNRVNLRDAKFMGCTFIESNDFEGCNFIYADLRDASFMNCMLSMANFQGANCFGLELRECDLKGANFSQANFVNHVSNKMYFCSAYITGCNLSYANFDKQCLEKCDLFENKWVGASLQGASFKESDLSRGSFSDDFWEQCRIQGCDLTHSELNGLEPRKVDLTGVKICSWQQEQLLEQLGVIVIPDKVF", "dna_sequence_from_broadstreet": "TTGAATTATTCCCATAAAACGTACGATCAAATTGATTTTTCCGGCCAAGATTTGAGCTCTCATCACTTTTCTCACTGTAAATTTTTTGGTTGTAATTTTAATCGAGTGAATTTACGTGATGCTAAATTCATGGGTTGTACATTTATTGAATCGAATGATTTTGAAGGATGTAATTTTATCTATGCAGACCTACGAGATGCTTCATTTATGAATTGCATGCTTTCAATGGCGAATTTCCAAGGGGCAAACTGTTTTGGCCTTGAATTGAGAGAATGCGATTTAAAAGGTGCTAATTTCTCACAGGCAAACTTTGTTAATCATGTTTCTAACAAAATGTATTTTTGCTCTGCTTACATTACGGGTTGTAATTTGTCTTATGCTAATTTCGATAAGCAATGCCTTGAAAAGTGTGATTTATTTGAAAATAAATGGGTAGGTGCAAGCCTGCAAGGGGCCTCTTTTAAAGAGTCAGACTTAAGTAGGGGATCATTTTCTGATGACTTTTGGGAGCAATGCAGAATTCAGGGGTGTGATCTCACTCATTCAGAATTAAATGGCTTAGAACCTCGTAAAGTGGATTTAACTGGCGTGAAAATTTGTTCATGGCAACAAGAGCAGCTTTTGGAGCAGTTGGGGGTGATTGTTATTCCAGACAAAGTGTTTTGA", "partial": "0", "query_start": 16301, "query_end": 16684, "hit_start": 150, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.18}, "gnl|BL_ORD_ID|212|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "234", "ARO_accession": "3002797", "ARO_name": "QnrS8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.68345e-06, "max_identities": 30, "bit_score": 45.4394, "cvterm_id": "35915", "query": "ELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "+L +   + + +D +RA LR     +C                + + D+       ADLR+A+  +  L  A+ S+AN    + R  DL+G +   T+    V  R     +    A + G +L  A++    + + ++  +R", "sequence_from_db": "DLTFTACTLIRSDFRRANLRDTTFVNCKF--------------IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNR-----MYFCSAFISGCNLSYANMERVCLEKCELFENR", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACACTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16271, "query_end": 16699, "hit_start": 57, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 20.98}, "gnl|BL_ORD_ID|212|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS8", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "234", "ARO_accession": "3002797", "ARO_name": "QnrS8", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.04663e-06, "max_identities": 38, "bit_score": 44.669, "cvterm_id": "35915", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": "A LR A  + C L  A  S A+  G      DL  A+    +       R     A +S  N+  A++    L   +L+     GT+L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "ADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQ", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTLIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACACTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16319, "query_end": 16684, "hit_start": 183, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.76}, "gnl|BL_ORD_ID|952|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.79637e-06, "max_identities": 36, "bit_score": 45.0542, "cvterm_id": "36891", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHL-----DGADLRGADLTDA", "match": "A LR A  + C L  A  SGA+  G      DL  A+   A        +     A +S  N+  A+L    L   +L+  +   A L  A L G +LS            +LRG DLT A", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16319, "query_end": 16666, "hit_start": 183, "hit_end": 546, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.75}, "gnl|BL_ORD_ID|952|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.17118e-05, "max_identities": 36, "bit_score": 40.4318, "cvterm_id": "36891", "query": "ADHKRAQLRGAILRDCDLRDARLS---------------GADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELS", "match": "A+   A   G   R+CDL+ A  S                A + G  LA A+L+   L + +L E   + ANL  A     DLS     +   +  +LRG DL   DL G    R  L G+++ ", "sequence_from_db": "ANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16304, "query_end": 16615, "hit_start": 228, "hit_end": 600, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.03}, "gnl|BL_ORD_ID|952|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA7", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1034", "ARO_accession": "3002713", "ARO_name": "QnrA7", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.95207e-05, "max_identities": 28, "bit_score": 40.0466, "cvterm_id": "36891", "query": "LARADLADADLREADLREATPARANLRD---------------------ADLSDANVRKADLRFADLRGVDLWG-----TDLRGAVLYRAKLAG-----LELSEAHLDGADLRGADLTDAAVARSQVL", "match": " +R DL+D+  R     +   +   LRD                     ADL DA+ +   L  A+  G + +G      DL+GA   RA+        +    A++ G +L  A+L+   + + ++ ", "sequence_from_db": "FSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELF", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSHGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGCGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGTAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCACGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGACCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16400, "query_end": 16690, "hit_start": 36, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.88}, "gnl|BL_ORD_ID|688|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.53136e-06, "max_identities": 36, "bit_score": 44.669, "cvterm_id": "36891", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHL-----DGADLRGADLTDA", "match": "A LR A  + C L  A  SGA+  G      DL  A+   A        +     A +S  N+  A+L    L   +L+  +   A L  A L G +LS            +LRG DLT A", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16319, "query_end": 16666, "hit_start": 183, "hit_end": 546, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.75}, "gnl|BL_ORD_ID|688|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.21944e-05, "max_identities": 42, "bit_score": 42.743, "cvterm_id": "36891", "query": "RSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLR-------------------------GVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVAR", "match": "R      D    QLR A   DC   +   SGA + G   + ADL DA  +          R +L  A+ S AN    + R  DL+                         G +L   +L G  L + +L     S A+L GA L G+DL+    +R", "sequence_from_db": "RCRFYQCDFSHCQLRDASFEDCSFIE---SGA-VEGCHFSYADLRDASFK--------ACRLSL--ANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSR", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16286, "query_end": 16678, "hit_start": 72, "hit_end": 498, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.92}, "gnl|BL_ORD_ID|688|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA4", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "747", "ARO_accession": "3002710", "ARO_name": "QnrA4", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000150429, "max_identities": 33, "bit_score": 39.2762, "cvterm_id": "36891", "query": "ADHKRAQLRGAILRDCDLRDARLS---------------GADLRGARLARADLADADLREADLREATPARANLRDADL---------------SDANVRKADLRFADLRGVD", "match": "A+   A   G   R+CDL+ A  S                A + G  LA A+L    L + +L E   + ANL  A L                  N+R  DL FADL G+D", "sequence_from_db": "ANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLD", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLNGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGCGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAACGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16304, "query_end": 16549, "hit_start": 228, "hit_end": 564, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.46}, "gnl|BL_ORD_ID|2054|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS10", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "425", "model_id": "3320", "ARO_accession": "3004622", "ARO_name": "QnrS10", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.57871e-06, "max_identities": 45, "bit_score": 44.669, "cvterm_id": "35915", "query": "ELGWDRSSPVAADHKRAQLRGAILRDC----------------DLRDARLSGADLRGARLARADLADADLREADLREATPARANL----------RDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": "+L +   + + +D +RA LR     +C                DLRDA      L  A  + A+    + R  DL+ A  +R N             A +S  N+  A++    L   +L+     GT+L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "DLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQ", "sequence_from_broadstreet": "MEIYSHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAATCTACAGTCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16271, "query_end": 16684, "hit_start": 57, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.46}, "gnl|BL_ORD_ID|348|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS1", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "381", "ARO_accession": "3002790", "ARO_name": "QnrS1", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.82903e-06, "max_identities": 45, "bit_score": 44.669, "cvterm_id": "35711", "query": "ELGWDRSSPVAADHKRAQLRGAILRDC----------------DLRDARLSGADLRGARLARADLADADLREADLREATPARANL----------RDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": "+L +   + + +D +RA LR     +C                DLRDA      L  A  + A+    + R  DL+ A  +R N             A +S  N+  A++    L   +L+     GT+L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "DLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQ", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16271, "query_end": 16684, "hit_start": 57, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.46}, "gnl|BL_ORD_ID|2180|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS15", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "3326", "ARO_accession": "3004627", "ARO_name": "QnrS15", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.99071e-06, "max_identities": 46, "bit_score": 44.669, "cvterm_id": "35914", "query": "THLPGVELGWDRSSPVAADHKRAQLRGAILRDC----------------DLRDARLSGADLRGARLARADLADADLREADLREATPARANL----------RDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": "+H    +L +   + + +D +RA LR     +C                DLRDA      L  A  + A+    + R  DL+ A  +R N             A +S  N+  A++    L   +L+     GT+L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "SHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQ", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCRFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCGCTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16253, "query_end": 16684, "hit_start": 39, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.21}, "gnl|BL_ORD_ID|735|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.16161e-06, "max_identities": 36, "bit_score": 44.2838, "cvterm_id": "36891", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHL-----DGADLRGADLTDA", "match": "A LR A  + C L  A  SGA+  G      DL  A+   A        +     A +S  N+  A+L    L   +L+  +   A L  A L G +LS            +LRG DLT A", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16319, "query_end": 16666, "hit_start": 183, "hit_end": 546, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.75}, "gnl|BL_ORD_ID|735|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.57897e-05, "max_identities": 42, "bit_score": 42.3578, "cvterm_id": "36891", "query": "RSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLR-------------------------GVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVAR", "match": "R      D    QLR A   DC   +   SGA + G   + ADL DA  +          R +L  A+ S AN    + R  DL+                         G +L   +L G  L + +L     S A+L GA L G+DL+    +R", "sequence_from_db": "RCRFYQCDFSHCQLRDASFEDCSFIE---SGA-VEGCHFSYADLRDASFK--------ACRLSL--ANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSR", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16286, "query_end": 16678, "hit_start": 72, "hit_end": 498, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.92}, "gnl|BL_ORD_ID|735|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "802", "ARO_accession": "3002709", "ARO_name": "QnrA3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.21515e-05, "max_identities": 33, "bit_score": 40.4318, "cvterm_id": "36891", "query": "ADHKRAQLRGAILRDCDLRDARLS---------------GADLRGARLARADLADADLREADLREATPARANLRDADL---------------SDANVRKADLRFADLRGVD", "match": "A+   A   G   R+CDL+ A  S                A + G  LA A+L+   L + +L E   + ANL  A L                  N+R  DL FADL G+D", "sequence_from_db": "ANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLD", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGTCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGCTGGCAACAGGTAAACCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16304, "query_end": 16549, "hit_start": 228, "hit_end": 564, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.46}, "gnl|BL_ORD_ID|1166|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS3", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1270", "ARO_accession": "3002792", "ARO_name": "QnrS3", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.6392e-06, "max_identities": 46, "bit_score": 44.2838, "cvterm_id": "35914", "query": "THLPGVELGWDRSSPVAADHKRAQLRGAILRDC----------------DLRDARLSGADLRGARLARADLADADLREADLREATPARANL----------RDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": "+H    +L +   + + +D +RA LR     +C                DLRDA      L  A  + A+    + R  DL+ A  +R N             A +S  N+  A++    L   +L+     GT+L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "SHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQ", "sequence_from_broadstreet": "ETYNHTYRHRNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "GAAACCTACAATCATACATATCGGCACCGCAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCACCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "1", "query_start": 16253, "query_end": 16684, "hit_start": 36, "hit_end": 606, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.21}, "gnl|BL_ORD_ID|162|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.80478e-06, "max_identities": 43, "bit_score": 44.2838, "cvterm_id": "36891", "query": "AQLRGAILRDCDLRDARLSGA----------DLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADL-----RFADLRGVDLWGTDLRGAVLYR-----AKLAGLELSEAHLDGADLRGADLTDAAVARSQ", "match": "A LR A  + C L  A  SGA          DL+GA  +RA   +    +     A  +  NL  A+LS   + K +L       A+L G  L G+DL      R       L G +L+ A LDG D R  +L    +   Q", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQ", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16319, "query_end": 16684, "hit_start": 183, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 30.28}, "gnl|BL_ORD_ID|162|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.28164e-05, "max_identities": 36, "bit_score": 40.0466, "cvterm_id": "36891", "query": "ADHKRAQLRGAILRDCDLRDARLS---------------GADLRGARLARADLADADLREADLREATPARANLRDA-----DLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELS", "match": "A+   A   G   R+CDL+ A  S                A + G  LA A+L+   L + +L E   + ANL  A     DLS     +   +  +LRG DL   DL G    R  L G+++ ", "sequence_from_db": "ANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16304, "query_end": 16615, "hit_start": 228, "hit_end": 600, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.03}, "gnl|BL_ORD_ID|162|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "179", "ARO_accession": "3002711", "ARO_name": "QnrA5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.50533e-05, "max_identities": 28, "bit_score": 40.0466, "cvterm_id": "36891", "query": "LARADLADADLREADLREATPARANLRD---------------------ADLSDANVRKADLRFADLRGVDLWG-----TDLRGAVLYRAKLAG-----LELSEAHLDGADLRGADLTDAAVARSQVL", "match": " +R DL+D+  R     +   +   LRD                     ADL DA+ +   L  A+  G + +G      DL+GA   RA+        +    A++ G +L  A+L+   + + ++ ", "sequence_from_db": "FSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELF", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGVIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATTGATAAAGTTTTTCAGCAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTTTATCAGTGTGACTTCAGCCATTGCCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTCGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCCTGCCGCCTGTCTTTGGCCAATTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAGTGCGATCTCAAGGGCGCCAATTTTTCCCGGGCCCGTTTTTACAATCAAATCAGCCATAAGATGTACTTCTGCTCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGCGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAACAACTGGAGCAATGCCAACCTCAGCGGCGCTTCCTTGATGGGCTCCGACCTCAGCTGCGGCACCTTCTCCCGCGACTGCTGGCAGCAGGTAAACCTGCGGGGCTGTGACCTGACTTTTGCCGATCTGGATGGGCTCGATCCCAGACGGGTCAACCTCGAAGGGGTCAAGATCTGTGCCTGGCAGCAGGAGCAACTGCTGGAACCCTTGGGAGTCATAGTGCTGCCGGATTAG", "partial": "0", "query_start": 16400, "query_end": 16690, "hit_start": 36, "hit_end": 420, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.88}, "gnl|BL_ORD_ID|2142|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "430", "model_id": "3325", "ARO_accession": "3004625", "ARO_name": "QnrS12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.49447e-06, "max_identities": 44, "bit_score": 43.8986, "cvterm_id": "35914", "query": "SSPVAADHKRAQLRGAILRDC----------------DLRDARLSGADLRGARLARADLADADLREADLREATPARANL----------RDADLSDANVRKADLRFADLRGVDLW-----GTDLRGAVLYRAKLA---------------GLELSEAHLDGADLRGADLTDAAVARSQ", "match": " + + +D +RA LR     +C                DLRDA      L  A  + A+    + R  DL+ A  +R N             A +S  N+  A++    L   +L+     GT+L GA L  + L+               G  L  A LDG D R  D +   +A  Q", "sequence_from_db": "CTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQ", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFAACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCGCCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCACAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16289, "query_end": 16684, "hit_start": 75, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.72}, "gnl|BL_ORD_ID|2142|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS12", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "430", "model_id": "3325", "ARO_accession": "3004625", "ARO_name": "QnrS12", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.02323e-05, "max_identities": 29, "bit_score": 42.743, "cvterm_id": "35914", "query": "RDARLSGADLRGARLARADLADADLREADLREATPARA----------------NLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAG-----LELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R    S  DL     A      +D R A+LR+ T                    +LRDA      +  A+   A+  G++    DL+GA   R   A      +    A + G +L  A++    + + ++  +R", "sequence_from_db": "RHHNFSHKDLSDLTFAACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENR", "sequence_from_broadstreet": "METYNHTYRHHNFSHKDLSDLTFAACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVTDLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANMERVCLEKCELFENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQELILEALGIVVYPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACAATCATACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGATCTCACCTTCGCCGCTTGCACATTCATTCGCAGCGACTTTCGACGTGCTAACTTGCGTGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCACAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTTGCGATGGCAAACTTCAGTAATGCCAATTGCTACGGTATAGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCATTTATTTCTGGATGTAATCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAAATGTGAGTTGTTTGAAAATCGCTGGATAGGAACGAACCTAGCGGGTGCATCACTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTCGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCCTGGCAGCAAGAACTGATTCTCGAAGCACTGGGTATTGTTGTTTATCCTGACTAA", "partial": "0", "query_start": 16358, "query_end": 16699, "hit_start": 24, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 21.48}, "gnl|BL_ORD_ID|1389|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.04263e-06, "max_identities": 36, "bit_score": 43.5134, "cvterm_id": "36891", "query": "AQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHL-----DGADLRGADLTDA", "match": "A LR A  + C L  A  SGA+  G      DL  A+   A        +     A +S  N+  A+L    L   +L+  +   A L  A L G +LS            +LRG DLT A", "sequence_from_db": "ADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFA", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 16319, "query_end": 16666, "hit_start": 183, "hit_end": 546, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.75}, "gnl|BL_ORD_ID|1389|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.91642e-05, "max_identities": 42, "bit_score": 41.9726, "cvterm_id": "36891", "query": "RSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLR-------------------------GVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVAR", "match": "R      D    QLR A   DC   +   SGA + G   + ADL DA  +          R +L  A+ S AN    + R  DL+                         G +L   +L G  L + +L     S A+L GA L G+DL+    +R", "sequence_from_db": "RCRFYQCDFSHCQLRDASFEDCSFIE---SGA-VEGCHFSYADLRDASFK--------ACRLSL--ANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSR", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 16286, "query_end": 16678, "hit_start": 72, "hit_end": 498, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 26.92}, "gnl|BL_ORD_ID|1389|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrA2", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "1508", "ARO_accession": "3002708", "ARO_name": "QnrA2", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.05645e-05, "max_identities": 33, "bit_score": 40.0466, "cvterm_id": "36891", "query": "ADHKRAQLRGAILRDCDLRDARLS---------------GADLRGARLARADLADADLREADLREATPARANLRDADL---------------SDANVRKADLRFADLRGVD", "match": "A+   A   G   R+CDL+ A  S                A + G  LA A+L+   L + +L E   + ANL  A L                  N+R  DL FADL G+D", "sequence_from_db": "ANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLD", "sequence_from_broadstreet": "MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFSYADLRDASFKACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCAAYISGCNLAYANLSGQCLEKCELFENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKICAWQQEQLLEPLGIIVLPD", "dna_sequence_from_broadstreet": "ATGGATATTATCGATAAAGTTTTTCAACAAGAGGATTTCTCACGCCAGGATTTGAGTGACAGCCGTTTTCGCCGCTGCCGCTTCTATCAGTGTGACTTCAGCCACTGTCAGCTAAGGGATGCCAGTTTCGAGGATTGCAGTTTCATTGAAAGCGGCGCCGTTGAAGGGTGCCACTTCAGCTATGCCGATCTGCGCGATGCCAGTTTCAAGGCTTGCCGTCTGTCTTTGGCTAACTTCAGCGGTGCCAACTGCTTTGGCATAGAGTTCAGGGAATGCGATCTCAAGGGCGCCAACTTTTCCCGGGCCCGCTTTTACAATCAAGTCAGCCATAAAATGTACTTTTGTGCGGCTTATATCTCAGGCTGCAACCTGGCCTATGCCAATTTGAGTGGCCAATGCCTGGAAAAGTGCGAGCTGTTTGAAAATAACTGGAGCAATGCCAATCTCAGCGGTGCTTCCTTGATGGGCTCCGACCTCAGCCGCGGCACCTTCTCCCGCGACTGTTGGCAACAGGTCAATCTGCGGGGCTGTGACCTGACCTTTGCCGATCTGGATGGACTCGATCCCAGGCGGGTCAACCTCGAGGGGGTCAAGATCTGTGCCTGGCAACAGGAGCAACTGTTAGAGCCTCTGGGGATAATAGTGCTTCCGGATTAG", "partial": "0", "query_start": 16304, "query_end": 16549, "hit_start": 228, "hit_end": 564, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 29.46}, "gnl|BL_ORD_ID|356|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.2029e-06, "max_identities": 40, "bit_score": 43.5134, "cvterm_id": "36957", "query": "LGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARAN-----LRDADLSDANVRKADLRFAD-------LRGVDLWGTDLRGAVLYRAKLAGLELSE-----AHLDGADLRGADLT", "match": "L +   + + +D +RA LR     +C      +   D+ G     ADL DA  ++  L  A  + AN      R  DL  AN  + +  FA             + G  L  A + R  L   EL E      HL GA L+ +DL+", "sequence_from_db": "LTFTACTFIRSDFRRANLRDTTFVNCKF----IEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTN--FAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLS", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 16274, "query_end": 16660, "hit_start": 60, "hit_end": 480, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.4}, "gnl|BL_ORD_ID|356|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.74543e-06, "max_identities": 30, "bit_score": 43.1282, "cvterm_id": "36957", "query": "RDARLSGADLRGARLARADLADADLREADLREATPAR----------------ANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAG-----LELSEAHLDGADLRGADLTDAAVARSQVLASR", "match": "R    S  DL            +D R A+LR+ T                   A+LRDA      +  A+   A+  G++    DL+GA   R   A      +    A + G  L  A++    + R ++  +R", "sequence_from_db": "RHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENR", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 16358, "query_end": 16699, "hit_start": 24, "hit_end": 429, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 22.22}, "gnl|BL_ORD_ID|356|hsp_num:2": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.13865, "max_identities": 29, "bit_score": 30.4166, "cvterm_id": "36957", "query": "ISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKAD", "match": " S  N AH  S      S  + G  L +            A +    L  C+L + R  G  L GA L  +DL+     E    + +   ANL  A+L   + RK D", "sequence_from_db": "FSRTNFAHQVSNRMYFCSAFITGCTLSY------------ANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVD", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 16199, "query_end": 16519, "hit_start": 294, "hit_end": 579, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 27.1}, "gnl|BL_ORD_ID|356|hsp_num:3": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.00599, "max_identities": 33, "bit_score": 27.7202, "cvterm_id": "36957", "query": "VPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLS---------------GADLRGARLARADLADADLREADLRE-----ATPARANLRDADLS----------DANVRKADLRFADLRGVD", "match": "V DLR       +L         A+   A   G   R CDL+ A  S                A + G  L+ A++    L   +L E        A A+L+++DLS            +++ A+L  A+L G+D", "sequence_from_db": "VADLRDASFQQCQLA-------MANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLD", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 16235, "query_end": 16549, "hit_start": 180, "hit_end": 564, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.44}, "gnl|BL_ORD_ID|356|hsp_num:4": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrS5", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "393", "ARO_accession": "3002794", "ARO_name": "QnrS5", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.47193, "max_identities": 30, "bit_score": 26.1794, "cvterm_id": "36957", "query": "NSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDAR-----LSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDL", "match": "N ++   +  + R+  L G      R++       R     A +  C L  A      L   +L   R     LA A L+E+DL     +        L  AN+  A+L   D R VD  G  +", "sequence_from_db": "NFSNANCYGIEFRACDLKGANFS--RTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKI", "sequence_from_broadstreet": "METYRHTYRHHNFSHKDLSALTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFDVADLRDASFQQCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFITGCTLSYANMERVCLERCELFENRWIGTHLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIAAWQQEQLLEALGIVVFPD", "dna_sequence_from_broadstreet": "ATGGAAACCTACCGTCACACATATCGGCACCACAACTTTTCACATAAAGACTTAAGTGCTCTCACCTTCACTGCTTGCACATTTATTCGCAGCGACTTTCGACGAGCTAACTTGCGCGATACGACATTCGTCAACTGCAAGTTCATTGAACAGGGTGATATCGAAGGCTGCCACTTTGATGTCGCAGATCTTCGTGATGCAAGTTTCCAACAATGCCAACTGGCGATGGCAAACTTCAGTAACGCCAATTGCTACGGTATTGAGTTCCGTGCGTGTGATTTAAAAGGTGCCAACTTTTCCCGAACAAACTTTGCCCATCAAGTGAGTAATCGTATGTACTTTTGCTCAGCCTTTATTACAGGATGTACTCTTTCCTATGCCAATATGGAGAGGGTTTGTTTAGAAAGATGTGAGTTGTTTGAAAATCGCTGGATAGGAACTCATCTAGCGGGTGCATCATTGAAAGAGTCAGACTTAAGTCGAGGTGTTTTTTCCGAAGATGTCTGGGGGCAATTTAGCCTACAGGGTGCCAATTTATGCCACGCCGAACTAGACGGTTTAGATCCCCGCAAAGTCGATACATCAGGTATCAAAATTGCAGCTTGGCAGCAAGAACAGCTTCTCGAAGCACTGGGTATTGTTGTTTTTCCTGACTAG", "partial": "0", "query_start": 16211, "query_end": 16567, "hit_start": 231, "hit_end": 597, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 24.19}, "gnl|BL_ORD_ID|4916|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 15893, "orf_end": 16795, "orf_from": "BGC0000254.1|Oxytetracycline_15 ", "model_name": "QnrAS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "5907", "ARO_accession": "3004668", "ARO_name": "QnrAS", "ARO_category": {"36558": {"category_aro_accession": "3000419", "category_aro_cvterm_id": "36558", "category_aro_name": "quinolone resistance protein (qnr)", "category_aro_description": "Qnr proteins are pentapeptide repeat proteins that mimic DNA and protect the cell from the activity of fluoroquinolone antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35954": {"category_aro_accession": "0000036", "category_aro_cvterm_id": "35954", "category_aro_name": "ciprofloxacin", "category_aro_description": "Ciprofloxacin is a bacteriocidal fluoroquinolone. It blocks bacterial DNA replication by binding to the toposiomerase II or IV-DNA complex (or cleavable complex), thereby causing double-stranded breaks in the bacterial chromosome.", "category_aro_class_name": "Antibiotic"}, "35988": {"category_aro_accession": "0000071", "category_aro_cvterm_id": "35988", "category_aro_name": "levofloxacin", "category_aro_description": "Levofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class. Its main target is topoisomerase IV, inhibiting its function and disrupting DNA replication.", "category_aro_class_name": "Antibiotic"}, "35991": {"category_aro_accession": "0000074", "category_aro_cvterm_id": "35991", "category_aro_name": "moxifloxacin", "category_aro_description": "Moxifloxacin is a fourth generation synthetic fluoroquinolone chemotherapeutic agent, and has been shown to be significantly more active than levofloxacin (4 to 8 times more) against Streptococcus pneumoniae. It acts by inhibiting bacterial DNA topoisomerases.", "category_aro_class_name": "Antibiotic"}, "37003": {"category_aro_accession": "3000659", "category_aro_cvterm_id": "37003", "category_aro_name": "gatifloxacin", "category_aro_description": "Gatifloxacin is an 8-methoxy, 7-piperazinyl, 6-fluoroquinolone that can be taken orally or by intravenous administration. It is active against most Gram-positive and Gram-negative bacteria, but inactive against non-fermenting Gram-negative rods including Pseudomonas aeruginosa.", "category_aro_class_name": "Antibiotic"}, "37005": {"category_aro_accession": "3000661", "category_aro_cvterm_id": "37005", "category_aro_name": "nalidixic acid", "category_aro_description": "Nalidixic acid is a quinolone derivative of naphthyridine active against many enterobacteria, but ineffective against Ps aeruginosa, Gram-positive bacteria, and anaerobes. Acquired resistance is common in nalidixic acid treatments.", "category_aro_class_name": "Antibiotic"}, "37006": {"category_aro_accession": "3000662", "category_aro_cvterm_id": "37006", "category_aro_name": "norfloxacin", "category_aro_description": "Norfloxacin is a 6-fluoro, 7-piperazinyl quinolone with a wide range of activity against Gram-negative bacteria. It is inactive against most anaerobes.", "category_aro_class_name": "Antibiotic"}, "37010": {"category_aro_accession": "3000666", "category_aro_cvterm_id": "37010", "category_aro_name": "sparfloxacin", "category_aro_description": "Sparfloxacin is a dimethylpiperazinyl difluoroquinolone that acts by inhibiting DNA gyrase. It is active against aerobic Gram-positive and Gram-negative bacteria, as well as some mycobacteria. It has moderate activity against some anaerobes.", "category_aro_class_name": "Antibiotic"}, "35920": {"category_aro_accession": "0000001", "category_aro_cvterm_id": "35920", "category_aro_name": "fluoroquinolone antibiotic", "category_aro_description": "The fluoroquinolones are a family of synthetic broad-spectrum antibiotics that are 4-quinolone-3-carboxylates. These compounds interact with topoisomerase II (DNA gyrase) to disrupt bacterial DNA replication, damage DNA, and cause cell death.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 6.58144e-05, "max_identities": 36, "bit_score": 40.4318, "cvterm_id": "46173", "query": "LRGAILRDCDLRDARLSGADLRGARLARADLADADLREADL-----REATPARANLRDADLSDAN-----VRKADLRFADLRGVDLWGTDLRGAVLYRA----------KLAGLELSEAHLDGADLRGADLTDAAVARSQ", "match": "LR A  + C L  +   GA+  G      DL  A+  +A        +     A +   +LS AN     + K DL      G +L G   +G+ L R           ++    L    LDG D R  DLT   +   Q", "sequence_from_db": "LRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQ", "sequence_from_broadstreet": "MAKYNEIFDNVDFSKQDLRESYFEGCKFYRCDFNRTNLRDSRFVDCVFIEQGAIEGCHFDYSDLRDASFKRCRLTMSNFKGANCFGVEFRECDLKGANFVQASFVNQISHQMYFCSAYITGCNLSYANFERLCIEKCDLFENKWNGANLQGASFKGSDLSRGAFSEDSWGQFRMQDANLCHCELDGLDPRRIDLTGVKICAWQQEQLLEPLGLVVLPD", "dna_sequence_from_broadstreet": "ATGGCTAAATATAATGAAATATTCGATAACGTGGATTTTTCGAAACAAGATTTAAGAGAATCCTATTTTGAAGGGTGTAAGTTTTATCGATGTGATTTCAATCGAACCAATCTGAGAGACTCCCGATTTGTTGATTGTGTTTTTATCGAACAGGGGGCAATTGAAGGTTGTCATTTTGATTACAGTGACTTAAGGGACGCATCATTTAAACGCTGTCGCTTAACCATGTCTAATTTTAAAGGCGCAAATTGCTTTGGTGTCGAATTTAGAGAGTGTGATTTAAAAGGAGCTAATTTTGTTCAAGCCAGTTTTGTTAATCAAATAAGTCATCAAATGTATTTCTGCTCTGCTTATATTACGGGGTGTAATTTGTCTTATGCGAATTTTGAACGCCTATGTATCGAGAAATGTGACTTGTTTGAGAACAAATGGAACGGAGCTAATTTACAAGGGGCATCTTTTAAGGGTTCGGACCTTTCTCGTGGCGCATTCTCTGAAGACTCGTGGGGTCAATTTAGAATGCAAGATGCAAACTTATGTCATTGTGAATTGGATGGTTTAGATCCCCGTAGAATTGATTTAACCGGTGTTAAGATCTGTGCATGGCAACAAGAGCAATTATTAGAGCCATTAGGATTAGTGGTACTGCCTGACTAA", "partial": "0", "query_start": 16325, "query_end": 16684, "hit_start": 189, "hit_end": 609, "orf_dna_sequence": "GTGCTGAGCCTCTGGTTCTCCAACCGCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTCAGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGCGCCTGGGCGGCATCTACGCCCTGCAGCGCAACATGGAGGACCTCCCCCGCGACCACCCCACCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCGGCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCGCCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGGGGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGATCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGAGGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCACTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGGACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGGTCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCGACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCCGCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCCGGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGA", "orf_prot_sequence": "MLSLWFSNRQVGNQLRIAQGELSTTREGQITERYTAAVGQLGEDSVDVRLGGIYALQRNMEDLPRDHPTIADVLAAYIRTHAGTPPKGGKRVPPDVLAALDVISGRNSAHDGSFVPDLRSTHLPGVELGWDRSSPVAADHKRAQLRGAILRDCDLRDARLSGADLRGARLARADLADADLREADLREATPARANLRDADLSDANVRKADLRFADLRGVDLWGTDLRGAVLYRAKLAGLELSEAHLDGADLRGADLTDAAVARSQVLASRIDAETRLPPDIARDPEVRARIAQAEAEDDGF", "perc_identity": 25.71}}, "BGC0000254.1|Oxytetracycline_17 # 17832 # 18881 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=CCC;rbs_spacer=15bp;gc_cont=0.739": {"gnl|BL_ORD_ID|2103|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 17832, "orf_end": 18881, "orf_from": "BGC0000254.1|Oxytetracycline_17 ", "model_name": "kdpE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "2331", "ARO_accession": "3003841", "ARO_name": "kdpE", "ARO_category": {"41098": {"category_aro_accession": "3004046", "category_aro_cvterm_id": "41098", "category_aro_name": "kdpDE", "category_aro_description": "kdpDE is a two-component regulatory system in Escherichia coli, well studied for its role in potassium transport and homeostasis. kdpE is also implicated in virulence loci regulation and overexpression of kdpE is shown to confer resistance to aminoglycoside antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "35966": {"category_aro_accession": "0000049", "category_aro_cvterm_id": "35966", "category_aro_name": "kanamycin A", "category_aro_description": "Kanamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Kanamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36590": {"category_aro_accession": "3000451", "category_aro_cvterm_id": "36590", "category_aro_name": "protein(s) and two-component regulatory system modulating antibiotic efflux", "category_aro_description": "Protein(s) and two component regulatory systems that directly or indirectly change rates of antibiotic efflux.", "category_aro_class_name": "Efflux Regulator"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.71581, "max_identities": 18, "bit_score": 28.4906, "cvterm_id": "36849", "query": "RRVLRTALEGAGFRVEHSEG---GLFLWATR", "match": "RR LRTALEG G RV  +E    GL   ATR", "sequence_from_db": "RRFLRTALEGDGMRVFEAETLQRGLLEAATR", "sequence_from_broadstreet": "MTNVLIVEDEQAIRRFLRTALEGDGMRVFEAETLQRGLLEAATRKPDLIILDLGLPDGDGIEFIRDLRQWSAVPVIVLSARSEESDKIAALDAGADDYLSKPFGIGELQARLRVALRRHSATTAPDPLVKFSDVTVDLAARVIHRGEEEVHLTPIEFRLLAVLLNNAGKVLTQRQLLNQVWGPNAVEHSHYLRIYMGHLRQKLEQDPARPRHFITETGIGYRFML", "dna_sequence_from_broadstreet": "GTGACAAACGTTCTGATTGTTGAAGATGAACAGGCTATTCGTCGCTTTCTGCGCACGGCGCTGGAGGGCGACGGGATGCGCGTCTTTGAGGCCGAAACGCTGCAACGCGGCTTGCTGGAAGCGGCAACCCGTAAGCCAGATTTGATTATTCTCGATCTCGGCCTGCCCGATGGTGATGGGATTGAGTTTATCCGCGACCTGCGCCAGTGGAGCGCGGTGCCGGTGATTGTGCTTTCCGCACGCAGCGAAGAGAGCGACAAAATCGCCGCGCTGGATGCCGGAGCGGATGATTATCTGAGTAAGCCGTTTGGCATTGGCGAATTGCAGGCCCGTCTGCGCGTCGCATTACGCCGCCACTCTGCCACCACCGCGCCCGATCCGCTGGTAAAATTTTCCGATGTTACCGTCGATTTAGCCGCCCGCGTGATTCACCGGGGTGAGGAAGAGGTGCATCTCACACCAATTGAGTTCCGCCTGCTGGCGGTGCTGCTCAACAATGCCGGAAAAGTACTCACCCAGCGCCAGCTCCTTAACCAGGTGTGGGGGCCAAACGCGGTCGAACACAGTCACTATTTGCGTATTTATATGGGACATCTGCGACAAAAACTGGAACAGGATCCCGCCCGCCCACGCCATTTCATTACTGAAACCGGTATTGGCTATCGGTTTATGCTTTGA", "partial": "0", "query_start": 18642, "query_end": 18725, "hit_start": 39, "hit_end": 132, "orf_dna_sequence": "GTGCTGCTGCCGTACAAGAAGCGCGCCGCGGCCCACCCCGACGGGCTGGTCAACCTGGCGCTGGGCGAACCGGTCGACGCCACGCCCGACGTGCTGCGCGACGCCCTCGCGGCGGCGACCGACGCGCCCGGCTACCCGCCCACGGAGGGGACGCCCGCGCTCCGCGAAGCGGCCGCCGCATGGCTGCGCCGCCGCCTGGGCGTGACGGTGGACCCCTCGGCCGTACTGCCCGCGGTCGGCACCAAGGAGCTGATCGCCTGGCTCCCGGCGATGCTGGGCACCGGCCCCGGCGACACGGTGGCCTTTCCCCGGCTGGCGTTTCCCACCTTCGACGTCAGCGCGCGCCTCGCGGGCGCGCGGGGGCGCCCGGTGGATTCACCGCTGGAGCTCGGCAGTGAACCGGTCAAGGTGGTCTGGCTCAACTCGCCGTCCAACCCGGAGGGCCGGGTGCTGTCCGTACCCGAGCTGCGCGAGATCGTGGCCTGGGCGCGGGACCGGGGCGCCGTCCTCGTCAACGACGAGTGCTACATCGAATACGGGTGGGACCGGCGGCCGGTGTCGCTGCTGGACTCGGCGGTGTGCGGCGGCAGTCACGATGGTCTGCTGGCGGTGCACTCGCTGTCCAAGCGGTCCAACCTCGCGGGCTACCGCGCGGGCGTCTGCTCCGGCGACCCGGCCCTGATCGGGCGCCTCCTCCAGGTACGCAAGCACGCCGGGCACGCGGTCCCGGCCCCCGTACAGGCGGCCATGGTGGCCGCCCTGGAGGACGACGCCCACGTGGAGCGGCAGCGAGACCGGTACGCCTACAGGCGGCGCGTTCTGCGCACGGCCCTGGAGGGGGCCGGGTTCCGCGTCGAGCATTCCGAAGGCGGCCTGTTCCTGTGGGCCACCCGGGGTGAGCCCTGCTGGCCCGCCGTACAGAAGCTGGCCGATCTCGGCATCCTCGTCGCACCCGGTGCCTTCTACGGCGAGGCCGGTGAGCAGTACGTACGGATTGCGTTCACGGCGACCGACGAACGCATCGCCGCGGCCGCCGCCCGGCTGACATGA", "orf_prot_sequence": "MLLPYKKRAAAHPDGLVNLALGEPVDATPDVLRDALAAATDAPGYPPTEGTPALREAAAAWLRRRLGVTVDPSAVLPAVGTKELIAWLPAMLGTGPGDTVAFPRLAFPTFDVSARLAGARGRPVDSPLELGSEPVKVVWLNSPSNPEGRVLSVPELREIVAWARDRGAVLVNDECYIEYGWDRRPVSLLDSAVCGGSHDGLLAVHSLSKRSNLAGYRAGVCSGDPALIGRLLQVRKHAGHAVPAPVQAAMVAALEDDAHVERQRDRYAYRRRVLRTALEGAGFRVEHSEGGLFLWATRGEPCWPAVQKLADLGILVAPGAFYGEAGEQYVRIAFTATDERIAAAAARLT", "perc_identity": 58.06}, "gnl|BL_ORD_ID|1035|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 17832, "orf_end": 18881, "orf_from": "BGC0000254.1|Oxytetracycline_17 ", "model_name": "AAC(3)-Ic", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "300", "model_id": "1131", "ARO_accession": "3002531", "ARO_name": "AAC(3)-Ic", "ARO_category": {"36461": {"category_aro_accession": "3000322", "category_aro_cvterm_id": "36461", "category_aro_name": "AAC(3)", "category_aro_description": "A category of aminoglycoside N-acetyltransferase enzymes with modification regiospecificity based at the 3-amino group of the respective antibiotic. These enzymes inactivate aminoglycoside antibiotics through acetylation of the 3-amino group of the compound.", "category_aro_class_name": "AMR Gene Family"}, "35922": {"category_aro_accession": "0000003", "category_aro_cvterm_id": "35922", "category_aro_name": "astromicin", "category_aro_description": "Astromicin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Astromicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35953": {"category_aro_accession": "0000035", "category_aro_cvterm_id": "35953", "category_aro_name": "sisomicin", "category_aro_description": "Sisomicin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Sisomicin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.50266, "max_identities": 20, "bit_score": 26.5646, "cvterm_id": "36752", "query": "AYRRRVLRTALEGAGFRVEHSEGG--LFLWATRGEPCWPAVQKLADLGI", "match": "AYRRR + TAL     R+ H  G   +F+ A  G+   PAV     LGI", "sequence_from_db": "AYRRRGIATALINELQRIAHDIGAYVIFVQADYGDD--PAVALYTKLGI", "sequence_from_broadstreet": "MISTQTKITRLNSQDVGVMRAMLGMFGEAFEDAENYCRAQPSDSYLQDLLCGSGFIAIAALQGQEVIGGLAAYVLPKFEQQRKEIYIYDLGVQGAYRRRGIATALINELQRIAHDIGAYVIFVQADYGDDPAVALYTKLGIREDVMHFDIEPQPAA", "dna_sequence_from_broadstreet": "ATGATCTCTACTCAAACCAAGATTACCCGCCTCAACTCTCAAGACGTTGGTGTAATGCGGGCAATGCTAGGCATGTTCGGCGAGGCTTTTGAGGACGCTGAGAACTATTGCCGCGCTCAACCAAGCGACAGTTACCTACAAGACTTACTGTGTGGCTCTGGCTTCATCGCAATCGCTGCGTTACAGGGGCAAGAGGTCATCGGTGGGCTCGCCGCGTATGTGCTCCCAAAGTTTGAACAACAGCGCAAAGAAATCTATATCTACGACTTAGGCGTGCAGGGAGCCTATCGCCGACGAGGCATCGCCACAGCCTTGATCAATGAACTCCAGCGTATCGCACATGATATTGGCGCTTATGTAATTTTTGTCCAGGCTGACTATGGGGACGATCCTGCGGTAGCGCTCTACACAAAACTCGGTATCCGGGAGGACGTGATGCACTTTGACATAGAACCTCAACCTGCTGCCTAA", "partial": "0", "query_start": 18633, "query_end": 18773, "hit_start": 282, "hit_end": 423, "orf_dna_sequence": "GTGCTGCTGCCGTACAAGAAGCGCGCCGCGGCCCACCCCGACGGGCTGGTCAACCTGGCGCTGGGCGAACCGGTCGACGCCACGCCCGACGTGCTGCGCGACGCCCTCGCGGCGGCGACCGACGCGCCCGGCTACCCGCCCACGGAGGGGACGCCCGCGCTCCGCGAAGCGGCCGCCGCATGGCTGCGCCGCCGCCTGGGCGTGACGGTGGACCCCTCGGCCGTACTGCCCGCGGTCGGCACCAAGGAGCTGATCGCCTGGCTCCCGGCGATGCTGGGCACCGGCCCCGGCGACACGGTGGCCTTTCCCCGGCTGGCGTTTCCCACCTTCGACGTCAGCGCGCGCCTCGCGGGCGCGCGGGGGCGCCCGGTGGATTCACCGCTGGAGCTCGGCAGTGAACCGGTCAAGGTGGTCTGGCTCAACTCGCCGTCCAACCCGGAGGGCCGGGTGCTGTCCGTACCCGAGCTGCGCGAGATCGTGGCCTGGGCGCGGGACCGGGGCGCCGTCCTCGTCAACGACGAGTGCTACATCGAATACGGGTGGGACCGGCGGCCGGTGTCGCTGCTGGACTCGGCGGTGTGCGGCGGCAGTCACGATGGTCTGCTGGCGGTGCACTCGCTGTCCAAGCGGTCCAACCTCGCGGGCTACCGCGCGGGCGTCTGCTCCGGCGACCCGGCCCTGATCGGGCGCCTCCTCCAGGTACGCAAGCACGCCGGGCACGCGGTCCCGGCCCCCGTACAGGCGGCCATGGTGGCCGCCCTGGAGGACGACGCCCACGTGGAGCGGCAGCGAGACCGGTACGCCTACAGGCGGCGCGTTCTGCGCACGGCCCTGGAGGGGGCCGGGTTCCGCGTCGAGCATTCCGAAGGCGGCCTGTTCCTGTGGGCCACCCGGGGTGAGCCCTGCTGGCCCGCCGTACAGAAGCTGGCCGATCTCGGCATCCTCGTCGCACCCGGTGCCTTCTACGGCGAGGCCGGTGAGCAGTACGTACGGATTGCGTTCACGGCGACCGACGAACGCATCGCCGCGGCCGCCGCCCGGCTGACATGA", "orf_prot_sequence": "MLLPYKKRAAAHPDGLVNLALGEPVDATPDVLRDALAAATDAPGYPPTEGTPALREAAAAWLRRRLGVTVDPSAVLPAVGTKELIAWLPAMLGTGPGDTVAFPRLAFPTFDVSARLAGARGRPVDSPLELGSEPVKVVWLNSPSNPEGRVLSVPELREIVAWARDRGAVLVNDECYIEYGWDRRPVSLLDSAVCGGSHDGLLAVHSLSKRSNLAGYRAGVCSGDPALIGRLLQVRKHAGHAVPAPVQAAMVAALEDDAHVERQRDRYAYRRRVLRTALEGAGFRVEHSEGGLFLWATRGEPCWPAVQKLADLGILVAPGAFYGEAGEQYVRIAFTATDERIAAAAARLT", "perc_identity": 40.82}, "gnl|BL_ORD_ID|2009|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 17832, "orf_end": 18881, "orf_from": "BGC0000254.1|Oxytetracycline_17 ", "model_name": "mexP", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "650", "model_id": "2211", "ARO_accession": "3003698", "ARO_name": "mexP", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "35963": {"category_aro_accession": "0000045", "category_aro_cvterm_id": "35963", "category_aro_name": "acriflavine", "category_aro_description": "Acriflavine is a topical antiseptic. It has the form of an orange or brown powder. It may be harmful in the eyes or if inhaled. Acriflavine is also used as treatment for external fungal infections of aquarium fish.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36309": {"category_aro_accession": "3000170", "category_aro_cvterm_id": "36309", "category_aro_name": "imipenem", "category_aro_description": "Imipenem is a broad-spectrum antibiotic and is usually taken with cilastatin, which prevents hydrolysis of imipenem by renal dehydropeptidase-I. It is resistant to hydrolysis by most other beta-lactamases. Notable exceptions are the KPC beta-lactamases and Ambler Class B enzymes.", "category_aro_class_name": "Antibiotic"}, "36327": {"category_aro_accession": "3000188", "category_aro_cvterm_id": "36327", "category_aro_name": "trimethoprim", "category_aro_description": "Trimethoprim is a synthetic 5-(3,4,5- trimethoxybenzyl) pyrimidine inhibitor of dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid. Tetrahydrofolic acid is an essential precursor in the de novo synthesis of the DNA nucleotide thymidine. Trimethoprim is a bacteriostatic antibiotic mainly used in the prophylaxis and treatment of urinary tract infections in combination with sulfamethoxazole, a sulfonamide antibiotic.", "category_aro_class_name": "Antibiotic"}, "36524": {"category_aro_accession": "3000385", "category_aro_cvterm_id": "36524", "category_aro_name": "chloramphenicol", "category_aro_description": "Chloramphenicol is a bacteriostatic antimicrobial originally derived from the bacterium Streptomyces venezuelae. It was the first antibiotic to be manufactured synthetically on a large scale. It functions by inhibiting peptidyl transferase activity of the bacterial ribosome, binding to A2451 and A2452 residues in the 23S rRNA of the 50S ribosomal subunit and preventing peptide bond formation.", "category_aro_class_name": "Antibiotic"}, "36595": {"category_aro_accession": "3000456", "category_aro_cvterm_id": "36595", "category_aro_name": "thiamphenicol", "category_aro_description": "Derivative of Chloramphenicol. The nitro group (-NO2) is substituted by a sulfomethyl group (-SO2CH3).", "category_aro_class_name": "Antibiotic"}, "37626": {"category_aro_accession": "3001227", "category_aro_cvterm_id": "37626", "category_aro_name": "kitasamycin", "category_aro_description": "Kitasamycin is a macrolide antibiotic and is produced by Streptoverticillium kitasatoense. The drug has antimicrobial activity against a wide spectrum of pathogens.", "category_aro_class_name": "Antibiotic"}, "40353": {"category_aro_accession": "3003701", "category_aro_cvterm_id": "40353", "category_aro_name": "rokitamycin", "category_aro_description": "Rokitamycin is a macrolide antibiotic. Synthesized from strains of Streptomyces kitasatoensis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35939": {"category_aro_accession": "0000020", "category_aro_cvterm_id": "35939", "category_aro_name": "carbapenem", "category_aro_description": "Carbapenems are a class of beta-lactam antibiotics with a broad spectrum of antibacterial activity, and have a structure which renders them highly resistant to beta-lactamases. Carbapenem antibiotics are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36310": {"category_aro_accession": "3000171", "category_aro_cvterm_id": "36310", "category_aro_name": "diaminopyrimidine antibiotic", "category_aro_description": "Diaminopyrimidines are a class of organic compounds containing a pyrimidine ring substituted by two amine groups.  They are inhibitors of dihydrofolate reductase, an enzyme critical for DNA synthesis.", "category_aro_class_name": "Drug Class"}, "36526": {"category_aro_accession": "3000387", "category_aro_cvterm_id": "36526", "category_aro_name": "phenicol antibiotic", "category_aro_description": "Phenicols are broad spectrum bacteriostatic antibiotics acting on bacterial protein synthesis. More specifically, the phenicols block peptide elongation by binding to the peptidyltansferase centre of the 70S ribosome.", "category_aro_class_name": "Drug Class"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.54235, "max_identities": 13, "bit_score": 25.0238, "cvterm_id": "36752", "query": "GTGPGDTVAFPRLAFPTFDVSARLAGARGRPVDSPLELGS", "match": "G  PG+ +    L  P   ++ RLA   G PVD    +G+", "sequence_from_db": "GLQPGERIVVKGLVRPDMQITPRLAEIDGTPVDLSKTVGA", "sequence_from_broadstreet": "MNLRHFIRITATLGVAALIAGCGESAPPGAASAPPSVPVAEVVVRPVTPYAEFTGSLTAVEQVELRPRVAGYIQDVTVPEGRLVEKGQQLFLIDPRVFKAAQDAARARLREAEAAALLARTEHERAELLYARKVVARERLDSAIASRNASKAQVDAARAALDAAQLDLGFTRVTAPIGGRVGHIQVTEGNYVTNGVTALTSIVSVDPLYVYFDVDERTYLQALAPTRGREGEQAPRVKVALLTDESYGRSSRLDFLANAADRGTGTVRVRAVVDNPDGQLTPGLFAKVRLETGKPRAQVLVADHSIGTDQGRRYVLVVDEGNKTQYRPVELGPMVDGLRVVRQGLQPGERIVVKGLVRPDMQITPRLAEIDGTPVDLSKTVGAAQ", "dna_sequence_from_broadstreet": "ATGAATCTCAGACACTTCATCCGCATCACCGCGACGCTAGGTGTCGCGGCCCTTATCGCTGGCTGCGGGGAATCGGCGCCGCCGGGGGCGGCGAGCGCCCCGCCAAGCGTTCCCGTCGCCGAGGTGGTGGTTCGCCCGGTGACACCCTACGCCGAGTTCACCGGCTCGCTGACCGCTGTCGAGCAGGTAGAACTGCGGCCGCGCGTCGCCGGCTACATCCAGGACGTTACGGTGCCGGAAGGCCGCCTGGTAGAGAAGGGCCAGCAACTGTTCCTCATCGACCCGCGCGTGTTCAAGGCGGCGCAGGATGCCGCCAGGGCACGCCTGCGCGAGGCCGAGGCCGCGGCGTTGCTGGCGCGCACCGAACACGAGCGAGCCGAGCTGCTGTATGCGCGGAAGGTCGTCGCCCGGGAGCGGCTCGACAGCGCCATCGCCTCGCGCAATGCCAGCAAGGCCCAGGTCGATGCGGCCAGGGCCGCCCTCGACGCGGCGCAACTGGATCTCGGCTTCACGCGGGTGACGGCACCGATCGGCGGGCGTGTCGGGCATATCCAGGTCACCGAGGGCAACTACGTCACCAATGGCGTCACCGCGCTGACCAGCATCGTTTCGGTCGATCCGCTGTACGTGTACTTCGATGTCGACGAGCGCACCTACCTGCAGGCCCTGGCGCCGACCCGCGGCAGGGAAGGCGAGCAGGCCCCCAGGGTCAAGGTGGCGCTGCTCACCGACGAGTCCTATGGACGAAGCAGTCGCCTCGATTTCCTCGCCAACGCCGCCGACCGCGGGACCGGCACGGTCCGGGTTCGGGCGGTGGTGGACAACCCGGACGGGCAACTGACGCCGGGGCTGTTCGCCAAGGTCAGGCTGGAGACCGGCAAGCCTCGCGCGCAGGTGCTGGTCGCCGACCATTCCATCGGCACCGACCAGGGCAGGCGCTATGTGCTGGTCGTCGACGAAGGCAACAAGACCCAGTACCGGCCGGTGGAACTCGGCCCGATGGTCGACGGCCTGCGGGTCGTCCGCCAGGGCCTGCAGCCGGGCGAGCGCATCGTCGTCAAGGGCCTGGTCCGGCCGGACATGCAGATCACACCGCGCCTTGCGGAAATCGATGGCACGCCCGTCGACCTGTCGAAGACCGTGGGGGCCGCACAATGA", "partial": "0", "query_start": 18108, "query_end": 18227, "hit_start": 1029, "hit_end": 1149, "orf_dna_sequence": "GTGCTGCTGCCGTACAAGAAGCGCGCCGCGGCCCACCCCGACGGGCTGGTCAACCTGGCGCTGGGCGAACCGGTCGACGCCACGCCCGACGTGCTGCGCGACGCCCTCGCGGCGGCGACCGACGCGCCCGGCTACCCGCCCACGGAGGGGACGCCCGCGCTCCGCGAAGCGGCCGCCGCATGGCTGCGCCGCCGCCTGGGCGTGACGGTGGACCCCTCGGCCGTACTGCCCGCGGTCGGCACCAAGGAGCTGATCGCCTGGCTCCCGGCGATGCTGGGCACCGGCCCCGGCGACACGGTGGCCTTTCCCCGGCTGGCGTTTCCCACCTTCGACGTCAGCGCGCGCCTCGCGGGCGCGCGGGGGCGCCCGGTGGATTCACCGCTGGAGCTCGGCAGTGAACCGGTCAAGGTGGTCTGGCTCAACTCGCCGTCCAACCCGGAGGGCCGGGTGCTGTCCGTACCCGAGCTGCGCGAGATCGTGGCCTGGGCGCGGGACCGGGGCGCCGTCCTCGTCAACGACGAGTGCTACATCGAATACGGGTGGGACCGGCGGCCGGTGTCGCTGCTGGACTCGGCGGTGTGCGGCGGCAGTCACGATGGTCTGCTGGCGGTGCACTCGCTGTCCAAGCGGTCCAACCTCGCGGGCTACCGCGCGGGCGTCTGCTCCGGCGACCCGGCCCTGATCGGGCGCCTCCTCCAGGTACGCAAGCACGCCGGGCACGCGGTCCCGGCCCCCGTACAGGCGGCCATGGTGGCCGCCCTGGAGGACGACGCCCACGTGGAGCGGCAGCGAGACCGGTACGCCTACAGGCGGCGCGTTCTGCGCACGGCCCTGGAGGGGGCCGGGTTCCGCGTCGAGCATTCCGAAGGCGGCCTGTTCCTGTGGGCCACCCGGGGTGAGCCCTGCTGGCCCGCCGTACAGAAGCTGGCCGATCTCGGCATCCTCGTCGCACCCGGTGCCTTCTACGGCGAGGCCGGTGAGCAGTACGTACGGATTGCGTTCACGGCGACCGACGAACGCATCGCCGCGGCCGCCGCCCGGCTGACATGA", "orf_prot_sequence": "MLLPYKKRAAAHPDGLVNLALGEPVDATPDVLRDALAAATDAPGYPPTEGTPALREAAAAWLRRRLGVTVDPSAVLPAVGTKELIAWLPAMLGTGPGDTVAFPRLAFPTFDVSARLAGARGRPVDSPLELGSEPVKVVWLNSPSNPEGRVLSVPELREIVAWARDRGAVLVNDECYIEYGWDRRPVSLLDSAVCGGSHDGLLAVHSLSKRSNLAGYRAGVCSGDPALIGRLLQVRKHAGHAVPAPVQAAMVAALEDDAHVERQRDRYAYRRRVLRTALEGAGFRVEHSEGGLFLWATRGEPCWPAVQKLADLGILVAPGAFYGEAGEQYVRIAFTATDERIAAAAARLT", "perc_identity": 32.5}}, "BGC0000254.1|Oxytetracycline_18 # 18908 # 19336 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.706": {"gnl|BL_ORD_ID|4786|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 18908, "orf_end": 19336, "orf_from": "BGC0000254.1|Oxytetracycline_18 ", "model_name": "nimG", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "150", "model_id": "5782", "ARO_accession": "3007109", "ARO_name": "nimG", "ARO_category": {"45671": {"category_aro_accession": "3007103", "category_aro_cvterm_id": "45671", "category_aro_name": "nitroimidazole reductase", "category_aro_description": "Nitroimidazole reductases are a group of enzymes that deactivate nitroimidazole antibiotics by reducing their nitro functional group to an amino group. These enzymes are associated with resistance to nitroimidazole derivatives in Bacteroides fragilis but have also been reported in a variety of anaerobic Gram-negative and Gram-positive genera. The minimum inhibitory concentrations for these enzymes vary greatly depending on species, strain, and precise nitroimidazole treatment used.", "category_aro_class_name": "AMR Gene Family"}, "37033": {"category_aro_accession": "3000689", "category_aro_cvterm_id": "37033", "category_aro_name": "metronidazole", "category_aro_description": "Metronidazole is a nitroimidazole that is active against anaerobic bacteria and protozoa. It is not effective against aerobic bacteria. Nitroimidazoles act by oxidizing DNA causing strand breaks and cell death.", "category_aro_class_name": "Antibiotic"}, "41239": {"category_aro_accession": "3004115", "category_aro_cvterm_id": "41239", "category_aro_name": "nitroimidazole antibiotic", "category_aro_description": "Nitroimidazoles are a group of drugs that have both antiprotozoal and antibacterial activity, classified with respect to the location of the nitro functional group.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000165564, "max_identities": 27, "bit_score": 36.965, "cvterm_id": "45678", "query": "TQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVV---DDV-PCRDPEVVRAVVIHGTAQALPTGGRER", "match": "T++ +  L     G LA  G  G P+ VPVS+   + +    I      +  K   ++++D+++F V   DD+ P       R+V++ G A+ L   G +R", "sequence_from_db": "TKESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGK----IYFHSAMKGHKVDAISRNDKISFCVVEQDDIKPSEFTTYFRSVIVFGKARILTDEGEKR", "sequence_from_broadstreet": "MFREMRRKRQLLSTKESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGKIYFHSAMKGHKVDAISRNDKISFCVVEQDDIKPSEFTTYFRSVIVFGKARILTDEGEKRVALGLLADKYSHGEAGMEAEIAKGFNHLLMVEITVEHMTGKESIELIKERNDCS", "dna_sequence_from_broadstreet": "ATGTTTAGAGAAATGCGCCGTAAACGGCAATTATTGTCAACAAAAGAAAGCGTTGCCATCCTTGAAAGGATGACGAACGGGACATTGGCTCTTCACGGGGATGACGGTTACCCGTATGCCGTCCCTGTCAGTTATGTATATGCCGATGGCAAAATATACTTCCACAGTGCCATGAAAGGTCACAAAGTGGATGCCATTTCGCGGAATGACAAGATTTCGTTCTGCGTGGTGGAACAGGATGATATCAAGCCTTCTGAGTTTACCACTTACTTCCGGAGCGTGATAGTTTTTGGCAAGGCCCGCATATTGACGGATGAAGGCGAGAAACGTGTTGCTTTGGGTTTATTGGCAGACAAGTATTCGCATGGCGAAGCTGGCATGGAGGCTGAAATAGCTAAGGGATTCAACCATTTGTTGATGGTGGAAATTACAGTTGAGCATATGACAGGCAAGGAGTCCATAGAACTGATTAAAGAAAGAAATGACTGTTCTTGA", "partial": "0", "query_start": 18917, "query_end": 19207, "hit_start": 39, "hit_end": 330, "orf_dna_sequence": "ATGCCGTTCACCCAGAAGGAAATCACCTACCTGCGCGCGCAGGGCTACGGCCGTCTGGCGACGGTCGGCGCCCATGGAGAACCCCACAACGTGCCCGTCTCGTTCGAGATCGACGAGGAGCGCGGCACCATCGAGATCACCGGCCGGGACATGGGCCGCAGCCGCAAGTTCCGGAACGTGGCGAAGAGCGACCGGGTCGCCTTCGTCGTGGACGACGTGCCGTGCCGCGACCCCGAGGTGGTCCGCGCCGTCGTCATCCACGGCACGGCCCAGGCGCTGCCCACCGGCGGCAGGGAGCGCCGGCCGCACTGCGCCGACGAGATGATCCGCATCCACCCCCGGCGCATCGTCACCTGGGGCATCGAAGGGGACCTGTCCACCGGGGTCCACGCACGCGACATCACGGCCGAGGACGGAGGACGGCGATGA", "orf_prot_sequence": "MPFTQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVVDDVPCRDPEVVRAVVIHGTAQALPTGGRERRPHCADEMIRIHPRRIVTWGIEGDLSTGVHARDITAEDGGRR", "perc_identity": 26.73}, "gnl|BL_ORD_ID|4787|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 18908, "orf_end": 19336, "orf_from": "BGC0000254.1|Oxytetracycline_18 ", "model_name": "nimH", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "150", "model_id": "5783", "ARO_accession": "3007110", "ARO_name": "nimH", "ARO_category": {"45671": {"category_aro_accession": "3007103", "category_aro_cvterm_id": "45671", "category_aro_name": "nitroimidazole reductase", "category_aro_description": "Nitroimidazole reductases are a group of enzymes that deactivate nitroimidazole antibiotics by reducing their nitro functional group to an amino group. These enzymes are associated with resistance to nitroimidazole derivatives in Bacteroides fragilis but have also been reported in a variety of anaerobic Gram-negative and Gram-positive genera. The minimum inhibitory concentrations for these enzymes vary greatly depending on species, strain, and precise nitroimidazole treatment used.", "category_aro_class_name": "AMR Gene Family"}, "37033": {"category_aro_accession": "3000689", "category_aro_cvterm_id": "37033", "category_aro_name": "metronidazole", "category_aro_description": "Metronidazole is a nitroimidazole that is active against anaerobic bacteria and protozoa. It is not effective against aerobic bacteria. Nitroimidazoles act by oxidizing DNA causing strand breaks and cell death.", "category_aro_class_name": "Antibiotic"}, "41239": {"category_aro_accession": "3004115", "category_aro_cvterm_id": "41239", "category_aro_name": "nitroimidazole antibiotic", "category_aro_description": "Nitroimidazoles are a group of drugs that have both antiprotozoal and antibacterial activity, classified with respect to the location of the nitro functional group.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.000202662, "max_identities": 29, "bit_score": 36.5798, "cvterm_id": "35916", "query": "TQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVV---DDV-PCRDPEVVRAVVIHGTAQALPTGGRER", "match": "T++ IT L     G LA  G +G P+ VPVS+   + +    I      +  K   + ++++V+F V   DDV P       R+V+  G A+ L   G ++", "sequence_from_db": "TEESITILEKMTNGTLALHGDNGYPYAVPVSYVYADGK----IYFHSAVKGHKVDAILRNNKVSFCVVEQDDVKPAEFTTYFRSVIAFGKARILADEGEKQ", "sequence_from_broadstreet": "FREMRRKRQLLPTEESITILEKMTNGTLALHGDNGYPYAVPVSYVYADGKIYFHSAVKGHKVDAILRNNKVSFCVVEQDDVKPAEFTTYFRSVIAFGKARILADEGEKQLAFRLLADKYSHGEVGMEAEIAKGFNHLLMVEIMVEHMTGKE", "dna_sequence_from_broadstreet": "TTCAGAGAAATGCGGCGTAAGCGGCAATTGTTGCCAACTGAGGAAAGCATCACTATCCTCGAAAAGATGACGAACGGAACGTTGGCTCTCCATGGGGACAACGGCTATCCGTATGCCGTCCCCGTCAGTTATGTATATGCAGATGGCAAGATATACTTCCACAGTGCCGTGAAAGGGCATAAAGTGGATGCCATCTTGCGAAACAATAAGGTCTCGTTCTGCGTGGTGGAGCAAGATGATGTCAAGCCTGCTGAATTTACCACTTACTTCCGAAGCGTGATAGCTTTCGGCAAAGCACGTATTCTGGCGGATGAGGGAGAAAAACAGCTTGCCTTTCGGCTATTGGCAGACAAGTATTCGCATGGTGAGGTCGGCATGGAAGCTGAAATAGCCAAAGGTTTCAATCATTTGCTGATGGTGGAAATCATGGTTGAGCACATGACAGGCAAGGAA", "partial": "1", "query_start": 18917, "query_end": 19207, "hit_start": 36, "hit_end": 327, "orf_dna_sequence": "ATGCCGTTCACCCAGAAGGAAATCACCTACCTGCGCGCGCAGGGCTACGGCCGTCTGGCGACGGTCGGCGCCCATGGAGAACCCCACAACGTGCCCGTCTCGTTCGAGATCGACGAGGAGCGCGGCACCATCGAGATCACCGGCCGGGACATGGGCCGCAGCCGCAAGTTCCGGAACGTGGCGAAGAGCGACCGGGTCGCCTTCGTCGTGGACGACGTGCCGTGCCGCGACCCCGAGGTGGTCCGCGCCGTCGTCATCCACGGCACGGCCCAGGCGCTGCCCACCGGCGGCAGGGAGCGCCGGCCGCACTGCGCCGACGAGATGATCCGCATCCACCCCCGGCGCATCGTCACCTGGGGCATCGAAGGGGACCTGTCCACCGGGGTCCACGCACGCGACATCACGGCCGAGGACGGAGGACGGCGATGA", "orf_prot_sequence": "MPFTQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVVDDVPCRDPEVVRAVVIHGTAQALPTGGRERRPHCADEMIRIHPRRIVTWGIEGDLSTGVHARDITAEDGGRR", "perc_identity": 28.71}, "gnl|BL_ORD_ID|4791|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 18908, "orf_end": 19336, "orf_from": "BGC0000254.1|Oxytetracycline_18 ", "model_name": "nimB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "150", "model_id": "5787", "ARO_accession": "3004655", "ARO_name": "nimB", "ARO_category": {"45671": {"category_aro_accession": "3007103", "category_aro_cvterm_id": "45671", "category_aro_name": "nitroimidazole reductase", "category_aro_description": "Nitroimidazole reductases are a group of enzymes that deactivate nitroimidazole antibiotics by reducing their nitro functional group to an amino group. These enzymes are associated with resistance to nitroimidazole derivatives in Bacteroides fragilis but have also been reported in a variety of anaerobic Gram-negative and Gram-positive genera. The minimum inhibitory concentrations for these enzymes vary greatly depending on species, strain, and precise nitroimidazole treatment used.", "category_aro_class_name": "AMR Gene Family"}, "37033": {"category_aro_accession": "3000689", "category_aro_cvterm_id": "37033", "category_aro_name": "metronidazole", "category_aro_description": "Metronidazole is a nitroimidazole that is active against anaerobic bacteria and protozoa. It is not effective against aerobic bacteria. Nitroimidazoles act by oxidizing DNA causing strand breaks and cell death.", "category_aro_class_name": "Antibiotic"}, "41239": {"category_aro_accession": "3004115", "category_aro_cvterm_id": "41239", "category_aro_name": "nitroimidazole antibiotic", "category_aro_description": "Nitroimidazoles are a group of drugs that have both antiprotozoal and antibacterial activity, classified with respect to the location of the nitro functional group.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00195387, "max_identities": 28, "bit_score": 33.8834, "cvterm_id": "35916", "query": "TQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVV---DDV-PCRDPEVVRAVVIHGTAQALPTGGRERR", "match": "T++ +  L     G LA  G  G P+ VP+S+   + +    I      +  K   + ++D+V+F V   DD+ P       R+V++ G A  L T   E+R", "sequence_from_db": "TEESVAILERMTNGTLALHGDDGYPYAVPISYVYADGK----IYFHSAMKGHKVDAILQNDKVSFCVVEQDDIRPSEFTTYFRSVIVFGKAHIL-TDELEKR", "sequence_from_broadstreet": "MFREMRRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPISYVYADGKIYFHSAMKGHKVDAILQNDKVSFCVVEQDDIRPSEFTTYFRSVIVFGKAHILTDELEKRVALGLLADKYSYGEAGMEAEIAKGFNHLLIVKIAIEHITGKEAIELTKNRNDRP", "dna_sequence_from_broadstreet": "ATGTTTAGAGAAATGCGACGTAAGCGGCAATTATTGCCAACAGAAGAAAGCGTTGCCATCCTTGAAAGGATGACGAACGGAACATTGGCTCTTCATGGGGACGATGGTTACCCGTATGCCGTTCCCATCAGTTATGTATATGCTGATGGCAAAATATATTTCCATAGTGCCATGAAAGGTCATAAAGTGGATGCCATTTTGCAGAATGACAAGGTATCATTCTGCGTGGTAGAACAGGATGACATCAGACCGTCTGAGTTTACCACTTACTTTCGAAGTGTGATAGTCTTTGGCAAAGCCCACATATTGACGGATGAACTCGAAAAACGTGTTGCTTTGGGTTTATTGGCAGACAAGTATTCGTATGGCGAAGCTGGCATGGAGGCTGAAATAGCCAAAGGGTTCAATCATTTGTTAATAGTGAAAATTGCAATTGAGCATATTACAGGCAAGGAAGCCATAGAACTGACCAAAAATAGGAATGACCGTCCTTGA", "partial": "0", "query_start": 18917, "query_end": 19210, "hit_start": 39, "hit_end": 330, "orf_dna_sequence": "ATGCCGTTCACCCAGAAGGAAATCACCTACCTGCGCGCGCAGGGCTACGGCCGTCTGGCGACGGTCGGCGCCCATGGAGAACCCCACAACGTGCCCGTCTCGTTCGAGATCGACGAGGAGCGCGGCACCATCGAGATCACCGGCCGGGACATGGGCCGCAGCCGCAAGTTCCGGAACGTGGCGAAGAGCGACCGGGTCGCCTTCGTCGTGGACGACGTGCCGTGCCGCGACCCCGAGGTGGTCCGCGCCGTCGTCATCCACGGCACGGCCCAGGCGCTGCCCACCGGCGGCAGGGAGCGCCGGCCGCACTGCGCCGACGAGATGATCCGCATCCACCCCCGGCGCATCGTCACCTGGGGCATCGAAGGGGACCTGTCCACCGGGGTCCACGCACGCGACATCACGGCCGAGGACGGAGGACGGCGATGA", "orf_prot_sequence": "MPFTQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVVDDVPCRDPEVVRAVVIHGTAQALPTGGRERRPHCADEMIRIHPRRIVTWGIEGDLSTGVHARDITAEDGGRR", "perc_identity": 27.45}, "gnl|BL_ORD_ID|4759|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 18908, "orf_end": 19336, "orf_from": "BGC0000254.1|Oxytetracycline_18 ", "model_name": "nimD", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "150", "model_id": "5779", "ARO_accession": "3007106", "ARO_name": "nimD", "ARO_category": {"45671": {"category_aro_accession": "3007103", "category_aro_cvterm_id": "45671", "category_aro_name": "nitroimidazole reductase", "category_aro_description": "Nitroimidazole reductases are a group of enzymes that deactivate nitroimidazole antibiotics by reducing their nitro functional group to an amino group. These enzymes are associated with resistance to nitroimidazole derivatives in Bacteroides fragilis but have also been reported in a variety of anaerobic Gram-negative and Gram-positive genera. The minimum inhibitory concentrations for these enzymes vary greatly depending on species, strain, and precise nitroimidazole treatment used.", "category_aro_class_name": "AMR Gene Family"}, "37033": {"category_aro_accession": "3000689", "category_aro_cvterm_id": "37033", "category_aro_name": "metronidazole", "category_aro_description": "Metronidazole is a nitroimidazole that is active against anaerobic bacteria and protozoa. It is not effective against aerobic bacteria. Nitroimidazoles act by oxidizing DNA causing strand breaks and cell death.", "category_aro_class_name": "Antibiotic"}, "41239": {"category_aro_accession": "3004115", "category_aro_cvterm_id": "41239", "category_aro_name": "nitroimidazole antibiotic", "category_aro_description": "Nitroimidazoles are a group of drugs that have both antiprotozoal and antibacterial activity, classified with respect to the location of the nitro functional group.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00943231, "max_identities": 29, "bit_score": 31.9574, "cvterm_id": "35916", "query": "TQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVV---DDV-PCRDPEVVRAVVIHGTAQALPTGGRERR", "match": "T++ +  L     G LA  G  G P+ VPVS+   + +    I      +  K   + ++D+V+F V   D+V P       R+V++ G A+ L T   E+R", "sequence_from_db": "TEESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGK----IYFHSAMQGPKVDAILRNDKVSFCVVEQDEVKPAEFTTYFRSVIVFGKARIL-TDENEKR", "sequence_from_broadstreet": "MFREMPRKRQLLPTEESVAILERMTNGTLALHGDDGYPYAVPVSYVYADGKIYFHSAMQGPKVDAILRNDKVSFCVVEQDEVKPAEFTTYFRSVIVFGKARILTDENEKRNALNLLADKYSHGEAGMEAEMAKGFNHLLMIEITVEQMTGKEAIELTRGRNGCS", "dna_sequence_from_broadstreet": "ATGTTTAGAGAAATGCCGCGTAAGCGGCAATTGTTGCCAACAGAAGAAAGCGTTGCCATTCTTGAACGGATGACAAACGGGACGTTGGCTCTTCATGGGGATGACGGCTATCCGTATGCCGTCCCTGTCAGTTATGTATATGCCGATGGCAAAATTTACTTCCACAGTGCCATGCAAGGGCCAAAAGTGGATGCCATCCTGCGGAATGACAAGGTCTCGTTCTGCGTAGTGGAGCAGGATGAGGTCAAGCCGGCCGAGTTTACCACCTATTTTCGGAGCGTGATAGTCTTTGGCAAGGCCCGCATACTGACCGACGAGAACGAAAAACGAAATGCCTTAAACCTGCTGGCCGACAAGTATTCGCATGGCGAAGCGGGCATGGAGGCTGAAATGGCCAAAGGGTTCAATCATTTGCTGATGATAGAAATCACAGTAGAGCAGATGACCGGAAAAGAAGCCATCGAACTGACAAGGGGAAGAAACGGATGTTCTTGA", "partial": "0", "query_start": 18917, "query_end": 19210, "hit_start": 39, "hit_end": 330, "orf_dna_sequence": "ATGCCGTTCACCCAGAAGGAAATCACCTACCTGCGCGCGCAGGGCTACGGCCGTCTGGCGACGGTCGGCGCCCATGGAGAACCCCACAACGTGCCCGTCTCGTTCGAGATCGACGAGGAGCGCGGCACCATCGAGATCACCGGCCGGGACATGGGCCGCAGCCGCAAGTTCCGGAACGTGGCGAAGAGCGACCGGGTCGCCTTCGTCGTGGACGACGTGCCGTGCCGCGACCCCGAGGTGGTCCGCGCCGTCGTCATCCACGGCACGGCCCAGGCGCTGCCCACCGGCGGCAGGGAGCGCCGGCCGCACTGCGCCGACGAGATGATCCGCATCCACCCCCGGCGCATCGTCACCTGGGGCATCGAAGGGGACCTGTCCACCGGGGTCCACGCACGCGACATCACGGCCGAGGACGGAGGACGGCGATGA", "orf_prot_sequence": "MPFTQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVVDDVPCRDPEVVRAVVIHGTAQALPTGGRERRPHCADEMIRIHPRRIVTWGIEGDLSTGVHARDITAEDGGRR", "perc_identity": 28.43}, "gnl|BL_ORD_ID|4784|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 18908, "orf_end": 19336, "orf_from": "BGC0000254.1|Oxytetracycline_18 ", "model_name": "nimE", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "150", "model_id": "5780", "ARO_accession": "3007107", "ARO_name": "nimE", "ARO_category": {"45671": {"category_aro_accession": "3007103", "category_aro_cvterm_id": "45671", "category_aro_name": "nitroimidazole reductase", "category_aro_description": "Nitroimidazole reductases are a group of enzymes that deactivate nitroimidazole antibiotics by reducing their nitro functional group to an amino group. These enzymes are associated with resistance to nitroimidazole derivatives in Bacteroides fragilis but have also been reported in a variety of anaerobic Gram-negative and Gram-positive genera. The minimum inhibitory concentrations for these enzymes vary greatly depending on species, strain, and precise nitroimidazole treatment used.", "category_aro_class_name": "AMR Gene Family"}, "37033": {"category_aro_accession": "3000689", "category_aro_cvterm_id": "37033", "category_aro_name": "metronidazole", "category_aro_description": "Metronidazole is a nitroimidazole that is active against anaerobic bacteria and protozoa. It is not effective against aerobic bacteria. Nitroimidazoles act by oxidizing DNA causing strand breaks and cell death.", "category_aro_class_name": "Antibiotic"}, "41239": {"category_aro_accession": "3004115", "category_aro_cvterm_id": "41239", "category_aro_name": "nitroimidazole antibiotic", "category_aro_description": "Nitroimidazoles are a group of drugs that have both antiprotozoal and antibacterial activity, classified with respect to the location of the nitro functional group.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.034336, "max_identities": 27, "bit_score": 30.4166, "cvterm_id": "35916", "query": "QKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVV---DDV-PCRDPEVVRAVVIHGTAQALPTGGRERR", "match": "++ +  L     G LA  G +G P+ VP+S+   +  G I      +G   K   + ++++V+F V   D++ P       R+V++ G A  L T   E+R", "sequence_from_db": "EESVAILEKMTNGTLALHGDNGYPYAVPLSYFYAD--GKIYFHCAKIG--HKVDAIMQNNKVSFCVVEQDNIKPAEFTTYFRSVIVFGKAYIL-TDETEKR", "sequence_from_broadstreet": "MFREMRRKRQLLPQEESVAILEKMTNGTLALHGDNGYPYAVPLSYFYADGKIYFHCAKIGHKVDAIMQNNKVSFCVVEQDNIKPAEFTTYFRSVIVFGKAYILTDETEKRMAMTLLVNKYSFGEPGLSDEIAKSINHLLMVKIDIEHMTGKEAIDLVREKEKFCTSEKTS", "dna_sequence_from_broadstreet": "ATGTTCAGAGAAATGCGTCGTAAACGACAGTTGTTGCCACAAGAAGAGAGCGTGGCAATTCTTGAAAAAATGACAAACGGGACTTTAGCTCTCCACGGAGATAATGGCTATCCTTATGCCGTTCCTCTCAGTTATTTTTATGCTGATGGCAAAATCTATTTTCATTGCGCCAAGATAGGGCATAAGGTGGACGCTATTATGCAAAACAATAAAGTATCGTTTTGCGTTGTGGAACAAGACAATATTAAACCTGCCGAATTCACGACCTACTTTCGAAGTGTGATAGTCTTTGGAAAGGCCTATATTTTAACCGACGAAACAGAAAAACGTATGGCTATGACTTTGCTGGTGAATAAATATTCTTTCGGTGAGCCAGGTTTGTCTGATGAAATAGCCAAAAGCATCAACCATCTACTGATGGTAAAGATCGATATCGAACACATGACGGGCAAGGAGGCCATCGATTTGGTTAGAGAGAAAGAAAAGTTTTGTACTTCAGAGAAAACCTCTTGA", "partial": "0", "query_start": 18920, "query_end": 19210, "hit_start": 42, "hit_end": 330, "orf_dna_sequence": "ATGCCGTTCACCCAGAAGGAAATCACCTACCTGCGCGCGCAGGGCTACGGCCGTCTGGCGACGGTCGGCGCCCATGGAGAACCCCACAACGTGCCCGTCTCGTTCGAGATCGACGAGGAGCGCGGCACCATCGAGATCACCGGCCGGGACATGGGCCGCAGCCGCAAGTTCCGGAACGTGGCGAAGAGCGACCGGGTCGCCTTCGTCGTGGACGACGTGCCGTGCCGCGACCCCGAGGTGGTCCGCGCCGTCGTCATCCACGGCACGGCCCAGGCGCTGCCCACCGGCGGCAGGGAGCGCCGGCCGCACTGCGCCGACGAGATGATCCGCATCCACCCCCGGCGCATCGTCACCTGGGGCATCGAAGGGGACCTGTCCACCGGGGTCCACGCACGCGACATCACGGCCGAGGACGGAGGACGGCGATGA", "orf_prot_sequence": "MPFTQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVVDDVPCRDPEVVRAVVIHGTAQALPTGGRERRPHCADEMIRIHPRRIVTWGIEGDLSTGVHARDITAEDGGRR", "perc_identity": 26.73}, "gnl|BL_ORD_ID|4785|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 18908, "orf_end": 19336, "orf_from": "BGC0000254.1|Oxytetracycline_18 ", "model_name": "nimF", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "150", "model_id": "5781", "ARO_accession": "3007108", "ARO_name": "nimF", "ARO_category": {"45671": {"category_aro_accession": "3007103", "category_aro_cvterm_id": "45671", "category_aro_name": "nitroimidazole reductase", "category_aro_description": "Nitroimidazole reductases are a group of enzymes that deactivate nitroimidazole antibiotics by reducing their nitro functional group to an amino group. These enzymes are associated with resistance to nitroimidazole derivatives in Bacteroides fragilis but have also been reported in a variety of anaerobic Gram-negative and Gram-positive genera. The minimum inhibitory concentrations for these enzymes vary greatly depending on species, strain, and precise nitroimidazole treatment used.", "category_aro_class_name": "AMR Gene Family"}, "41239": {"category_aro_accession": "3004115", "category_aro_cvterm_id": "41239", "category_aro_name": "nitroimidazole antibiotic", "category_aro_description": "Nitroimidazoles are a group of drugs that have both antiprotozoal and antibacterial activity, classified with respect to the location of the nitro functional group.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0344968, "max_identities": 27, "bit_score": 30.4166, "cvterm_id": "39546", "query": "TQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVV---DDV-PCRDPEVVRAVVIHGTAQAL", "match": " ++ I  L     G LA  G  G P+ VPVS+   + +    I      +  K   + +++RV+F V   DDV P       R+VV+ G  + L", "sequence_from_db": "AEESIAILERMTNGVLALHGDEGYPYAVPVSYVYADGK----IYFHSAMKGHKVDAIMRNERVSFCVVERDDVCPGEFTTYFRSVVLFGKTRIL", "sequence_from_broadstreet": "MFREMRRKRQQLSAEESIAILERMTNGVLALHGDEGYPYAVPVSYVYADGKIYFHSAMKGHKVDAIMRNERVSFCVVERDDVCPGEFTTYFRSVVLFGKTRILTEEAEKLAALSLLADKYSPGEPGKDAEIAKGFNLLMVEIAVEHMTGKE", "dna_sequence_from_broadstreet": "ATGTTCAGAGAAATGCGGCGTAAGCGGCAGCAACTGTCTGCCGAAGAAAGTATTGCCATCCTTGAACGGATGACGAACGGAGTGCTGGCACTTCATGGGGATGAAGGTTATCCGTATGCCGTCCCTGTCAGTTATGTATATGCGGATGGGAAGATTTATTTCCACAGTGCCATGAAAGGCCATAAGGTGGATGCCATCATGCGGAATGAACGTGTTTCGTTCTGCGTAGTGGAACGGGACGATGTCTGTCCGGGCGAGTTCACCACCTACTTCAGGAGCGTGGTGCTCTTCGGCAAGACCCGTATTTTGACGGAAGAGGCCGAAAAGTTGGCGGCCTTGAGCTTGCTTGCCGACAAATATTCACCGGGAGAACCCGGTAAAGATGCCGAAATCGCCAAAGGGTTTAACCTGCTGATGGTGGAAATTGCAGTCGAGCACATGACAGGCAAGGAA", "partial": "1", "query_start": 18917, "query_end": 19186, "hit_start": 39, "hit_end": 309, "orf_dna_sequence": "ATGCCGTTCACCCAGAAGGAAATCACCTACCTGCGCGCGCAGGGCTACGGCCGTCTGGCGACGGTCGGCGCCCATGGAGAACCCCACAACGTGCCCGTCTCGTTCGAGATCGACGAGGAGCGCGGCACCATCGAGATCACCGGCCGGGACATGGGCCGCAGCCGCAAGTTCCGGAACGTGGCGAAGAGCGACCGGGTCGCCTTCGTCGTGGACGACGTGCCGTGCCGCGACCCCGAGGTGGTCCGCGCCGTCGTCATCCACGGCACGGCCCAGGCGCTGCCCACCGGCGGCAGGGAGCGCCGGCCGCACTGCGCCGACGAGATGATCCGCATCCACCCCCGGCGCATCGTCACCTGGGGCATCGAAGGGGACCTGTCCACCGGGGTCCACGCACGCGACATCACGGCCGAGGACGGAGGACGGCGATGA", "orf_prot_sequence": "MPFTQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVVDDVPCRDPEVVRAVVIHGTAQALPTGGRERRPHCADEMIRIHPRRIVTWGIEGDLSTGVHARDITAEDGGRR", "perc_identity": 28.72}, "gnl|BL_ORD_ID|4782|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 18908, "orf_end": 19336, "orf_from": "BGC0000254.1|Oxytetracycline_18 ", "model_name": "nimA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "150", "model_id": "5777", "ARO_accession": "3007104", "ARO_name": "nimA", "ARO_category": {"45671": {"category_aro_accession": "3007103", "category_aro_cvterm_id": "45671", "category_aro_name": "nitroimidazole reductase", "category_aro_description": "Nitroimidazole reductases are a group of enzymes that deactivate nitroimidazole antibiotics by reducing their nitro functional group to an amino group. These enzymes are associated with resistance to nitroimidazole derivatives in Bacteroides fragilis but have also been reported in a variety of anaerobic Gram-negative and Gram-positive genera. The minimum inhibitory concentrations for these enzymes vary greatly depending on species, strain, and precise nitroimidazole treatment used.", "category_aro_class_name": "AMR Gene Family"}, "37033": {"category_aro_accession": "3000689", "category_aro_cvterm_id": "37033", "category_aro_name": "metronidazole", "category_aro_description": "Metronidazole is a nitroimidazole that is active against anaerobic bacteria and protozoa. It is not effective against aerobic bacteria. Nitroimidazoles act by oxidizing DNA causing strand breaks and cell death.", "category_aro_class_name": "Antibiotic"}, "41239": {"category_aro_accession": "3004115", "category_aro_cvterm_id": "41239", "category_aro_name": "nitroimidazole antibiotic", "category_aro_description": "Nitroimidazoles are a group of drugs that have both antiprotozoal and antibacterial activity, classified with respect to the location of the nitro functional group.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.132886, "max_identities": 25, "bit_score": 28.4906, "cvterm_id": "39546", "query": "GRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVVDD----VPCRDPEVVRAVVIHGTAQAL", "match": "G LA  G +G P+ VPVS+   +  G I   G   G   K   + +   V+F V +    VP       R+V++ G A+ L", "sequence_from_db": "GTLALHGDNGYPYAVPVSYVYAD--GKIYFHGAVQG--HKMDAIRQHPEVSFCVVEQDRIVPAEFTTYFRSVIVFGKARIL", "sequence_from_broadstreet": "MFREMRRKRQLLPPEESLAILERMTGGTLALHGDNGYPYAVPVSYVYADGKIYFHGAVQGHKMDAIRQHPEVSFCVVEQDRIVPAEFTTYFRSVIVFGKARILTDEVEKRAALLRLAEKYSSGESGMQDEIDKGFDHLVMVEITVEHMTGKEAIQLVRRKGNNRWDAFPSKDVFIR", "dna_sequence_from_broadstreet": "ATGTTCAGAGAAATGCGGCGCAAACGCCAGTTGTTGCCGCCCGAAGAAAGCTTGGCGATACTGGAGCGCATGACCGGCGGTACGCTTGCCCTTCATGGCGACAACGGATATCCGTATGCCGTCCCCGTGAGCTATGTGTATGCCGACGGGAAGATTTATTTTCACGGTGCCGTGCAAGGGCATAAGATGGATGCCATCAGGCAGCATCCCGAAGTCTCGTTTTGTGTGGTGGAGCAAGACCGGATAGTTCCTGCCGAGTTTACAACCTATTTCCGGAGTGTCATTGTCTTCGGTAAAGCCCGTATCCTGACCGATGAGGTCGAGAAGCGTGCCGCTCTGCTTCGGCTGGCAGAGAAGTATTCGTCCGGCGAGTCGGGTATGCAAGACGAGATAGACAAGGGATTCGACCATCTGGTAATGGTGGAGATAACCGTCGAGCACATGACAGGCAAGGAGGCTATACAGCTGGTGCGCAGAAAGGGAAATAACAGGTGGGACGCTTTTCCGTCAAAGGACGTTTTTATCAGATAG", "partial": "0", "query_start": 18956, "query_end": 19186, "hit_start": 78, "hit_end": 309, "orf_dna_sequence": "ATGCCGTTCACCCAGAAGGAAATCACCTACCTGCGCGCGCAGGGCTACGGCCGTCTGGCGACGGTCGGCGCCCATGGAGAACCCCACAACGTGCCCGTCTCGTTCGAGATCGACGAGGAGCGCGGCACCATCGAGATCACCGGCCGGGACATGGGCCGCAGCCGCAAGTTCCGGAACGTGGCGAAGAGCGACCGGGTCGCCTTCGTCGTGGACGACGTGCCGTGCCGCGACCCCGAGGTGGTCCGCGCCGTCGTCATCCACGGCACGGCCCAGGCGCTGCCCACCGGCGGCAGGGAGCGCCGGCCGCACTGCGCCGACGAGATGATCCGCATCCACCCCCGGCGCATCGTCACCTGGGGCATCGAAGGGGACCTGTCCACCGGGGTCCACGCACGCGACATCACGGCCGAGGACGGAGGACGGCGATGA", "orf_prot_sequence": "MPFTQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVVDDVPCRDPEVVRAVVIHGTAQALPTGGRERRPHCADEMIRIHPRRIVTWGIEGDLSTGVHARDITAEDGGRR", "perc_identity": 30.86}, "gnl|BL_ORD_ID|4790|hsp_num:0": {"type_match": "Loose", "orf_strand": "-", "orf_start": 18908, "orf_end": 19336, "orf_from": "BGC0000254.1|Oxytetracycline_18 ", "model_name": "nimK", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "150", "model_id": "5786", "ARO_accession": "3007113", "ARO_name": "nimK", "ARO_category": {"45671": {"category_aro_accession": "3007103", "category_aro_cvterm_id": "45671", "category_aro_name": "nitroimidazole reductase", "category_aro_description": "Nitroimidazole reductases are a group of enzymes that deactivate nitroimidazole antibiotics by reducing their nitro functional group to an amino group. These enzymes are associated with resistance to nitroimidazole derivatives in Bacteroides fragilis but have also been reported in a variety of anaerobic Gram-negative and Gram-positive genera. The minimum inhibitory concentrations for these enzymes vary greatly depending on species, strain, and precise nitroimidazole treatment used.", "category_aro_class_name": "AMR Gene Family"}, "37033": {"category_aro_accession": "3000689", "category_aro_cvterm_id": "37033", "category_aro_name": "metronidazole", "category_aro_description": "Metronidazole is a nitroimidazole that is active against anaerobic bacteria and protozoa. It is not effective against aerobic bacteria. Nitroimidazoles act by oxidizing DNA causing strand breaks and cell death.", "category_aro_class_name": "Antibiotic"}, "41239": {"category_aro_accession": "3004115", "category_aro_cvterm_id": "41239", "category_aro_name": "nitroimidazole antibiotic", "category_aro_description": "Nitroimidazoles are a group of drugs that have both antiprotozoal and antibacterial activity, classified with respect to the location of the nitro functional group.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.8599, "max_identities": 23, "bit_score": 25.409, "cvterm_id": "45684", "query": "TQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVV----DDVPCRDPEVVRAVVIHGTAQAL", "match": "T++ I  L     G LA     G P+ VP+S+   + +    I      +  K   + K++ V+F V      VP       ++V++ G A+ L", "sequence_from_db": "TEECIAILEKMTSGVLALNEEGGYPYAVPLSYVYSDNK----IYFHSAIKGHKIELLEKNENVSFCVIFQDHIVPEEFTTYFQSVIVFGKARIL", "sequence_from_broadstreet": "MFREMRRKRQQLSTEECIAILEKMTSGVLALNEEGGYPYAVPLSYVYSDNKIYFHSAIKGHKIELLEKNENVSFCVIFQDHIVPEEFTTYFQSVIVFGKARILLDEKEKMSALWKLGEKYSSGNAEALSAEISKGKNHLLIIEIAIEHMTGKESIELVRAKKSIKESK", "dna_sequence_from_broadstreet": "ATGTTCAGAGAAATGCGTCGCAAGCGACAACAGTTATCCACAGAAGAGTGCATTGCTATTCTTGAAAAAATGACTTCTGGTGTATTGGCTCTTAATGAAGAAGGCGGCTATCCTTATGCCGTTCCTTTAAGTTACGTATATTCGGATAATAAAATCTACTTTCACAGTGCCATAAAAGGACATAAGATAGAATTACTGGAAAAGAATGAAAACGTCTCTTTTTGCGTAATTTTTCAAGACCATATCGTTCCTGAAGAATTTACCACTTATTTCCAAAGTGTAATTGTATTTGGCAAAGCCCGTATTTTATTGGATGAGAAGGAAAAGATGTCAGCGTTGTGGAAATTAGGAGAAAAATATTCATCAGGTAACGCCGAAGCACTGTCTGCAGAGATAAGTAAAGGGAAGAACCATCTGCTTATTATTGAGATTGCTATCGAGCATATGACAGGAAAAGAATCTATAGAGTTGGTACGGGCCAAGAAATCGATAAAAGAGTCCAAATAG", "partial": "0", "query_start": 18917, "query_end": 19186, "hit_start": 39, "hit_end": 309, "orf_dna_sequence": "ATGCCGTTCACCCAGAAGGAAATCACCTACCTGCGCGCGCAGGGCTACGGCCGTCTGGCGACGGTCGGCGCCCATGGAGAACCCCACAACGTGCCCGTCTCGTTCGAGATCGACGAGGAGCGCGGCACCATCGAGATCACCGGCCGGGACATGGGCCGCAGCCGCAAGTTCCGGAACGTGGCGAAGAGCGACCGGGTCGCCTTCGTCGTGGACGACGTGCCGTGCCGCGACCCCGAGGTGGTCCGCGCCGTCGTCATCCACGGCACGGCCCAGGCGCTGCCCACCGGCGGCAGGGAGCGCCGGCCGCACTGCGCCGACGAGATGATCCGCATCCACCCCCGGCGCATCGTCACCTGGGGCATCGAAGGGGACCTGTCCACCGGGGTCCACGCACGCGACATCACGGCCGAGGACGGAGGACGGCGATGA", "orf_prot_sequence": "MPFTQKEITYLRAQGYGRLATVGAHGEPHNVPVSFEIDEERGTIEITGRDMGRSRKFRNVAKSDRVAFVVDDVPCRDPEVVRAVVIHGTAQALPTGGRERRPHCADEMIRIHPRRIVTWGIEGDLSTGVHARDITAEDGGRR", "perc_identity": 24.47}}, "BGC0000254.1|Oxytetracycline_19 # 19438 # 21003 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=CCGGC;rbs_spacer=15bp;gc_cont=0.735": {"gnl|BL_ORD_ID|4834|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "Nocardia farcinica rox", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "550", "model_id": "5821", "ARO_accession": "3007210", "ARO_name": "Nocardia farcinica rox", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.93352e-126, "max_identities": 237, "bit_score": 375.17, "cvterm_id": "41346", "query": "DVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLR-GGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFG", "match": "DV+IAG GPTGLMLA ELRL G RT+VLE+   P   S++ G+HAR++E++D RGL E F A   + R GG FA L      +  DT H Y L +PQV TE LLT  A ELGAE+RRG  V  L+QDADGVT  +        +   YLVGCDGG STVR+LLG+DFPG+   +  ++AD R   ++P       +    V +  LR  F A P     +R  V       ADR AP  +E ++  L   AG+DFG+H  RWLSR  D +R AERYR GRVLLAGDA HIH P GGQGLNLG QDA NLGWKL A I G APP+LLD+Y  ER P+AA VL NTRAQ  L+  DP    +R LM EL+  P+ NR+L   I+A+ VRY +   H L+GRR+ D+PL       +L       RG+LL    D+      + W DRVD      +ADPG+A+D + A L+RPDG++ W    +   D L   L  WFG", "sequence_from_db": "DVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWP-ADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGT---RLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRI--DVPVETLTAVVAE--VRKTQLR--FGAVPAGDGFFRLIVPA-QGLSADRAAPTLDE-LKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEG----RLYERMRGGRGLLL----DRTGRLSVSGWSDRVD-----HLADPGAALD-VPAALLRPDGHVAWVGEDQ---DDLLAHLPRWFG", "sequence_from_broadstreet": "MIDVIIAGGGPTGLMLAGELRLHGVRTVVLEKEPTPNQHSRSRGLHARSIEVMDQRGLLERFLAHGEQFRVGGFFAGLAAEWPADLDTAHSYVLAIPQVVTERLLTEHATELGAEIRRGCEVAGLDQDADGVTAELADGTRLRARYLVGCDGGRSTVRRLLGVDFPGEPTRVETLLADVRIDVPVETLTAVVAEVRKTQLRFGAVPAGDGFFRLIVPAQGLSADRAAPTLDELKRCLHATAGTDFGVHSPRWLSRFGDATRLAERYRTGRVLLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAAIGGWAPPDLLDSYHDERHPVAAEVLDNTRAQMTLLSLDPGPRAVRRLMAELVEFPDVNRHLIEKITAIAVRYDLGDGHDLVGRRLRDIPLTEGRLYERMRGGRGLLLDRTGRLSVSGWSDRVDHLADPGAALDVPAALLRPDGHVAWVGEDQDDLLAHLPRWFGAAT", "dna_sequence_from_broadstreet": "GTGATCGATGTGATCATCGCGGGTGGCGGACCGACCGGCTTGATGCTGGCCGGCGAACTGCGCCTGCACGGTGTGCGCACGGTGGTACTGGAGAAGGAGCCCACCCCGAACCAGCACTCCCGCAGTCGGGGCCTGCACGCGCGCAGCATCGAGGTGATGGACCAGCGCGGGCTGCTGGAGCGGTTCCTCGCGCACGGCGAGCAGTTCCGGGTCGGCGGGTTCTTCGCCGGGCTGGCCGCCGAATGGCCCGCCGACCTGGACACCGCGCACTCCTACGTGCTCGCGATTCCCCAGGTCGTCACCGAGCGCCTGCTCACCGAGCACGCCACCGAACTCGGCGCCGAGATCCGCCGCGGCTGCGAAGTGGCCGGGTTGGATCAGGACGCGGACGGGGTGACCGCCGAGCTGGCCGACGGCACGCGGTTGCGCGCCCGGTACCTGGTCGGCTGCGACGGCGGACGCTCGACCGTGCGCCGTCTGCTCGGGGTCGACTTCCCCGGCGAACCCACCCGGGTCGAGACGTTGCTGGCCGACGTGCGGATCGACGTGCCGGTCGAGACACTGACCGCGGTGGTCGCCGAGGTGCGCAAGACCCAACTGCGATTCGGGGCCGTCCCGGCCGGCGACGGGTTCTTCCGGCTGATCGTGCCCGCGCAGGGCCTGTCCGCGGACCGCGCCGCACCCACCCTCGACGAGCTGAAGCGATGCCTGCACGCGACGGCGGGCACCGATTTCGGCGTGCACTCCCCGCGCTGGCTGTCCCGCTTCGGCGACGCCACCCGGCTCGCCGAGCGCTACCGCACCGGGCGGGTGCTGCTGGCGGGCGACGCCGCCCACATCCATCCGCCGACCGGCGGCCAGGGCCTCAATCTGGGCATCCAGGACGCCTTCAACCTCGGCTGGAAGCTCGCCGCCGCGATCGGCGGCTGGGCGCCGCCGGACCTGCTGGACAGCTACCACGACGAACGCCATCCGGTCGCCGCCGAGGTGCTGGACAACACCCGCGCCCAGATGACGCTGCTCTCCCTCGACCCCGGCCCGCGCGCGGTGCGCAGACTGATGGCGGAGCTGGTCGAATTCCCCGACGTGAACCGGCACCTGATCGAGAAGATCACCGCGATCGCCGTCCGCTACGACCTCGGCGACGGCCACGACCTGGTCGGTCGACGGCTGCGCGACATCCCGCTCACCGAAGGCCGCCTCTACGAGCGGATGCGCGGCGGCCGCGGGCTGCTGCTCGACCGGACCGGGCGGCTGTCGGTATCGGGCTGGTCCGACCGCGTCGACCACCTCGCCGACCCGGGCGCGGCGCTCGACGTCCCGGCGGCGCTGCTGCGCCCGGACGGGCACGTCGCGTGGGTGGGCGAGGACCAGGACGATCTGCTCGCCCACCTGCCCCGCTGGTTCGGCGCCGCCACCTGA", "partial": "0", "query_start": 19501, "query_end": 20988, "hit_start": 6, "hit_end": 1410, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 47.69}, "gnl|BL_ORD_ID|4833|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "Streptomyces venezuelae rox", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "5820", "ARO_accession": "3007209", "ARO_name": "Streptomyces venezuelae rox", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.14984e-118, "max_identities": 226, "bit_score": 353.984, "cvterm_id": "36873", "query": "YDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLR-GGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARF---REELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFG", "match": "+DV++ G GPTGLMLA ELRL G R LVLE+  EP   S+A G+H R++E++  RGL E F      +  GG FA L         DT H Y L VPQV TE+LL   A  LGAE+RRG A+  L QD DGVTV +   E   ++   Y+VGCDGG STVRKLLG+ FPG+   +  ++ +      +EEL     M  +R         +  F A PL   V+R  V   +    DR A  T ++ +  L   AG+DFG+H  RWLSR  D +RQAERYR  RV LAGDA HIH P GGQGLNLG QDA NLGWKL A + G AP  LLDTY AER P+A  VL NTRAQ  L+  +P  + +R LM EL+     NRYL   I+A+ VRY +   H LLGRR+ DL L  + G  +L    H  RG+LL    DQ      A W+DRVD      V +    +D + A+L+RPDG++ W    +     L   +  WFG", "sequence_from_db": "FDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWP-ERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGE---QLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELT--SVMTEVRKT-------QQRFGAMPLGDGVFRVVVPA-EGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLAL--KHG--RLYERMHEGRGLLL----DQTGRLSVAGWEDRVD-----HVVEVSEELD-VPAVLLRPDGHVVWAGEDQ---QELLTRMPAWFG", "sequence_from_broadstreet": "MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG", "dna_sequence_from_broadstreet": "ATGTTTGACGTGATCGTTGTCGGTGGCGGTCCGACCGGCTTGATGCTGGCCGGCGAACTGCGGCTGCACGGCGTGCGCGTACTCGTGCTGGAGAAGGAGACGGAGCCGACGCGGCAGTCCCGCGCGCAGGGGCTGCACGTCCGCAGCATCGAGGTGATGGCCCAGCGCGGGCTCCTGGAGCGCTTCCTCGAACGCGGGCACACGGTCGCGGTCGGCGGCTTCTTCGCCGGTCTGGCGACCTCGTGGCCCGAGCGGCTGGACACCGCGCACTCGTACGTCCTCGCCGTCCCGCAGGTGATCACCGAGCAGCTGCTGGCCGAGCACGCCACCGCACTCGGAGCCGAGATCCGACGCGGCCGGGCACTGGTCGGTCTCCGCCAGGACGAGGACGGCGTGACGGTCGACCTGGCCGACGGCGAACAGCTGCGCGCACGGTACGTCGTCGGCTGCGACGGCGGCCGCAGCACGGTGCGCAAGCTGCTCGGCGTGGCGTTCCCCGGCGAGCCGTCCAGGGTCGAGACCCTGCTCGGCGAGATGGAGATGACCGCCTCCCAGGAGGAGTTGACCTCCGTCATGACCGAGGTCCGCAAGACCCAGCAGCGATTCGGCGCGATGCCCCTGGGGGACGGGGTCTTCCGCGTCGTCGTCCCCGCCGAGGGCGTCGCCGAGGACCGGACGGCCTCCCCGACCCTCGACGAGTTCAAGCAGCAGCTGCGGGCCCACGCCGGGACGGACTTCGGCGTGCACTCGCCCCGGTGGCTCTCCCGCTTCGGCGACGCCACCCGACAGGCCGAGCGCTACCGGGTCGACCGGGTGTTCCTCGCTGGCGACGCGGCGCACATCCACCCGCCGACCGGCGGGCAGGGCCTCAACCTCGGCATCCAGGACGCGTTCAACCTCGGCTGGAAGCTGGCCGCCGAGGTCGACGGCTGGGCGCCGGAGGGACTCCTCGACACGTACCACGCCGAGCGGCACCCGGTGGCCACCGAGGTCCTGGACAACACCCGCGCGCAGATCCAGCTGATGTCGACGGAGCCGGGGCCGCAGGCGGTCCGCCGGCTCATGGCGGAACTCGTGGAGTTCGAGAACGTCAACCGGTACCTGATCGAGAAGATCACGGCGATCTCGGTCCGTTACGACGTCGGCGAGGGCCACGAGCTGCTCGGCCGCCGGATGCGGGACCTCGCGCTCAAGCACGGCCGGCTCTACGAGCGGATGCACGAGGGCCGTGGACTGCTGCTCGACCAGACCGGCCGGCTCTCGGTCGCCGGGTGGGAGGACCGGGTCGACCACGTCGTCGAGGTCAGCGAGGAACTGGACGTGCCCGCGGTGCTGCTGCGTCCCGACGGCCACGTCGTGTGGGCGGGCGAGGACCAGCAGGAGCTGCTCACCCGGATGCCCGCGTGGTTCGGCGCCGCCACGGCCGGCTGA", "partial": "0", "query_start": 19498, "query_end": 20988, "hit_start": 3, "hit_end": 1413, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 45.11}, "gnl|BL_ORD_ID|729|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "iri", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "900", "model_id": "796", "ARO_accession": "3002884", "ARO_name": "iri", "ARO_category": {"36584": {"category_aro_accession": "3000445", "category_aro_cvterm_id": "36584", "category_aro_name": "rifampin monooxygenase", "category_aro_description": "Enzyme responsible for the decolorization of rifampin by monoxygenation.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36656": {"category_aro_accession": "3000517", "category_aro_cvterm_id": "36656", "category_aro_name": "rifaximin", "category_aro_description": "Rifaximin is a semi-synthetic rifamycin used to treat traveller's diarrhea. Rifaximin inhibits RNA synthesis by binding to the beta subunit of bacterial RNA polymerase.", "category_aro_class_name": "Antibiotic"}, "36669": {"category_aro_accession": "3000530", "category_aro_cvterm_id": "36669", "category_aro_name": "rifabutin", "category_aro_description": "Rifabutin is a semisynthetic rifamycin used in tuberculosis therapy. It inhibits DNA-dependent RNA synthesis.", "category_aro_class_name": "Antibiotic"}, "36673": {"category_aro_accession": "3000534", "category_aro_cvterm_id": "36673", "category_aro_name": "rifapentine", "category_aro_description": "Rifapentine is a semisynthetic rifamycin that inhibits DNA-dependent RNA synthesis. It is often used in the treatment of tuberculosis and leprosy.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.58796e-100, "max_identities": 204, "bit_score": 307.76, "cvterm_id": "36897", "query": "DVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKL-RGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGID-FPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEP---DVYRATVAFFDRPYADRRA-PVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPA", "match": "DV+I GAGPTGLMLA ELRL G   +V+++  EP  F +ALG+H R++E+++ RGL + F A   K   GG FA +  P   +  DT H Y L +PQ   + +L   A E+GA+++RG  V A+ QD D V   ++       +   YLVGCDGG STVRKL     FP        +I +          +   P      +  ++R     F + P     +R  V   +   AD RA P T +D++  L  +AG+DFG+H  RWLSR  D +R A+ YR  RV LAGDA HIH P GGQGLNLG QDA NLGWKL A I G AP  LLDTYE+ERRP+AA VL NTRAQA LI      + +R L+ EL+   +  RYL   I+A+ +RY       LLGRR+ ++ L   +    L     + RG+LL    DQ        W DR D      + D  + ++   A+L+RPDG++ W    +   D     L TWFG  A", "sequence_from_db": "DVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAP-AHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGT---TLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEM---------DVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAE--VADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGN----LYDLMRSGRGLLL----DQGGQLSVDGWSDRAD-----HIVDTSTELEA-PAVLLRPDGHVAWIGDAQAELD---TQLSTWFGRSA", "sequence_from_broadstreet": "MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA", "dna_sequence_from_broadstreet": "ATGAGTGACGTCATCATTGTCGGTGCTGGACCAACTGGATTGATGCTGGCAGGTGAGCTCCGGCTACAGGGCGTCGATGTCGTCGTCGTGGACAAGGACGAGGAGCCGACTCAGTTCGTCCGTGCCCTCGGCATCCATGTGCGCAGCATCGAAATCATGGAGCAGCGCGGGTTGCTGGACAAGTTCCTCGCGCACGGCCGCAAGTATCCGCTCGGTGGATTCTTCGCGGGGATCAGCAAACCGGCACCCGCGCACCTCGATACTGCGCACGGGTACGTCCTGGGCATACCTCAGCCCGAGATCGACAGGATTCTTGCCGAACATGCCACCGAAGTCGGCGCGGACATTCAGCGAGGGAAGCGCGTCGTCGCGATCCGTCAAGATACCGACAACGTCGCAGCGGAATTGTCCGACGGCACAACACTTCACGCGCGGTACCTTGTAGGCTGCGACGGCGGCCGCAGCACTGTTCGGAAGCTGAGATCGACGTCGGTATTCCCGGCGAGCCGTACGAGCGCCGACACGTTGATCGGCGAAATGGACGTGACCATGCCTGCTGATGAACTGGCCGCCGTTGTCGCCGAAATCCGGGAAACGCACAAACGATTCGGAGTCGGTCCCGCCGGCAACGGTGCTTTTCGTGTCGTGGTCCCTGCGGCCGAAGTTGCCGACGGTCGCGCAACACCGACCACCCTCGACGACATCAAACAACAGCTACTGGCCATTGCCGGTACCGACTTCGGTGTGCACTCGCCGCGGTGGCTCTCGCGCTTCGGCGACGCCACTCGTCTGGCGGACGACTACCGGCGCGACCGGGTGTTTCTCGCCGGCGACGCCGCACACATCCACCCACCGATGGGCGGTCAAGGTCTCAATCTCGGTGTGCAGGACGCCTTCAACCTCGGCTGGAAGCTCGCCGCCGAGATCAACGGCTGGGCACCGGTGGGCCTGCTCGACACGTACGAATCGGAACGGCGTCCGGTGGCTGCCGACGTGCTGGACAACACGCGCGCCCAGGCCGAGTTGATCTCCACCGCTGCCGGACCACAAGCGGTGCGGCGCTTGATCTCCGAGCTGATGGAATTCGAAGACGTCAAGCGCTATTTGACCGAGAAGATCACTGCGATCTCGATTCGCTACGATTTCGGCGAAGGCGACGACCTACTCGGTCGGAGGCTGCGGAACATCGCGTTGACGCGCGGCAACCTGTACGACCTGATGCGATCCGGCCGCGGACTTCTTCTCGACCAGGGTGGCCAACTGTCCGTCGATGGTTGGAGCGATCGCGCCGACCATATCGTTGACACAAGCACTGAATTGGAAGCTCCGGCTGTCCTGCTTCGGCCGGACGGTCATGTGGCATGGATCGGGGATGCGCAGGCGGAGTTGGATACTCAGCTGTCCACATGGTTCGGCCGGTCGGCGAGGGACCGCGCGTGA", "partial": "0", "query_start": 19501, "query_end": 20997, "hit_start": 6, "hit_end": 1425, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 40.4}, "gnl|BL_ORD_ID|792|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(56)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "3302", "ARO_accession": "3004603", "ARO_name": "tet(56)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.00410063, "max_identities": 43, "bit_score": 36.5798, "cvterm_id": "42547", "query": "GHAVTALEQDADGVTV-SVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTD---------TSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGF", "match": "  ++ ++EQ+AD VTV  + G    Y++    ++  DG  S +R+++      Q  H+ A ++       +P+  G+  +       + L +  +     P++ RA   F  +   +    + +E  +         DFG      L+R+ +         T  +   +  GR+ L GDA +   P  GQG NL F", "sequence_from_db": "NQSIISIEQNADNVTVIFMDGRIEQYDL----VIAADGIHSAIRRMIFEKNEYQLIHLGAYLSTF----TIPNYLGLSHIDLECEANNKLVSINS--DNNPEIARAGFMFRSQHLLN---DIRDEQEQKQFLRDTFRDFGWETQNILNRMPESNDFYFDAITQVKMNSWTKGRIALVGDAGYCPSPLSGQGNNLAF", "sequence_from_broadstreet": "MSKNIKILVIGAGVAGPAVCYWLRRFGFSPVLIEKYASIRKGGQALDVRGIATHIAREMGIYDQICEMRTRIERGRFVDSSGKVLHEEQGEKFGFRQDDEVEILRGDLVEILMKTIADVPCYFNQSIISIEQNADNVTVIFMDGRIEQYDLVIAADGIHSAIRRMIFEKNEYQLIHLGAYLSTFTIPNYLGLSHIDLECEANNKLVSINSDNNPEIARAGFMFRSQHLLNDIRDEQEQKQFLRDTFRDFGWETQNILNRMPESNDFYFDAITQVKMNSWTKGRIALVGDAGYCPSPLSGQGNNLAFVGAYILAGELKVANGNYTRAFTRYNALLRSFVDANQKFGVWVSESFLVKDEVSKEIAEERSNKILAMIKSISNGITLPQYESS", "dna_sequence_from_broadstreet": "ATGTCTAAAAATATCAAAATTCTCGTCATTGGCGCTGGTGTAGCTGGCCCTGCTGTTTGTTATTGGCTAAGAAGGTTTGGTTTTTCTCCTGTTTTGATTGAAAAATATGCGTCTATTAGAAAAGGGGGTCAGGCACTGGATGTTCGTGGCATAGCAACTCATATCGCCAGAGAAATGGGTATCTATGATCAAATATGTGAGATGCGCACGCGAATAGAGCGCGGTCGCTTTGTAGACTCATCGGGTAAAGTGCTGCATGAAGAACAGGGTGAGAAATTCGGGTTTAGGCAAGATGACGAAGTCGAAATTCTCCGTGGTGATTTGGTTGAAATCCTGATGAAAACAATTGCTGATGTCCCTTGTTATTTCAATCAATCCATTATTAGCATTGAGCAGAATGCTGATAACGTTACCGTTATTTTCATGGATGGCAGGATTGAACAATATGATCTGGTGATCGCTGCAGATGGGATTCACTCTGCTATAAGGCGCATGATTTTTGAAAAAAATGAATATCAGTTAATTCACCTTGGCGCATATCTCAGTACATTTACCATTCCAAATTACCTTGGCTTGAGTCACATAGATCTGGAATGTGAGGCTAATAATAAATTAGTCTCAATAAATAGCGATAACAATCCTGAAATAGCAAGAGCAGGATTTATGTTCCGTTCCCAGCATCTCCTGAATGACATCCGTGATGAGCAGGAACAAAAGCAATTCCTACGTGATACTTTTCGCGATTTTGGCTGGGAAACACAAAATATTTTAAATCGAATGCCAGAAAGCAATGATTTTTATTTTGATGCGATTACGCAAGTAAAAATGAATAGTTGGACCAAAGGTCGAATAGCGCTTGTCGGTGATGCAGGCTATTGTCCTTCTCCGTTATCTGGCCAAGGGAATAATTTGGCATTCGTTGGAGCATATATACTGGCGGGAGAATTAAAAGTTGCTAATGGAAATTATACCCGAGCGTTTACTCGTTATAATGCACTGCTACGTTCCTTCGTTGATGCCAATCAAAAATTTGGTGTTTGGGTCAGTGAATCATTCCTTGTAAAAGATGAAGTTTCCAAGGAAATTGCAGAAGAACGCTCGAACAAAATCCTAGCCATGATAAAATCAATTTCGAATGGGATTACCTTACCTCAATATGAATCATCATAG", "partial": "0", "query_start": 19849, "query_end": 20406, "hit_start": 369, "hit_end": 918, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 21.94}, "gnl|BL_ORD_ID|4803|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(X1)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "650", "model_id": "3888", "ARO_accession": "3005166", "ARO_name": "tet(X1)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0515849, "max_identities": 19, "bit_score": 33.113, "cvterm_id": "39568", "query": "VLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYE", "match": "+ L GD  H+  P  GQG+N+G  DA+ L   L     GT     +D YE", "sequence_from_db": "ITLIGDTAHLMPPFAGQGVNIGLMDALILSENLTNGKFGTI-QSAIDDYE", "sequence_from_broadstreet": "MANLLQQNGIDITVYERDENPKARVWGGTLDLHKNSGQEAMKKVGLLQTYYDLALPMGVNFADEKGNIIATRNPTLENKFDNPEINRNALRKMLLGSLKNDTVVWDRKSIGLEQENGKWLLHFENKPTALADFIIVSNGGMSKIRNFVSDNEVEETGTFIIQGDIPEPETNCPEFYKLCNNNRLMTAHQGNLLVANPFNNGMLTYGVIFKKPEEWNNGKGLDFKPTKSVSEFLTNRFSNWSNEYKELIRSTTFFVGLTIKIFPLDKKPWKSNRPLPITLIGDTAHLMPPFAGQGVNIGLMDALILSENLTNGKFGTIQSAIDDYEQRMFVYATEAQADSTKNEIEMRNPSFTFQQLMNV", "dna_sequence_from_broadstreet": "ATGGCAAACTTGTTACAACAAAACGGTATTGACATTACCGTTTACGAAAGAGATGAAAACCCAAAAGCACGAGTTTGGGGCGGAACGCTTGACCTTCACAAAAATTCAGGACAAGAAGCAATGAAAAAAGTAGGATTGTTGCAAACCTACTATGATTTGGCGCTACCTATGGGCGTAAACTTTGCTGATGAGAAGGGTAACATTATAGCAACAAGAAACCCGACACTCGAAAATAAGTTTGACAACCCCGAAATAAATAGAAACGCGTTGCGAAAAATGTTGCTTGGCAGCTTGAAAAATGACACAGTTGTTTGGGATAGAAAATCTATTGGGCTTGAACAAGAAAACGGAAAATGGCTGCTACATTTTGAAAATAAGCCAACTGCATTGGCCGACTTTATTATTGTTTCCAATGGTGGAATGTCTAAAATAAGAAATTTTGTTTCAGATAATGAAGTCGAAGAAACAGGTACTTTTATTATTCAGGGCGACATTCCTGAACCAGAAACGAACTGCCCTGAATTTTATAAGTTGTGCAACAACAATAGACTAATGACCGCACATCAAGGGAATTTATTAGTTGCGAATCCATTTAACAACGGAATGTTAACTTACGGTGTCATTTTCAAAAAGCCTGAAGAATGGAATAATGGAAAAGGATTAGATTTTAAGCCCACAAAAAGCGTTTCCGAGTTCTTGACAAACAGGTTTTCAAATTGGAGCAATGAATACAAGGAGTTAATTCGTTCAACAACTTTTTTCGTTGGTTTAACAATAAAAATATTTCCGCTAGACAAAAAGCCTTGGAAGAGTAATCGTCCGTTACCCATAACTTTAATTGGCGACACAGCTCACCTAATGCCACCTTTTGCAGGGCAGGGCGTAAACATTGGACTAATGGACGCTTTGATTTTGTCAGAAAATCTTACAAACGGGAAATTTGGAACGATACAAAGTGCTATTGATGACTATGAACAACGAATGTTTGTTTACGCAACAGAAGCACAAGCGGACTCGACAAAGAATGAAATAGAAATGCGAAATCCGAGCTTTACTTTTCAACAGCTAATGAATGTATAA", "partial": "0", "query_start": 20338, "query_end": 20487, "hit_start": 828, "hit_end": 975, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 38.0}, "gnl|BL_ORD_ID|2722|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(50)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3287", "ARO_accession": "3004584", "ARO_name": "tet(50)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0829224, "max_identities": 46, "bit_score": 32.3426, "cvterm_id": "36791", "query": "ELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTD---------TSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGF", "match": "E+L     ++  E ++  +V  +EQ+ D VTV  T  +G  E     ++  DG  S  R   G+ F  ++ +    +        +P+  G+  M       H L         +    +A   F  R        + +E  +      +  +FG      L+R+ +         T  + + +  GR+ L GDA +   P  GQG NL F", "sequence_from_db": "EILMKAIADIPCEFKQ--SVIKIEQNEDSVTV--TYKDGRVE-NYDLVIAADGIHSATR---GMVFS-KNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKL----VTLQSDSQADKAMAGFMFRS-KHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAF", "sequence_from_broadstreet": "MTKHIKILVIGVGVAGPAVAYWLKRFGFSPVLIEKSAAVRKGGQALDIRGIATHIAKEMGIYDQICNMRTQIKCGRYVDVKGNVLHEEQGETFGFRQDDEVEILRGDLVEILMKAIADIPCEFKQSVIKIEQNEDSVTVTYKDGRVENYDLVIAADGIHSATRGMVFSKNEYQLINLGSYVSAFTIPNYLGLDHMELLCESNHKLVTLQSDSQADKAMAGFMFRSKHVLEDIRDEQEQKHFLHASFQNFGWETQNILNRMPESDDFYFDAITQIKMKSWTKGRIALIGDAAYCPSPLSGQGNNLAFVGAYILAGELKKADGDYIQAFTRYNELLHPFVEANQQFGVWVSESFLLKDDEVSKEIAEARSNKILAMIKSVSNSINLPQYE", "dna_sequence_from_broadstreet": "ATGACTAAACATATAAAAATTCTTGTAATAGGGGTTGGGGTTGCGGGCCCTGCAGTCGCTTATTGGTTAAAAAGATTTGGGTTTTCTCCGGTCTTAATTGAAAAATCAGCTGCCGTTAGAAAAGGGGGCCAGGCACTTGATATTCGCGGCATAGCCACACATATCGCTAAAGAAATGGGCATTTACGACCAGATATGTAACATGCGGACTCAAATAAAGTGTGGACGTTATGTGGATGTAAAGGGTAATGTTTTGCATGAAGAACAAGGTGAAACCTTTGGTTTCCGGCAAGATGACGAAGTTGAGATTCTTCGTGGAGACCTAGTTGAAATTCTAATGAAAGCAATTGCAGATATACCTTGTGAATTCAAACAATCCGTCATAAAAATTGAACAAAACGAAGATAGTGTAACTGTCACCTACAAAGATGGCAGAGTTGAAAATTATGACCTTGTGATCGCTGCCGATGGTATTCATTCTGCTACCAGGGGAATGGTTTTTAGTAAAAATGAATATCAGTTGATTAATCTCGGCTCCTACGTCAGCGCATTTACCATCCCAAATTATCTCGGTTTGGATCACATGGAACTCCTATGTGAATCAAATCATAAACTGGTTACTCTACAAAGCGACAGCCAAGCTGACAAAGCCATGGCGGGATTTATGTTCCGTTCAAAACATGTATTAGAAGATATTCGTGATGAGCAAGAACAAAAACATTTCTTACACGCCAGTTTTCAAAATTTCGGTTGGGAAACACAAAATATTTTAAATCGAATGCCAGAAAGCGATGACTTTTATTTTGACGCGATTACTCAAATCAAAATGAAAAGCTGGACTAAAGGCCGTATAGCCTTAATCGGCGATGCCGCTTATTGCCCCTCACCTTTATCAGGTCAGGGGAATAATTTAGCTTTTGTTGGCGCTTATATTTTGGCGGGTGAATTGAAAAAGGCTGATGGTGATTATATACAAGCATTTACCCGATATAACGAATTGCTACATCCCTTTGTTGAGGCTAACCAACAATTTGGTGTGTGGGTAAGCGAATCCTTTCTCCTAAAAGATGATGAAGTCTCTAAAGAGATTGCGGAAGCCCGTTCTAATAAAATTTTGGCAATGATAAAGTCAGTCTCTAATTCAATAAACTTGCCACAATACGAATAA", "partial": "0", "query_start": 19801, "query_end": 20406, "hit_start": 327, "hit_end": 918, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 21.8}, "gnl|BL_ORD_ID|4801|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(X3)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "760", "model_id": "3401", "ARO_accession": "3004719", "ARO_name": "tet(X3)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.108535, "max_identities": 22, "bit_score": 31.9574, "cvterm_id": "35507", "query": "VLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVL-RNTRAQAVLIDPDPRYEGLREL", "match": "+ + GDA H+  P  GQG+N G  DA+ L   L      T+    ++ YE +    A      +T  +  +  P+  ++ L  L", "sequence_from_db": "ITMIGDAAHLMSPFAGQGVNTGLLDALILSENL-TNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGTGGAATGTCGAAAATAAGGAGCTTTGTTACCGACACGCAAGTTGAAGAAACCGGTACTTTCAACATCCAAGCTGATATTCTTCAACCGGAAATAAACTGTCCCGGATTTTTTCAGCTATGCAACGGCAACCGATTAATGGCGGGACATCAGGGCATTTTATTGTTTGCCAATCCCAATAATAATGGTGCATTGTATTTAGGAATTAGTTTTAAAACGCCCGATGAATGGAAAAATAAAATTCCCTTAGATTTTCAGGACAGAAACAGCGTTGCCGATTTTTTATTGAAAAGATTTTCCAAATGGAGTGAAGTTTACAAACAATTAATACGTTCGGTATCAACATTTCAATGCTTGCCCACAAGGAAATTTCCTTTGAACAATGATTGGAAAAGTAACCGTCCATTACCCATAACAATGATTGGCGATGCTGCTCATTTGATGTCGCCTTTTGCAGGACAGGGTGTAAATACGGGATTATTGGATGCTTTGATATTGTCTGAAAACCTTACAAACGGAGAATTTACAAGTATTGAAAATGCCATCGAAAACTACGAACAACAAATGTTTGTTTATGCAAAAGATACGCAGGACGAATCGACAGAAAACGAAACCGAAATGTTTAGTCCCAATTTTTCGTTTCAAAAATTATTGAATCTATAA", "partial": "0", "query_start": 20338, "query_end": 20586, "hit_start": 915, "hit_end": 1164, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 26.19}, "gnl|BL_ORD_ID|4802|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(X6)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3797", "ARO_accession": "3005056", "ARO_name": "tet(X6)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.281893, "max_identities": 17, "bit_score": 30.8018, "cvterm_id": "43258", "query": "VLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAE", "match": "+ + GDA H+  P  GQG+N G  DA+ L   L       +  E ++ YE +", "sequence_from_db": "ITMIGDAAHLMPPFAGQGVNSGLMDALILSDNL-TNGKFNSIEEAIENYEQQ", "sequence_from_broadstreet": "MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL", "dna_sequence_from_broadstreet": "ATGACTTTACTAAAACATAAAAAAATTACAATAATTGGTGCCGGGCCTGTTGGATTAACAATGGCGAGATTGTTACAGCAAAACGGCGTGGACATTACAGTTTACGAGAGAGACAAAGACCAAGATGCAAGGATTTTTGGTGGGACACTTGATCTGCACAGGGATTCGGGACAGGAAGCAATGAAAAGAGCGGGATTGTTACAAACTTATTATGACTTAGCTTTACCAATGGGTGTAAATATTGTTGATGAAAAGGGCAATATTTTAACCACAAAAAATGTAAGACCCGAAAATCGTTTTGACAATCCTGAAATAAACAGAAATGACTTAAGGACTATCCTATTAAATAGTTTACAAAATGATACCGTCATTTGGGATAGAAAACTTGTTACCCTTGAACCTGATAAGGAGAAGTGGATACTAACTTTTGAGGATAAATCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCGGAGGTGAACTGTCCTGGATTTTTTCAGCTTTGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAGCAAAACGCGGGTAGATTTTCAAGACAGAAATAGTGTCGTTGATTTTCTCCTGAAAAAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTTTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGATAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGTGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTGCTTATGGAAGAGAAGCACAGGCAGAATCAATAATAAACGAAACGGAAATGTTCAGCCTCGACTTTTCTTTCCAAAAACTAATGAATCTATAA", "partial": "0", "query_start": 20338, "query_end": 20493, "hit_start": 885, "hit_end": 1038, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 32.69}, "gnl|BL_ORD_ID|4802|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(X6)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3797", "ARO_accession": "3005056", "ARO_name": "tet(X6)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 5.19771, "max_identities": 13, "bit_score": 26.5646, "cvterm_id": "43258", "query": "VVIAGAGPTGLMLACELRLAGARTLVLER", "match": "+ I GAGP GL +A  L+  G    V ER", "sequence_from_db": "ITIIGAGPVGLTMARLLQQNGVDITVYER", "sequence_from_broadstreet": "MTLLKHKKITIIGAGPVGLTMARLLQQNGVDITVYERDKDQDARIFGGTLDLHRDSGQEAMKRAGLLQTYYDLALPMGVNIVDEKGNILTTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL", "dna_sequence_from_broadstreet": "ATGACTTTACTAAAACATAAAAAAATTACAATAATTGGTGCCGGGCCTGTTGGATTAACAATGGCGAGATTGTTACAGCAAAACGGCGTGGACATTACAGTTTACGAGAGAGACAAAGACCAAGATGCAAGGATTTTTGGTGGGACACTTGATCTGCACAGGGATTCGGGACAGGAAGCAATGAAAAGAGCGGGATTGTTACAAACTTATTATGACTTAGCTTTACCAATGGGTGTAAATATTGTTGATGAAAAGGGCAATATTTTAACCACAAAAAATGTAAGACCCGAAAATCGTTTTGACAATCCTGAAATAAACAGAAATGACTTAAGGACTATCCTATTAAATAGTTTACAAAATGATACCGTCATTTGGGATAGAAAACTTGTTACCCTTGAACCTGATAAGGAGAAGTGGATACTAACTTTTGAGGATAAATCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCGGAGGTGAACTGTCCTGGATTTTTTCAGCTTTGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAGCAAAACGCGGGTAGATTTTCAAGACAGAAATAGTGTCGTTGATTTTCTCCTGAAAAAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTTTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGATAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGTGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTGCTTATGGAAGAGAAGCACAGGCAGAATCAATAATAAACGAAACGGAAATGTTCAGCCTCGACTTTTCTTTCCAAAAACTAATGAATCTATAA", "partial": "0", "query_start": 19504, "query_end": 19590, "hit_start": 24, "hit_end": 111, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 44.83}, "gnl|BL_ORD_ID|2802|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(X5)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3798", "ARO_accession": "3005057", "ARO_name": "tet(X5)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.302227, "max_identities": 17, "bit_score": 30.8018, "cvterm_id": "36787", "query": "VLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAE", "match": "+ + GDA H+  P  GQG+N G  DA+ L   L       +  E ++ YE +", "sequence_from_db": "ITMIGDAAHLMPPFAGQGVNSGLMDALILSDNL-TNGKFNSIEEAIENYEQQ", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVRPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLVTLEPDKEKWILTFEDKSSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKSKTRVDFQDRNSVVDFLLKKFSDWDERYKELIRLTSSFVGLATRIFPLDKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFAYGREAQAESIINETEMFSLDFSFQKLMNL", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAGACCCGAAAATCGTTTTGACAATCCTGAAATAAACAGAAATGACTTAAGGACTATCCTATTAAATAGTTTACAAAATGATACCGTCATTTGGGATAGAAAACTTGTTACCCTTGAACCTGATAAGGAGAAGTGGATACTAACTTTTGAGGATAAATCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCGGAGGTGAACTGTCCTGGATTTTTTCAGCTTTGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAGCAAAACGCGGGTAGATTTTCAAGACAGAAATAGTGTCGTTGATTTTCTCCTGAAAAAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTTTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGATAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGTGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTGCTTATGGAAGAGAAGCACAGGCAGAATCAATAATAAACGAAACGGAAATGTTCAGCCTCGACTTTTCTTTCCAAAAACTAATGAATCTATAA", "partial": "0", "query_start": 20338, "query_end": 20493, "hit_start": 915, "hit_end": 1068, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 32.69}, "gnl|BL_ORD_ID|2277|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(X4)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3402", "ARO_accession": "3004720", "ARO_name": "tet(X4)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.35547, "max_identities": 17, "bit_score": 30.4166, "cvterm_id": "35914", "query": "VLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAE", "match": "+ + GDA H+  P  GQG+N G  DA+ L   L       +  E ++ YE +", "sequence_from_db": "ITMIGDAAHLMPPFAGQGVNSGLMDALILSDNL-TNGKFNSIEEAIENYEQQ", "sequence_from_broadstreet": "MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGAGCAATAAAGAAAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATGAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATCTGGTTATTATTGCCAATGGTGGAATGTCTAAAGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCATCCAGAGGTGAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCTGCTCATCAAGGTAATTTATTATTTGCGAATCCTAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAACTGATTCGTGTGACATCATCTTTTGTAGGGTTAGCGACACGAATATTTCCCTTAGGTAAGTCTTGGAAAAGTAAGCGTCCATTACCCATAACGATGATTGGAGATGCTGCTCATTTGATGCCTCCTTTTGCAGGACAAGGCGTAAACAGCGGGTTGATGGATGCCTTGATATTGTCGGATAATCTGACCAATGGGAAATTTAACAGCATTGAAGAGGCTATTGAAAATTATGAACAGCAAATGTTTATCTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 20338, "query_end": 20493, "hit_start": 906, "hit_end": 1059, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 32.69}, "gnl|BL_ORD_ID|2726|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(54)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3292", "ARO_accession": "3004590", "ARO_name": "tet(54)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.535748, "max_identities": 44, "bit_score": 30.0314, "cvterm_id": "36791", "query": "GHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFR-EELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTD---------TSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGA", "match": "  ++ ++EQ+ D V V        +      ++G DG  S++R+++      +D +    +A+A F    +P+   +        ++ +      +   + D   A VAF  R          E +    L ++   DFG    + L  + +         T  +   +  G+V L GDA +   P  GQG NL    A  L  +L A", "sequence_from_db": "NQSIDSIEQNDDDVIVYFKDARVEH---YDLIIGADGIHSSIRRMVF----DKDEYRLVNLAEAYFSIFSIPNYLNLSHTE----VQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIF-HDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQGNNLALVGAYILAGELKA", "sequence_from_broadstreet": "MSTIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCHFNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQGNNLALVGAYILAGELKAAEGNYRLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKEVAEERSNRILQKVQIISNAIKLPEYE", "dna_sequence_from_broadstreet": "ATGTCTACTATAAAAAAAATTCTCGTGATAGGAGCCGGTATTGCCGGTACTGCAGTCTGTTATTGGTTACGAAGATTTGGTTTTTATCCTGTATTAATTGAAAAATCTGCGTGTATACGAAAAGGCGGCCAAGGTTTGGATATTCGTGGGGTTGCAATCGATATCGTTAAAAAAATGGTTATTTATGAGCAAATATGCAAGATGCGCACGCAGGTAGAATGTGGTCGCTATGTGGATGTCGTAGGCAAAACACTACATGAAGAAAAAGGTGAAAAATTTGCCTTTAGGCAAGATGAAGATGTTGAAATTCTCCGCGGTGATTTAATCGAGATCCTAATGAAAACCATTGACGATGTTCCCTGTCATTTTAATCAATCCATTGACAGTATTGAACAGAATGACGATGACGTCATAGTTTATTTCAAAGATGCCAGAGTTGAGCACTATGATTTGATTATTGGCGCTGATGGGATACACTCATCGATCAGGCGCATGGTATTTGACAAAGATGAATATAGATTAGTTAATCTTGCAGAGGCGTACTTCAGTATATTTAGCATTCCGAATTATCTCAATTTAAGCCACACGGAAGTGCAGTGTGAGACTAATGAAAAATTGGTATCTATCACTAGCGATAAAGATCCCAAGACGGCTCAAGTTGCATTTATGTTCCGTTCGCAACATGTCTGGAATAATCTTCGCGATGAACACGAACAGATGCAATTTTTGCGGGATATTTTTCATGACTTTGGTTGGGAGGCGCAAAAAATACTTGAACTAATGCCAAATAGCCATGATTTTTATTTTGATTCAGTTACACAGGTGAAAATGCGTTCCTGGACCAAAGGACAAGTTGCTTTAGTAGGTGATGCGAGTTACTCTGCATCTCCACTATCGGGTCAAGGTAATAATCTGGCTCTAGTTGGTGCTTATATTTTGGCAGGAGAACTAAAAGCAGCGGAAGGAAATTATAGGCTCGCATTTAATCGTTATAATGAATTATTACATCCCTTCGTTGAGGCTAATCAACAGCTTGGAGCTTGGGTTAGCGAATCGTTTCTTGTCCCAGATGCAGTATCCAAAGAAGTTGCAGAAGAACGCTCAAACAGAATCCTGCAAAAAGTACAAATCATATCGAATGCGATCAAGCTGCCTGAGTATGAATGA", "partial": "0", "query_start": 19849, "query_end": 20442, "hit_start": 369, "hit_end": 957, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 21.15}, "gnl|BL_ORD_ID|2698|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(52)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3289", "ARO_accession": "3004587", "ARO_name": "tet(52)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.73958, "max_identities": 22, "bit_score": 29.261, "cvterm_id": "36791", "query": "YRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPI", "match": "+  GRV L GDA +   P  GQG NL    A  L  +L    AG       D Y    RP ", "sequence_from_db": "WTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQ--AGGNYKRAFDRYNEILRPF", "sequence_from_broadstreet": "MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH", "dna_sequence_from_broadstreet": "ATGTCTAATGTGAATAAAATTCTCGTCATCGGGGCTGGCATTGCTGGCCCCGCGGCTTGTTATTGGTTAAGAAGATTCGGATTTTCTCCCGTCCTCGTAGAAAGATCTGCCAGTTTACGAAAAGGCGGTCATGCACTGGACGTTCGAGGTGTTGCAATAGACCTCGTCAAAAGAATGGGTATTTATCAGAAAATATATAATATGCGCACTCAGCTGGAGTTTGGGCGGCATGTTGACCCCGAAGGGAATACGCTTCATGAAGAGAAGGGCGAAAGATTTGGCTTTAGGGAAGGTCAAGATGTTGAAATTATCCGCAGTGATTTGGTCGAGATATTGATAGATTCCATTGAAGGCGTCCCCCTTCAGTTCAATCAAACGATTGAGAGCGTTAAACAGACTGATGCTGTTGTCGAAGTTCAATTTAAAGATGGCAGAACCGAACACTTCGATTTGGTTATCGGGGCTGACGGCTTGCACTCAACAACAAGACGTATCGTATTTGATAAACATGAATATAAATTAAATGACCTTGGTGCTTACTTTAGTGTTTTCAGTATTCCAAATTATCTAAATTTGAATAACACCGAAGTTCAGTGCGAAGCTAATCAAAAACTGTTATCTATAACGAGCGACAAGAACCGCAAGATGGCTGAGGTCGCATTCTCATTTCGTGGCCAGAATGTTTTGAATAATGTTCGTGATGAAAGCGAGCAACGGCGAGTCCTACGCGACACTTTTCAAGACTTTGGCTGGGAAGCACCAAGAATACTTGAACTGATGTCAGATAGTGATGATTTTTATTCTGATTCATTCACTCAGGTAATAATGAAATCATGGACTAAAGGTCGAGTTGCATTATTGGGAGATGCTGCGTACAGCGCGTCGCCAATATCGGGGCAAGGTAATAATCTGGCCCTGGTCGGCGCTTATGTTTTGGCAGGAGAACTAAAACAGGCAGGCGGCAATTATAAGCGGGCATTTGATCGTTATAATGAAATATTACGTCCATTTATTGAAGCTAATCAAAAATTGGGAGTCTTGGTTAACGAATCGTTTCTTGTTCGCGATGAAGTCTCTAAAGAGGTTGCGGAAGAACGGTCAAATAATATTATGGAACAGGTAAAAATCGCATCGAACATGATTGTGTTGCAGGATTACGCCAATCCGCACTGA", "partial": "0", "query_start": 20323, "query_end": 20505, "hit_start": 834, "hit_end": 1011, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 36.07}, "gnl|BL_ORD_ID|763|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(X)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "776", "ARO_accession": "3000205", "ARO_name": "tet(X)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35986": {"category_aro_accession": "0000069", "category_aro_cvterm_id": "35986", "category_aro_name": "doxycycline", "category_aro_description": "Doxycycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36667": {"category_aro_accession": "3000528", "category_aro_cvterm_id": "36667", "category_aro_name": "chlortetracycline", "category_aro_description": "Chlortetracycline was an early, first-generation tetracycline antibiotic developed in the 1940's. It inhibits bacterial protein synthesis by binding to the 30S subunit of bacterial ribosomes, preventing the aminoacyl-tRNA from binding to the ribosome.", "category_aro_class_name": "Antibiotic"}, "37011": {"category_aro_accession": "3000667", "category_aro_cvterm_id": "37011", "category_aro_name": "demeclocycline", "category_aro_description": "Demeclocycline is a tetracycline analog with 7-chloro and 6-methyl groups. Due to its fast absorption and slow excretion, it maintains higher effective blood levels compared to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.878223, "max_identities": 18, "bit_score": 29.261, "cvterm_id": "35916", "query": "VLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAE", "match": "+ + GDA H+  P  GQG+N G  DA+ L   L A     +  E +  YE +", "sequence_from_db": "ITMIGDAAHLMPPFAGQGVNSGLVDALILSDNL-ADGKFNSIEEAVKNYEQQ", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATAAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGCGGGATGTCCAAGGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCAGAGATAAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCATCTCACCAAGGTAATTTATTATTTGCTAACCCCAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAATTGATTCATACGACGTTGTCATTTGTAGGATTGGCTACACGGATATTTCCTTTAGAAAAGCCTTGGAAAAGCAAGCGCCCATTACCCATAACAATGATTGGGGATGCCGCACATTTGATGCCGCCTTTTGCAGGGCAGGGAGTAAATAGTGGGTTGGTGGATGCCTTGATATTGTCTGATAATCTAGCCGATGGAAAATTTAATAGCATTGAAGAGGCTGTTAAAAATTATGAACAGCAAATGTTTATGTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 20338, "query_end": 20493, "hit_start": 915, "hit_end": 1068, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 34.62}, "gnl|BL_ORD_ID|763|hsp_num:1": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(X)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "776", "ARO_accession": "3000205", "ARO_name": "tet(X)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35949": {"category_aro_accession": "0000030", "category_aro_cvterm_id": "35949", "category_aro_name": "tigecycline", "category_aro_description": "Tigecycline is an glycylcycline antibiotic. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "35986": {"category_aro_accession": "0000069", "category_aro_cvterm_id": "35986", "category_aro_name": "doxycycline", "category_aro_description": "Doxycycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "36667": {"category_aro_accession": "3000528", "category_aro_cvterm_id": "36667", "category_aro_name": "chlortetracycline", "category_aro_description": "Chlortetracycline was an early, first-generation tetracycline antibiotic developed in the 1940's. It inhibits bacterial protein synthesis by binding to the 30S subunit of bacterial ribosomes, preventing the aminoacyl-tRNA from binding to the ribosome.", "category_aro_class_name": "Antibiotic"}, "37011": {"category_aro_accession": "3000667", "category_aro_cvterm_id": "37011", "category_aro_name": "demeclocycline", "category_aro_description": "Demeclocycline is a tetracycline analog with 7-chloro and 6-methyl groups. Due to its fast absorption and slow excretion, it maintains higher effective blood levels compared to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "35960": {"category_aro_accession": "0000042", "category_aro_cvterm_id": "35960", "category_aro_name": "glycylcycline", "category_aro_description": "Glycylcyclines are a new class of antibiotics derived from tetracycline. These tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance. Presently, there is only one glycylcycline antibiotic for clinical use: tigecycline. It works by inhibiting action of the prokaryotic 30S ribosome, preventing the binding of aminoacyl-tRNA.", "category_aro_class_name": "Drug Class"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 9.84522, "max_identities": 13, "bit_score": 25.7942, "cvterm_id": "35916", "query": "DVVIAGAGPTGLMLACELRLAGARTLVLER", "match": "+V I G GP GL +A  L+  G    V ER", "sequence_from_db": "NVAIIGGGPVGLTMAKLLQQNGIDVSVYER", "sequence_from_broadstreet": "MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEINCPGFFQLCNGNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIHTTLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLADGKFNSIEEAVKNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV", "dna_sequence_from_broadstreet": "ATGACAATGCGAATAGATACAGACAAACAAATGAATTTACTTAGTGATAAGAACGTTGCAATAATTGGTGGTGGACCCGTTGGACTGACTATGGCAAAATTATTACAGCAAAACGGCATAGACGTTTCAGTTTACGAAAGAGACAACGACCGAGAGGCAAGAATTTTTGGTGGAACCCTTGACCTACACAAAGGTTCAGGTCAGGAAGCAATGAAAAAAGCGGGATTGTTACAAACTTATTATGACTTAGCCTTACCAATGGGTGTAAATATTGCTGATAAAAAAGGCAATATTTTATCCACAAAAAATGTAAAGCCCGAAAATCGATTTGACAATCCTGAAATAAACAGAAATGACTTAAGGGCTATCTTGTTGAATAGTTTAGAAAACGACACGGTTATTTGGGATAGAAAACTTGTTATGCTTGAACCTGGTAAGAAGAAGTGGACACTAACTTTTGAGAATAAACCGAGTGAAACAGCAGATTTGGTTATTCTTGCCAATGGCGGGATGTCCAAGGTAAGAAAATTTGTTACCGACACGGAAGTTGAAGAAACAGGTACTTTCAATATACAAGCCGATATTCATCAACCAGAGATAAACTGTCCTGGATTTTTTCAGCTATGCAATGGAAACCGGCTAATGGCATCTCACCAAGGTAATTTATTATTTGCTAACCCCAATAATAATGGTGCATTGCATTTTGGAATAAGTTTTAAAACACCTGATGAATGGAAAAACCAAACGCAGGTAGATTTTCAAAACAGAAATAGTGTCGTTGATTTTCTTCTGAAAGAATTTTCCGATTGGGACGAACGCTACAAAGAATTGATTCATACGACGTTGTCATTTGTAGGATTGGCTACACGGATATTTCCTTTAGAAAAGCCTTGGAAAAGCAAGCGCCCATTACCCATAACAATGATTGGGGATGCCGCACATTTGATGCCGCCTTTTGCAGGGCAGGGAGTAAATAGTGGGTTGGTGGATGCCTTGATATTGTCTGATAATCTAGCCGATGGAAAATTTAATAGCATTGAAGAGGCTGTTAAAAATTATGAACAGCAAATGTTTATGTATGGCAAAGAAGCACAAGAAGAATCAACTCAAAACGAAATTGAAATGTTTAAACCCGACTTTACGTTTCAGCAATTGTTAAATGTATAA", "partial": "0", "query_start": 19501, "query_end": 19590, "hit_start": 51, "hit_end": 141, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 43.33}, "gnl|BL_ORD_ID|2695|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(49)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3285", "ARO_accession": "3004582", "ARO_name": "tet(49)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.982227, "max_identities": 20, "bit_score": 28.8758, "cvterm_id": "36791", "query": "VTEEDVRAALTEVAGSDFGMHDVRWLSRLTD---------TSRQAERYRDGRVLLAGDACHIHLPAGGQGLNL", "match": "+ +E+ +         DFG    + L  ++D         T  + + +  GRV L GDA +   P  GQG NL", "sequence_from_db": "IRDENEQQKFLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQGNNL", "sequence_from_broadstreet": "MSAINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMGIYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVPCHFNQWIDGIKQSDNDVEVQFKDGRTEHYGLVIGADGLHSKTRRMVFNEDEYKLTNLGLYFSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQKFLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQGNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNESTLVYGEVSQEVAEERSNKIMQEVEIAANMISLPNYE", "dna_sequence_from_broadstreet": "ATGTCTGCAATAAATAAAATTCTCGTAATAGGAGCCGGCATTGCTGGACCTACTGTTTGTTATTGGTTAAAAAGATTTGGCTTTTCTCCCACTCTAATTGAAAGGTCTTCCAAAATACGAAAAGGAGGGCAAGGATTGGATGTTCGGGGTGTTGCCATCGATATCGTTAAAAGAATGGGTATCTATGAGAAAATATGCAATATGCGCACCCAAGTGGAATTAGGACGGTATGTTGACGCCAGAGGCAATATCTTGCATGAAGAAAAAGGTGAAAGATTTGCCTTTAGGCAAGGTGAAGATGTTGAAATTAACCGCGGTGATTTAGTCGAAATACTGATACAGACTATTGAAGGTGTTCCCTGTCATTTCAATCAATGGATTGACGGTATTAAACAGAGTGATAATGATGTAGAAGTTCAATTTAAAGATGGTAGAACCGAACATTATGGCTTGGTTATTGGGGCTGATGGTTTACACTCAAAAACAAGACGTATGGTTTTCAATGAGGATGAATATAAATTAACTAACCTTGGTTTATATTTTAGCGTTTTTAGCATCCCAAATTATCTTAATTTGAACCACACCGAAGTTCAGTTCGAGGCCAATCAAAAACTTATATCTCTTACTAGTGATAAGAATCCTAAGATGGCTGAAGCCGCATTCTGCTTTCGTACACAAAATGTCTTAAATAATATTCGCGATGAAAATGAGCAACAGAAATTCCTACGCGATACTTTTCAAGATTTTGGCTGGGAAACGTCAAAAATACTTGAACTGATGTCTGATAGCGATAATTTTTATTTTGATTCAGTCACCCAGGTGGAAATGAAATCATGGACTAAAGGACGAGTGGCTTTGCTGGGAGATGCGGGTTACTCCGCATCTCCAATATCTGGTCAAGGTAATAATCTGGCACTAGTGGGAGCGTATGTTTTTGCAGGAGAACTAAAACAAGCAGGTGGCAATTATCATCGAGCATTTAGCCGTTATAATGAATTATTACACTCATTTGTTGAAGCCAATCAAAAATTGGGAATTTTGGTTAACGAATCAACTCTTGTTTATGGTGAAGTCTCTCAGGAGGTTGCAGAAGAAAGATCAAATAAGATTATGCAAGAGGTAGAAATCGCAGCGAATATGATTTCGTTACCTAATTATGAATAA", "partial": "0", "query_start": 20209, "query_end": 20400, "hit_start": 693, "hit_end": 912, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 27.4}, "gnl|BL_ORD_ID|2727|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(55)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3293", "ARO_accession": "3004591", "ARO_name": "tet(55)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.10726, "max_identities": 49, "bit_score": 28.8758, "cvterm_id": "36791", "query": "HAVTALEQDADGVTVSV-TGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHM------FAVIADARFREELPHGEGMGPMRPYGVM---RHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSR---------QAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKL", "match": "HA+ +L Q  D VTV    G    Y++    ++  DG  S  R+++   F   D H+       +V +   + + L H E +   +   V      D    FA F     ++R++    + P   R     ++ +R   T     + G    + LS + D +          + + +  GR+ L GDA +   P  GQG +L    A  L  +L", "sequence_from_db": "HAIESLTQHDDHVTVQFKNGKTENYDL----VIAADGLHSATRRMV---FSKDDYHLRNLGCYISVFSIPNYLQ-LDHCETLLEAKQKLVSITSDKDSTKAFAGF-----MFRSS----NSPNYIRDEASQKDFLRENFT-----NHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQGTSLALVGAYILAGEL", "sequence_from_broadstreet": "MPHTKKILVIGASIAGPALCYWLNHYGFQPTLVEKNQSTRKGGYAIDLRGIAVDVAKQMGIYDSVCAMRTSLQCVRYVDAAGNLLFEEHGEKGGFRQGDEVEIVRGDLVDILMKTITDIPCFYDHAIESLTQHDDHVTVQFKNGKTENYDLVIAADGLHSATRRMVFSKDDYHLRNLGCYISVFSIPNYLQLDHCETLLEAKQKLVSITSDKDSTKAFAGFMFRSSNSPNYIRDEASQKDFLRENFTNHGWESNKLLSLMNDANDFYFDAIMQVKMKDWTKGRIALVGDAGYTPSPLSGQGTSLALVGAYILAGELKTATDHVAAFARYNELLKPYVEANQAFGVWVSESFLADEPLSAEQAEERNNIVLGIMKKATHAIELPEY", "dna_sequence_from_broadstreet": "ATGCCCCACACCAAAAAAATCCTAGTCATAGGTGCAAGTATCGCCGGCCCAGCATTATGCTACTGGCTAAACCACTACGGCTTCCAACCCACCCTCGTAGAAAAAAACCAATCAACAAGAAAAGGCGGATATGCAATCGATCTCCGCGGCATAGCAGTGGATGTCGCCAAACAAATGGGAATCTACGACTCAGTCTGCGCCATGCGTACCAGTCTGCAGTGCGTCCGCTATGTTGATGCGGCAGGAAATTTACTATTCGAAGAGCACGGCGAAAAAGGCGGTTTCAGGCAAGGCGATGAAGTAGAAATCGTGCGTGGTGATTTAGTGGATATCTTAATGAAAACCATTACGGATATTCCTTGTTTTTATGATCATGCAATCGAAAGTTTGACCCAGCATGATGATCATGTCACCGTGCAATTTAAAAATGGCAAAACCGAAAATTATGATTTAGTGATAGCGGCTGATGGTTTGCATTCTGCTACACGTCGTATGGTTTTCAGTAAAGATGACTATCATTTGCGAAATCTTGGTTGTTACATCAGTGTGTTTAGCATACCTAATTATTTGCAGCTGGATCACTGCGAGACACTATTAGAAGCCAAGCAAAAATTGGTTTCTATTACCAGTGATAAAGATTCTACTAAGGCCTTCGCTGGTTTTATGTTTCGTTCCAGTAATAGTCCAAACTACATTCGTGATGAAGCATCACAAAAAGATTTTCTAAGAGAAAATTTCACAAATCACGGCTGGGAATCAAATAAGCTATTGTCACTGATGAATGATGCCAATGATTTTTATTTTGATGCGATTATGCAGGTTAAAATGAAAGACTGGACTAAAGGGCGTATCGCGTTAGTGGGTGATGCTGGTTATACACCTTCACCCTTATCAGGGCAGGGAACCAGCCTCGCTTTGGTTGGGGCTTATATATTGGCGGGTGAATTGAAAACAGCTACTGATCATGTTGCGGCTTTTGCTCGATATAATGAGTTATTGAAGCCTTATGTTGAGGCTAATCAGGCGTTTGGGGTTTGGGTTAGTGAATCGTTTTTGGCGGATGAGCCTTTGTCTGCAGAGCAGGCGGAAGAGCGGAATAATATTGTTTTAGGGATAATGAAAAAAGCCACGCATGCGATCGAGTTGCCGGAGTATTAA", "partial": "0", "query_start": 19852, "query_end": 20436, "hit_start": 372, "hit_end": 948, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 22.9}, "gnl|BL_ORD_ID|2723|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(51)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3288", "ARO_accession": "3004586", "ARO_name": "tet(51)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.79573, "max_identities": 18, "bit_score": 26.9498, "cvterm_id": "36791", "query": "SDFGMHDVRWLSRLTD---------TSRQAERYRDGRVLLAGDACHIHLPAGGQGLN", "match": " DFG    + L  ++D         T  + + +  GRV L GDA +   P  GQG N", "sequence_from_db": "QDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSN", "sequence_from_broadstreet": "MPIINKILVIGAGIAGPAVCYWLRRFGFSPILVERCANLRKGGHAVDIRGVAIDLAKSMGIYKKICNMRTQVELGRYVDAEGNILHEEKGERFGFREGDDIEILRGDLVQILIDAMGDVPCHFNQWVESIKQRDNDVEVQFKDGRTELYDLVIGADGLHSTTRRMVFDKDEYKLTNLGAYFSAFSIPNYLNLNHTDVQFEANQKLISMASDKNPKIAITGFCFRAQNVLNNLRDENEQRRFLRDTFQDFGWETSKILELMSDSNDFYFDSFTQVKMKSWTKGRVALVGDAGYCASPFPGQGSNQALVGAYIFAGELKQAEGNYHRAFNRYNELLQPFVEANQKFGVLVNESFLVRDEVSKEVAEERSNKIMQEIKIVSNMISLPNYE", "dna_sequence_from_broadstreet": "ATGCCTATCATAAATAAAATTCTGGTAATAGGAGCCGGCATTGCTGGACCCGCGGTTTGTTATTGGTTAAGAAGATTTGGCTTTTCTCCCATTTTAGTTGAAAGGTGTGCCAATTTACGAAAAGGAGGGCATGCTGTGGATATTCGAGGTGTTGCTATCGATCTTGCTAAAAGCATGGGTATTTATAAAAAAATATGCAATATGCGCACCCAGGTGGAATTAGGAAGGTATGTTGACGCCGAAGGTAATATCTTGCATGAAGAAAAAGGCGAAAGATTTGGCTTTAGGGAGGGTGATGATATTGAAATTCTCCGCGGTGATTTAGTTCAAATACTGATAGATGCCATGGGAGATGTTCCCTGTCATTTCAATCAATGGGTTGAGAGCATTAAGCAGAGGGATAATGATGTAGAGGTTCAATTTAAAGATGGTAGAACGGAACTTTACGATTTGGTTATCGGTGCTGATGGCTTGCATTCAACCACCAGAAGGATGGTTTTTGATAAGGATGAATATAAATTAACTAACCTTGGTGCATACTTTAGTGCTTTTAGTATTCCAAATTATCTTAATTTGAATCACACCGATGTGCAATTCGAGGCTAATCAAAAACTTATATCTATGGCTAGCGATAAGAACCCTAAAATTGCTATAACAGGATTCTGTTTCCGTGCACAGAATGTCTTGAATAATTTGCGCGATGAAAACGAGCAACGGAGATTTCTACGCGATACTTTTCAAGATTTTGGCTGGGAGACATCCAAAATACTTGAACTGATGTCAGATAGTAATGATTTTTATTTTGATTCATTCACTCAAGTGAAAATGAAGTCATGGACAAAAGGACGAGTTGCTTTGGTGGGCGATGCAGGTTACTGCGCATCCCCATTCCCTGGTCAAGGTAGTAATCAGGCACTGGTAGGTGCTTATATTTTTGCAGGAGAACTAAAACAGGCAGAAGGCAATTATCATCGAGCATTTAACCGTTATAATGAATTATTACAACCATTTGTTGAAGCCAATCAAAAATTTGGCGTCTTGGTTAACGAATCGTTTCTCGTTCGTGATGAAGTCTCTAAGGAGGTGGCAGAAGAAAGATCGAATAAGATTATGCAAGAGATAAAAATTGTATCGAATATGATTTCGTTGCCGAATTATGAATGA", "partial": "0", "query_start": 20254, "query_end": 20397, "hit_start": 738, "hit_end": 909, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 31.58}, "gnl|BL_ORD_ID|4799|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(47)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3308", "ARO_accession": "3004613", "ARO_name": "tet(47)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.01499, "max_identities": 13, "bit_score": 26.1794, "cvterm_id": "36791", "query": "QAERYRDGRVLLAGDACHIHLPAGGQGLNL", "match": "+ + +  GRV L GDA +   P  GQG NL", "sequence_from_db": "KMKSWTKGRVALLGDAGYCASPISGQGNNL", "sequence_from_broadstreet": "MRCHFRCNLALPLLVFLNLSRAIKDYQTMSSINNILVIGAGIAGPSVCYWLKRFGFSPVLIEKSANLRKGGHALDVRGVAIDLVKRMGIYEKIGNRRTQVEFGRYMDTQGNILHEEKGERFCYREGEDVEITRGDLVEILIDAIEGVPCYLNQSIDSIKQRDGDVAVRFKDGKIEYYDLIIGADGLHSTTRRMVFDKDEYQLTNLGAYFSVFSIPNYLNLNHTEIQFEANQKLISMTSDKNPKMAEVAFMFRVQNVLNNRRDENEQKRFLRDTFQGFGWETSKILELMSDSDDFYFDSVSQVKMKSWTKGRVALLGDAGYCASPISGQGNNLALVGAYVLAGELKQASDNYHQAFNRYNELLHPFIEANQKLGVLVNESFLVQDEVSKEVAEERSNKIMEEVKIVSNMISLPDYE", "dna_sequence_from_broadstreet": "ATGCGCTGTCATTTCCGATGTAATCTCGCGCTGCCGCTTCTTGTATTCCTCAATCTTAGTAGAGCAATAAAGGATTATCAAACAATGTCTTCTATAAATAATATTCTTGTAATAGGAGCTGGAATTGCTGGACCCTCAGTCTGCTATTGGTTAAAAAGATTTGGTTTTTCTCCCGTTTTAATTGAAAAGTCTGCCAATTTACGAAAAGGAGGGCATGCACTGGATGTTCGAGGTGTTGCAATCGACCTCGTCAAAAGAATGGGCATCTACGAAAAAATAGGCAATAGGCGCACTCAGGTGGAATTTGGACGATACATGGACACTCAAGGCAATATCTTGCATGAAGAAAAGGGTGAAAGATTTTGCTATAGAGAAGGTGAGGATGTTGAAATTACCCGCGGTGATTTAGTTGAGATATTGATAGATGCCATTGAAGGCGTTCCCTGCTATCTCAATCAATCGATTGACAGCATTAAACAGAGGGATGGCGATGTAGCCGTTCGATTTAAAGATGGCAAGATCGAGTATTACGATCTGATTATTGGCGCTGACGGCTTGCATTCAACAACAAGACGCATGGTTTTTGATAAAGATGAATATCAATTAACTAACCTTGGGGCGTACTTTAGCGTTTTTAGTATTCCAAATTATCTCAATTTGAATCACACCGAAATCCAGTTCGAGGCCAATCAAAAACTGATATCTATGACTAGCGACAAGAATCCTAAAATGGCTGAAGTCGCATTCATGTTCCGTGTACAGAATGTCTTGAATAATAGGCGCGATGAAAATGAGCAAAAGAGATTCCTACGCGACACTTTTCAAGGTTTTGGTTGGGAAACGTCGAAAATACTTGAACTGATGTCAGATAGTGATGATTTTTATTTTGATTCAGTCTCCCAAGTGAAAATGAAGTCATGGACTAAGGGTCGAGTTGCCTTATTGGGCGACGCGGGTTACTGCGCATCCCCAATATCTGGTCAAGGTAATAATCTGGCACTAGTTGGTGCTTATGTTTTGGCGGGAGAACTAAAACAGGCAAGCGACAATTATCACCAAGCATTTAATCGTTATAATGAATTGTTACATCCATTCATTGAAGCCAATCAAAAATTGGGAGTCTTGGTTAACGAGTCGTTTCTCGTTCAGGATGAAGTCTCAAAGGAAGTTGCGGAAGAACGATCAAATAAGATAATGGAAGAAGTAAAAATCGTCTCGAATATGATTTCGTTACCGGATTATGAATGA", "partial": "0", "query_start": 20311, "query_end": 20400, "hit_start": 906, "hit_end": 996, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 43.33}, "gnl|BL_ORD_ID|2724|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 19438, "orf_end": 21003, "orf_from": "BGC0000254.1|Oxytetracycline_19 ", "model_name": "tet(53)", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "750", "model_id": "3290", "ARO_accession": "3004589", "ARO_name": "tet(53)", "ARO_category": {"36176": {"category_aro_accession": "3000036", "category_aro_cvterm_id": "36176", "category_aro_name": "tetracycline inactivation enzyme", "category_aro_description": "Enzymes or other gene products which hydroxylate tetracycline and other tetracycline derivatives. Hydroxylation inactivates tetracycline-like antibiotics, thus conferring resistance to these compounds.", "category_aro_class_name": "AMR Gene Family"}, "35968": {"category_aro_accession": "0000051", "category_aro_cvterm_id": "35968", "category_aro_name": "tetracycline", "category_aro_description": "Tetracycline is a broad-spectrum polyketide antibiotic produced by many Streptomyces. It works by inhibiting action of the prokaryotic 30S ribosome.", "category_aro_class_name": "Antibiotic"}, "36291": {"category_aro_accession": "3000152", "category_aro_cvterm_id": "36291", "category_aro_name": "minocycline", "category_aro_description": "Minocycline is second generation semi-synthetic derivative of the tetracycline group of antibiotics. It inhibits bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome and preventing the aminotransferase-tRNA from associating with the ribosome.", "category_aro_class_name": "Antibiotic"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 7.4584, "max_identities": 71, "bit_score": 26.1794, "cvterm_id": "36791", "query": "VVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFA-SLGVPLDFSS---FDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVT-GPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHM------FAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLT-------DTSRQAE--RYRDGRVLLAGDACHIHLPAGGQG", "match": "+++ GAG  G  +   LR  G   +++E+ A      +AL      ++++    + E       +L  G +  + G  L       F  R    + + +    E+LTG A+E G        + +++Q  D V V    G    Y++    ++G DG  ST R   G+ F   +  +      F V +   +   L H E           +  +  W    P       A VAF  R   +    +  ++ +  L   A  DFG    + L  +T       D++ Q +   +  GRV L GDA +   P  GQG", "sequence_from_db": "ILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTG-AIE-GIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDL----VIGADGIYSTTR---GMVFDKDEYKLVNLGVCFGVFSILNYLN-LSHTEVQCEAN-----QKLISIWSHKNP-----KMAEVAFVFRT-QNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQG", "sequence_from_broadstreet": "MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE", "dna_sequence_from_broadstreet": "ATGTCTACTATAAATAAAATTCTCGTGATCGGAGCTGGTATTGCCGGACCCGCGGTTTGTTATTGGTTAAGAAGATTTGGCTTTTCTCCTGTCCTCATTGAAAAATTTGCCAATATACGAAAAGAAGGGCAGGCACTGGATTTTCGAGGCGTTGCGATCGACATCGTTAAAGGAATGAATATTTATGAGAAAATGTGCAATATGCACAAGCAGTTGGAGGTCGGGCGGTATGTGGACACAGAAGGCAATACCCTGCATGAAGAAAGAGGTGAAAGATTTTGCTTTAGACAAGGTGAAGACGTTGAAATTGCCCGCGGTGATTTCGCCGAAATACTGACGGGTGCCATTGAAGGTATTCCCTGTCATTTTAATCAAGTAATTGACAGCATTAAACAGAGTGACGATGATGTAAAAGTCCAGTTCAACGATGGCAGAGTCGAGCATTATGACTTGGTTATTGGTGCTGATGGCATATACTCGACAACGAGAGGTATGGTTTTTGATAAAGACGAATATAAATTAGTTAACCTTGGTGTGTGCTTTGGCGTATTTAGCATTCTGAATTATCTCAATTTGAGCCACACCGAAGTGCAGTGTGAGGCCAATCAAAAGCTGATATCTATCTGGAGCCACAAAAATCCCAAGATGGCTGAAGTTGCGTTTGTGTTCCGTACGCAGAATGTCTTGAATAACATTCGCAATAAAAACGAGCAGCAGCAACTCCTGCGTGATGCTTTTCAAGATTTTGGCTGGGAAGCATCAAAAATACTTGAGCTGATGACAGGTAGTGATGATTTTTATTTTGATTCAGCCACACAGGTAAAAATGAAATCGTGGACGAAAGGGCGGGTTGCTTTATTGGGTGATGCTGGTTACTCTGCATCTCCACTATCTGGTCAGGGTAATTATCTGGCACTGGTTGGCGCTTATATTTTTGCCGGAGAACTAAAAAAAGCAGATGGCAATTATACTCGTGCATTTAGTCGTTATAATGAATTATTACATCCACTCGTTGAAGCCTGTCACAAGTTGGGGGTCTTAGTTAGCGAATCGTTCCTCGTCCCAGATGAAGTCTCCAAAGAAGTTGCAGAAGAACGATCAAATAAGATTCTGCAAGAGGTGAAAATCGTATCGAATATGATTTCGTTGCCAGAGTATGAATGA", "partial": "0", "query_start": 19504, "query_end": 20391, "hit_start": 18, "hit_end": 903, "orf_dna_sequence": "ATGCCCGCGGTCAGCATGCTCGGCGGCAACCCACTGATGATCCGAGGAGCGTGTATGCGGTACGACGTGGTGATCGCCGGCGCCGGGCCGACCGGCCTGATGCTCGCCTGCGAACTGCGCCTGGCCGGTGCCAGGACCCTGGTGCTGGAACGCCTGGCGGAGCCGGTCGACTTCTCCAAGGCCCTCGGTGTGCACGCGCGCACCGTCGAGCTGCTGGACATGCGCGGGCTGGGCGAGGGGTTCCAGGCCGAGGCGCCGAAGCTGCGCGGCGGGAACTTCGCCAGCCTCGGAGTACCCCTGGACTTCTCGTCGTTCGACACCCGGCACCCGTACGCGCTGTTCGTCCCCCAGGTGCGTACCGAGGAGCTGCTGACCGGGCGGGCCCTGGAGCTGGGGGCCGAGCTGCGGCGCGGGCACGCGGTGACGGCGCTGGAGCAGGACGCCGACGGCGTGACCGTCTCCGTCACCGGGCCCGAGGGGCCGTACGAGGTCGAGTGCGCGTACCTGGTGGGCTGCGACGGCGGCGGCAGCACCGTACGCAAGCTGCTCGGCATCGACTTCCCCGGGCAGGACCCGCACATGTTCGCGGTGATCGCGGATGCCCGGTTCCGTGAGGAGCTGCCGCACGGGGAGGGCATGGGACCGATGCGGCCGTACGGCGTCATGCGGCACGACCTGCGCGCCTGGTTCGCCGCCTTCCCGCTGGAGCCGGACGTCTACCGGGCCACGGTCGCCTTCTTCGACCGGCCCTACGCCGACCGCCGGGCGCCGGTCACCGAGGAGGACGTGCGGGCCGCGCTGACCGAGGTGGCCGGCAGCGACTTCGGGATGCACGACGTGCGCTGGCTCTCCCGGCTCACCGACACCTCACGCCAGGCCGAGCGGTACCGCGACGGCCGGGTCCTGCTGGCCGGCGACGCCTGCCACATCCACCTGCCCGCGGGCGGCCAGGGCCTCAACCTGGGCTTCCAGGACGCGGTGAACCTGGGCTGGAAGCTGGGCGCGACCATCGCGGGCACGGCTCCGCCGGAGCTGCTGGACACCTACGAGGCCGAGCGCCGCCCGATCGCCGCCGGCGTACTGCGCAACACCCGCGCGCAAGCCGTGCTGATCGACCCGGACCCGCGTTACGAGGGGCTGCGGGAGCTGATGATCGAGCTGCTGCACGTCCCGGAGACCAACCGCTATCTGGCGGGCCTCATCTCGGCGCTGGACGTGCGGTACCCCATGGCGGGCGAGCACCCGCTGCTGGGGCGCCGCGTACCGGACCTGCCGCTCGTCACCGAGGACGGCACCCGGCAGCTGAGCACGTACTTCCACGCGGCGCGCGGCGTCCTGCTGACGCTCGGCTGCGACCAGCCGCTCGCCGACGAGGCCGCGGCCTGGAAGGACCGGGTGGACCTGGTCGCGGCCGAGGGCGTCGCGGACCCGGGCTCCGCGGTCGACGGGCTGACCGCGCTGCTCGTACGCCCCGACGGCTACATCTGCTGGACCGCGGCTCCGGAGACGGGTACGGACGGGCTCACCGACGCCCTGCGCACCTGGTTCGGGCCGCCCGCCATGTGA", "orf_prot_sequence": "MPAVSMLGGNPLMIRGACMRYDVVIAGAGPTGLMLACELRLAGARTLVLERLAEPVDFSKALGVHARTVELLDMRGLGEGFQAEAPKLRGGNFASLGVPLDFSSFDTRHPYALFVPQVRTEELLTGRALELGAELRRGHAVTALEQDADGVTVSVTGPEGPYEVECAYLVGCDGGGSTVRKLLGIDFPGQDPHMFAVIADARFREELPHGEGMGPMRPYGVMRHDLRAWFAAFPLEPDVYRATVAFFDRPYADRRAPVTEEDVRAALTEVAGSDFGMHDVRWLSRLTDTSRQAERYRDGRVLLAGDACHIHLPAGGQGLNLGFQDAVNLGWKLGATIAGTAPPELLDTYEAERRPIAAGVLRNTRAQAVLIDPDPRYEGLRELMIELLHVPETNRYLAGLISALDVRYPMAGEHPLLGRRVPDLPLVTEDGTRQLSTYFHAARGVLLTLGCDQPLADEAAAWKDRVDLVAAEGVADPGSAVDGLTALLVRPDGYICWTAAPETGTDGLTDALRTWFGPPAM", "perc_identity": 22.47}}, "BGC0000254.1|Oxytetracycline_20 # 21064 # 22098 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=CCC;rbs_spacer=15bp;gc_cont=0.722": {"gnl|BL_ORD_ID|671|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 21064, "orf_end": 22098, "orf_from": "BGC0000254.1|Oxytetracycline_20 ", "model_name": "ErmS", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "727", "ARO_accession": "3001304", "ARO_name": "ErmS", "ARO_category": {"36699": {"category_aro_accession": "3000560", "category_aro_cvterm_id": "36699", "category_aro_name": "Erm 23S ribosomal RNA methyltransferase", "category_aro_description": "Erm proteins are part of the RNA methyltransferase family and methylate A2058 (E. coli nomenclature) of the 23S ribosomal RNA conferring degrees of resistance to Macrolides, Lincosamides and Streptogramin b. This is called the MLSb phenotype.", "category_aro_class_name": "AMR Gene Family"}, "35964": {"category_aro_accession": "0000046", "category_aro_cvterm_id": "35964", "category_aro_name": "lincomycin", "category_aro_description": "Lincomycin is a lincosamide antibiotic that comes from the actinomyces Streptomyces lincolnensis. It binds to the 23s portion of the 50S subunit of bacterial ribosomes and inhibit early elongation of peptide chain by inhibiting transpeptidase reaction.", "category_aro_class_name": "Antibiotic"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37022": {"category_aro_accession": "3000678", "category_aro_cvterm_id": "37022", "category_aro_name": "pristinamycin IC", "category_aro_description": "Pristinamycin IC is a class B streptogramin derived from virginiamycin S1.", "category_aro_class_name": "Antibiotic"}, "37627": {"category_aro_accession": "3001228", "category_aro_cvterm_id": "37627", "category_aro_name": "carbomycin", "category_aro_description": "Produced by Streptomyces halstedii and Streptomyces thermotolerans.", "category_aro_class_name": "Antibiotic"}, "37629": {"category_aro_accession": "3001230", "category_aro_cvterm_id": "37629", "category_aro_name": "niddamycin", "category_aro_description": "Produced by Streptomyces caelestis.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35945": {"category_aro_accession": "0000026", "category_aro_cvterm_id": "35945", "category_aro_name": "streptogramin antibiotic", "category_aro_description": "Streptogramin antibiotics are natural products produced by various members of the Streptomyces genus. These antibiotics bind to the P site of the 50S subunit of bacterial ribosomes to inhibit protein synthesis. The family consists of two subgroups, type A and type B, which are simultaneously produced by the same bacterial species in a ratio of roughly 70:30.", "category_aro_class_name": "Drug Class"}, "35967": {"category_aro_accession": "0000050", "category_aro_cvterm_id": "35967", "category_aro_name": "streptogramin B antibiotic", "category_aro_description": "Streptogramin B antibiotics are are cyclic hepta- or hexa-depsipeptides.  Type B streptogramins block the peptide exit tunnel of the 50S bacterial ribosome. The general composition of group B streptogramins is 3-hydroxypicolinic acid-L-Thr-D-aminobutyric acid (or D-Ala)-L-Pro-L-Phe (or 4-N-,N-(dimethylamino)-L-Phe)-X-L-phenylglycine. Used alone, streptogramin B antibiotics are bacteriostatic, but is bactericidal when used with streptogramin A antibiotics.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0401551, "max_identities": 32, "bit_score": 32.7278, "cvterm_id": "36838", "query": "EDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDLPALAPLAGELIRER---GLEGRVRFHGGDFLTDPLPSADAVVTGHV", "match": "  P+RAR+ ++         AE +AR V  +  G  +++G  RG L   +A     L     D P L P     +R+R        VR  GGDFL  P+P     + G++", "sequence_from_db": "RSPDRARRELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEID-PRLLP----ALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNI", "sequence_from_broadstreet": "MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRARRELSQNFLARRAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGPHHAHVRISGGDFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSLLTVRTWPRHEWRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASLRRAHRAGPLDAAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR", "dna_sequence_from_broadstreet": "GTGGCCCGTGCACCCCGATCGCCCCACCCTGCCCGCTCGCGGGAGACCTCCCGCGCCCACCCGCCGTACGGCACCCGTGCGGATCGCGCCCCCGGCCGTGGCCGTGACCGTGACCGCAGCCCCGACAGCCCCGGCAACACCAGCAGCCGCGACGGCGGCCGCAGCCCCGACCGCGCGCGGCGCGAGCTCTCGCAGAACTTCCTCGCCCGCCGGGCCGTCGCCGAGCGCGTCGCGCGCCTGGTCCGGCCGGCCCCCGGCGGTCTGTTGCTGGAGGTCGGCGCCGGGCGCGGCGTCCTGACCGAGGCGCTGGCCCCGTACTGCGGGCGGCTGGTCGCCCACGAGATCGACCCCCGTCTGCTGCCGGCGCTGCGCGACCGGTTCGGCGGCCCGCACCATGCCCATGTGCGGATCAGCGGCGGCGACTTCCTGGCAGCCCCCGTCCCCCGTGAGCCGTTCGCCCTCGCGGGGAACATCCCCTACTCCCGGACCGCGGGAATCGTGGACTGGGCGCTGCGGGCGCGCACGCTCACCTCGGCGACCTTCGTCACCCAGCTCGAGTACGCCCGCAAGCGGACCGGCGACTATGGACGCTGGAGCCTGCTGACGGTGCGGACCTGGCCCCGCCACGAGTGGCGGCTGCTCGGCAGGGTCTCCCGCCGGGAGTTCCGGCCGGTGCCCCGCGTGGACTCGGGCATCCTCCGGATCGAGCGGCGCGAGCGGCCCCTGCTGCCGTCCGCCGCCCTCGGCGACTACCACCGCATGGTGGAGCTGGGTTTCTCCGGCGTGGGCGGATCGCTGTACGCATCGCTGCGCCGGGCCCACCGGGCGGGGCCGCTCGACGCCGCGTTCCGTGCCGCGCGGCTGGACCGCTCCGTCGTCGTCGCGTATGTCACACCGGAGCAGTGGCTCACGGTCTTCCGCACGTTGCGGCCCGTCCGCAGCCGACCGGCCGGACGGTGA", "partial": "0", "query_start": 21490, "query_end": 21810, "hit_start": 159, "hit_end": 474, "orf_dna_sequence": "ATGACCACCACACCGCTCGCCCCCGTGGCCCAGGCCCGCTCGCTGCTGCAGCTGACCACCGCGTACCACCAGGCGAAGGCCCTGCACAGCGCCGTGGAGCTGGGCCTGTTCGACCTGCTCGCCGACGGGCCCGCGACCGCCGAGGAGGTGAAGGACCGGCTGCGGATCGTCCATCCGCTGGCCAAGGAGTTCCTCGACGCGCTCGTCGCGCTGGAGTTGCTGGAAGCGGACGGCGACCGCTACCGCAACTCCCCCGCCGCCCAGGCGTTCCTGGTGTCCGGCGCCTCCGAATACCTGGGCGGCACCGTCCTCCAGCACGCCCGCAAGCACTACCACGTATGGGCCGGGCTGACGACGGCGCTCCAGGAGGGCGAGGCGGGTTCCGGCGCCGAAGCGCACGGGCCCGAGGCGTACCCCAAGCACTACGAGGACCCGGAGCGGGCCCGTCAGGTCATGGCGCACTTCGACACCTTCAGCTCCTTCACGGCCGAGGAGCTGGCGCGCCGCGTCGACTGGAGCGGGTACGGGTCCTTCATCGACATCGGCGGCGCACGGGGCAACCTCGCCACGCGGGTGGCCCTGGCCCACCCGCACCTGCACGGCGCCGTGTTCGACCTGCCCGCGCTGGCCCCGCTGGCCGGCGAGCTGATCCGTGAGCGCGGCCTCGAAGGCCGCGTCCGCTTCCACGGCGGCGACTTCCTGACCGACCCGCTGCCGTCCGCGGACGCCGTGGTCACCGGGCACGTACTGCCCGACTGGCCGGTACCGCAGCGGCGCAAGCTCCTCGCGCGCATCCACGAGGCGCTGCCCTCCGGCGGCGCGCTGGTGGTCTACGACCTGATGACGGATCCGGCCACCACGACGGTGCACGACGTACTGCAACGGCTCAACCACGGCCTCATCCGCGGCGACAGCTCGTCCAGCAGCGTCGAGGAGTACCGCGCGGAGATCGAGGAGGCCGGCTTCCGGGTGCGGCAGGCGGAGCGCATCGACAACCTCCTCGGTGACTGGCTGATAGTCGCCGTCAAGCCCTGA", "orf_prot_sequence": "MTTTPLAPVAQARSLLQLTTAYHQAKALHSAVELGLFDLLADGPATAEEVKDRLRIVHPLAKEFLDALVALELLEADGDRYRNSPAAQAFLVSGASEYLGGTVLQHARKHYHVWAGLTTALQEGEAGSGAEAHGPEAYPKHYEDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDLPALAPLAGELIRERGLEGRVRFHGGDFLTDPLPSADAVVTGHVLPDWPVPQRRKLLARIHEALPSGGALVVYDLMTDPATTTVHDVLQRLNHGLIRGDSSSSSVEEYRAEIEEAGFRVRQAERIDNLLGDWLIVAVKP", "perc_identity": 29.09}, "gnl|BL_ORD_ID|198|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 21064, "orf_end": 22098, "orf_from": "BGC0000254.1|Oxytetracycline_20 ", "model_name": "npmA", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "400", "model_id": "218", "ARO_accession": "3002665", "ARO_name": "npmA", "ARO_category": {"41436": {"category_aro_accession": "3004272", "category_aro_cvterm_id": "41436", "category_aro_name": "16S rRNA methyltransferase (A1408)", "category_aro_description": "Methyltransferases that methylate the A1408 position of 16S rRNA, which is part of an aminoglycoside binding site.", "category_aro_class_name": "AMR Gene Family"}, "35924": {"category_aro_accession": "0000005", "category_aro_cvterm_id": "35924", "category_aro_name": "neomycin", "category_aro_description": "Neomycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Neomycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35932": {"category_aro_accession": "0000013", "category_aro_cvterm_id": "35932", "category_aro_name": "amikacin", "category_aro_description": "Amikacin is an aminoglycoside antibiotic that works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "35940": {"category_aro_accession": "0000021", "category_aro_cvterm_id": "35940", "category_aro_name": "ribostamycin", "category_aro_description": "Ribostamycin is an aminoglycoside antibiotic used to treat different types of bacterial infections. Ribostamycin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Antibiotic"}, "40942": {"category_aro_accession": "3004015", "category_aro_cvterm_id": "40942", "category_aro_name": "gentamicin A", "category_aro_description": "Gentamicin A is part of a complex of broad spectrum aminoglycoside antibiotics. Gentamicin inhibits protein synthesis, resulting in bacterial cell death.", "category_aro_class_name": "Antibiotic"}, "46133": {"category_aro_accession": "3007382", "category_aro_cvterm_id": "46133", "category_aro_name": "gentamicin", "category_aro_description": "Gentamicin is a commonly used aminoglycoside antibiotic derived from members of the Micromonospora genus of bacteria. It acts by binding the 30S ribosomal subunit, thus inhibiting protein synthesis. Gentamicin is typically used to treat Gram-negative infections of the repiratory and urinary tract, as well as infections of the bone and soft tissue. It also exhibits considerable nephrotoxicity and ototoxicity. Gentamicin is administered as a mixture of gentamicin type C (which makes about around 80% of the complex) and types A, B, and X (distributed in the remaining 20% of the complex).", "category_aro_class_name": "Antibiotic"}, "35935": {"category_aro_accession": "0000016", "category_aro_cvterm_id": "35935", "category_aro_name": "aminoglycoside antibiotic", "category_aro_description": "Aminoglycosides are a group of antibiotics that are mostly effective against Gram-negative bacteria. These molecules consist of aminated sugars attached to a dibasic cyclitol. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit (some work by binding to the 50S subunit), inhibiting the translocation of the peptidyl-tRNA from the A-site to the P-site and also causing misreading of mRNA, leaving the bacterium unable to synthesize proteins vital to its growth.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.697407, "max_identities": 9, "bit_score": 28.4906, "cvterm_id": "35914", "query": "EEYRAEIEEAGFRVRQAERIDN", "match": "E+Y+AE+  +GFR+   + +DN", "sequence_from_db": "EQYKAELSNSGFRIDDVKELDN", "sequence_from_broadstreet": "MLILKGTKTVDLSKDELTEIIGQFDRVHIDLGTGDGRNIYKLAINDQNTFYIGIDPVKENLFDISKKIIKKPSKGGLSNVVFVIAAAESLPFELKNIADSISILFPWGTLLEYVIKPNRDILSNVADLAKKEAHFEFVTTYSDSYEEAEIKKRGLPLLSKAYFLSEQYKAELSNSGFRIDDVKELDNEYVKQFNSLWAKRLAFGRKRSFFRVSGHVSKH", "dna_sequence_from_broadstreet": "TTGTTAATACTCAAAGGAACAAAGACGGTTGATTTATCAAAAGATGAATTGACAGAAATAATAGGTCAGTTTGATCGTGTGCATATAGATTTGGGTACTGGAGACGGTAGAAATATATATAAACTTGCAATTAATGATCAAAACACTTTCTATATCGGAATAGATCCGGTAAAAGAAAACTTGTTTGATATATCCAAAAAAATTATAAAGAAGCCCTCAAAAGGAGGGCTATCTAATGTGGTGTTTGTTATTGCAGCTGCAGAGTCTCTCCCTTTTGAATTGAAAAACATTGCTGATTCAATTTCCATTTTGTTTCCTTGGGGGACATTGCTTGAATATGTAATTAAACCGAATAGAGATATTCTTTCGAATGTTGCAGATTTGGCTAAAAAAGAAGCTCACTTTGAATTTGTGACCACATACTCAGATTCATACGAAGAAGCGGAAATAAAAAAAAGAGGACTTCCTCTTTTAAGTAAGGCCTATTTTTTGAGCGAACAATACAAAGCTGAATTATCAAACTCAGGTTTTCGCATTGATGATGTTAAGGAATTGGACAATGAGTATGTAAAACAGTTTAATTCTCTTTGGGCAAAGCGATTAGCTTTTGGGCGAAAACGTTCTTTCTTTCGAGTTTCTGGCCATGTTTCAAAACATTAA", "partial": "0", "query_start": 21994, "query_end": 22059, "hit_start": 495, "hit_end": 561, "orf_dna_sequence": "ATGACCACCACACCGCTCGCCCCCGTGGCCCAGGCCCGCTCGCTGCTGCAGCTGACCACCGCGTACCACCAGGCGAAGGCCCTGCACAGCGCCGTGGAGCTGGGCCTGTTCGACCTGCTCGCCGACGGGCCCGCGACCGCCGAGGAGGTGAAGGACCGGCTGCGGATCGTCCATCCGCTGGCCAAGGAGTTCCTCGACGCGCTCGTCGCGCTGGAGTTGCTGGAAGCGGACGGCGACCGCTACCGCAACTCCCCCGCCGCCCAGGCGTTCCTGGTGTCCGGCGCCTCCGAATACCTGGGCGGCACCGTCCTCCAGCACGCCCGCAAGCACTACCACGTATGGGCCGGGCTGACGACGGCGCTCCAGGAGGGCGAGGCGGGTTCCGGCGCCGAAGCGCACGGGCCCGAGGCGTACCCCAAGCACTACGAGGACCCGGAGCGGGCCCGTCAGGTCATGGCGCACTTCGACACCTTCAGCTCCTTCACGGCCGAGGAGCTGGCGCGCCGCGTCGACTGGAGCGGGTACGGGTCCTTCATCGACATCGGCGGCGCACGGGGCAACCTCGCCACGCGGGTGGCCCTGGCCCACCCGCACCTGCACGGCGCCGTGTTCGACCTGCCCGCGCTGGCCCCGCTGGCCGGCGAGCTGATCCGTGAGCGCGGCCTCGAAGGCCGCGTCCGCTTCCACGGCGGCGACTTCCTGACCGACCCGCTGCCGTCCGCGGACGCCGTGGTCACCGGGCACGTACTGCCCGACTGGCCGGTACCGCAGCGGCGCAAGCTCCTCGCGCGCATCCACGAGGCGCTGCCCTCCGGCGGCGCGCTGGTGGTCTACGACCTGATGACGGATCCGGCCACCACGACGGTGCACGACGTACTGCAACGGCTCAACCACGGCCTCATCCGCGGCGACAGCTCGTCCAGCAGCGTCGAGGAGTACCGCGCGGAGATCGAGGAGGCCGGCTTCCGGGTGCGGCAGGCGGAGCGCATCGACAACCTCCTCGGTGACTGGCTGATAGTCGCCGTCAAGCCCTGA", "orf_prot_sequence": "MTTTPLAPVAQARSLLQLTTAYHQAKALHSAVELGLFDLLADGPATAEEVKDRLRIVHPLAKEFLDALVALELLEADGDRYRNSPAAQAFLVSGASEYLGGTVLQHARKHYHVWAGLTTALQEGEAGSGAEAHGPEAYPKHYEDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDLPALAPLAGELIRERGLEGRVRFHGGDFLTDPLPSADAVVTGHVLPDWPVPQRRKLLARIHEALPSGGALVVYDLMTDPATTTVHDVLQRLNHGLIRGDSSSSSVEEYRAEIEEAGFRVRQAERIDNLLGDWLIVAVKP", "perc_identity": 40.91}, "gnl|BL_ORD_ID|2387|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 21064, "orf_end": 22098, "orf_from": "BGC0000254.1|Oxytetracycline_20 ", "model_name": "LpeB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "1700", "model_id": "2759", "ARO_accession": "3004100", "ARO_name": "LpeB", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "35925": {"category_aro_accession": "0000006", "category_aro_cvterm_id": "35925", "category_aro_name": "erythromycin", "category_aro_description": "Erythromycin is a macrolide antibiotic with a 14-carbon ring that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people that have an allergy to penicillins. Erythromycin may possess bacteriocidal activity, particularly at higher concentrations by binding to the 50S subunit of the bacterial 70S rRNA complex, inhibiting peptidyl-tRNA translocation. Thus, protein synthesis and subsequently structure/function processes critical for life or replication are inhibited.", "category_aro_class_name": "Antibiotic"}, "36295": {"category_aro_accession": "3000156", "category_aro_cvterm_id": "36295", "category_aro_name": "spiramycin", "category_aro_description": "Spiramycin is a 16-membered macrolide and is natural product produced by Streptomyces ambofaciens. It binds to the 50S subunit of bacterial ribosomes and inhibits peptidyl transfer activity to disrupt protein synthesis.", "category_aro_class_name": "Antibiotic"}, "36297": {"category_aro_accession": "3000158", "category_aro_cvterm_id": "36297", "category_aro_name": "azithromycin", "category_aro_description": "Azithromycin is a 15-membered macrolide and falls under the subclass of azalide. Like other macrolides, azithromycin binds bacterial ribosomes to inhibit protein synthesis. The nitrogen substitution at the C-9a position prevents its degradation.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.71227, "max_identities": 20, "bit_score": 27.7202, "cvterm_id": "41208", "query": "HVWAGLTTALQEGEAGSGAE----AHGPEAYPKHYEDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFID", "match": "HVW+  T      +AGSG+E       P+ + + +++ E+ + V+   D    F A     R+D  GY   +D", "sequence_from_db": "HVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVL---DKSKLFAAVNYDLRLDTMGYNIDLD", "sequence_from_broadstreet": "MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE", "dna_sequence_from_broadstreet": "ATGAAACTCACCAGCTATTTCATCAAACATCCTGTAATCACCATCATCTTAAACGCCATGATTGTTGTTCTGGGGTTATTATGTCTCTATAATTTATCCGTTAGGGAATATCCTGATATCAATTTTCCTACAATAACTGTTTCAGCAAGCTACCCCAACGCCAGTCCCGATTTAGTTGAAACCGCAATAACCAATGTTCTGGAGGACCGTCTTGCAGGTATAGAAGGGTTAGAAACAATTACGTCGCAATCAAGTGCAGGCTATGCGCAAATCACCTTGATGTTTCGTTCCGGAACATCCATGGATAGAGCACTGAGTACCACTCAAGACGCCGTAGGAGTAGCCAAAGCACTTCTGCCACCGGAGGTAAGATCGCCAACAGTTGAACGCCAACGCAAATCCAATGGCCTTCCTTTTATTGGGATTTCATTGGAATCAACATCCAAAGACTTTGGTGAGCTGACTCATTACGCTAATCTTAATTTAAAAAATGTCTTTCGCAGTGTGCAAGGTGTTGCTTCCGTTGAAGTATGGGGGCAACCCTATACATACAACATTACCCTTCAACCTGAAAAATTATTTTCTTTTGGAGTTAATGTTGATGAAATAGTGAATGCGCTCGCAAAAAATCGTATTTCGTTGCCCGCAGGTAATTATAGAAATAAAATTCCCAGTACTCTTAATTCTGAGCTGAAAACCCGGGAAGATTATGAGAATCTTTTAATCAAGGCAAATTCCAAACATCCCATTTTACTCAAATCACTGGCTAATGTCGCATTGGAAACCGATAACTCACAAATGCGAGTTCGCGTTAATGGGCACGCTGGTGTTGTGCTTTCTATCAATAAAGCGAATGAAGCCAATCCTATTGAAGTCTCTAAAGAAATTAGAAAAGTGATTAAAGGATTACAACAAGGGTTGCCCAAGGATCTGAAAATAAACACTATTATTGATCAATCGGATTTTATTAATGCCTCCATTAAAAACATTAGATCCGCGATTGGTGAAGCCATTTTTTTAGTCTTAATCATAGTCTTCCTTTTTTTACGTAATATTAAAGCCACCATCATCCCTCTAATTACCATTCCAATTTCATTATTGGGGTCCTTGCTTTTCCTTAAATTGTTTGGTTTTTCAATCAATTTAATGACCTTACTGGCTATGGTATTGGCAATCGGTTTGGTTGTAGACGATGCGATTATTGTCTTGGAAAACATTTGGCGTCATATTGAAAGCGGATTATCTCCTTTGGATGCTGCGCTTAAAGGAGCACGTGAAATTGGCTTCGCCATTATAGCGATGACATTTACCCTTAGCAGTGTTTATTTGCCTATAGCCTTTATCCAGGGGATGCTGGGACAGCTCTTCGTTGAATTTGCTGTTGCTCTGGCAGGCAGTGTTTTCATTTCGGGGATTGTTGCCCTGACACTTTCACCATTGATGTGTGCCAACCTTTTGAGTGCATCTTCTAAAAACTGGTGGCCACAATTCGATAATGCTCTTGAAAAGTTAACTAAACATTACTCCAATATTTTACAATTCATTCTGAAACACCAAAAGATTACTTTGCTAACAGCTCTAATTTCTGTCGTTGCTTGCTTTGGATTTTATAATTTAATTAGCCATGAAACCGCTCCTAAAGAAGATCGAGGTTTAATAGGTATTTATATCCCTCCTGTAGCAGGAGAAGACATAGGGATGTTGGACAACAAAACAGGAAAACTTGAAAAAAAACTAGATGCCATCCCCGAGGCAAATAATCGCCTGACTTTTATTGGTGACTGGGGCGGGTCAATAGTACTGCCATTAAAACCTCATGCTCAACGTCATCGAAGTGCGAACCAGATTGTTGAGAAATTAAGACCTTCTTTTAACCACTTCCCCTCCATGGATCCTCATGTATGGAGTTGGGATACAGGCTTACCAGGAGTTGATGATGCCGGGAGTGGATCTGAATTGACTCTGGTTATTTCTACCCCAGACCATTTCAGGCAATTATTTGATGAAACTGAAAAATTAAAAAGTGTTCTAGACAAGAGCAAATTATTTGCAGCAGTGAACTATGACCTTCGCCTTGATACCATGGGATACAATATAGACCTTGATTATAACCAACTGGCGAAACTTGGACTGACAGCAAATCAGGTGGCAAAGACGATTGAGGTATTTTTCAGTGGCGACAAGTCACAAACCTTTGAAAAAGATGGGGTCGTTTATAATATATCGATTAAAGGAGATTCCTCCCCCTGGACTTTGAATGAACTTTATTTAACTACAAATGAAGGGAAGTCTGTTTCATTGGGAGCTATTACCAAAATGCAGCCCAAGGCTCAACCGGCAACTCTTGATCATTATCAGCAAATGCGTTCGACCACTCTCCATGTCCAATTACATAAGGGAGACTCTATGGCAAAGGCTATTGAAAAATTATGGGGCACTACCAAAGAAGTGATGCCTCAACACTATAAACTGACCTGGATTGGTGCGGCCAAAGCATTCCATGAATCTTCCAATTCCATGTTATTTTTGTTTTTCTTATCTTTGGCTTTCATCTATGCCATTTTATGCACACAATTCGAGAATTTTACTGACCCCTTCATTATTCTATTCACTGTACCACTAGCCTGCTCGGGCGCCTTATTATTCACTTATTTATTTGGACAATCCTTAAACATTTATACTCAGGTAGGTTTGATTACTTTAATCGGGCTCATTAGCAAACACGGTATTTTAATAGTGGAATTTGCTAATAAACTTCATAAAGATGGTGCTTCGTTGCCAGAAGCTATACAGAAATCAGCTGCATTGCGTTTACGGCCTATATTAATGACAACTGGCGCCATGGTTTTTGGCGCCATCCCTTTGGTATTATCGCATGATGCGGGTTCTGAATCCCGGCATGCCATAGGAACTGTATTGATTAGCGGGCTCGGTCTTGGAACACTATTTACCCTATTTGTTTTGCCTGCGGTTTACAACATCATCAAATCCAAACTAATTGATATGCAAAAAACAGGGGGCAAAAAACGGTGCAGCAAAGAATAA", "partial": "0", "query_start": 21397, "query_end": 21603, "hit_start": 1896, "hit_end": 2106, "orf_dna_sequence": "ATGACCACCACACCGCTCGCCCCCGTGGCCCAGGCCCGCTCGCTGCTGCAGCTGACCACCGCGTACCACCAGGCGAAGGCCCTGCACAGCGCCGTGGAGCTGGGCCTGTTCGACCTGCTCGCCGACGGGCCCGCGACCGCCGAGGAGGTGAAGGACCGGCTGCGGATCGTCCATCCGCTGGCCAAGGAGTTCCTCGACGCGCTCGTCGCGCTGGAGTTGCTGGAAGCGGACGGCGACCGCTACCGCAACTCCCCCGCCGCCCAGGCGTTCCTGGTGTCCGGCGCCTCCGAATACCTGGGCGGCACCGTCCTCCAGCACGCCCGCAAGCACTACCACGTATGGGCCGGGCTGACGACGGCGCTCCAGGAGGGCGAGGCGGGTTCCGGCGCCGAAGCGCACGGGCCCGAGGCGTACCCCAAGCACTACGAGGACCCGGAGCGGGCCCGTCAGGTCATGGCGCACTTCGACACCTTCAGCTCCTTCACGGCCGAGGAGCTGGCGCGCCGCGTCGACTGGAGCGGGTACGGGTCCTTCATCGACATCGGCGGCGCACGGGGCAACCTCGCCACGCGGGTGGCCCTGGCCCACCCGCACCTGCACGGCGCCGTGTTCGACCTGCCCGCGCTGGCCCCGCTGGCCGGCGAGCTGATCCGTGAGCGCGGCCTCGAAGGCCGCGTCCGCTTCCACGGCGGCGACTTCCTGACCGACCCGCTGCCGTCCGCGGACGCCGTGGTCACCGGGCACGTACTGCCCGACTGGCCGGTACCGCAGCGGCGCAAGCTCCTCGCGCGCATCCACGAGGCGCTGCCCTCCGGCGGCGCGCTGGTGGTCTACGACCTGATGACGGATCCGGCCACCACGACGGTGCACGACGTACTGCAACGGCTCAACCACGGCCTCATCCGCGGCGACAGCTCGTCCAGCAGCGTCGAGGAGTACCGCGCGGAGATCGAGGAGGCCGGCTTCCGGGTGCGGCAGGCGGAGCGCATCGACAACCTCCTCGGTGACTGGCTGATAGTCGCCGTCAAGCCCTGA", "orf_prot_sequence": "MTTTPLAPVAQARSLLQLTTAYHQAKALHSAVELGLFDLLADGPATAEEVKDRLRIVHPLAKEFLDALVALELLEADGDRYRNSPAAQAFLVSGASEYLGGTVLQHARKHYHVWAGLTTALQEGEAGSGAEAHGPEAYPKHYEDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDLPALAPLAGELIRERGLEGRVRFHGGDFLTDPLPSADAVVTGHVLPDWPVPQRRKLLARIHEALPSGGALVVYDLMTDPATTTVHDVLQRLNHGLIRGDSSSSSVEEYRAEIEEAGFRVRQAERIDNLLGDWLIVAVKP", "perc_identity": 27.4}, "gnl|BL_ORD_ID|4719|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 21064, "orf_end": 22098, "orf_from": "BGC0000254.1|Oxytetracycline_20 ", "model_name": "Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "2000", "model_id": "2914", "ARO_accession": "3004480", "ARO_name": "Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin", "ARO_category": {"36349": {"category_aro_accession": "3000210", "category_aro_cvterm_id": "36349", "category_aro_name": "rifamycin-resistant beta-subunit of RNA polymerase (rpoB)", "category_aro_description": "Rifampin resistant RNA polymerases include amino acids substitutions which disrupt the affinity of rifampin for its binding site. These mutations are frequently concentrated in the rif I region of the beta-subunit and most often involve amino acids which make direct interactions with rifampin. However, mutations which also confer resistance can occur outside this region and may involve amino acids which do not directly make contact with rifampin.", "category_aro_class_name": "AMR Gene Family"}, "36308": {"category_aro_accession": "3000169", "category_aro_cvterm_id": "36308", "category_aro_name": "rifampin", "category_aro_description": "Rifampin is a semi-synthetic rifamycin, and inhibits RNA synthesis by binding to RNA polymerase. Rifampin is the mainstay agent for the treatment of tuberculosis, leprosy and complicated Gram-positive infections.", "category_aro_class_name": "Antibiotic"}, "36296": {"category_aro_accession": "3000157", "category_aro_cvterm_id": "36296", "category_aro_name": "rifamycin antibiotic", "category_aro_description": "Rifamycin antibiotics are a group of broad-spectrum ansamycin antibiotics that inhibit bacterial RNA polymerase by binding to a highly conserved region, blocking the oligonucleotide exit tunnel, and preventing the extension of nascent mRNAs.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}, "35998": {"category_aro_accession": "0001002", "category_aro_cvterm_id": "35998", "category_aro_name": "antibiotic target replacement", "category_aro_description": "Replacement or substitution of antibiotic action target, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.85855, "max_identities": 12, "bit_score": 26.9498, "cvterm_id": "42564", "query": "TTAYHQAKALHSAVELGLFDLLADGPATAE", "match": "TT Y+Q   +H    +    +LADGPAT +", "sequence_from_db": "TTCYNQVPLIHDGERVEAGTVLADGPATQK", "sequence_from_broadstreet": "MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ", "dna_sequence_from_broadstreet": "TTGGCTGAGGCTACGACGAACACCACCACCATCATCGCACGCGCCGACCAGCATGATATTGATCTGCACAAGGCGTCGGACCGTGTGAATTTCGGCTCCATCCGCGAGCCCATTGATGTACCCTACCTGTTGGGTGTACAGACTGACAGCTTTGACTGGCTCATCGGCAACGAGCGCTGGCAGAAGCGAGTCCAGGAGGATCTGGAGAACGGCACCAACACCGTGCCCCACACCTCCGGTCTTGACGAGGTCTTCCAGGAGATCTCCCCGATCGAGAACTTCGCTCAGACCATGAGCCTGACCTTCTCCGATCCGTACTTCGAAGAACCGCGCCACACCGTGCAGGAATGCAAGGAGAAGGATTACACCTACTCCGCGCCGCTGTACGTGAACGCCGAATTCGAGAACGGCGACACCGGCGAAATCAAGTCCCAGACCGTGTTCATGGGCGATTTCCCGCTGCAGACCCCGCACGGCACCTTCATCATCGGTGGTACCGAGCGAGTGATCGTGTCCCAGCTCGTGCGTTCCCCGGGCGTGTACTTCGACCGTTCCCAGGACCGTACCTCCGATAAGGAAGTCTTCGGCGCGAAGATCATCCCGAGCCGTGGCGCATGGCTCGAGTTCGAGATCGACAAGCGCGACGTCCTCGGCGTGCGCGTGGACCGTAAGCGCAAGCAGTCCGCCATCGTGTTCCTCATGGCCATCGGCATGACCAAGGATGAAATTGCCGACGCCTTCAAGGACTACCCGCTGGTCATGGACGCTCTCGCCAAGGAGACCGTGCAGACCCAGGACGAGGCCCTGACCGACCTGTACCGCAAGATCCGTCCGGCCGACACCCCGACTCCGGAAGCCGGCAAGAACCTGCTGGACTCCTTCTACTTCAACACCAAGCGTTACGATCTGGCCCGCGTCGGCCGTTACAAGATCAACCGCAAGCTTGGTCTGGAAAAGGACGTCAACGACCGCAGCCTGTCCCGCGAGGACATCATCGCCACCATCAAGTACTTGGTCACCCTGCATGCGGGCGAGACCAAGTTCCCGGGCAAGCGCGACGGCCAGGACGTTGACCTGCGCGTGGACGTCGACGATATCGACCACTTCGGCAACCGTCGTATCCGCCAGGTCGGCGAGCTGATCCAGAACCAGCTGCGCACCGGTCTGAGCCGTATGGAGCGTGTGGTCCGCGAACGTATGACCACCCAGGATCCCGAGGCCATCACCCCGCAGTCCCTGATCAACATCCGTCCGGTGAACGCCACCATCAAGGAGTTCTTCGGAACCTCCCAGCTGTCCCAGTTCATGGATCAGAACAACCCGCTGGCTGGCGTGACCAACAAGCGTCGTCTGTCCGCTCTGGGCCCCGGTGGCCTGTCCCGCGACCGCGCCTCCATGGAAGTGCGAGACGTGCACCCGTCCCATTTCGGCCGTATGTGCCCGATCGAGTCTCCTGAAGGCCCGAACATCGGTCTGATCGGCTCCCTGGCAACCTTCGGTCGCATCAACCCGTTCGGTTTCATCGAGACCCCGTACCGCAAGGTCGTCAACGGCCACGTCACCGATGAAGTCGAGTACATGACCGCTGACCGCGATGCCGAGCACGTCATCGCCCAGGCCAACCAGGAGCTCGACGAGAACGGCAACTTCGTCAAGAAGCAGGCTCTTGCCCGAGTCGGCGAAGAGGAAGCGGTCGATGTGCCGGTCAGCTCCGTCGATTACATGGACGTCTCCCCGCGTCAGATGGTTTCCGTCGGCGCCTCCCTGATTCCGTTCCTGGAGCACGATGAGGGCCACCGAGCGCTGATGGGCACCAACATGCAGCGTCAGGCCGTGCCGCTGATCGAATCCGAGCGTCCGCTCGTGGGCACCGGCGCCGAATGGCGCGCCGCCGTCGATTCCGGCGACGTCATCCTGGCCGAGAAGCCGGGCGTGGTGACCTACGTGTCCGCCGACATCATCCGTACCATGAACGACGATGGCACCACCAGCTCCTACAAGCTGGCCAAATTCCAGCGTTCCAACCAGACCACCTGCTACAACCAGGTCCCGCTCATCCACGACGGTGAACGCGTGGAAGCCGGCACCGTGCTGGCCGATGGTCCGGCAACCCAGAAGGGCGAGATGGCACTGGGCAAGAACCTGCTCATCGCCTTCATGCCGTGGAACGGCTACAACTACGAGGATGCTGTGATCATCTCCCAGCGCCTTGTGCAGGACGACACCCTGAGCTCCATCCACATCGAGGAGTACGAGATCGATGCCCGTGAAACCAAGCTGGGCGCCGAAGAGATCACCCGCGACCTGCCGAACGTCGGCGAGGACGCGGTGGCCAACCTCGACGAGCGTGGCATCATCCGCATCGGCGCCGAAGTCGAAGCCGGCGACATCCTGGTCGGCAAGGTCACCCCGAAGGGCGAGACCGAGCTGACTCCGGAAGAGCGCCTGCTGCGCGCCATCTTCGGTGAGAAGAGCCGCGAAGTGCGTGACACCTCGCTGCGCGTGCCTCACGGCGAGACCGGCACCGTCATCGCGGTCAAGGAAATCACCCGCGAGGACGCCGAGGAAGACGGCGACGAACTGCCGAACGGCGTGAACCAGATGATTCGCGTCTACATCGCACAGCACCGTAAGATCACCCAGGGCGACAAGCTCTCCGGCCGTCACGGCAACAAGGGCGTCATCTCCCGCATCCTGCCGGAAGAGGACATGCCGTTCCTCGCCGACGGTACTCCGGTGGACATCATGCTGAACCCGCTGGGCGTGCCTTCTCGAATGAACCTTGGCCAGGTGCTGGAACTGCACCTCGGCTGGATCGCGCACGCTGGCTGGGACATCTCCCTGGATCCGGATGCCGAGGCCGCTTGGAAGAAGTACGTGCCGCAGGGCGCCGAAAAGGGCGCTCCGGGCACTCCGGTGGCCACCCCGGTGTTCGACGGCGTCCGTCCGGAAACCATCAAGGGCCTGCTCAGCTGCACCCTTCCGGACCGCGACGGCAACAAGCTCGTCGGCCCCGACGGCAAGGCGACCCTGTTCGACGGCCGTACCGGCGAACCGTTCCCGAAGCCGATCTCCGTGGGCTACATGTACATGCTGAAGCTGCACCACCTGGTCGACGACAAGATCCACGCCCGCTCCACCGGCCCGTACTCCATGATCACCCAGCAGCCGCTGGGCGGCAAGGCTCAGTTCGGTGGCCAGCGCTTCGGCGAGATGGAAGTGTGGGCCCTCGAGGCCTACGGTGCCGCCTACACGCTGCACGAAATGATGACCACCAAGTCCGATGACGTCGACGGCCGCGTGCGCGTCTACGGCGCCATCGTGAAGGGCGAGAACCTGCCGCCGGCAGGCATCCCGGAGTCCTTCAAGGTGCTGCTTAAGGAAATGCAGTCCCTGTCCCTGAATGTCGAAGTGCTCAACGCCGACGGCGTGGCTATCGACATGAAGGAAGAGGACGACGATCCGTCCACATCCTCCGATGATCTGGGCTTCAACATTGGTGCGCGTCCTGACGCTGCCGCCAAGGAAGATCAGGTTGCCGAGGAACCCGAATTCCAGTGA", "partial": "0", "query_start": 21118, "query_end": 21207, "hit_start": 2028, "hit_end": 2118, "orf_dna_sequence": "ATGACCACCACACCGCTCGCCCCCGTGGCCCAGGCCCGCTCGCTGCTGCAGCTGACCACCGCGTACCACCAGGCGAAGGCCCTGCACAGCGCCGTGGAGCTGGGCCTGTTCGACCTGCTCGCCGACGGGCCCGCGACCGCCGAGGAGGTGAAGGACCGGCTGCGGATCGTCCATCCGCTGGCCAAGGAGTTCCTCGACGCGCTCGTCGCGCTGGAGTTGCTGGAAGCGGACGGCGACCGCTACCGCAACTCCCCCGCCGCCCAGGCGTTCCTGGTGTCCGGCGCCTCCGAATACCTGGGCGGCACCGTCCTCCAGCACGCCCGCAAGCACTACCACGTATGGGCCGGGCTGACGACGGCGCTCCAGGAGGGCGAGGCGGGTTCCGGCGCCGAAGCGCACGGGCCCGAGGCGTACCCCAAGCACTACGAGGACCCGGAGCGGGCCCGTCAGGTCATGGCGCACTTCGACACCTTCAGCTCCTTCACGGCCGAGGAGCTGGCGCGCCGCGTCGACTGGAGCGGGTACGGGTCCTTCATCGACATCGGCGGCGCACGGGGCAACCTCGCCACGCGGGTGGCCCTGGCCCACCCGCACCTGCACGGCGCCGTGTTCGACCTGCCCGCGCTGGCCCCGCTGGCCGGCGAGCTGATCCGTGAGCGCGGCCTCGAAGGCCGCGTCCGCTTCCACGGCGGCGACTTCCTGACCGACCCGCTGCCGTCCGCGGACGCCGTGGTCACCGGGCACGTACTGCCCGACTGGCCGGTACCGCAGCGGCGCAAGCTCCTCGCGCGCATCCACGAGGCGCTGCCCTCCGGCGGCGCGCTGGTGGTCTACGACCTGATGACGGATCCGGCCACCACGACGGTGCACGACGTACTGCAACGGCTCAACCACGGCCTCATCCGCGGCGACAGCTCGTCCAGCAGCGTCGAGGAGTACCGCGCGGAGATCGAGGAGGCCGGCTTCCGGGTGCGGCAGGCGGAGCGCATCGACAACCTCCTCGGTGACTGGCTGATAGTCGCCGTCAAGCCCTGA", "orf_prot_sequence": "MTTTPLAPVAQARSLLQLTTAYHQAKALHSAVELGLFDLLADGPATAEEVKDRLRIVHPLAKEFLDALVALELLEADGDRYRNSPAAQAFLVSGASEYLGGTVLQHARKHYHVWAGLTTALQEGEAGSGAEAHGPEAYPKHYEDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDLPALAPLAGELIRERGLEGRVRFHGGDFLTDPLPSADAVVTGHVLPDWPVPQRRKLLARIHEALPSGGALVVYDLMTDPATTTVHDVLQRLNHGLIRGDSSSSSVEEYRAEIEEAGFRVRQAERIDNLLGDWLIVAVKP", "perc_identity": 40.0}, "gnl|BL_ORD_ID|274|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 21064, "orf_end": 22098, "orf_from": "BGC0000254.1|Oxytetracycline_20 ", "model_name": "chrB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "500", "model_id": "305", "ARO_accession": "3001302", "ARO_name": "chrB", "ARO_category": {"37697": {"category_aro_accession": "3001298", "category_aro_cvterm_id": "37697", "category_aro_name": "non-erm 23S ribosomal RNA methyltransferase (G748)", "category_aro_description": "Non-erm 23S ribosomal RNA methyltransferases modify guanosine 748 (E. coli numbering) to confer resistance to some macrolides and lincosamides.", "category_aro_class_name": "AMR Gene Family"}, "36284": {"category_aro_accession": "3000145", "category_aro_cvterm_id": "36284", "category_aro_name": "tylosin", "category_aro_description": "Tylosin is a 16-membered macrolide, naturally produced by Streptomyces fradiae. It interacts with the bacterial ribosome 50S subunit to inhibit protein synthesis.", "category_aro_class_name": "Antibiotic"}, "37621": {"category_aro_accession": "3001222", "category_aro_cvterm_id": "37621", "category_aro_name": "chalcomycin", "category_aro_description": "Produced by Streptomyces bikiniensis.", "category_aro_class_name": "Antibiotic"}, "37623": {"category_aro_accession": "3001224", "category_aro_cvterm_id": "37623", "category_aro_name": "mycinamicin", "category_aro_description": "Produced by Micromonospora\u00a0griseorubida.", "category_aro_class_name": "Antibiotic"}, "35919": {"category_aro_accession": "0000000", "category_aro_cvterm_id": "35919", "category_aro_name": "macrolide antibiotic", "category_aro_description": "Macrolides are a group of drugs (typically antibiotics) that have a large macrocyclic lactone ring of 12-16 carbons to which one or more deoxy sugars, usually cladinose and desosamine, may be attached. Macrolides bind to the 50S-subunit of bacterial ribosomes, inhibiting the synthesis of vital proteins.", "category_aro_class_name": "Drug Class"}, "35936": {"category_aro_accession": "0000017", "category_aro_cvterm_id": "35936", "category_aro_name": "lincosamide antibiotic", "category_aro_description": "Lincosamides (e.g. lincomycin, clindamycin) are a class of drugs which bind to the 23s portion of the 50S subunit of bacterial ribosomes. This interaction inhibits early elongation of peptide chains by inhibiting the transpeptidase reaction, acting similarly to macrolides.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 3.17116, "max_identities": 15, "bit_score": 26.5646, "cvterm_id": "39573", "query": "HFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDL", "match": "H+D       +   R  D +  G  +DIGG  G+    V  A P   G + D+", "sequence_from_db": "HYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDI", "sequence_from_broadstreet": "MLNRIVRYLACPHCGASLAQGDRALFCPAGHSFDIAKQGYVNLLPRATKLRADTKEMVEARDAFLSAGHYDPVMDALVDLARRTADPAVPGCVVDIGGGTGHYHAGVMEAFPDAQGLLLDISKYAVRRAAKAHPRIAAAVTDAWQTLPLRDAAAGMVINTFAPRNGPELHRVLHPRGVLLVVTPLPDHLREVIGALGLLQVDEGKESRLAEQLAPHFSAVATEELTRTMALDHQALAHLVGMGPNAWHRDAQRDLETIQRLPAPTRVTLSVRLSAYRLSA", "dna_sequence_from_broadstreet": "ATGCTCAACAGGATCGTGCGCTACCTCGCCTGCCCGCACTGCGGTGCTTCGCTGGCTCAGGGCGACCGCGCACTTTTCTGCCCCGCCGGACACTCCTTCGACATCGCGAAGCAGGGTTATGTGAATCTGCTTCCCAGGGCGACGAAGCTGCGGGCCGACACCAAGGAAATGGTGGAGGCCCGGGACGCATTCCTGTCGGCGGGTCACTACGACCCCGTGATGGATGCGCTGGTCGATCTGGCGCGGCGGACGGCCGATCCGGCCGTGCCCGGCTGTGTGGTCGACATCGGTGGGGGGACGGGCCACTATCACGCCGGGGTCATGGAAGCGTTCCCCGATGCCCAGGGCCTGCTGCTGGACATCTCCAAGTACGCCGTGCGGCGTGCCGCGAAGGCGCATCCGCGGATCGCGGCCGCGGTGACCGACGCCTGGCAGACGCTTCCGCTGCGGGATGCCGCAGCCGGCATGGTGATCAACACGTTCGCTCCCCGCAACGGTCCTGAACTGCATCGCGTTCTCCATCCCCGTGGCGTTCTCCTGGTTGTCACTCCTCTGCCCGATCACCTGCGGGAGGTGATCGGCGCCCTCGGCCTGCTGCAGGTGGACGAAGGCAAGGAGTCGCGTCTCGCGGAGCAGCTCGCTCCGCACTTCTCGGCCGTCGCCACGGAGGAGTTGACCCGGACCATGGCTCTCGACCACCAGGCTCTGGCGCACCTGGTCGGCATGGGGCCCAATGCCTGGCACCGTGACGCGCAGCGGGATCTGGAGACGATCCAGCGGCTGCCGGCGCCGACTCGGGTCACGCTCTCCGTGCGGCTCTCCGCCTACCGGTTGTCGGCGTAG", "partial": "0", "query_start": 21523, "query_end": 21681, "hit_start": 204, "hit_end": 363, "orf_dna_sequence": "ATGACCACCACACCGCTCGCCCCCGTGGCCCAGGCCCGCTCGCTGCTGCAGCTGACCACCGCGTACCACCAGGCGAAGGCCCTGCACAGCGCCGTGGAGCTGGGCCTGTTCGACCTGCTCGCCGACGGGCCCGCGACCGCCGAGGAGGTGAAGGACCGGCTGCGGATCGTCCATCCGCTGGCCAAGGAGTTCCTCGACGCGCTCGTCGCGCTGGAGTTGCTGGAAGCGGACGGCGACCGCTACCGCAACTCCCCCGCCGCCCAGGCGTTCCTGGTGTCCGGCGCCTCCGAATACCTGGGCGGCACCGTCCTCCAGCACGCCCGCAAGCACTACCACGTATGGGCCGGGCTGACGACGGCGCTCCAGGAGGGCGAGGCGGGTTCCGGCGCCGAAGCGCACGGGCCCGAGGCGTACCCCAAGCACTACGAGGACCCGGAGCGGGCCCGTCAGGTCATGGCGCACTTCGACACCTTCAGCTCCTTCACGGCCGAGGAGCTGGCGCGCCGCGTCGACTGGAGCGGGTACGGGTCCTTCATCGACATCGGCGGCGCACGGGGCAACCTCGCCACGCGGGTGGCCCTGGCCCACCCGCACCTGCACGGCGCCGTGTTCGACCTGCCCGCGCTGGCCCCGCTGGCCGGCGAGCTGATCCGTGAGCGCGGCCTCGAAGGCCGCGTCCGCTTCCACGGCGGCGACTTCCTGACCGACCCGCTGCCGTCCGCGGACGCCGTGGTCACCGGGCACGTACTGCCCGACTGGCCGGTACCGCAGCGGCGCAAGCTCCTCGCGCGCATCCACGAGGCGCTGCCCTCCGGCGGCGCGCTGGTGGTCTACGACCTGATGACGGATCCGGCCACCACGACGGTGCACGACGTACTGCAACGGCTCAACCACGGCCTCATCCGCGGCGACAGCTCGTCCAGCAGCGTCGAGGAGTACCGCGCGGAGATCGAGGAGGCCGGCTTCCGGGTGCGGCAGGCGGAGCGCATCGACAACCTCCTCGGTGACTGGCTGATAGTCGCCGTCAAGCCCTGA", "orf_prot_sequence": "MTTTPLAPVAQARSLLQLTTAYHQAKALHSAVELGLFDLLADGPATAEEVKDRLRIVHPLAKEFLDALVALELLEADGDRYRNSPAAQAFLVSGASEYLGGTVLQHARKHYHVWAGLTTALQEGEAGSGAEAHGPEAYPKHYEDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDLPALAPLAGELIRERGLEGRVRFHGGDFLTDPLPSADAVVTGHVLPDWPVPQRRKLLARIHEALPSGGALVVYDLMTDPATTTVHDVLQRLNHGLIRGDSSSSSVEEYRAEIEEAGFRVRQAERIDNLLGDWLIVAVKP", "perc_identity": 28.3}, "gnl|BL_ORD_ID|2873|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 21064, "orf_end": 22098, "orf_from": "BGC0000254.1|Oxytetracycline_20 ", "model_name": "CMY-143", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "700", "model_id": "3891", "ARO_accession": "3005204", "ARO_name": "CMY-143", "ARO_category": {"36208": {"category_aro_accession": "3000069", "category_aro_cvterm_id": "36208", "category_aro_name": "CMY beta-lactamase", "category_aro_description": "CMY beta-lactamases are plasmid-mediated class C beta-lactamases that encodes for resistance to cephamycins.", "category_aro_class_name": "AMR Gene Family"}, "35962": {"category_aro_accession": "0000044", "category_aro_cvterm_id": "35962", "category_aro_name": "cephamycin", "category_aro_description": "Cephamycins are a group of beta-lactam antibiotics, very similar to cephalosporins. Together with cephalosporins, they form a sub-group of antibiotics known as cephems. Cephamycins are bactericidal, and act by inhibiting the synthesis of the peptidoglycan layer of bacterial cell walls. The peptidoglycan layer is important for cell wall structural integrity, especially in Gram-positive organisms. The 7-alpha-methoxy group increases resistance to beta-lactamases.", "category_aro_class_name": "Drug Class"}, "36000": {"category_aro_accession": "0001004", "category_aro_cvterm_id": "36000", "category_aro_name": "antibiotic inactivation", "category_aro_description": "Enzymatic inactivation of antibiotic to confer drug resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 4.07663, "max_identities": 16, "bit_score": 26.1794, "cvterm_id": "35914", "query": "AKALHSAVELGLFDLLADGPA--TAEEVKDRLRIVHPL", "match": "AK L++   +GLFD LA  P+  + EE   R R++ PL", "sequence_from_db": "AKRLYANSSIGLFDALAVKPSGMSYEEAMTR-RVLQPL", "sequence_from_broadstreet": "MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFDALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPVRVEAAWRILEKLQ", "dna_sequence_from_broadstreet": "ATGATGAAAAAATCGTTATGCTGCGCTCTGCTGCTGACAGCCTCTTTCTCCACATTTGCTGCCGCAAAAACAGAACAACAGATTGCCGATATCGTTAATCGCACCATCACCCCGTTGATGCAGGAGCAGGCTATTCCGGGTATGGCCGTTGCCGTTATCTACCAGGGAAAACCCTATTATTTCACCTGGGGTAAAGCCGATATCGCCAATAACCACCCAGTCACGCAGCAAACGCTGTTTGAGCTAGGATCGGTTAGTAAGACGTTTAACGGCGTGTTGGGCGGCGATGCTATCGCCCGCGGCGAAATTAAGCTCAGCGATCCGGTCACGAAATACTGGCCAGAACTGACAGGCAAACAGTGGCAGGGTATCCGCCTGCTGCACTTAGCCACCTATACGGCAGGCGGCCTACCGCTGCAGATCCCCGATGACGTTAGGGATAAAGCCGCATTACTGCATTTTTATCAAAACTGGCAGCCGCAATGGACTCCGGGCGCTAAGCGACTTTACGCTAACTCCAGCATTGGTCTGTTTGACGCGCTGGCGGTGAAACCCTCAGGAATGAGTTACGAAGAGGCAATGACCAGACGCGTCCTGCAACCATTAAAACTGGCGCATACCTGGATTACGGTTCCGCAGAACGAACAAAAAGATTATGCCTGGGGCTATCGCGAAGGGAAGCCCGTACACGTTTCTCCGGGACAACTTGACGCCGAAGCCTATGGCGTGAAATCCAGCGTTATTGATATGGCCCGCTGGGTTCAGGCCAACATGGATGCCAGCCACGTTCAGGAGAAAACGCTCCAGCAGGGCATTGCGCTTGCGCAGTCTCGCTACTGGCGTATTGGCGATATGTACCAGGGATTAGGCTGGGAGATGCTGAACTGGCCGCTGAAAGCTGATTCGATCATCAACGGCAGCGACAGCAAAGTGGCATTGGCAGCGCTTCCCGCCGTTGAGGTAAACCCGCCCGCCCCCGCAGTGAAAGCCTCATGGGTGCATAAAACGGGCTCCACTGGTGGATTTGGCAGCTACGTAGCCTTCGTTCCAGAAAAAAACCTTGGCATCGTGATGCTGGCAAACAAAAGCTATCCTAACCCTGTCCGTGTCGAGGCGGCCTGGCGCATTCTTGAAAAGCTGCAATAA", "partial": "0", "query_start": 21136, "query_end": 21243, "hit_start": 495, "hit_end": 606, "orf_dna_sequence": "ATGACCACCACACCGCTCGCCCCCGTGGCCCAGGCCCGCTCGCTGCTGCAGCTGACCACCGCGTACCACCAGGCGAAGGCCCTGCACAGCGCCGTGGAGCTGGGCCTGTTCGACCTGCTCGCCGACGGGCCCGCGACCGCCGAGGAGGTGAAGGACCGGCTGCGGATCGTCCATCCGCTGGCCAAGGAGTTCCTCGACGCGCTCGTCGCGCTGGAGTTGCTGGAAGCGGACGGCGACCGCTACCGCAACTCCCCCGCCGCCCAGGCGTTCCTGGTGTCCGGCGCCTCCGAATACCTGGGCGGCACCGTCCTCCAGCACGCCCGCAAGCACTACCACGTATGGGCCGGGCTGACGACGGCGCTCCAGGAGGGCGAGGCGGGTTCCGGCGCCGAAGCGCACGGGCCCGAGGCGTACCCCAAGCACTACGAGGACCCGGAGCGGGCCCGTCAGGTCATGGCGCACTTCGACACCTTCAGCTCCTTCACGGCCGAGGAGCTGGCGCGCCGCGTCGACTGGAGCGGGTACGGGTCCTTCATCGACATCGGCGGCGCACGGGGCAACCTCGCCACGCGGGTGGCCCTGGCCCACCCGCACCTGCACGGCGCCGTGTTCGACCTGCCCGCGCTGGCCCCGCTGGCCGGCGAGCTGATCCGTGAGCGCGGCCTCGAAGGCCGCGTCCGCTTCCACGGCGGCGACTTCCTGACCGACCCGCTGCCGTCCGCGGACGCCGTGGTCACCGGGCACGTACTGCCCGACTGGCCGGTACCGCAGCGGCGCAAGCTCCTCGCGCGCATCCACGAGGCGCTGCCCTCCGGCGGCGCGCTGGTGGTCTACGACCTGATGACGGATCCGGCCACCACGACGGTGCACGACGTACTGCAACGGCTCAACCACGGCCTCATCCGCGGCGACAGCTCGTCCAGCAGCGTCGAGGAGTACCGCGCGGAGATCGAGGAGGCCGGCTTCCGGGTGCGGCAGGCGGAGCGCATCGACAACCTCCTCGGTGACTGGCTGATAGTCGCCGTCAAGCCCTGA", "orf_prot_sequence": "MTTTPLAPVAQARSLLQLTTAYHQAKALHSAVELGLFDLLADGPATAEEVKDRLRIVHPLAKEFLDALVALELLEADGDRYRNSPAAQAFLVSGASEYLGGTVLQHARKHYHVWAGLTTALQEGEAGSGAEAHGPEAYPKHYEDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDLPALAPLAGELIRERGLEGRVRFHGGDFLTDPLPSADAVVTGHVLPDWPVPQRRKLLARIHEALPSGGALVVYDLMTDPATTTVHDVLQRLNHGLIRGDSSSSSVEEYRAEIEEAGFRVRQAERIDNLLGDWLIVAVKP", "perc_identity": 42.11}, "gnl|BL_ORD_ID|2003|hsp_num:0": {"type_match": "Loose", "orf_strand": "+", "orf_start": 21064, "orf_end": 22098, "orf_from": "BGC0000254.1|Oxytetracycline_20 ", "model_name": "TriB", "model_type": "protein homolog model", "model_type_id": 40292, "pass_evalue": "n/a", "pass_bitscore": "600", "model_id": "2193", "ARO_accession": "3003680", "ARO_name": "TriB", "ARO_category": {"36005": {"category_aro_accession": "0010004", "category_aro_cvterm_id": "36005", "category_aro_name": "resistance-nodulation-cell division (RND) antibiotic efflux pump", "category_aro_description": "Directed pumping of antibiotic out of a cell to confer resistance. Resistance-nodulation-division (RND) proteins are found in both prokaryotic and eukaryotic cells and have diverse substrate specificities and physiological roles. However, there are relatively few RND transporters and they are secondary transporters, energized not by ATP binding/hydrolysis but by proton movement down the transmembrane electrochemical gradient.", "category_aro_class_name": "AMR Gene Family"}, "37250": {"category_aro_accession": "3000870", "category_aro_cvterm_id": "37250", "category_aro_name": "triclosan", "category_aro_description": "Triclosan is a common antibacterial agent added to many consumer products as a biocide.  It is an inhibitor of fatty acid biosynthesis by blocking enoyl-carrier protein reductase (FabI).", "category_aro_class_name": "Antibiotic"}, "43746": {"category_aro_accession": "3005386", "category_aro_cvterm_id": "43746", "category_aro_name": "disinfecting agents and antiseptics", "category_aro_description": "Disinfectants that can also interact with antimicrobial resistance mechanisms, e.g. molecule efflux, and thus are the targets of disinfectant resistance.", "category_aro_class_name": "Drug Class"}, "36298": {"category_aro_accession": "3000159", "category_aro_cvterm_id": "36298", "category_aro_name": "efflux pump complex or subunit conferring antibiotic resistance", "category_aro_description": "Efflux proteins that pump antibiotic out of a cell to confer resistance.", "category_aro_class_name": "Efflux Component"}, "36001": {"category_aro_accession": "0010000", "category_aro_cvterm_id": "36001", "category_aro_name": "antibiotic efflux", "category_aro_description": "Antibiotic resistance via the transport of antibiotics out of the cell.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 8.0004, "max_identities": 10, "bit_score": 25.409, "cvterm_id": "36804", "query": "VALAHPHLHGAVFDLP", "match": "V LA P +  AVFDLP", "sequence_from_db": "VTLARPEVREAVFDLP", "sequence_from_broadstreet": "MKPFSLAGLFGFALLLSGCGDEPPPAPPRPVLTVTVKTLKNDDLGRFAGSIQARYESVLGFRTNGRIASRLFDVGDFVGKGALLATLDPTDQQNQLRASQGDLASAEAQLIDAQANARRQEELFARSVTAQARLDDARTRLKTSQASFDQAKAAVQQARDQLSYTRLVTDFDGVITTWHAEAGQVVSAGQAVVTLARPEVREAVFDLPTEVAESLPADARFLVSAQLDPQARTTGSIRELGPQADASTRTRRVRLSLAQTPEAFRLGSTIQVQLSSAGSVRSVLPASVLLERDGKTQVWVVDGKQSSVALREVQVLSRDERQVVIGQGLADGDRVVRAGVNSLKPGQKIKLDEDAR", "dna_sequence_from_broadstreet": "ATGAAGCCGTTTTCCCTCGCCGGCCTGTTCGGCTTCGCCCTGCTCCTCTCCGGCTGCGGCGACGAGCCGCCGCCGGCACCGCCGCGGCCGGTGCTGACGGTGACCGTGAAGACCCTGAAGAACGACGACCTCGGTCGCTTCGCCGGGAGCATCCAGGCGCGCTACGAGAGCGTGCTCGGCTTCCGCACCAACGGACGGATCGCCTCGCGCCTGTTCGACGTCGGTGACTTCGTCGGCAAGGGCGCGCTGCTGGCGACCCTCGACCCCACCGACCAGCAGAACCAGTTGCGCGCCAGCCAGGGCGACCTGGCCAGCGCCGAGGCACAGTTGATCGACGCCCAGGCCAATGCCCGGCGCCAGGAAGAACTGTTCGCCCGCAGCGTCACCGCCCAGGCGCGCCTGGACGATGCGCGGACCCGCCTGAAGACCAGCCAGGCCAGCTTCGACCAGGCCAAAGCGGCGGTGCAGCAGGCCAGGGACCAGCTTTCCTACACGCGCCTGGTGACCGATTTCGACGGCGTCATCACCACCTGGCACGCCGAGGCCGGGCAAGTGGTCAGCGCCGGCCAGGCGGTGGTCACCCTGGCCCGGCCCGAAGTGCGCGAGGCAGTCTTCGACCTGCCCACCGAGGTCGCCGAGAGCCTGCCGGCCGACGCGCGCTTCCTGGTCAGCGCCCAGCTCGACCCGCAGGCCAGGACCACCGGCAGCATCCGCGAGCTGGGTCCGCAGGCCGACGCCTCGACCCGCACCCGTCGCGTGCGCCTGAGCCTGGCGCAGACGCCGGAGGCGTTTCGCCTCGGTTCGACCATCCAGGTCCAGCTGAGCAGCGCCGGTAGCGTGCGCAGCGTGCTGCCGGCCAGCGTGCTGCTGGAGCGCGACGGCAAGACCCAGGTCTGGGTCGTCGATGGGAAACAGTCCAGCGTGGCCCTGCGCGAGGTACAGGTGCTCAGCCGCGACGAACGCCAGGTGGTGATCGGACAGGGCCTGGCCGACGGCGACCGGGTGGTCCGCGCCGGAGTCAACAGCCTCAAGCCCGGCCAGAAGATCAAACTCGACGAGGATGCGCGATGA", "partial": "0", "query_start": 21637, "query_end": 21684, "hit_start": 576, "hit_end": 624, "orf_dna_sequence": "ATGACCACCACACCGCTCGCCCCCGTGGCCCAGGCCCGCTCGCTGCTGCAGCTGACCACCGCGTACCACCAGGCGAAGGCCCTGCACAGCGCCGTGGAGCTGGGCCTGTTCGACCTGCTCGCCGACGGGCCCGCGACCGCCGAGGAGGTGAAGGACCGGCTGCGGATCGTCCATCCGCTGGCCAAGGAGTTCCTCGACGCGCTCGTCGCGCTGGAGTTGCTGGAAGCGGACGGCGACCGCTACCGCAACTCCCCCGCCGCCCAGGCGTTCCTGGTGTCCGGCGCCTCCGAATACCTGGGCGGCACCGTCCTCCAGCACGCCCGCAAGCACTACCACGTATGGGCCGGGCTGACGACGGCGCTCCAGGAGGGCGAGGCGGGTTCCGGCGCCGAAGCGCACGGGCCCGAGGCGTACCCCAAGCACTACGAGGACCCGGAGCGGGCCCGTCAGGTCATGGCGCACTTCGACACCTTCAGCTCCTTCACGGCCGAGGAGCTGGCGCGCCGCGTCGACTGGAGCGGGTACGGGTCCTTCATCGACATCGGCGGCGCACGGGGCAACCTCGCCACGCGGGTGGCCCTGGCCCACCCGCACCTGCACGGCGCCGTGTTCGACCTGCCCGCGCTGGCCCCGCTGGCCGGCGAGCTGATCCGTGAGCGCGGCCTCGAAGGCCGCGTCCGCTTCCACGGCGGCGACTTCCTGACCGACCCGCTGCCGTCCGCGGACGCCGTGGTCACCGGGCACGTACTGCCCGACTGGCCGGTACCGCAGCGGCGCAAGCTCCTCGCGCGCATCCACGAGGCGCTGCCCTCCGGCGGCGCGCTGGTGGTCTACGACCTGATGACGGATCCGGCCACCACGACGGTGCACGACGTACTGCAACGGCTCAACCACGGCCTCATCCGCGGCGACAGCTCGTCCAGCAGCGTCGAGGAGTACCGCGCGGAGATCGAGGAGGCCGGCTTCCGGGTGCGGCAGGCGGAGCGCATCGACAACCTCCTCGGTGACTGGCTGATAGTCGCCGTCAAGCCCTGA", "orf_prot_sequence": "MTTTPLAPVAQARSLLQLTTAYHQAKALHSAVELGLFDLLADGPATAEEVKDRLRIVHPLAKEFLDALVALELLEADGDRYRNSPAAQAFLVSGASEYLGGTVLQHARKHYHVWAGLTTALQEGEAGSGAEAHGPEAYPKHYEDPERARQVMAHFDTFSSFTAEELARRVDWSGYGSFIDIGGARGNLATRVALAHPHLHGAVFDLPALAPLAGELIRERGLEGRVRFHGGDFLTDPLPSADAVVTGHVLPDWPVPQRRKLLARIHEALPSGGALVVYDLMTDPATTTVHDVLQRLNHGLIRGDSSSSSVEEYRAEIEEAGFRVRQAERIDNLLGDWLIVAVKP", "perc_identity": 62.5}}, "BGC0000254.1|Oxytetracycline_21 # 22257 # 23312 # 1 # ID=1_21;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.721": {"gnl|BL_ORD_ID|4807|hsp_num:0": {"type_match": "Strict", "orf_strand": "+", "orf_start": 22257, "orf_end": 23312, "orf_from": "BGC0000254.1|Oxytetracycline_21", "model_name": "Streptomyces rimosus otr(A)", "model_type": "protein homolog model", "model_type_id": 40292, "model_id": "1273", "pass_evalue": "n/a", "pass_bitscore": "275", "ARO_accession": "3002891", "ARO_name": "Streptomyces rimosus otr(A)", "ARO_category": {"35921": {"category_aro_accession": "0000002", "category_aro_cvterm_id": "35921", "category_aro_name": "tetracycline-resistant ribosomal protection protein", "category_aro_description": "A family of proteins known to bind to the 30S ribosomal subunit. This interaction prevents tetracycline and tetracycline derivatives from inhibiting ribosomal function. Thus, these proteins confer elevated resistance to tetracycline derivatives as a ribosomal protection protein.", "category_aro_class_name": "AMR Gene Family"}, "37012": {"category_aro_accession": "3000668", "category_aro_cvterm_id": "37012", "category_aro_name": "oxytetracycline", "category_aro_description": "Oxytetracycline is a derivative of tetracycline with a 5-hydroxyl group. Its activity is similar to other tetracyclines.", "category_aro_class_name": "Antibiotic"}, "36189": {"category_aro_accession": "3000050", "category_aro_cvterm_id": "36189", "category_aro_name": "tetracycline antibiotic", "category_aro_description": "These antibiotics are derived from tetracycline, a polyketide antibiotic that inhibits the 30S subunit of bacterial ribosomes.", "category_aro_class_name": "Drug Class"}, "35999": {"category_aro_accession": "0001003", "category_aro_cvterm_id": "35999", "category_aro_name": "antibiotic target protection", "category_aro_description": "Protection of antibiotic action target from antibiotic binding, which process will result in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 0.0, "bit_score": 688.723, "max_identities": 352, "cvterm_id": "36773", "query": "MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGP", "match": "MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGP", "sequence_from_db": "MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGP", "sequence_from_broadstreet": "MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV", "dna_sequence_from_broadstreet": "ATGAACAAGCTGAATCTGGGCATCCTGGCCCACGTTGACGCCGGCAAGACCAGCCTCACCGAGCGCCTGCTGCACCGCACCGGTGTGATCGACGAGGTCGGCAGCGTGGACGCCGGCACCACGACGACCGACTCGATGGAGCTGGAGCGGCAGCGCGGCATCACCATCCGGTCCGCCGTGGCCACGTTCGTCCTGGACGATCTCAAGGTCAACCTCATCGACACCCCGGGCCACTCCGACTTCATCTCCGAGGTCGAGCGGGCGCTCGGGGTGCTCGACGGCGCGGTCCTGGTGGTCTCGGCCGTCGAGGGCGTCCAGCCGCAGACCCGCATCCTGATGCGGACCCTGCGCAGGCTGGGCATTCCCACGCTGGTCTTCGTCAACAAGATCGACCGGGGCGGCGCGCGTCCCGACGGTGTGCTGCGGGAGATCCGCGACCGGCTCACCCCCGCCGCGGTGGCACTGTCCGCCGTGGCGGACGCCGGCACGCCGCGGGCCCGCGCGATCGCGCTCGGCCCGGACACCGACCCGGACTTCGCCGTCCGGGTCGGTGAGCTGCTGGCCGACCACGACGACGCGTTCCTCACCGCCTACCTGGACGAGGAACACGTACTGACCGAGAAGGAGTACGCGGAGGAACTGGCCGCGCAGACCGCGCGCGGTCTGGTGCACCCGGTGTACTTCGGGTCCGCGCTGACCGGCGAGGGCCTGGACCATCTGGTGCACGGCATCCGGGAGTTGCTGCCGTCCGTGCACGCGTCGCAGGACGCGCCGCTGCGGGCCACCGTGTTCAAGGTGGACCGTGGCGCGCGCGGCGAGGCCGTCGCGTACCTGCGGCTGGTCTCCGGCACGCTGGGCACCCGCGATTCGGTGACGCTGCACCGCGTCGACCACACCGGCCGGGTCACCGAGCACGCCGGACGCATCACCGCGCTGCGGGTCTTCGAGCACGGGTCGGCCACCAGCGAGACCCGGGCGACCGCCGGGGACATCGCGCAGGCGTGGGGCCTGAAGGACGTACGGGTCGGTGACCGGGCCGGGCACCTCGACGGTCCCCCGCCGCGCAACTTCTTCGCGCCGCCCAGCCTGGAGACCGTGATCAGGCCGGAGCGCCCGGAGGAAGCGGGACGGCTGCACGCCGCGCTGCGCATGCTGGACGAGCAGGACCCCTCGATCGACCTGCGGCAGGACGAGGAGAACGCGGCCGGCGCGGTGGTCCGCCTCTACGGGGAGGTGCAGAAGGAGATCCTCGGCAGCACGCTCGCGGAGTCCTTCGGCGTACGGGTGCGCTTCGACCCGACCCGTACGGTCTGCATCGAAAAGCCCGTGGGGACCGGCGAGGCGCTGATCGAGCTGGACACGCGGACGCACAACTACTTCTGGGGCGCACCGTGGGTCTGCGCGTCGGACCGGCCGAGCCCGGCGCGGGCGATCACGTTCCGTTTGGCGGTGGAACTGGGCTCGCTCCCCCTGGCCTTCCACAAGGCCATCGAGGAGACGGTGCACACCACCCTGCGGCACGGTCTGTACGGCTGGCAGGTCACCGACTGCGCCGTCACCCTGACCCGTACCGGCGTTCGCAGTCCGGTCAGCGCGGCCGACGACTTCCGCAAGGCCAACGCGCGCTTGGTCCTGATGGACGCGCTCGGCAGGGCCGGTACGGAGGTGCACGAGCCGGTCAGCTCCTTCGAACTGGAGGTGCCCGCCGCCCGGCTCAGCCCGGTACTTGCGAAACTCGCGGAACTGGGCGCGACGCCCGGTGTGCCCACGGCCGAGGGGGACGTCTTCCGCCTGGAGGGCACGATGCCGACCAGCCTCGTGCACGACTTCAACCAGCGGGTTCCCGGACTGACCCAGGGCGAGGGCGTGTTCCTGGCCGAGCACCGGGGCTACCGGCCCGCCGTCGGACAGCCGCCCGTGCGGCCGCGGCCCGAGGGGCCCAACCCGCTCAACCGCGACGAGTACATCCTGCACGTGCTCAAGCGCGTGTGA", "partial": "0", "query_start": 22257, "query_end": 23312, "hit_start": 0, "hit_end": 1056, "orf_dna_sequence": "ATGAACAAGCTGAATCTGGGCATCCTGGCCCACGTTGACGCCGGCAAGACCAGCCTCACCGAGCGCCTGCTGCACCGCACCGGTGTGATCGACGAGGTCGGCAGCGTGGACGCCGGCACCACGACGACCGACTCGATGGAGCTGGAGCGGCAGCGCGGCATCACCATCCGGTCCGCCGTGGCCACGTTCGTCCTGGACGATCTCAAGGTCAACCTCATCGACACCCCGGGCCACTCCGACTTCATCTCCGAGGTCGAGCGGGCGCTCGGGGTGCTCGACGGCGCGGTCCTGGTGGTCTCGGCCGTCGAGGGCGTCCAGCCGCAGACCCGCATCCTGATGCGGACCCTGCGCAGGCTGGGCATTCCCACGCTGGTCTTCGTCAACAAGATCGACCGGGGCGGCGCGCGTCCCGACGGTGTGCTGCGGGAGATCCGCGACCGGCTCACCCCCGCCGCGGTGGCACTGTCCGCCGTGGCGGACGCCGGCACGCCGCGGGCCCGCGCGATCGCGCTCGGCCCGGACACCGACCCGGACTTCGCCGTCCGGGTCGGTGAGCTGCTGGCCGACCACGACGACGCGTTCCTCACCGCCTACCTGGACGAGGAACACGTACTGACCGAGAAGGAGTACGCGGAGGAACTGGCCGCGCAGACCGCGCGCGGTCTGGTGCACCCGGTGTACTTCGGGTCCGCGCTGACCGGCGAGGGCCTGGACCATCTGGTGCACGGCATCCGGGAGTTGCTGCCGTCCGTGCACGCGTCGCAGGACGCGCCGCTGCGGGCCACCGTGTTCAAGGTGGACCGTGGCGCGCGCGGCGAGGCCGTCGCGTACCTGCGGCTGGTCTCCGGCACGCTGGGCACCCGCGATTCGGTGACGCTGCACCGCGTCGACCACACCGGCCGGGTCACCGAGCACGCCGGACGCATCACCGCGCTGCGGGTCTTCGAGCACGGGTCGGCCACCAGCGAGACCCGGGCGACCGCCGGGGACATCGCGCAGGCGTGGGGCCTGAAGGACGTACGGGTCGGTGACCGGGCCGGGCACCTCGACGGTCCC", "orf_prot_sequence": "MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGP", "perc_identity": 100.0, "orf_start_possible": 21324, "orf_end_possible": 23313}, "gnl|BL_ORD_ID|1969|hsp_num:0": {"type_match": "Loose", "snp": {"original": "Q", "change": "R", "position": 125}, "query_snp": {"original": "Q", "change": "R", "position": 113}, "orf_strand": "+", "orf_start": 22257, "orf_end": 23312, "orf_from": "BGC0000254.1|Oxytetracycline_21 ", "model_name": "Escherichia coli EF-Tu mutants conferring resistance to kirromycin", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 700, "model_id": "2137", "ARO_accession": "3003368", "ARO_name": "Escherichia coli EF-Tu mutants conferring resistance to kirromycin", "ARO_category": {"37711": {"category_aro_accession": "3001312", "category_aro_cvterm_id": "37711", "category_aro_name": "elfamycin resistant EF-Tu", "category_aro_description": "Sequence variants of elongation factor Tu that confer resistance to elfamycin antibiotics.", "category_aro_class_name": "AMR Gene Family"}, "37633": {"category_aro_accession": "3001234", "category_aro_cvterm_id": "37633", "category_aro_name": "kirromycin", "category_aro_description": "Kirromycin, also known as mocimycin, is the representative molecule of its own class of elfamycins which is composed of more than 10 analogs. Kirromycin binds to the domain 1,2 interface of elongation factor Tu. This interaction maintains the EF-Tu*GTP conformation even after GTP is hydrolyzed to GDP. EF-Tu*GDP normally releases aa-tRNA and then exits the ribosome; however, kirromycin*EF-Tu*GDP*aa-tRNA forms a strong complex and remains bound to the ribosome, prohibits translocation of the peptide chain and translation is halted.", "category_aro_class_name": "Antibiotic"}, "37618": {"category_aro_accession": "3001219", "category_aro_cvterm_id": "37618", "category_aro_name": "elfamycin antibiotic", "category_aro_description": "Elfamycins are molecules that inhibit bacterial elongation factor Tu (EF-Tu), a key protein which brings aminoacyl-tRNA (aa-tRNA) to the ribosome during protein synthesis. Elfamycins defined by their target (EF-Tu), rather than a conserved chemical backbone. Elfamycins follow two mechanisms to disrupt protein synthesis: 1. kirromycins and enacyloxin fix EF-Tu in the GTP bound conformation and lock EF-Tu onto the ribosome, and 2. pulvomycin and GE2270 cover the binding site of aa-tRNA disallowing EF-Tu from being charged with aa-tRNA. All elfamycins cause increased the affinity of EF-Tu for GTP.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 2.46117e-15, "bit_score": 73.559, "max_identities": 44, "cvterm_id": "35914", "query": "LNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIP-TLVFVNKID", "match": "+N+G + HVD GKT+LT  +   T +    G         D+   E+ RGITI ++   +         +D PGH+D++  +      +DGA+LVV+A +G  PQTR  +   R++G+P  +VF+NK D", "sequence_from_db": "VNVGTIGHVDHGKTTLTAAIT--TVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCD", "sequence_from_broadstreet": "MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGAARAFDQIDNAPEEKARGITINTSHVEYDTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQVLAKPGTIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG", "dna_sequence_from_broadstreet": "GTGTCTAAAGAAAAATTTGAACGTACAAAACCGCACGTTAACGTTGGTACTATCGGCCACGTTGACCACGGTAAAACTACTCTGACCGCTGCAATCACCACCGTACTGGCTAAAACCTACGGCGGTGCTGCTCGTGCATTCGACCAGATCGATAACGCGCCGGAAGAAAAAGCTCGTGGTATCACCATCAACACTTCTCACGTTGAATACGACACCCCGACCCGTCACTACGCACACGTAGACTGCCCGGGGCACGCCGACTATGTTAAAAACATGATCACCGGTGCTGCTCAGATGGACGGCGCGATCCTGGTAGTTGCTGCGACTGACGGCCCGATGCCGCAGACTCGTGAGCACATCCTGCTGGGTCGTCAGGTAGGCGTTCCGTACATCATCGTGTTCCTGAACAAATGCGACATGGTTGATGACGAAGAGCTGCTGGAACTGGTTGAAATGGAAGTTCGTGAACTTCTGTCTCAGTACGACTTCCCGGGCGACGACACTCCGATCGTTCGTGGTTCTGCTCTGAAAGCGCTGGAAGGCGACGCAGAGTGGGAAGCGAAAATCCTGGAACTGGCTGGCTTCCTGGATTCTTATATTCCGGAACCAGAGCGTGCGATTGACAAGCCGTTCCTGCTGCCGATCGAAGACGTATTCTCCATCTCCGGTCGTGGTACCGTTGTTACCGGTCGTGTAGAACGCGGTATCATCAAAGTTGGTGAAGAAGTTGAAATCGTTGGTATCAAAGAGACTCAGAAGTCTACCTGTACTGGCGTTGAAATGTTCCGCAAACTGCTGGACGAAGGCCGTGCTGGTGAGAACGTAGGTGTTCTGCTGCGTGGTATCAAACGTGAAGAAATCGAACGTGGTCAGGTACTGGCTAAGCCGGGCACCATCAAGCCGCACACCAAGTTCGAATCTGAAGTGTACATTCTGTCCAAAGATGAAGGCGGCCGTCATACTCCGTTCTTCAAAGGCTACCGTCCGCAGTTCTACTTCCGTACTACTGACGTGACTGGTACCATCGAACTGCCGGAAGGCGTAGAGATGGTAATGCCGGGCGACAACATCAAAATGGTTGTTACCCTGATCCACCCGATCGCGATGGACGACGGTCTGCGTTTCGCAATCCGTGAAGGCGGCCGTACCGTTGGCGCGGGCGTTGTTGCTAAAGTTCTGGGCTAA", "partial": "0", "query_start": 22266, "query_end": 22649, "hit_start": 36, "hit_end": 417, "orf_dna_sequence": "ATGAACAAGCTGAATCTGGGCATCCTGGCCCACGTTGACGCCGGCAAGACCAGCCTCACCGAGCGCCTGCTGCACCGCACCGGTGTGATCGACGAGGTCGGCAGCGTGGACGCCGGCACCACGACGACCGACTCGATGGAGCTGGAGCGGCAGCGCGGCATCACCATCCGGTCCGCCGTGGCCACGTTCGTCCTGGACGATCTCAAGGTCAACCTCATCGACACCCCGGGCCACTCCGACTTCATCTCCGAGGTCGAGCGGGCGCTCGGGGTGCTCGACGGCGCGGTCCTGGTGGTCTCGGCCGTCGAGGGCGTCCAGCCGCAGACCCGCATCCTGATGCGGACCCTGCGCAGGCTGGGCATTCCCACGCTGGTCTTCGTCAACAAGATCGACCGGGGCGGCGCGCGTCCCGACGGTGTGCTGCGGGAGATCCGCGACCGGCTCACCCCCGCCGCGGTGGCACTGTCCGCCGTGGCGGACGCCGGCACGCCGCGGGCCCGCGCGATCGCGCTCGGCCCGGACACCGACCCGGACTTCGCCGTCCGGGTCGGTGAGCTGCTGGCCGACCACGACGACGCGTTCCTCACCGCCTACCTGGACGAGGAACACGTACTGACCGAGAAGGAGTACGCGGAGGAACTGGCCGCGCAGACCGCGCGCGGTCTGGTGCACCCGGTGTACTTCGGGTCCGCGCTGACCGGCGAGGGCCTGGACCATCTGGTGCACGGCATCCGGGAGTTGCTGCCGTCCGTGCACGCGTCGCAGGACGCGCCGCTGCGGGCCACCGTGTTCAAGGTGGACCGTGGCGCGCGCGGCGAGGCCGTCGCGTACCTGCGGCTGGTCTCCGGCACGCTGGGCACCCGCGATTCGGTGACGCTGCACCGCGTCGACCACACCGGCCGGGTCACCGAGCACGCCGGACGCATCACCGCGCTGCGGGTCTTCGAGCACGGGTCGGCCACCAGCGAGACCCGGGCGACCGCCGGGGACATCGCGCAGGCGTGGGGCCTGAAGGACGTACGGGTCGGTGACCGGGCCGGGCACCTCGACGGTCCC", "orf_prot_sequence": "MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGP", "perc_identity": 34.11}}, "BGC0000254.1|Oxytetracycline_2 # 860 # 2047 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722": {"gnl|BL_ORD_ID|1968|hsp_num:0": {"type_match": "Loose", "snp": {"original": "F", "change": "L", "position": 413}, "query_snp": {"original": "F", "change": "L", "position": 318}, "orf_strand": "+", "orf_start": 860, "orf_end": 2047, "orf_from": "BGC0000254.1|Oxytetracycline_2 ", "model_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "model_type": "protein variant model", "model_type_id": 40293, "pass_evalue": "n/a", "pass_bitscore": 750, "model_id": "1943", "ARO_accession": "3003463", "ARO_name": "Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid", "ARO_category": {"40055": {"category_aro_accession": "3003462", "category_aro_cvterm_id": "40055", "category_aro_name": "antibiotic resistant kasA", "category_aro_description": "kasA is a  ketoacyl acyl carrier protein synthase that catalyzes the condensation reaction of fatty acid synthesis by the addition to an acyl acceptor of two carbons from malonyl-ACP. It is involved in elongation of fatty acids intermediate in the biosynthetic pathway of mycolic acids.", "category_aro_class_name": "AMR Gene Family"}, "36659": {"category_aro_accession": "3000520", "category_aro_cvterm_id": "36659", "category_aro_name": "isoniazid", "category_aro_description": "Isoniazid is an organic compound that is the first-line anti tuberculosis medication in prevention and treatment. As a prodrug, it is activated by mycobacterial catalase-peroxidases such as M. tuberculosis KatG. Isoniazid inhibits mycolic acid synthesis, which prevents cell wall synthesis in mycobacteria.", "category_aro_class_name": "Antibiotic"}, "45734": {"category_aro_accession": "3007152", "category_aro_cvterm_id": "45734", "category_aro_name": "isoniazid-like antibiotic", "category_aro_description": "A group of antibiotics containing isoniazid and its derivatives.", "category_aro_class_name": "Drug Class"}, "35997": {"category_aro_accession": "0001001", "category_aro_cvterm_id": "35997", "category_aro_name": "antibiotic target alteration", "category_aro_description": "Mutational alteration or enzymatic modification of antibiotic target which results in antibiotic resistance.", "category_aro_class_name": "Resistance Mechanism"}}, "evalue": 1.5788e-52, "bit_score": 177.948, "max_identities": 116, "cvterm_id": "39507", "query": "LADSGVTGEADPLRTGVMAGTACGMTMSLDREYAVVSDEGRLWQVDDAHGVPYLYDYFVPSSMAAEIAWLAEAEGPAGVVS--AGCTSGIDVLTHAADLVRDGAAEVMVAGASDAAISPITVACFDAIKATTPRNDEPETASRPFDRTRNGFVLGEGAAFFVLEEYAHARRRGARAYAEIAGYAGRCNAYSMTGLRSDGRELAEAVSRALDIARVDPSEVDYVNAHGSATKQNDLHETAAFKRSLGPHAYSVPISSIKSMIGHSLGAICALEVAASALRIEHGVIPPTANLREPDPDCDLDYVPLVAREAEVSTVVSVASGFGGFQSAIVL", "match": "L +S  + E DP R  V+ GT  G    +   Y ++ + G   +V      P      +P+  AA I     A   AGV++  + C+SG + + HA   +  G A+V V G  +  I  + +A F  ++A + RNDEPE ASRPFD+ R+GFV GE  A  ++E   HA+ RGA+  A + G     +A+ M    +DG     A++R+L++A + P+++D+VNAHG+AT   D  E  A + +    A    + + KS +GHS+GA+ ALE   + L +  GVIPPT N   PDP+ DLD V    R  +    V+ + GFGG   A+  ", "sequence_from_db": "LWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLM-NAGGPRKVS-----PLAVQMIMPNGAAAVIGLQLGAR--AGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAA---VYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAF", "sequence_from_broadstreet": "MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY", "dna_sequence_from_broadstreet": "GTGAGTCAGCCTTCCACCGCTAATGGCGGTTTCCCCAGCGTTGTGGTGACCGCCGTCACAGCGACGACGTCGATCTCGCCGGACATCGAGAGCACGTGGAAGGGTCTGTTGGCCGGCGAGAGCGGCATCCACGCACTCGAAGACGAGTTCGTCACCAAGTGGGATCTAGCGGTCAAGATCGGCGGTCACCTCAAGGATCCGGTCGACAGCCACATGGGCCGACTCGACATGCGACGCATGTCGTACGTCCAGCGGATGGGCAAGTTGCTGGGCGGACAGCTATGGGAGTCCGCCGGCAGCCCGGAGGTCGATCCAGACCGGTTCGCCGTTGTTGTCGGCACCGGTCTAGGTGGAGCCGAGAGGATTGTCGAGAGCTACGACCTGATGAATGCGGGCGGCCCCCGGAAGGTGTCCCCGCTGGCCGTTCAGATGATCATGCCCAACGGTGCCGCGGCGGTGATCGGTCTGCAGCTTGGGGCCCGCGCCGGGGTGATGACCCCGGTGTCGGCCTGTTCGTCGGGCTCGGAAGCGATCGCCCACGCGTGGCGTCAGATCGTGATGGGCGACGCCGACGTCGCCGTCTGCGGCGGTGTCGAAGGACCCATCGAGGCGCTGCCCATCGCGGCGTTCTCCATGATGCGGGCCATGTCGACCCGCAACGACGAGCCTGAGCGGGCCTCCCGGCCGTTCGACAAGGACCGCGACGGCTTTGTGTTCGGCGAGGCCGGTGCGCTGATGCTCATCGAGACGGAGGAGCACGCCAAAGCCCGTGGCGCCAAGCCGTTGGCCCGATTGCTGGGTGCCGGTATCACCTCGGACGCCTTTCATATGGTGGCGCCCGCGGCCGATGGTGTTCGTGCCGGTAGGGCGATGACTCGCTCGCTGGAGCTGGCCGGGTTGTCGCCGGCGGACATCGACCACGTCAACGCGCACGGCACGGCGACGCCTATCGGCGACGCCGCGGAGGCCAACGCCATCCGCGTCGCCGGTTGTGATCAGGCCGCGGTGTACGCGCCGAAGTCTGCGCTGGGCCACTCGATCGGCGCGGTCGGTGCGCTCGAGTCGGTGCTCACGGTGCTGACGCTGCGCGACGGCGTCATCCCGCCGACCCTGAACTACGAGACACCCGATCCCGAGATCGACCTTGACGTCGTCGCCGGCGAACCGCGCTATGGCGATTACCGCTACGCAGTCAACAACTCGTTCGGGTTCGGCGGCCACAATGTGGCGCTTGCCTTCGGGCGTTACTGA", "partial": "0", "query_start": 1037, "query_end": 2023, "hit_start": 279, "hit_end": 1239, "orf_dna_sequence": "ATGCTCACCGCGGGCCGTACCGCCACCCGCCCGATCTCGTCCTTCGACGCCTCGCCCTTCCGCTCCCAGGTGGCGGCGGAGTGCGACTTCGACCCGGCGGCGGAGGGGCTGAGCCAGCGGCAGGTCCGCGCCTGGGACCGCACCATGCAGTTCGCTTACGTGGCCGCGCGGGAGGCGCTGGCGGACAGCGGTGTGACGGGCGAGGCGGACCCGCTGCGCACCGGCGTCATGGCCGGCACCGCCTGCGGCATGACGATGAGCCTGGACCGCGAGTACGCGGTGGTCAGCGACGAGGGCCGGCTGTGGCAGGTGGACGACGCCCATGGGGTGCCGTACCTCTACGACTACTTCGTGCCCTCGTCGATGGCGGCCGAGATCGCCTGGCTGGCGGAGGCGGAGGGCCCGGCCGGGGTGGTCTCGGCCGGCTGCACCTCCGGCATCGACGTGCTCACCCACGCGGCGGACCTGGTACGCGACGGCGCGGCCGAGGTGATGGTGGCCGGGGCATCGGACGCCGCCATCTCCCCCATCACGGTGGCGTGCTTCGACGCGATCAAGGCCACCACGCCGCGCAACGACGAGCCGGAGACGGCGTCCCGTCCGTTCGACCGCACCCGCAACGGCTTCGTGCTGGGCGAGGGGGCGGCGTTCTTCGTCCTGGAGGAGTACGCGCACGCCAGGCGGCGGGGGGCCCGCGCGTACGCGGAGATCGCCGGGTACGCCGGGCGGTGCAACGCGTACAGCATGACCGGGCTGCGCTCGGACGGGCGGGAGCTGGCCGAGGCGGTGAGCCGCGCGCTCGACATCGCGCGCGTCGATCCGTCGGAGGTGGACTACGTCAACGCCCACGGTTCGGCGACCAAGCAGAACGATCTCCATGAGACGGCGGCGTTCAAGCGGAGCCTGGGTCCGCACGCCTACTCGGTCCCGATCAGCTCCATCAAATCGATGATCGGCCACTCGCTCGGTGCCATCTGCGCGCTGGAGGTCGCGGCGAGCGCGCTGAGGATCGAGCACGGGGTGATCCCACCCACCGCGAACCTGCGGGAGCCGGACCCCGACTGCGACCTGGACTATGTGCCGCTGGTCGCCAGGGAGGCCGAGGTGTCCACCGTGGTGTCCGTGGCCAGCGGATTCGGCGGCTTCCAGAGCGCGATCGTGCTCACCGAGCCGGGGAGGCAGCGATGA", "orf_prot_sequence": "MLTAGRTATRPISSFDASPFRSQVAAECDFDPAAEGLSQRQVRAWDRTMQFAYVAAREALADSGVTGEADPLRTGVMAGTACGMTMSLDREYAVVSDEGRLWQVDDAHGVPYLYDYFVPSSMAAEIAWLAEAEGPAGVVSAGCTSGIDVLTHAADLVRDGAAEVMVAGASDAAISPITVACFDAIKATTPRNDEPETASRPFDRTRNGFVLGEGAAFFVLEEYAHARRRGARAYAEIAGYAGRCNAYSMTGLRSDGRELAEAVSRALDIARVDPSEVDYVNAHGSATKQNDLHETAAFKRSLGPHAYSVPISSIKSMIGHSLGAICALEVAASALRIEHGVIPPTANLREPDPDCDLDYVPLVAREAEVSTVVSVASGFGGFQSAIVLTEPGRQR", "perc_identity": 35.05}}}